
<html lang="en"     class="pb-page"  data-request-id="c9ed7283-0411-4c39-8f08-9b9a554a5ce7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b01808;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Applications of Deuterium in Medicinal Chemistry" /></meta><meta name="dc.Creator" content="Tracey  Pirali" /></meta><meta name="dc.Creator" content="Marta  Serafini" /></meta><meta name="dc.Creator" content="Sarah  Cargnin" /></meta><meta name="dc.Creator" content="Armando A.  Genazzani" /></meta><meta name="dc.Description" content="The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simp..." /></meta><meta name="Description" content="The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simp..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 14, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01808" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01808" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01808" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01808" /></link>
        
    
    

<title>Applications of Deuterium in Medicinal Chemistry | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01808" /></meta><meta property="og:title" content="Applications of Deuterium in Medicinal Chemistry" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0025.jpeg" /></meta><meta property="og:description" content="The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions, and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of coadministered boosters, and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing, and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This Perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01808"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01808">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01808&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01808&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01808&amp;href=/doi/10.1021/acs.jmedchem.8b01808" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5276-5297</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01698" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b00058" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Applications of Deuterium in Medicinal Chemistry</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Tracey Pirali</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tracey Pirali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 0039-0321-375852. Fax: 0039-0321-375821. E-mail: <a href="/cdn-cgi/l/email-protection#c6b2b4a7a5a3bfe8b6afb4a7aaaf86b3a8afb3b6a9e8afb2"><span class="__cf_email__" data-cfemail="e397918280869acd938a91828f8aa3968d8a96938ccd8a97">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tracey++Pirali">Tracey Pirali</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3936-4787" title="Orcid link">http://orcid.org/0000-0003-3936-4787</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Serafini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Serafini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Serafini">Marta Serafini</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah Cargnin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah Cargnin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Cargnin">Sarah Cargnin</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Armando A. Genazzani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Armando A. Genazzani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Armando+A.++Genazzani">Armando A. Genazzani</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1923-7430" title="Orcid link">http://orcid.org/0000-0003-1923-7430</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01808&amp;href=/doi/10.1021%2Facs.jmedchem.8b01808" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5276–5297</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 14, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 November 2018</li><li><span class="item_label"><b>Published</b> online</span>14 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01808" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01808</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5276%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTracey%2BPirali%252C%2BMarta%2BSerafini%252C%2BSarah%2BCargnin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D11%26contentID%3Dacs.jmedchem.8b01808%26title%3DApplications%2Bof%2BDeuterium%2Bin%2BMedicinal%2BChemistry%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5297%26publicationDate%3DJune%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01808"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">10969</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">113</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01808" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Applications of Deuterium in Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tracey&quot;,&quot;last_name&quot;:&quot;Pirali&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Serafini&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Cargnin&quot;},{&quot;first_name&quot;:&quot;Armando&quot;,&quot;last_name&quot;:&quot;A. Genazzani&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5276-5297&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01808&quot;},&quot;abstract&quot;:&quot;The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions, and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of coadministered boosters, and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing, and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This Perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01808&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01808" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01808&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01808" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01808&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01808" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01808&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01808&amp;href=/doi/10.1021/acs.jmedchem.8b01808" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01808" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01808" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01808%26sid%3Dliteratum%253Aachs%26pmid%3D30640460%26genre%3Darticle%26aulast%3DPirali%26date%3D2019%26atitle%3DApplications%2Bof%2BDeuterium%2Bin%2BMedicinal%2BChemistry%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D11%26spage%3D5276%26epage%3D5297%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292130" title="Hydrogen isotopes">Hydrogen isotopes</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/jmcmar.2019.62.issue-11/20190613/jmcmar.2019.62.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions, and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of coadministered boosters, and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing, and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This Perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Deuterium is a rare, stable, nonradioactive isotope of hydrogen, which differs from protium by a single neutron. It is produced in high amounts in stars and can be found on Earth with a natural abundance of 0.0156% of all the naturally occurring hydrogen in the oceans.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Deuterium was first described by Harold Urey in 1932,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> the same scientist that in the 1950s came up with the landmark Miller–Urey experiment,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> demonstrating that spark discharge through a simulated reducing atmosphere yields amino acids from a primordial inorganic soup. In 2017, Cooper et al. capitalized on Urey’s discoveries<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and compared the products of a “deuterated world”, containing fully deuterated starting materials, with the standard “hydrogenated world”. Remarkably, the authors observed the production of unique species in the deuterated soup, confirming that the presence of this isotope in the natural world leads to additional complexity in the chemical space. Its incorporation in place of protium has been exploited in many different disciplines in life sciences, including proteomics, metabolomics, and diagnostics.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">This Perspective aims at providing a snapshot of the potential of deuterium in medicinal chemistry. We have mainly limited our efforts to peer-reviewed papers in order to base our reporting on unbiased results, although we acknowledge that, given the industrial interest in the field, the patent literature and other online resources (such as poster abstracts and company Web sites) also provide additional clues on the applications of deuterated compounds. These resources, though, present biases, and we have therefore used them sparingly. We have concentrated, where possible, on recent examples, and we refer the reader to other excellent papers<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and book chapters<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> that had reviewed earlier work.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> How Does Deuterium Differ from Protium from a Medicinal Chemistry Viewpoint?</h3><div class="NLM_p">Compared to protium (that at times we will refer to as hydrogen, H), deuterium (D) displays a smaller molar volume (by 0.140 cm<sup>3</sup>/mol per atom), is less lipophilic (Δlog <i>P</i><sub>oct</sub> = −0.006), and might display a slightly different p<i>K</i><sub>a</sub>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> More importantly, C–D bonds are shorter (by 0.005 Å) and at times more stable to oxidative processes. Indeed, D has a 2-fold higher mass than H, leading to a reduced vibrational stretching frequency of the C–D bond compared to the C–H bond and, therefore, a lower ground-state energy. It follows that the activation energy required for reaching the transition state for bond cleavage is greater for C–D than C–H and the reaction rate (represented by rate constant <i>k</i>) is slower (<i>k</i><sub>H</sub> > <i>k</i><sub>D</sub>).</div><div class="NLM_p">The difference in stability of isotopically substituted molecules is referred to as the primary kinetic isotopic effect (KIE),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> which for deuterium can be defined as the deuterium kinetic isotope effect (DKIE). DKIE is quantified as the ratio of the rate constants for the reaction (<i>k</i><sub>H</sub>/<i>k</i><sub>D</sub>) and typically ranges from 1 (for reactions where deuterium has no effect) to 7, with the theoretical limit being 9,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> even though DKIEs lower than 1 <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> or up to 16 <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> have been reported. Obviously, given that enzyme-catalyzed transformations are multistep, to observe high DKIEs, it is necessary that the C–H cleavage step is at least partially rate-limiting.</div><div class="NLM_p">It must be acknowledged that in other kinetic models the quantum-mechanical tunneling is invoked to explain a secondary DKIE.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> While this is usually much smaller in magnitude than the primary effect (typically 1.1–1.2), this mechanism can lead to significantly larger effects.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">Despite the above differences, the substitution of protium with deuterium represents the most conservative example of isosteric replacement.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Indeed, deuterium keeps 3D surface, shape, and steric flexibility unaltered compared to protium. It follows that deuterium-modified compounds usually retain biochemical potency and selectivity. Even when differences are reported, they are usually minor (although not necessarily irrelevant) as in the case of <i>d</i><sub>5</sub>-sildenafil,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> which has been reported to be 2- to 3-fold more selective than the parent compound for phosphodiesterase V versus II and VI. In the present manuscuript, we will use the term parent to indicate the nondeuterated compound.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Historical Timeline of Deuterated Compounds in the Medicinal Chemistry Field</h3><div class="NLM_p">The very first examples of deuterium incorporation in bioactive compounds date back to the 1960s, when two independent groups reported a decreased metabolism for <i>d</i><sub>2</sub>-tyramine<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and <i>d</i><sub>3</sub>-morphine<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> compared to the parent compounds. In the following decade, deuterium substitution was exploited with the aim to lower oxidative clearance of halothane<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and fludalanine,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with a consequent decrease in liver and central nervous system toxicity, respectively.</div><div class="NLM_p">For many years thereafter, deuterated compounds have been used as internal standards for bioanalytical methods,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> a current and important medicinal chemistry application that will not be covered by this review.</div><div class="NLM_p">Deuteration in drug design did not attract significant interest until the first decade of the new millennium, when several companies that presented deuterated compounds as their core business rose to the attention of the scientific and investment community (e.g., Concert Pharmaceuticals, Deuteria Pharmaceuticals, DeuteRx, Protia, Auspex, Retrotope). Acquisitions or licensing deals exceeding 7 billion dollars have been reported since 2014, demonstrating the attractiveness of the field.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">In April 2017, deutetrabenazine (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was approved by the FDA for the treatment of choreas associated with Huntington’s disease and for tardive dyskinesias,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> the same indications of the parent drug, tetrabenazine, which is also on the market. This represented a milestone per se for the field and gave courage to the industrial world as deutetrabenazine was allowed to submit as a new chemical entity (providing exclusivity advantages to the manufacturer). Moreover, deutetrabenazine was approved via a hybrid regulatory pathway (505(b)(2)) that allowed the applicant to rely in part on data from the parent compound. Approval of deutetrabenazine relied on a placebo-controlled trial, and it is therefore difficult to ascertain its added clinical value compared to tetrabenazine, although it presents a reduced number of daily administrations. It has been suggested that tolerability of the deuterated form is improved over the parent compound,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> although others have pointed out that indirect comparisons are unreliable and dependent on the statistical strategy used<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and that only head-to-head trials would answer the question on the real added value of the new compound. It should be noticed that at least another deuterated-compound-containing-medicine (<i>d</i><sub>6</sub>-dextromethorphan/quinidine) has received fast track designation by the FDA, but the medicine has not yet reached regulatory approval.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of deutetrabenazine, BMS-986165, VX-984, and CTP-354.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both examples above represent putative improvements of medicines already on the market, in a manner that is referred to as deuterium switch. Yet deuterium has also been incorporated in the early stages of the drug discovery process, giving rise to deuterated bioactive compounds that do not have counterparts on the market. This is exemplified by two molecules that have reached clinical trials, BMS-986165 and VX-984 (<b>2</b> and <b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The former is a potent (<i>K</i><sub>i</sub> of 0.02 nM) and selective (as determined against other 265 kinases and pseudokinases) inhibitor of tyrosine kinase 2 (Tyk2) and has shown its efficacy in a number of preclinical models.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Encouraging data in a placebo-controlled clinical trial on psoriasis have recently been published.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> VX-984 is a selective DNA-dependent protein kinase (DNA-PK) inhibitor<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and has completed a phase I trial for the treatment of recurrent or metastatic endometrial cancer.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> It is interesting to note that in the very recent paper in the <i>New England Journal of Medicine</i> reporting the clinical efficacy of BMS-986165 there is no mention about its deuterated nature,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> suggesting that this modification is now considered common practice in drug development.</div><div class="NLM_p last">A further use of deuteration that is emerging is the salvaging of compounds that had shown weaknesses in their nondeuterated form. For example, the GABA-<sub>A</sub> modulator L-838417 did not advance to the clinical stage due to its poor pharmacokinetic profile.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Its <i>d</i><sub>9</sub>-deuterated analogue, CTP-354 (<b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), was shown to have comparable binding affinity, subunit specificity, and pharmacological activity, displaying such improved pharmacokinetics in rodents that a phase I clinical trial was initiated.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> CTP-354 represents therefore an example where deuteration is used to rescue a drug.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> This is of extreme interest as it suggests that deuterium might allow revitalization of abandoned drug programs.</div></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Deuteration and Drug Metabolism</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The most straightforward application of deuterium substitution is to slow down drug metabolism, especially cytochrome P450 (CYP450)-mediated transformations.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Among the myriad of reactions catalyzed by this superfamily, high DKIEs are usually displayed by dealkylations of ethers and amides (>2), while amine N-dealkylation is less affected (<2), even if the rationale for this is still a subject of debate. Regarding the oxidation of alkyl groups, the magnitude of DKIE heavily depends on the rate-limiting step in a particular reaction. Last, DKIE is close to 1 for those reactions, such as aryl hydroxylations, epoxidations, and heteroatom oxygenations, in which no C–H bond is broken during enzyme catalysis, and therefore a precision deuteration can rely only on a secondary kinetic isotope effect.<a onclick="showRef(event, 'cit33b cit33c'); return false;" href="javascript:void(0);" class="ref cit33b cit33c">(33b,c)</a></div><div class="NLM_p">The effect of deuterium incorporation on oxidizing transformations catalyzed by other enzymes has also received attention. For example, aldehyde oxidase (AO) is involved in the oxidation of the formyl carbon of aldehydes as its name implies but is also involved in the oxidation of α-carbons next to nitrogens in heteroaromatic ring systems (e.g., pyridines, pyrimidines, benzimidazoles) through a C–H bond cleavage as the rate-limiting step. Therefore, it can be targeted by precision deuteration, as first described for carbazeran and zoniporide.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> A more recent and advanced example is given by the already described VX-984 (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), where deuterium incorporation mitigates the AO-driven metabolism.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">The development of <i>d</i><sub>3</sub>-L-DOPA, SD-1077 (<b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), has clearly demonstrated that also reactions catalyzed by monoamine oxidases (MAO) and dopamine β-hydroxylases (DBH) can be affected. After decarboxylation of <i>d</i><sub>3</sub>-L-DOPA <b>5</b> by aromatic <span class="smallcaps smallerCapital">l</span>-amino acid decarboxylase (AADC), the metabolism of <i>d</i><sub>3</sub>-dopamine <b>6</b> can be fine-tuned by deuteration. Indeed, incorporation of deuterium at the α-carbon slows down MAO activity and the formation of <i>d</i><sub>2</sub>-3,4-dihydroxyphenylacetic acid <b>7</b>, while at the β-carbon it attenuates DBH functionality with consequent reductions of <i>d</i><sub>2</sub>-noradrenaline <b>8</b>. The result is that <i>d</i><sub>3</sub>-L-DOPA is a more potent anti-akinetic compared to L-DOPA in a rodent model of Parkinson’s disease, without increasing dyskinesias.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Given that this modification should affect dopamine metabolism at synapses, it is not surprising that the recently published phase I clinical trial<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> highlighted comparable peripheral pharmacokinetic (PK) and safety following a single oral dose of SD-1077/carbidopa and L-DOPA/carbidopa in healthy subjects, without indication of a major shift in the main systemic metabolic pathways.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>d</i><sub>3</sub>-L-DOPA and its metabolites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The activity of other members of the amine oxidase family also appears to be affected by deuteration. This is exemplified by <i>d</i><sub>2</sub>-AVE5638, a tryptase inhibitor<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> metabolized by semicarbazide sensitive amine oxidase, and <i>d</i><sub>2</sub>-lysine, which is a substrate for lysyl oxidase.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">This change in metabolic rate of deuterated drugs may be capitalized upon to modify the profile of bioactive molecules in a range of different aspects:</div><div id="sec1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> (a) Optimization of the Pharmacokinetic Properties</h3><div class="NLM_p">It is not surprising that ample literature is devoted to deuteration as a means to improve the PK profile of drugs. To give an overview of the effect of deuteration on PK, we have collected some recent examples where deuterated and parent compound were tested side-by-side (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Most experiments in the literature have a parallel group design, in which separate animals/humans are administered either the deuterated or the nondeuterated compound. Yet it is interesting to note that there are examples in which the same animal/individual is administered both compounds simultaneously, given the possibility to trace separately the two species analytically. This latter strategy reduces inter- and intraindividual variability and allows a reduction in the number of subjects/animals (<i>n</i>) required per study. Generalizing, it can be observed that when deuteration is successful, it results in an increased AUC and a reduced clearance, <i>C</i><sub>max</sub> and <i>t</i><sub>1/2</sub> are usually increased, while <i>T</i><sub>max</sub> is less affected. Changes are observed in both enteral and parenteral administrations, and bioavailability is at times affected (presumably when the first-pass effect is of relevance).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vivo Pharmacokinetic Properties of Selected Compounds and Related Deuterated Forms<a class="ref internalNav" href="#t1fn6" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">pharmacokinetic parameters (expressed as fold change)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">enzymatic reaction</th><th class="colsep0 rowsep0" align="center">in vivo model</th><th class="colsep0 rowsep0" align="center">ROA</th><th class="colsep0 rowsep0" align="center">deuterated form (dose, mg/kg)/parent compd (dose, mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center">AUC</th><th class="colsep0 rowsep0" align="center">clearance</th><th class="colsep0 rowsep0" align="center">bioavailability</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L-DOPA/carbidopa<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></td><td class="colsep0 rowsep0" align="left">MAO and DBH oxidation</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">SD-1077 (<b>5</b>) + L-DOPA (150.0)/parent (150.0)</td><td class="colsep0 rowsep0" align="left">0.91 ≈</td><td class="colsep0 rowsep0" align="left">1.00 ≈</td><td class="colsep0 rowsep0" align="left">0.91 ≈</td><td class="colsep0 rowsep0" align="left">0.90 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rofecoxib<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a><sup>,</sup><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></td><td class="colsep0 rowsep0" align="left">aryl hydroxylation</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>5</sub>-rofecoxib (<b>9</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.73 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.00 ≈</td><td class="colsep0 rowsep0" align="left">1.78 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α6β2/3γ2 GABA<sub>A</sub>R selective ligands<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a><sup>,</sup><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td><td class="colsep0 rowsep0" align="left">O-dealkylation</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">ip</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub> (<b>10</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">0.88 ≈</td><td class="colsep0 rowsep0" align="left">1.67 <b>↑</b></td><td class="colsep0 rowsep0" align="left">2.34 <b>↑↑</b></td><td class="colsep0 rowsep0" align="left">0.84 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imatinib<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></td><td class="colsep0 rowsep0" align="left">amine N-dealkylation</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub>-imatinib (<b>11</b>) (1.0)/parent (1.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.91 ≈</td><td class="colsep0 rowsep0" align="left">0.94 ≈</td><td class="colsep0 rowsep0" align="left">1.12 ≈</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora kinase inhibitors<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a><sup>,</sup><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></td><td class="colsep0 rowsep0" align="left">alkyl oxidation</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (50.0)/parent (50.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.82 <b>↑↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.62 <b>↓</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (3.0)/parent (3.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6.56 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left">0.16 <b>↓↓↓</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (30.0)/parent (30.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9.00 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.74 <b>↑</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.19 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left">0.19 <b>↓↓↓</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.19 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.65 <b>↑</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (1.0)/parent (0.3)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">22.5 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left">0.14 <b>↓↓↓</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (30.0)/parent (30.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.00 <b>↑↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.00 ≈</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub> (<b>12</b>) (1.0)/parent (0.3)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13.57 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left">0.23 <b>↓↓↓</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dapaglifozin<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a><sup>,</sup><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td><td class="colsep0 rowsep0" align="left">O-dealkylation</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub> (<b>13</b>) (1.0)/(<b>14</b>) (1.0)</td><td class="colsep0 rowsep0" align="left">1.56 <b>↑</b></td><td class="colsep0 rowsep0" align="left">0.89 ≈</td><td class="colsep0 rowsep0" align="left">1.08 ≈</td><td class="colsep0 rowsep0" align="left">1.08 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub> (<b>13</b>) (3.0)/(<b>14</b>) (3.0)</td><td class="colsep0 rowsep0" align="left">0.91 ≈</td><td class="colsep0 rowsep0" align="left">2.13 <b>↑↑</b></td><td class="colsep0 rowsep0" align="left">1.79 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.31 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub> (<b>13</b>) (1.0)/(<b>14</b>) (1.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.29 ≈</td><td class="colsep0 rowsep0" align="left">1.09 ≈</td><td class="colsep0 rowsep0" align="left">0.90 ≈</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNJ38877605<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></td><td class="colsep0 rowsep0" align="left">AO oxidation</td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>1</sub>-JNJ38877605 (<b>15</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.56 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.33 <b>↑</b></td><td class="colsep0 rowsep0" align="left">0.78 ≈</td><td class="colsep0 rowsep0" align="left">1.88 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4,6-benzylidene-<span class="smallcaps smallerCapital">d</span>-glucose<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a><sup>,</sup><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></td><td class="colsep0 rowsep0" align="left">reduction</td><td class="colsep0 rowsep0" align="left">mice</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>1</sub>-4,6-benzylidene-<span class="smallcaps smallerCapital">d</span>-glucose (<b>16</b>) (164.0)/parent (272.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.86 ≈</td><td class="colsep0 rowsep0" align="left">0.74 ≈</td><td class="colsep0 rowsep0" align="left">1.00 ≈</td><td class="colsep0 rowsep0" align="left">1.07 ≈</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>1</sub>-4,6-benzylidene-<span class="smallcaps smallerCapital">d</span>-glucose (<b>16</b>) (218.0)/parent (272.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.00 ≈</td><td class="colsep0 rowsep0" align="left">0.96 ≈</td><td class="colsep0 rowsep0" align="left">0.75 ≈</td><td class="colsep0 rowsep0" align="left">1.07 ≈</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>1</sub>-4,6-benzylidene-<span class="smallcaps smallerCapital">d</span>-glucose (<b>16</b>) (264.0)/parent (272.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.93 ≈</td><td class="colsep0 rowsep0" align="left">1.26 ≈</td><td class="colsep0 rowsep0" align="left">0.90 ≈</td><td class="colsep0 rowsep0" align="left">1.14 ≈</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>1</sub>-4,6-benzylidene-<span class="smallcaps smallerCapital">d</span>-glucose (<b>16</b>) (85.0)/parent (85.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.12 ≈</td><td class="colsep0 rowsep0" align="left">1.44 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.12 ≈</td><td class="colsep0 rowsep0" align="left">1.45 <b>↑</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tivozanib<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td><td class="colsep0 rowsep0" align="left">O-dealkylation</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>6</sub><i>-</i>tivozanib (<b>17</b>) (2.5)/parent (2.5)</td><td class="colsep0 rowsep0" align="left">1.30 ≈</td><td class="colsep0 rowsep0" align="left">1.04 ≈</td><td class="colsep0 rowsep0" align="left">1.19 ≈</td><td class="colsep0 rowsep0" align="left">1.50 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">apalutamide<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a><sup>,</sup><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td><td class="colsep0 rowsep0" align="left">amide N-dealkylation</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub><i>-</i>apalutamide (<b>18</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.35 <b>↑</b></td><td class="colsep0 rowsep0" align="left">0.67 <b>↓</b></td><td class="colsep0 rowsep0" align="left">5.47 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left">1.43 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub><i>-</i>apalutamide (<b>18</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.79 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.0 ≈</td><td class="colsep0 rowsep0" align="left">1.20 ≈</td><td class="colsep0 rowsep0" align="left">1.95 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brecanavir<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a><sup>,</sup><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></td><td class="colsep0 rowsep0" align="left">multiple reactions</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">parent + RTV (1.0 + 4.0)/parent (1.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">11.0 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left">11.73 <b>↑↑↑</b></td><td class="colsep0 rowsep0" align="left">0.08 <b>↓↓↓</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>19</sub><i>-</i>brecanavir (<b>19</b>) (1.0)/parent (1.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.0 ≈</td><td class="colsep0 rowsep0" align="left">0.89 ≈</td><td class="colsep0 rowsep0" align="left">0.91 ≈</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>16</sub><i>-</i>brecanavir (<b>20</b>) (1.0)/parent (1.0)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.0 ≈</td><td class="colsep0 rowsep0" align="left">0.97 ≈</td><td class="colsep0 rowsep0" align="left">0.98 ≈</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">enzalutamide<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a></td><td class="colsep0 rowsep0" align="left">N-dealkylation</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub><i>-</i>enzalutamide (<b>21</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">0.77 ≈</td><td class="colsep0 rowsep0" align="left">0.80 ≈</td><td class="colsep0 rowsep0" align="left">1.93 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.29 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t1fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub><i>-</i>enzalutamide (<b>21</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.35 <b>↑</b></td><td class="colsep0 rowsep0" align="left">2.35 <b>↑↑</b></td><td class="colsep0 rowsep0" align="left">1.54 <b>↑</b></td><td class="colsep0 rowsep0" align="left">2.03 <b>↑↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NVS-CRF38<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a><sup>,</sup><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></td><td class="colsep0 rowsep0" align="left">O-dealkylation</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub><i>-</i>NVS-CRF38 (<b>22</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.49 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.62 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.60 <b>↑</b></td><td class="colsep0 rowsep0" align="left">2.57 <b>↑↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ivacaftor<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></td><td class="colsep0 rowsep0" align="left">alkyl oxidations</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>-ivacaftor (CTP-656, <b>23</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.03 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.26 <b>≈</b></td><td class="colsep0 rowsep0" align="left">1.09 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>18</sub>-ivacaftor (<b>24</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.29 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.41 <b>↑</b></td><td class="colsep0 rowsep0" align="left">1.42 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>-ivacaftor (CTP-656, <b>23</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.54 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.29 <b>≈</b></td><td class="colsep0 rowsep0" align="left">1.69 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>18</sub>-ivacaftor (<b>24</b>) (10.0)/parent (10.0)</td><td class="colsep0 rowsep0" align="left">1.34 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.02 ≈</td><td class="colsep0 rowsep0" align="left">1.36 <b>↑</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nerispirdine<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a><sup>,</sup><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></td><td class="colsep0 rowsep0" align="left">multiple reactions</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>14</sub>-nerispirdine (<b>25</b>) (20.0)/parent (20.0)</td><td class="colsep0 rowsep0" align="left">1.18 ≈</td><td class="colsep0 rowsep0" align="left">0.50 <b>↓</b></td><td class="colsep0 rowsep0" align="left">1.08 ≈</td><td class="colsep0 rowsep0" align="left">0.91 ≈</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn6"><div class="footnote" id="t1fn6"><sup><sup>a</sup></sup><p class="last">Legend: ≈, fold-changes values between 0.70 and 1.30; <b>↑</b>, fold-change values between 1.31 and 2.00; <b>↑↑</b>, fold-change values between 2.01 and 4.00; <b>↑↑↑</b>, fold-change values of >4.00; <b>↓</b>, fold-change values between 0.50 and 0.70; <b>↓↓</b>, fold-change values between 0.25 and 0.49; <b>↓↓↓</b>: fold-change values of <0.25; ip, intraperitoneal administration; iv, intravenous administration; po, per os; ROA, route of administration; RTV, ritonavir.</p></div><div class="footnote" id="t1fn1"><sup><sup>b</sup></sup><p class="last">Different doses were tested.</p></div><div class="footnote" id="t1fn2"><sup><sup>c</sup></sup><p class="last">Deuterated compounds other than the reported ones were tested.</p></div><div class="footnote" id="t1fn3"><sup><sup>d</sup></sup><p class="last">Routes of administrations other than po were assessed.</p></div><div class="footnote" id="t1fn4"><sup><sup>e</sup></sup><p class="last">The parent compound and its deuterated form were simultaneously administered in order to minimize individual differences between animals.</p></div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of molecules from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> not shown elsewhere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A range of different competing effects might mask or even reverse the consequences of deuteration, such as different rate-limiting steps in enzyme mechanisms, alternative metabolic routes,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> or competing nonmetabolic elimination mechanisms<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> rendering the translation of in vitro results to in vivo challenging and highly unpredictable. The case of rofecoxib exemplifies this unpredictability.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Indeed, <i>d</i><sub>5</sub>-rofecoxib (<b>9</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) showed a <i>C</i><sub>max</sub> of 4181 μg/L compared to a <i>C</i><sub>max</sub> of 2416 μg/L for the nondeuterated compound in male rats after 10 mg/kg dose (po), but the two isotopologs exhibited identical half-life values (4.29 h versus 4.18 h). The increase in <i>C</i><sub>max</sub> is surprising as deuteration of the aromatic ring should in principle not afford substantial improvements due to a primary DKIE since CYP450-mediated aromatic oxidations are known to occur without cleavage of the C–H/D bond.<a onclick="showRef(event, 'cit33b cit33c'); return false;" href="javascript:void(0);" class="ref cit33b cit33c">(33b,c)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of <i>d</i><sub>5</sub>-rofecoxib, <i>d</i><sub>3</sub>-ligand for GABA<sub>A</sub>-α6, <i>d</i><sub>3</sub>-imatinib, <i>d</i><sub>2</sub>-aurora kinase inhibitor, and <i>d</i><sub>5</sub>-maraviroc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In stark contrast to rofecoxib, the effect of precision deuteration on recently reported selective ligands for GABA<sub>A</sub> receptor α6 subunits (<b>10</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), which display key soft positions susceptible to O-demethylation, showed a significant increase in half-life, an almost 2-fold increase in maximal brain concentration in rats, but no effect on systemic <i>C</i><sub>max</sub>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Importantly, in this example, the prolongation of the half-life was predictable in vitro, where metabolic stability was about tripled for the <i>d</i><sub>3</sub>-form in both human and mouse liver microsomes compared to the nondeuterated compound (8.7 and 10.5 h, respectively, compared to 3 h for the nondeuterated).</div><div class="NLM_p"><i>d</i><sub>3</sub>-Imatinib (<b>11</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), despite being significantly less susceptible to N-demethylation upon incubation with human liver microsomes, when intravenously administered to rats inexplicably does not show any increased exposure compared to the parent drug.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The results could also be explained by a reduced N-demethylation of imatinib in rats compared to humans, highlighting the difficulty in translating PK across species. Indeed, deuteration can lead to different results across different species, as is the norm in metabolism. This is exemplified in a very thorough PK investigation performed on imidazo[1,2-<i>a</i>]pyrazine-based inhibitors of aurora kinase (<b>12</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Here, the simultaneous replacement of hydrogens at two known soft-spots of a lead compound by two deuterium and two fluorine atoms enabled the identification of an orally available compound where increase in drug exposure was reached in four different species (rats, mice, dogs, and monkeys). Yet, as it can be observed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, differences between deuterated and nondeuterated forms varied considerably, both qualitatively and quantitatively, across species,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> suggesting that deuterium does not mitigate the risk of metabolic differences between species.</div><div class="NLM_p">Among the reasons for which the effect of deuteration is not always predictable is the possibility that the drug may undergo a metabolic switch; i.e., the incorporation of deuterium at one site successfully reduces metabolism on that site but enhances metabolism at another site. This is well exemplified by maraviroc, a negative allosteric modulator of CCR5 for the treatment of HIV infections. In this instance, deuteration at the methyl group (<b>26</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) switches metabolism to N-dealkylation and paradoxically accelerates in vitro microsomal clearance (<i>t</i><sub>1/2</sub> in human liver microsomes; 97.2 versus 45.5 min). Therefore, in this specific case, simultaneous deuteration at both sites of metabolism is necessary to see a significant decline in microsomal turnover (HLM <i>t</i><sub>1/2</sub> = 145.5 min).<a onclick="showRef(event, 'cit7b ref54'); return false;" href="javascript:void(0);" class="ref cit7b ref54">(7b,54)</a> Unfortunately, no in vivo data are available.</div><div class="NLM_p">This example, though, suggests that for molecules displaying more than one oxidizable hotspot, a possible strategy is to initially perdeuterate all these positions, profile the in vivo PK to observe any potential benefit, and then pinpoint any metabolic soft-spot sensitive to deuterium incorporation by selectively reverting deuterium back to hydrogen. Yet metabolic switches do not always occur. An example of this circumstance is the work by Sun and collaborators that aimed at optimizing dapagliflozin, a SGLT2 inhibitor for the treatment of type 2 diabetes. Given that there were worries regarding a possible hepatotoxicity related to the formation of methine-quinones, a traditional medicinal chemistry approach coupled to deuteration of selected compounds was performed in order to increase metabolic stability and reduce the possibility of forming these toxic metabolites. Indeed, the single substitution of the soft-spot -OCH<sub>2</sub>CH<sub>3</sub> in dapaglifozin with -OCD<sub>3</sub> (<b>13</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) was sufficient to significantly improve the PK profile and reduce the formation of metabolites (<b>28</b>) of possible toxicological worry, although other soft-spots were present.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> No improvements, or a slight detrimental effect, were instead observed when further deuterations were performed, suggesting that more is not always better (i.e., <i>t</i><sub>1/2</sub> of 6.34 h for <i>d</i><sub>3</sub> versus 5.66 h for <i>d</i><sub>5</sub>, <b>27</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Deuteration of dapaglifozin analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Many retroviral agents have metabolism as their Achilles’ heel, and some of these compounds are purposely coadministered with CYP enzyme inhibitors, known as boosters, to prolong the systemic exposure. Yet the literature is particularly scarce on this issue, suggesting that the deuterium strategy might not have been successful in many instances. We have retrieved a patent application of <i>d</i><sub>15</sub>-atazanavir, named CTP-518 (<b>29</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), and it appears that phase I clinical trials have been completed for this compound.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a><i>d</i><sub>15</sub>-Atazanavir has been reported to display an average 52% increase of half-life compared to atazanavir in primates. Whether this will be clinically relevant is yet to be determined.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>d</i><sub>15</sub>-Atazanavir and <i>d</i><sub>6</sub>-dextromethorphan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A very similar strategy has led to the development of a fixed combination (AVP-786) of <i>d</i><sub>6</sub>-dextromethorphan (<b>30</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) and quinidine for agitation in Alzheimer’s disease. This new combination is currently undergoing phase III clinical trials and represents a deuterium switch of a previously approved medication, Nuedexta, for pseudobulbar affect. Quinidine acts as a booster, reducing the first-pass metabolism of dextromethorphan to its O-demethylated metabolite and increasing the plasma half-life. An improved half-life of <i>d</i><sub>6</sub>-dextromethorphan requires a lower dose of quinidine, therefore theoretically sparing patients of some of the unwanted side effects of the latter drug.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Noteworthy, deuterium can be also used for the prolongation of drug release and polymer biodegradation. The first report describing the use of the isotope in a drug delivery system has been very recently published.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> More specifically, a drug is covalently attached via a carbamate to hydrogel microspheres using a β-eliminative linker, which is also installed into cross-links of the polymer to trigger degelation after drug release. After subcutaneous injection of the conjugate, the drug is slowly released into the systemic circulation, followed by degradation of the hydrogel. The incorporation of deuterium in the α-carbon of the linker (<b>31</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), because of a significant DKIE (<i>k</i><sub>H</sub>/<i>k</i><sub>D</sub> = 2.5–3.5), is able to significantly extend drug release, in vivo elimination of the drug (i.e., octreotide), and in vivo biodegradation of the hydrogel, compared to hydrogen-containing counterparts. Such finding might open up a completely novel avenue for deuterium in pharmaceutical technology.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Deuteration applied to drug release and polymer biodegradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> (b) Deuterium-Induced Reduction of Toxicity</h3><div class="NLM_p">Independent of PK parameters, deuteration of a soft-spot can be capitalized upon to reduce the formation of unwanted metabolites, as well as to increase the formation of desirable active metabolites, a phenomenon named metabolic shunting. In the past, a plethora of examples where deuterium-mediated metabolic shunting exerted protective effects against side effects that hampered the use of nondeuterated drugs have been reported. These include <i>d</i><sub>3</sub>-nevirapine,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> characterized by reduced incidence and severity of skin rashes compared to nevirapine, <i>d</i><sub>1</sub>-efavirenz, featuring an attenuated nephrotoxicity in rats,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and [<i>d</i><sub>5</sub>-ethyl]-tamoxifen, endowed with a reduced genotoxicity compared to tamoxifen.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">Recently, it has been reported that incorporation of deuterium at the α and α′ carbons in ifosfamide (<b>35</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) results in enhanced hydroxylation at the 4′ position, while reducing N-dechlorination for all CYPs tested, compared to the nondeuterated drug.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The metabolic shunting favoring the 4-hydroxylation over N-dechlorination is noteworthy, as the latter leads to more toxic and less efficacious metabolites, such as chloroacetaldehyde <b>38</b>, responsible for the ifosfamide-specific nephrotoxicity, suggesting that the deuterium-induced metabolic shunting might improve the therapeutic index of this chemotherapeutic agent.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Metabolic pathway of <i>d</i><sub>4</sub>-ifosfamide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Precision deuteration has enabled the reduction of nephrotoxicity also in the case of JNJ38877605 (<b>15</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), a c-Met inhibitor, whose clinical study was terminated due to the poor solubility of its AO metabolites that are responsible for renal toxicity. In order to lower the AO-driven metabolism, two strategies were pursued. The first one, which eventually led to volitinib (<b>40</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), which is currently in clinical trials, was the substitution of the quinoline substructure with an imidazo[1,2-<i>a</i>]pyridine.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Yet a parallel deuterium approach was also undertaken. Indeed, incorporation of deuterium at the 2-position of quinoline ring (<b>15</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) resulted in retention of biological activity, an improved stability toward AO, and a reduction in the formation of the two metabolites in plasma (<b>41</b> and <b>42</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), together with an increased oral exposure (1.88-fold AUC and 1.56-fold <i>C</i><sub>max</sub>) compared to the nondeuterated analogue.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> This led to the demonstration of higher efficacy/potency in a cancer xenograft model. It is interesting to note that other substitutions, for example, with a fluorine atom, would not have been possible as they would have hampered a key hydrogen bond between the quinoline nitrogen atom and Met1160 of the kinase.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Metabolic pathway of <i>d</i><sub>1</sub>- JNJ38877605.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another report, even if at an early stage of development, describes the potential reduction of the gut motility side effects associated with erythromycin B.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In acidic aqueous solution, erythromycin exists in equilibrium with its 6,9-enol ether, which is likely to be responsible for the activity on gut motility. The incorporation of deuterium into position 8 (<b>44</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) led to a significant reduction of the acid-catalyzed enol ether (<b>45</b>) formation and did not compromise the antibacterial effect, although the decrease of the gut motilide effects in vivo was not demonstrated.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Metabolic pathway of <i>d</i><sub>1</sub>-erythromycin B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The potential of the work on tramadol is just as surprising. Briefly, tramadol is rapidly metabolized to its <i>O</i>-desmethyl metabolite, which, unlike the parent compound, displays important activity on opioid receptors. In vitro, <i>d</i><sub>9</sub>-tramadol (<b>47</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) shows a 5- to 10-fold higher metabolic stability. Despite this, when intraperitoneally administered in a rat tail-flick model at the same dose, tramadol and <i>d</i><sub>9</sub>-tramadol did not show any difference in the extent and duration of analgesia.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> While of interest, these results may have a number of different explanations, which have not been elucidated further by the authors. Indeed, tramadol is often referred to as a prodrug, and therefore it would have been expected that the effect of <i>d</i><sub>9</sub>-tramadol should have been blunted. Given that this is not the case, it might reflect differences between in vitro and in vivo metabolism or an effect of tramadol itself on norepinephrine and serotonin reuptake, a reported action of this drug as well as a known mechanism to achieve an analgesic effect (e.g., duloxetine, venlafaxine). This latter explanation would mean that the two drugs exert similar overall effects via separate mechanisms. This possibility is worth exploring in the future, as it would suggest <i>d</i><sub>9</sub>-tramadol is a strong analgesic not acting on opioid receptors and therefore devoid of opioid-related side effects. Unfortunately, the authors did not characterize the deuterated form of the <i>O</i>-desmethyl metabolite (<b>48</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) in vivo, as this might have yielded further data. While inconclusive, this example suggests in principle that a further application of deuteration would be to modify drug to metabolite ratio to eventually exert different clinical effects.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. <i>d</i><sub>9</sub>-Tramadol and its <i>O</i>-desmethyl metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Last, precision deuteration may also be used in a paradoxical manner to reduce drug–drug interactions, which may indirectly cause significant side effects. CYP2D6 is inhibited by paroxetine (<b>49</b>) as it first catalyzes the oxidation of the methelenedioxy carbon (<b>50</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) and then forms an irreversible complex <b>52</b> with the carbene species <b>51</b> formed after dehydration. The incorporation of deuterium at this hot-spot (<i>d</i><sub>2</sub>-paroxetine <b>53</b>, CTP-347) attenuates this pathway, both in in vitro and in in vivo settings. Multidose PK in humans demonstrates that deuteration increases the rate of metabolism by reducing CYP2D6 inactivation and, at the same time, reduces possible drug–drug interactions, as exemplified when dextromethorphan was used as a selective probe for CYP2D6 activity.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Irreversible complex with CYP2D6 of paroxetine and structure of <i>d</i><sub>2</sub>-paroxetine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> (c) Deuterium-Induced Increase of Bioactivation</h3><div class="NLM_p">Clopidogrel is an antithrombotic prodrug that requires the CYP450-mediated thiophene 2-activation for its bioactivation. The observed clinical variability and resistance have been, in part, associated with low bioactivation efficiency, which in turn has been attributed to extensive metabolism, including oxidation, of the nonactivating piperidine motif. Perdeuteration of the piperidine substructure potentiated the prodrug activation percentage in vitro (19.3% of bioactivation percentage for <i>d</i><sub>6</sub>-clopidogrel <b>55</b> versus 14.5% for clopidogrel <b>54</b>) and led to a higher inhibitory activity against ADP-induced platelet aggregation in a rat model, thereby suggesting that deuteration of competing soft-spots in prodrugs may be a possible strategy (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Clopidogrel and <i>d</i><sub>6</sub>-clopidogrel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> (d) Deuterium To Stabilize Chemically Unstable Stereoisomers</h3><div class="NLM_p">Since 1992, many compounds originally developed as racemates have been separated, evaluated, and developed as single preferred enantiomers, the so-called eutomers.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> This approach, known as chiral switching, has resulted in several drugs marketed as pure enantiomers. Nevertheless, for a cluster of compounds chiral switching is impossible, due to the rapid interconversion of the stereoisomers in vitro and/or in vivo. In this setting, the substitution of the acidic proton with deuterium at the chiral center of a single stereoisomer might decrease the rate of atom abstraction and afford a good strategy to stabilize chemically unstable stereoisomers.</div><div class="NLM_p">This approach was initially demonstrated in 2009, with the selective deuteration of telaprevir (<b>56</b>, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The chiral center next to the α-ketoamide in <b>56</b> (<i>S</i>-configuration) is prone to epimerization through proton exchange at alkaline pH via an enol tautomer, and the resulting (<i>R</i>)-diastereoisomer is approximately 30-fold less active against HCV proteases. Selective incorporation of deuterium at the chiral center was proven to decrease the rate of epimerization (with a DKIE ranging from 4 to 7), to enhance in vitro pH and plasma stability, and to reduce epimerization in preclinical models.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <i>d</i><sub>1</sub>-Telaprevir, <i>d</i><sub>1</sub>-CC-122 and <i>d</i><sub>1</sub>-pioglitazone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similarly, thalidomide bears a chiral center with an exchangeable hydrogen, and the ignominious teratogenic effect is attributed mainly to the (<i>S</i>)-enantiomer.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The administration of the single (<i>R</i>)-enantiomer does not overcome teratogenicity due to the considerable and rapid epimerization under physiological conditions. Deuteration was shown to be partly effective at overcoming this drawback as (<i>R</i>)-<i>d</i><sub>1</sub>-thalidomide was shown to be 5 times more stable than (<i>R</i>)-thalidomide toward epimerization in various buffer solutions, although biological characterization of the deuterated form is not provided.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">Given the importance that thalidomide derivatives (e.g., lenalidomide, pomalidomide, CC-11006, CC-220) have in blood cancers and may have in inflammatory diseases, a similar strategy was applied for the generation of further analogues, including CC-122 (<b>57</b>, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The authors show that deuterium stabilizes the configuration of the chiral center and that the (−)-deuterated enantiomer is the preferred stereoisomer for its in vitro anti-inflammatory and in vivo antitumorigenic effects, leading to an approach named as deuterium enabled chiral switching.</div><div class="NLM_p last">Pioglitazone is a racemic mixture of two interconverting enantiomers. The ability of deuterium to stabilize the preferred (<i>R</i>)-enantiomer of pioglitazone (<b>58</b>, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>) has also been suggested,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> although no full paper has been published.</div></div><div id="sec1_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> (e) Deuterating Compounds as Experimental Strategies To Elucidate Mechanisms</h3><div class="NLM_p">Deuteration can also be used as a means to expand knowledge, for example, to test the contribution of a metabolite to the action of a particular drug, and work performed on ketamine (KET, <b>59</b>, <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) provides an example of this. This drug is known for its short-acting anesthetic effect, but it has recently been suggested that a single subhallucinogenic dose of ketamine leads to a rapid antidepressant effect. This effect starts 4 h after intravenous administration and lasts for 1–2 weeks.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> To verify the mechanism of the antidepressant activity, the levels of ketamine and its metabolites, such as (2<i>S</i>,6<i>S</i>;2<i>R</i>,6<i>R</i>)-hydroxyketamine (HK, <b>60</b>), norketamine (nor-KET, <b>61</b>), and (2<i>S</i>,6<i>S</i>;2<i>R</i>,6<i>R</i>)-hydroxynorketamine (HNK, <b>62</b>, i.e., the major metabolite found in plasma and brain), were monitored in the brains of female and male rodents. Indeed, the antidepressant activity seems to be more marked in female than in male. Surprisingly, in the brain of females 3-fold higher levels of HNK than in male were discovered, suggesting that this metabolite was responsible for the antidepressant activity. Indeed, the synthesis of <i>d</i><sub>2</sub>-KET <b>63</b>, which does not affect overall ketamine levels in brain but leads to a significantly lower levels HNK, had no antidepressant effects.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Ketamine, its metabolites, and <i>d</i><sub>2</sub>-ketamine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (f) PET Tracers</h3><div class="NLM_p">A field in which deuterium switch has gained increasing attention is represented by PET tracers, which have the great potential to both detect disease-related biochemical changes and serve as biomarkers during the development of potential drugs because of the presence of a radionuclide in their structure (commonly <sup>18</sup>F or <sup>11</sup>C). On the other hand, the development of PET tracers is challenging, and success or failure is determined by numerous physicochemical and pharmacological factors among which metabolism is of great relevance. PET imaging agents need to display fast clearance, but not too fast, and precision deuteration can represent a viable solution in achieving the best compromise, improving in vivo behavior of the parent radioligand.</div><div class="NLM_p">Among the early examples is the peripheral benzodiazepine receptor (PBR) radioligand [<sup>18</sup>F]-<b>64</b> reported in 2005.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> As PBR density is increased in injured brains and in tumors, PBR imaging might be useful for visualizing the distribution of the receptor in these regions. The authors started from [<sup>18</sup>F]-<b>64</b>, a potent ligand for PBR that, after in vivo administration, was rapidly metabolized by defluorination to form [<sup>18</sup>F]F<sup>–</sup>. This species is largely accumulated in bones, decreasing the effective signal and the sensitivity of PET image in brain. Deuterium incorporation would decrease the rate of defluorination, where the cleavage of the C–D is the rate-limiting step. Despite the <i>T</i><sub>1/2</sub> (calculated as ln 2/decay constant) in mouse plasma remaining almost the same (2.575 min for <i>d</i><sub>2</sub>-[<sup>18</sup>F]<b>-64</b> versus 2.367 min for [<sup>18</sup>F]<b>-64</b>), the <i>T</i><sub>1/2</sub> in mouse brain was more than 60 min for <i>d</i><sub>2</sub>-[<sup>18</sup>F]<b>-64</b>, whereas that of [<sup>18</sup>F]<b>-64</b> was 2.227 min, with decreased radioactivity levels in mouse bones (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>). The authors suggest that this is related to the level of enzymes that in plasma is much higher than in brain. Unfortunately, after <i>d</i><sub>2</sub>-[<sup>18</sup>F]<b>-64</b> injection, PET images of monkey revealed that there was higher radioactivity in skull compared to the brain, highlighting that <i>d</i><sub>2</sub>-[<sup>18</sup>F]<b>-64</b> is rapidly defluorinated to form [<sup>18</sup>F]F<sup>–</sup>.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of selected PET tracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similarly, the translocator protein (TSPO) is overexpressed in ischemic brain injury and degenerative brain diseases, and for this reason it has become an attractive biomarker to visualize neuroinflammation. Among the TSPO selective radiotracers developed so far, [<sup>18</sup>F]-fluoromethyl-PBR28 shows promising profile in terms of in vitro biological properties, but it is affected by a low metabolic stability due to defluorination.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The corresponding deuterated analogue, <i>d</i><sub>2</sub>-[<sup>18</sup>F]-fluoromethyl-PBR28 <b>65</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>), while retaining the same in vitro biological properties, shows higher organ uptake (except for the skull), enhanced in vivo stability and reaches the highest target-to-background ratio, an index commonly used in the field, at an early imaging time (3.8-fold versus 3.0-fold for the nondeuterated compound).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">Both of these examples suggest that deuterium substitution could be an effective strategy to reduce defluorination rate and improve the stability of fluoromethoxy groups.</div><div class="NLM_p">In a similar manner as for TSPO, deuteration has recently found application in the development of agents able to visualize the in vivo activity of MAO-B. MAO-B system is up-regulated in neuroinflammatory processes, and radiolabeled MAO-B inhibitors may serve as biomarkers in neuroinflammation and neurodegeneration (e.g., Alzheimer and Parkinson diseases, epilepsy). <i>d</i><sub>2</sub>-[<sup>18</sup>F]-Fluoroselegiline <b>66</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) is a radiolabeled MAO-B inhibitor developed as a molecular imaging biomarker for the quantification of the enzyme activity in brain.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Its nondeuterated counterpart binds too quickly and irreversibly to the enzyme, and therefore, the distribution in tissue is limited by blood flow rather than by MAO-B levels.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> As the MAO-B catalyzed cleavage of the C–H bond in the propargyl moiety is the rate-limiting step in the retention of the radioligand in brain, the authors suggested that the substitution of H with D would have reduced the rate of cleavage and, therefore, the affinity to MAO-B, ultimately improving the sensitivity. Indeed, the deuterated tracer showed a less irreversible behavior and a decreased rate of trapping in the monkey brain with an improved sensitivity. Furthermore, deuterium incorporation increased the stability in monkey blood plasma.</div><div class="NLM_p">While in the above example the deuteration approach has proven to be successful, very recently it has been reported that incorporation of deuterium in the metabolic trapping agent [<sup>11</sup>C]-Cou <b>67</b> (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>) did not afford the expected results. [<sup>11</sup>C]-Cou undergoes a MAO-B oxidation followed by hydrolysis, and the resulting metabolite is trapped in the brain. Similar to <i>d</i><sub>2</sub>-[<sup>18</sup>F]-fluoroselegiline <b>66</b>, the rapid trapping rate makes it difficult to discriminate between regions of high and low MAO enzymatic activity. Incorporation of deuterium in the tetrahydropyridine ring did not reduce the rate of trapping in brain tissues, despite strong literature precedent demonstrating a significant DKIE (3.55) on MPTP and similar substructures.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Indeed, no effect of deuterium in slowing the MAO-B mediated oxidation step and reducing the rate of trapping in brain tissues was seen, neither in in vitro nor in in vivo PK studies.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> This can be explained by considering the masking of the DKIE by the second rate-limiting hydrolytic step leading to <b>69</b> and <b>70</b>, in the overall metabolism of this radiotracer.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Metabolic pathway of <i>d</i><sub>7</sub>-[<sup>11</sup>C]-Cou.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Synthetic Approaches in Precision Deuteration</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the synthesis of deuterium-labeled compounds, two main approaches can be explored: a conventional multistep synthesis that we name “deuterated pool” (DP) synthesis and an isotope exchange approach.</div><div class="NLM_p">In the first case, the desired compound is afforded using conventional reactions through a multistep route, starting from commercially available and low molecular weight deuterium-labeled building blocks. Obviously, deuterated reagents are more expensive than the corresponding parent ones, but this is counterbalanced by the fact that deuterated pool synthesis ensures perfect regio- and chemoselectivity and almost 100% efficiency. A variety of deuterated reagents are commercially available from dedicated companies, such as C/D/N Isotopes, Cambridge Isotope Laboratories, and CombiPhos Catalysts. The source of all the deuterated starting reagents is deuterium oxide, produced from regular water by using Girdler sulfide process, an industrial procedure to enrich deuterium in water up to 20%. This mixture is then distilled to afford pure deuterium oxide, representing the only case in which it is possible to separate labeled compounds from the corresponding nondeuterated one. Notably, a company named Isowater (<a href="https://www.isowater.com" class="extLink">https://www.isowater.com</a>) supplies heavy water to non-nuclear users in life sciences and high technology and is currently developing a new proprietary process for making D<sub>2</sub>O.</div><div class="NLM_p">In the isotope exchange approach, deuterium is inserted on the target molecule or on a late intermediate using a deuterium donor (usually D<sub>2</sub>O or D<sub>2</sub> gas) by (i) reductive deuteration, such as hydrogenation and borohydride reduction;<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> (ii) X/D (halogen–deuterium) exchange via aromatic dehalogenation;<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> or (iii) H/D (hydrogen–deuterium) exchange.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Alternative methods have started to appear in the literature concomitantly with the explosion of precision deuteration of bioactive compounds, and in particular, elegant photocatalytic deuteration methods have been very recently described.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p">Among all the methods belonging to the isotope exchange approach, the H/D exchange approach is the most exploited one and includes the pH-dependent H/D exchange<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and the metal-catalyzed H/D exchange.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p">The pH-dependent H/D exchange is based on the enolization of specific groups in the substrate, requires a deuterium source, and can be acid- or base-catalyzed. In the first case, both Lewis and deuterated Bronsted acids can be used, while in the second case a deuterated or nondeuterated base is necessary. Moreover, for some pH-dependent H/D exchanges, acids and bases are unnecessary as deuterium oxide, due to its autoprotolysis process, is able to deuterate acidic positions.</div><div class="NLM_p">Among the metal catalyzed H/D exchange procedures, both heterogeneous and homogeneous systems are reported.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> In general, homogeneous catalysis offers a better selectivity in the incorporation at the different positions and milder reaction conditions, but conversely, it needs the preparation of complex catalysts and is usually associated with higher costs. A plethora of different catalysts (e.g., Ir,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Ru,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Pd,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Pt<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a>) are reported in the literature for the H/D exchange of aromatic, aliphatic, allylic, vinylic, heteroaromatic positions or for the exchange of hydrogen adjacent to oxygen- and nitrogen-based directing groups.</div><div class="NLM_p">Except for a few cases, the H/D exchange approach requires harsh experimental conditions, including the use of strong acids and bases and heavy metals. In the context of drug development, this might represent a big concern, in terms of both safety and tolerance toward functional groups, especially when the exchange is performed in the late-stage part of the synthetic route. Lower selectivity and efficiency are sometimes encountered, with the consequent necessity of reiterating the exchange process to achieve high deuterium enrichment. For these reasons, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>, it is not surprising that the most exploited method for accessing deuterated drug candidates is currently represented by the deuterated pool approach, with the use of quite simple deuterated starting materials, but the isotope exchange approach without catalysts is also well represented. The only exception is VX-984 (<b>3</b>) that is synthesized by halogen–deuterium exchange using formic acid-<i>d</i><sub>2</sub> and CD<sub>3</sub>OD in the presence of Pd/C.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The rather higher costs of deuterated starting materials (the most expensive one reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> is 1,4-dibromobutane-<i>d</i><sub>8</sub>, about 150 € for 1 g) have not represented an impediment to the use of precision deuteration strategy in drug development, also considering that these reagents usually display a very low molecular weight compared to the final product.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Synthetic Approaches Used for the Most Advanced Deuterated Candidates</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">synthetic approach</th><th class="colsep0 rowsep0" align="center">deuterium source<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">deutetrabenazine, <b>1</b></td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left">CD<sub>3</sub>OD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>-ivacaftor, <b>23</b> (CTP-656)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left">D<sub>2</sub>SO<sub>4</sub>, <i>d</i><sub>10</sub>-<i>tert</i>-butanol</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>6</sub>-dextromethorphan, <b>30</b> (+quinidine, AVP-786)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left">CD<sub>3</sub>I</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub>-linoleic acid ethyl ester, <b>92</b> (RT001)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub>-paraformaldehyde</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>4</sub>-sodium oxibate, <b>81</b> (JZP-386)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>4</sub>-succinic anhydride, CH<sub>3</sub>OD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub>-sorafenib, <b>106</b> (donafenib)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub>-methyl amine</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>5</sub>-apremilast, <b>83</b> (CTP-730)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>5</sub>-bromoethane</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>15</sub>-atazanavir, <b>29</b> (CTP-518)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>-2-chloro-2-methylpropane, CD<sub>3</sub>OD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMS-986165, <b>2</b></td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub>-methylamine hydrochloride</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>-L-838417, <b>4</b> (CTP-354)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>- trimethylpivalic acid</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>7</sub>-tolperisone,<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><b>71</b> (BDD-10103)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>8</sub>-toluene</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>-venlafaxine, <b>72</b> (SD-254)</td><td class="colsep0 rowsep0" align="left">deuterated pool</td><td class="colsep0 rowsep0" align="left">CD<sub>3</sub>I</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VX-984, <b>3</b></td><td class="colsep0 rowsep0" align="left">X/D exchange</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub>-formic acid, Pd, CD<sub>3</sub>OD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub>-vitamin A, <b>93</b> (ALK-001)</td><td class="colsep0 rowsep0" align="left">H/D exchange</td><td class="colsep0 rowsep0" align="left">D<sub>2</sub>O, NaOD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTP-499, <b>105</b></td><td class="colsep0 rowsep0" align="left">H/D exchange</td><td class="colsep0 rowsep0" align="left">D<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>3</sub>-L-DOPA, <b>5</b> (SD-1077)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H/D exchange</td><td class="colsep0 rowsep0" align="left">DCl, D<sub>2</sub>O, CD<sub>3</sub>OD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>1</sub>-pioglitazone, <b>58</b> (PXL065)</td><td class="colsep0 rowsep0" align="left">H/D exchange</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>6</sub>-DMSO, CD<sub>3</sub>OD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>9</sub>-ruxolitinib, <b>82</b> (CTP-543)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H/D exchange and deuterated pool</td><td class="colsep0 rowsep0" align="left"><i>d</i><sub>8</sub>-1,4-dibromobutane, D<sub>2</sub>O, NaOD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>d</i><sub>2</sub>-paroxetine, <b>53</b> (CTP-347)</td><td class="colsep0 rowsep0" align="left">H/D exchange and deuterated pool</td><td class="colsep0 rowsep0" align="left">D<sub>2</sub>O, CD<sub>2</sub>Cl<sub>2</sub></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The structure has not been disclosed yet. The reported synthetic approach and the deuterium source are putative.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The deuterium sources are those reported in patent literature. The synthetic approaches used for industrial productions may be different.</p></div></div></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of molecules from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> not shown elsewhere.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">()</a><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">()</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among the examples reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, the synthesis of <i>d</i><sub>2</sub>-paroxetine <b>53</b> (CTP-347), the deuterated analogue of the antidepressant paroxetine previously described, soundly exemplifies both the deuterated pool and the exchange approaches (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Synthesis of <i>d</i><sub>2</sub>-paroxetine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The synthetic route starts from 3,4-dihydroxybenzaldehyde <b>73</b> that is selectively deuterated using a pH-dependent exchange approach in the presence of deuterium oxide as deuterium source. The corresponding dideuterocatechol <b>74</b> reacts with <i>d</i><sub>2</sub>-dichloromethane in a deuterated pool synthesis and affords <i>d</i><sub>2</sub>-piperonal <b>75</b>, which is then treated with hydrogen peroxide in the presence of formic acid. The <i>d</i><sub>2</sub><i>-</i>sesamol <b>76</b> is then used in the synthesis of <i>d</i><sub>2</sub>-paroxetine following a four-step synthetic route starting from ((3<i>S</i>,4<i>R</i>)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol <b>77</b> (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).</div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Deuterated Compounds in Clinical Development</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the wave of the deutetrabenazine success, a number of other deuterated compounds have entered clinical trials. Nevertheless, an exhaustive picture of these is still lacking. In order to fill this gap, we searched up to September 2018 in the publicly accessible Clinicaltrial.gov database (available online at <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a>) by using the Boolean combination of the following key terms: “deuterium” OR “deu” OR “deuterated” OR “deuteration”. The database search yielded 20 333 hits that we thoroughly screened (S.C. and M.S.) in order to identify all trials registered therein in which a deuterated compound was used as a therapeutic intervention. In addition, a manual search for relevant published clinical trial results was performed on PubMed, Web of Knowledge, and SciFinder databases, and references cited in related studies were reviewed in order to identify clinical trials that were not initially retrieved. Conversely, we excluded from the review all the trials in which deuterated compounds were used for diagnostic purposes (e.g., deuterium labeled creatine dilution, deuterated 3-methylhistidine) or as internal standards.</div><div class="NLM_p">Deuterium-labeled compounds identified through the Clinicaltrial.gov database search were 13 and are listed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>. Among these 13 molecules, 9 were deuterium switch analogues of marketed active compounds (i.e., deutetrabenazine <b>1</b>, CTP-656 <b>23</b>, AVP-786, CTP-518 <b>29</b>, JPZ-386 <b>81</b>, CTP-543 <b>82</b>, CTP-730 <b>83</b>, donafenib <b>106</b>) or related metabolites (i.e., CTP-499 <b>105</b>), 2 were deuterated forms of nutritional compounds (i.e., RT001 <b>92</b>, ALK001 <b>93</b>), while the remaining 2 were molecules that did not previously have a nondeuterated counterpart (i.e., BMS-986165 <b>2</b>, VX-984 <b>3</b>). If we exclude deutetrabenazine, which is already in clinical practice, only 4 deuterated compounds (i.e., AVP-786, RT001, donafenib, and BMS-986165) appear to have reached potential pivotal registration trials sufficient for regulatory submission/approval.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Deuterated Compounds Entered in Clinical Development and Found via a Systematic Search on ClinicalTrials.gov<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">deuterated compd (synonyms)</th><th class="colsep0 rowsep0" align="center">parent compd</th><th class="colsep0 rowsep0" align="center">therapeutic indication</th><th class="colsep0 rowsep0" align="center">ClinicalTrials.gov identifier (year of data registration)</th><th class="colsep0 rowsep0" align="center">phase</th><th class="colsep0 rowsep0" align="center">status</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="9" align="left">deutetrabenazine, <b>1</b> (<i>d</i><sub>6</sub>-tetrabenazine; SD809; SD-809, TEV-50717)</td><td class="colsep0 rowsep0" align="left">tetrabenazine</td><td class="colsep0 rowsep0" align="left">Chorea associated with Huntington disease</td><td class="colsep0 rowsep0" align="left">NCT01897896 (2013)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Completed/FDA approval</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Chorea associated with Huntington disease</td><td class="colsep0 rowsep0" align="left">NCT01795859 (2013)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Completed/FDA approval</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tardive dyskinesia</td><td class="colsep0 rowsep0" align="left">NCT02195700 (2014)</td><td class="colsep0 rowsep0" align="left">Phase II/III</td><td class="colsep0 rowsep0" align="left">Completed/FDA approval</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tardive dyskinesia</td><td class="colsep0 rowsep0" align="left">NCT02198794 (2014)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Active, not recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tardive dyskinesia</td><td class="colsep0 rowsep0" align="left">NCT02291861 (2014)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Completed/FDA approval</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tourette syndrome</td><td class="colsep0 rowsep0" align="left">NCT02674321 (2016)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tourette syndrome</td><td class="colsep0 rowsep0" align="left">NCT03571256 (2018)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tourette syndrome</td><td class="colsep0 rowsep0" align="left">NCT03567291 (2018)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tourette syndrome</td><td class="colsep0 rowsep0" align="left">NCT03452943 (2018)</td><td class="colsep0 rowsep0" align="left">Phase II/III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMS-986165, <b>2</b></td><td class="colsep0 rowsep0" align="left">novel compound</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02534636 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03004768 (2016)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03044873 (2017)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03262727 (2017)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03254784 (2017)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03419910 (2018)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03541564 (2018)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03660436 (2018)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03402087 (2018)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Psoriasis</td><td class="colsep0 rowsep0" align="left">NCT02931838 (2016)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Psoriasis</td><td class="colsep0 rowsep0" align="left">NCT03624127 (2018)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Psoriasis</td><td class="colsep0 rowsep0" align="left">NCT03611751 (2018)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Systemic lupus erythematosus</td><td class="colsep0 rowsep0" align="left">NCT03252587 (2017)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Crohn’s disease</td><td class="colsep0 rowsep0" align="left">NCT03599622 (2018)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VX-984, <b>3</b> (M9831)</td><td class="colsep0 rowsep0" align="left">novel compound</td><td class="colsep0 rowsep0" align="left">Advanced solid tumors</td><td class="colsep0 rowsep0" align="left">NCT02644278 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left">CTP-656, <b>23</b> (<i>d</i><sub>9</sub>-ivacaftor, VX-561, c-10358, c-10355)</td><td class="colsep0 rowsep0" align="left">ivacaftor</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02599792 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02392702 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02680249 (2016)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Cystic fibrosis</td><td class="colsep0 rowsep0" align="left">NCT02971839 (2016)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Terminated</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Cystic fibrosis</td><td class="colsep0 rowsep0" align="left">NCT03227471 (2017)</td><td class="colsep0 rowsep0" align="left">Phase I/II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Cystic fibrosis</td><td class="colsep0 rowsep0" align="left">NCT03224351 (2017)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTP-518, <b>29</b> (<i>d</i><sub>15</sub>-atazanavir)</td><td class="colsep0 rowsep0" align="left">atazanavir</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT01458769 (2011)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="14" align="left">AVP-786 (<i>d</i><sub>6</sub>-dextromethorphan <b>30</b> + quinidine; CTP-786; <i>d</i>-DM; deudextromethorphan hydrobromide [<i>d</i><sub>6</sub>-DM <b>30</b>]/quinidine sulfate [Q]; deuterated dextromethorphan plus ultra low dose quinidine; deuterated DM plus ultra low dose quinidine; deuterated-dextromethorphan; deuterated DM)</td><td class="colsep0 rowsep0" align="left">dextromethorphan</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT01787747 (2013)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02174822 (2014)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02174835 (2014)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Major depressive disorder</td><td class="colsep0 rowsep0" align="left">NCT02153502 (2014)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02336347 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02402595 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Disinhibition syndrome</td><td class="colsep0 rowsep0" align="left">NCT02534038 (2015)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Terminated</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Residual schizophrenia</td><td class="colsep0 rowsep0" align="left">NCT02477670 (2015)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Agitation in patients with dementia of the Alzheimer’s type</td><td class="colsep0 rowsep0" align="left">NCT02446132 (2015)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Agitation in patients with dementia of the Alzheimer’s type</td><td class="colsep0 rowsep0" align="left">NCT02442765 (2015)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Agitation in patients with dementia of the Alzheimer’s type</td><td class="colsep0 rowsep0" align="left">NCT02442778 (2015)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Agitation in patients with dementia of the Alzheimer’s type</td><td class="colsep0 rowsep0" align="left">NCT03393520 (2018)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Neurobehavioral disinhibition</td><td class="colsep0 rowsep0" align="left">NCT03095066 (2017)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Intermittent explosive disorder</td><td class="colsep0 rowsep0" align="left">NCT03420222 (2018)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JZP-386, <b>81</b> (<i>d</i><sub>4</sub>-sodium oxybate; C-10323)</td><td class="colsep0 rowsep0" align="left">sodium oxybate</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02215499 (2014)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">CTP-543, <b>82</b> (<i>d</i><sub>8</sub>-ruxolitinib)</td><td class="colsep0 rowsep0" align="left">ruxolitinib</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02960945 (2016)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02777008 (2016)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alopecia areata</td><td class="colsep0 rowsep0" align="left">NCT03137381 (2017)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Active, not recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">CTP-730, <b>83</b> (<i>d</i><sub>5</sub>-apremilast)</td><td class="colsep0 rowsep0" align="left">apremilast</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02239081 (2014)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02404922 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">RT001, <b>92</b> (<i>d</i><sub>2</sub>-linoleic acid ethyl ester; 11,11-D2-ethyl linoleate; ethyl 11,11-D2-linoleate)</td><td class="colsep0 rowsep0" align="left">linoleic acid</td><td class="colsep0 rowsep0" align="left">Friedreich’s ataxia</td><td class="colsep0 rowsep0" align="left">NCT02445794 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I/II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Infantile neuroaxonal dystrophy</td><td class="colsep0 rowsep0" align="left">NCT03570931 (2018)</td><td class="colsep0 rowsep0" align="left">Phase II/III</td><td class="colsep0 rowsep0" align="left">Not yet recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">ALK-001, <b>93</b> (<i>d</i><sub>3</sub>-vitamin A; C20-D3-retinyl acetate)</td><td class="colsep0 rowsep0" align="left">vitamin A</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02230228 (2014)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Stargardt disease</td><td class="colsep0 rowsep0" align="left">NCT02402660 (2015)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">CTP-499, <b>105</b> (PCS-499)</td><td class="colsep0 rowsep0" align="left">1-[(<i>S</i>)-5-hydroxylhexyl]-3,7-dimethylxanthine (HDX)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT01328821 (2011)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Nondialysis patients associated with moderate chronic kidney disease</td><td class="colsep0 rowsep0" align="left">NCT01460199 (2011)</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Type 2 diabetic nephropathy</td><td class="colsep0 rowsep0" align="left">NCT01487109 (2011)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="9" align="left">donafenib, <b>106</b> (<i>d</i><sub>3</sub>-sorafenib; CM 4307)</td><td class="colsep0 rowsep0" align="left">sorafenib</td><td class="colsep0 rowsep0" align="left">Advanced hepatocellular carcinoma</td><td class="colsep0 rowsep0" align="left">NCT02229071 (2014)</td><td class="colsep0 rowsep0" align="left">Phase I/II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Advanced hepatocellular carcinoma</td><td class="colsep0 rowsep0" align="left">NCT02645981 (2016)</td><td class="colsep0 rowsep0" align="left">Phase II/III</td><td class="colsep0 rowsep0" align="left">Not recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Advanced gastric cancer</td><td class="colsep0 rowsep0" align="left">NCT02489214 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I/II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Advanced, inoperable esophageal cancer</td><td class="colsep0 rowsep0" align="left">NCT02489201 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I/II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Metastatic colorectal cancer</td><td class="colsep0 rowsep0" align="left">NCT02489916 (2015)</td><td class="colsep0 rowsep0" align="left">Phase I/II</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Metastatic colorectal cancer</td><td class="colsep0 rowsep0" align="left">NCT02870582 (2016)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Metastatic nasopharyngeal carcinoma</td><td class="colsep0 rowsep0" align="left">NCT02698111 (2016)</td><td class="colsep0 rowsep0" align="left">Phase I/II</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Thyroid cancer</td><td class="colsep0 rowsep0" align="left">NCT02870569 (2016)</td><td class="colsep0 rowsep0" align="left">Phase II</td><td class="colsep0 rowsep0" align="left">Active, not recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Differentiated thyroid cancer</td><td class="colsep0 rowsep0" align="left">NCT03602495 (2018)</td><td class="colsep0 rowsep0" align="left">Phase III</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The list might not be complete as not all sponsors might have declared the deuterated nature of the investigational drug.</p></div></div></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures of clinical candidates from <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> not shown elsewhere.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">()</a><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">()</a><a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">()</a><a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">()</a><a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">()</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We acknowledge that a number of deuterated compounds other than those listed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> have been reported to have initiated clinical trials (e.g., CTP-354 <b>4</b>,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> SD-1077 <b>5</b>,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> CTP-518 <b>29</b>,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> CTP-347 <b>53</b>,<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> PXL065 <b>58</b>,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> BDD-10103 <b>71</b>,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> SD-254 <b>72</b>,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> SD-560 <b>84</b>,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> CTP-692 <b>85</b><a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a>). However, they have not been included in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> as trials relating to these molecules were not found in Clinicaltrials.gov, the unbiased source we chose to identify the molecules. Registration on Clinicaltrials.gov is mandatory only for those trials that enroll patients in the United States and is not required for phase I clinical candidates. To overcome this limitation, we searched company Web sites and we used search engines to compile a further list of deuterated drugs entered in clinical development (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Furthermore, it must be highlighted that pharmaceutical companies often adopt the policy of not disclosing chemical structures until late clinical development; hence we cannot exclude that some other deuterated compounds may have entered clinical development without being recognized as such.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Deuterated Compounds Declared To Be in Clinical Development but Not Found with the Systematic Search Described in the Text<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">deuterated compd (alternative names)</th><th class="colsep0 rowsep0" align="center">parent compd</th><th class="colsep0 rowsep0" align="center">therapeutic indication</th><th class="colsep0 rowsep0" align="center">phase</th><th class="colsep0 rowsep0" align="center">status</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTP-354, <b>4</b> (<i>d</i><sub>9</sub>-L838417; C-21191)</td><td class="colsep0 rowsep0" align="left">L-838417</td><td class="colsep0 rowsep0" align="left">Spasticity</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD-1077, <b>5</b> (<i>d</i><sub>3</sub>-L-DOPA)</td><td class="colsep0 rowsep0" align="left">L-DOPA</td><td class="colsep0 rowsep0" align="left">Parkinson’s disease</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Unknown<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTP-518, <b>29</b> (<i>d</i><sub>15</sub>-atazanavir)</td><td class="colsep0 rowsep0" align="left">atazanavir</td><td class="colsep0 rowsep0" align="left">HIV infections</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Unknown<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTP-347, <b>53</b> (<i>d</i><sub>2</sub>-paroxetine)</td><td class="colsep0 rowsep0" align="left">paroxetine</td><td class="colsep0 rowsep0" align="left">Menopause, hot flashes and vasomotor symptoms</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PXL065, <b>58</b> (<i>d</i><sub>1</sub>-pioglitazone; DRX-065)</td><td class="colsep0 rowsep0" align="left">pioglitazone</td><td class="colsep0 rowsep0" align="left">Adrenomyeloneuropathy, nonalcoholic steatohepatitis</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Recruiting</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BDD-10103, <b>71</b> (<i>d</i><sub>7</sub>-tolperisone)</td><td class="colsep0 rowsep0" align="left">tolperisone</td><td class="colsep0 rowsep0" align="left">Spastic paralyzes</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Unknown<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD-254, <b>72</b> (<i>d</i><sub>9</sub>-venlafaxine)</td><td class="colsep0 rowsep0" align="left">venlafaxine</td><td class="colsep0 rowsep0" align="left">Major depressive disorder</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Completed</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD-560, <b>84</b> (<i>d</i><sub>3</sub>-pirfenidone)</td><td class="colsep0 rowsep0" align="left">pirfenidone</td><td class="colsep0 rowsep0" align="left">Idiopathic pulmonary fibrosis</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Unknown<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTP-692, <b>85</b> (<i>d</i><sub>3</sub>-<span class="smallcaps smallerCapital">d</span>-serine)</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">d</span>-serine</td><td class="colsep0 rowsep0" align="left">Schizophrenia</td><td class="colsep0 rowsep0" align="left">Phase I</td><td class="colsep0 rowsep0" align="left">Recruting</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup><sup>a</sup></sup><p class="last">Information was found on search engines and on company Web sites, and therefore the list might not be complete.</p></div><div class="footnote" id="t4fn1"><sup><sup>b</sup></sup><p class="last">No explicit information concerning the status of the trial is available on the company Web site.</p></div></div></div><div class="NLM_p">Among the plethora of deuterated compounds that we identified, we arbitrarily describe below those compounds not extensively elucidated in previous reviews and for which we found literature that, in our opinion, represents successful examples of precision deuteration and that go beyond simple slowing down of metabolism.</div><div id="sec1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Inhibition of Chemical Processes of Nutritional Agents</h3><div id="sec1_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">1.  The Case of RT001</h4><div class="NLM_p">Linoleic acid (<b>86</b>, <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>), the most abundant polyunsaturated fatty acid (PUFA) in humans,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> displays an 18-carbon chain containing a bis-allylic methylene group (−CH═CH–CH<sub>2</sub>–CH═CH−). The C–H bonds in the methylene group therein are weak enough to be cleaved by reactive oxygen species (ROS), thus allowing the initiation of the lipoperoxidation process.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> More precisely, when ROS rip hydrogens from susceptible bis-allylic methylene groups, resonance-stabilized free radicals <b>87</b> and <b>88</b> are formed. The latter, after having reacted with oxygen, are then transformed into lipid radicals, which trigger the lipid peroxidation chain reactions. 11,11-<i>d</i><sub>2</sub>-Linoleic acid ethyl ester (RT001, <b>92</b>) has been developed on the basis that the bis-allylic methylene group could be stabilized by a double hydrogen–deuterium substitution, thereby reducing the progress of lipid peroxidation.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Lipoperoxidation process of linoleic acid and structure of RT001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given encouraging results in a number of in vitro and in vivo models of neurological degenerative disorders in which free radicals are thought to play a role,<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> the sponsor (Retrotope) decided to test the compound in Friedreich’s ataxia (FA),<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> which is a rare inherited disorder caused by a mutation of the gene encoding for frataxin (FXN). Mitochondrial abnormalities due to FXN mutations and consequent increased lipid peroxidation are thought to be relevant in FA and are the rationale to test RT001.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Patients affected by FA, for which there is no approved medicine, suffer from progressive ataxia associated with areflexia, dysarthria, scoliosis, sensory deficits, cardiomyopathy, and increased odds of developing diabetes mellitus.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></div><div class="NLM_p">In the recent phase I/II double blind, comparator-controlled trial (NCT02445794), the preliminary efficacy, safety, and PK properties of RT001 were tested in 19 FA adult patients that were randomized to receive either RT001 or nondeuterated linoleic acid for 28 days. The deuterated compound was shown to be safe, well-tolerated and to lead to an ameliorated motor capability in FA patients. However, this preliminary evidence, even if encouraging, must be interpreted with caution given the extremely limited sample size and the short duration of the study, which might overestimate the beneficial effects.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> It should be noticed that the use of the nondeuterated compound as comparator makes the trial design informative.</div><div class="NLM_p last">Retrotope has more recently also sponsored a trial on infantile neuroaxonal dystrophy (NCT03570931), an ultrarare life-threatening neurodegenerative disorder.</div></div><div id="sec1_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">2.  ALK-001 in Stargardt’s Disease</h4><div class="NLM_p">Stargardt’s disease, also known as juvenile macular degeneration, is an autosomal recessive macular dystrophy, in which there is an irreversible central visual loss arising in teenage years, which is primarily due to atrophy of the retinal pigment epithelium (RPE) and progressive loss of photoreceptors functionality. As for Friedrich’s ataxia, no cure is at present available for Stargardt’s disease.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p">Stargardt’s disease is attributable to mutations of the gene encoding for the ABCA4 protein (ATP-binding cassette, subfamily A, member 4), a transmembrane flippase expressed in retinal photoreceptors that transports retinaldehyde-PE Schiff base from the luminal side of the disc membrane to the outer side, thus ensuring photoreceptor homeostasis. If a defective functioning of ABCA4 protein exists, retinaldehyde-PE conjugates react to form vitamin A polyene dimers (<i>N</i>-retinylidene-<i>N</i>-retynylethanolamine <b>101</b> and all-<i>trans</i>-retinaldehyde dimer <b>102</b>, <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>), which, once deposited in the RPE, foster the production of lipofuscin, responsible for retinal degeneration.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Biosynthesis of vitamin A polyene dimers and structure of ALK-001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the rate-determining step in vitamin A dimerization is the cleavage of a C20 C–H bond in retinaldehyde-PE Schiff base, deuterium atoms were substituted to C20 hydrogens in order to slow vitamin A dimerization.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Interestingly, the intraperitoneal administration of deuterated vitamin A (<i>d</i><sub>3</sub>-vitamin A <b>93</b>) in wild-type rodents with no defects in vitamin A processing was shown to diminish the biosynthesis of vitamin A dimers.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Preclinical evidence subsequently confirmed that <i>d</i><sub>3</sub>-vitamin A, when orally administered as ALK001 (Alkeus Pharmaceuticals) in mouse models of Stargardt’s disease, has the capability of both slowing vitamin A dimerization rate and lipofuscinogenesis.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> However, it must be highlighted that the preclinical demonstration of the efficacy of <i>d</i><sub>3</sub>-vitamin A in reducing dimerization of vitamin A and lipofuscin formation required a complete replacement of vitamin A with its deuterated form in mouse models,<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116,117)</a> and hence, the translatability of these data to humans needs to be demonstrated.</div><div class="NLM_p last">To date, a phase I clinical trial (NCT02230228) has been conducted in order to assess the safety and PK properties of ALK001 in 40 healthy adults. The trial is complete, although no data are available, and a multicenter, randomized, placebo-controlled phase II study (NCT02402660) aimed at assessing the long-term safety and efficacy of ALK001 on the progression of Stargardt’s disease in both pediatric and adult patients is now ongoing.</div></div></div><div id="sec1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> CTP-499: A Deuterated Metabolite of Pentoxifylline</h3><div class="NLM_p">Pentoxifylline (PTX <b>103</b>, <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>) is a synthetic dimethylxanthine derivative that acts as a nonselective phosphodiesterase inhibitor. Given its well-known hemorheologic properties, PTX has long been used to treat occlusive peripheral vascular diseases. Interestingly, PTX is recognized to have a number of favorable effects other than those on blood flow, including anti-inflammatory, antiproliferative, immunomodulatory, and antifibrotic properties, all of which have contributed to make PTX a good drug for treating chronic kidney disease (CDK). Such a renoprotective function is mainly attributed to one of PTX active metabolites, which is 1-[(<i>S</i>)-5-hydroxylhexyl]-3,7-dimethylxanthine (HDX <b>104</b>). In order to increase the stability of HDX, five hydrogen atoms at the 4- and 6-positions of the hexyl moiety of HDX were replaced by deuterium atoms (CTP-499 <b>105</b>). Preclinical evidence suggests that, similar to HDX, CTP-499 has antifibrogenic, antioxidative, and anti-inflammatory properties in rat models of CDK.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Pentoxifylline, HDX, and <i>d</i><sub>5</sub>-HDX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A phase I study (NCT01328821) on CTP-499 was conducted to assess its PK, safety, and tolerability after single dose administration. CTP-499 exposure was herein compared with that of PTX in male healthy adults (phase Ia). Interestingly, the plasma concentrations of CTP-499 and related major metabolites (M1-M5) were shown to be higher compared to those of PTX.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> The tolerated dose and the effects of food on CTP-499 PK were also defined herein.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Hence, a subsequent phase Ib randomized, placebo-controlled study was performed to investigate safety and tolerability of CTP-499 in CKD patients. The deuterated compound was reported to be safe and to be rapidly absorbed, with a low interindividual variability.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> On this basis, a 24-week phase II study (NCT01487109) was initiated to evaluate the safety and efficacy of CTP-499 in patients affected by diabetic nephropathy and treated with an ACE inhibitor and/or an angiotensin II receptor blocker. Even if the study is now completed, trial results are not yet publicly available.</div></div><div id="sec1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Nomenclature of Deuterated Compounds</h3><div class="NLM_p">Most regulated countries require that drugs that enter the market are assigned an approved name. While a number of countries have their own naming agency (United States, Great Britain, Japan, China), most countries rely on the World Health Organization (WHO) to allocate an international nonproprietary name (INN), i.e., the global approved name. Importantly, also where national agencies exist, there is always the will to align their decisions to those of WHO, whenever possible, to reduce confusion which may lead to medication errors. Names follow conventions and deuterated compounds usually are flagged with the prefix deu- and take the identical INN of the parent nondeuterated compound, if allocated beforehand (for example, deutetrabenazine). A list of all WHO approved names and structures is published by the WHO. The list includes deutolperisone, deutetrabenazine, deudextromethorphan, and deutivacaftor. One of the deuterated compounds in clinical trials well illustrates why this system is in place. Indeed, clinical trials have been initiated in a number of cancer types with a compound referred to by the applicant and in the literature as donafenib (<b>106</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). It is likely that this name was chosen by the company developing the compound and not by any naming agency as it represents a deuterated form of the known and approved tyrosine kinase inhibitor sorafenib. If clinical trials were to be successful and the drug were to be approved, it would therefore most likely receive the INN deusorafenib to show the relationship with sorafenib. It is also interesting that the naming conventions of WHO has changed through the years. Indeed, in the 1990s a deuterated derivative of ascorbic acid, possibly the first deuterated drug to receive an INN, was named zilascorb(2H) (<b>107</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). Zilascorb(2H) was studied in phase 1 trials for cancer and was later abandoned.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. <i>d</i><sub>3</sub>-Sorafenib and zilascorb(2H).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec1_9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Final Remarks and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While the use of deuterium in drug design is steadily increasing, a number of issues have probably slowed down the uptake of this bioisosteric replacement in recent years, namely, (i) an erroneous perceived possible toxicity of deuterium, (ii) risks associated with intellectual property, (iii) uncertainties around the costs associated with the active principle, and (iv) from an industrial setting, the regulatory path that will be applied by regulatory agencies for deu-evergreening.</div><div class="NLM_p">Most studies relating to the toxicity of deuterium are relatively old, yet data are reassuring. While it could be expected that deuterium, at high enough concentrations, may be toxic, it is estimated that the threshold for clinically relevant side effects is between 200 and 400 mg/kg of pure D<sub>2</sub>O (i.e., 14 g for a 70 kg person), well above what can be envisaged for a medical use.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Indeed, the amount of deuterium in bioactive molecules would be lower by 2–3 orders of magnitude. Safety of deuterium per se is not therefore a real concern. Another issue that limited deuterated drug R&D in the past was sensitive analytical techniques (e.g., LC/MS/MS) to determine the percentage of deuterium content of a compound with a single deuterium.</div><div class="NLM_p">Patentability of deuterated compounds is a subtler issue. De novo deuterated compounds obviously do not present any issues of obviousness, but deuterium switches are more complex from an intellectual point of view. Patent applications for deuterated compounds in this latter category have been allowed, rejected, or allowed after restriction.<a onclick="showRef(event, 'cit21b cit21c'); return false;" href="javascript:void(0);" class="ref cit21b cit21c">(21b,c)</a> Presumably, the different outcome depends on the effect that the deuterated compound has compared to the ancestor, on the data that support the claims, and on the prior art of the nondeuterated compound. Therefore, it is possible to protect the intellectual property in this instance if well supported by data. Indeed, the present review highlights that while the rationale to deuterate a compound may in many instances be strong, the outcome of deuteration is instead unpredictable and in no way obvious. It should be noted that postapproval litigations over deuterated drugs may be possible. Also, it must be considered that for many years deuteration was not an obvious practice and therefore should not be considered obvious in the prior art when considering older patents. It is therefore not surprising that the prevalence of patents that protect both deuterated and nondeuterated drugs is significantly increasing (independently of whether examples are present in the patent), an indication of the fact that the pharmaceutical industry is becoming sensitive to this issue, both scientifically (when examples are given) and legally (when examples are not given).</div><div class="NLM_p">A further concern relating to a new deuterated compound is usually given by manufacturing costs. For everyday academic researchers who work on small scales, this is, in our experience, not an issue, as reagents are only moderately more expensive than their nondeuterated counterparts. Yet in a previous review in this journal, Gant suggested that this is not a concern also in industrial scale-up settings, and the cost of reagents should not represent a barrier, and bulk purchases will further reduce the price.<a onclick="showRef(event, 'cit6a'); return false;" href="javascript:void(0);" class="ref cit6a">(6a)</a> Indeed, the cost of enriched D<sub>2</sub>O as a manufacturing deuterium source is low enough (and will probably decrease in the future) to generally enable acceptable costs for manufacturing heavy drugs. Furthermore, a deuterium switch can potentially lead to a lower dose, which ultimately may cost less to produce. While this is generally true, it should be noted that also in this case it will actually depend on the single compound. Most drugs currently in development relate to rare diseases or are for indications in which manufacturing costs will not affect at all the sale price. It is at present unclear whether costs might become a limiting factor for drugs in primary care or for compounds that might need to compete in the generic arena. The news that an abbreviated, hybrid pathway was employed (505(b)(2) by the FDA for deutetrabenazine approval increases the chance that deu-ever-greening may turn to an opportunity, reducing risks and lowering the costs of preclinical and clinical development.</div><div class="NLM_p">In summary, a critical appraisal of the literature suggests that deuterium is entering the medicinal chemist’s toolbox, and it is foreseeable that drugs will be increasingly endowed with deuterium atoms in the future. Deuterium incorporation is particularly appropriate for those soft spots that suffer from strict and rigid structure–activity relationships, where no change in steric hindrance or electronegativity is tolerated. While a pure deuterium switch has become more difficult due to patentability concerns, we are already witnessing an increasing use of deuterium incorporation during de novo drug discovery and development. Nevertheless, medicinal chemists should be aware that designing and developing a successful deuterated drug are far from straightforward. First of all, both intuition and rigor are necessary for selecting compounds and positions that might be amenable to precision deuteration and this cannot go beyond the understandings of metabolic fates, an evaluation of the nature of the oxidation reactions, their DKIEs and the synthetic feasibility of the deuterated compound. A beneficial effect of deuterium in vitro does not guarantee a success in biological systems. Indeed, substantial differences among species are often found and many different factors competing with DKIE might mask or even reverse the desired effects of deuteration. While finding an effect of deuteration may be left to a serendipitous approach, the literature is now providing examples of extremely rigorous and elegant approaches to obtaining the most from deuterium. This is nicely exemplified by the thorough work of Stringer et al.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> when developing the CRF<sub>1</sub> antagonist <i>d</i><sub>3</sub>-NVS-CRF38.</div><div class="NLM_p last">In conclusion, the examples provided by the literature would suggest that deuterium isosteric replacement will come of age and will be a great opportunity for medical chemists. Indeed, we share the vision of Sheila DeWitt, CEO of a pharmaceutical company that focuses its efforts on deuterated drugs, that in a recent interview stated “Fluorine was in less than 2% of drugs in the 1970s but is now in as many as 25% of approved drugs. You see fluorine in places you never thought possible. The same will happen to deuterium.”<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> On this note, it is interesting to appreciate that nowadays deuterium has also been used for bioisosteric replacements when fluorine replacement is unfeasible,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> further strengthening the parallel between the two.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01808" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracey Pirali</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3936-4787" title="Orcid link">http://orcid.org/0000-0003-3936-4787</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3a4e485b595f43144a53485b56537a4f54534f4a5514534e"><span class="__cf_email__" data-cfemail="1561677476706c3b657c6774797c55607b7c60657a3b7c61">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Serafini</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Cargnin</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armando A. Genazzani</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Largo Donegani 2, 28100 Novara, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1923-7430" title="Orcid link">http://orcid.org/0000-0003-1923-7430</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Tracey Pirali</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=BIO-d7e5543-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tracey Pirali</b> received her degree in Pharmaceutical Chemistry and Technology in 2004 and her Ph.D. in Science of Bioactive Compounds from the Università del Piemonte Orientale (Novara, Italy) in 2007. She spent sabbatical leaves in Prof. Jieping Zhu’s lab at the CNRS in Gif-sur-Yvette (Paris) and at the School of Chemistry in Edinburgh (U.K.) with Prof. Michael Greaney. In 2012 she received the Farmindustria Prize by the Italian Chemical Society. In 2016 she cofounded the Start Up ChemICare. Currently, she is Associate Professor of Medicinal Chemistry at the Università del Piemonte Orientale and her main research interest is the design and synthesis of bioactive compounds, with a special emphasis on deuterium incorporation.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Marta Serafini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=BIO-d7e5548-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Marta Serafini</b> received her degree in Pharmaceutical Chemistry and Technology in 2015 from the Università del Piemonte Orientale (Novara, Italy). At present, she is a Ph.D. student in Chemistry and Biology at the Department of Pharmaceutical Sciences in Novara under Prof. Tracey Pirali’s supervision. Her fields of interest focus on the discovery of SOCE modulators, TRPV1 soft drugs, and deuterated bioactive compounds.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Sarah Cargnin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=BIO-d7e5553-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sarah Cargnin</b> received her degree in Pharmacy in 2011 and her Ph.D. in Pharmaceutical and Food Biotechnologies in 2016 at the Università del Piemonte Orientale (Novara, Italy). At present, she is a postdoc in Pharmacology at the Department of Pharmaceutical Sciences in Novara. Her main research interest focuses on personalized medicine.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Armando A. Genazzani</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=BIO-d7e5558-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Armando A. Genazzani</b> received his medical degree from the Università di Catania (Italy) and obtained his D.Phil. in Pharmacology from the University of Oxford (U.K.). After a postdoctoral position at the ETH-Zurich he became a University Lecturer at the University of Cambridge (U.K.) and a Clare Hall Official Fellow. At present, he is a Full Professor of Pharmacology at the Università del Piemonte Orientale (Novara, Italy). His main research interests concern cell signaling and the mechanisms of action of old and new biologically active compounds.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62638" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62638" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">S.C. holds a temporary research fellowship (Bando Formazione CRT, ID 393) supported by Università degli Studi del Piemonte Orientale, which is deeply acknowledged. M.S. is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) fellowship from Italy. T.P. gratefully acknowledges AIRC and Fondazione Cariplo (Grant 15918) and Ricerca Locale DSF 2016.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AADC</td><td class="NLM_def"><p class="first last">aromatic <span class="smallcaps smallerCapital">l</span>-amino acid decarboxylase</p></td></tr><tr><td class="NLM_term">ABCA4</td><td class="NLM_def"><p class="first last">ATP-binding cassette, subfamily A, member 4</p></td></tr><tr><td class="NLM_term">AO</td><td class="NLM_def"><p class="first last">aldehyde oxidase</p></td></tr><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">C–C chemokine receptor type 5</p></td></tr><tr><td class="NLM_term">CdSe</td><td class="NLM_def"><p class="first last">cadmium selenide</p></td></tr><tr><td class="NLM_term">CEO</td><td class="NLM_def"><p class="first last">Chief Executive Officer</p></td></tr><tr><td class="NLM_term">CKD</td><td class="NLM_def"><p class="first last">chronic kidney disease</p></td></tr><tr><td class="NLM_term">CRF1</td><td class="NLM_def"><p class="first last">corticotropin-releasing hormone receptor 1</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P;</p></td></tr><tr><td class="NLM_term">D</td><td class="NLM_def"><p class="first last">deuterium</p></td></tr><tr><td class="NLM_term">DBH</td><td class="NLM_def"><p class="first last">dopamine β-hydroxylase</p></td></tr><tr><td class="NLM_term">DKIE</td><td class="NLM_def"><p class="first last">deuterium kinetic isotope effect</p></td></tr><tr><td class="NLM_term">DNA-PK</td><td class="NLM_def"><p class="first last">DNA-dependent protein kinase</p></td></tr><tr><td class="NLM_term">DP</td><td class="NLM_def"><p class="first last">deuterated pool</p></td></tr><tr><td class="NLM_term">FA</td><td class="NLM_def"><p class="first last">Friedreich’s ataxia</p></td></tr><tr><td class="NLM_term">FXN</td><td class="NLM_def"><p class="first last">frataxin</p></td></tr><tr><td class="NLM_term">H</td><td class="NLM_def"><p class="first last">protium</p></td></tr><tr><td class="NLM_term">HDX</td><td class="NLM_def"><p class="first last">1-[(<i>S</i>)-5-hydroxylhexyl]-3,7-dimethylxanthine</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HK</td><td class="NLM_def"><p class="first last">(2<i>S</i>,6<i>S</i>;2<i>R</i>,6<i>R</i>)-hydroxyketamine</p></td></tr><tr><td class="NLM_term">HNK</td><td class="NLM_def"><p class="first last">(2<i>S</i>,6<i>S</i>;2<i>R</i>,6<i>R</i>)-hydroxynorketamine</p></td></tr><tr><td class="NLM_term">INN</td><td class="NLM_def"><p class="first last">international nonproprietary name</p></td></tr><tr><td class="NLM_term">KET</td><td class="NLM_def"><p class="first last">ketamine</p></td></tr><tr><td class="NLM_term">KIE</td><td class="NLM_def"><p class="first last">kinetic isotope effect</p></td></tr><tr><td class="NLM_term">L-DOPA</td><td class="NLM_def"><p class="first last">levodopa</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">MPTP</td><td class="NLM_def"><p class="first last">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</p></td></tr><tr><td class="NLM_term">PBR</td><td class="NLM_def"><p class="first last">peripheral benzodiazepine receptor</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PTX</td><td class="NLM_def"><p class="first last">pentoxifylline</p></td></tr><tr><td class="NLM_term">PUFA</td><td class="NLM_def"><p class="first last">polyunsaturated fatty acid</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RPE</td><td class="NLM_def"><p class="first last">retinal pigment epithelium</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SGLT2</td><td class="NLM_def"><p class="first last">sodium–glucose cotransporter-2</p></td></tr><tr><td class="NLM_term">TSPO</td><td class="NLM_def"><p class="first last">translocator protein</p></td></tr><tr><td class="NLM_term">Tyk2</td><td class="NLM_def"><p class="first last">tyrosine kinase 2.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 123 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> Established by the internationally
accepted Vienna Standard Mean Ocean Water (VSMOW).<span class="NLM_contrib-group"><span class="NLM_string-name">Rosman, K. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P. D. P.</span></span> <span> </span><span class="NLM_article-title">Isotopic compositions of the elements 1997 (Technical Report)</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1351/pac199870010217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1351%2Fpac199870010217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1cXjsVGntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=217-235&author=K.+J.+R.+Rosmanauthor=P.+D.+P.+Taylor&title=Isotopic+compositions+of+the+elements+1997+%28Technical+Report%29&doi=10.1351%2Fpac199870010217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isotopic compositions of the elements, 1997</span></div><div class="casAuthors">Rosman, K. J. R.; Taylor, P. D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-235</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The Commission's Subcommittee for the Isotopic Compn. of the Elements (SIAM) has carried out its biennial review of isotopic compns., such as detd. by mass spectrometry and other relevant methods.  This involves a crit. evaluation of the published literature, element by element, and forms th basis of the Table of Isotopic Compns. of the Elements as detd. by Mass Spectroscopy presented here.  New guidelines have been used to arrive at the uncertainties on the isotopic abundances and there are numerous changes to the Table since it was last published in 1991.  At. wts. calcd. from this table are consistent with Sr(E) values listed in the Table of Std. At. Wts. 1997.  A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5qh2-u64-Z7Vg90H21EOLACvtfcHk0lhM1GExgpvyRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsVGntLY%253D&md5=209535668c87b00dfb80ea67bea10bb0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1351%2Fpac199870010217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac199870010217%26sid%3Dliteratum%253Aachs%26aulast%3DRosman%26aufirst%3DK.%2BJ.%2BR.%26aulast%3DTaylor%26aufirst%3DP.%2BD.%2BP.%26atitle%3DIsotopic%2520compositions%2520of%2520the%2520elements%25201997%2520%2528Technical%2520Report%2529%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1998%26volume%3D70%26spage%3D217%26epage%3D235%26doi%3D10.1351%2Fpac199870010217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urey, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brickwedde, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G. M.</span></span> <span> </span><span class="NLM_article-title">A hydrogen isotope of mass 2 and its concentration</span>. <i>Phys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1932</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1103/PhysRev.40.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1103%2FPhysRev.40.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaA38XktFWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1932&pages=1-15&author=H.+C.+Ureyauthor=F.+G.+Brickweddeauthor=G.+M.+Murphy&title=A+hydrogen+isotope+of+mass+2+and+its+concentration&doi=10.1103%2FPhysRev.40.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The hydrogen isotope of mass 2 and its concentration</span></div><div class="casAuthors">Urey, Harold C.; Brickwedde, F. G.; Murphy, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Review</span>
        (<span class="NLM_cas:date">1932</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">PHRVAO</span>;
        ISSN:<span class="NLM_cas:issn">0031-899X</span>.
    </div><div class="casAbstract">cf. C. A. 26, 1857.  An isotope of H with mass no. 2 has been found present to the extent of one part in about 4000 in ordinary H.  No evidence for H3 was obtained.  The vapor pressures of pure crystals contg. only a single species of the isotopic mols. H1H1, H1H2, H1F3 were calcd. after postulating (1) that the rotational and vibrational energies of the mols. are the same in the solid and gaseous states; (2) that in the Debye theory of the solid state, θ is inversely proportional to the square root of the mol. mass; (3) that the free energy of the gas is given by the free-energy equation of an ideal monat. gas; and (4) that there is a zero-point lattice energy equal to (9/8) R θ per mol.  The calcd. vapor pressures of the 3 isotopic mols. in equil. with their solids at the triple point for ordinary H are in the ratio p11:p12:p13 = 1:0.37:0.29.  The isotope was concd. in 3 samples of gas by evapg. large quantities of liquid H2 and collecting the gas which evapd. from the last 2 or 3 cc.  These samples and ordinary H2 were investigated for the visible at. Balmer series spectra of H2 and H3 from a H2 discharge tube with a 21-ft. grating that had a dispersion of 1.31 A. U. per mm.  When with ordinary H2 the times of exposure required just to record the strong H2 lines were increased 4000 times, very faint lines appeared at the calcd. positions for the H2 lines accompanying H1β, H1γ and H1δ on the short-wave side and sepd. from them by between 1 and 2 A. U.  These lines do not agree in wave length with any known mol. lines and do not appear on plates recording the strong mol. spectrum.  With ordinary H2 they were so weak that it was difficult to be sure that they were not irregular ghosts of the strongly overexposed at. lines.  Two of the above samples evapd. near the triple point show these lines and another near H1α greatly enhanced relative to the H1 lines over those with ordinary H2, showing that these new lines are not ghosts and that there was a considerable increase in the concn. of the isotope in these samples.  In the other sample evapd. near the b. p. no appreciable increase in concn. was detected.  The new lines agree in wave length with those calcd. for an H2 isotope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2X1i_rUc9prVg90H21EOLACvtfcHk0lhM1GExgpvyRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA38XktFWnsQ%253D%253D&md5=78d56b7779af35e502534b028b6b511c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1103%2FPhysRev.40.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1103%252FPhysRev.40.1%26sid%3Dliteratum%253Aachs%26aulast%3DUrey%26aufirst%3DH.%2BC.%26aulast%3DBrickwedde%26aufirst%3DF.%2BG.%26aulast%3DMurphy%26aufirst%3DG.%2BM.%26atitle%3DA%2520hydrogen%2520isotope%2520of%2520mass%25202%2520and%2520its%2520concentration%26jtitle%3DPhys.%2520Rev.%26date%3D1932%26volume%3D40%26spage%3D1%26epage%3D15%26doi%3D10.1103%2FPhysRev.40.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. L.</span></span> <span> </span><span class="NLM_article-title">A production of amino acids under possible primitive earth conditions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1126/science.117.3046.528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.117.3046.528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=13056598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaG3sXms1aktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1953&pages=528-529&author=S.+L.+Miller&title=A+production+of+amino+acids+under+possible+primitive+earth+conditions&doi=10.1126%2Fscience.117.3046.528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Production of amino acids under possible primitive earth conditions</span></div><div class="casAuthors">Miller, Stanley L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">528-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The hypothesis that org. compds. that served as the basis of life were formed when the earth had an atm. of CH4, NH3, H2O, and H2 was tested by circulating these gases past an elec. discharge for a week.  A description of the app. is given.  The resulting mixt. was assayed for amino acids by paper chromatography, α-Alanine and β-alanine were positively identified in significant amts.  A tentative identification of aspartic acid, α-aminobutyric acid, and possibly β- and γ-amino acids was also made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUGzMBklf_WbVg90H21EOLACvtfcHk0ljUJu3YV8lNEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXms1aktA%253D%253D&md5=05aafc0268edcf17220815adf7f0d978</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.117.3046.528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.117.3046.528%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BL.%26atitle%3DA%2520production%2520of%2520amino%2520acids%2520under%2520possible%2520primitive%2520earth%2520conditions%26jtitle%3DScience%26date%3D1953%26volume%3D117%26spage%3D528%26epage%3D529%26doi%3D10.1126%2Fscience.117.3046.528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colón-Santos, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gromski, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suárez Marina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, L.</span></span> <span> </span><span class="NLM_article-title">Miller-Urey spark-discharge experiments in the deuterium world</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8079</span>– <span class="NLM_lpage">8082</span>, <span class="refDoi"> DOI: 10.1002/anie.201610837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.201610837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=8079-8082&author=G.+J.+T.+Cooperauthor=A.+J.+Surmanauthor=J.+McIverauthor=S.+M.+Col%C3%B3n-Santosauthor=P.+S.+Gromskiauthor=S.+Buchwaldauthor=I.+Su%C3%A1rez+Marinaauthor=L.+Cronin&title=Miller-Urey+spark-discharge+experiments+in+the+deuterium+world&doi=10.1002%2Fanie.201610837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Miller-Urey spark-discharge experiments in the deuterium world</span></div><div class="casAuthors">Cooper, Geoffrey J. T.; Surman, Andrew J.; McIver, Jim; Colon-Santos, Stephanie M.; Gromski, Piotr S.; Buchwald, Saskia; Suarez Marina, Irene; Cronin, Leroy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8079-8082</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We designed and conducted a series of primordial-soup Miller-Urey-style expts. with deuterated gases and reagents to compare the spark-discharge products of a "deuterated world" with the std. reaction in the "hydrogenated world".  While the deuteration of the system had little effect on the distribution of amino acid products, significant differences were seen in other regions of the product-space.  Not only did we observe ∼120 new species, we also saw significant differences in their distribution if the 2 hydrogen isotope worlds were compared.  Several isotopolog matches could be identified in both, but a large proportion of products had no equiv. in the corresponding isotope world with ∼43 new species in the D world and ∼39 new species in the H world.  This showed that isotopic exchange (the addn. of only one neutron) may lead to significant addnl. complexity in chem. space under otherwise identical reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW6eGhBl97wbVg90H21EOLACvtfcHk0ljUJu3YV8lNEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWqu7w%253D&md5=6b0378229092fcd756d73c231ae961f1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fanie.201610837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201610837%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DG.%2BJ.%2BT.%26aulast%3DSurman%26aufirst%3DA.%2BJ.%26aulast%3DMcIver%26aufirst%3DJ.%26aulast%3DCol%25C3%25B3n-Santos%26aufirst%3DS.%2BM.%26aulast%3DGromski%26aufirst%3DP.%2BS.%26aulast%3DBuchwald%26aufirst%3DS.%26aulast%3DSu%25C3%25A1rez%2BMarina%26aufirst%3DI.%26aulast%3DCronin%26aufirst%3DL.%26atitle%3DMiller-Urey%2520spark-discharge%2520experiments%2520in%2520the%2520deuterium%2520world%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D8079%26epage%3D8082%26doi%3D10.1002%2Fanie.201610837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">The use of stable isotopes in pharmacological research</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=7029573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL38XlsFGksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1981&pages=81-132&author=T.+A.+Baillie&title=The+use+of+stable+isotopes+in+pharmacological+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The use of stable isotopes in pharmacological research</span></div><div class="casAuthors">Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-132</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">A review with 507 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx_TMoDPwOELVg90H21EOLACvtfcHk0ljUJu3YV8lNEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlsFGksLw%253D&md5=fb15a0ef3c0405714ad6c5baa2b9d584</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DThe%2520use%2520of%2520stable%2520isotopes%2520in%2520pharmacological%2520research%26jtitle%3DPharmacol.%2520Rev.%26date%3D1981%26volume%3D33%26spage%3D81%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M.</span></span> <span> </span><span class="NLM_article-title">Deuterium- and tritium-labelled compounds: applications in the life sciences</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1758</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1002/anie.201704146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.201704146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1758-1784&author=J.+Atzrodtauthor=V.+Derdauauthor=W.+J.+Kerrauthor=M.+Reid&title=Deuterium-+and+tritium-labelled+compounds%3A+applications+in+the+life+sciences&doi=10.1002%2Fanie.201704146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences</span></div><div class="casAuthors">Atzrodt, Jens; Derdau, Volker; Kerr, William J.; Reid, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1758-1784</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Hydrogen isotopes are unique tools for identifying and understanding biol. and chem. processes.  Hydrogen isotope labeling allows for the traceless and direct incorporation of an addnl. mass or radioactive tag into an org. mol. with almost no changes in its chem. structure, phys. properties, or biol. activity.  Using deuterium-labeled isotopologues to study the unique mass-spectrometric patterns generated from mixts. of biol. relevant mols. drastically simplifies anal.  Such methods are now providing unprecedented levels of insight in a wide and continuously growing range of applications in the life sciences and beyond.  Tritium (3H), in particular, has seen an increase in utilization, esp. in pharmaceutical drug discovery.  The efforts and costs assocd. with the synthesis of labeled compds. are more than compensated for by the enhanced mol. sensitivity during anal. and the high reliability of the data obtained.  In this Review, advances in the application of hydrogen isotopes in the life sciences are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2Jh-Cv5aPbVg90H21EOLACvtfcHk0ljUJu3YV8lNEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgtw%253D%253D&md5=4d6ee858335dbe9f59601428a56415bd</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201704146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201704146%26sid%3Dliteratum%253Aachs%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DKerr%26aufirst%3DW.%2BJ.%26aulast%3DReid%26aufirst%3DM.%26atitle%3DDeuterium-%2520and%2520tritium-labelled%2520compounds%253A%2520applications%2520in%2520the%2520life%2520sciences%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D1758%26epage%3D1784%26doi%3D10.1002%2Fanie.201704146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gant, T. G.</span></span> <span> </span><span class="NLM_article-title">Using deuterium in drug discovery: leaving the label in the drug</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3595</span>– <span class="NLM_lpage">3611</span>, <span class="refDoi"> DOI: 10.1021/jm4007998</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4007998" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3595-3611&author=T.+G.+Gant&title=Using+deuterium+in+drug+discovery%3A+leaving+the+label+in+the+drug&doi=10.1021%2Fjm4007998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Using Deuterium in Drug Discovery: Leaving the Label in the Drug</span></div><div class="casAuthors">Gant, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3595-3611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Deuterium, the stable isotope of hydrogen, is known to medicinal chemists for its utility in mechanistic, spectroscopic, and tracer studies.  In fact, well-known applications utilizing deuterium exist within every subdiscipline in pharmaceutical discovery and development.  Recent emphasis on incorporation of deuterium into the active pharmaceutical ingredient has come about as a result of inquiries into the potential for substantial benefits of the deuterium kinetic isotope effect on the safety and disposition of the drug substance.  This Perspective traces the author's experience in reviving and expanding this potential utility, first suggested many decades prior by the discoverer of this, the simplest of all isotopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4z14tbfBfBbVg90H21EOLACvtfcHk0ljCUqJYuK8dMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrvJ&md5=3818a1dba9be431098ad9dd941dababc</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm4007998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4007998%26sid%3Dliteratum%253Aachs%26aulast%3DGant%26aufirst%3DT.%2BG.%26atitle%3DUsing%2520deuterium%2520in%2520drug%2520discovery%253A%2520leaving%2520the%2520label%2520in%2520the%2520drug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3595%26epage%3D3611%26doi%3D10.1021%2Fjm4007998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span> <span> </span><span class="NLM_article-title">Deuterium medicinal chemistry comes of age</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.4155%2Ffmc-2016-0032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27079428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=491-494&author=R.+D.+Tung&title=Deuterium+medicinal+chemistry+comes+of+age&doi=10.4155%2Ffmc-2016-0032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium medicinal chemistry comes of age</span></div><div class="casAuthors">Tung, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-494</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UJsj0IBrHbVg90H21EOLACvtfcHk0ljCUqJYuK8dMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsr4%253D&md5=1709a6193f9dee254450a11ee0e523d9</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0032%26sid%3Dliteratum%253Aachs%26aulast%3DTung%26aufirst%3DR.%2BD.%26atitle%3DDeuterium%2520medicinal%2520chemistry%2520comes%2520of%2520age%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D491%26epage%3D494%26doi%3D10.4155%2Ffmc-2016-0032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span> <span> </span><span class="NLM_article-title">Deuterium in drug discovery and development</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-386009-5.00003-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FB978-0-12-386009-5.00003-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCks7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=403-471&author=S.+L.+Harbesonauthor=R.+D.+Tung&title=Deuterium+in+drug+discovery+and+development&doi=10.1016%2FB978-0-12-386009-5.00003-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium in drug discovery and development</span></div><div class="casAuthors">Harbeson, Scott L.; Tung, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">403-417</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review presents the use of deuterium to alter the metabolic properties of compds. and discusses past and current development of potential deuterium-contg. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLrwZvjXhTkrVg90H21EOLACvtfcHk0ljCUqJYuK8dMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCks7fL&md5=48188b3d60119f12cad9ae7ebe877ef5</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-386009-5.00003-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-386009-5.00003-5%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DTung%26aufirst%3DR.%2BD.%26atitle%3DDeuterium%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D403%26epage%3D471%26doi%3D10.1016%2FB978-0-12-386009-5.00003-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doller, D.</span></span> <span> </span><span class="NLM_article-title">A decade of deuteration in medicinal chemistry</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1016/bs.armc.2017.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fbs.armc.2017.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOlsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=519-542&author=J.+F.+Liuauthor=S.+L.+Harbesonauthor=C.+L.+Brummelauthor=R.+Tungauthor=R.+Silvermanauthor=D.+Doller&title=A+decade+of+deuteration+in+medicinal+chemistry&doi=10.1016%2Fbs.armc.2017.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of deuteration in medicinal chemistry</span></div><div class="casAuthors">Liu, Julie F.; Harbeson, Scott L.; Brummel, Christopher L.; Tung, Roger; Silverman, Robert; Doller, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519-542</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The use of deuterium to drive DIEs and favorably alter pharmacokinetics and metab. in drug discovery has accelerated in the last decade.  The first major wave of patent applications came from small biotechnol. organizations and were aimed at improving pharmacokinetic properties of marketed drugs or enhancing properties offailed drug candidates.  A substantial no. of patent applications were published beginning in 2006, and the deuterium chem. patent estate continues to expand.  Deuterated drug candidates have progressed from early patent filings to successful proof-of-concept human studies, including the first FDA-approved deuterated drug.  The use of DIEs in drug design has expanded, and now deuteration of drug candidates and tool compds., including imaging ligands, has become a welcome instrument in the arsenal of medicinal chemists.  It is expected that experimentation with strategic introduction of deuterium into the structures of org. compds. will continue to increase and may enable the future development ofa variety ofnovel drugs and chem. tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRWRQHDkKt5LVg90H21EOLACvtfcHk0lgIcmzLLFfQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOlsrvF&md5=18499ed5ccfb021913c4dea9e51946b7</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fbs.armc.2017.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.armc.2017.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DTung%26aufirst%3DR.%26aulast%3DSilverman%26aufirst%3DR.%26aulast%3DDoller%26aufirst%3DD.%26atitle%3DA%2520decade%2520of%2520deuteration%2520in%2520medicinal%2520chemistry%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2017%26volume%3D50%26spage%3D519%26epage%3D542%26doi%3D10.1016%2Fbs.armc.2017.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lgIcmzLLFfQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’
Ferrall, R. A. M.</span></span> <span> </span><span class="NLM_article-title">A pictorial representation of zero-point energy and tunnelling contributions to primary hydrogen isotope effects</span>. <i>J. Phys. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1002/poc.1738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fpoc.1738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVKksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=572-579&author=R.+A.+M.+O%E2%80%99%0AFerrall&title=A+pictorial+representation+of+zero-point+energy+and+tunnelling+contributions+to+primary+hydrogen+isotope+effects&doi=10.1002%2Fpoc.1738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A pictorial representation of zero-point energy and tunnelling contributions to primary hydrogen isotope effects</span></div><div class="casAuthors">O'Ferrall, R. A. More</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">572-579</span>CODEN:
                <span class="NLM_cas:coden">JPOCEE</span>;
        ISSN:<span class="NLM_cas:issn">0894-3230</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The interpretation of primary hydrogen isotope effects in terms of isotopic sensitivities of zero-point energies in the reactants and transition state is reviewed.  The reader is reminded that the transition state for a hydrogen transfer reaction corresponds to the position of max. energy on the min. energy path defined by the motion of the heavy atoms between which hydrogen is transferred.  Tunnelling occurs through the potential energy barrier sepg. the reactant and product channels of the potential energy surface for this reaction.  It is a consequence of rapid vibrational motion of the hydrogen within a collision complex and the overlap of vibrational wave functions between reactant and product sides of the barrier.  Comparing zero-point energies of a tunnelling complex and a hydrogen bond confirms results of calcns. indicating that the zero-point energy of the complex is likely to be less than that of the reactants.  It follows that there should be a compensation between contributions from zero-point energy changes and tunnelling which may explain why tunnelling rarely leads to very large isotope effects at ambient temps.  The isotopic sensitivity of the zero-point energy of the transition state is discussed in terms of variations in force consts. of reacting bonds within a three-center model.  A shift in isotopic sensitivity from the reaction coordinate mode to real stretching vibration as the structure of the transition state becomes more reactant- or product-like, which provides a basis for the Westheimer effect, contrasts with the behavior of hydrogen bonds, for which there is no change in isotopic sensitivity of the two stretching modes.  Copyright © 2010 John Wiley and Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1hJQ_5gMHWLVg90H21EOLACvtfcHk0lgIcmzLLFfQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVKksrg%253D&md5=5afb1d44e4b847c3364b93c24221554f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fpoc.1738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpoc.1738%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599%2BFerrall%26aufirst%3DR.%2BA.%2BM.%26atitle%3DA%2520pictorial%2520representation%2520of%2520zero-point%2520energy%2520and%2520tunnelling%2520contributions%2520to%2520primary%2520hydrogen%2520isotope%2520effects%26jtitle%3DJ.%2520Phys.%2520Org.%2520Chem.%26date%3D2010%26volume%3D23%26spage%3D572%26epage%3D579%26doi%3D10.1002%2Fpoc.1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. P.</span></span> <span> </span><span class="NLM_article-title">Liversidge Lecture. Recent advances in the study of kinetic hydrogen isotope effects</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1039/cs9740300513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2Fcs9740300513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaE2MXktVymsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1974&pages=513-544&author=R.+P.+Bell&title=Liversidge+Lecture.+Recent+advances+in+the+study+of+kinetic+hydrogen+isotope+effects&doi=10.1039%2Fcs9740300513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Liversidge lecture.  Recent advances in the study of kinetic hydrogen isotope effects</span></div><div class="casAuthors">Bell, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-44</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    </div><div class="casAbstract">A review with 78 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJuCuIO5qMALVg90H21EOLACvtfcHk0lhZp5QDa8VemA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVymsbw%253D&md5=419c9a2de63db60a0a2058291269c908</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2Fcs9740300513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcs9740300513%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BP.%26atitle%3DLiversidge%2520Lecture.%2520Recent%2520advances%2520in%2520the%2520study%2520of%2520kinetic%2520hydrogen%2520isotope%2520effects%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D1974%26volume%3D3%26spage%3D513%26epage%3D544%26doi%3D10.1039%2Fcs9740300513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzlik, R. P.</span></span> <span> </span><span class="NLM_article-title">Deuterium isotope effects on toluene metabolism. Product release as a rate-limiting step in cytochrome P-450 catalysis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">849</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(89)92511-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2F0006-291X%2889%2992511-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=2719701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL1MXktFyqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1989&pages=844-849&author=K.+H.+Lingauthor=R.+P.+Hanzlik&title=Deuterium+isotope+effects+on+toluene+metabolism.+Product+release+as+a+rate-limiting+step+in+cytochrome+P-450+catalysis&doi=10.1016%2F0006-291X%2889%2992511-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects on toluene metabolism.  Product release as a rate-limiting step in cytochrome P-450 catalysis</span></div><div class="casAuthors">Ling, Kah Hiing John; Hanzlik, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">844-9</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Liver microsomes from phenobarbital-induced rats oxidize toluene to a mixt. of benzyl alc. plus o-, m- and p-cresol (∼69 : 31).  Stepwise deuteration of the Me group causes stepwise decreases in the yield of benzyl alc. relative to cresols (∼24 : 76 for toluene-d3).  For benzyl alc. formation from toluene-d3 DV = 1.92 and D(V/K) = 3.53.  Surprisingly, however, stepwise deuteration induces stepwise increase in total oxidn., giving rise to an inverse isotope effect overall (DV = 0.67 for toluene-d3).  Throughout the series (i.e., d0, d1, d2, d3) the ratios of cresol isomers remain const.  These results are interpreted in terms of product release for benzyl alc. being slower than release of cresols (or their epoxide precursors), and slow enough to be partially rate-limiting in turnover.  Thus, metabolic switching to cresol formation causes a net acceleration of turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVHNXMj6jfsrVg90H21EOLACvtfcHk0lhZp5QDa8VemA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktFyqtr4%253D&md5=ab9524405e3052d19ea364b0d17a94d1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2889%2992511-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252889%252992511-4%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DK.%2BH.%26aulast%3DHanzlik%26aufirst%3DR.%2BP.%26atitle%3DDeuterium%2520isotope%2520effects%2520on%2520toluene%2520metabolism.%2520Product%2520release%2520as%2520a%2520rate-limiting%2520step%2520in%2520cytochrome%2520P-450%2520catalysis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1989%26volume%3D160%26spage%3D844%26epage%3D849%26doi%3D10.1016%2F0006-291X%2889%2992511-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westheimer, F. H.</span></span> <span> </span><span class="NLM_article-title">The magnitude of the primary kinetic isotope effect for compounds of hydrogen and deuterium</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1021/cr60211a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr60211a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaF3MXnvFKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1961&pages=265-273&author=F.+H.+Westheimer&title=The+magnitude+of+the+primary+kinetic+isotope+effect+for+compounds+of+hydrogen+and+deuterium&doi=10.1021%2Fcr60211a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The magnitude of the primary kinetic isotope effect for compounds of hydrogen and deuterium</span></div><div class="casAuthors">Westheimer, F. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-73</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with 50 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM52N3J2pQWLVg90H21EOLACvtfcHk0lhZp5QDa8VemA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXnvFKgtA%253D%253D&md5=cad6f4241e50d9390a1b50746d4b0f89</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr60211a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60211a004%26sid%3Dliteratum%253Aachs%26aulast%3DWestheimer%26aufirst%3DF.%2BH.%26atitle%3DThe%2520magnitude%2520of%2520the%2520primary%2520kinetic%2520isotope%2520effect%2520for%2520compounds%2520of%2520hydrogen%2520and%2520deuterium%26jtitle%3DChem.%2520Rev.%26date%3D1961%26volume%3D61%26spage%3D265%26epage%3D273%26doi%3D10.1021%2Fcr60211a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klinman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohen, A.</span></span> <span> </span><span class="NLM_article-title">Hydrogen tunneling links protein dynamics to enzyme catalysis</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-051710-133623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1146%2Fannurev-biochem-051710-133623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=23746260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=471-496&author=J.+P.+Klinmanauthor=A.+Kohen&title=Hydrogen+tunneling+links+protein+dynamics+to+enzyme+catalysis&doi=10.1146%2Fannurev-biochem-051710-133623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen tunneling links protein dynamics to enzyme catalysis</span></div><div class="casAuthors">Klinman, Judith P.; Kohen, Amnon</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">471-496</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The relationship between protein dynamics and function is a subject of considerable contemporary interest.  Although protein motions are frequently obsd. during ligand binding and release steps, the contribution of protein motions to the catalysis of bond making/breaking processes is more difficult to probe and verify.  Here, we show how the quantum mech. hydrogen tunneling assocd. with enzymic C-H bond cleavage provides a unique window into the necessity of protein dynamics for achieving optimal catalysis.  Exptl. findings support a hierarchy of thermodynamically equilibrated motions that control the H-donor and -acceptor distance and active-site electrostatics, creating an ensemble of conformations suitable for H-tunneling.  A possible extension of this view to Me transfer and other catalyzed reactions is also presented.  The impact of understanding these dynamics on the conceptual framework for enzyme activity, inhibitor/drug design, and biomimetic catalyst design is likely to be substantial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJuUE_QVx_NrVg90H21EOLACvtfcHk0ljUm1EDc6_lYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsr3I&md5=6e24730783d3737dc346d51c2a27d473</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-051710-133623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-051710-133623%26sid%3Dliteratum%253Aachs%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26aulast%3DKohen%26aufirst%3DA.%26atitle%3DHydrogen%2520tunneling%2520links%2520protein%2520dynamics%2520to%2520enzyme%2520catalysis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2013%26volume%3D82%26spage%3D471%26epage%3D496%26doi%3D10.1146%2Fannurev-biochem-051710-133623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolczanski, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinckman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundari, T. R.</span></span> <span> </span><span class="NLM_article-title">Inter- and intramolecular experimental and calculated equilibrium isotope effects for (silox)<sub>2</sub>(tBu<sub>3</sub>SiND)TiR + RH (silox = tBu<sub>3</sub>SiO): inferred kinetic isotope effects for RH/D addition to transient (silox)<sub>2</sub>Ti=NSitBu<sub>3</sub></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">7953</span>– <span class="NLM_lpage">7975</span>, <span class="refDoi"> DOI: 10.1021/ja000112q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja000112q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslOltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=7953-7975&author=L.+M.+Slaughterauthor=P.+T.+Wolczanskiauthor=T.+R.+Klinckmanauthor=T.+R.+Cundari&title=Inter-+and+intramolecular+experimental+and+calculated+equilibrium+isotope+effects+for+%28silox%292%28tBu3SiND%29TiR+%2B+RH+%28silox+%3D+tBu3SiO%29%3A+inferred+kinetic+isotope+effects+for+RH%2FD+addition+to+transient+%28silox%292Ti%3DNSitBu3&doi=10.1021%2Fja000112q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inter- and Intramolecular Experimental and Calculated Equilibrium Isotope Effects for (silox)2(tBu3SiND)TiR + RH (silox = tBu3SiO): Inferred Kinetic Isotope Effects for RH/D Addition to Transient (silox)2Ti:NSitBu3</span></div><div class="casAuthors">Slaughter, LeGrande M.; Wolczanski, Peter T.; Klinckman, Thomas R.; Cundari, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7953-7975</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Intermol. equil. isotope effects (EIEs) were measured (26.5°) and calcd. for (silox)2(tBu3SiND)TiRD (1-ND-RD) + RHH ↹ (silox)2(tBu3SiNH)TiRH (1-RH) + RDD: RHH/RDD = CH4/CD4, 2.00(6), calcd. 1.88; C2H6/C2D6, 2.22(8), 1.93; cC3H6/cC3D6, 1.71(4), 1.48; C2H4/C2D4, 1.41(11), 1.34; C6H6/C6D6, 1.22(7), 1.26; C7H8/C7D8 (50.0°), 1.59(6), 1.55.  Related intramol. EIEs for (silox)2(tBu3SiND)TiR' (1-ND-R') ↹ (silox)2(tBu3SiNH)TiR (1-R) are provided: RH = R'D = CH3D, 3.16(25), calcd. 2.60; CH2D2, 1.13(8), 0.911; CHD3, 0.389(20), 0.303; CH3CD3, 1.53(3), 1.44; 1,1-cC3H4D2, 2.58(6), 2.53; trans-HDC:CHD, 1.00(2), 1.00; 1,3,5-C6H3D3, 1.273(4), 1.25; PhCH2D (50.0°), 2.06(2), 1.98.  Calcns. of pertinent model complexes (e.g., (HO)2(H2N)TiR (1'-R)) generated the vibrational frequencies necessary to interpret the EIEs in terms of a statistical mechanics description using gas-phase partition functions; EIE = SYM × MMI × EXC × EXP[-(ΔΔZPE/kBT)].  The large MMI term in the intermol. cases-a consequence of using perprotio vs. perdeuterio small mol. substrates-is attenuated by EXC and EXP[-(ΔΔZPE/kBT)] contributions derived from low-energy core vibrations.  The EIEs are differentiated on the basis of the EXP[-(ΔΔZPE/kBT)] term, with CH-based bending vibrations playing the major role.  Substrate bending vibrations that are absent in intramol. cases are primarily responsible for the greater intermol. values.  Using measured (or calcd.) EIEs and kinetic isotope effects for 1,2-RH-elimination (KIEelim) from 1-R, KIEaddn values for 1,2-RH-addn. to putative intermediate (silox)2Ti:NSitBu3 were inferred via EIE = KIEaddn/KIEelim.  Extraordinary intermol. KIEaddn values ranging from ∼30 (CH4/CD4, C2H6/C2D6) to ∼9 (C6H6/C6D6) are consistent with previous mechanistic accounts and may be conventionally rationalized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrligLZFkNDGLVg90H21EOLACvtfcHk0ljUm1EDc6_lYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslOltr0%253D&md5=71a52333014380127ad8a11129906896</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja000112q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000112q%26sid%3Dliteratum%253Aachs%26aulast%3DSlaughter%26aufirst%3DL.%2BM.%26aulast%3DWolczanski%26aufirst%3DP.%2BT.%26aulast%3DKlinckman%26aufirst%3DT.%2BR.%26aulast%3DCundari%26aufirst%3DT.%2BR.%26atitle%3DInter-%2520and%2520intramolecular%2520experimental%2520and%2520calculated%2520equilibrium%2520isotope%2520effects%2520for%2520%2528silox%25292%2528tBu3SiND%2529TiR%2520%252B%2520RH%2520%2528silox%2520%253D%2520tBu3SiO%2529%253A%2520inferred%2520kinetic%2520isotope%2520effects%2520for%2520RH%252FD%2520addition%2520to%2520transient%2520%2528silox%25292Ti%253DNSitBu3%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D7953%26epage%3D7975%26doi%3D10.1021%2Fja000112q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern-Dogru, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillgenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R. G.</span></span> <span> </span><span class="NLM_article-title">Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil</span>. <i>Arzneim. Forsch.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1296622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1055%2Fs-0031-1296622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17688073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFaksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2007&pages=293-298&author=F.+Schneiderauthor=E.+Mattern-Dogruauthor=M.+Hillgenbergauthor=R.+G.+Alken&title=Changed+phosphodiesterase+selectivity+and+enhanced+in+vitro+efficacy+by+selective+deuteration+of+sildenafil&doi=10.1055%2Fs-0031-1296622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil</span></div><div class="casAuthors">Schneider, Frank; Mattern-Dogru, Emine; Hillgenberg, Moritz; Alken, Rudolf-Giesbert</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">In order to explore whether selective deuteration of sildenafil affects selectivity and efficacy of the drug, the inhibitory activity of sildenafil (1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d] pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine citrate, CAS 139755-83-2) and three deuterated sildenafil derivs., D8-piperazine-sildenafil (BDD-10402), D3-methyl-D8-piperazine-sildenafil (BDD-10403) and D5-ethoxy-Sildenafil (BDD-10406) against phosphodiesterases 1-6 was compared.  Furthermore, the relaxant effect of sildenafil and its deuterated derivs. in a contractility assay on rabbit corpus cavernosum strips from New Zealand rabbits was investigated.  BDD-10406 exhibits a 2-fold higher selectivity for phosphodiesterase 5 vs. phosphodiesterase 6 than sildenafil.  BDD-10406 and sildenafil inhibited cGMP formation with IC50 values of 6 nmol/L and 9 nmol/L, resp.  The corresponding IC80 values for BDD-10406 and Sildenafil were 33 nmol/L and 40 nmol/L, resp.  Sildenafil, BDD-10402, BDD-10403 and BDD-10406 relaxed the rabbit corpus cavernosum strips in a dose-dependent manner with ED50 values of 245 nmol/L, 91 nmol/L, 121 nmol/L and 85 nmol/L, resp.  Deuteration of sildenafil on the ethoxy group (BDD-10406) leads to enhanced selectivity for phosphodiesterase 5 vs. phosphodiesterase 6 and higher efficacy in vitro.  This is the first example of a deuteration effect on the inhibitory activity of a reversible enzyme inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_8StsIDodP7Vg90H21EOLACvtfcHk0ljUm1EDc6_lYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFaksbY%253D&md5=0a3fcae5b13dc8eaa9563ae72c8e8799</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296622%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DMattern-Dogru%26aufirst%3DE.%26aulast%3DHillgenberg%26aufirst%3DM.%26aulast%3DAlken%26aufirst%3DR.%2BG.%26atitle%3DChanged%2520phosphodiesterase%2520selectivity%2520and%2520enhanced%2520in%2520vitro%2520efficacy%2520by%2520selective%2520deuteration%2520of%2520sildenafil%26jtitle%3DArzneim.%2520Forsch.%26date%3D2007%26volume%3D57%26spage%3D293%26epage%3D298%26doi%3D10.1055%2Fs-0031-1296622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belleau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pindell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiffenstein, J.</span></span> <span> </span><span class="NLM_article-title">Effect of deuterium substitution in sympathomimetic amines on adrenergic responses</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1126/science.133.3446.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.133.3446.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17769335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaF3MXksVKhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1961&pages=102-104&author=B.+Belleauauthor=J.+Burbaauthor=M.+Pindellauthor=J.+Reiffenstein&title=Effect+of+deuterium+substitution+in+sympathomimetic+amines+on+adrenergic+responses&doi=10.1126%2Fscience.133.3446.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of deuterium substitution on sympathomimetic amines on adrenergic responses</span></div><div class="casAuthors">Belleau, B.; Burba, J.; Pindell, M.; Reiffenstein, J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Replacement of the α-H atoms of tyramine and tryptamine by D markedly intensifies the blood-pressure effects and nictitating-membrane contraction normally produced by these amines.  The results are interpreted on the basis of kinetic isotope effects at the level of monoamine oxidase and clearly establish the importance of this enzyme in the limitations of responses when tyramine and tryptamine are involved.  The observed D isotope effects with tyramine-α,α-D2 were reproduced with only one of the optical isomers of monodeuteriotyramine.  This finding shows a high degree of optical specificity for the enzyme.  The use of l-bisdeuterionoradrenaline showed that noradrenaline cannot be attacked by the enzyme at the effector-cell level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWZ5ZrOOJHlrVg90H21EOLACvtfcHk0ljUm1EDc6_lYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXksVKhtg%253D%253D&md5=3eb9b927157a39b5b48f5bf472cf9dd5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.133.3446.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.133.3446.102%26sid%3Dliteratum%253Aachs%26aulast%3DBelleau%26aufirst%3DB.%26aulast%3DBurba%26aufirst%3DJ.%26aulast%3DPindell%26aufirst%3DM.%26aulast%3DReiffenstein%26aufirst%3DJ.%26atitle%3DEffect%2520of%2520deuterium%2520substitution%2520in%2520sympathomimetic%2520amines%2520on%2520adrenergic%2520responses%26jtitle%3DScience%26date%3D1961%26volume%3D133%26spage%3D102%26epage%3D104%26doi%3D10.1126%2Fscience.133.3446.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapoport, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, H. W.</span></span> <span> </span><span class="NLM_article-title">Effect of deuteration of N--CH3 group on potency and enzymatic <i>N</i>-demethylation of morphine</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">1078</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1126/science.134.3485.1078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.134.3485.1078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=13889855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaF38XnvFCj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1961&pages=1078-1079&author=C.+Elisonauthor=H.+Rapoportauthor=R.+Laursenauthor=H.+W.+Elliott&title=Effect+of+deuteration+of+N%2D%2DCH3+group+on+potency+and+enzymatic+N-demethylation+of+morphine&doi=10.1126%2Fscience.134.3485.1078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of deuteration of the N-CH3 group on potency and enzymatic N-demethylation of morphine</span></div><div class="casAuthors">Elison, C.; Rapoport, H.; Laursen, R.; Elliott, H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1078-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Normorphine treated with excess CICO2Et followed by LiAlD4 gave morphine-N-CD3, pKa 8.17 (morphine pKa, 8.05), which was less potent, had a lower rate of oxidative demethylation, and had a weaker bond with enzyme, active centers than morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXIRZRFoSgrVg90H21EOLACvtfcHk0lgYCKZzN-X9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38XnvFCj&md5=b45fa6f5c8a1b802a3cb2e32e275c251</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.134.3485.1078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.134.3485.1078%26sid%3Dliteratum%253Aachs%26aulast%3DElison%26aufirst%3DC.%26aulast%3DRapoport%26aufirst%3DH.%26aulast%3DLaursen%26aufirst%3DR.%26aulast%3DElliott%26aufirst%3DH.%2BW.%26atitle%3DEffect%2520of%2520deuteration%2520of%2520N--CH3%2520group%2520on%2520potency%2520and%2520enzymatic%2520N-demethylation%2520of%2520morphine%26jtitle%3DScience%26date%3D1961%26volume%3D134%26spage%3D1078%26epage%3D1079%26doi%3D10.1126%2Fscience.134.3485.1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sipes, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandolfi, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. R.</span></span> <span> </span><span class="NLM_article-title">Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">716</span>– <span class="NLM_lpage">720</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=7400974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL3cXlsl2mtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1980&pages=716-720&author=I.+G.+Sipesauthor=A.+J.+Gandolfiauthor=L.+R.+Pohlauthor=G.+Krishnaauthor=B.+R.+Brown&title=Comparison+of+the+biotransformation+and+hepatotoxicity+of+halothane+and+deuterated+halothane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane</span></div><div class="casAuthors">Sipes, I. Glenn; Gandolfi, A. Jay; Pohl, Lance R.; Krishna, Gopal; Brown, Burnell R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">716-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">To investigate the effect of 2H substitution on the biotransformation and hepatotoxicity of halothane (CF3CHBrCl)  [151-67-7] male phenobarbital-pretreated rats were exposed for 2 h to 1% halothane or deuterated halothane delivered in 14% O-85% N.  The exposures were performed at mildly hypoxic conditions (14% O) since it was previously established that the decreased O tension promotes both the reductive metab. of halothane and halothane-induced liver injury.  At the end of anesthesia or at 24 h, the rats were sacrificed so that blood, liver, and urine samples could be obtained for measurement of metabolites and assessment of liver damage.  2H substitution did not affect the levels of reductive metabolites of halothane (CF3CH2Cl and CF2CHCl  [359-10-4]) nor did it alter the degree of hepatotoxicity as assessed by serum glutamic-pyruvic transaminase levels and morphol. examn.  The levels of oxidative metabolites (CF3COOH  [76-05-1] and Br) were significantly reduced at the end of anesthesia and at 24 h.  Apparently, halothane-induced hepatotoxicity is initiated by reactive intermediates formed during its reductive metab. and that cleavage of the C-H bond is not involved in this pathway.  The oxidative biotransformation of halothane proceeds by an oxygen insertion reaction at the C-H bond.  Thus, the increased stability of the C-D bond explains the redn. in oxidative metabolites obsd. after exposure to deuterated halothane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcmrpQrlUjV7Vg90H21EOLACvtfcHk0lgYCKZzN-X9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlsl2mtbY%253D&md5=95fa5c6822ed681b056022747f4a9347</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSipes%26aufirst%3DI.%2BG.%26aulast%3DGandolfi%26aufirst%3DA.%2BJ.%26aulast%3DPohl%26aufirst%3DL.%2BR.%26aulast%3DKrishna%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%2BR.%26atitle%3DComparison%2520of%2520the%2520biotransformation%2520and%2520hepatotoxicity%2520of%2520halothane%2520and%2520deuterated%2520halothane%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1980%26volume%3D214%26spage%3D716%26epage%3D720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darland, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenheuvel, W. J.</span></span> <span> </span><span class="NLM_article-title">Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=2877824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL2sXnvVWltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1986&pages=668-673&author=G.+K.+Darlandauthor=R.+Hajduauthor=H.+Kroppauthor=F.+M.+Kahanauthor=R.+W.+Walkerauthor=W.+J.+Vandenheuvel&title=Oxidative+and+defluorinative+metabolism+of+fludalanine%2C+2-2H-3-fluoro-D-alanine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine</span></div><div class="casAuthors">Darland, Gary K.; Hajdu, Richard; Kropp, Helmut; Kahan, Frederick M.; Walker, Robert W.; Vandenheuvel, William J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-73</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">The antibacterial agent fludalanine  [35523-45-6] (used in this study as the deuterated analog 2-2H-3-fluoro-D-alanine (DFA)  [35523-45-6]) is a potent inhibitor of bacterial alanine racemase, an enzyme required for the generation of D-alanine, an essential component of the bacterial cell wall.  Primary metab. of DFA involves its oxidn. to fluoropyruvate (FP)  [433-48-7]; this org. F- is then rapidly reduced to fluorolactate (FL)  [433-47-6], which is the major org. metabolite in lab. animals.  Gas-liq. chromatog. chem. ionization mass spectrometric assays were developed for these 2 metabolites.  FL is the predominant organofluoride metabolite of DFA in the circulation.  FP was detected in the urine although recovery was very low.  The rapid conversion of FP to FL precludes assay of the former in serum.  Max. serum FL concns. in the rat appear about 1 h after the dose of DFA and are relatively const. for several hours thereafter.  The peak FL concn. is proportional to the dose of DFA; repeated daily dosing of DFA appears to cause neither satn. nor induction of metabolic pathways.  Comparison of FL concns. detd. using the GC/MS assay with those based on an enzymic method specific for L-(+)-FL  [3130-92-5] demonstrated that only the latter isomer is found in the plasma of monkeys dosed with DFA.  In vivo exchange studies involving the α-proton of FL indicate that a small FP pool exists and is in equil. with FL.  A crude pyruvate dehydrogenase  [9014-20-4] complex isolated from beef heart mitochondria was shown to produce equimolar quantities of acetate  [64-19-7], CO2, and F- from FP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquI8diq2iUbbVg90H21EOLACvtfcHk0lgYCKZzN-X9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXnvVWltA%253D%253D&md5=554409be533e8ce74036e9ca2cf19dfb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarland%26aufirst%3DG.%2BK.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKropp%26aufirst%3DH.%26aulast%3DKahan%26aufirst%3DF.%2BM.%26aulast%3DWalker%26aufirst%3DR.%2BW.%26aulast%3DVandenheuvel%26aufirst%3DW.%2BJ.%26atitle%3DOxidative%2520and%2520defluorinative%2520metabolism%2520of%2520fludalanine%252C%25202-2H-3-fluoro-D-alanine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1986%26volume%3D14%26spage%3D668%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span> <span> </span><span class="NLM_article-title">Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2016.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.jpba.2016.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27178301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslaltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2016&pages=181-193&author=T.+Higashiauthor=S.+Ogawa&title=Isotope-coded+ESI-enhancing+derivatization+reagents+for+differential+analysis%2C+quantification+and+profiling+of+metabolites+in+biological+samples+by+LC%2FMS%3A+A+review&doi=10.1016%2Fj.jpba.2016.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review</span></div><div class="casAuthors">Higashi, Tatsuya; Ogawa, Shoujiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-193</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The anal. of the qual. and quant. changes of metabolites in body fluids and tissues yields valuable information for the diagnosis, pathol. anal. and treatment of many diseases.  Recently, liq. chromatog./electrospray ionization-(tandem) mass spectrometry [LC/ESI-MS(/MS)] has been widely used for these purposes due to the high sepn. capability of LC, broad coverage of ESI for various compds. and high specificity of MS(/MS).  However, there are still two major problems to be solved regarding the biol. sample anal.; lack of sensitivity and limited availability of stable isotope-labeled analogs (internal stds., ISs) for most metabolites.  Stable isotope-coded derivatization (ICD) can be the answer for these problems.  By the ICD, different isotope-coded moieties are introduced to the metabolites and one of the resulting derivs. can serve as the IS, which minimize the matrix effects.  Furthermore, the derivatization can improve the ESI efficiency, fragmentation property in the MS/MS and chromatog. behavior of the metabolites, which lead to a high sensitivity and specificity in the various detection modes.  Based on this background, this article reviews the recently-reported isotope-coded ESI-enhancing derivatization (ICEED) reagents, which are key components for the ICD-based LC/MS(/MS) studies, and their applications to the detection, identification, quantification and profiling of metabolites in human and animal samples.  The LC/MS(/MS) using the ICEED reagents is the powerful method esp. for the differential anal. (relative quantification) of metabolites in two comparative samples, simultaneous quantification of multiple metabolites whose stable isotope-labeled ISs are not available, and submetabolome profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocVMjZPX-cS7Vg90H21EOLACvtfcHk0lhLBU8Zk4WaUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslaltbY%253D&md5=58fa03f80874ca453470aceda3723623</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DS.%26atitle%3DIsotope-coded%2520ESI-enhancing%2520derivatization%2520reagents%2520for%2520differential%2520analysis%252C%2520quantification%2520and%2520profiling%2520of%2520metabolites%2520in%2520biological%2520samples%2520by%2520LC%252FMS%253A%2520A%2520review%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D130%26spage%3D181%26epage%3D193%26doi%3D10.1016%2Fj.jpba.2016.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Halford, B.</span></span> <span> </span><span class="NLM_article-title">Deuterium switcheroo breathes life into old drugs</span>. <i>Chem. Eng. News</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=32-36&author=B.+Halford&title=Deuterium+switcheroo+breathes+life+into+old+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalford%26aufirst%3DB.%26atitle%3DDeuterium%2520switcheroo%2520breathes%2520life%2520into%2520old%2520drugs%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2016%26volume%3D94%26spage%3D32%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, G. S.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs: where are we now?</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1075</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.943184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1517%2F13543776.2014.943184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25069517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1067-1075&author=G.+S.+Timmins&title=Deuterated+drugs%3A+where+are+we+now%3F&doi=10.1517%2F13543776.2014.943184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs: where are we now?</span></div><div class="casAuthors">Timmins, Graham S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1067-1075</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Deuterated versions of existing drugs can exhibit improved pharmacokinetic or toxicol. properties due the stronger deuterium- carbon bond modifying their metab.  There is great interest in the current state of development of this approach.  Areas covered: This review covers recent US patent applications and prosecutions in this area that are based on beneficial modifications in metab. of deuterated versions of existing drugs.  The current state of 35 U.S.C. 103 'obviousness' rejections are emphasized, as is the development of strategies to overcome such rejections.  Current trials and market considerations are also discussed.  Expert opinion: Deuterated drugs collectively are worth at least US$1 billion.  It would seem that the likelihood of obviousness rejections is increasing in this area.  However, careful elucidation of metabolic outcomes from deuteration that would not be anticipated from the prior art, and are instead unexpected and unobvious, has enabled allowance.  Showing that drug deuteration alters pharmacokinetics by mechanisms not currently part of the prior art surrounding deuterated drugs has also been successful.  Development of these and other strategies, combined with developing the extensive base of issued patents will enable the field to remain com. attractive for some time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0xlLKQqhufrVg90H21EOLACvtfcHk0lhLBU8Zk4WaUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE&md5=c697e60a642f7ea3d8ad9f4588bc3ade</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.943184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.943184%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26atitle%3DDeuterated%2520drugs%253A%2520where%2520are%2520we%2520now%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1067%26epage%3D1075%26doi%3D10.1517%2F13543776.2014.943184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, G. S.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs; updates and obviousness analysis</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1353</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1378350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1080%2F13543776.2017.1378350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28885861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFSmtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1353-1361&author=G.+S.+Timmins&title=Deuterated+drugs%3B+updates+and+obviousness+analysis&doi=10.1080%2F13543776.2017.1378350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs; updates and obviousness analysis</span></div><div class="casAuthors">Timmins, Graham S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1353-1361</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The pharmacokinetics and/or toxicity of many known drugs can be modified by selective deuteration, an area of significant com. interest and scientific and regulatory progress.  This review firstly discusses recent developments in deuterated drugs including the FDA approval of deutetrabenazine.  Secondly, it discusses 35 U.S.C. Sec. 103 'obviousness' as it relates to recent patent prosecution, and also to Inter Partes Review (IPR).  IPR is a new post-award review of patentability under Sec. 102 or Sec. 103, two IPR petitions upon deuterated drugs have been instituted and included Sec. 103 arguments.  Finally, an extended anal. of Sec. 103 obviousness based upon the practices of major pharmaceutical companies is provided, that supports rather late priority dates, while Sec. 102 is also discussed.  The total value of transactions involving deuterated drugs is close to $5 billion.  While the importance of Sec. 103 'obviousness' rejections remains in patent applications under current prosecution, IPR of issued patents is developing and will affect likely affect Sec. 103 interpretations in this area.  However, patents are still issuing with later priority dates, and further litigation will likely occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplgaJXt_pSD7Vg90H21EOLACvtfcHk0lhLBU8Zk4WaUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFSmtbjO&md5=d29367a0daec2c70367a58327fbccd9c</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1378350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1378350%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26atitle%3DDeuterated%2520drugs%253B%2520updates%2520and%2520obviousness%2520analysis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D1353%26epage%3D1361%26doi%3D10.1080%2F13543776.2017.1378350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span> <span> </span><span class="NLM_article-title">First deuterated drug approved</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.1038/nbt0617-493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fnbt0617-493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28591114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlOhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=493-494&author=C.+Schmidt&title=First+deuterated+drug+approved&doi=10.1038%2Fnbt0617-493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">First deuterated drug approved</span></div><div class="casAuthors">Schmidt, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">493-494</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwr4PZKkjHN7Vg90H21EOLACvtfcHk0lhLBU8Zk4WaUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlOhsL8%253D&md5=cd594cc4762bd153c41e797e8526c090</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnbt0617-493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt0617-493%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%26atitle%3DFirst%2520deuterated%2520drug%2520approved%26jtitle%3DNat.%2520Biotechnol.%26date%3D2017%26volume%3D35%26spage%3D493%26epage%3D494%26doi%3D10.1038%2Fnbt0617-493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claassen, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Boer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayyagari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamler, D.</span></span> <span> </span><span class="NLM_article-title">Indirect tolerability comparison of deutetrabenazine and tetrabenazine for Huntington disease</span>. <i>J. Clin. Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1186/s40734-017-0051-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1186%2Fs40734-017-0051-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28265459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1czjsVShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=3-13&author=D.+O.+Claassenauthor=B.+Carrollauthor=L.+M.+De+Boerauthor=E.+Wuauthor=R.+Ayyagariauthor=S.+Gandhiauthor=D.+Stamler&title=Indirect+tolerability+comparison+of+deutetrabenazine+and+tetrabenazine+for+Huntington+disease&doi=10.1186%2Fs40734-017-0051-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease</span></div><div class="casAuthors">Claassen Daniel O; Carroll Benjamin; Gandhi Sanjay; De Boer Lisa M; Stamler David; Wu Eric; Ayyagari Rajeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical movement disorders</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">2054-7072</span>.
    </div><div class="casAbstract">BACKGROUND:  Vesicular monoamine transporter 2 (VMAT2) inhibitors can improve hyperkinetic movements, and are effective treatment options for chorea of Huntington disease (HD).  Tetrabenazine was assessed for treating chorea in the TETRA-HD trial, and while efficacious, there are tolerability concerns possibly due to its pharmacokinetic properties.  Deutetrabenazine is a novel VMAT2 inhibitor that contains deuterium, which extends active metabolite half-lives and minimizes drug concentration fluctuations.  In the First-HD trial, deutetrabenazine was efficacious in treating chorea and was generally well tolerated.  In the absence of a head-to-head trial, we performed an indirect treatment comparison (ITC) of the tolerability of deutetrabenazine and tetrabenazine for the treatment of HD-associated chorea, as observed in the First-HD and TETRA-HD trials, using well-established comparison methods.  METHODS:  Data from the Phase III, 12-week, parallel-group, clinical trials First-HD (N = 90) and TETRA-HD (N = 84) were used to conduct an ITC of the tolerability of deutetrabenazine versus tetrabenazine using two anchor-based methods: Bucher comparison for unadjusted ITCs, and matching indirect comparison for adjusted ITCs.  Overall adverse events (AEs; mild, moderate, and severe), serious AEs, specific AEs occurring in ≥10% of patients, and discontinuations (all-cause and AE-related) were included in the analysis.  The risk differences of these outcomes for deutetrabenazine and tetrabenazine were estimated by subtracting the applicable placebo-adjusted risk in First-HD from that of TETRA-HD.  Sensitivity analyses were performed to address differences between trials, and p-values were obtained from z-tests.  RESULTS:  Compared with tetrabenazine, deutetrabenazine was associated with a significantly lower risk of moderate to severe AEs and neuropsychiatric AEs including agitation, akathisia, depression, depression/agitated depression, drowsiness/somnolence, insomnia, and parkinsonism in both adjusted and unadjusted analyses (p < 0.05 for each).  Deutetrabenazine had a significantly lower rate of dose reduction or dose reduction/suspension in the unadjusted and adjusted analyses (p < 0.001 for each).  Deutetrabenazine resulted in numerically more mild AEs, such as diarrhea and coughing; however, these results were not statistically significant.  CONCLUSIONS:  This indirect treatment comparison demonstrates that for the treatment of HD chorea, deutetrabenazine has a favorable tolerability profile compared to tetrabenazine.  TRIAL REGISTRATION:  ClinicalTrials.gov NCT01795859 and NCT00219804.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0nI0g9LkSp-2mnZh2OgS0fW6udTcc2ebueuU5g84M57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjsVShsA%253D%253D&md5=c7a5245c020613fcf6d48f8f77e4fe6c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs40734-017-0051-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40734-017-0051-5%26sid%3Dliteratum%253Aachs%26aulast%3DClaassen%26aufirst%3DD.%2BO.%26aulast%3DCarroll%26aufirst%3DB.%26aulast%3DDe%2BBoer%26aufirst%3DL.%2BM.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DAyyagari%26aufirst%3DR.%26aulast%3DGandhi%26aufirst%3DS.%26aulast%3DStamler%26aufirst%3DD.%26atitle%3DIndirect%2520tolerability%2520comparison%2520of%2520deutetrabenazine%2520and%2520tetrabenazine%2520for%2520Huntington%2520disease%26jtitle%3DJ.%2520Clin.%2520Mov.%2520Disord.%26date%3D2017%26volume%3D4%26spage%3D3%26epage%3D13%26doi%3D10.1186%2Fs40734-017-0051-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, E. J.</span></span> <span> </span><span class="NLM_article-title">Tetrabenazine versus deutetrabenazine for Huntington’s disease: twins or distant cousins?</span>. <i>Mov. Disord. Clin. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1002/mdc3.12483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fmdc3.12483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28920068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1cbpsFagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=582-585&author=F.+B.+Rodriguesauthor=G.+S.+Duarteauthor=J.+Costaauthor=J.+J.+Ferreiraauthor=E.+J.+Wild&title=Tetrabenazine+versus+deutetrabenazine+for+Huntington%E2%80%99s+disease%3A+twins+or+distant+cousins%3F&doi=10.1002%2Fmdc3.12483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?</span></div><div class="casAuthors">Rodrigues Filipe B; Wild Edward J; Rodrigues Filipe B; Duarte Goncalo S; Costa Joao; Ferreira Joaquim J; Rodrigues Filipe B; Duarte Goncalo S; Costa Joao; Ferreira Joaquim J; Costa Joao; Costa Joao</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders clinical practice</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">582-585</span>
        ISSN:<span class="NLM_cas:issn">2330-1619</span>.
    </div><div class="casAbstract">BACKGROUND:  Tetrabenazine is the only US Food and Drug Administration-approved drug for Huntington's disease, and deutetrabenazine was recently tested against placebo.  A switching-trial from tetrabenazine to deutetrabenazine is underway, but no head-to-head, blinded, randomized controlled trial is planned.  Using meta-analytical methodology, the authors compared these molecules.  METHODS:  RCTs comparing tetrabenazine or deutetrabenazine with placebo in Huntington's disease were searched.  The authors assessed the Cochrane risk-of-bias tool, calculated indirect treatment comparisons, and applied the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework.  RESULTS:  The evidence network for this report comprised 1 tetrabenazine trial and 1 deutetrabenazine trial, both against placebo.  Risk of bias was moderate in both.  Participants in the tetrabenazine and deutetrabenazine trials did not differ significantly on motor scores or adverse events.  Depression and somnolence scales significantly favored deutetrabenazine.  CONCLUSION:  There is low-quality evidence that tetrabenazine and deutetrabenazine do not differ in efficacy or safety.  It is important to note that these results are likely to remain the only head-to-head comparison between these 2 compounds in Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvkk3DHdxs8lm8bhe6roZYfW6udTcc2ebueuU5g84M57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbpsFagsA%253D%253D&md5=bc9902048211ec9978d92f95e53ac2f3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmdc3.12483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmdc3.12483%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DF.%2BB.%26aulast%3DDuarte%26aufirst%3DG.%2BS.%26aulast%3DCosta%26aufirst%3DJ.%26aulast%3DFerreira%26aufirst%3DJ.%2BJ.%26aulast%3DWild%26aufirst%3DE.%2BJ.%26atitle%3DTetrabenazine%2520versus%2520deutetrabenazine%2520for%2520Huntington%25E2%2580%2599s%2520disease%253A%2520twins%2520or%2520distant%2520cousins%253F%26jtitle%3DMov.%2520Disord.%2520Clin.%2520Pract.%26date%3D2017%26volume%3D4%26spage%3D582%26epage%3D585%26doi%3D10.1002%2Fmdc3.12483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garay, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossberg, G. T.</span></span> <span> </span><span class="NLM_article-title">AVP-786 for the treatment of agitation in dementia of the Alzheimer’s type</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1080/13543784.2017.1267726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1080%2F13543784.2017.1267726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27936965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOlu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=121-132&author=R.+P.+Garayauthor=G.+T.+Grossberg&title=AVP-786+for+the+treatment+of+agitation+in+dementia+of+the+Alzheimer%E2%80%99s+type&doi=10.1080%2F13543784.2017.1267726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">AVP-786 for the treatment of agitation in dementia of the Alzheimer's type</span></div><div class="casAuthors">Garay, Ricardo P.; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-132</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Agitation is common and distressing in patients with Alzheimer-type dementia, but safe, effective treatments remain elusive.  Psychol. treatments are first-line options, but they have limited efficacy.  Off-label psychotropic medications are frequently used, but they also have limited effectiveness, and their use may have harmful side effects, including death.  This review discusses the history leading to the conception of AVP-786 (deuterated (d6)-dextromethorphan/quinidine), its pharmacokinetic and pharmacodynamic profiles and safety issues, together with an overview of recent clin. trials.  Data were found in the medical literature, in US and EU clin. trial registries and in information provided by the manufacturer.: AVP-786 is one of six investigational compds. in recent phase III clin. development for agitation in Alzheimer disease (AD).  Quinidine and deuteration appear to prolong dextromethorphan's plasma half-life and facilitate brain penetration.  The FDA granted fast-track designation to AVP-786 and allowed use of data generated on dextromethorphan-quinidine (AVP-923, Nuedexta) for regulatory filings.  AVP-923 reduced agitation in AD and was well tolerated in a phase II RCT that included more than 200 patients.  A phase III clin. development program of AVP-786 for AD agitation was recently initiated.  This program is expected to start generating results in July 2018.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_AL-sfgaS9bVg90H21EOLACvtfcHk0ljwHNtmuKtmqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOlu7fP&md5=87b364678882778445cb4dabc5a65b57</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F13543784.2017.1267726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2017.1267726%26sid%3Dliteratum%253Aachs%26aulast%3DGaray%26aufirst%3DR.%2BP.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DAVP-786%2520for%2520the%2520treatment%2520of%2520agitation%2520in%2520dementia%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520type%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2017%26volume%3D26%26spage%3D121%26epage%3D132%26doi%3D10.1080%2F13543784.2017.1267726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupa-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moslin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobleski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J.</span></span> <span> </span><span class="NLM_article-title">349 - BMS-986165 is a highly potent and selective allosteric inhibitor of TYK2, blocks IL-12, IL-23 and type I interferon signaling and provides for robust efficacy in preclinical models of systemic lupus erythematosus and inflammatory bowel disease</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">S-1357</span>, <span class="refDoi"> DOI: 10.1016/S0016-5085(18)34439-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0016-5085%2818%2934439-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=S-1357&author=J.+H.+Xieauthor=K.+Gilloolyauthor=Y.+Zhangauthor=X.+Yangauthor=A.+Zupa-Fernandezauthor=L.+Chengauthor=J.+Strnadauthor=E.+Heimrichauthor=X.+Zhouauthor=J.+Chenauthor=C.+Chaudhryauthor=S.+Liauthor=R.+Moslinauthor=S.+Wrobleskiauthor=D.+Weinsteinauthor=J.+Burke&title=349+-+BMS-986165+is+a+highly+potent+and+selective+allosteric+inhibitor+of+TYK2%2C+blocks+IL-12%2C+IL-23+and+type+I+interferon+signaling+and+provides+for+robust+efficacy+in+preclinical+models+of+systemic+lupus+erythematosus+and+inflammatory+bowel+disease&doi=10.1016%2FS0016-5085%2818%2934439-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2818%2934439-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252818%252934439-1%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZupa-Fernandez%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DStrnad%26aufirst%3DJ.%26aulast%3DHeimrich%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMoslin%26aufirst%3DR.%26aulast%3DWrobleski%26aufirst%3DS.%26aulast%3DWeinstein%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DJ.%26atitle%3D349%2520-%2520BMS-986165%2520is%2520a%2520highly%2520potent%2520and%2520selective%2520allosteric%2520inhibitor%2520of%2520TYK2%252C%2520blocks%2520IL-12%252C%2520IL-23%2520and%2520type%2520I%2520interferon%2520signaling%2520and%2520provides%2520for%2520robust%2520efficacy%2520in%2520preclinical%2520models%2520of%2520systemic%2520lupus%2520erythematosus%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DGastroenterology%26date%3D2018%26volume%3D154%26spage%3DS-1357%26doi%3D10.1016%2FS0016-5085%2818%2934439-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D.</span>; <span class="NLM_string-name">Wrobleski, S.</span>; <span class="NLM_string-name">Moslin, R.</span>; <span class="NLM_string-name">Lin, S.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Spergel, S.</span>; <span class="NLM_string-name">Mertzman, M.</span>; <span class="NLM_string-name">Tokarski, J.</span>; <span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Chiney, M.</span>; <span class="NLM_string-name">Elzinga, P.</span>; <span class="NLM_string-name">Aranibar, N.</span>; <span class="NLM_string-name">Chimalakonda, A.</span>; <span class="NLM_string-name">Strnad, J.</span>; <span class="NLM_string-name">Zupa-Fernandez, A.</span>; <span class="NLM_string-name">Cheng, L.</span>; <span class="NLM_string-name">Gillooly, K.</span>; <span class="NLM_string-name">Mcintyre, K.</span>; <span class="NLM_string-name">Carter, P.</span>; <span class="NLM_string-name">Lombardo, L.</span>; <span class="NLM_string-name">Burke, J.</span>; <span class="NLM_string-name">Macor, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Pseudokinase Domain Ligand as an Allosteric Inhibitor of TYK2 for the Treatment of Autoimmune Diseases</span>.  <i>Abstracts of Papers</i>, 252nd National Meeting and Exposition of the American Chemical Society, Philadelphia, PA, August 21–25, 2016; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+Weinstein&author=S.+Wrobleski&author=R.+Moslin&author=S.+Lin&author=Y.+Zhang&author=S.+Spergel&author=M.+Mertzman&author=J.+Tokarski&author=H.+Sun&author=M.+Chiney&author=P.+Elzinga&author=N.+Aranibar&author=A.+Chimalakonda&author=J.+Strnad&author=A.+Zupa-Fernandez&author=L.+Cheng&author=K.+Gillooly&author=K.+Mcintyre&author=P.+Carter&author=L.+Lombardo&author=J.+Burke&author=J.+Macor&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520Pseudokinase%2520Domain%2520Ligand%2520as%2520an%2520Allosteric%2520Inhibitor%2520of%2520TYK2%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520Diseases%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooderham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girgis, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span> <span> </span><span class="NLM_article-title">Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1806382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1056%2FNEJMoa1806382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=30205746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWlsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2018&pages=1313-1321&author=K.+Pappauthor=K.+Gordonauthor=D.+Thaciauthor=A.+Moritaauthor=M.+Gooderhamauthor=P.+Foleyauthor=I.+G.+Girgisauthor=S.+Kunduauthor=S.+Banerjee&title=Phase+2+trial+of+selective+tyrosine+kinase+2+inhibition+in+psoriasis&doi=10.1056%2FNEJMoa1806382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis</span></div><div class="casAuthors">Papp, Kim; Gordon, Kenneth; Thaci, Diamant; Morita, Akimichi; Gooderham, Melinda; Foley, Peter; Girgis, Ihab G.; Kundu, Sudeep; Banerjee, Subhashis</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1313-1321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Tyrosine kinase 2 (TYK2) signaling pathways, which mediate cytokine signaling, are implicated in the pathophysiol. of psoriasis.  Selective inhibitors of TYK2 may be effective in treating psoriasis. methods We conducted a phase 2, double-blind trial of a TYK2 inhibitor, BMS-986165, in adults with moderate-to-severe psoriasis, excluding patients with a previous lack of response to agents targeting cytokine signaling through the same tyrosine kinase pathway.  Patients were randomly assigned to receive the drug orally at a dose of 3 mg every other day, 3 mg daily, 3 mg twice daily, 6 mg twice daily, or 12 mg daily or to receive placebo.  The primary end point was a 75% or greater redn. from baseline in the Psoriasis Area and Severity Index (PASI) score at week 12 (higher scores indicate greater severity of psoriasis). results A total of 267 patients received at least one dose in an intervention group of the trial.  At week 12, the percentage of patients with a 75% or greater redn. in the PASI score was 7% (3 of 45 patients) with placebo, 9% (4 of 44 patients) with 3 mg of BMS-986165 every other day (P = 0.49 vs. placebo), 39% (17 of 44 patients) with 3 mg daily (P<0.001 vs. placebo), 69% (31 of 45 patients) with 3 mg twice daily (P<0.001 vs. placebo), 67% (30 of 45 patients) with 6 mg twice daily (P<0.001 vs. placebo), and 75% (33 of 44 patients) with 12 mg daily (P<0.001 vs. placebo).  There were three serious adverse events in patients receiving the active drug, as well as one case of malignant melanoma 96 days after the start of treatment. conclusions Selective inhibition of TYK2 with the oral agent BMS-986165 at doses of 3 mg daily and higher resulted in greater clearing of psoriasis than did placebo over a period of 12 wk.  Larger and longer-duration trials of this drug are required to det. its safety and durability of effect in patients with psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhqWANKhDdt7Vg90H21EOLACvtfcHk0lhe98FO1v6A3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWlsrbE&md5=ededd5d925dd557cceacc472839a966a</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1806382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1806382%26sid%3Dliteratum%253Aachs%26aulast%3DPapp%26aufirst%3DK.%26aulast%3DGordon%26aufirst%3DK.%26aulast%3DThaci%26aufirst%3DD.%26aulast%3DMorita%26aufirst%3DA.%26aulast%3DGooderham%26aufirst%3DM.%26aulast%3DFoley%26aufirst%3DP.%26aulast%3DGirgis%26aufirst%3DI.%2BG.%26aulast%3DKundu%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DPhase%25202%2520trial%2520of%2520selective%2520tyrosine%2520kinase%25202%2520inhibition%2520in%2520psoriasis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D379%26spage%3D1313%26epage%3D1321%26doi%3D10.1056%2FNEJMoa1806382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span>An Investigational Study To Evaluate Experimental Medication
BMS-986165 Compared to Placebo and a Currently Available Treatment
in Participants with Moderate to Severe Plaque Psoriasis (POETYK-PSO-1).
ClinicalTrials.gov identifier: NCT03624127. Last update: October 10,
2018. Accessed on October 22, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Investigational+Study+To+Evaluate+Experimental+Medication%0ABMS-986165+Compared+to+Placebo+and+a+Currently+Available+Treatment%0Ain+Participants+with+Moderate+to+Severe+Plaque+Psoriasis+%28POETYK-PSO-1%29.%0AClinicalTrials.gov+identifier%3A+NCT03624127.+Last+update%3A+October+10%2C%0A2018.+Accessed+on+October+22%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span>An Investigational Study To Evaluate Experimental
Medication BMS-986165 Compared to Placebo and a Currently Available
Treatment in Participants with Moderate-to-Severe Plaque Psoriasis
(POETYK-PSO-2). ClinicalTrials.gov identifier: NCT03611751. Last update:
October 10, 2018. Accessed on October 22, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Investigational+Study+To+Evaluate+Experimental%0AMedication+BMS-986165+Compared+to+Placebo+and+a+Currently+Available%0ATreatment+in+Participants+with+Moderate-to-Severe+Plaque+Psoriasis%0A%28POETYK-PSO-2%29.+ClinicalTrials.gov+identifier%3A+NCT03611751.+Last+update%3A%0AOctober+10%2C+2018.+Accessed+on+October+22%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misenko, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thandoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhawar, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunting, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffty, B. G.</span></span> <span> </span><span class="NLM_article-title">VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">25833</span>– <span class="NLM_lpage">25841</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.25383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.18632%2Foncotarget.25383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29899825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1MbntVGntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=25833-25841&author=A.+J.+Khanauthor=S.+M.+Misenkoauthor=A.+Thandoniauthor=D.+Schiffauthor=S.+R.+Jhawarauthor=S.+F.+Buntingauthor=B.+G.+Haffty&title=VX-984+is+a+selective+inhibitor+of+non-homologous+end+joining%2C+with+possible+preferential+activity+in+transformed+cells&doi=10.18632%2Foncotarget.25383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells</span></div><div class="casAuthors">Khan Atif J; Khan Atif J; Thandoni Aditya; Schiff Devora; Jhawar Sachin R; Haffty Bruce G; Misenko Sarah M; Bunting Samuel F</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">25833-25841</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Purpose:  DNA double-strand breaks (DSBs) can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR).  We demonstrate the selectivity of VX-984, a DNA-PK inhibitor, using assays not previously reported.  Experimental Design:  The class switch recombination assay (CSR) in primary B cells was used to measure efficiency of NHEJ.  A cellular reporter assay (U2OS EJ-DR) was used to assess the efficiency of HR and NHEJ in cells treated with VX-984.  Immunofluorescence assays (IF) evaluated γ-H2AX foci for DSB repair kinetics in human astrocytes and T98G glioma cells.  Western blotting was used to evaluate phosphorylation of DNA-PKcs substrates.  Results:  We found a dose-dependent reduction in CSR efficiency with VX-984, and through the EJ-DR assay, dramatic dose-dependent increases in HR and mNHEJ.  Immunofluorescence assays showed an inability of malignant cells to resolve γ-H2AX foci in the presence of VX-984.  Radiation-induced phosphorylation of DNA-PK substrates was further reduced by treatment with VX-984.  Conclusions:  VX-984 efficiently inhibits NHEJ, resulting in compensatory increases in alternative repair pathways, increases DSBs, and appears to affect transformed cells preferentially.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMzH74v_wRzcyail4HZd-ifW6udTcc2ebt4tfMC9M3n7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbntVGntQ%253D%253D&md5=6af1738162bf28f56ab9431546488993</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.25383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.25383%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%2BJ.%26aulast%3DMisenko%26aufirst%3DS.%2BM.%26aulast%3DThandoni%26aufirst%3DA.%26aulast%3DSchiff%26aufirst%3DD.%26aulast%3DJhawar%26aufirst%3DS.%2BR.%26aulast%3DBunting%26aufirst%3DS.%2BF.%26aulast%3DHaffty%26aufirst%3DB.%2BG.%26atitle%3DVX-984%2520is%2520a%2520selective%2520inhibitor%2520of%2520non-homologous%2520end%2520joining%252C%2520with%2520possible%2520preferential%2520activity%2520in%2520transformed%2520cells%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D25833%26epage%3D25841%26doi%3D10.18632%2Foncotarget.25383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, D.</span>; <span class="NLM_string-name">Newsome, D.</span>; <span class="NLM_string-name">Takemoto, D.</span>; <span class="NLM_string-name">Hillier, S.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Arimoto, R.</span>; <span class="NLM_string-name">Maxwell, J.</span>; <span class="NLM_string-name">Charifson, P.</span>; <span class="NLM_string-name">Fields, S. Z.</span>; <span class="NLM_string-name">Tanner, K.</span>; <span class="NLM_string-name">Penney, M. S.</span></span> <span> </span><span class="NLM_article-title">Preclinical Characterization of VX-984, a Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor in Combination with Doxorubicin in Breast and Ovarian Cancers</span>.  <i>Abstracts of Papers</i>, 2016 San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+Boucher&author=D.+Newsome&author=D.+Takemoto&author=S.+Hillier&author=Y.+Wang&author=R.+Arimoto&author=J.+Maxwell&author=P.+Charifson&author=S.+Z.+Fields&author=K.+Tanner&author=M.+S.+Penney&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DD.%26atitle%3DPreclinical%2520Characterization%2520of%2520VX-984%252C%2520a%2520Selective%2520DNA-Dependent%2520Protein%2520Kinase%2520%2528DNA-PK%2529%2520Inhibitor%2520in%2520Combination%2520with%2520Doxorubicin%2520in%2520Breast%2520and%2520Ovarian%2520Cancers%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span>First-in-Human
Study of the Safety,
Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984
in Combination with Chemotherapy. ClinicalTrials.gov identifier: NCT02644278.
Last update: June 5, 2018. Accessed on November 15, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=First-in-Human%0AStudy+of+the+Safety%2C%0ATolerability%2C+and+Pharmacokinetic%2FPharmacodynamic+Profile+of+VX-984%0Ain+Combination+with+Chemotherapy.+ClinicalTrials.gov+identifier%3A+NCT02644278.%0ALast+update%3A+June+5%2C+2018.+Accessed+on+November+15%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Stevens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worboys, P.</span></span> <span> </span><span class="NLM_article-title">Rodent pharmacokinetics and receptor occupancy of the GABA<sub>A</sub> receptor subtype selective benzodiazepine site ligand L-838417</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1002/bdd.423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fbdd.423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=15578749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=13-20&author=P.+Scott-Stevensauthor=J.+R.+Atackauthor=B.+Sohalauthor=P.+Worboys&title=Rodent+pharmacokinetics+and+receptor+occupancy+of+the+GABAA+receptor+subtype+selective+benzodiazepine+site+ligand+L-838417&doi=10.1002%2Fbdd.423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417</span></div><div class="casAuthors">Scott-Stevens, P.; Atack, J. R.; Sohal, B.; Worboys, P.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The pharmacokinetics of L-838417, a GABAA receptor subtype selective benzodiazepine site agonist, were studied in rats and mice after single oral (p.o.), i.p., and i.v. doses.  In both species L-838417 was well absorbed following i.p. administration and while in rats p.o. bioavailability was good (41%), in mice it was negligible (<1%), precluding this as a route of administration for mouse behavioral studies.  Despite having a similar vol. of distribution (ca 1.41/kg) in rats and mice, L-838417 was cleared at twice liver blood flow in mice (161 mL/min/kg) and moderately cleared in rats (24 mL/min/kg), potentially explaining the poor oral bioavailability in mice.  Finally, as a pharmacodynamic readout the benzodiazepine binding site occupancy was detd. in rats (0.3-3 mg/kg, p.o.) and mice (1-30 mg/kg, i.p.) using a [3H]Ro 15-1788 in vivo binding assay.  Although the resulting dose-occupancy relationship for both species demonstrated a dose-dependent increase in receptor occupancy, appreciable variability was obsd. at low dose levels, potentially making interpretation of behavioral responses difficult.  In contrast, a clear relationship between plasma and brain concns. and receptor occupancy were detd. suggesting the obsd. dose-occupancy variability is a consequence of the pharmacokinetic properties of L-838417.  The plasma and brain concns. required to occupy 50% of the benzodiazepine binding sites were similar in both rats (28 ng/mL and 33 ng/mlg, resp.) and mice (63 ng/mL and 53 ng/mlg, resp.), with a non-linear concn. response obsd. with increasing doses of L-838417.  These studies demonstrate the importance of utilizing pharmacokinetic/receptor occupancy data when interpreting pharmacodynamic responses at a given dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaynJT0wl1-LVg90H21EOLACvtfcHk0lgLZa6cWH2a0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFamtA%253D%253D&md5=6deed2c048d9edb5f54f8a4b7497ebc1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fbdd.423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.423%26sid%3Dliteratum%253Aachs%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DWorboys%26aufirst%3DP.%26atitle%3DRodent%2520pharmacokinetics%2520and%2520receptor%2520occupancy%2520of%2520the%2520GABAA%2520receptor%2520subtype%2520selective%2520benzodiazepine%2520site%2520ligand%2520L-838417%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2005%26volume%3D26%26spage%3D13%26epage%3D20%26doi%3D10.1002%2Fbdd.423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Scott Harbeson, S.</span>; <span class="NLM_string-name">Vinita Uttamsingh, V.</span>; <span class="NLM_string-name">Morales, A. J.</span>; <span class="NLM_string-name">Nguyen, S.</span>; <span class="NLM_string-name">Bridson, G.</span>; <span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Wu, L.</span></span> <span> </span><span class="NLM_article-title">CTP-354: A Novel Deuterated Subtype-Selective GABA(A) Modulator for Treatment of Neuropathic Pain, Spasticity and Anxiety Disorders</span>. Presented at the American College of Neuropsychopharmacology (ACNP) 51st Annual Meeting, Hollywood, FL, December 2–6, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+F.+Liu&author=S.+Scott+Harbeson&author=V.+Vinita+Uttamsingh&author=A.+J.+Morales&author=S.+Nguyen&author=G.+Bridson&author=C.+Cheng&author=A.+Aslanian&author=L.+Wu&title=CTP-354%3A+A+Novel+Deuterated+Subtype-Selective+GABA%28A%29+Modulator+for+Treatment+of+Neuropathic+Pain%2C+Spasticity+and+Anxiety+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26atitle%3DCTP-354%253A%2520A%2520Novel%2520Deuterated%2520Subtype-Selective%2520GABA%2528A%2529%2520Modulator%2520for%2520Treatment%2520of%2520Neuropathic%2520Pain%252C%2520Spasticity%2520and%2520Anxiety%2520Disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span>; <span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Harbeson, S.</span>; <span class="NLM_string-name">Uttamsingh, V.</span>; <span class="NLM_string-name">Bridson, G.</span>; <span class="NLM_string-name">Wu, L.</span>; <span class="NLM_string-name">Shipley, J. E.</span></span> <span> </span><span class="NLM_article-title">Preliminary Clinical Outcomes for CTP-354, a Novel Subtype-Selective GABA(A) Modulator</span>. Presented at the American Neurological Association (ANA) 2014 Annual Meeting, Baltimore, MD, October 12–14, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=V.+Braman&author=J.+F.+Liu&author=S.+Harbeson&author=V.+Uttamsingh&author=G.+Bridson&author=L.+Wu&author=J.+E.+Shipley&title=Preliminary+Clinical+Outcomes+for+CTP-354%2C+a+Novel+Subtype-Selective+GABA%28A%29+Modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBraman%26aufirst%3DV.%26atitle%3DPreliminary%2520Clinical%2520Outcomes%2520for%2520CTP-354%252C%2520a%2520Novel%2520Subtype-Selective%2520GABA%2528A%2529%2520Modulator%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A. A.</span>; <span class="NLM_string-name">Harris, C. J.</span>; <span class="NLM_string-name">Smith, D. A.</span></span> <i>Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+A.+Alex&author=C.+J.+Harris&author=D.+A.+Smith&title=Attrition+in+the+Pharmaceutical+Industry%3A+Reasons%2C+Implications%2C+and+Pathways+Forward"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%2BA.%26btitle%3DAttrition%2520in%2520the%2520Pharmaceutical%2520Industry%253A%2520Reasons%252C%2520Implications%252C%2520and%2520Pathways%2520Forward%26pub%3DWiley%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trager, W. F.</span></span> <span> </span><span class="NLM_article-title">The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1481</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1124/dmd.31.12.1481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.31.12.1481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=14625345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1KgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1481-1498&author=S.+D.+Nelsonauthor=W.+F.+Trager&title=The+use+of+deuterium+isotope+effects+to+probe+the+active+site+properties%2C+mechanism+of+cytochrome+P450-catalyzed+reactions%2C+and+mechanisms+of+metabolically+dependent+toxicity&doi=10.1124%2Fdmd.31.12.1481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity</span></div><div class="casAuthors">Nelson, Sidney D.; Trager, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1481-1498</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Crit. elements from studies that have led to our current understanding of the factors that cause the obsd. primary deuterium isotope effect, (kH/kD)obs, of most enzymically mediated reactions to be much smaller than the "true" or intrinsic primary deuterium isotope effect, kH/kD, for the reaction are presented.  This new understanding has provided a unique and powerful tool for probing the catalytic and active site properties of enzymes, particularly the cytochromes P 450 (P 450).  Examples are presented that illustrate how the technique has been used to det. kH/kD, and properties such as the catalytic nature of the reactive oxenoid intermediate, prochiral selectivity, the chem. and enzymic mechanisms of cytochrome P 450-catalyzed reactions, and the relative active site size of different P 450 isoforms.  Examples are also presented of how deuterium isotope effects have been used to probe mechanisms of the formation of reactive metabolites that can cause toxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbj0BX3noYBrVg90H21EOLACvtfcHk0lgLZa6cWH2a0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1KgsLw%253D&md5=015951029d6b68dd54a02711e6dac307</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.12.1481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.12.1481%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DS.%2BD.%26aulast%3DTrager%26aufirst%3DW.%2BF.%26atitle%3DThe%2520use%2520of%2520deuterium%2520isotope%2520effects%2520to%2520probe%2520the%2520active%2520site%2520properties%252C%2520mechanism%2520of%2520cytochrome%2520P450-catalyzed%2520reactions%252C%2520and%2520mechanisms%2520of%2520metabolically%2520dependent%2520toxicity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D1481%26epage%3D1498%26doi%3D10.1124%2Fdmd.31.12.1481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic deuterium isotope effects in cytochrome P450 reactions</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>596</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/bs.mie.2017.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fbs.mie.2017.06.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28911772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvFSjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=596&publication_year=2017&pages=217-238&author=F.+P.+Guengerich&title=Kinetic+deuterium+isotope+effects+in+cytochrome+P450+reactions&doi=10.1016%2Fbs.mie.2017.06.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic deuterium isotope effects in cytochrome P450 reactions</span></div><div class="casAuthors">Guengerich, Frederick P.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">596</span>
        (<span class="NLM_cas:issue">Measurement and Analysis of Kinetic Isotope Effects</span>),
    <span class="NLM_cas:pages">217-238</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (P 450, CYP) research provides many opportunities for the application of kinetic isotope effect (KIE) strategies.  P450s collectively catalyze oxidns. of more substrates than any other group of enzymes, and C - H bond cleavage is a major feature in a large fraction of these reactions.  The presence of a significant primary deuterium KIE is evidence that hydrogen abstraction is at least partially rate-limiting in the reactions, and this appears to be the case in many P 450 reactions.  The first report of a KIE in (P 450-linked) drug metab. appeared in 1961 (for morphine N-demethylation), and in a no. of cases, it has been possible to modulate the in vivo metab. or toxicity of chems. by deuterium substitution.  A no. of efforts are in progress to utilize deuterium substitution to alter the metab. of drugs in an advantageous manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Wfw_I6hKCLVg90H21EOLACvtfcHk0ljWRCrqGr3f-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvFSjtbc%253D&md5=b16fdb188155619cc2cd49ddbd9ce25e</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1016%2Fbs.mie.2017.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.mie.2017.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520deuterium%2520isotope%2520effects%2520in%2520cytochrome%2520P450%2520reactions%26jtitle%3DMethods%2520Enzymol.%26date%3D2017%26volume%3D596%26spage%3D217%26epage%3D238%26doi%3D10.1016%2Fbs.mie.2017.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic deuterium isotope effects in cytochrome P450 oxidation reactions</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fjlcr.3031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=24285515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=428-431&author=F.+P.+Guengerich&title=Kinetic+deuterium+isotope+effects+in+cytochrome+P450+oxidation+reactions&doi=10.1002%2Fjlcr.3031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic deuterium isotope effects in cytochrome P 450 oxidation reactions</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) isoforms account for ∼75% of the metab. of drugs.  Most of the reactions catalyzed by P 450 isoforms are mixed-function oxidns., and a C-H bond is (usually) broken.  The rate-limiting nature of this step can be analyzed using the kinetic isotope effect (KIE) approach.  The most relevant type of KIE is one termed intermol. noncompetitive, indicative of rate-limiting C-H bond breaking.  A plot of KIE vs. kcat for several P 450s showed a correlation coeff. (r2) of 0.62.  Deuterium substitution has been considered as a potential means of slowing drug metab. or redirecting sites of metab. in some cases, and several general points can be made regarding the potential for application of deuterium in drug design/development based on what is known about P 450 KIEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKzliIFqb7trVg90H21EOLACvtfcHk0ljWRCrqGr3f-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D&md5=b06a7c3232f556435d16bf97b567199f</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3031%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520deuterium%2520isotope%2520effects%2520in%2520cytochrome%2520P450%2520oxidation%2520reactions%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D428%26epage%3D431%26doi%3D10.1002%2Fjlcr.3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schildknegt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D. N.</span></span> <span> </span><span class="NLM_article-title">Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.111.042770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=22190693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=625-634&author=R.+Sharmaauthor=T.+J.+Strelevitzauthor=H.+Gaoauthor=A.+J.+Clarkauthor=K.+Schildknegtauthor=R.+S.+Obachauthor=S.+L.+Rippauthor=D.+K.+Spracklinauthor=L.+M.+Tremaineauthor=A.+D.+N.+Vaz&title=Deuterium+isotope+effects+on+drug+pharmacokinetics.+I.+System-dependent+effects+of+specific+deuteration+with+aldehyde+oxidase+cleared+drugs&doi=10.1124%2Fdmd.111.042770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs</span></div><div class="casAuthors">Sharma, Raman; Strelevitz, Timothy J.; Gao, Hongying; Clark, Alan J.; Schildknegt, Klaas; Obach, R. Scott; Ripp, Sharon L.; Spracklin, Douglas K.; Tremaine, Larry M.; Vaz, Alfin D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The pharmacokinetic properties of drugs may be altered by kinetic deuterium isotope effects.  With specifically deuterated model substrates and drugs metabolized by aldehyde oxidase, we demonstrate how knowledge of the enzyme's reaction mechanism, species differences in the role played by other enzymes in a drug's metabolic clearance, and differences in systemic clearance mechanisms are critically important for the pharmacokinetic application of deuterium isotope effects.  Ex vivo methods to project the in vivo outcome using deuterated carbazeran and zoniporide with hepatic systems demonstrate the importance of establishing the extent to which other metabolic enzymes contribute to the metabolic clearance mechanism.  Differences in pharmacokinetic outcomes in guinea pig and rat, with the same metabolic clearance mechanism, show how species differences in the systemic clearance mechanism can affect the in vivo outcome.  Overall, to gain from the application of deuteration as a strategy to alter drug pharmacokinetics, these studies demonstrate the importance of understanding the systemic clearance mechanism and knowing the identity of the metabolic enzymes involved, the extent to which they contribute to metabolic clearance, and the extent to which metab. contributes to the systemic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCSMFZQoq7tbVg90H21EOLACvtfcHk0ljWRCrqGr3f-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D&md5=8d94242f5ef844ab3f45cfe92275ecda</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042770%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DSchildknegt%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26atitle%3DDeuterium%2520isotope%2520effects%2520on%2520drug%2520pharmacokinetics.%2520I.%2520System-dependent%2520effects%2520of%2520specific%2520deuteration%2520with%2520aldehyde%2520oxidase%2520cleared%2520drugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D625%26epage%3D634%26doi%3D10.1124%2Fdmd.111.042770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malmlöf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rylander, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cenci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilström, B.</span></span> <span> </span><span class="NLM_article-title">Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>225</i></span>,  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2010.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.expneurol.2010.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=20659451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC3cfhtVSqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2010&pages=408-415&author=T.+Malml%C3%B6fauthor=D.+Rylanderauthor=R.+G.+Alkenauthor=F.+Schneiderauthor=T.+H.+Svenssonauthor=M.+A.+Cenciauthor=B.+Schilstr%C3%B6m&title=Deuterium+substitutions+in+the+L-DOPA+molecule+improve+its+anti-akinetic+potency+without+increasing+dyskinesias&doi=10.1016%2Fj.expneurol.2010.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias</span></div><div class="casAuthors">Malmlof Torun; Rylander Daniella; Alken Rudolf-Giesbert; Schneider Frank; Svensson Torgny H; Cenci M Angela; Schilstrom Bjorn</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">408-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment of Parkinson's disease is complicated by a high incidence of L-DOPA-induced dyskinesias (LID).  Strategies to prevent the development of LID aim at providing more stable dopaminergic stimulation.  We have previously shown that deuterium substitutions in the L-DOPA molecule (D3-L-DOPA) yield dopamine that appears more resistant to enzymatic breakdown.  We here investigated the effects of D3-L-DOPA on motor performance and development of dyskinesias in a rodent model of Parkinson's disease.  Through acute experiments, monitoring rotational behavior, dose-effect curves were established for D3-L-DOPA and L-DOPA.  The equipotent dose of D3-L-DOPA was estimated to be 60% of L-DOPA.  Subsequently, animals were treated with either the equipotent dose of D3-L-DOPA (5 mg/kg), the equivalent dose of D3-L-DOPA (8 mg/kg), L-DOPA (8 mg/kg) or vehicle.  The equivalent dose of D3-L-DOPA produced superior anti-akinetic effects compared to L-DOPA in the cylinder test (p<0.05), whereas the equipotent dose of D3-L-DOPA produced an anti-akinetic effect similar to L-DOPA.  Dyskinesias developed to the same degree in the groups treated with equivalent doses of D3-L-DOPA and L-DOPA.  The equipotent dose of D3-L-DOPA induced fewer dyskinesias than L-DOPA (p<0.05).  In conclusion, our study provides evidence for improved potency and reduced side-effects of L-DOPA by deuterium substitutions in the molecule.  These results are of clinical interest since the occurrence of LID is related to the total L-DOPA dose administered.  D3-L-DOPA may thus represent a novel strategy to reduce the total dose requirement and yet achieve an effective control of parkinsonian symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCCKPVGe_D6_6BottYdIAWfW6udTcc2eYBqBTOO6cWGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfhtVSqsw%253D%253D&md5=1b36548fa566e2bb7b71e0206ab494a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2010.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2010.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DMalml%25C3%25B6f%26aufirst%3DT.%26aulast%3DRylander%26aufirst%3DD.%26aulast%3DAlken%26aufirst%3DR.%2BG.%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DSvensson%26aufirst%3DT.%2BH.%26aulast%3DCenci%26aufirst%3DM.%2BA.%26aulast%3DSchilstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DDeuterium%2520substitutions%2520in%2520the%2520L-DOPA%2520molecule%2520improve%2520its%2520anti-akinetic%2520potency%2520without%2520increasing%2520dyskinesias%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D225%26spage%3D408%26epage%3D415%26doi%3D10.1016%2Fj.expneurol.2010.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erisson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beygi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Barak, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grachev, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loupe, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savola, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracewell, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velinova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelstein, O.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">2422</span>– <span class="NLM_lpage">2432</span>, <span class="refDoi"> DOI: 10.1111/bcp.13702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1111%2Fbcp.13702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29959802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=2422-2432&author=F.+Schneiderauthor=L.+Erissonauthor=H.+Beygiauthor=M.+Bradburyauthor=O.+Cohen-Barakauthor=I.+D.+Grachevauthor=S.+Guzyauthor=P.+S.+Loupeauthor=M.+Leviauthor=M.+McDonaldauthor=J.+M.+Savolaauthor=S.+Papapetropoulosauthor=W.+G.+Tracewellauthor=M.+Velinovaauthor=O.+Spiegelstein&title=Pharmacokinetics%2C+metabolism+and+safety+of+deuterated+L-DOPA+%28SD-1077%29%2Fcarbidopa+compared+to+L-DOPA%2Fcarbidopa+following+single+oral+dose+administration+in+healthy+subjects&doi=10.1111%2Fbcp.13702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects</span></div><div class="casAuthors">Schneider, Frank; Erisson, Lavi; Beygi, Hooman; Bradbury, Margaret; Cohen-Barak, Orit; Grachev, Igor D.; Guzy, Serge; Loupe, Pippa S.; Levi, Micha; McDonald, Mirna; Savola, Juha-Matti; Papapetropoulos, Spyros; Tracewell, William G.; Velinova, Maria; Spiegelstein, Ofer</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2422-2432</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : SD-1077, a selectively deuterated precursor of dopamine (DA) structurally related to L-3,4-dihydroxyphenylalanine (L-DOPA), is under development for treatment of motor symptoms of Parkinson's disease.  Preclin. models have shown slower metab. of central deuterated DA.  The present study investigated the peripheral pharmacokinetics (PK), metab. and safety of SD-1077.  Methods : Plasma and urine PK of drug and metabolites and safety after a single oral 150 mg SD-1077 dose were compared to 150 mg L-DOPA, each in combination with 37.5 mg carbidopa (CD) in a double-blind, two-period, crossover study in healthy volunteers (n = 16).  Results : Geometric least squares mean ratios (GMRs) and 90% confidence intervals (90% CI) of SD-1077 vs. L-DOPA for Cmax, AUC0-t, and AUC0-inf were 88.4 (75.9-103.1), 89.5 (84.1-95.3), and 89.6 (84.2-95.4), resp.  Systemic exposure to DA was significantly higher after SD-1077/CD compared to that after L-DOPA/CD, with GMRs (90% CI) of 1.8 (1.45-2.24; P = 0.0005) and 2.06 (1.68-2.52; P < 0.0001) for Cmax and AUC0-t and a concomitant redn. in the ratio of 3,4-dihydroxyphenylacetic acid/DA confirming slower metabolic breakdown of DA by monoamine oxidase (MAO).  There were increases in systemic exposures to metabolites of catechol O-methyltransferase (COMT) reaction, 3-methoxytyramine (3-MT) and 3-O-methyldopa (3-OMD) with GMRs (90% CI) for SD-1077/CD to L-DOPA/CD for 3-MT exposure of 1.33 (1.14-1.56; P = 0.0077) and 1.66 (1.42-1.93; P < 0.0001) for Cmax and AUC0-t, resp. and GMRs (90% CI) for 3-OMD of 1.19 (1.15, 1.23; P < 0.0001) and 1.31 (1.27, 1.36; P < 0.0001) for Cmax and AUC0-t.  SD-1077/CD exhibited comparable tolerability and safety to L-DOPA/CD.  Conclusions : SD-1077/CD demonstrated the potential to prolong exposure to central DA at comparable peripheral PK and safety to the ref. L-DOPA/CD combination.  A single dose of SD-1077 is safe for further clin. development in Parkinson's disease patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnz4G1z5uGtLVg90H21EOLACvtfcHk0lhTcBlCZSYK5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7nM&md5=e9d5896c4b86af0a661bddad5cd6db8b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13702%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DErisson%26aufirst%3DL.%26aulast%3DBeygi%26aufirst%3DH.%26aulast%3DBradbury%26aufirst%3DM.%26aulast%3DCohen-Barak%26aufirst%3DO.%26aulast%3DGrachev%26aufirst%3DI.%2BD.%26aulast%3DGuzy%26aufirst%3DS.%26aulast%3DLoupe%26aufirst%3DP.%2BS.%26aulast%3DLevi%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DM.%26aulast%3DSavola%26aufirst%3DJ.%2BM.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DTracewell%26aufirst%3DW.%2BG.%26aulast%3DVelinova%26aufirst%3DM.%26aulast%3DSpiegelstein%26aufirst%3DO.%26atitle%3DPharmacokinetics%252C%2520metabolism%2520and%2520safety%2520of%2520deuterated%2520L-DOPA%2520%2528SD-1077%2529%252Fcarbidopa%2520compared%2520to%2520L-DOPA%252Fcarbidopa%2520following%2520single%2520oral%2520dose%2520administration%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2018%26volume%3D84%26spage%3D2422%26epage%3D2432%26doi%3D10.1111%2Fbcp.13702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zane, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Horn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czepczor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, M.</span></span> <span> </span><span class="NLM_article-title">Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3831</span>– <span class="NLM_lpage">3842</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmc.2015.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25900628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVeqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3831-3842&author=J.+Schofieldauthor=V.+Derdauauthor=J.+Atzrodtauthor=P.+Zaneauthor=Z.+Guoauthor=R.+van+Hornauthor=V.+Czepczorauthor=A.+Stoltzauthor=M.+Pardon&title=Effect+of+deuteration+on+metabolism+and+clearance+of+Nerispirdine+%28HP184%29+and+AVE5638&doi=10.1016%2Fj.bmc.2015.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638</span></div><div class="casAuthors">Schofield, Joseph; Derdau, Volker; Atzrodt, Jens; Zane, Patricia; Guo, Zuyu; van Horn, Robert; Czepczor, Valerie; Stoltz, Axelle; Pardon, Magalie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3831-3842</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Replacing hydrogen with deuterium as a means of altering ADME properties of drug mols. has recently enjoyed a renaissance, such that at least two deuterated chem. entities are currently in clin. development.  Although most research in this area aims to increase the metabolic stability, and hence half-life of the active species, experience has shown that prediction of the in vivo behavior of deuterated mols. is difficult and depends on multiple factors including the complexity of the metabolic scheme, the enzymes involved and hence the mechanism of the rate-detg. step in the biotransformation.  In an effort to elucidate some of these factors we examd. the metabolic behavior of two mols. from the Sanofi portfolio in a range of in vitro and in vivo systems.  Although some key metabolic reactions of the acetylcholine release stimulator HP184 4 were slowed in vitro and in vivo when deuterium was present at the sites of metab., this did not translate to an increase in overall metabolic stability.  By contrast, the tryptase inhibitor AVE5638 13 was much more metabolically stable in vitro in its deuterated form than when unlabeled.  These results indicate that it could be of value to conc. efforts in this area to mols. which are metabolised by a major pathway that involves enzymes of the amine oxidase family or other low-capacity enzyme families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0Zfh2LmGWu7Vg90H21EOLACvtfcHk0lhTcBlCZSYK5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVeqtbk%253D&md5=376f5c853c811f8e8a7aaae21d4f0b46</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DSchofield%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DZane%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3Dvan%2BHorn%26aufirst%3DR.%26aulast%3DCzepczor%26aufirst%3DV.%26aulast%3DStoltz%26aufirst%3DA.%26aulast%3DPardon%26aufirst%3DM.%26atitle%3DEffect%2520of%2520deuteration%2520on%2520metabolism%2520and%2520clearance%2520of%2520Nerispirdine%2520%2528HP184%2529%2520and%2520AVE5638%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3831%26epage%3D3842%26doi%3D10.1016%2Fj.bmc.2015.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pestov, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okkelman, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmanai, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurski, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Control of lysyl oxidase activity through site-specific deuteration of lysine</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2010.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21106372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=255-258&author=N.+B.+Pestovauthor=I.+A.+Okkelmanauthor=V.+V.+Shmanaiauthor=A.+L.+Hurskiauthor=A.+J.+Giacciaauthor=M.+S.+Shchepinov&title=Control+of+lysyl+oxidase+activity+through+site-specific+deuteration+of+lysine&doi=10.1016%2Fj.bmcl.2010.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Control of lysyl oxidase activity through site-specific deuteration of lysine</span></div><div class="casAuthors">Pestov, Nikolay B.; Okkelman, Irina A.; Shmanai, Vadim V.; Hurski, Alaksiej L.; Giaccia, Amato J.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">255-258</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysyl oxidase (LOX) is implicated in several extracellular matrix related disorders, including fibrosis and cancer.  Methods of inhibition of LOX in vivo include antibodies, copper sequestration and toxic small mols. such as β-aminopropionitrile.  Here, we propose a novel approach to modulation of LOX activity based on the kinetic isotope effect (KIE).  We show that 6,6-D2-lysine is oxidized by LOX at substantially lower rate, with apparent deuterium effect on V max/K m as high as 4.35 ± 0.22.  Lys is an essential nutrient, so dietary ingestion of D2Lys and its incorporation via normal Lys turnover suggests new approaches to mitigating LOX-assocd. pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJbj0BwwCWn7Vg90H21EOLACvtfcHk0lhTcBlCZSYK5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7E&md5=f50a798d4f7ba12fd8f2999da1f118ff</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DPestov%26aufirst%3DN.%2BB.%26aulast%3DOkkelman%26aufirst%3DI.%2BA.%26aulast%3DShmanai%26aufirst%3DV.%2BV.%26aulast%3DHurski%26aufirst%3DA.%2BL.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DControl%2520of%2520lysyl%2520oxidase%2520activity%2520through%2520site-specific%2520deuteration%2520of%2520lysine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D255%26epage%3D258%26doi%3D10.1016%2Fj.bmcl.2010.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillgenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koytchev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R. G.</span></span> <span> </span><span class="NLM_article-title">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span>. <i>Arzneim. Forsch.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1296724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1055%2Fs-0031-1296724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=16724516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2006&pages=295-300&author=F.+Schneiderauthor=M.+Hillgenbergauthor=R.+Koytchevauthor=R.+G.+Alken&title=Enhanced+plasma+concentration+by+selective+deuteration+of+rofecoxib+in+rats&doi=10.1055%2Fs-0031-1296724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span></div><div class="casAuthors">Schneider, Frank; Hillgenberg, Moritz; Koytchev, Rossen; Alken, Rudolf-Giesbert</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-300</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">The plasma concns. of BDD-11602 (4-[4-(methanesulfonyl)phenyl]-3-(pentadeuterophenyl)-5H-furan-2-one), a rofecoxib deriv. in which the positions 2', 3', 4', 5' and 6' of the Ph ring were deuterated, and rofecoxib (4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one, CAS 162011-90-7) were compared in order to explore the effects of selective deuteration on the systemic bioavailability.  The COX-2 selectivity in vitro was also compared.  Following oral gavage administration of 0.1, 1 or 10 mg/kg BDD-11602 to Sprague Dawley rats, AUCo-t (area under the curve) and Cmax (max. concn.) values were statistically significant higher than those of rofecoxib at the same doses.  The overall increase in AUCo-t and Cmax for BDD-11602 over rofecoxib was 1.53-fold and 1.60-fold, resp.  BDD-11602 and rofecoxib inhibited COX-2-derived PGE(2) synthesis with IC50 values of 173 nmol/1 and 169 nmol/1, resp.  IC50 values for inhibition of human platelet COX-1 were estd. to be above 1 μmol/l for both compds.  The substitution of hydrogen by deuterium on the positions 2', 3', 4', 5' and 6' in BDD-11602 leads to superior oral availability compared to the non-deuterated compd., whereas the COX-2 selectivity is not affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLsIVPsmwYBrVg90H21EOLACvtfcHk0lhvoSArbaVgmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D&md5=55f8165f69f41ed6113c6761297a1fd1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296724%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DHillgenberg%26aufirst%3DM.%26aulast%3DKoytchev%26aufirst%3DR.%26aulast%3DAlken%26aufirst%3DR.%2BG.%26atitle%3DEnhanced%2520plasma%2520concentration%2520by%2520selective%2520deuteration%2520of%2520rofecoxib%2520in%2520rats%26jtitle%3DArzneim.%2520Forsch.%26date%3D2006%26volume%3D56%26spage%3D295%26epage%3D300%26doi%3D10.1055%2Fs-0031-1296724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divović, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treven, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobričić, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meirelles, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzigmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihovilovic, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savić, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieghart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel deuterated ligands functionally selective for the γ-aminobutyric acid type A receptor (GABA<sub>A</sub>R) α6 subtype with improved metabolic stability and enhanced bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2422</span>– <span class="NLM_lpage">2446</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01664</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2422-2446&author=D.+E.+Knutsonauthor=R.+Kodaliauthor=B.+Divovi%C4%87author=M.+Trevenauthor=M.+R.+Stephenauthor=N.+M.+Zahnauthor=V.+Dobri%C4%8Di%C4%87author=A.+T.+Huberauthor=M.+A.+Meirellesauthor=R.+S.+Vermaauthor=L.+Wimmerauthor=C.+Witzigmannauthor=L.+A.+Arnoldauthor=L.+C.+Chiouauthor=M.+Ernstauthor=M.+D.+Mihovilovicauthor=M.+M.+Savi%C4%87author=W.+Sieghartauthor=J.+M.+Cook&title=Design+and+synthesis+of+novel+deuterated+ligands+functionally+selective+for+the+%CE%B3-aminobutyric+acid+type+A+receptor+%28GABAAR%29+%CE%B16+subtype+with+improved+metabolic+stability+and+enhanced+bioavailability&doi=10.1021%2Facs.jmedchem.7b01664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability</span></div><div class="casAuthors">Knutson, Daniel E.; Kodali, Revathi; Divovic, Branka; Treven, Marco; Stephen, Michael R.; Zahn, Nicolas M.; Dobricic, Vladimir; Huber, Alec T.; Meirelles, Matheus A.; Verma, Ranjit S.; Wimmer, Laurin; Witzigmann, Christopher; Arnold, Leggy A.; Chiou, Lih-Chu; Ernst, Margot; Mihovilovic, Marko D.; Savic, Miroslav M.; Sieghart, Werner; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2422-2446</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent reports indicate that α6β2/3γ2 GABAAR selective ligands may be important for the treatment of trigeminal activation-related pain and neuropsychiatric disorders with sensorimotor gating deficits.  Based on 3 functionally α6β2/3γ2 GABAAR selective pyrazoloquinolinones I (R1 = 7-OMe, R2 = 4'-OMe; R1 = 8-Cl, R2 = 3'-OMe; R1 = 7-Br, R2 = 4'-OMe), 42 novel analogs were synthesized, and their in vitro metabolic stability and cytotoxicity as well as their in vivo pharmacokinetics, basic behavioral pharmacol., and effects on locomotion were investigated.  Incorporation of deuterium into the methoxy substituents of the ligands increased their duration of action via improved metabolic stability and bioavailability, while their selectivity for the GABAAR α6 subtype was retained. 8b was identified as the lead compd. with a substantially improved pharmacokinetic profile.  The ligands allosterically modulated diazepam insensitive α6β2/3γ2 GABAARs and were functionally silent at diazepam sensitive α1β2/3γ2 GABAARs, thus no sedation was detected.  In addn., these analogs were not cytotoxic, which render them interesting candidates for treatment of CNS disorders mediated by GABAAR α6β2/3γ2 subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMM96AABYKIbVg90H21EOLACvtfcHk0lhvoSArbaVgmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOls7k%253D&md5=e0591a3a9c7af56343483ff7aa0c254c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01664%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DD.%2BE.%26aulast%3DKodali%26aufirst%3DR.%26aulast%3DDivovi%25C4%2587%26aufirst%3DB.%26aulast%3DTreven%26aufirst%3DM.%26aulast%3DStephen%26aufirst%3DM.%2BR.%26aulast%3DZahn%26aufirst%3DN.%2BM.%26aulast%3DDobri%25C4%258Di%25C4%2587%26aufirst%3DV.%26aulast%3DHuber%26aufirst%3DA.%2BT.%26aulast%3DMeirelles%26aufirst%3DM.%2BA.%26aulast%3DVerma%26aufirst%3DR.%2BS.%26aulast%3DWimmer%26aufirst%3DL.%26aulast%3DWitzigmann%26aufirst%3DC.%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DChiou%26aufirst%3DL.%2BC.%26aulast%3DErnst%26aufirst%3DM.%26aulast%3DMihovilovic%26aufirst%3DM.%2BD.%26aulast%3DSavi%25C4%2587%26aufirst%3DM.%2BM.%26aulast%3DSieghart%26aufirst%3DW.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520deuterated%2520ligands%2520functionally%2520selective%2520for%2520the%2520%25CE%25B3-aminobutyric%2520acid%2520type%2520A%2520receptor%2520%2528GABAAR%2529%2520%25CE%25B16%2520subtype%2520with%2520improved%2520metabolic%2520stability%2520and%2520enhanced%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2422%26epage%3D2446%26doi%3D10.1021%2Facs.jmedchem.7b01664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichholz, R.</span></span> <span> </span><span class="NLM_article-title">The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3239</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmc.2013.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=23611771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3231-3239&author=P.+W.+Manleyauthor=F.+Blascoauthor=J.+Mestanauthor=R.+Aichholz&title=The+kinetic+deuterium+isotope+effect+as+applied+to+metabolic+deactivation+of+imatinib+to+the+des-methyl+metabolite%2C+CGP74588&doi=10.1016%2Fj.bmc.2013.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588</span></div><div class="casAuthors">Manley, Paul W.; Blasco, Francesca; Mestan, Jurgen; Aichholz, Reiner</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3231-3239</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There has recently been a burgeoning interest in impeding drug metab. by replacing hydrogen atoms with deuterium to invoke a kinetic isotope effect.  Imatinib, a front-line therapy for both chronic myeloid leukemia and of gastrointestinal stromal tumors, is often substantially metabolised via N-demethylation to the significantly less active CGP74588.  Since deuterium-carbon bonds are stronger than hydrogen-carbon bonds, we hypothesised that the N-trideuteromethyl analog of imatinib might be subject to a reduced metabolic turnover as compared to imatinib and lead to different pharmacokinetic properties, and hence improved efficacy, in vivo.  Consequently, we investigated whether the N-trideuteromethyl analog would maintain target inhibition and show a reduced propensity for N-demethylation in in vitro assays with liver microsomes and following oral administration to rats.  The N-trideuteromethyl compd. exhibited similar activity as a tyrosine kinase inhibitor as imatinib and similar efficacy as an antiproliferative in cellular assays.  In comparison to imatinib, the trideuterated analog also showed reduced N-demethylation upon incubation with both rat and human liver microsomes, consistent with a deuterium isotope effect.  However, the reduced in vitro metab. did not translate into increased exposure of the N-trideuteromethyl analog following i.v. administration of the compd. to rats and no significant difference was obsd. for the formation of the N-desmethyl metabolite from either parent drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhr0hlhno4rVg90H21EOLACvtfcHk0lhvoSArbaVgmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12htL4%253D&md5=5b5f26913b519661be875550cff41af0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DAichholz%26aufirst%3DR.%26atitle%3DThe%2520kinetic%2520deuterium%2520isotope%2520effect%2520as%2520applied%2520to%2520metabolic%2520deactivation%2520of%2520imatinib%2520to%2520the%2520des-methyl%2520metabolite%252C%2520CGP74588%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3231%26epage%3D3239%26doi%3D10.1016%2Fj.bmc.2013.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerekes, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposite, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagat, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelusky, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tevar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span> <span> </span><span class="NLM_article-title">Aurora kinase inhibitors based on the imidazo[1,2-a]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1021/jm1010995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1010995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=201-210&author=A.+D.+Kerekesauthor=S.+J.+Espositeauthor=R.+J.+Dollauthor=J.+R.+Tagatauthor=T.+Yuauthor=Y.+Xiaoauthor=Y.+Zhangauthor=D.+B.+Preluskyauthor=S.+Tevarauthor=K.+Grayauthor=G.+A.+Terracinaauthor=S.+Leeauthor=J.+Jonesauthor=M.+Liuauthor=A.+D.+Bassoauthor=E.+B.+Smith&title=Aurora+kinase+inhibitors+based+on+the+imidazo%5B1%2C2-a%5Dpyrazine+core%3A+fluorine+and+deuterium+incorporation+improve+oral+absorption+and+exposure&doi=10.1021%2Fjm1010995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure</span></div><div class="casAuthors">Kerekes, Angela D.; Esposite, Sara J.; Doll, Ronald J.; Tagat, Jayaram R.; Yu, Tao; Xiao, Yushi; Zhang, Yonglian; Prelusky, Dan B.; Tevar, Seema; Gray, Kimberly; Terracina, Gaby A.; Lee, Suining; Jones, Jennifer; Liu, Ming; Basso, Andrea D.; Smith, Elizabeth B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aurora kinases are cell cycle regulated serine/threonine kinases that have been linked to cancer.  Compd. 1 was identified as a potent Aurora inhibitor but lacked oral bioavailability.  Optimization of 1 led to the discovery of a series of fluoroamine and deuterated analogs, exemplified by compd. 25 (I), with an improved pharmacokinetic profile.  We found that blocking oxidative metab. at the benzylic position and decreasing the basicity of the amine are important to obtaining compds. with good biol. profiles and oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3YIdBKno7NLVg90H21EOLACvtfcHk0ljFlrNeI0TJrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP&md5=af7c338866058e7d63116c8c8aa2d3fd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm1010995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010995%26sid%3Dliteratum%253Aachs%26aulast%3DKerekes%26aufirst%3DA.%2BD.%26aulast%3DEsposite%26aufirst%3DS.%2BJ.%26aulast%3DDoll%26aufirst%3DR.%2BJ.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPrelusky%26aufirst%3DD.%2BB.%26aulast%3DTevar%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DTerracina%26aufirst%3DG.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26atitle%3DAurora%2520kinase%2520inhibitors%2520based%2520on%2520the%2520imidazo%255B1%252C2-a%255Dpyrazine%2520core%253A%2520fluorine%2520and%2520deuterium%2520incorporation%2520improve%2520oral%2520absorption%2520and%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D201%26epage%3D210%26doi%3D10.1021%2Fjm1010995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberge, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welihinda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of deuterated <i>C</i>-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1021/jm401780b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401780b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1236-1251&author=G.+Xuauthor=B.+Lvauthor=J.+Y.+Robergeauthor=B.+Xuauthor=J.+Duauthor=J.+Dongauthor=Y.+Chenauthor=K.+Pengauthor=L.+Zhangauthor=X.+Tangauthor=Y.+Fengauthor=M.+Xuauthor=W.+Fuauthor=W.+Zhangauthor=L.+Zhuauthor=Z.+Dengauthor=Z.+Shengauthor=A.+Welihindaauthor=X.+Sun&title=Design%2C+synthesis%2C+and+biological+evaluation+of+deuterated+C-aryl+glycoside+as+a+potent+and+long-acting+renal+sodium-dependent+glucose+cotransporter+2+inhibitor+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm401780b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Xu, Ge; Lv, Binhua; Roberge, Jacques Y.; Xu, Baihua; Du, Jiyan; Dong, Jiajia; Chen, Yuanwei; Peng, Kun; Zhang, Lili; Tang, Xinxing; Feng, Yan; Xu, Min; Fu, Wei; Zhang, Wenbin; Zhu, Liangcheng; Deng, Zhongping; Sheng, Zelin; Welihinda, Ajith; Sun, Xun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1236-1251</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SGLT2 inhibitors deuterated at sites susceptible to oxidative metab. were found to have a slightly longer tmax and half-life (t1/2), dose-dependent increase in urinary glucose excretion (UGE) in rats, and slightly superior effects on UGE in dogs while retaining similar in vitro inhibitory activities against hSGLT2.  In particular, deuterated compd. 41 has the potential to be a robust long-acting antidiabetic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpflgQPhYZ21rVg90H21EOLACvtfcHk0ljFlrNeI0TJrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eiu7w%253D&md5=3923fd85107c3cd4c0aa872a2fa65d83</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm401780b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401780b%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DG.%26aulast%3DLv%26aufirst%3DB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DWelihinda%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520deuterated%2520C-aryl%2520glycoside%2520as%2520a%2520potent%2520and%2520long-acting%2520renal%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1236%26epage%3D1251%26doi%3D10.1021%2Fjm401780b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span> <span> </span><span class="NLM_article-title">Evaluation of deuterium-labeled JNJ38877605: pharmacokinetic, metabolic, and <i>in vivo</i> antitumor profiles</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=1213-1218&author=Z.+Zhanauthor=X.+Pengauthor=Y.+Sunauthor=J.+Aiauthor=W.+Duan&title=Evaluation+of+deuterium-labeled+JNJ38877605%3A+pharmacokinetic%2C+metabolic%2C+and+in+vivo+antitumor+profiles&doi=10.1021%2Facs.chemrestox.8b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Deuterium-Labeled JNJ38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles</span></div><div class="casAuthors">Zhan, Zhengsheng; Peng, Xia; Sun, Yiming; Ai, Jing; Duan, Wenhu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1213-1218</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C-Met inhibitor JNJ38877605 has proven curative as an antitumor agent, while its clin. study was terminated due to renal toxicity.  It was reported that the renal toxicity was caused by the poor soly. of its aldehyde oxidase (AO) metabolites.  Therefore, blocking AO oxidn. of JNJ38877605 might diminish the toxic metabolites and overcome the renal toxicity.  Compd. 3, the AO metabolic site deuterated JNJ38877605, was then synthesized as the target mol.  In vitro monkey liver S9 fraction incubation of 3 manifested that the renal toxic metabolite M2-2 was significantly reduced, which connoted that this deuteration has partly blocked AO oxidn.  After po. nasal gavage to cynomolgus monkeys, compd. 3 revealed decreased AO metabolites M2-2 and M3-2 in the plasma as well as 1.88-fold AUC and 1.56-fold Cmax compared with JNJ38877605, indicating that deuterium replacement significantly blocked AO metab. in vivo.  Besides, metabolic profiles of 3 were investigated by anal. of the plasma and the urine of the po. administrated cynomolgus monkeys.  Moreover, after oral administration to the EBC-1 tumor-bearing nude mice, compd. 3 exhibited a better antitumor efficacy than JNJ38877605.  In conclusion, deuteration on the AO metabolic site of JNJ38877605 improved its AO metab., oral exposure, as well as in vivo antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbsjIia0zdsbVg90H21EOLACvtfcHk0lh9ERVeOzBHGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM&md5=a9e66686424cd885998b17b603827313</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00191%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26atitle%3DEvaluation%2520of%2520deuterium-labeled%2520JNJ38877605%253A%2520pharmacokinetic%252C%2520metabolic%252C%2520and%2520in%2520vivo%2520antitumor%2520profiles%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26spage%3D1213%26epage%3D1218%26doi%3D10.1021%2Facs.chemrestox.8b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunsaed, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornish, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. O.</span></span> <span> </span><span class="NLM_article-title">The bioavailability and dose dependency of the deuterated anti-tumour agent 4,6-benzylidene-<i>d</i><sub><i>1</i></sub><i>-D</i>-glucose in mice and rats</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1007/BF00686830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1007%2FBF00686830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=7882455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK2MXmtVWntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1995&pages=464-470&author=C.+B.+Dunsaedauthor=J.+M.+Dornishauthor=E.+O.+Pettersen&title=The+bioavailability+and+dose+dependency+of+the+deuterated+anti-tumour+agent+4%2C6-benzylidene-d1-D-glucose+in+mice+and+rats&doi=10.1007%2FBF00686830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The bioavailability and dose dependency of the deuterated anti-tumor agent 4,6-benzylidene-d1-D-glucose in mice and rats</span></div><div class="casAuthors">Dunsaed, Camilla Bruno; Dornish, John Michael; Pettersen, Erik Olai</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-70</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The benzaldehyde deriv. 4,6-benzylidene-D-glucose (BG) induces an inhibition of protein synthesis at otherwise non-toxic doses in cells grown in vitro.  To increase the biol. effect of BG, the hydrogen in the formyl group was exchanged with deuterium, resulting in 4,6-benzylidene-d1-D-glucose (P-1013).  In this study we compared the bioavailability of BG and P-1013, since both i.p. and, esp., oral administration of the drugs would be a great advantage.  We also examd. whether or not P-1013 displays dose-dependent pharmacokinetics.  Pharmacokinetics were studied by analyzing plasma samples using reversed-phase high-performance liq. chromatog. (HPLC).  P-1013 was given at four different doses i.v. (60, 120, 145 and 230 mg/kg) and p.o. (60, 120, 170 and 230 mg/kg) to female Bom:NMRI-numice.  The bioavailability was more than 50% for all doses.  The results also indicate that P-1013 shows linear pharmacokinetics, with no change being obsd. in the half-life (t1/2) with increasing dose and only a slightly more than proportional increase in the area under the concn. time curve (AUC) occurring with increasing dose.  A doubling in dose resulted in a 2.2-fold increase in the AUC. P-1013 and BG were also given i.v., p.o. and i.p. to female nu/nu-BALB/cABom mice and male Wistar rats.  A high degree of bioavailability was found in both species, with 55-100% of the delivered dose being absorbed.  Deuteration of BG does not seem to alter its bioavailability, as we found the same bioavailability for P-1013 as for BG.  We conclude that the pharmacokinetics of P-1013 does not prevent its use as a cancer treatment drug given orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjkHTMHLx-rrVg90H21EOLACvtfcHk0lh9ERVeOzBHGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtVWntLc%253D&md5=178f53f64b220ed6619be336c81e07c1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2FBF00686830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00686830%26sid%3Dliteratum%253Aachs%26aulast%3DDunsaed%26aufirst%3DC.%2BB.%26aulast%3DDornish%26aufirst%3DJ.%2BM.%26aulast%3DPettersen%26aufirst%3DE.%2BO.%26atitle%3DThe%2520bioavailability%2520and%2520dose%2520dependency%2520of%2520the%2520deuterated%2520anti-tumour%2520agent%25204%252C6-benzylidene-d1-D-glucose%2520in%2520mice%2520and%2520rats%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D35%26spage%3D464%26epage%3D470%26doi%3D10.1007%2FBF00686830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of deuterated tivozanib for improving pharmacokinetic properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2425</span>– <span class="NLM_lpage">2428</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2015.03.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25908516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2425-2428&author=S.+Guoauthor=X.+Pangauthor=L.+Pengauthor=M.+Zhanauthor=L.+Fanauthor=Y.+Gongauthor=F.+Kangauthor=Y.+Chen&title=Design%2C+synthesis+and+biological+evaluation+of+deuterated+tivozanib+for+improving+pharmacokinetic+properties&doi=10.1016%2Fj.bmcl.2015.03.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic properties</span></div><div class="casAuthors">Guo, Shiwei; Pang, Xuehai; Peng, Lingling; Zhan, Miao; Fan, Lei; Gong, Yu; Kang, Fanyuan; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2425-2428</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tivozanib is a potent and selective tyrosine kinase inhibitor of vascular endothelial growth factor receptor-1(VEGFR1), -2(VEGFR2), and -3(VEGFR3).  Analog of Tivozanib with deuterium-for-hydrogen replacement in metabolically active site was prepd. and evaluated in vitro.  Compared to its prototype, deuterated Tivozanib compd. HC-1144 retained in vitro activity against VEGFR tyrosine kinases.  In vivo pharmacokinetic studies indicated HC-1144 clearly altered the blood circulation behavior, which was proved by significantly prolonged blood circulation half life time (t1/2) and increased AUC0-∞.  Therefore, HC-1144 has the potential to be a novel inhibitor against VEGFR tyrosine kinases with long-acting plasma exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYY9xvMR4V2bVg90H21EOLACvtfcHk0lh9ERVeOzBHGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2rs7g%253D&md5=734920cd5f849f1f8498d16ec5b59454</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.088%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DZhan%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520deuterated%2520tivozanib%2520for%2520improving%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2425%26epage%3D2428%26doi%3D10.1016%2Fj.bmcl.2015.03.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2803</span>– <span class="NLM_lpage">2806</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2017.04.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28478926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2803-2806&author=X.+Pangauthor=Y.+Wangauthor=Y.+Chen&title=Design%2C+synthesis%2C+and+biological+evaluation+of+deuterated+apalutamide+with+improved+pharmacokinetic+profiles&doi=10.1016%2Fj.bmcl.2017.04.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles</span></div><div class="casAuthors">Pang, Xuehai; Wang, Yingwei; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2803-2806</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of deuterated apalutamide were designed and prepd.  Compared to apalutamide I (R = Me, R1 = H, X = CH2), deuterated analogs I (R = CD3, R1 = H, X = CH2; R = CD3, R1 = D, X = CH2) showed obviously higher plasma concns. and better PK parameters after oral administration in mice.  In rats, N-trideuteromethyl compd. I (R = CD3, R1 = H, X = CH2) displayed 1.8-fold peak concn. (Cmax), and nearly doubled its drug exposure in plasma (AUC0-∞) compared to apalutamide.  Unsurprisingly, apalutamide and I (R = CD3, R1 = H, X = CH2) had similar affinity for AR in vitro.  In summary, the deuteration strategy could obviously improve PK parameters of apalutamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9_FtfnSPBILVg90H21EOLACvtfcHk0lh9ERVeOzBHGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWku7k%253D&md5=674f20b10eface6a39641bc37b8f4b16</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.071%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520deuterated%2520apalutamide%2520with%2520improved%2520pharmacokinetic%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2803%26epage%3D2806%26doi%3D10.1016%2Fj.bmcl.2017.04.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velthuisen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baughman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.ejmech.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=23474906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=202-212&author=E.+J.+Velthuisenauthor=T.+M.+Baughmanauthor=B.+A.+Johnsauthor=D.+P.+Temelkoffauthor=J.+G.+Weatherhead&title=Synthesis+and+pharmacokinetic+profile+of+highly+deuterated+brecanavir+analogs&doi=10.1016%2Fj.ejmech.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs</span></div><div class="casAuthors">Velthuisen, Emile J.; Baughman, Todd M.; Johns, Brian A.; Temelkoff, David P.; Weatherhead, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">202-212</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Two highly deuterated analogs of the HIV-1 protease inhibitor brecanavir have been prepd. to study the effect of deuterium upon metabolic stability.  The sites for deuterium incorporation were initially chosen to maximize the potential for a kinetic isotope effect; locations where C-H bond breaking is the rate limiting step.  The analogs have been profiled in both in vitro and in vivo pharmacokinetic studies and the result are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoermaHUY6pyrVg90H21EOLACvtfcHk0lgkUtTBACJgag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaqsr4%253D&md5=5b50523d7205335cb683f41be15d0973</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DVelthuisen%26aufirst%3DE.%2BJ.%26aulast%3DBaughman%26aufirst%3DT.%2BM.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520and%2520pharmacokinetic%2520profile%2520of%2520highly%2520deuterated%2520brecanavir%2520analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D63%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.ejmech.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Effect of <i>N</i>-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fjlcr.3516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28432800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1ertbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=401-409&author=X.+Pangauthor=L.+Pengauthor=Y.+Chen&title=Effect+of+N-methyl+deuteration+on+pharmacokinetics+and+pharmacodynamics+of+enzalutamide&doi=10.1002%2Fjlcr.3516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of N-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide</span></div><div class="casAuthors">Pang, Xuehai; Peng, Lingling; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">401-409</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Enzalutamide, a second-generation antiandrogen, has been developed for the treatment of castration-resistance prostate cancer.  We synthesized the deuterated analogs 6 and found that it showed higher drug exposure and thus stronger antitumor potency in preclin. settings.  Compd. I is being developed clin. for the potential to be differentiated from enzalutamide through reduced dosages and a higher safety margin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnd9MVelxwsbVg90H21EOLACvtfcHk0lgkUtTBACJgag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1ertbo%253D&md5=2ff3c608d528e516aa69b500063bb58c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3516%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DEffect%2520of%2520N-methyl%2520deuteration%2520on%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520enzalutamide%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2017%26volume%3D60%26spage%3D401%26epage%3D409%26doi%3D10.1002%2Fjlcr.3516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Effect of <i>N</i>-methyl deuteration on metabolism and pharmacokinetics of enzalutamide</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S111352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.2147%2FDDDT.S111352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27462143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslSitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=2181-2191&author=J.+Jiangauthor=X.+Pangauthor=L.+Liauthor=X.+Daiauthor=X.+Diaoauthor=X.+Chenauthor=D.+Zhongauthor=Y.+Wangauthor=Y.+Chen&title=Effect+of+N-methyl+deuteration+on+metabolism+and+pharmacokinetics+of+enzalutamide&doi=10.2147%2FDDDT.S111352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide</span></div><div class="casAuthors">Jiang, Jinfang; Pang, Xuehai; Li, Liang; Dai, Xiaojian; Diao, Xingxing; Chen, Xiaoyan; Zhong, Dafang; Wang, Yingwei; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2181-2191</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: The replacement of hydrogen with deuterium invokes a kinetic isotope effect.  Thus, this method is an attractive way to slow down the metabolic rate and modulate pharmacokinetics.  Purpose: Enzalutamide (ENT) acts as a competitive inhibitor of the androgen receptor and has been approved for the treatment of metastatic castration-resistant prostate cancer by the US Food and Drug Administration in 2012.  To attenuate the N-demethylation pathway, hydrogen atoms of the N-CH3 moiety were replaced by the relatively stable isotope deuterium, which showed similar pharmacol. activities but exhibited favorable pharmacokinetic properties.  Methods: We estd. in vitro and in vivo pharmacokinetic parameters for ENT and its deuterated analog (d3-ENT).  For in vitro studies, intrinsic primary isotope effects (KH/KD) were detd. by the ratio of intrinsic clearance (CLint) obtained for ENT and d3-ENT.  The CLint values were obtained by the substrate depletion method.  For in vivo studies, ENT and d3-ENT were orally given to male Sprague Dawley rats sep. and simultaneously to assess the disposition and metab. of them.  We also investigated the main metabolic pathway of ENT by comparing the rate of oxidn. and hydrolysis in vitro.  Results: The in vitro CLint (max. velocity/Michaelis const. [Vmax/Km]) of d3-ENT in rat and human liver microsomes were 49.7% and 72.9% lower than those of the non-deuterated compd., corresponding to the KH/KD value of ∼2.  The max. obsd. plasma concn., Cmax, and area under the plasma concn. -time curve from time zero to the last measurable sampling time point (AUC0-t) were 35% and 102% higher than those of ENT when orally administered to rats (10 mg/kg).  The exposure of the N-demethyl metabolite M2 was eightfold lower, whereas that of the amide hydrolysis metabolite M1 and other minor metabolites was unchanged.  The obsd. hydrolysis rate of M2 was at least ten times higher than that of ENT and d3-ENT in rat plasma.  Conclusion: ENT was mainly metabolized through the "parent→M2→M1" pathway based on in vitro and in vivo elimination behavior.  The obsd. in vitro deuterium isotope effect translated into increased exposure of the deuterated analog in rats.  Once the carbon-hydrogen was replaced with carbon-deuterium (C-D) bonds, the major metabolic pathway was retarded because of the relatively stable C-D bonds.  The systemic exposure to d3-ENT can increase in humans, so the dose requirements can be reduced appropriately.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Eb9Ddza7HrVg90H21EOLACvtfcHk0lgkUtTBACJgag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslSitbk%253D&md5=9880328f912b0816d7a875197b61d4be</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S111352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S111352%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DDiao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DEffect%2520of%2520N-methyl%2520deuteration%2520on%2520metabolism%2520and%2520pharmacokinetics%2520of%2520enzalutamide%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2016%26volume%3D10%26spage%3D2181%26epage%3D2191%26doi%3D10.2147%2FDDDT.S111352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J. A.</span></span> <span> </span><span class="NLM_article-title">Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.057265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.114.057265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=24616265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFSjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=954-962&author=R.+A.+Stringerauthor=G.+Williamsauthor=F.+Picardauthor=B.+Sohalauthor=O.+Kretzauthor=J.+McKennaauthor=J.+A.+Krauser&title=Application+of+a+deuterium+replacement+strategy+to+modulate+the+pharmacokinetics+of+7-%283%2C5-dimethyl-1H-1%2C2%2C4-triazol-1-yl%29-3-%284-methoxy-2-methylphenyl%29-2%2C6-dimethylpyrazolo%5B5%2C1-b%5Doxazole%2C+a+novel+CRF1+antagonist&doi=10.1124%2Fdmd.114.057265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist</span></div><div class="casAuthors">Stringer, Rowan A.; Williams, Gareth; Picard, Franck; Sohal, Bindi; Kretz, Olivier; McKenna, Jeff; Krauser, Joel A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">954-962, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Deuterium isotope effects were evaluated as a strategy to optimize the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole (NVS-CRF38), a novel corticotropin-releasing factor receptor 1 (CRF1) antagonist.  In an attempt to suppress O-demethylation of NVS-CRF38 without losing activity against the CRF1 receptor, the protons at the site of metab. were replaced with deuterium.  For in vitro and in vivo studies, intrinsic primary isotope effects (KH/KD) were detd. by the ratio of intrinsic clearance (CLint) obtained for NVS-CRF38 and deuterated NVS-CRF38.  In vitro kinetic isotope effects (KH/KD) were more pronounced when CLint values were calcd. based on the rate of formation of the O-desmethyl metabolite (KH/KD ∼7) compared with the substrate depletion method (KH/KD ∼2).  In vivo isotope effects were measured in rats after i.v. (1 mg/kg) and oral (10 mg/kg) administration.  For both administration routes, isotope effects calcd. from in vivo CLint corresponding to all biotransformation pathways were lower (KH/KD ∼2) compared with CLint values calcd. from the O-demethylation reaction alone (KH/KD ∼7).  Comparative metabolite identification studies were undertaken using rat and human microsomes to explore the potential for metabolic switching.  As expected, a marked redn. of the O-demethylated metabolite was obsd. for NVS-CRF38; however, levels of NVS-CRF38's other metabolites increased, compensating to some extent for the isotope effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodlJXqyxbZSbVg90H21EOLACvtfcHk0lhfolDfj3Xtlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFSjs7Y%253D&md5=62cc533373f96e6fe53d46a3d4867aa1</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.057265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.057265%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DPicard%26aufirst%3DF.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DKretz%26aufirst%3DO.%26aulast%3DMcKenna%26aufirst%3DJ.%26aulast%3DKrauser%26aufirst%3DJ.%2BA.%26atitle%3DApplication%2520of%2520a%2520deuterium%2520replacement%2520strategy%2520to%2520modulate%2520the%2520pharmacokinetics%2520of%25207-%25283%252C5-dimethyl-1H-1%252C2%252C4-triazol-1-yl%2529-3-%25284-methoxy-2-methylphenyl%2529-2%252C6-dimethylpyrazolo%255B5%252C1-b%255Doxazole%252C%2520a%2520novel%2520CRF1%2520antagonist%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D954%26epage%3D962%26doi%3D10.1124%2Fdmd.114.057265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridson, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttamsingh, V.</span></span> <span> </span><span class="NLM_article-title">Altering metabolic profiles of drugs by precision deuteration 2: discovery of a deuterated analog of ivacaftor with differentiated pharmacokinetics for clinical development</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.241497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fjpet.117.241497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28611092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CmtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2017&pages=359-367&author=S.+L.+Harbesonauthor=A.+J.+Morganauthor=J.+F.+Liuauthor=A.+M.+Aslanianauthor=S.+Nguyenauthor=G.+W.+Bridsonauthor=C.+L.+Brummelauthor=L.+Wuauthor=R.+D.+Tungauthor=L.+Piljaauthor=V.+Bramanauthor=V.+Uttamsingh&title=Altering+metabolic+profiles+of+drugs+by+precision+deuteration+2%3A+discovery+of+a+deuterated+analog+of+ivacaftor+with+differentiated+pharmacokinetics+for+clinical+development&doi=10.1124%2Fjpet.117.241497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Altering metabolic profiles of drugs by precision deuteration 2: discovery of a deuterated analog of ivacaftor with differentiated pharmacokinetics for clinical development</span></div><div class="casAuthors">Harbeson, Scott L.; Morgan, Adam J.; Liu, Julie F.; Aslanian, Ara M.; Nguyen, Sophia; Bridson, Gary W.; Brummel, Christopher L.; Wu, Lijun; Tung, Roger D.; Pilja, Lana; Braman, Virginia; Uttamsingh, Vinita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-367</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination therapy with lumacaftor (Orkambi; Vertex Pharmaceuticals).  Each therapy targets specific patient populations: Kalydeco treats patients carrying one of nine gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein, whereas Orkambi treats patients homozygous for the F508del CFTR mutation.  In this study, we explored the pharmacol. and metabolic effects of precision deuteration chem. on ivacaftor by synthesizing two novel deuterated ivacaftor analogs, CTP-656 (d9-ivacaftor) and d18-ivacaftor.  Ivacaftor is administered twice daily and is extensively converted in humans to major metabolites M1 and M6; therefore, the corresponding deuterated metabolites were also prepd.  Both CTP-656 and d18-ivacaftor showed in vitro pharmacol. potency similar to that in ivacaftor, and the deuterated M1 and M6 metabolites showed pharmacol. equiv. to that in the corresponding metabolites of ivacaftor, which is consistent with the findings of previous studies of deuterated compds.  However, CTP-656 exhibited markedly enhanced stability when tested in vitro.  The deuterium isotope effects for CTP-656 metab. (DV = 3.8, DV/K = 2.2) were notably large for a cytochrome P 450-mediated oxidn.  The pharmacokinetic (PK) profile of CTP-656 and d18-ivacaftor were assessed in six healthy volunteers in a single-dose crossover study, which provided the basis for advancing CTP-656 in development.  The overall PK profile, including the 15.9-h half-life for CTP-656, suggests that CTP-656 may be dosed once daily, thereby enhancing patient adherence.  Together, these data continue to validate deuterium substitution as a viable approach for creating novel therapeutic agents with properties potentially differentiated from existing drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopNUSS95AadbVg90H21EOLACvtfcHk0lhfolDfj3Xtlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CmtbbI&md5=bf7d11a94c047902d2c6e1a3cd3e8a62</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.241497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.241497%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DMorgan%26aufirst%3DA.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DAslanian%26aufirst%3DA.%2BM.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3DBridson%26aufirst%3DG.%2BW.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DPilja%26aufirst%3DL.%26aulast%3DBraman%26aufirst%3DV.%26aulast%3DUttamsingh%26aufirst%3DV.%26atitle%3DAltering%2520metabolic%2520profiles%2520of%2520drugs%2520by%2520precision%2520deuteration%25202%253A%2520discovery%2520of%2520a%2520deuterated%2520analog%2520of%2520ivacaftor%2520with%2520differentiated%2520pharmacokinetics%2520for%2520clinical%2520development%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D362%26spage%3D359%26epage%3D367%26doi%3D10.1124%2Fjpet.117.241497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helfenbein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noirault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legailliard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmier, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madelmont, J. C.</span></span> <span> </span><span class="NLM_article-title">Isotopic effect study of propofol deuteration on the metabolism, activity, and toxicity of the anesthetic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5806</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1021/jm020864q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020864q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVSnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5806-5808&author=J.+Helfenbeinauthor=C.+Lartigueauthor=E.+Noiraultauthor=E.+Azimauthor=J.+Legailliardauthor=M.+J.+Galmierauthor=J.+C.+Madelmont&title=Isotopic+effect+study+of+propofol+deuteration+on+the+metabolism%2C+activity%2C+and+toxicity+of+the+anesthetic&doi=10.1021%2Fjm020864q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Isotopic Effect Study of Propofol Deuteration on the Metabolism, Activity, and Toxicity of the Anesthetic</span></div><div class="casAuthors">Helfenbein, J.; Lartigue, C.; Noirault, E.; Azim, E.; Legailliard, J.; Galmier, M. J.; Madelmont, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5806-5808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of isotopic substitution to delay the oxidative metab. of the anesthetic propofol 1 was studied.  The arom. hydrogens of propofol 1 were replaced by deuterium to produce the mono- and trideuterated derivs. 4 and 5.  In vitro metabolic studies on human hepatic microsomes showed no isotopic effect in the para hydroxylation of propofol, and 1, 4, and 5 display similar hypnotic activity and toxicity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1QQcND8virVg90H21EOLACvtfcHk0lhfolDfj3Xtlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVSnsLo%253D&md5=f16d4e122ef9fdd0d1149b148178c590</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm020864q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020864q%26sid%3Dliteratum%253Aachs%26aulast%3DHelfenbein%26aufirst%3DJ.%26aulast%3DLartigue%26aufirst%3DC.%26aulast%3DNoirault%26aufirst%3DE.%26aulast%3DAzim%26aufirst%3DE.%26aulast%3DLegailliard%26aufirst%3DJ.%26aulast%3DGalmier%26aufirst%3DM.%2BJ.%26aulast%3DMadelmont%26aufirst%3DJ.%2BC.%26atitle%3DIsotopic%2520effect%2520study%2520of%2520propofol%2520deuteration%2520on%2520the%2520metabolism%252C%2520activity%252C%2520and%2520toxicity%2520of%2520the%2520anesthetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5806%26epage%3D5808%26doi%3D10.1021%2Fjm020864q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czarnik, A. W.</span></span> <span> </span><span class="NLM_article-title">Deuterium-Enriched Maraviroc</span>. U.S. Patent <span class="NLM_patent">0,062,331</span>, March 05, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+W.+Czarnik&title=Deuterium-Enriched+Maraviroc"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCzarnik%26aufirst%3DA.%2BW.%26atitle%3DDeuterium-Enriched%2520Maraviroc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barratt, M. J.</span>; <span class="NLM_string-name">Frail, D. E.</span></span> <i>Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2F9781118274408" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+J.+Barratt&author=D.+E.+Frail&title=Drug+Repositioning%3A+Bringing+New+Life+to+Shelved+Assets+and+Existing+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2F9781118274408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118274408%26sid%3Dliteratum%253Aachs%26aulast%3DBarratt%26aufirst%3DM.%2BJ.%26btitle%3DDrug%2520Repositioning%253A%2520Bringing%2520New%2520Life%2520to%2520Shelved%2520Assets%2520and%2520Existing%2520Drugs%26pub%3DWiley%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontaine, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henise, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D. V.</span></span> <span> </span><span class="NLM_article-title">Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2018.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.jconrel.2018.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29577950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1ersrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2018&pages=74-79&author=B.+R.+Hearnauthor=S.+D.+Fontaineauthor=S.+J.+Pfaffauthor=E.+L.+Schneiderauthor=J.+Heniseauthor=G.+W.+Ashleyauthor=D.+V.+Santi&title=Primary+deuterium+kinetic+isotope+effects+prolong+drug+release+and+polymer+biodegradation+in+a+drug+delivery+system&doi=10.1016%2Fj.jconrel.2018.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system</span></div><div class="casAuthors">Hearn, Brian R.; Fontaine, Shaun D.; Pfaff, Samuel J.; Schneider, Eric L.; Henise, Jeff; Ashley, Gary W.; Santi, Daniel V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed a chem.-controlled drug delivery system in which a drug is covalently attached via a carbamate to hydrogel microspheres using a β-eliminative linker; rate-detg. proton removal from a C-H bond adjacent to an electron withdrawing group results in a β-elimination to cleave the carbamate and release the drug.  After s.c. injection of the hydrogel-drug conjugate, the drug is slowly released into the systemic circulation and acquires an elimination t1/2,β that matches the t1/2 of linker cleavage.  A similar β-eliminative linker with a slower cleavage rate is installed into crosslinks of the polymer to trigger gel degrdn. after drug release.  We have now prepd. β-eliminative linkers that contain deuterium in place of the hydrogen whose removal initiates cleavage.  In vitro model systems of drug release and degelation show large primary deuterium kinetic isotope effects of kH/kD ∼ 2.5 to 3.5.  Using a deuterated linker to attach the peptide octreotide to hydrogel-microspheres, the in vivo t1/2,β of the drug was increased from ∼1.5 to 4.5 wk in the rat.  Similarly, the in vivo time to biodegrdn. of hydrogels with deuterium-contg. crosslinks could be extended ∼2.5-fold compared to hydrogen-contg. counterparts.  Thus, the use of primary deuterium kinetic isotope effects in a single platform technol. can control rates of β-elimination reactions in drug release and polymer biodegrdn. rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAj_ME0TbvcbVg90H21EOLACvtfcHk0lj1gKfMH-Hiqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1ersrw%253D&md5=ae3bfd165fa65ce7f6cf6269bf8be380</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2018.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2018.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DHearn%26aufirst%3DB.%2BR.%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DPfaff%26aufirst%3DS.%2BJ.%26aulast%3DSchneider%26aufirst%3DE.%2BL.%26aulast%3DHenise%26aufirst%3DJ.%26aulast%3DAshley%26aufirst%3DG.%2BW.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26atitle%3DPrimary%2520deuterium%2520kinetic%2520isotope%2520effects%2520prolong%2520drug%2520release%2520and%2520polymer%2520biodegradation%2520in%2520a%2520drug%2520delivery%2520system%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2018%26volume%3D278%26spage%3D74%26epage%3D79%26doi%3D10.1016%2Fj.jconrel.2018.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannargudi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J.</span></span> <span> </span><span class="NLM_article-title">Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1870</span>, <span class="refDoi"> DOI: 10.1021/tx800177k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800177k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVaru7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1862-1870&author=J.+Chenauthor=B.+M.+Mannargudiauthor=L.+Xuauthor=J.+Uetrecht&title=Demonstration+of+the+metabolic+pathway+responsible+for+nevirapine-induced+skin+rash&doi=10.1021%2Ftx800177k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Demonstration of the Metabolic Pathway Responsible for Nevirapine-Induced Skin Rash</span></div><div class="casAuthors">Chen, Jie; Mannargudi, Baskar M.; Xu, Ling; Uetrecht, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1862-1870</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The reverse transcriptase inhibitor, nevirapine (NVP), causes skin rashes and hepatotoxicity.  We used a rat model to det. if the rash is caused by the parent drug or a reactive metabolite.  By manipulation of metabolic pathways and testing analogs, we eliminated all but one pathway, 12-hydroxylation, which involves the oxidn. of an exocyclic Me group, as being responsible for the rash.  Treatment with 12-OH-NVP caused a rash, and an analog in which the Me hydrogens were replaced by deuterium to inhibit the 12-OH pathway did not cause a rash; however, quite unexpectedly, blood levels of the deuterated analog were very low.  This is due to partitioning of the benzylic free radial intermediate between oxygen rebound to form 12-OH-NVP and loss of another hydrogen atom to form a reactive quinone methide, which inactivates P 450.  Cotreatment with the P 450 inhibitor, 1-aminobenzotriazole, led to comparable levels of NVP and the deuterated analog, and the deuterated analog still caused a lower rash incidence.  These data clearly point to the 12-hydroxy pathway being responsible for NVP skin rash.  We propose that the hepatotoxicity of NVP in humans is due to the quinone methide formed by P 450 in the liver, while the skin rash may be due to the quinone methide formed in the skin by sulfation of 12-OH metabolite followed by loss of sulfate.  This is the first example in which a valid animal model of an idiosyncratic drug reaction was used to det. the metabolic pathway responsible for the reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlMJkFo6EdMLVg90H21EOLACvtfcHk0lj1gKfMH-Hiqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVaru7fK&md5=be5f10bfb4ef8579c80eaa30c6778cc9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Ftx800177k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800177k%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMannargudi%26aufirst%3DB.%2BM.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DDemonstration%2520of%2520the%2520metabolic%2520pathway%2520responsible%2520for%2520nevirapine-induced%2520skin%2520rash%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1862%26epage%3D1870%26doi%3D10.1021%2Ftx800177k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemzik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krahn, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwalder, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, G. T.</span></span> <span> </span><span class="NLM_article-title">The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1006/taap.2000.9055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1006%2Ftaap.2000.9055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=11076702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFyrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2000&pages=102-113&author=A.+E.+Mutlibauthor=R.+J.+Gersonauthor=P.+C.+Meunierauthor=P.+J.+Haleyauthor=H.+Chenauthor=L.+S.+Ganauthor=M.+H.+Daviesauthor=B.+Gemzikauthor=D.+D.+Christauthor=D.+F.+Krahnauthor=J.+A.+Markwalderauthor=S.+P.+Seitzauthor=R.+T.+Robertsonauthor=G.+T.+Miwa&title=The+species-dependent+metabolism+of+efavirenz+produces+a+nephrotoxic+glutathione+conjugate+in+rats&doi=10.1006%2Ftaap.2000.9055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Species-Dependent Metabolism of Efavirenz Produces a Nephrotoxic Glutathione Conjugate in Rats</span></div><div class="casAuthors">Mutlib, Abdul E.; Gerson, Ronald J.; Meunier, Paul C.; Haley, Patrick J.; Chen, Hao; Gan, Lawrence S.; Davies, Marc H.; Gemzik, Brian; Christ, David D.; Krahn, David F.; Markwalder, Jay A.; Seitz, Steven P.; Robertson, Richard T.; Miwa, Gerald T.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-113</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Efavirenz, a potent nonnucleoside reverse transcriptase inhibitor widely prescribed for the treatment of HIV infection, produces renal tubular epithelial cell necrosis in rats but not in cynomolgus monkeys or humans.  This species selectivity in nephrotoxicity could result from differences in the prodn. or processing of reactive metabolites, or both.  A detailed comparison of the metabolites produced by rats, monkeys, and humans revealed that rats produce a unique glutathione adduct.  The mechanism of formation and role of this glutathione adduct in the renal toxicity were investigated using both chem. and biochem. probes.  Efavirenz was labeled at the methine position on the cyclopropyl ring with the stable isotope deuterium, effectively reducing the formation of the cyclopropanol metabolite, an obligate precursor to the glutathione adduct.  This substitution markedly reduced both the incidence and severity of nephrotoxicity as measured histol.  Further processing of this glutathione adduct was also important in producing the lesion and was demonstrated by inhibiting γ-glutamyltranspeptidase with acivicin pretreatment (10 mg/kg, IV) prior to dosing with efavirenz.  Again, both the incidence and severity of the nephrotoxicity were reduced, such that four of nine rats given acivicin were without detectable lesions.  These studies provide compelling evidence that a species-specific formation of glutathione conjugate(s) from efavirenz is involved in producing nephrotoxicity in rats.  Mechanisms are proposed for the formation of reactive metabolites that could be responsible for the renal toxicity obsd. in rats.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtZ2yUYxMePrVg90H21EOLACvtfcHk0liwazGLCdYQLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFyrt7Y%253D&md5=13f8d2f66902fef25d827b2f492f88ce</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1006%2Ftaap.2000.9055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ftaap.2000.9055%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DGerson%26aufirst%3DR.%2BJ.%26aulast%3DMeunier%26aufirst%3DP.%2BC.%26aulast%3DHaley%26aufirst%3DP.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DGan%26aufirst%3DL.%2BS.%26aulast%3DDavies%26aufirst%3DM.%2BH.%26aulast%3DGemzik%26aufirst%3DB.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DKrahn%26aufirst%3DD.%2BF.%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DRobertson%26aufirst%3DR.%2BT.%26aulast%3DMiwa%26aufirst%3DG.%2BT.%26atitle%3DThe%2520species-dependent%2520metabolism%2520of%2520efavirenz%2520produces%2520a%2520nephrotoxic%2520glutathione%2520conjugate%2520in%2520rats%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2000%26volume%3D169%26spage%3D102%26epage%3D113%26doi%3D10.1006%2Ftaap.2000.9055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crofton-Sleigh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venitt, S.</span></span> <span> </span><span class="NLM_article-title">Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1487</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1093/carcin/15.8.1487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1093%2Fcarcin%2F15.8.1487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=8055624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK2cXlslakurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=1487-1492&author=D.+H.+Phillipsauthor=G.+A.+Potterauthor=M.+N.+Hortonauthor=A.+Hewkerauthor=C.+Crofton-Sleighauthor=M.+Jarmanauthor=S.+Venitt&title=Reduced+genotoxicity+of+%5BD5-ethyl%5D-tamoxifen+implicates+alpha-hydroxylation+of+the+ethyl+group+as+a+major+pathway+of+tamoxifen+activation+to+a+liver+carcinogen&doi=10.1093%2Fcarcin%2F15.8.1487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen</span></div><div class="casAuthors">Phillips, David H.; Potter, Gerard A.; Horton, Martin N.; Hewer, Alan; Crofton-Sleigh, Christopher; Jarman, Michael; Venitt, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1487-92</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    </div><div class="casAbstract">A proposed mechanism for the metabolic activation of tamoxifen to electrophilic species that form DNA adducts leading to liver cancer involves α-hydroxylation of the Et group in the crit. first step.  This mechanism predicts that tamoxifen deuterated at the α-position would be less genotoxic than the non-deuterated compd. owing to an isotope effect that would reduce the rate of oxidative metab. at this position.  This hypothesis has now been tested with expts. conducted in rats in vivo and in human cells in vitro.  It was found that the deuterated compd. [D5-ethyl]-tamoxifen is significantly less genotoxic than tamoxifen.  Administration of 0.06 and 0.12 mmol/kg [D5-ethyl]-tamoxifen to female Fischer rats by gavage resulted in a 2.5- and 1.7-fold redn. resp. in the levels of hepatic DNA adducts present 24 h after treatment, compared with the non-deuterated compd.  Treatment of MCL-5 cells with [D5-ethyl]-tamoxifen resulted in a 2- to 3-fold decrease, compared with tamoxifen, in the no. of micronuclei induced in cells arrested in cytokinesis by cytochalasin-B.  Further evidence is provided by UV irradn. of the major hepatic DNA adducts isolated from tamoxifen-treated rats, which caused a large shift in the chromatog. mobility of the adducts, consistent with the presence of a 1,2-olefinic linkage in the tamoxifen residue of the adduct leading to cyclization to a phenanthrenylic compd., and consistent with this adduct having arisen from reaction with DNA at the α-position of tamoxifen.  Taken together, these data strongly suggest that tamoxifen is metabolized to a liver carcinogen by α-hydroxylation of its Et group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEXQzaVDyDbVg90H21EOLACvtfcHk0liwazGLCdYQLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslakurY%253D&md5=a7c5764d6c99261714312c767fc62597</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F15.8.1487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F15.8.1487%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DD.%2BH.%26aulast%3DPotter%26aufirst%3DG.%2BA.%26aulast%3DHorton%26aufirst%3DM.%2BN.%26aulast%3DHewker%26aufirst%3DA.%26aulast%3DCrofton-Sleigh%26aufirst%3DC.%26aulast%3DJarman%26aufirst%3DM.%26aulast%3DVenitt%26aufirst%3DS.%26atitle%3DReduced%2520genotoxicity%2520of%2520%255BD5-ethyl%255D-tamoxifen%2520implicates%2520alpha-hydroxylation%2520of%2520the%2520ethyl%2520group%2520as%2520a%2520major%2520pathway%2520of%2520tamoxifen%2520activation%2520to%2520a%2520liver%2520carcinogen%26jtitle%3DCarcinogenesis%26date%3D1994%26volume%3D15%26spage%3D1487%26epage%3D1492%26doi%3D10.1093%2Fcarcin%2F15.8.1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calinski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludeman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">Hydroxylation and <i>N</i>-dechloroethylation of ifosfamide and deuterated ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1084</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.063628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.115.063628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25934575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1084-1090&author=D.+M.+Calinskiauthor=H.+Zhangauthor=S.+Ludemanauthor=M.+E.+Dolanauthor=P.+F.+Hollenberg&title=Hydroxylation+and+N-dechloroethylation+of+ifosfamide+and+deuterated+ifosfamide+by+the+human+cytochrome+p450s+and+their+commonly+occurring+polymorphisms&doi=10.1124%2Fdmd.115.063628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylation and N-dechloroethylation of ifosfamide and deuterated ifosfamide by the human cytochrome P450s and their commonly occurring polymorphisms</span></div><div class="casAuthors">Calinski, Diane M.; Zhang, Haoming; Ludeman, Susan; Dolan, M. Eileen; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1084-1090</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The hydroxylation and N-dechloroethylation of deuterated ifosfamide (d4IFO) and ifosfamide (IFO) by several human P450s have been detd. and compared.  D4IFO was synthesized with deuterium at the alpha and alpha' carbons to decrease the rate of N-dechloroethylation and thereby enhance hydroxylation of the drug at the 4' position.  The purpose was to decrease the toxic and increase the efficacious metabolites of IFO.  For all of the P450s tested, hydroxylation of d4IFO was improved and dechloroethylation was reduced as compared with nondeuterated IFO.  Although the differences were not statistically significant, the trend favoring the 4'-hydroxylation pathway was noteworthy.  CYP3A5 and CYP2C19 were the most efficient enzymes for catalyzing IFO hydroxylation.  The importance of these enzymes in IFO metab. has not been reported previously and warrants further investigation.  The catalytic ability of the common polymorphisms of CYP2B6 and CYP2C9 for both reactions were tested with IFO and d4IFO.  It was detd. that the commonly expressed polymorphisms CYP2B6*4 and CYP2B6*6 had reduced catalytic ability for IFO compared with CYP2B6*1, whereas CYP2B6*7 and CYP2B6*9 had enhanced catalytic ability.  As with the wild-type enzymes, d4IFO was more readily hydroxylated by the polymorphic variants than IFO, and d4IFO was not dechloroethylated by any of the polymorphic forms.  We also assessed the use of specific inhibitors of P 450 to favor hydroxylation in human liver microsomes.  We were unable to sep. the pathways with these expts., suggesting that multiple P450s are responsible for catalyzing both metabolic pathways for IFO, which is not obsd. with the closely related drug cyclophosphamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHBNrWzkX76rVg90H21EOLACvtfcHk0liwazGLCdYQLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFKltLw%253D&md5=72886338328f517a0c47abaf9e41c6fd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.063628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.063628%26sid%3Dliteratum%253Aachs%26aulast%3DCalinski%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLudeman%26aufirst%3DS.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DHydroxylation%2520and%2520N-dechloroethylation%2520of%2520ifosfamide%2520and%2520deuterated%2520ifosfamide%2520by%2520the%2520human%2520cytochrome%2520p450s%2520and%2520their%2520commonly%2520occurring%2520polymorphisms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26spage%3D1084%26epage%3D1090%26doi%3D10.1124%2Fdmd.115.063628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7577</span>– <span class="NLM_lpage">7589</span>, <span class="refDoi"> DOI: 10.1021/jm500510f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500510f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7577-7589&author=H.+Jiaauthor=G.+Daiauthor=J.+Wengauthor=Z.+Zhangauthor=Q.+Wangauthor=F.+Zhouauthor=L.+Jiaoauthor=Y.+Cuiauthor=Y.+Renauthor=S.+Fanauthor=J.+Zhouauthor=W.+Qingauthor=Y.+Guauthor=J.+Wangauthor=Y.+Saiauthor=W.+Su&title=Discovery+of+%28S%29-1-%281-%28Imidazo%5B1%2C2-a%5Dpyridin-6-yl%29ethyl%29-6-%281-methyl-1H-pyrazol-4-yl%29-1H-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-b%5Dpyrazine+%28volitinib%29+as+a+highly+potent+and+selective+mesenchymal-epithelial+transition+factor+%28c-Met%29+inhibitor+in+clinical+development+for+treatment+of+cancer&doi=10.1021%2Fjm500510f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer</span></div><div class="casAuthors">Jia, Hong; Dai, Guangxiu; Weng, Jianyang; Zhang, Zhulin; Wang, Qing; Zhou, Feng; Jiao, Longxian; Cui, Yumin; Ren, Yongxin; Fan, Shiming; Zhou, Jinghong; Qing, Weiguo; Gu, Yi; Wang, Jian; Sai, Yang; Su, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7577-7589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HGF/c-Met signaling has been implicated in human cancers.  Herein we describe the invention of a series of novel triazolopyrazine c-Met inhibitors.  The structure-activity relation of these compds. was investigated, leading to the identification of Volitinib (I), which demonstrated favorable pharmacokinetic properties in mice and good antitumor activities in the human glioma xenograft model in athymic nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmuzIGrPGZbVg90H21EOLACvtfcHk0ljlDytQPb6KCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN&md5=aced38bbd7431f5ac01b6698e8657261</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm500510f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500510f%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%2528Imidazo%255B1%252C2-a%255Dpyridin-6-yl%2529ethyl%2529-6-%25281-methyl-1H-pyrazol-4-yl%2529-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-b%255Dpyrazine%2520%2528volitinib%2529%2520as%2520a%2520highly%2520potent%2520and%2520selective%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-Met%2529%2520inhibitor%2520in%2520clinical%2520development%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7577%26epage%3D7589%26doi%3D10.1021%2Fjm500510f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhadra, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanzadeh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J.</span></span> <span> </span><span class="NLM_article-title">Enhancement of the properties of a drug by mono-deuteriation: reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6289</span>– <span class="NLM_lpage">6296</span>, <span class="refDoi"> DOI: 10.1039/C6OB00785F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2FC6OB00785F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27273525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVyisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=6289-6296&author=P.+B.+Bhadraauthor=A.+Hassanzadehauthor=B.+Arsicauthor=D.+G.+Allisonauthor=G.+A.+Morrisauthor=J.+Barber&title=Enhancement+of+the+properties+of+a+drug+by+mono-deuteriation%3A+reduction+of+acid-catalysed+formation+of+a+gut-motilide+enol+ether+from+8-deuterio-erythromycin+B&doi=10.1039%2FC6OB00785F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of the properties of a drug by mono-deuteration: reduction of acid-catalyzed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B</span></div><div class="casAuthors">Bhadra, Pranab K.; Hassanzadeh, Abdolreza; Arsic, Biljana; Allison, David G.; Morris, Gareth A.; Barber, Jill</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6289-6296</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Erythromycin B is structurally very similar to erythromycin A, and also shares its clin. important antibacterial activity.  Its potential advantage is that it is much more stable to acid.  Both compds. are susceptible to 6-9-enol ether formation, involving loss of a proton from C-8.  The enol ethers lack antibacterial activity and can give rise to unpleasant gut motilide side-effects.  Our previous work on degrdn. kinetics revealed that the formation of erythromycin B enol ether from erythromycin B is subject to a large deuterium isotope effect.  We therefore synthesized 8-d-erythromycin B (in 87% yield) in the hope that acid-catalyzed enol ether formation would be reduced, relative to erythromycin B.  In a range of microbiol. and biochem. assays, deuteration did not appear to compromise the efficacy of the drug.  Degrdn. studies showed, however, that incorporation of deuterium into erythromycin B reduces (though does not completely suppress) enol ether formation, providing the possibility of using a facile mono-deuteration to reduce the gut motilide side-effects of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMp1KCLuoU67Vg90H21EOLACvtfcHk0ljlDytQPb6KCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVyisbY%253D&md5=4a7980698997bdc156fecc1e2be4bff9</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1039%2FC6OB00785F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB00785F%26sid%3Dliteratum%253Aachs%26aulast%3DBhadra%26aufirst%3DP.%2BB.%26aulast%3DHassanzadeh%26aufirst%3DA.%26aulast%3DArsic%26aufirst%3DB.%26aulast%3DAllison%26aufirst%3DD.%2BG.%26aulast%3DMorris%26aufirst%3DG.%2BA.%26aulast%3DBarber%26aufirst%3DJ.%26atitle%3DEnhancement%2520of%2520the%2520properties%2520of%2520a%2520drug%2520by%2520mono-deuteriation%253A%2520reduction%2520of%2520acid-catalysed%2520formation%2520of%2520a%2520gut-motilide%2520enol%2520ether%2520from%25208-deuterio-erythromycin%2520B%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D6289%26epage%3D6296%26doi%3D10.1039%2FC6OB00785F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abolin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M.</span></span> <span> </span><span class="NLM_article-title">Derivatives of tramadol for increased duration of effect</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">691</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2005.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=16257206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCiu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=691-694&author=L.+Shaoauthor=C.+Abolinauthor=M.+C.+Hewittauthor=P.+Kochauthor=M.+Varney&title=Derivatives+of+tramadol+for+increased+duration+of+effect&doi=10.1016%2Fj.bmcl.2005.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives of tramadol for increased duration of effect</span></div><div class="casAuthors">Shao, Liming; Abolin, Craig; Hewitt, Michael C.; Koch, Patrick; Varney, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">691-694</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tramadol is a centrally acting opioid analgesic structurally related to codeine and morphine.  Analogs of tramadol with deuterium-for-hydrogen replacement at metabolically active sites were prepd. and evaluated in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqySbghRXcnxbVg90H21EOLACvtfcHk0ljlDytQPb6KCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCiu7bE&md5=6670712406293bbd421e52ac1f693781</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DL.%26aulast%3DAbolin%26aufirst%3DC.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DVarney%26aufirst%3DM.%26atitle%3DDerivatives%2520of%2520tramadol%2520for%2520increased%2520duration%2520of%2520effect%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D691%26epage%3D694%26doi%3D10.1016%2Fj.bmcl.2005.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uttamsingh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallegos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridson, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R.</span></span> <span> </span><span class="NLM_article-title">Altering metabolic profiles of drugs by precision deuteration: reducing mechanism-based inhibition of CYP2D6 by paroxetine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.223768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fjpet.115.223768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25943764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFalsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=43-54&author=V.+Uttamsinghauthor=R.+Gallegosauthor=J.+F.+Liuauthor=S.+L.+Harbesonauthor=G.+W.+Bridsonauthor=C.+Chengauthor=D.+S.+Wellsauthor=P.+B.+Grahamauthor=R.+Zelleauthor=R.+Tung&title=Altering+metabolic+profiles+of+drugs+by+precision+deuteration%3A+reducing+mechanism-based+inhibition+of+CYP2D6+by+paroxetine&doi=10.1124%2Fjpet.115.223768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Altering metabolic profiles of drugs by precision deuteration: reducing mechanism-based inhibition of CYP2D6 by paroxetine</span></div><div class="casAuthors">Uttamsingh, Vinita; Gallegos, Richard; Liu, Julie F.; Harbeson, Scott L.; Bridson, Gary W.; Cheng, Changfu; Wells, David S.; Graham, Philip B.; Zelle, Robert; Tung, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Selective deuterium substitution as a means of ameliorating clin. relevant pharmacokinetic drug interactions is demonstrated in this study.  Carbon-deuterium bonds are more stable than corresponding carbon-hydrogen bonds.  Using a precision deuteration platform, the two hydrogen atoms at the methylenedioxy carbon of paroxetine were substituted with deuterium.  The new chem. entity, CTP-347 [(3S,4R)-3-((2,2-dideuterobenzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine], demonstrated similar selectivity for the serotonin receptor, as well as similar neurotransmitter uptake inhibition in an in vitro rat synaptosome model, as unmodified paroxetine.  However, human liver microsomes cleared CTP-347 faster than paroxetine as a result of decreased inactivation of CYP2D6.  In phase 1 studies, CTP-347 wasmetabolized more rapidly in humans and exhibited a lower pharmacokinetic accumulation index than paroxetine.  These alterations in the metab. profile resulted in significantly reduced drug-drug interactions between CTP-347 and two other CYP2D6-metabolized drugs: tamoxifen (in vitro) and dextromethorphan (in humans).  Our results show that precision deuteration can improve the metab. profiles of existing pharmacotherapies without affecting their intrinsic pharmacologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr61zgvmYDyg7Vg90H21EOLACvtfcHk0lha6gD6C3mrrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFalsLrN&md5=8e7fa68ba7ab319df75badeb50700c20</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.223768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.223768%26sid%3Dliteratum%253Aachs%26aulast%3DUttamsingh%26aufirst%3DV.%26aulast%3DGallegos%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DBridson%26aufirst%3DG.%2BW.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DD.%2BS.%26aulast%3DGraham%26aufirst%3DP.%2BB.%26aulast%3DZelle%26aufirst%3DR.%26aulast%3DTung%26aufirst%3DR.%26atitle%3DAltering%2520metabolic%2520profiles%2520of%2520drugs%2520by%2520precision%2520deuteration%253A%2520reducing%2520mechanism-based%2520inhibition%2520of%2520CYP2D6%2520by%2520paroxetine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D43%26epage%3D54%26doi%3D10.1124%2Fjpet.115.223768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Deuterated clopidogrel analogues as a new generation of antiplatelet agents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1021/ml300460t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300460t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFalur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=349-352&author=Y.+Zhuauthor=J.+Zhouauthor=B.+Jiao&title=Deuterated+clopidogrel+analogues+as+a+new+generation+of+antiplatelet+agents&doi=10.1021%2Fml300460t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated Clopidogrel Analogues as a New Generation of Antiplatelet Agents</span></div><div class="casAuthors">Zhu, Yaoqiu; Zhou, Jiang; Jiao, Bo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-352</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clopidogrel (CPG) is an antithrombotic prodrug that needs hepatic cytochrome P 450 (CYP) enzymes for its bioactivation.  The clin. effects of CPG have been assocd. with high intersubject variability and a certain level of resistance.  Recently, comprehensive biotransformation studies of CPG support that the obsd. clin. uncertainty stems from the low bioactivation efficiency, which is attributed to extensive attritional metab. (e.g., hydrolysis of the Me ester functionality and oxidn. of the piperidine moiety).  With the goal of potentiating the desired thiophene 2-oxidn. through minimal structural modification, we have adopted the strategy of targeted metab. shift and have designed and synthesized deuterated piperidine analogs of CPG.  In vitro studies showed that the prodrug activation percentages have been significantly increased for the deuterated analogs as a result of stability enhancement of the piperidine moiety.  In a pharmacol. study with a rat model, oral administration of the deuterated analogs also demonstrated higher inhibitory activity than that of CPG against ADP (ADP) induced platelet aggregation.  These deuterated analogs represent a new generation of antiplatelet agents with the potential to overcome the major clin. drawbacks of CPG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWV-TRwwRc2LVg90H21EOLACvtfcHk0lha6gD6C3mrrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFalur0%253D&md5=854953ae4202446b44807d14a277423c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fml300460t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300460t%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DDeuterated%2520clopidogrel%2520analogues%2520as%2520a%2520new%2520generation%2520of%2520antiplatelet%2520agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D349%26epage%3D352%26doi%3D10.1021%2Fml300460t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. W.</span></span> <span> </span><span class="NLM_article-title">Chiral toxicology: It’s the same thing···only different</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfp097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1093%2Ftoxsci%2Fkfp097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=19414517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=4-30&author=S.+W.+Smith&title=Chiral+toxicology%3A+It%E2%80%99s+the+same+thing%C2%B7%C2%B7%C2%B7only+different&doi=10.1093%2Ftoxsci%2Fkfp097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral Toxicology: It's the Same Thing...Only Different</span></div><div class="casAuthors">Smith, Silas W.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-30</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Chiral substances possess a unique architecture such that, despite sharing identical mol. formulas, atom-to-atom linkages, and bonding distances, they cannot be superimposed.  Thus, in the environment of living systems, where specific structure-activity relationships may be required for effect (e.g., enzymes, receptors, transporters, and DNA), the physiochem. and biochem. properties of racemic mixts. and individual stereoisomers can differ significantly.  In drug development, enantiomeric selection to maximize clin. effects or mitigate drug toxicity has yielded both success and failure.  Further complicating genetic polymorphisms in drug disposition, stereoselective metab. of chiral compds. can addnl. influence pharmacokinetics, pharmacodynamics, and toxicity.  Optically pure pharmaceuticals may undergo racemization in vivo, negating single enantiomer benefits or inducing unexpected effects.  Appropriate chiral antidotes must be selected for therapeutic benefit and to minimize adverse events.  Enantiomers may possess different carcinogenicity and teratogenicity.  Environmental toxicol. provides several examples in which compd. bioaccumulation, persistence, and toxicity show chiral dependence.  In forensic toxicol., chiral anal. has been applied to illicit drug prepns. and biol. specimens, with the potential to assist in detn. of cause of death and aid in the correct interpretation of substance abuse and "doping" screens.  Adrenergic agonists and antagonist, nonsteroidal anti-inflammatory agents, SSRIs, opioids, warfarin, valproate, thalidomide, retinoic acid, N-acetylcysteine, carnitine, penicillamine, leucovorin, glucarpidase, pesticides, polychlorinated biphenyls, phenylethylamines, and addnl. compds. will be discussed to illustrate important concepts in "chiral toxicol.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOidSllleGK7Vg90H21EOLACvtfcHk0lha6gD6C3mrrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKktbg%253D&md5=abfbe5e7d6bdc98e217ed4c66e674786</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfp097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfp097%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BW.%26atitle%3DChiral%2520toxicology%253A%2520It%25E2%2580%2599s%2520the%2520same%2520thing%25C2%25B7%25C2%25B7%25C2%25B7only%2520different%26jtitle%3DToxicol.%2520Sci.%26date%3D2009%26volume%3D110%26spage%3D4%26epage%3D30%26doi%3D10.1093%2Ftoxsci%2Fkfp097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit66b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Csuk, R.</span></span> <i>Biocatalysis in the Pharma and Biotech Industries</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. N.</span></span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">716</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=699-716&author=R.+Csukauthor=R.+N.+Patel&title=Biocatalysis+in+the+Pharma+and+Biotech+Industries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCsuk%26aufirst%3DR.%26btitle%3DBiocatalysis%2520in%2520the%2520Pharma%2520and%2520Biotech%2520Industries%26aulast%3DPatel%26aufirst%3DR.%2BN.%26pub%3DCRC%2520Press%26date%3D2007%26spage%3D699%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit66c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hutt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentova, J.</span></span> <span> </span><span class="NLM_article-title">The chiral switch: The development of single enantiomer drugs from racemates</span>. <i>Acta Fac. Pharm. Univ. Comenianae</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2003&pages=7-23&author=A.+J.+Huttauthor=J.+Valentova&title=The+chiral+switch%3A+The+development+of+single+enantiomer+drugs+from+racemates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutt%26aufirst%3DA.%2BJ.%26aulast%3DValentova%26aufirst%3DJ.%26atitle%3DThe%2520chiral%2520switch%253A%2520The%2520development%2520of%2520single%2520enantiomer%2520drugs%2520from%2520racemates%26jtitle%3DActa%2520Fac.%2520Pharm.%2520Univ.%2520Comenianae%26date%3D2003%26volume%3D50%26spage%3D7%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit66d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, I.</span></span> <span> </span><span class="NLM_article-title">Homochiral drug design and development by racemization</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.2174/138620707781662835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.2174%2F138620707781662835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17896928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFansb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=326-335&author=I.+Ali&title=Homochiral+drug+design+and+development+by+racemization&doi=10.2174%2F138620707781662835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66dR"><div class="casContent"><span class="casTitleNuber">66d</span><div class="casTitle"><span class="NLM_cas:atitle">Homochiral drug design and development by racemization</span></div><div class="casAuthors">Ali, Imran</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">326-335</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the enantiomers of a racemic drug may be pharmacol. inactive or toxic or ballast and, hence, U.S. FDA and European agencies have issued certain guidelines for marketing of optically active (homochiral) drugs.  However, some homochiral drug enantiomers racemize in to human body leading to the generation of other antipodes, which may be toxic or ballast to the human beings.  In addn., racemization reduces the administered dosage concn. when the optically active enantiomer is converted into its inactive form.  Therefore, racemization studies of homochiral drugs are the important and urgent need of today.  This article reviews in vitro and in vivo racemization of homochiral drugs.  The racemization of some homochiral drugs is described considering the affect of different variables such as temp., concn. of the drug, ionic concn., pH, addn. of cyclodextrins, formation of inclusion complexes, etc.  Efforts have also been made to discuss the mechanisms of the racemization process.  Attempts have been made to suggest safe dosages of such drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOBwW0qOPFNrVg90H21EOLACvtfcHk0li2MTjCNMcQOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFansb3K&md5=2eee57bc284fdea2780aa09e30a1cb98</span></div><a href="/servlet/linkout?suffix=cit66d&amp;dbid=16384&amp;doi=10.2174%2F138620707781662835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620707781662835%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DI.%26atitle%3DHomochiral%2520drug%2520design%2520and%2520development%2520by%2520racemization%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2007%26volume%3D10%26spage%3D326%26epage%3D335%26doi%3D10.2174%2F138620707781662835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit66e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Somogyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D.</span></span> <span> </span><span class="NLM_article-title">Inside the isomers: The tale of chiral switches</span>. <i>Aust. Prescr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.18773/austprescr.2004.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.18773%2Faustprescr.2004.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=47-49&author=A.+Somogyiauthor=F.+Bochnerauthor=D.+Foster&title=Inside+the+isomers%3A+The+tale+of+chiral+switches&doi=10.18773%2Faustprescr.2004.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66e&amp;dbid=16384&amp;doi=10.18773%2Faustprescr.2004.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18773%252Faustprescr.2004.039%26sid%3Dliteratum%253Aachs%26aulast%3DSomogyi%26aufirst%3DA.%26aulast%3DBochner%26aufirst%3DF.%26aulast%3DFoster%26aufirst%3DD.%26atitle%3DInside%2520the%2520isomers%253A%2520The%2520tale%2520of%2520chiral%2520switches%26jtitle%3DAust.%2520Prescr.%26date%3D2004%26volume%3D27%26spage%3D47%26epage%3D49%26doi%3D10.18773%2Faustprescr.2004.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perni, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawgo, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Town, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazhanisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raybuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namchuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y. L.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo isotope effects with hepatitis C protease inhibitors: enhanced plasma exposure of deuterated telaprevir versus telaprevir in rats</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7993</span>– <span class="NLM_lpage">8001</span>, <span class="refDoi"> DOI: 10.1021/jm901023f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901023f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7993-8001&author=F.+Maltaisauthor=Y.+C.+Jungauthor=M.+Chenauthor=J.+Tanouryauthor=R.+B.+Perniauthor=N.+Maniauthor=L.+Laitinenauthor=H.+Huangauthor=S.+Liaoauthor=H.+Gaoauthor=H.+Tsaoauthor=E.+Blockauthor=C.+Maauthor=R.+S.+Shawgoauthor=C.+Townauthor=C.+L.+Brummelauthor=D.+Howeauthor=S.+Pazhanisamyauthor=S.+Raybuckauthor=M.+Namchukauthor=Y.+L.+Bennani&title=In+vitro+and+in+vivo+isotope+effects+with+hepatitis+C+protease+inhibitors%3A+enhanced+plasma+exposure+of+deuterated+telaprevir+versus+telaprevir+in+rats&doi=10.1021%2Fjm901023f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and In Vivo Isotope Effects with Hepatitis C Protease Inhibitors: Enhanced Plasma Exposure of Deuterated Telaprevir versus Telaprevir in Rats</span></div><div class="casAuthors">Maltais, Francois; Jung, Young Chun; Chen, Minzhang; Tanoury, Jerry; Perni, Robert B.; Mani, Nagraj; Laitinen, Leena; Huang, Hui; Liao, Shengkai; Gao, Hongying; Tsao, Hong; Block, Eric; Ma, Chien; Shawgo, Rebecca S.; Town, Christopher; Brummel, Christopher L.; Howe, David; Pazhanisamy, S.; Raybuck, Scott; Namchuk, Mark; Bennani, Youssef L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7993-8001</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Telaprevir (I) (VX-950), an inhibitor of the hepatitis C virus (HCVa) NS3-4A protease, is in phase 3 clin. trials.  One of the major metabolites of I is its P1-(R)-diastereoisomer (VRT-394), contg. an inversion at the chiral center next to the α-ketoamide on exchange of a proton with solvent.  Compd. VRT-394 is approx. 30-fold less active against HCV protease.  In an attempt to suppress the epimerization of I without losing activity against the HCV protease, the proton at that chiral site was replaced with deuterium (d).  The compd. II (d-telaprevir) is as efficacious as I in in vitro inhibition of protease activity and viral replication (replicon) assays.  The kinetics of in vitro stability of I and II in buffered pH solns. and plasma samples, including human plasma, suggest that II is significantly more stable than I.  Oral administration (10 mg/kg) in rats resulted in a ∼13% increase of AUC for II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkqwA80elhh7Vg90H21EOLACvtfcHk0li2MTjCNMcQOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrbI&md5=244f41b401086e8541efc9203d22b503</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm901023f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901023f%26sid%3Dliteratum%253Aachs%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DJung%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DLaitinen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DTsao%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DE.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DShawgo%26aufirst%3DR.%2BS.%26aulast%3DTown%26aufirst%3DC.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DHowe%26aufirst%3DD.%26aulast%3DPazhanisamy%26aufirst%3DS.%26aulast%3DRaybuck%26aufirst%3DS.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520isotope%2520effects%2520with%2520hepatitis%2520C%2520protease%2520inhibitors%253A%2520enhanced%2520plasma%2520exposure%2520of%2520deuterated%2520telaprevir%2520versus%2520telaprevir%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7993%26epage%3D8001%26doi%3D10.1021%2Fjm901023f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakoshima, T.</span></span> <span> </span><span class="NLM_article-title">Structural basis of thalidomide enantiomer binding to cereblon</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1294</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-19202-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fs41598-018-19202-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29358579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1MvjtFOksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1294-1307&author=T.+Moriauthor=T.+Itoauthor=S.+Liuauthor=H.+Andoauthor=S.+Sakamotoauthor=Y.+Yamaguchiauthor=E.+Tokunagaauthor=N.+Shibataauthor=H.+Handaauthor=T.+Hakoshima&title=Structural+basis+of+thalidomide+enantiomer+binding+to+cereblon&doi=10.1038%2Fs41598-018-19202-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of thalidomide enantiomer binding to cereblon</span></div><div class="casAuthors">Mori Tomoyuki; Hakoshima Toshio; Ito Takumi; Ando Hideki; Handa Hiroshi; Ito Takumi; Liu Shujie; Sakamoto Satoshi; Yamaguchi Yuki; Tokunaga Etsuko; Shibata Norio</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Thalidomide possesses two optical isomers which have been reported to exhibit different pharmacological and toxicological activities.  However, the precise mechanism by which the two isomers exert their different activities remains poorly understood.  Here, we present structural and biochemical studies of (S)- and (R)-enantiomers bound to the primary target of thalidomide, cereblon (CRBN).  Our biochemical studies employed deuterium-substituted thalidomides to suppress optical isomer conversion, and established that the (S)-enantiomer exhibited ~10-fold stronger binding to CRBN and inhibition of self-ubiquitylation compared to the (R)-enantiomer.  The crystal structures of the thalidomide-binding domain of CRBN bound to each enantiomer show that both enantiomers bind the tri-Trp pocket, although the bound form of the (S)-enantiomer exhibited a more relaxed glutarimide ring conformation.  The (S)-enantiomer induced greater teratogenic effects on fins of zebrafish compared to the (R)-enantiomer.  This study has established a mechanism by which thalidomide exerts its effects in a stereospecific manner at the atomic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9kUcSD4Ihdlf1XRtfYM0dfW6udTcc2eZ36j6pCH5Zo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvjtFOksw%253D%253D&md5=d211214d07ec35f76fd5e0bd9080f800</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-19202-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-19202-7%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DTokunaga%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DHakoshima%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520of%2520thalidomide%2520enantiomer%2520binding%2520to%2520cereblon%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D1294%26epage%3D1307%26doi%3D10.1038%2Fs41598-018-19202-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toru, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and configurational stability of (S)- and (R)-deuteriothalidomides</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1248/cpb.58.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1248%2Fcpb.58.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=20045977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVWrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=110-112&author=T.+Yamamotoauthor=E.+Tokunagaauthor=S.+Nakamuraauthor=N.+Shibataauthor=T.+Toru&title=Synthesis+and+configurational+stability+of+%28S%29-+and+%28R%29-deuteriothalidomides&doi=10.1248%2Fcpb.58.110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and configurational stability of (S)- and (R)-deuteriothalidomides</span></div><div class="casAuthors">Yamamoto, Takeshi; Tokunaga, Etsuko; Nakamura, Shuichi; Shibata, Norio; Toru, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-112</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">(±)-3'-Deuteriothalidomide (I) was synthesized and resolved into its enantiomers.  S-I was five times more stable than S-thalidomide toward racemization at physiol. pH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKN76kpCl-TrVg90H21EOLACvtfcHk0lj65DoetbkySg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVWrtrw%253D&md5=e8771280b945e2ab0a28499c4ffbd28e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1248%2Fcpb.58.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.58.110%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DTokunaga%26aufirst%3DE.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DToru%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520configurational%2520stability%2520of%2520%2528S%2529-%2520and%2520%2528R%2529-deuteriothalidomides%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D58%26spage%3D110%26epage%3D112%26doi%3D10.1248%2Fcpb.58.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnik, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Ploeg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWitt, S. H.</span></span> <span> </span><span class="NLM_article-title">Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E1471</span>– <span class="NLM_lpage">E1479</span>, <span class="refDoi"> DOI: 10.1073/pnas.1417832112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1073%2Fpnas.1417832112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25775521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E1471-E1479&author=V.+Jacquesauthor=A.+W.+Czarnikauthor=T.+M.+Judgeauthor=L.+H.+Van+der+Ploegauthor=S.+H.+DeWitt&title=Differentiation+of+antiinflammatory+and+antitumorigenic+properties+of+stabilized+enantiomers+of+thalidomide+analogs&doi=10.1073%2Fpnas.1417832112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs</span></div><div class="casAuthors">Jacques, Vincent; Czarnik, Anthony W.; Judge, Thomas M.; Van der Ploeg, Lex H. T.; De Witt, Sheila H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">E1471-E1479</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Therapeutics developed and sold as racemates can exhibit a limited therapeutic index because of side effects resulting from the undesired enantiomer (distomer) and/or its metabolites, which at times, forces researchers to abandon valuable scaffolds.  Therefore, most chiral drugs are developed as single enantiomers.  Unfortunately, the development of some chirally pure drug mols. is hampered by rapid in vivo racemization.  The class of compds. known as immunomodulatory drugs derived from thalidomide is developed and sold as racemates because of racemization at the chiral center of the 3-aminoglutarimide moiety.  Herein, the authors show that replacement of the exchangeable hydrogen at the chiral center with deuterium allows the stabilization and testing of individual enantiomers for two thalidomide analogs, including CC-122, a compd. currently in human clin. trials for hematol. cancers and solid tumors.  Using "deuterium-enabled chiral switching" (DECS), in vitro anti-inflammatory differences of up to 20-fold are obsd. between the deuterium-stabilized enantiomers.  In vivo, the exposure is dramatically increased for each enantiomer while they retain similar pharmacokinetics.  Furthermore, the single deuterated enantiomers related to CC-122 exhibit profoundly different in vivo responses in an NCI-H929 myeloma xenograft model.  The (-)-deuterated enantiomer is antitumorigenic, whereas the (+)-deuterated enantiomer has little to no effect on tumor growth.  The ability to stabilize and differentiate enantiomers by DECS opens up a vast window of opportunity to characterize the class effects of thalidomide analogs and improve on the therapeutic promise of other racemic compds., including the development of safer therapeutics and the discovery of new mechanisms and clin. applications for existing therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf_lmu7VE5AbVg90H21EOLACvtfcHk0lj65DoetbkySg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCgurk%253D&md5=c4d855163335f0cf839ce4cc25c1a33f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1417832112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1417832112%26sid%3Dliteratum%253Aachs%26aulast%3DJacques%26aufirst%3DV.%26aulast%3DCzarnik%26aufirst%3DA.%2BW.%26aulast%3DJudge%26aufirst%3DT.%2BM.%26aulast%3DVan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%26aulast%3DDeWitt%26aufirst%3DS.%2BH.%26atitle%3DDifferentiation%2520of%2520antiinflammatory%2520and%2520antitumorigenic%2520properties%2520of%2520stabilized%2520enantiomers%2520of%2520thalidomide%2520analogs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3DE1471%26epage%3DE1479%26doi%3D10.1073%2Fpnas.1417832112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, V.</span>; <span class="NLM_string-name">Van der Ploeg, L.</span>; <span class="NLM_string-name">Dewitt, S. H.</span></span> <span> </span><span class="NLM_article-title">DRX- 065, the Deuterated (<i>R</i>)-Enantiomer of Pioglitazone, as a Nonalcoholic Steatohepatitis (NASH) Drug Candidate: Preclinical and Phase 1 Results</span>.  <i>Abstracts of Papers</i>, 256th National Meeting and Exposition of the American Chemical Society, Boston, MA, August 19–23, 2018; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=V.+Jacques&author=L.+Van+der+Ploeg&author=S.+H.+Dewitt&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJacques%26aufirst%3DV.%26atitle%3DDRX-%2520065%252C%2520the%2520Deuterated%2520%2528R%2529-Enantiomer%2520of%2520Pioglitazone%252C%2520as%2520a%2520Nonalcoholic%2520Steatohepatitis%2520%2528NASH%2529%2520Drug%2520Candidate%253A%2520Preclinical%2520and%2520Phase%25201%2520Results%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdallah, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelmendi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esterlis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanacora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span> <span> </span><span class="NLM_article-title">Ketamine’s mechanism of action: a path to rapid-acting antidepressants</span>. <i>Depression Anxiety</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1002/da.22501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fda.22501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27062302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1eht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=689-697&author=C.+G.+Abdallahauthor=T.+G.+Adamsauthor=B.+Kelmendiauthor=I.+Esterlisauthor=G.+Sanacoraauthor=J.+H.+Krystal&title=Ketamine%E2%80%99s+mechanism+of+action%3A+a+path+to+rapid-acting+antidepressants&doi=10.1002%2Fda.22501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS</span></div><div class="casAuthors">Abdallah, Chadi G.; Adams, Thomas G.; Kelmendi, Benjamin; Esterlis, Irina; Sanacora, Gerard; Krystal, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Depression and Anxiety</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">689-697</span>CODEN:
                <span class="NLM_cas:coden">DEANF5</span>;
        ISSN:<span class="NLM_cas:issn">1091-4269</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Major depressive disorder (MDD) is a common and debilitating psychiatric disorder.  Traditional antidepressants are of limited efficacy and take weeks to months to yield full therapeutic effects.  Thus, there is a clear need for effective rapid-acting antidepressant medications.  The N-methyl-D-aspartate receptor (NMDA-R) antagonist, ketamine, has received a great deal of attention over the last 20 years due to the discovery that a single subanesthetic dose leads to a rapid antidepressant effect in individuals with treatment-resistant depression.  Animal and human research suggest that ketamine's antidepressant effects are mediated by a glutamate surge that leads to a cascade of events that result in synaptogenesis and reversal of the neg. effects of chronic stress and depression, particularly within the prefrontal cortex (PFC).  Preclin. and clin. data have provided compelling insights into the mechanisms underlying the rapid-acting antidepressant effects of ketamine.  This review discusses stress-related neurobiol. of depression and the safety, tolerability, and efficacy of ketamine for MDD, along with a review of ketamine's mechanism of action and prospective predictors of treatment response.  Research limitations and future clin. prospects are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd3oDPBjGt0rVg90H21EOLACvtfcHk0lj65DoetbkySg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1eht7fI&md5=b020b2afdffce0393a5e4920d26a8115</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fda.22501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fda.22501%26sid%3Dliteratum%253Aachs%26aulast%3DAbdallah%26aufirst%3DC.%2BG.%26aulast%3DAdams%26aufirst%3DT.%2BG.%26aulast%3DKelmendi%26aufirst%3DB.%26aulast%3DEsterlis%26aufirst%3DI.%26aulast%3DSanacora%26aufirst%3DG.%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26atitle%3DKetamine%25E2%2580%2599s%2520mechanism%2520of%2520action%253A%2520a%2520path%2520to%2520rapid-acting%2520antidepressants%26jtitle%3DDepression%2520Anxiety%26date%3D2016%26volume%3D33%26spage%3D689%26epage%3D697%26doi%3D10.1002%2Fda.22501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moaddel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkondon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribut, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossou, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainer, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T. D.</span></span> <span> </span><span class="NLM_article-title">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>533</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nature17998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fnature17998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27144355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=481-486&author=P.+Zanosauthor=R.+Moaddelauthor=P.+J.+Morrisauthor=P.+Georgiouauthor=J.+Fischellauthor=G.+I.+Elmerauthor=M.+Alkondonauthor=P.+Yuanauthor=H.+J.+Pributauthor=N.+S.+Singhauthor=K.+S.+Dossouauthor=Y.+Fangauthor=X.+P.+Huangauthor=C.+L.+Mayoauthor=I.+W.+Wainerauthor=E.+X.+Albuquerqueauthor=S.+M.+Thompsonauthor=C.+J.+Thomasauthor=C.+A.+Zarateauthor=T.+D.+Gould&title=NMDAR+inhibition-independent+antidepressant+actions+of+ketamine+metabolites&doi=10.1038%2Fnature17998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span></div><div class="casAuthors">Zanos, Panos; Moaddel, Ruin; Morris, Patrick J.; Georgiou, Polymnia; Fischell, Jonathan; Elmer, Greg I.; Alkondon, Manickavasagom; Yuan, Peixiong; Pribut, Heather J.; Singh, Nagendra S.; Dossou, Katina S. S.; Fang, Yuhong; Huang, Xi-Ping; Mayo, Cheryl L.; Wainer, Irving W.; Albuquerque, Edson X.; Thompson, Scott M.; Thomas, Craig J.; Zarate, Carlos A., Jr; Gould, Todd D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7604</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Major depressive disorder affects around 16% of the world population at some point in their lives.  Despite the availability of numerous monoaminergic-based antidepressants, most patients require several weeks, if not months, to respond to these treatments, and many patients never attain sustained remission of their symptoms.  The noncompetitive, glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist (R,S)-ketamine exerts rapid and sustained antidepressant effects after a single dose in patients with depression, but its use is assocd. with undesirable side effects.  Here the authors show that the metab. of (R,S)-ketamine to (2S,6S;2R,6R)-hydroxynorketamine (HNK) is essential for its antidepressant effects, and that the (2R,6R)-HNK enantiomer exerts behavioral, electroencephalog., electrophysiol. and cellular antidepressant-related actions in mice.  These antidepressant actions are independent of NMDAR inhibition but involve early and sustained activation of AMPARs (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors).  The authors also establish that (2R,6R)-HNK lacks ketamine-related side effects.  The data implicate a novel mechanism underlying the antidepressant properties of (R,S)-ketamine and have relevance for the development of next-generation, rapid-acting antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzu3ydujHJ37Vg90H21EOLACvtfcHk0lh0AIjdJC_VkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D&md5=fcb8479079696cf3dc0ee89f5fadd72a</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnature17998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17998%26sid%3Dliteratum%253Aachs%26aulast%3DZanos%26aufirst%3DP.%26aulast%3DMoaddel%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DP.%2BJ.%26aulast%3DGeorgiou%26aufirst%3DP.%26aulast%3DFischell%26aufirst%3DJ.%26aulast%3DElmer%26aufirst%3DG.%2BI.%26aulast%3DAlkondon%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DPribut%26aufirst%3DH.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%2BS.%26aulast%3DDossou%26aufirst%3DK.%2BS.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMayo%26aufirst%3DC.%2BL.%26aulast%3DWainer%26aufirst%3DI.%2BW.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DThompson%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26aulast%3DGould%26aufirst%3DT.%2BD.%26atitle%3DNMDAR%2520inhibition-independent%2520antidepressant%2520actions%2520of%2520ketamine%2520metabolites%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature17998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of <i>N</i>-(5-fluoro-2-phenoxyphenyl)-<i>N</i>-(2-[<sup>18</sup>F]fluoromethoxy-d<sub>2</sub>-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1811</span>– <span class="NLM_lpage">1818</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.11.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmc.2004.11.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=15698799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1811-1818&author=M.-R.+Zhangauthor=J.+Maedaauthor=T.+Itoauthor=T.+Okauchiauthor=M.+Ogawaauthor=J.+Noguchiauthor=T.+Suharaauthor=C.+Halldinauthor=K.+Suzuki&title=Synthesis+and+evaluation+of+N-%285-fluoro-2-phenoxyphenyl%29-N-%282-%5B18F%5Dfluoromethoxy-d2-5-methoxybenzyl%29acetamide%3A+a+deuterium-substituted+radioligand+for+peripheral+benzodiazepine+receptor&doi=10.1016%2Fj.bmc.2004.11.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoromethoxy-d2-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor</span></div><div class="casAuthors">Zhang, Ming-Rong; Maeda, Jun; Ito, Takehito; Okauchi, Takashi; Ogawa, Masanao; Noguchi, Junko; Suhara, Tetsuya; Halldin, Christer; Suzuki, Kazutoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1811-1818</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoromethoxy-d2-5-methoxybenzyl)acetamide ([18F]2) is a potent ligand (IC50: 1.71 nM) for peripheral benzodiazepine receptor (PBR).  However, in vivo evaluation on rodents and primates showed that this ligand was unstable and rapidly metabolized to [18F]F- by defluorination of the [18F]fluoromethyl moiety.  In this study, we designed a deuterium-substituted analog, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoromethoxy-d2-5-methoxybenzyl)acetamide ([18F]5) as a radioligand for PBR to reduce the in vivo metabolic rate of the non-deuterated [18F]2.  The design principle was based on the hypothesis that the deuterium substitution may reduce the rate of defluorination initiated by cleavage of the C-H bond without altering the binding affinity for PBR.  The non-radioactive 5 was prepd. by reacting diiodomethane-d2 (CD2I2, 6) with a phenol precursor 7, followed by treatment with tetrabutylammonium fluoride.  The ligand [18F]5 was synthesized by the alkylation of 7 with [18F]fluoromethyl iodide-d2 ([18F]FCD2I, [18F]9).  Compd. 5 displayed a similar in vitro affinity to PBR (IC50: 1.90 nM) with 2.  In vivo evaluation demonstrated that [18F]5 was metabolized by defluorination to [18F]F- as a main radioactive component, but its metabolic rate was slower than that of [18F]2 in the brain of mice.  The deuterium substitution decreased the radioactivity level of [18F]5 in the bone of mouse, augmented by the percentage of specific binding to PBR in the rat brain detd. by ex vivo autoradiog.  However, the PET image of [18F]5 for monkey brain showed high radioactivity in the brain and skull, suggesting a possible species difference between rodents and primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1VeN13UDtaLVg90H21EOLACvtfcHk0lh0AIjdJC_VkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs7k%253D&md5=4a74d02933e376b0761fea175300c50c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.11.058%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DJ.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520N-%25285-fluoro-2-phenoxyphenyl%2529-N-%25282-%255B18F%255Dfluoromethoxy-d2-5-methoxybenzyl%2529acetamide%253A%2520a%2520deuterium-substituted%2520radioligand%2520for%2520peripheral%2520benzodiazepine%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D1811%26epage%3D1818%26doi%3D10.1016%2Fj.bmc.2004.11.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span> <span> </span><span class="NLM_article-title">[<sup>18</sup>F]Fluoromethyl-PBR28 as a potential radiotracer for TSPO: preclinical comparison with [<sup>11</sup>C]PBR28 in a rat model of neuroinflammation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1021/bc400556h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc400556h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=442-450&author=B.+S.+Moonauthor=B.+S.+Kimauthor=C.+Parkauthor=J.+H.+Jungauthor=Y.+W.+Leeauthor=H.-Y.+Leeauthor=D.+Y.+Chiauthor=B.+C.+Leeauthor=S.+E.+Kim&title=%5B18F%5DFluoromethyl-PBR28+as+a+potential+radiotracer+for+TSPO%3A+preclinical+comparison+with+%5B11C%5DPBR28+in+a+rat+model+of+neuroinflammation&doi=10.1021%2Fbc400556h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]Fluoromethyl-PBR28 as a Potential Radiotracer for TSPO: Preclinical Comparison with [11C]PBR28 in a Rat Model of Neuroinflammation</span></div><div class="casAuthors">Moon, Byung Seok; Kim, Bom Sahn; Park, Chansoo; Jung, Jae Ho; Lee, Youn Woo; Lee, Ho-Young; Chi, Dae Yoon; Lee, Byung Chul; Kim, Sang Eun</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To develop radiotracer for the translocator protein 18 kDa (TSPO) in vivo, N-(2-[18F]-fluoromethoxybenzyl)-N-(4-phenoxypyridin-3-yl)-acetamide ([18F]1, [18F]-fluoromethyl-PBR28) was prepd. by incorporating of fluorine-18 into triazolium triflate-PBR28 precursor (7).  The radiochem. yield of [18F]1 after HPLC purifn. was 35.8 ± 3.2% (n = 11, decay cor.).  Radiotracer [18F]1 was found to be chem. stable when incubated in human serum for 4 h at 37 °C.  Both aryloxyanilide analogs (1 and 2) behaved similarly in terms of lipophilicity and in vitro affinity for TSPO.  Here, both radiotracers were directly compared in the same inflammatory rat to det. whether either radiotracer provides more promising in vivo TSPO binding.  Uptake of [18F]1 in the inflammatory lesion was comparable to that of [11C]-PBR28, and [18F]1 rapidly approached the highest target-to-background ratio at early imaging time (35 min postinjection vs. 85 min postinjection for [11C]-PBR28).  These results suggest that [18F]1 is a promising radiotracer for imaging acute neuroinflammation in rat.  In addn., our use of a triazolium triflate precursor for [18F]-fluoromethyl ether group provides the convenient application for radiofluorination of radiotracer contg. a methoxy group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5aYe0CJbIkLVg90H21EOLACvtfcHk0lh0AIjdJC_VkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVOhtQ%253D%253D&md5=e3348cc433b34d2d59e8193990f9f601</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fbc400556h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc400556h%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DY.%2BW.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BE.%26atitle%3D%255B18F%255DFluoromethyl-PBR28%2520as%2520a%2520potential%2520radiotracer%2520for%2520TSPO%253A%2520preclinical%2520comparison%2520with%2520%255B11C%255DPBR28%2520in%2520a%2520rat%2520model%2520of%2520neuroinflammation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2014%26volume%3D25%26spage%3D442%26epage%3D450%26doi%3D10.1021%2Fbc400556h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span> <span> </span><span class="NLM_article-title">Preclinical comparison study between [<sup>18</sup>F]fluoromethyl-PBR28 and its deuterated analog in a rat model of neuroinflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2925</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2018.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=30122224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2925-2929&author=B.+S.+Moonauthor=J.+H.+Jungauthor=H.+S.+Parkauthor=M.+Continoauthor=N.+Denoraauthor=B.+C.+Leeauthor=S.+E.+Kim&title=Preclinical+comparison+study+between+%5B18F%5Dfluoromethyl-PBR28+and+its+deuterated+analog+in+a+rat+model+of+neuroinflammation&doi=10.1016%2Fj.bmcl.2018.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical comparison study between [18F]fluoromethyl-PBR28 and its deuterated analog in a rat model of neuroinflammation</span></div><div class="casAuthors">Moon, Byung Seok; Jung, Jae Ho; Park, Hyun Soo; Contino, Marialessandra; Denora, Nunzio; Lee, Byung Chul; Kim, Sang Eun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2925-2929</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We designed and synthesized deuterium-substituted [18F]fluoromethyl-PBR28 ([18F]1-d2) as a novel translocator protein 18 kDa (TSPO)-targeted radioligand with enhanced in vivo stability.  The comparison studies between [18F]fluoromethyl-PBR28 ([18F]1) and its deuterate analog ([18F]1-d2) were investigated in terms of in vitro binding affinity, lipophilicity and in vivo stability.  In addn., the accuracies of both radioligands were detd. by comparing the PET imaging data in the same LPS-induced neuroinflammation rat model.  Both aryloxyanilide analogs showed similar lipophilicity and in vitro affinity for TSPO.  However, [18F]1-d2 provided significantly lower femur uptake than [18F]1 (1.5 ± 1.2 vs. 4.1 ± 1.7%ID/g at 2 h post-injection) in an ex vivo biodistribution study. [18F]1-d2 was also selectively accumulated in the inflammatory lesion with the binding potential of the specifically bound radioligand relative to the non-displaceable radioligand in tissue (BPND = 3.17 ± 0.48), in a LPS-induced acute neuroinflammation rat model, comparable to that of [18F]1 (BPND = 2.13 ± 0.51).  These results indicate that [18F]1-d2 had higher in vivo stability, which resulted in an enhanced target-to-background ratio compared to that induced by [18F]1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Fy-Dh-PJbLVg90H21EOLACvtfcHk0ljcF8u5LRY4og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfI&md5=537cd26cacc8be34f39e6ea881d72749</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DJung%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BE.%26atitle%3DPreclinical%2520comparison%2520study%2520between%2520%255B18F%255Dfluoromethyl-PBR28%2520and%2520its%2520deuterated%2520analog%2520in%2520a%2520rat%2520model%2520of%2520neuroinflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2925%26epage%3D2929%26doi%3D10.1016%2Fj.bmcl.2018.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettschau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svedberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catafau, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannestad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">In vivo and in vitro characterization of a novel MAO-B inhibitor radioligand, <sup>18</sup>F-labeled deuterated fluorodeprenyl</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.161083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.2967%2Fjnumed.115.161083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=26585057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=315-320&author=S.+Nagauthor=P.+Fazioauthor=L.+Lehmannauthor=G.+Kettschauauthor=T.+Heinrichauthor=A.+Thieleauthor=M.+Svedbergauthor=N.+Aminiauthor=S.+Leeschauthor=A.+M.+Catafauauthor=J.+Hannestadauthor=A.+Varroneauthor=C.+Halldin&title=In+vivo+and+in+vitro+characterization+of+a+novel+MAO-B+inhibitor+radioligand%2C+18F-labeled+deuterated+fluorodeprenyl&doi=10.2967%2Fjnumed.115.161083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro characterization of a novel MAO-B inhibitor radioligand, 18F-labeled deuterated fluorodeprenyl</span></div><div class="casAuthors">Nag, Sangram; Fazio, Patrik; Lehmann, Lutz; Kettschau, Georg; Heinrich, Tobias; Thiele, Andrea; Svedberg, Marie; Amini, Nahid; Leesch, Samira; Catafau, Ana M.; Hannestad, Jonas; Varrone, Andrea; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">The aim of this study was to radiolabel a novel bis-deuterium substituted l-deprenyl analog (fluorodeprenyl-D2) with 18F and to evaluate its potential to visualize and quantify monoamine oxidase (MAO) B activity in vivo.  Methods: The precursor compd. (5a + 5b) and ref. std. (6) were synthesized in multistep syntheses.  Recombinant human MAO-B and MAO-A enzyme prepns. were used to det. inhibitory concns. of 50%.  Radiolabeling was accomplished by a nucleophilic substitution reaction.  Whole-hemisphere autoradiog. was performed with 18F-fluorodeprenyl-D2.  A PET study was performed on a cynomolgus monkey.  Radiometabolites were measured in monkey plasma using high-performance liq. chromatog.  Results: The 50% inhibitory concn. of compd. 6 for MAO-B was 227 ± 36.8 nM.  Radiolabeling was accomplished with high radiochem. yield, purity, and specific radioactivity.  The autoradiog. binding d. of 18F-fluorodeprenyl-D2 was consistent with known MAO-B expression in the human brain.  In vivo, 18F-fluorodeprenyl-D2 showed favorable kinetic properties, with relatively fast washout from the brain.  Regional time-activity curves were better described by the 2-tissue-compartment model.  Administration of a 1 mg/kg dose of l-deprenyl yielded 70% inhibition of MAO-B in all regions.  Radiometabolite studies demonstrated 20% unchanged radioligand at 120 min after injection. 18F-fluorodeprenyl-D2 showed less irreversibility than did previously reported MAO-B radioligands.  Conclusion: The results suggest that 18F-fluorodeprenyl-D2 is a suitable PET radioligand for visualization of MAO-B activity in the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy_X--Sdcf4rVg90H21EOLACvtfcHk0ljcF8u5LRY4og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVKlsA%253D%253D&md5=2934d0478f5981d0e72921fe49330246</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.161083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.161083%26sid%3Dliteratum%253Aachs%26aulast%3DNag%26aufirst%3DS.%26aulast%3DFazio%26aufirst%3DP.%26aulast%3DLehmann%26aufirst%3DL.%26aulast%3DKettschau%26aufirst%3DG.%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DThiele%26aufirst%3DA.%26aulast%3DSvedberg%26aufirst%3DM.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DLeesch%26aufirst%3DS.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26aulast%3DHannestad%26aufirst%3DJ.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520characterization%2520of%2520a%2520novel%2520MAO-B%2520inhibitor%2520radioligand%252C%252018F-labeled%2520deuterated%2520fluorodeprenyl%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D315%26epage%3D320%26doi%3D10.2967%2Fjnumed.115.161083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tóth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettschau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">In vivo evaluation in cynomolgus monkey brain and metabolism of [<sup>18</sup>F]fluorodeprenyl: a new MAO-B pet radioligand</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1002/syn.21514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fsyn.21514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=22124971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12mur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=323-330&author=S.+Nagauthor=A.+Varroneauthor=M.+T%C3%B3thauthor=A.+Thieleauthor=G.+Kettschauauthor=T.+Heinrichauthor=L.+Lehmannauthor=C.+Halldin&title=In+vivo+evaluation+in+cynomolgus+monkey+brain+and+metabolism+of+%5B18F%5Dfluorodeprenyl%3A+a+new+MAO-B+pet+radioligand&doi=10.1002%2Fsyn.21514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo evaluation in cynomolgus monkey brain and metabolism of [18F]fluorodeprenyl: A new MAO-B pet radioligand</span></div><div class="casAuthors">Nag, Sangram; Varrone, Andrea; Toth, Miklos; Thiele, Andrea; Kettschau, Georg; Heinrich, Tobias; Lehmann, Lutz; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-330</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In this study, we evaluated the in vivo characteristics of a new monoamine oxidase type B (MAO-B) radioligand, [18F]fluorodeprenyl, by positron emission tomog. (PET) in two cynomolgus monkeys.  The brain uptake of [18F]fluorodeprenyl was more than 7% (600% SUV) of the total injected radioactivity and similar to that of [11C]deprenyl, an established MAO-B radioligand.  The highest uptake was obsd. in the striatum, one of the MAO-B-rich regions, with a peak at approx. 2-3 min after injection, followed by lower uptake in the thalamus and the cortex and lowest uptake in the cerebellum.  Brain uptake of [18F]fluorodeprenyl was largely inhibited by preadministration of the MAO-B inhibitor, L-deprenyl, whereas clorgyline, a MAO Type A blocker, had no significant inhibitory effect, thus demonstrating selectivity for MAO-B. [18F]Fluorodeprenyl showed relatively slow metab. with the presence of two radiometabolite peaks with similar retention time as the labeled metabolites of [11C]deprenyl.  These results suggest that [18F]fluorodeprenyl is a potential PET radioligand for visualization of MAO-B activity.  Synapse, 2011. © 2011 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyrFOKakuTCLVg90H21EOLACvtfcHk0ljcF8u5LRY4og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12mur7L&md5=d3caf0ddce8198b533c5446f53ecc8b3</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21514%26sid%3Dliteratum%253Aachs%26aulast%3DNag%26aufirst%3DS.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DT%25C3%25B3th%26aufirst%3DM.%26aulast%3DThiele%26aufirst%3DA.%26aulast%3DKettschau%26aufirst%3DG.%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DLehmann%26aufirst%3DL.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520evaluation%2520in%2520cynomolgus%2520monkey%2520brain%2520and%2520metabolism%2520of%2520%255B18F%255Dfluorodeprenyl%253A%2520a%2520new%2520MAO-B%2520pet%2520radioligand%26jtitle%3DSynapse%26date%3D2012%26volume%3D66%26spage%3D323%26epage%3D330%26doi%3D10.1002%2Fsyn.21514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ottoboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span> <span> </span><span class="NLM_article-title">Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">13684</span>– <span class="NLM_lpage">13688</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=2788162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL1MXlsVyht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=13684-13688&author=S.+Ottoboniauthor=P.+Calderaauthor=A.+Trevorauthor=N.+Castagnoli&title=Deuterium+isotope+effect+measurements+on+the+interactions+of+the+neurotoxin+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+with+monoamine+oxidase+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B</span></div><div class="casAuthors">Ottoboni, Susanne; Caldera, Patricia; Trevor, Anthony; Castagnoli, Neal, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13684-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Kinetic deuterium isotope effects for the noncompetitive, intermol. monoamine oxidase B-catalyzed oxidn. of MPTP to the corresponding 1-methyl-4-phenyl-2,3-dihydropyridinium species MPDP+ were 3.55 on Vmax and 8.01 on Vmax/Km with MPTP-6,6-d2 as the deuterated substrate.  Similar values were obtained with MPTP-2,2,6,6-d4 and MPTP-CD3-2,2,6,6-d4.  The deuterium isotope effect for the electrochem. oxidn. of 1 mM MPTP-2,2,6,6-d4 was only 1.35.  These results indicate that the monoamine oxidase B-catalyzed oxidn. of this substrate may not proceed via a reaction pathway involving α-carbon deprotonation of an aminium radical intermediate.  Isotope effect measurements also established that the rate of inactivation of monoamine oxidase B by MPTP is unaffected by replacement of the C-6 methylene protons with deuterons, but is retarded by replacement of the C-2 methylene protons (DKi = 1.9).  The mechanism-based inactivation of monoamine oxidase B by MPTP, therefore, is likely to be mediated by a species derived from the enzyme-generated 2,3-dihydropyridinium oxidn. product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGbhYn3avwrVg90H21EOLACvtfcHk0lgKY3IswofqAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlsVyht7w%253D&md5=356a2c8952b6ba8481aa39d43e7de1cb</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOttoboni%26aufirst%3DS.%26aulast%3DCaldera%26aufirst%3DP.%26aulast%3DTrevor%26aufirst%3DA.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DDeuterium%2520isotope%2520effect%2520measurements%2520on%2520the%2520interactions%2520of%2520the%2520neurotoxin%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520with%2520monoamine%2520oxidase%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D13684%26epage%3D13688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drake, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mufarreh, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeppe, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilbourn, M. R.</span></span> <span> </span><span class="NLM_article-title">Deuterium kinetic isotope effect studies of a potential in vivo metabolic trapping agent for monoamine oxidase B</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3024</span>– <span class="NLM_lpage">3027</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVemtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3024-3027&author=L.+R.+Drakeauthor=A.+F.+Brooksauthor=A.+J.+Mufarrehauthor=J.+M.+Phamauthor=R.+A.+Koeppeauthor=X.+Shaoauthor=P.+J.+H.+Scottauthor=M.+R.+Kilbourn&title=Deuterium+kinetic+isotope+effect+studies+of+a+potential+in+vivo+metabolic+trapping+agent+for+monoamine+oxidase+B&doi=10.1021%2Facschemneuro.8b00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium Kinetic Isotope Effect Studies of a Potential in Vivo Metabolic Trapping Agent for Monoamine Oxidase B</span></div><div class="casAuthors">Drake, Lindsey R.; Brooks, Allen F.; Mufarreh, Anthony J.; Pham, Jonathan M.; Koeppe, Robert A.; Shao, Xia; Scott, Peter J. H.; Kilbourn, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3024-3027</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Visualizing the in vivo activity of monoamine oxidase B (MAO-B) is a valuable tool in the ongoing investigation into astrogliosis in neurodegeneration.  Existing strategies for imaging changes in MAO enzyme expression or activity have utilized the irreversible suicide inhibitors or high-affinity reversibly binding inhibitors as PET ligands.  As an alternative approach, we developed 4-methyl-7-((1-[11C]methyl-1,2,3,6-tetrahydropyridin-4-yl)oxy)-2H-chromen-2-one ([11C]Cou) as a metabolic trapping agent for MAO-B.  Trapping of [11C]Cou in rhesus monkey brain demonstrated MAO-B selectivity.  In this work we have attempted to improve on the in vivo pharmacokinetics of [11C]Cou by using the deuterium kinetic isotope effect (KIE) to slow the MAO-B mediated oxidn. step and thus reduce the rate of trapping in brain tissues.  However, in vitro assays of enzyme kinetics and in vivo PET imaging of pharmacokinetics in primate brain showed no effects of deuterium substitution on the tetrahydropyridine ring of [11C]Cou.  The results are possibly due to masking of the KIE by a second step in the overall metab. of the new imaging agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjw1zi8AKxRrVg90H21EOLACvtfcHk0lgKY3IswofqAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVemtLfN&md5=9db622b5b8a8eb194ff438505dd75bbc</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00219%26sid%3Dliteratum%253Aachs%26aulast%3DDrake%26aufirst%3DL.%2BR.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DMufarreh%26aufirst%3DA.%2BJ.%26aulast%3DPham%26aufirst%3DJ.%2BM.%26aulast%3DKoeppe%26aufirst%3DR.%2BA.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26atitle%3DDeuterium%2520kinetic%2520isotope%2520effect%2520studies%2520of%2520a%2520potential%2520in%2520vivo%2520metabolic%2520trapping%2520agent%2520for%2520monoamine%2520oxidase%2520B%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D3024%26epage%3D3027%26doi%3D10.1021%2Facschemneuro.8b00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Qahtani, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleator, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danks, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmonds, A. J.</span></span> <span> </span><span class="NLM_article-title">Microwave enhanced hydrogenation reactions using solid hydrogen, deuterium and tritium donors</span>. <i>J. Chem. Res., Synop.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1039/a802040j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2Fa802040j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1cXktlemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=400-401&author=M.+H.+Al-Qahtaniauthor=N.+Cleatorauthor=T.+N.+Danksauthor=R.+N.+Garmanauthor=J.+R.+Jonesauthor=S.+Stefaniakauthor=A.+D.+Morganauthor=A.+J.+Simmonds&title=Microwave+enhanced+hydrogenation+reactions+using+solid+hydrogen%2C+deuterium+and+tritium+donors&doi=10.1039%2Fa802040j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81aR"><div class="casContent"><span class="casTitleNuber">81a</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave Enhanced Hydrogenation Reactions using Solid Hydrogen, Deuterium and Tritium Donors</span></div><div class="casAuthors">Al-Qahtani, Mohammed H.; Cleator, Nicola; Danks, Timothy N.; Garman, Russell N.; Jones, John R.; Stefaniak, Stefan; Morgan, Alan D.; Simmonds, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Research, Synopses</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">400-401</span>CODEN:
                <span class="NLM_cas:coden">JRPSDC</span>;
        ISSN:<span class="NLM_cas:issn">0308-2342</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Microwave enhanced hydrogenation reactions in which H2/D2/T2 gases are replaced by various formates proceed very rapidly.  The pattern of labeling can be easily modified, and the advantages are particularly noteworthy in the case of tritium, where problems assocd. with handling T2 gas are avoided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEkJ6i5xcsT7Vg90H21EOLACvtfcHk0lgKY3IswofqAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktlemsbw%253D&md5=43b8d07a765459ba61a73c60de039933</span></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1039%2Fa802040j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa802040j%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Qahtani%26aufirst%3DM.%2BH.%26aulast%3DCleator%26aufirst%3DN.%26aulast%3DDanks%26aufirst%3DT.%2BN.%26aulast%3DGarman%26aufirst%3DR.%2BN.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DStefaniak%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DA.%2BD.%26aulast%3DSimmonds%26aufirst%3DA.%2BJ.%26atitle%3DMicrowave%2520enhanced%2520hydrogenation%2520reactions%2520using%2520solid%2520hydrogen%252C%2520deuterium%2520and%2520tritium%2520donors%26jtitle%3DJ.%2520Chem.%2520Res.%252C%2520Synop.%26date%3D1998%26spage%3D400%26epage%3D401%26doi%3D10.1039%2Fa802040j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit81b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. Y.</span></span> <span> </span><span class="NLM_article-title">Microwave enhanced deuterations in the solid state using alumina doped sodium borodeuteride</span>. <i>J. Chem. Res., Synop.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1039/a906977a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2Fa906977a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1MXnsFyntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=728-729&author=T.+W.+Erbauthor=J.+R.+Jonesauthor=S.+Y.+Lu&title=Microwave+enhanced+deuterations+in+the+solid+state+using+alumina+doped+sodium+borodeuteride&doi=10.1039%2Fa906977a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave enhanced deuteriations in the solid state using alumina doped sodium borodeuteride</span></div><div class="casAuthors">Erb, Wouter Th.; Jones, John R.; Lu, Shui-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Research, Synopses</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">728-729</span>CODEN:
                <span class="NLM_cas:coden">JRPSDC</span>;
        ISSN:<span class="NLM_cas:issn">0308-2342</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Deuteriated alcs. were rapidly (ca. 1 min) prepd. through the microwave enhanced solid state redn. of aldehydes and ketones using alumina doped sodium borodeuteride (NaBD4).  Thus, microwave irradn. of PhCHO and alumina doped NaBD4 for one minute gave 37% PhCHDOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7fW6PnFuJsbVg90H21EOLACvtfcHk0ljLMFHHEeOxyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsFyntbo%253D&md5=85c2e0e9afe0fcb4d81d76a0e73e60a3</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1039%2Fa906977a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa906977a%26sid%3Dliteratum%253Aachs%26aulast%3DErb%26aufirst%3DT.%2BW.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DLu%26aufirst%3DS.%2BY.%26atitle%3DMicrowave%2520enhanced%2520deuterations%2520in%2520the%2520solid%2520state%2520using%2520alumina%2520doped%2520sodium%2520borodeuteride%26jtitle%3DJ.%2520Chem.%2520Res.%252C%2520Synop.%26date%3D1999%26spage%3D728%26epage%3D729%26doi%3D10.1039%2Fa906977a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit81c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guaragna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedatella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of C-protected 2,2-dideutero β3-amino acids</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2006</i></span>,  <span class="NLM_fpage">4013</span>– <span class="NLM_lpage">4016</span>, <span class="refDoi"> DOI: 10.1055/s-2006-950314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1055%2Fs-2006-950314" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=4013-4016&author=A.+Guaragnaauthor=S.+Pedatellaauthor=V.+Pintoauthor=G.+Palumbo&title=Synthesis+of+C-protected+2%2C2-dideutero+%CE%B23-amino+acids&doi=10.1055%2Fs-2006-950314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81c&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-950314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-950314%26sid%3Dliteratum%253Aachs%26aulast%3DGuaragna%26aufirst%3DA.%26aulast%3DPedatella%26aufirst%3DS.%26aulast%3DPinto%26aufirst%3DV.%26aulast%3DPalumbo%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520C-protected%25202%252C2-dideutero%2520%25CE%25B23-amino%2520acids%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D4013%26epage%3D4016%26doi%3D10.1055%2Fs-2006-950314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chapelle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. D.</span></span> <span> </span><span class="NLM_article-title">Development of combined microwave-enhanced labelling procedures for maximising deuterium incorporation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">5117</span>– <span class="NLM_lpage">5118</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(02)00986-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0040-4039%2802%2900986-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVent7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=5117-5118&author=M.+R.+Chapelleauthor=B.+B.+Kentauthor=J.+R.+Jonesauthor=S.+Y.+Luauthor=A.+D.+Morgan&title=Development+of+combined+microwave-enhanced+labelling+procedures+for+maximising+deuterium+incorporation&doi=10.1016%2FS0040-4039%2802%2900986-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82aR"><div class="casContent"><span class="casTitleNuber">82a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of combined microwave-enhanced labelling procedures for maximizing deuterium incorporation</span></div><div class="casAuthors">Chapelle, Michael R.; Kent, Barry B.; Jones, John R.; Lu, Shui-Yu; Morgan, Alan D.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5117-5118</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Combined hydrogenation/arom. dehalogenation under microwave-enhanced conditions provides a rapid route to deuterium labeled compds. with enhanced isotopic incorporation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHy2NnX4zkzrVg90H21EOLACvtfcHk0ljLMFHHEeOxyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVent7k%253D&md5=5a57bfc0af2563dd38196c18afbcf858</span></div><a href="/servlet/linkout?suffix=cit82a&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900986-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900986-3%26sid%3Dliteratum%253Aachs%26aulast%3DChapelle%26aufirst%3DM.%2BR.%26aulast%3DKent%26aufirst%3DB.%2BB.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DLu%26aufirst%3DS.%2BY.%26aulast%3DMorgan%26aufirst%3DA.%2BD.%26atitle%3DDevelopment%2520of%2520combined%2520microwave-enhanced%2520labelling%2520procedures%2520for%2520maximising%2520deuterium%2520incorporation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D5117%26epage%3D5118%26doi%3D10.1016%2FS0040-4039%2802%2900986-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit82b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span> <span> </span><span class="NLM_article-title">Deuterated ammonium formate as deuterium source in a mild catalytic deuterium transfer reaction of pyridines, pyrazines and isoquinolines</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">8889</span>– <span class="NLM_lpage">8893</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2004.09.165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.tetlet.2004.09.165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1SrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=8889-8893&author=V.+Derdau&title=Deuterated+ammonium+formate+as+deuterium+source+in+a+mild+catalytic+deuterium+transfer+reaction+of+pyridines%2C+pyrazines+and+isoquinolines&doi=10.1016%2Fj.tetlet.2004.09.165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82bR"><div class="casContent"><span class="casTitleNuber">82b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated ammonium formate as deuterium source in a mild catalytic deuterium transfer reaction of pyridines, pyrazines, and isoquinolines</span></div><div class="casAuthors">Derdau, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">8889-8893</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The application of deuterated ammonium formate as deuterium source in transfer deuteration reactions of arom. heterocycles for the synthesis of highly deuterated, substituted piperidines, piperazines, and tetrahydroisoquinolines has been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1lzC6eAUtx7Vg90H21EOLACvtfcHk0ljLMFHHEeOxyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1SrsLY%253D&md5=b2230835f8144a2acf1962cebb646a71</span></div><a href="/servlet/linkout?suffix=cit82b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2004.09.165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2004.09.165%26sid%3Dliteratum%253Aachs%26aulast%3DDerdau%26aufirst%3DV.%26atitle%3DDeuterated%2520ammonium%2520formate%2520as%2520deuterium%2520source%2520in%2520a%2520mild%2520catalytic%2520deuterium%2520transfer%2520reaction%2520of%2520pyridines%252C%2520pyrazines%2520and%2520isoquinolines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D8889%26epage%3D8893%26doi%3D10.1016%2Fj.tetlet.2004.09.165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span> <span> </span><span class="NLM_article-title">The renaissance of H/D exchange</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7744</span>– <span class="NLM_lpage">7765</span>, <span class="refDoi"> DOI: 10.1002/anie.200700039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.200700039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17886815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1alsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7744-7765&author=J.+Atzrodtauthor=V.+Derdauauthor=T.+Feyauthor=J.+Zimmermann&title=The+renaissance+of+H%2FD+exchange&doi=10.1002%2Fanie.200700039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The renaissance of H/D exchange</span></div><div class="casAuthors">Atzrodt, Jens; Derdau, Volker; Fey, Thorsten; Zimmermann, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7744-7765</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The increasing demand for stable isotopically labeled compds. has led to an increased interest in H/D-exchange reactions at carbon centers.  Today deuterium-labeled compds. are used as internal stds. in mass spectrometry or to help elucidate mechanistic theories.  Access to these deuterated compds. takes place significantly more efficiently and more cost effectively by exchange of hydrogen by deuterium in the target mol. than by classical synthesis.  This review will conc. on the preparative application of the H/D-exchange reaction in the prepn. of deuterium-labeled compds.  Advances over the last ten years are brought together and critically evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxcoKufJE7Vg90H21EOLACvtfcHk0lhopRIr5tphow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1alsL3M&md5=d4c01740a03e307d6e89ab954bd11809</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fanie.200700039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200700039%26sid%3Dliteratum%253Aachs%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DFey%26aufirst%3DT.%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3DThe%2520renaissance%2520of%2520H%252FD%2520exchange%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D7744%26epage%3D7765%26doi%3D10.1002%2Fanie.200700039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, K. P.</span></span> <span> </span><span class="NLM_article-title">Controllable deuteration of halogenated compounds by photocatalytic D<sub>2</sub>O splitting</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02551-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fs41467-017-02551-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29311606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1MzosFWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=80-88&author=C.+Liuauthor=Z.+Chenauthor=C.+Suauthor=X.+Zhaoauthor=Q.+Gaoauthor=G.+H.+Ningauthor=H.+Zhuauthor=W.+Tangauthor=K.+Lengauthor=W.+Fuauthor=B.+Tianauthor=X.+Pengauthor=J.+Liauthor=Q.+H.+Xuauthor=W.+Zhouauthor=K.+P.+Loh&title=Controllable+deuteration+of+halogenated+compounds+by+photocatalytic+D2O+splitting&doi=10.1038%2Fs41467-017-02551-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84aR"><div class="casContent"><span class="casTitleNuber">84a</span><div class="casTitle"><span class="NLM_cas:atitle">Controllable deuteration of halogenated compounds by photocatalytic D2O splitting</span></div><div class="casAuthors">Liu Cuibo; Su Chenliang; Gao Qiang; Tian Bingbing; Li Jing; Xu Qing-Hua; Loh Kian Ping; Liu Cuibo; Chen Zhongxin; Su Chenliang; Zhao Xiaoxu; Gao Qiang; Ning Guo-Hong; Zhu Hai; Leng Kai; Fu Wei; Tian Bingbing; Peng Xinwen; Li Jing; Xu Qing-Hua; Loh Kian Ping; Chen Zhongxin; Zhao Xiaoxu; Tang Wei; Zhou Wu</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Deuterium labeling is of great value in organic synthesis and the pharmaceutical industry.  However, the state-of-the-art C-H/C-D exchange using noble metal catalysts or strong bases/acids suffers from poor functional group tolerances, poor selectivity and lack of scope for generating molecular complexity.  Herein, we demonstrate the deuteration of halides using heavy water as the deuteration reagent and porous CdSe nanosheets as the catalyst.  The deuteration mechanism involves the generation of highly active carbon and deuterium radicals via photoinduced electron transfer from CdSe to the substrates, followed by tandem radicals coupling process, which is mechanistically distinct from the traditional methods involving deuterium cations or anions.  Our deuteration strategy shows better selectivity and functional group tolerances than current C-H/C-D exchange methods.  Extending the synthetic scope, deuterated boronic acids, halides, alkynes, and aldehydes can be used as synthons in Suzuki coupling, Click reaction, C-H bond insertion reaction etc. for the synthesis of complex deuterated molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__KWoaDFa1dXdcedVHT5tfW6udTcc2eZJbEnZw9Q2Frntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzosFWksg%253D%253D&md5=354d6efd3da9b6e77c02c34868eb867c</span></div><a href="/servlet/linkout?suffix=cit84a&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02551-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02551-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DNing%26aufirst%3DG.%2BH.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLeng%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DQ.%2BH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLoh%26aufirst%3DK.%2BP.%26atitle%3DControllable%2520deuteration%2520of%2520halogenated%2520compounds%2520by%2520photocatalytic%2520D2O%2520splitting%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D80%26epage%3D88%26doi%3D10.1038%2Fs41467-017-02551-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit84b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, Y.
Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, D. W.C.</span></span> <span> </span><span class="NLM_article-title">Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1126/science.aap9674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.aap9674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29123019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=1182-1187&author=Y.%0AY.+Lohauthor=K.+Nagaoauthor=A.+J.+Hooverauthor=D.+Heskauthor=N.+R.+Riveraauthor=S.+L.+Collettiauthor=I.+W.+Daviesauthor=D.+W.C.+MacMillan&title=Photoredox-catalyzed+deuteration+and+tritiation+of+pharmaceutical+compounds&doi=10.1126%2Fscience.aap9674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84bR"><div class="casContent"><span class="casTitleNuber">84b</span><div class="casTitle"><span class="NLM_cas:atitle">Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds</span></div><div class="casAuthors">Loh, Yong Yao; Nagao, Kazunori; Hoover, Andrew J.; Hesk, David; Rivera, Nelo R.; Colletti, Steven L.; Davies, Ian W.; MacMillan, David W. C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">6367</span>),
    <span class="NLM_cas:pages">1182-1187</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Deuterium- and tritium-labeled pharmaceutical compds. are pivotal diagnostic tools in drug discovery research, providing vital information about the biol. fate of drugs and drug metabolites.  Herein we demonstrate that a photoredox-mediated hydrogen atom transfer protocol can efficiently and selectively install deuterium (D) and tritium (T) at α-amino sp3 carbon-hydrogen bonds in a single step, using isotopically labeled water (D2O or T2O) as the source of hydrogen isotope.  In this context, we also report a convenient synthesis of T2O from T2, providing access to high-specific-activity T2O.  This protocol has been successfully applied to the high incorporation of deuterium and tritium in 18 drug mols., which meet the requirements for use in ligand-binding assays and absorption, distribution, metab., and excretion studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8CqSF3I-fbVg90H21EOLACvtfcHk0lhopRIr5tphow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73L&md5=5897756ff395dd790e5a3b7f587f5c64</span></div><a href="/servlet/linkout?suffix=cit84b&amp;dbid=16384&amp;doi=10.1126%2Fscience.aap9674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aap9674%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DY.%2BY.%26aulast%3DNagao%26aufirst%3DK.%26aulast%3DHoover%26aufirst%3DA.%2BJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DRivera%26aufirst%3DN.%2BR.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.C.%26atitle%3DPhotoredox-catalyzed%2520deuteration%2520and%2520tritiation%2520of%2520pharmaceutical%2520compounds%26jtitle%3DScience%26date%3D2017%26volume%3D358%26spage%3D1182%26epage%3D1187%26doi%3D10.1126%2Fscience.aap9674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thulasiram, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulter, C. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of deuterium-labeled derivatives of dimethylallyl diphosphate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1741</span>, <span class="refDoi"> DOI: 10.1021/jo052384n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052384n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1739-1741&author=H.+V.+Thulasiramauthor=R.+M.+Phanauthor=S.+B.+Riveraauthor=C.+D.+Poulter&title=Synthesis+of+deuterium-labeled+derivatives+of+dimethylallyl+diphosphate&doi=10.1021%2Fjo052384n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Deuterium-Labeled Derivatives of Dimethylallyl Diphosphate</span></div><div class="casAuthors">Thulasiram, Hirekodathakallu V.; Phan, Richard M.; Rivera, Susan B.; Poulter, C. Dale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1739-1741</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Short practical syntheses for five deuterium-labeled derivs. of dimethylallyl diphosphate (DMAPP) useful for enzymol. studies are reported.  These include the prepn. of the C1-labeled derivs. (R)-[1-2H]3-methylbut-2-enyl diphosphate ((R)-[1-2H]1-OPP) and (S)-[1-2H]3-methylbut-2-enyl diphosphate ((S)-[1-2H]1-OPP), the C2-labeled deriv. [2-2H]3-methylbut-2-enyl diphosphate ([2-2H]1-OPP), and the methyl-labeled derivs. (E)-[4,4,4-2H3]3-methylbut-2-enyl diphosphate ((E)-[4,4,4-2H3]1-OPP) and (Z)-[4,4,4-2H3]3-methyl-but-2-enyl diphosphate ((Z)-[4,4,4-2H3]1-OPP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_m6zukyilG7Vg90H21EOLACvtfcHk0lhopRIr5tphow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWlsw%253D%253D&md5=437dff76a4aeae7d87bcec6105c185e2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjo052384n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052384n%26sid%3Dliteratum%253Aachs%26aulast%3DThulasiram%26aufirst%3DH.%2BV.%26aulast%3DPhan%26aufirst%3DR.%2BM.%26aulast%3DRivera%26aufirst%3DS.%2BB.%26aulast%3DPoulter%26aufirst%3DC.%2BD.%26atitle%3DSynthesis%2520of%2520deuterium-labeled%2520derivatives%2520of%2520dimethylallyl%2520diphosphate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1739%26epage%3D1741%26doi%3D10.1021%2Fjo052384n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, A.</span></span> <span> </span><span class="NLM_article-title">Hydrogen/Deuterium (H/D) exchange catalysis in alkanes</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2312</span>, <span class="refDoi"> DOI: 10.1021/acscatal.7b04201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.7b04201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=2296-2312&author=A.+Sattler&title=Hydrogen%2FDeuterium+%28H%2FD%29+exchange+catalysis+in+alkanes&doi=10.1021%2Facscatal.7b04201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen/Deuterium (H/D) Exchange Catalysis in Alkanes</span></div><div class="casAuthors">Sattler, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2296-2312</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The catalytic exchange of hydrogen and deuterium (H/D exchange) in light alkanes has been studied for almost a century.  While alkanes and their C-H bonds are relatively inert, H/D exchange studies have shown that a large no. of materials can catalytically activate these bonds.  These studies helped elucidate the mechanisms by which alkane C-H bonds interact with catalytic materials.  This perspective serves to review this area of research, focusing on two main classes of heterogeneous materials, metals and metal oxides, and their trends in reactivities and selectivities are described in detail.  Furthermore, the ability of these materials to carry out C-H bond activation and H/D exchange catalysis is compared with that of mol. organometallic complexes, and the mechanistic relationships and similarities in these processes are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5r5ybp23TbVg90H21EOLACvtfcHk0lg-tYs6LqPcgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCju78%253D&md5=6b760852f6baad8d4fd46a028aaf446d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facscatal.7b04201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.7b04201%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DA.%26atitle%3DHydrogen%252FDeuterium%2520%2528H%252FD%2529%2520exchange%2520catalysis%2520in%2520alkanes%26jtitle%3DACS%2520Catal.%26date%3D2018%26volume%3D8%26spage%3D2296%26epage%3D2312%26doi%3D10.1021%2Facscatal.7b04201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span> <span> </span><span class="NLM_article-title">Pd- and Pt-catalyzed H/D exchange methods and their application for internal MS standard preparation from a Sanofi-Aventis perspective</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1002/jlcr.1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fjlcr.1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1SjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=674-685&author=J.+Atzrodtauthor=V.+Derdau&title=Pd-+and+Pt-catalyzed+H%2FD+exchange+methods+and+their+application+for+internal+MS+standard+preparation+from+a+Sanofi-Aventis+perspective&doi=10.1002%2Fjlcr.1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Pd- and Pt-catalyzed H/D exchange methods and their application for internal MS standard preparation from a Sanofi-Aventis perspective</span></div><div class="casAuthors">Atzrodt, Jens; Derdau, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">674-685</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">This review addresses method developments both homogeneous and heterogeneous Pd- and Pt-catalyzed exchange, including catalyst activation principles and recent practical applications together with example procedures.  Specific requirements for isotopically labeled internal MS std. prepn. are discussed from a Sanofi-Aventis perspective on recent examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfpdKfsKZvh7Vg90H21EOLACvtfcHk0lg-tYs6LqPcgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1SjsA%253D%253D&md5=7cb25562f3949122991f6b6aa776e73f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1818%26sid%3Dliteratum%253Aachs%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26atitle%3DPd-%2520and%2520Pt-catalyzed%2520H%252FD%2520exchange%2520methods%2520and%2520their%2520application%2520for%2520internal%2520MS%2520standard%2520preparation%2520from%2520a%2520Sanofi-Aventis%2520perspective%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2010%26volume%3D53%26spage%3D674%26epage%3D685%26doi%3D10.1002%2Fjlcr.1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yung, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, R. G.</span></span> <span> </span><span class="NLM_article-title">Stoichiometric and catalytic H/D incorporation by cationic iridium complexes:  a common monohydrido-iridium intermediate</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">13033</span>– <span class="NLM_lpage">13043</span>, <span class="refDoi"> DOI: 10.1021/ja046825g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja046825g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlOjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=13033-13043&author=C.+M.+Yungauthor=M.+B.+Skaddanauthor=R.+G.+Bergman&title=Stoichiometric+and+catalytic+H%2FD+incorporation+by+cationic+iridium+complexes%3A%E2%80%89+a+common+monohydrido-iridium+intermediate&doi=10.1021%2Fja046825g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88aR"><div class="casContent"><span class="casTitleNuber">88a</span><div class="casTitle"><span class="NLM_cas:atitle">Stoichiometric and Catalytic H/D Incorporation by Cationic Iridium Complexes: A Common Monohydrido-Iridium Intermediate</span></div><div class="casAuthors">Yung, Cathleen M.; Skaddan, Marc B.; Bergman, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">13033-13043</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mechanistic study of the stoichiometric and catalytic H/D exchange reactions involving cationic iridium complexes is presented.  Strong evidence suggests that both stoichiometric and catalytic reactions proceed via a monohydrido-iridium species.  Stoichiometric deuterium incorporation reactions introduce multiple deuterium atoms into the org. products when aryliridium compds. Cp*PMe3Ir(C6H4X)(OTf) (X = H, o-CH3, m-CH3, p-CH3) react with D2.  Multiple deuteration occurs at the unhindered positions (para and meta) of toluene, when X = CH3.  The multiple-deuteration pathway is suppressed in the presence of an excess of the coordinating ligand, CH3CN.  The compd. Cp*PMe3IrH(OTf) (1-OTf) is obsd. in low-temp., stoichiometric expts. to support a monohydrido-iridium intermediate that is responsible for catalyzing multiple deuteration in the stoichiometric system.  When paired with acetone-d6, [Cp*PMe3IrH3][OTf] (4)catalytically deuterates a wide range of substrates with a variety of functional groups.  Catalyst 4 decomps. to [Cp*PMe3Ir(η3-CH2C(OH)CH2)][OTf] in acetone and to [Cp*PMe3IrH(CO)][OTf] in CH3OH.  The catalytic H/D exchange reaction is not catalyzed by simple H+ transfer, but instead proceeds by a reversible C-H bond activation mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqBh5IDNZQ4bVg90H21EOLACvtfcHk0lg-tYs6LqPcgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlOjsbs%253D&md5=cc791c061e7de018e91bd1fc24cd8ff8</span></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=10.1021%2Fja046825g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046825g%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DC.%2BM.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DBergman%26aufirst%3DR.%2BG.%26atitle%3DStoichiometric%2520and%2520catalytic%2520H%252FD%2520incorporation%2520by%2520cationic%2520iridium%2520complexes%253A%25E2%2580%2589%2520a%2520common%2520monohydrido-iridium%2520intermediate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D13033%26epage%3D13043%26doi%3D10.1021%2Fja046825g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit88b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Iridium-catalyzed H/D exchange at vinyl groups without olefin isomerization</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5783</span>– <span class="NLM_lpage">5787</span>, <span class="refDoi"> DOI: 10.1002/anie.200801992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.200801992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVelsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5783-5787&author=J.+Zhouauthor=J.+F.+Hartwig&title=Iridium-catalyzed+H%2FD+exchange+at+vinyl+groups+without+olefin+isomerization&doi=10.1002%2Fanie.200801992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88bR"><div class="casContent"><span class="casTitleNuber">88b</span><div class="casTitle"><span class="NLM_cas:atitle">Iridium-catalyzed H/D exchange at vinyl groups without olefin isomerization</span></div><div class="casAuthors">Zhou, Jianrong; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5783-5787</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The title reaction represents a rare example of olefinic C-H activation without olefin isomerization.  The conditions are sufficiently mild so that functional groups such as ketones, esters, nitriles, amines, sulfides, and alcs. are tolerated.  This selectivity is demonstrated by deuterium labeling of several complex mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqlvqgRi3M1LVg90H21EOLACvtfcHk0lg-tYs6LqPcgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVelsLw%253D&md5=4f56325a45a0fb7cbcb71f55c5bd8829</span></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=10.1002%2Fanie.200801992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200801992%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DIridium-catalyzed%2520H%252FD%2520exchange%2520at%2520vinyl%2520groups%2520without%2520olefin%2520isomerization%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D5783%26epage%3D5787%26doi%3D10.1002%2Fanie.200801992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, S.</span></span> <span> </span><span class="NLM_article-title">Ruthenium catalyzed deuterium labelling of α-carbon in primary alcohol and primary/secondary amine in D<sub>2</sub>O</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">192</span>, <span class="refDoi"> DOI: 10.1246/cl.2005.192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1246%2Fcl.2005.192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2005&pages=192&author=M.+Takahashiauthor=K.+Oshimaauthor=S.+Matsubara&title=Ruthenium+catalyzed+deuterium+labelling+of+%CE%B1-carbon+in+primary+alcohol+and+primary%2Fsecondary+amine+in+D2O&doi=10.1246%2Fcl.2005.192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89aR"><div class="casContent"><span class="casTitleNuber">89a</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium catalyzed deuterium labeling of α-carbon in primary alcohol and primary/secondary amine in D2O</span></div><div class="casAuthors">Takahashi, Masaaki; Oshima, Koichiro; Matsubara, Seijiro</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">192-193</span>CODEN:
                <span class="NLM_cas:coden">CMLTAG</span>;
        ISSN:<span class="NLM_cas:issn">0366-7022</span>.
    
            (<span class="NLM_cas:orgname">Chemical Society of Japan</span>)
        </div><div class="casAbstract">Primary alcs. and primary/secondary amines are labeled with deuterium atom at α-position regioselectively by means of deuterium oxide and ruthenium catalyst.  For example, the microwave-mediated ruthenium-catalyzed deuteration of (1S,2S,5S)-6,6-dimethylbicyclo[3.1.1]heptane-2-methanol (myrtanol) gave (1S,2S,5S)-6,6-dimethylbicyclo[3.1.1]heptane-2-methan-α,α-d2-ol.  Deuteration at the β-position could be suppressed, if the reaction was carried out below 100° with the use of microwaves.  In the case of primary amines H-D-exchange was obsd. at the α-position selectively. a work-up with NaOD gave high contents of deuterium on nitrogen as well.  H-D-exchange on a tertiary amine gave only a small amt. of exchanged product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoS8VI0DMVgbVg90H21EOLACvtfcHk0lhKPPtvHTqPGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCisr0%253D&md5=bc69130e9c7543884da4050e3c12155d</span></div><a href="/servlet/linkout?suffix=cit89a&amp;dbid=16384&amp;doi=10.1246%2Fcl.2005.192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.2005.192%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DMatsubara%26aufirst%3DS.%26atitle%3DRuthenium%2520catalyzed%2520deuterium%2520labelling%2520of%2520%25CE%25B1-carbon%2520in%2520primary%2520alcohol%2520and%2520primary%252Fsecondary%2520amine%2520in%2520D2O%26jtitle%3DChem.%2520Lett.%26date%3D2005%26volume%3D34%26spage%3D192%26doi%3D10.1246%2Fcl.2005.192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit89b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beller, M.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed selective α,β-deuteration of bioactive amines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">12239</span>– <span class="NLM_lpage">12244</span>, <span class="refDoi"> DOI: 10.1021/ja3041338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3041338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=12239-12244&author=L.+Neubertauthor=D.+Michalikauthor=S.+Bahnauthor=S.+Immauthor=H.+Neumannauthor=J.+Atzrodtauthor=V.+Derdauauthor=W.+Hollaauthor=M.+Beller&title=Ruthenium-catalyzed+selective+%CE%B1%2C%CE%B2-deuteration+of+bioactive+amines&doi=10.1021%2Fja3041338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89bR"><div class="casContent"><span class="casTitleNuber">89b</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Selective α,β-Deuteration of Bioactive Amines</span></div><div class="casAuthors">Neubert, Lorenz; Michalik, Dirk; Baehn, Sebastian; Imm, Sebastian; Neumann, Helfried; Atzrodt, Jens; Derdau, Volker; Holla, Wolfgang; Beller, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">12239-12244</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel and convenient protocol for the catalytic hydrogen-deuterium exchange of biol. active tertiary amines using the borrowing hydrogen methodol. has been developed.  In the presence of the readily available Shvo catalyst, excellent chemoselectivity toward α- and β-protons with respect to the nitrogen atom as well as high degree of deuterium incorporation and functional group tolerance is achieved.  This allowed for the deuteration of complex pharmaceutically interesting substrates, including examples for actual marketed drug compds.  Notably, this method constitutes a powerful tool for the generation of valuable internal std. materials for LC-MS/MS analyses highly demanded for various life-science applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCbbBCFEhJobVg90H21EOLACvtfcHk0lhKPPtvHTqPGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmtrY%253D&md5=83d0827f35573bc1c507dbbcf8f9ea4b</span></div><a href="/servlet/linkout?suffix=cit89b&amp;dbid=16384&amp;doi=10.1021%2Fja3041338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3041338%26sid%3Dliteratum%253Aachs%26aulast%3DNeubert%26aufirst%3DL.%26aulast%3DMichalik%26aufirst%3DD.%26aulast%3DBahn%26aufirst%3DS.%26aulast%3DImm%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DH.%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DHolla%26aufirst%3DW.%26aulast%3DBeller%26aufirst%3DM.%26atitle%3DRuthenium-catalyzed%2520selective%2520%25CE%25B1%252C%25CE%25B2-deuteration%2520of%2520bioactive%2520amines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D12239%26epage%3D12244%26doi%3D10.1021%2Fja3041338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit89c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span> <span> </span><span class="NLM_article-title">A convenient and effective method for the regioselective deuteration of alcohols</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2218</span>, <span class="refDoi"> DOI: 10.1002/adsc.200800407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fadsc.200800407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2008&pages=2215-2218&author=T.+Maegawaauthor=Y.+Fujiwaraauthor=Y.+Inagakiauthor=Y.+Monguchiauthor=H.+Sajiki&title=A+convenient+and+effective+method+for+the+regioselective+deuteration+of+alcohols&doi=10.1002%2Fadsc.200800407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89cR"><div class="casContent"><span class="casTitleNuber">89c</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient and effective method for the regioselective deuteration of alcohols</span></div><div class="casAuthors">Maegawa, Tomohiro; Fujiwara, Yuta; Inagaki, Yuya; Monguchi, Yasunari; Sajiki, Hironao</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">14+15</span>),
    <span class="NLM_cas:pages">2215-2218</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The convenient and regioselective deuteration of hydroxy groups on vicinal carbons was achieved by the combination of 5% ruthenium on carbon (Ru/C), hydrogen gas and deuterium oxide (D2O).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmZ-_j8k9M7Vg90H21EOLACvtfcHk0lhKPPtvHTqPGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjs7zI&md5=8220f072ac5590b8344da2f698e620bf</span></div><a href="/servlet/linkout?suffix=cit89c&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200800407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200800407%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DMonguchi%26aufirst%3DY.%26aulast%3DSajiki%26aufirst%3DH.%26atitle%3DA%2520convenient%2520and%2520effective%2520method%2520for%2520the%2520regioselective%2520deuteration%2520of%2520alcohols%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2008%26volume%3D350%26spage%3D2215%26epage%3D2218%26doi%3D10.1002%2Fadsc.200800407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Boun, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-Q.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed ortho-selective C-H deuteration of arenes: evidence for superior reactivity of weakly coordinated palladacycles</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1002/anie.201305388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.201305388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOhsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=734-737&author=S.+Maauthor=G.+Villaauthor=P.+S.+Thuy-Bounauthor=A.+Homsauthor=J.-Q.+Yu&title=Palladium-catalyzed+ortho-selective+C-H+deuteration+of+arenes%3A+evidence+for+superior+reactivity+of+weakly+coordinated+palladacycles&doi=10.1002%2Fanie.201305388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90aR"><div class="casContent"><span class="casTitleNuber">90a</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed ortho-Selective C-H Deuteration of Arenes: Evidence for Superior Reactivity of Weakly Coordinated Palladacycles</span></div><div class="casAuthors">Ma, Sandy; Villa, Giorgio; Thuy-Boun, Peter S.; Homs, Anna; Yu, Jin-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">734-737</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We disclose a protocol for the palladium-catalyzed ortho-selective C-H deuteration of arenes.  Phenylacetic acids and benzoic acids are suitable substrates for this reaction.  This reaction offers a catalytic route to ortho-deuterated phenylacetic acids and benzoic acids and demonstrates the sharp difference in reactivity of palladacycle intermediates held together by weak and strong coordination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJvGaB7OeZF7Vg90H21EOLACvtfcHk0lhz2jSa-v6ZAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOhsLbK&md5=a2a7f70d33b75a62b79a8161f81245ad</span></div><a href="/servlet/linkout?suffix=cit90a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201305388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201305388%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DG.%26aulast%3DThuy-Boun%26aufirst%3DP.%2BS.%26aulast%3DHoms%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.-Q.%26atitle%3DPalladium-catalyzed%2520ortho-selective%2520C-H%2520deuteration%2520of%2520arenes%253A%2520evidence%2520for%2520superior%2520reactivity%2520of%2520weakly%2520coordinated%2520palladacycles%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D734%26epage%3D737%26doi%3D10.1002%2Fanie.201305388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit90b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span> <span> </span><span class="NLM_article-title">Efficient C–H/C–D exchange reaction on the alkyl side chain of aromatic compounds using heterogeneous Pd/C in D<sub>2</sub>O</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1485</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1021/ol0496374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0496374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitl2qsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1485-1487&author=H.+Sajikiauthor=F.+Aokiauthor=H.+Esakiauthor=T.+Maegawaauthor=K.+Hirota&title=Efficient+C%E2%80%93H%2FC%E2%80%93D+exchange+reaction+on+the+alkyl+side+chain+of+aromatic+compounds+using+heterogeneous+Pd%2FC+in+D2O&doi=10.1021%2Fol0496374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90bR"><div class="casContent"><span class="casTitleNuber">90b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient C-H/C-D Exchange Reaction on the Alkyl Side Chain of Aromatic Compounds Using Heterogeneous Pd/C in D2O</span></div><div class="casAuthors">Sajiki, Hironao; Aoki, Fumiyo; Esaki, Hiroyoshi; Maegawa, Tomohiro; Hirota, Kosaku</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1485-1487</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient and extensive deuterium incorporation using heterogeneous Pd/C-D2O-H2 system into many different types of unactivated C-H bond positions was developed.  The present method provides a deuterium gas-free, totally catalytic, and post-synthetic deuterium labeling method in D2O media.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovG5xvSTvc57Vg90H21EOLACvtfcHk0lhz2jSa-v6ZAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitl2qsLs%253D&md5=9de0ad361005195046893eacb4c6214b</span></div><a href="/servlet/linkout?suffix=cit90b&amp;dbid=16384&amp;doi=10.1021%2Fol0496374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0496374%26sid%3Dliteratum%253Aachs%26aulast%3DSajiki%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DF.%26aulast%3DEsaki%26aufirst%3DH.%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DEfficient%2520C%25E2%2580%2593H%252FC%25E2%2580%2593D%2520exchange%2520reaction%2520on%2520the%2520alkyl%2520side%2520chain%2520of%2520aromatic%2520compounds%2520using%2520heterogeneous%2520Pd%252FC%2520in%2520D2O%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D1485%26epage%3D1487%26doi%3D10.1021%2Fol0496374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maesawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span> <span> </span><span class="NLM_article-title">Aromatic ring favorable and efficient H–D exchange reaction catalyzed by Pt/C</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6995</span>– <span class="NLM_lpage">6998</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2005.08.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.tetlet.2005.08.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVSnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=6995-6998&author=H.+Sajikiauthor=N.+Itoauthor=H.+Esakiauthor=T.+Maesawaauthor=T.+Maegawaauthor=K.+Hirota&title=Aromatic+ring+favorable+and+efficient+H%E2%80%93D+exchange+reaction+catalyzed+by+Pt%2FC&doi=10.1016%2Fj.tetlet.2005.08.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic ring favorable and efficient H-D exchange reaction catalyzed by Pt/C</span></div><div class="casAuthors">Sajiki, Hironao; Ito, Nobuhiro; Esaki, Hiroyoshi; Maesawa, Tsuneaki; Maegawa, Tomohiro; Hirota, Kosaku</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6995-6998</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An effective and applicable Pt/C-catalyzed deuteration method of arom. rings using D2O as a deuterium source under hydrogen atm. was developed.  Five percent Pt/C would lead to quite effective H-D exchange results on the arom. ring systems.  The reaction is general for a variety of arom. compds. including biol. active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo06277ll_RdbVg90H21EOLACvtfcHk0lhz2jSa-v6ZAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVSnu7w%253D&md5=73f0a8ecebc1ba74a83723c676f3125a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.08.067%26sid%3Dliteratum%253Aachs%26aulast%3DSajiki%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DEsaki%26aufirst%3DH.%26aulast%3DMaesawa%26aufirst%3DT.%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DAromatic%2520ring%2520favorable%2520and%2520efficient%2520H%25E2%2580%2593D%2520exchange%2520reaction%2520catalyzed%2520by%2520Pt%252FC%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D6995%26epage%3D6998%26doi%3D10.1016%2Fj.tetlet.2005.08.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span>; <span class="NLM_string-name">Cottrell, K. M.</span>; <span class="NLM_string-name">Deng, H.</span>; <span class="NLM_string-name">Duffy, J.
P.</span>; <span class="NLM_string-name">Gao, H.</span>; <span class="NLM_string-name">Giroux, S.</span>; <span class="NLM_string-name">Green, J.</span>; <span class="NLM_string-name">Jackson, K. L.</span>; <span class="NLM_string-name">Kennedy, J. M.</span>; <span class="NLM_string-name">Lauffer, D. J.</span>; <span class="NLM_string-name">Ledeboer, M. W.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Maxwell, J. P.</span>; <span class="NLM_string-name">Morris, M. A.</span>; <span class="NLM_string-name">Pierce, A. C.</span>; <span class="NLM_string-name">Waal, N. D.</span>; <span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">DNA-PK Inhibitors</span>. U.S. Patent <span class="NLM_patent">9,925,188</span>, March 27, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+S.+Charifson&author=K.+M.+Cottrell&author=H.+Deng&author=J.%0AP.+Duffy&author=H.+Gao&author=S.+Giroux&author=J.+Green&author=K.+L.+Jackson&author=J.+M.+Kennedy&author=D.+J.+Lauffer&author=M.+W.+Ledeboer&author=P.+Li&author=J.+P.+Maxwell&author=M.+A.+Morris&author=A.+C.+Pierce&author=N.+D.+Waal&author=J.+Xu&title=DNA-PK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DDNA-PK%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R.-G.</span>; <span class="NLM_string-name">Stabingis, T.</span></span> <span> </span><span class="NLM_article-title">Deuterated 3-Piperidinopropiophenone and Medicaments Containing Said Compounds</span>. Eur. Pat. Appl. <span class="NLM_patent">1383752</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.-G.+Alken&author=T.+Stabingis&title=Deuterated+3-Piperidinopropiophenone+and+Medicaments+Containing+Said+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlken%26aufirst%3DR.-G.%26atitle%3DDeuterated%25203-Piperidinopropiophenone%2520and%2520Medicaments%2520Containing%2520Said%2520Compounds%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gant, T. G.</span>; <span class="NLM_string-name">Sarshar, S.</span></span> <span> </span><span class="NLM_article-title">Methods of Reduction of Interpatient Variability</span>. U.S. Patent <span class="NLM_patent">0,076,087</span>, March 25, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+G.+Gant&author=S.+Sarshar&title=Methods+of+Reduction+of+Interpatient+Variability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGant%26aufirst%3DT.%2BG.%26atitle%3DMethods%2520of%2520Reduction%2520of%2520Interpatient%2520Variability%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><a href="http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1-clinical-trial-ctp-354" class="extLink">http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1-clinical-trial-ctp-354</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fir.concertpharma.com%2Fnews-releases%2Fnews-release-details%2Fconcert-pharmaceuticals-initiates-phase-1-clinical-trial-ctp-354+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><a href="https://www.tevapharm.com/files/pipeline/Public_pipeline_Feb2017.pdf" class="extLink">https://www.tevapharm.com/files/pipeline/Public_pipeline_Feb2017.pdf</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.tevapharm.com%2Ffiles%2Fpipeline%2FPublic_pipeline_Feb2017.pdf+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><a href="http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1b-clinical-trial-ctp" class="extLink">http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1b-clinical-trial-ctp</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fir.concertpharma.com%2Fnews-releases%2Fnews-release-details%2Fconcert-pharmaceuticals-initiates-phase-1b-clinical-trial-ctp+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><a href="http://ir.concertpharma.com/static-files/9dddc59a-d13d-4c64-86e5-d343562fda1b" class="extLink">http://ir.concertpharma.com/static-files/9dddc59a-d13d-4c64-86e5-d343562fda1b</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fir.concertpharma.com%2Fstatic-files%2F9dddc59a-d13d-4c64-86e5-d343562fda1b+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><a href="https://adisinsight.springer.com/trials/700276018" class="extLink">https://adisinsight.springer.com/trials/700276018</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fadisinsight.springer.com%2Ftrials%2F700276018+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><a href="https://www.businesswire.com/news/home/20081023005201/en/Auspex-Pharmaceuticals-Announces-Positive-Results-Clinical-Study" class="extLink">https://www.businesswire.com/news/home/20081023005201/en/Auspex-Pharmaceuticals-Announces-Positive-Results-Clinical-Study</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20081023005201%2Fen%2FAuspex-Pharmaceuticals-Announces-Positive-Results-Clinical-Study+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><a href="https://www.sec.gov/Archives/edgar/data/1454189/000156459015001726/aspx-ex991_2015031628.htm" class="extLink">https://www.sec.gov/Archives/edgar/data/1454189/000156459015001726/aspx-ex991_2015031628.htm</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1454189%2F000156459015001726%2Faspx-ex991_2015031628.htm+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><a href="https://www.concertpharma.com/product-pipeline/" class="extLink">https://www.concertpharma.com/product-pipeline/</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.concertpharma.com%2Fproduct-pipeline%2F+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxybutyric Acid Analogs</span>. U.S. Patent <span class="NLM_patent">9,815,763</span>, November 14, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+D.+Tung&title=4-Hydroxybutyric+Acid+Analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTung%26aufirst%3DR.%2BD.%26atitle%3D4-Hydroxybutyric%2520Acid%2520Analogs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. T.</span>; <span class="NLM_string-name">Cassella, J. V.</span>; <span class="NLM_string-name">Graham, P. B.</span>; <span class="NLM_string-name">Braman, V.</span>, <span class="NLM_string-name">Uttamsingh, V.</span>; <span class="NLM_string-name">Von Hehn, J.</span>; <span class="NLM_string-name">Hamilton, C. E.</span></span> <span> </span><span class="NLM_article-title">Treatment of Hair Loss Disorders with Deuterated JAK Inhibitors</span>. WO Patent <span class="NLM_patent">192,905</span>, September 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+T.+Wagner&author=J.+V.+Cassella&author=P.+B.+Graham&author=V.+Braman&author=V.+Uttamsingh&author=J.+Von+Hehn&author=C.+E.+Hamilton&title=Treatment+of+Hair+Loss+Disorders+with+Deuterated+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DA.%2BT.%26atitle%3DTreatment%2520of%2520Hair%2520Loss%2520Disorders%2520with%2520Deuterated%2520JAK%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span> <span> </span><span class="NLM_article-title">Deuterated Isoindoline-1,3-Dione Derivatives as PDE4 and TNF-Alpha Inhibitors</span>. Eur. Pat. Appl. <span class="NLM_patent">2690092</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+F.+Liu&title=Deuterated+Isoindoline-1%2C3-Dione+Derivatives+as+PDE4+and+TNF-Alpha+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26atitle%3DDeuterated%2520Isoindoline-1%252C3-Dione%2520Derivatives%2520as%2520PDE4%2520and%2520TNF-Alpha%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julie, F.</span>; <span class="NLM_string-name">Liu, J.
F.</span>; <span class="NLM_string-name">Dong, Y.</span></span> <span> </span><span class="NLM_article-title">Deuterated Pirfenidone</span>. U.S. Patent <span class="NLM_patent">0,131,485</span>, May 21, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=F.+Julie&author=J.%0AF.+Liu&author=Y.+Dong&title=Deuterated+Pirfenidone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJulie%26aufirst%3DF.%26atitle%3DDeuterated%2520Pirfenidone%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masse, C. E.</span></span> <span> </span><span class="NLM_article-title">Deuterated 2-Amino-3-hydroxypropanoic Acid Derivatives</span>. U.S. Patent <span class="NLM_patent">8,704,001</span>, April 22, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+E.+Masse&title=Deuterated+2-Amino-3-hydroxypropanoic+Acid+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMasse%26aufirst%3DC.%2BE.%26atitle%3DDeuterated%25202-Amino-3-hydroxypropanoic%2520Acid%2520Derivatives%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spiteller, G.</span></span> <span> </span><span class="NLM_article-title">Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0009-3084(98)00091-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0009-3084%2898%2900091-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=9853364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=105-162&author=G.+Spiteller&title=Linoleic+acid+peroxidation%2D%2Dthe+dominant+lipid+peroxidation+process+in+low+density+lipoprotein%2D%2Dand+its+relationship+to+chronic+diseases&doi=10.1016%2FS0009-3084%2898%2900091-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Linoleic acid peroxidation - the dominant lipid peroxidation process in low density lipoprotein - and its relationship to chronic diseases</span></div><div class="casAuthors">Spiteller, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-162</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with ∼550 refs.  Modern sepn. and identification methods enable detailed insight in lipid peroxidn. (LPO) processes.  The following deductions can be made:.  (1) Cell injury activates enzymes: lipoxygenases generate lipid hydroperoxides (LOOHs), proteases liberate Fe ions - these two processes are prerequisites to produce radicals.  (2) Radicals attack any activated CH2-group of polyunsatd. fatty acids (PUFAs) with about a similar probability.  Since linoleic acid (LA) is the most abundant PUFA in mammals, its LPO products dominate.  (3) LOOHs are easily reduced in biol. surroundings to corresponding hydroxy acids (LOHs).  LOHs derived from LA, hydroxyoctadecadienoic acids (HODEs), surmount other markers of LPO.  HODEs are of high physiol. relevance.  (4) In some diseases characterized by inflammation or cell injury HODEs are present in low d. lipoproteins (LDL) at 10-100 higher concn., compared to LDL from healthy individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1T1V74IFAbVg90H21EOLACvtfcHk0lhVjebUiESSmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWgtL4%253D&md5=23e0ba4cce9a16e5f110571c3aab03d0</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2FS0009-3084%2898%2900091-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-3084%252898%252900091-7%26sid%3Dliteratum%253Aachs%26aulast%3DSpiteller%26aufirst%3DG.%26atitle%3DLinoleic%2520acid%2520peroxidation--the%2520dominant%2520lipid%2520peroxidation%2520process%2520in%2520low%2520density%2520lipoprotein--and%2520its%2520relationship%2520to%2520chronic%2520diseases%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D1998%26volume%3D95%26spage%3D105%26epage%3D162%26doi%3D10.1016%2FS0009-3084%2898%2900091-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. A.</span></span> <span> </span><span class="NLM_article-title">Free radical lipid peroxidation: mechanisms and analysis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">5944</span>– <span class="NLM_lpage">5972</span>, <span class="refDoi"> DOI: 10.1021/cr200084z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200084z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=5944-5972&author=H.+Yinauthor=L.+Xuauthor=N.+A.+Porter&title=Free+radical+lipid+peroxidation%3A+mechanisms+and+analysis&doi=10.1021%2Fcr200084z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Free Radical Lipid Peroxidation: Mechanisms and Analysis</span></div><div class="casAuthors">Yin, Huiyong; Xu, Libin; Porter, Ned A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5944-5972</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is the aim of this Review to discuss the chem. assocd. with each of the steps of the free radical chain sequence in the reaction of lipids and mol. oxygen.  The primary reactions of lipid peroxidn. include hydrogen-atom abstraction by peroxyl or alkoxyl radicals; oxygen addn. to carbon radicals; peroxyl radical fragmentation or rearrangement; peroxyl radical addn. to carbon-carbon double bonds or cyclization; and peroxylperoxyl termination.  There are a no. of reviews of lipid peroxidn. that have appeared in recent years, particularly related to the biol. of lipid oxidn. products.  We focus here principally on the basic free radical chem. of lipid peroxidn. and recent developments for the detection and anal. of free radical lipid peroxidn. products and their biol. relevance.  The anal. of lipid peroxidn. products has been particularly important in the advancement of research in this field because of the complexity of product mixts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqho2_FEY6sLrVg90H21EOLACvtfcHk0lgcFrvhfrYwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvM&md5=ffbd9a5547deb1b9e6d962f95d1a26a2</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fcr200084z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200084z%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26atitle%3DFree%2520radical%2520lipid%2520peroxidation%253A%2520mechanisms%2520and%2520analysis%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D5944%26epage%3D5972%26doi%3D10.1021%2Fcr200084z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning-Boğ, A. B.</span></span> <span> </span><span class="NLM_article-title">Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson’s disease</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2011.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.toxlet.2011.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21906664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2011&pages=97-103&author=M.+S.+Shchepinovauthor=V.+P.+Chouauthor=E.+Pollockauthor=J.+W.+Langstonauthor=C.+R.+Cantorauthor=R.+J.+Molinariauthor=A.+B.+Manning-Bo%C4%9F&title=Isotopic+reinforcement+of+essential+polyunsaturated+fatty+acids+diminishes+nigrostriatal+degeneration+in+a+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.toxlet.2011.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110aR"><div class="casContent"><span class="casTitleNuber">110a</span><div class="casTitle"><span class="NLM_cas:atitle">Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease</span></div><div class="casAuthors">Shchepinov, Mikhail S.; Chou, Vivian P.; Pollock, Erik; Langston, J. William; Cantor, Charles R.; Molinari, Robert J.; Manning-Bog, Amy B.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Oxidative damage of membrane polyunsatd. fatty acids (PUFA) is thought to play a major role in mitochondrial dysfunction related to Parkinson's disease (PD).  The toxic products formed by PUFA oxidn. inflict further damage on cellular components and contribute to neuronal degeneration.  Here, we tested the hypothesis that isotopic reinforcement, by deuteration of the bisallylic sites most susceptible to oxidn. in PUFA may provide at least partial protection against nigrostriatal injury in a mouse model of oxidative stress and cell death, the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model.  Mice were fed a fat-free diet supplemented with satd. acids, oleic acid and essential PUFA: either normal, hydrogenated linoleic (LA, 18:2n - 6) and α-linolenic (ALA, 18:3n - 3) or deuterated 11,11-D2-LA and 11,11,14,14-D4-ALA in a ratio of 1:1 (to a total of 10% mass fat) for 6 days; each group was divided into two cohorts receiving either MPTP or saline and then continued on resp. diets for 6 days.  Brain homogenates from mice receiving deuterated PUFA (D-PUFA) vs. hydrogenated PUFA (H-PUFA) demonstrated a significant incorporation of deuterium as measured by isotope ratio mass-spectrometry.  Following MPTP exposure, mice fed H-PUFA revealed 78.7% striatal dopamine (DA) depletion compared to a 46.8% redn. in the D-PUFA cohort (as compared to their resp. saline-treated controls), indicating a significant improvement in DA concn. with D-PUFA.  Similarly, higher levels of the DA metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) were detected in MPTP-exposure mice administered D-PUFA; however, saline-treated mice revealed no change in DA or DOPAC levels.  Western blot analyses of tyrosine hydroxylase (TH) confirmed neuroprotection with D-PUFA, as striatal homogenates showed higher levels of TH immunoreactivity in D-PUFA (88.5% control) vs. H-PUFA (50.4% control) in the MPTP-treated cohorts.  In the substantia nigra, a significant improvement was noted in the no. of nigral dopaminergic neurons following MPTP exposure in the D-PUFA (79.5% control) vs. H-PUFA (58.8% control) mice using unbiased stereol. cell counting.  Taken together, these findings indicate that dietary isotopic reinforcement with D-PUFA partially protects against nigrostriatal damage from oxidative injury elicited by MPTP in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZvaUEvBv5rVg90H21EOLACvtfcHk0lgcFrvhfrYwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt7zK&md5=c1753c25878a7fa974fe3e69daa75a46</span></div><a href="/servlet/linkout?suffix=cit110a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2011.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2011.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26aulast%3DChou%26aufirst%3DV.%2BP.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DLangston%26aufirst%3DJ.%2BW.%26aulast%3DCantor%26aufirst%3DC.%2BR.%26aulast%3DMolinari%26aufirst%3DR.%2BJ.%26aulast%3DManning-Bo%25C4%259F%26aufirst%3DA.%2BB.%26atitle%3DIsotopic%2520reinforcement%2520of%2520essential%2520polyunsaturated%2520fatty%2520acids%2520diminishes%2520nigrostriatal%2520degeneration%2520in%2520a%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DToxicol.%2520Lett.%26date%3D2011%26volume%3D207%26spage%3D97%26epage%3D103%26doi%3D10.1016%2Fj.toxlet.2011.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit110b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Elharram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czegledy, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golod, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer’s disease</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">4083</span>– <span class="NLM_lpage">4095</span>, <span class="refDoi"> DOI: 10.1111/febs.14291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1111%2Ffebs.14291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29024570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaltbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=4083-4095&author=A.+Elharramauthor=N.+M.+Czegledyauthor=M.+Golodauthor=G.+L.+Milneauthor=E.+Pollockauthor=B.+M.+Bennettauthor=M.+S.+Shchepinov&title=Deuterium-reinforced+polyunsaturated+fatty+acids+improve+cognition+in+a+mouse+model+of+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1111%2Ffebs.14291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110bR"><div class="casContent"><span class="casTitleNuber">110b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease</span></div><div class="casAuthors">Elharram, Ahmed; Czegledy, Nicole M.; Golod, Michael; Milne, Ginger L.; Pollock, Erik; Bennett, Brian M.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4083-4095</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Oxidative damage resulting from increased lipid peroxidn. (LPO) is considered an important factor in the development of late onset/age-related Alzheimer's disease (AD).  Deuterium-reinforced polyunsatd. fatty acids (D-PUFAs) are more resistant to the reactive oxygen species-initiated chain reaction of LPO than regular hydrogenated (H-) PUFAs.  The authors investigated the effect of D-PUFA treatment on LPO and cognitive performance in aldehyde dehydrogenase 2 (Aldh2) null mice, an established model of oxidative stress-related cognitive impairment that exhibits AD-like pathologies.  Mice were fed a Western-type diet contg. either D- or H-PUFAs for 18 wk.  D-PUFA treatment markedly decreased cortex and hippocampus F2-isoprostanes by approx. 55% and prostaglandin F2α by 20-25% as compared to H-PUFA treatment.  D-PUFAs consistently improved performance in cognitive/memory tests, essentially resetting performance of the D-PUFA-fed Aldh2-/- mice to that of wild-type mice fed a typical lab. diet.  D-PUFAs therefore represent a promising new strategy to broadly reduce rates of LPO, and combat cognitive decline in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGf_rv48oL7Vg90H21EOLACvtfcHk0lgcFrvhfrYwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaltbrO&md5=b800a84fa86cb85d08a623d71ba078c1</span></div><a href="/servlet/linkout?suffix=cit110b&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14291%26sid%3Dliteratum%253Aachs%26aulast%3DElharram%26aufirst%3DA.%26aulast%3DCzegledy%26aufirst%3DN.%2BM.%26aulast%3DGolod%26aufirst%3DM.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DDeuterium-reinforced%2520polyunsaturated%2520fatty%2520acids%2520improve%2520cognition%2520in%2520a%2520mouse%2520model%2520of%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D4083%26epage%3D4095%26doi%3D10.1111%2Ffebs.14291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit110c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Raefsky, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid beta-peptide levels, without discernible behavioural effects in an APP/PS1 mutant transgenic mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2018.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.neurobiolaging.2018.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29579687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlt1Sru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=165-176&author=S.+M.+Raefskyauthor=R.+Furmanauthor=G.+Milneauthor=E.+Pollockauthor=P.+Axelsenauthor=M.+P.+Mattsonauthor=M.+S.+Shchepinov&title=Deuterated+polyunsaturated+fatty+acids+reduce+brain+lipid+peroxidation+and+hippocampal+amyloid+beta-peptide+levels%2C+without+discernible+behavioural+effects+in+an+APP%2FPS1+mutant+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2018.02.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110cR"><div class="casContent"><span class="casTitleNuber">110c</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Raefsky, Sophia M.; Furman, Ran; Milne, Ginger; Pollock, Erik; Axelsen, Paul; Mattson, Mark P.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) involves progressive deposition of amyloid β-peptide (Aβ), synapse loss, and neuronal death, which occur in brain regions crit. for learning and memory.  Considerable evidence suggests that lipid peroxidn. contributes to synaptic dysfunction and neuronal degeneration, both upstream and downstream of Aβ pathol.  Recent findings suggest that lipid peroxidn. can be inhibited by replacement of polyunsatd. fatty acids (PUFA) with isotope-reinforced (deuterated) PUFA (D-PUFA), and that D-PUFA can protect neurons in exptl. models of Parkinson's disease.  Here, we detd. whether dietary D-PUFA would ameliorate Aβ pathol. and/or cognitive deficits in a mouse model of AD (amyloid precursor protein/presenilin 1 double mutant transgenic mice).  The D-PUFA diet did not ameliorate spatial learning and memory deficits in the AD mice.  Compared to mice fed an hydrogenated-PUFA control diet, those fed D-PUFA for 5 mo exhibited high levels of incorporation of deuterium into arachidonic acid and docosahexaenoic acid, and reduced concns. of lipid peroxidn. products (F2 isoprostanes and neuroprostanes), in the brain tissues.  Concns. of Aβ40 and Aβ38 in the hippocampus were significantly lower, with a trend to reduced concns. of Aβ42, in mice fed D-PUFA compared to those fed hydrogenated-PUFA.  We conclude that a D-PUFA diet reduces the brain tissue concns. of both arachidonic acid and docosahexaenoic acid oxidn. products, as well as the concn. of Aβs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRCOVwXpYgerVg90H21EOLACvtfcHk0lgcFrvhfrYwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlt1Sru70%253D&md5=3dbf86ac42adc8f45ba3f079b7e10c55</span></div><a href="/servlet/linkout?suffix=cit110c&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2018.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2018.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DRaefsky%26aufirst%3DS.%2BM.%26aulast%3DFurman%26aufirst%3DR.%26aulast%3DMilne%26aufirst%3DG.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DAxelsen%26aufirst%3DP.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DDeuterated%2520polyunsaturated%2520fatty%2520acids%2520reduce%2520brain%2520lipid%2520peroxidation%2520and%2520hippocampal%2520amyloid%2520beta-peptide%2520levels%252C%2520without%2520discernible%2520behavioural%2520effects%2520in%2520an%2520APP%252FPS1%2520mutant%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2018%26volume%3D66%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.neurobiolaging.2018.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit110d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Berbée, J. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mol, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lütjohann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rensen, P. C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Ploeg, L. H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2017.06.916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.atherosclerosis.2017.06.916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28655430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=2017&pages=100-107&author=J.+F.+P.+Berb%C3%A9eauthor=I.+M.+Molauthor=G.+L.+Milneauthor=E.+Pollockauthor=G.+Hoekeauthor=D.+L%C3%BCtjohannauthor=C.+Monacoauthor=P.+C.+N.+Rensenauthor=L.+H.+T.+van+der+Ploegauthor=M.+S.+Shchepinov&title=Deuterium-reinforced+polyunsaturated+fatty+acids+protect+against+atherosclerosis+by+lowering+lipid+peroxidation+and+hypercholesterolemia&doi=10.1016%2Fj.atherosclerosis.2017.06.916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110dR"><div class="casContent"><span class="casTitleNuber">110d</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia</span></div><div class="casAuthors">Berbee, Jimmy F. P.; Mol, Isabel M.; Milne, Ginger L.; Pollock, Erik; Hoeke, Geerte; Luetjohann, Dieter; Monaco, Claudia; Rensen, Patrick C. N.; van der Ploeg, Lex H. T.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxidative modification of lipoproteins is a crucial step in atherosclerosis development.  Isotopic-reinforced polyunsatd. fatty acids (D-PUFAs) are more resistant to reactive oxygen species-initiated chain reaction of lipid peroxidn. than regular hydrogenated (H-)PUFAs.  We aimed at investigating the effect of D-PUFA treatment on lipid peroxidn., hypercholesterolemia and atherosclerosis development.Transgenic APOE*3-Leiden.  CETP mice, a well-established model for human-like lipoprotein metab., were pre-treated with D-PUFAs or control H-PUFAs-contg. diet (1.2%, wt./wt.) for 4 wk.  Thereafter, mice were fed a Western-type diet (contg. 0.15% cholesterol, wt./wt.) for another 12 wk, while continuing the D-/H-PUFA treatment.  D-PUFA treatment markedly decreased hepatic and plasma F2-isoprostanes (approx. -80%) and prostaglandin F2α (approx. -40%) as compared to H-PUFA treatment.  Moreover, D-PUFAs reduced body wt. gain during the study (-54%) by decreasing body fat mass gain (-87%) without altering lean mass.  D-PUFAs consistently reduced plasma total cholesterol levels (approx. -25%), as reflected in reduced plasma non-HDL-cholesterol (-28%).  Addnl. analyses of hepatic cholesterol metab. indicated that D-PUFAs reduced the hepatic cholesterol content (-21%).  Sterol markers of intestinal cholesterol absorption and cholesterol breakdown were decreased.  Markers of cholesterol synthesis were increased.  Finally, D-PUFAs reduced atherosclerotic lesion area formation throughout the aortic root of the heart (-26%).  D-PUFAs reduce body wt. gain, improve cholesterol handling and reduce atherosclerosis development by reducing lipid peroxidn. and plasma cholesterol levels.  D-PUFAs, therefore, represent a promising new strategy to broadly reduce rates of lipid peroxidn., and combat hypercholesterolemia and cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsRc9Kipy7KLVg90H21EOLACvtfcHk0lji02DBw1YjtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7%252FF&md5=bbb5158d3fa757f86f8e158dff40906f</span></div><a href="/servlet/linkout?suffix=cit110d&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2017.06.916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2017.06.916%26sid%3Dliteratum%253Aachs%26aulast%3DBerb%25C3%25A9e%26aufirst%3DJ.%2BF.%2BP.%26aulast%3DMol%26aufirst%3DI.%2BM.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DHoeke%26aufirst%3DG.%26aulast%3DL%25C3%25BCtjohann%26aufirst%3DD.%26aulast%3DMonaco%26aufirst%3DC.%26aulast%3DRensen%26aufirst%3DP.%2BC.%2BN.%26aulast%3Dvan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%2BT.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DDeuterium-reinforced%2520polyunsaturated%2520fatty%2520acids%2520protect%2520against%2520atherosclerosis%2520by%2520lowering%2520lipid%2520peroxidation%2520and%2520hypercholesterolemia%26jtitle%3DAtherosclerosis%26date%3D2017%26volume%3D264%26spage%3D100%26epage%3D107%26doi%3D10.1016%2Fj.atherosclerosis.2017.06.916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit110e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abeti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renganathan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunti, P.</span></span> <span> </span><span class="NLM_article-title">Targeting lipid peroxidation and mitochondrial imbalance in Friedreich’s ataxia</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.phrs.2015.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=26141703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2015&pages=344-350&author=R.+Abetiauthor=E.+Uzunauthor=I.+Renganathanauthor=T.+Hondaauthor=M.+A.+Pookauthor=P.+Giunti&title=Targeting+lipid+peroxidation+and+mitochondrial+imbalance+in+Friedreich%E2%80%99s+ataxia&doi=10.1016%2Fj.phrs.2015.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110eR"><div class="casContent"><span class="casTitleNuber">110e</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia</span></div><div class="casAuthors">Abeti, Rosella; Uzun, Ebru; Renganathan, Indhushri; Honda, Tadashi; Pook, Mark A.; Giunti, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">344-350</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Friedreich's ataxia (FRDA) is an autosomal recessive disorder, caused by reduced levels of the protein frataxin.  This protein is located in the mitochondria, where it functions in the biogenesis of iron-sulfur clusters (ISCs), which are important for the function of the mitochondrial respiratory chain complexes.  Moreover, disruption in iron biogenesis may lead to oxidative stress.  Oxidative stress can be the cause and/or the consequence of mitochondrial energy imbalance, leading to cell death.  Fibroblasts from two FRDA mouse models, YG8R and KIKO, were used to analyze two different categories of protective compds.: deuterised poly-unsatd. fatty acids (dPUFAs) and Nrf2-inducers.  The former have been shown to protect the cell from damage induced by lipid peroxidn. and the latter trigger the well-known Nrf2 antioxidant pathway.  Our results show that the sensitivity to oxidative stress of YG8R and KIKO mouse fibroblasts, resulting in cell death and lipid peroxidn., can be prevented by d4-PUFA and Nrf2-inducers (SFN and TBE-31).  The mitochondrial membrane potential (ΔΨm) of YG8R and KIKO fibroblasts revealed a difference in their mitochondrial pathophysiol., which may be due to the different genetic basis of the two models.  This suggests that variable levels of reduced frataxin may act differently on mitochondrial pathophysiol. and that these two cell models could be useful in recapitulating the obsd. differences in the FRDA phenotype.  This may reflect a different modulatory effect towards cell death that will need to be investigated further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZe5gSWElTSbVg90H21EOLACvtfcHk0lji02DBw1YjtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemsLrF&md5=e56cdbc2d5453868739f5709db413fef</span></div><a href="/servlet/linkout?suffix=cit110e&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DAbeti%26aufirst%3DR.%26aulast%3DUzun%26aufirst%3DE.%26aulast%3DRenganathan%26aufirst%3DI.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DPook%26aufirst%3DM.%2BA.%26aulast%3DGiunti%26aufirst%3DP.%26atitle%3DTargeting%2520lipid%2520peroxidation%2520and%2520mitochondrial%2520imbalance%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D99%26spage%3D344%26epage%3D350%26doi%3D10.1016%2Fj.phrs.2015.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zesiewicz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerinckx, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omidvar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Randomized, clinical trial of RT001: early signals of efficacy in Friedreich’s ataxia</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1002/mds.27353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fmds.27353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29624723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOku7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=1000-1005&author=T.+Zesiewiczauthor=F.+Heerinckxauthor=R.+De+Jagerauthor=O.+Omidvarauthor=M.+Kilpatrickauthor=J.+Shawauthor=M.+S.+Shchepinov&title=Randomized%2C+clinical+trial+of+RT001%3A+early+signals+of+efficacy+in+Friedreich%E2%80%99s+ataxia&doi=10.1002%2Fmds.27353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia</span></div><div class="casAuthors">Zesiewicz, Theresa; Heerinckx, Frederic; De Jager, Robert; Omidvar, Omid; Kilpatrick, Marcus; Shaw, Jessica; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Movement Disorders</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1000-1005</span>CODEN:
                <span class="NLM_cas:coden">MOVDEA</span>;
        ISSN:<span class="NLM_cas:issn">0885-3185</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : RT001 is a deuterated Et linoleate that inhibits lipid peroxidn. and is hypothesized to reduce cellular damage and recover mitochondrial function in degenerative diseases such as Friedreich's ataxia.  Objective : To evaluate the safety, pharmacokinetics, and preliminary efficacy of RT001 in Friedreich's ataxia patients.  Design/Methods : We conducted a phase I/II double-blind, comparator-controlled trial with 2 doses of RT001 in Friedreich's ataxia patients (9 subjects each cohort).  Subjects were randomized 2:1 to receive either RT001 (1.8 or 9.0 g/day), or a matching dose of nondeuterated Et linoleate as comparator for 28 days.  The primary endpoints were safety, tolerability, and pharmacokinetic anal.  Secondary endpoints included cardiopulmonary exercise testing and timed 25-ft walk.  Results : Nineteen patients enrolled in the trial, and 18 completed all safety and efficacy measurements.  RT001 was found to be safe and tolerable, with plasma levels approaching satn. by 28 days.  One subject with a low body mass index experienced steatorrhea taking a high dose and discontinued the study.  Deuterated arachidonic acid (a brain-penetrant metabolite of RT001) was found to be present in plasma on day 28.  There was an improvement in peak workload in the drug group compared to placebo (0.16 W/kg; P = 0.008), as well as an improvement trend in peak oxygen consumption (change of 0.16 L/min; P = 0.116), and in stride speed (P = 0.15).  Conclusions : RT001 was found to be safe and tolerable over 28 days, and improved peak workload.  Further research into the effect of RT001 in Friedreich's ataxia is warranted. © 2018 International Parkinson and Movement Disorder Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXK9u3lsoLM7Vg90H21EOLACvtfcHk0lisycaLXfvfUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOku7vF&md5=513306408c100e7ca67842d49fcc51f5</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fmds.27353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.27353%26sid%3Dliteratum%253Aachs%26aulast%3DZesiewicz%26aufirst%3DT.%26aulast%3DHeerinckx%26aufirst%3DF.%26aulast%3DDe%2BJager%26aufirst%3DR.%26aulast%3DOmidvar%26aufirst%3DO.%26aulast%3DKilpatrick%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DRandomized%252C%2520clinical%2520trial%2520of%2520RT001%253A%2520early%2520signals%2520of%2520efficacy%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%26jtitle%3DMov.%2520Disord.%26date%3D2018%26volume%3D33%26spage%3D1000%26epage%3D1005%26doi%3D10.1002%2Fmds.27353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abeti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelova, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, A. Y.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich’s ataxia</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e2237</span> <span class="refDoi"> DOI: 10.1038/cddis.2016.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fcddis.2016.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27228352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVyqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=R.+Abetiauthor=M.+H.+Parkinsonauthor=I.+P.+Hargreavesauthor=P.+R.+Angelovaauthor=C.+Sandiauthor=M.+A.+Pookauthor=P.+Giuntiauthor=A.+Y.+Abramov&title=Mitochondrial+energy+imbalance+and+lipid+peroxidation+cause+cell+death+in+Friedreich%E2%80%99s+ataxia&doi=10.1038%2Fcddis.2016.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'</span></div><div class="casAuthors">Abeti, R.; Parkinson, M. H.; Hargreaves, I. P.; Angelova, P. R.; Sandi, C.; Pook, M. A.; Giunti, P.; Abramov, A. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2237</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Friedreich's ataxia (FRDA) is an inherited neurodegenerative disease.  The mutation consists of a GAA repeat expansion within the FXN gene, which downregulates frataxin, leading to abnormal mitochondrial iron accumulation, which may in turn cause changes in mitochondrial function.  Although, many studies of FRDA patients and mouse models have been conducted in the past two decades, the role of frataxin in mitochondrial pathophysiol. remains elusive.  Are the mitochondrial abnormalities only a side effect of the increased accumulation of reactive iron, generating oxidative stress Or does the progressive lack of iron-sulfur clusters (ISCs), induced by reduced frataxin, cause an inhibition of the electron transport chain complexes (CI, II and III) leading to reactive oxygen species escaping from oxidative phosphorylation reactions To answer these crucial questions, we have characterised the mitochondrial pathophysiol. of a group of disease-relevant and readily accessible neurons, cerebellar granule cells, from a validated FRDA mouse model.  By using live cell imaging and biochem. techniques we were able to demonstrate that mitochondria are deregulated in neurons from the YG8R FRDA mouse model, causing a decrease in mitochondrial membrane potential (ΔΨm) due to an inhibition of Complex I, which is partially compensated by an overactivation of Complex II.  This complex activity imbalance leads to ROS generation in both mitochondrial matrix and cytosol, which results in glutathione depletion and increased lipid peroxidn.  Preventing this increase in lipid peroxidn., in neurons, protects against in cell death.  This work describes the pathophysiol. properties of the mitochondria in neurons from a FRDA mouse model and shows that lipid peroxidn. could be an important target for novel therapeutic strategies in FRDA, which still lacks a cure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjVgk3SappW7Vg90H21EOLACvtfcHk0lisycaLXfvfUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVyqsrk%253D&md5=c0e7adafffd68cd8f0211e8b7f7df473</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.111%26sid%3Dliteratum%253Aachs%26aulast%3DAbeti%26aufirst%3DR.%26aulast%3DParkinson%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DI.%2BP.%26aulast%3DAngelova%26aufirst%3DP.%2BR.%26aulast%3DSandi%26aufirst%3DC.%26aulast%3DPook%26aufirst%3DM.%2BA.%26aulast%3DGiunti%26aufirst%3DP.%26aulast%3DAbramov%26aufirst%3DA.%2BY.%26atitle%3DMitochondrial%2520energy%2520imbalance%2520and%2520lipid%2520peroxidation%2520cause%2520cell%2520death%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fcddis.2016.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvadurai, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corben, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou-Karistianis, N.</span></span> <span> </span><span class="NLM_article-title">Cerebral abnormalities in Friedreich ataxia: A review</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2017.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.neubiorev.2017.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28823857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1cfpvFelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=394-406&author=L.+P.+Selvaduraiauthor=I.+H.+Hardingauthor=L.+A.+Corbenauthor=N.+Georgiou-Karistianis&title=Cerebral+abnormalities+in+Friedreich+ataxia%3A+A+review&doi=10.1016%2Fj.neubiorev.2017.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral abnormalities in Friedreich ataxia: A review</span></div><div class="casAuthors">Selvadurai Louisa P; Harding Ian H; Corben Louise A; Georgiou-Karistianis Nellie</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience and biobehavioral reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">394-406</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Friedreich ataxia (FRDA) is an inherited degenerative disorder affecting multiple systems of the body and resulting in symptoms which include progressive ataxia, dysarthria, and cardiomyopathy.  Central nervous system pathology has been traditionally ascribed to the spinal cord and dentate nucleus of the cerebellum.  However, cerebral abnormalities in FRDA are being increasingly documented via multiple neuroimaging techniques.  Understanding the nature and implications of cerebral abnormalities in FRDA provides more comprehensive knowledge of nervous system involvement in this disorder and increases the prospects of identifying effective treatment targets.  We review the cerebellar and the cerebral involvement with a focus on the emerging in vivo human neuroimaging findings suggesting wide-spread cerebral involvement, including aberrant cerebellar-cerebral connectivity.  We synthesise the findings by proposing potential mechanisms that may drive these effects.  Finally, we identify future research directions which, we argue, will lead to a better understanding of the extent and potential mechanisms of cerebral aberrations in FRDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQyzGsRbgbKXqj_yg7twvpfW6udTcc2eaSAwaRcK6LSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfpvFelsA%253D%253D&md5=5ae6c861bcb168de8985f800c3ae9b2a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2017.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DSelvadurai%26aufirst%3DL.%2BP.%26aulast%3DHarding%26aufirst%3DI.%2BH.%26aulast%3DCorben%26aufirst%3DL.%2BA.%26aulast%3DGeorgiou-Karistianis%26aufirst%3DN.%26atitle%3DCerebral%2520abnormalities%2520in%2520Friedreich%2520ataxia%253A%2520A%2520review%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D84%26spage%3D394%26epage%3D406%26doi%3D10.1016%2Fj.neubiorev.2017.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelides, M.</span></span> <span> </span><span class="NLM_article-title">Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1136/bjophthalmol-2016-308823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1136%2Fbjophthalmol-2016-308823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27491360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC2s3nvVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2017&pages=25-30&author=P.+Tannaauthor=R.+W.+Straussauthor=K.+Fujinamiauthor=M.+Michaelides&title=Stargardt+disease%3A+clinical+features%2C+molecular+genetics%2C+animal+models+and+therapeutic+options&doi=10.1136%2Fbjophthalmol-2016-308823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options</span></div><div class="casAuthors">Tanna Preena; Strauss Rupert W; Fujinami Kaoru; Michaelides Michel; Tanna Preena; Strauss Rupert W; Fujinami Kaoru; Michaelides Michel; Strauss Rupert W; Fujinami Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Stargardt disease (STGD1; MIM 248200) is the most prevalent inherited macular dystrophy and is associated with disease-causing sequence variants in the gene ABCA4 Significant advances have been made over the last 10 years in our understanding of both the clinical and molecular features of STGD1, and also the underlying pathophysiology, which has culminated in ongoing and planned human clinical trials of novel therapies.  The aims of this review are to describe the detailed phenotypic and genotypic characteristics of the disease, conventional and novel imaging findings, current knowledge of animal models and pathogenesis, and the multiple avenues of intervention being explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1O7dKCBnilFm8bhe6roZYfW6udTcc2eaSAwaRcK6LSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3nvVCqtA%253D%253D&md5=5e14416ce301aef335552542142c7b77</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1136%2Fbjophthalmol-2016-308823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjophthalmol-2016-308823%26sid%3Dliteratum%253Aachs%26aulast%3DTanna%26aufirst%3DP.%26aulast%3DStrauss%26aufirst%3DR.%2BW.%26aulast%3DFujinami%26aufirst%3DK.%26aulast%3DMichaelides%26aufirst%3DM.%26atitle%3DStargardt%2520disease%253A%2520clinical%2520features%252C%2520molecular%2520genetics%252C%2520animal%2520models%2520and%2520therapeutic%2520options%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2017%26volume%3D101%26spage%3D25%26epage%3D30%26doi%3D10.1136%2Fbjophthalmol-2016-308823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azarian, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzekov, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travis, G. H.</span></span> <span> </span><span class="NLM_article-title">Insights into the function of Rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80602-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0092-8674%2800%2980602-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10412977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1MXks1Kksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=13-23&author=J.+Wengauthor=N.+L.+Mataauthor=S.+M.+Azarianauthor=R.+T.+Tzekovauthor=D.+G.+Birchauthor=G.+H.+Travis&title=Insights+into+the+function+of+Rim+protein+in+photoreceptors+and+etiology+of+Stargardt%E2%80%99s+disease+from+the+phenotype+in+abcr+knockout+mice&doi=10.1016%2FS0092-8674%2800%2980602-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice</span></div><div class="casAuthors">Weng, Jian; Mata, Nathan L.; Azarian, Sassan M.; Tzekov, Radouil T.; Birch, David G.; Travis, Gabriel H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-23</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rim protein (RmP) is an ABC transporter of unknown function in rod outer segment disks.  The human gene for RmP (ABCR) is affected in several recessive retinal degenerations.  Here, the authors characterize the ocular phenotype in abcr knockout mice.  Mice lacking RmP show delayed dark adaptation, increased all-trans-retinaldehyde (all-trans-RAL) following light exposure, elevated phosphatidylethanolamine (PE) in outer segments, accumulation of the protonated Schiff base complex of all-trans-RAL and PE (N-retinylidene-PE), and striking deposition of a major lipofuscin fluorophore (A2-E) in retinal pigment epithelium (RPE).  These data suggest that RmP functions as an outwardly directed flippase for N-retinylidene-PE.  Delayed dark adaptation is likely due to accumulation in disks of the noncovalent complex between opsin and all-trans-RAL.  Finally, ABCR-mediated retinal degeneration may result from "poisoning" of the RPE due to A2-E accumulation, with secondary photoreceptor degeneration due to loss of the RPE support role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZy7tbqxEaJLVg90H21EOLACvtfcHk0ljhosdgI-1HvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1Kksbg%253D&md5=27252383bb56fa6b75b66e878eab8ec1</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980602-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980602-9%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DMata%26aufirst%3DN.%2BL.%26aulast%3DAzarian%26aufirst%3DS.%2BM.%26aulast%3DTzekov%26aufirst%3DR.%2BT.%26aulast%3DBirch%26aufirst%3DD.%2BG.%26aulast%3DTravis%26aufirst%3DG.%2BH.%26atitle%3DInsights%2520into%2520the%2520function%2520of%2520Rim%2520protein%2520in%2520photoreceptors%2520and%2520etiology%2520of%2520Stargardt%25E2%2580%2599s%2520disease%2520from%2520the%2520phenotype%2520in%2520abcr%2520knockout%2520mice%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D13%26epage%3D23%26doi%3D10.1016%2FS0092-8674%2800%2980602-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, I.</span></span> <span> </span><span class="NLM_article-title">Deuterium enrichment of vitamin A at the C20 position slows the formation of detrimental vitamin A dimers in wild-type rodents</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">7958</span>– <span class="NLM_lpage">7965</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.178640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1074%2Fjbc.M110.178640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21075840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislylsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=7958-7965&author=Y.+Kaufmanauthor=L.+Maauthor=I.+Washington&title=Deuterium+enrichment+of+vitamin+A+at+the+C20+position+slows+the+formation+of+detrimental+vitamin+A+dimers+in+wild-type+rodents&doi=10.1074%2Fjbc.M110.178640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium Enrichment of Vitamin A at the C20 Position Slows the Formation of Detrimental Vitamin A Dimers in Wild-type Rodents</span></div><div class="casAuthors">Kaufman, Yardana; Ma, Li; Washington, Ilyas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7958-7965</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Degenerative eye diseases are the most common causes of untreatable blindness.  Accumulation of lipofuscin (granular deposits) in the retinal pigment epithelium (RPE) is a hallmark of major degenerative eye diseases such as Stargardt disease, Best disease, and age-related macular degeneration.  The intrinsic reactivity of vitamin A leads to its dimerization and to the formation of pigments such as A2E, and is believed to play a key role in the formation of ocular lipofuscin.  We sought a clin. pragmatic method to slow vitamin A dimerization as a means to elucidate the pathogenesis of macular degenerations and to develop a therapeutic intervention.  We prepd. vitamin A enriched with the stable isotope deuterium at carbon twenty (C20-D3-vitamin A).  Results showed that dimerization of deuterium-enriched vitamin A was considerably slower than that of vitamin A at natural abundance as measured in vitro.  Administration of C20-D3-vitamin A to wild-type rodents with no obvious genetic defects in vitamin A processing, slowed A2E biosynthesis.  This study elucidates the mechanism of A2E biosynthesis and suggests that administration of C20-D3-vitamin A may be a viable, long-term approach to retard vitamin A dimerization and by extension, may slow lipofuscin deposition and the progression of common degenerative eye diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwDhq5_pVl7Vg90H21EOLACvtfcHk0ljhosdgI-1HvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislylsbg%253D&md5=e9d667f82e20835a3c737c832e77c896</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.178640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.178640%26sid%3Dliteratum%253Aachs%26aulast%3DKaufman%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWashington%26aufirst%3DI.%26atitle%3DDeuterium%2520enrichment%2520of%2520vitamin%2520A%2520at%2520the%2520C20%2520position%2520slows%2520the%2520formation%2520of%2520detrimental%2520vitamin%2520A%2520dimers%2520in%2520wild-type%2520rodents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D7958%26epage%3D7965%26doi%3D10.1074%2Fjbc.M110.178640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, I.</span></span> <span> </span><span class="NLM_article-title">C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">7966</span>– <span class="NLM_lpage">7974</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.178657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1074%2Fjbc.M110.178657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21156790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislylsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=7966-7974&author=L.+Maauthor=Y.+Kaufmanauthor=J.+Zhangauthor=I.+Washington&title=C20-D3-vitamin+A+slows+lipofuscin+accumulation+and+electrophysiological+retinal+degeneration+in+a+mouse+model+of+Stargardt+disease&doi=10.1074%2Fjbc.M110.178657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117aR"><div class="casContent"><span class="casTitleNuber">117a</span><div class="casTitle"><span class="NLM_cas:atitle">C20-D3-vitamin A Slows Lipofuscin Accumulation and Electrophysiological Retinal Degeneration in a Mouse Model of Stargardt Disease</span></div><div class="casAuthors">Ma, Li; Kaufman, Yardana; Zhang, Jun-Hua; Washington, Ilyas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7966-7974</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Stargardt disease, also known as juvenile macular degeneration, occurs in approx. one in 10,000 people and results from genetic defects in the ABCA4 gene.  The disease is characterized by premature accumulation of lipofuscin in the retinal pigment epithelium (RPE) of the eye and by vision loss.  No cure or treatment is available.  Although lipofuscin is considered a hallmark of Stargardt disease, its mechanism of formation and its role in disease pathogenesis are poorly understood.  In this work we investigated the effects of long-term administration of D3-enriched vitamin A, C20-D3-vitamin A, on RPE lipofuscin deposition and eye function in a mouse model of Stargardt's disease.  Results support the notion that lipofuscin forms partly as a result of the aberrant reactivity of vitamin A through the formation of vitamin A dimers, provide evidence that preventing vitamin A dimerization may slow disease related, retinal physiol. changes and perhaps vision loss and suggest that administration of C20-D3-vitamin A may be a potential clin. strategy to ameliorate clin. symptoms resulting from ABCA4 genetic defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwr5N5Cud57Vg90H21EOLACvtfcHk0ljhosdgI-1HvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislylsbk%253D&md5=f1edbe3819d5b754b6a38025faf7f9b4</span></div><a href="/servlet/linkout?suffix=cit117a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.178657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.178657%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWashington%26aufirst%3DI.%26atitle%3DC20-D3-vitamin%2520A%2520slows%2520lipofuscin%2520accumulation%2520and%2520electrophysiological%2520retinal%2520degeneration%2520in%2520a%2520mouse%2520model%2520of%2520Stargardt%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D7966%26epage%3D7974%26doi%3D10.1074%2Fjbc.M110.178657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit117b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Charbel Issa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLaren, R. E.</span></span> <span> </span><span class="NLM_article-title">Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">8415</span>– <span class="NLM_lpage">8420</span>, <span class="refDoi"> DOI: 10.1073/pnas.1506960112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1073%2Fpnas.1506960112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=26106163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC2MbmsVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=8415-8420&author=P.+Charbel+Issaauthor=A.+R.+Barnardauthor=P.+Herrmannauthor=I.+Washingtonauthor=R.+E.+MacLaren&title=Rescue+of+the+Stargardt+phenotype+in+Abca4+knockout+mice+through+inhibition+of+vitamin+A+dimerization&doi=10.1073%2Fpnas.1506960112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117bR"><div class="casContent"><span class="casTitleNuber">117b</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization</span></div><div class="casAuthors">Charbel Issa Peter; Barnard Alun R; Herrmann Philipp; Washington Ilyas; MacLaren Robert E</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">8415-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Stargardt disease, an ATP-binding cassette, subfamily A, member 4 (ABCA4)-related retinopathy, is a genetic condition characterized by the accelerated accumulation of lipofuscin in the retinal pigment epithelium, degeneration of the neuroretina, and loss of vision.  No approved treatment exists.  Here, using a murine model of Stargardt disease, we show that the propensity of vitamin A to dimerize is responsible for triggering the formation of the majority of lipofuscin and transcriptional dysregulation of genes associated with inflammation.  Data further demonstrate that replacing vitamin A with vitamin A deuterated at the carbon 20 position (C20-D3-vitamin A) impedes the dimerization rate of vitamin A--by approximately fivefold for the vitamin A dimer A2E--and subsequent lipofuscinogenesis and normalizes the aberrant transcription of complement genes without impairing retinal function.  Phenotypic rescue by C20-D3-vitamin A was also observed noninvasively by quantitative autofluorescence, an imaging technique used clinically, in as little as 3 months after the initiation of treatment, whereas upon interruption of treatment, the age-related increase in autofluorescence resumed.  Data suggest that C20-D3-vitamin A is a clinically amiable tool to inhibit vitamin A dimerization, which can be used to determine whether slowing the dimerization of vitamin A can prevent vision loss caused by Stargardt disease and other retinopathies associated with the accumulation of lipofuscin in the retina.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbMx_OWblUPoYPsCkJIw00fW6udTcc2eaTG-8oiBK8mrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbmsVSqsg%253D%253D&md5=dead140a5a2719fea37d79fb65bf60ae</span></div><a href="/servlet/linkout?suffix=cit117b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1506960112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1506960112%26sid%3Dliteratum%253Aachs%26aulast%3DCharbel%2BIssa%26aufirst%3DP.%26aulast%3DBarnard%26aufirst%3DA.%2BR.%26aulast%3DHerrmann%26aufirst%3DP.%26aulast%3DWashington%26aufirst%3DI.%26aulast%3DMacLaren%26aufirst%3DR.%2BE.%26atitle%3DRescue%2520of%2520the%2520Stargardt%2520phenotype%2520in%2520Abca4%2520knockout%2520mice%2520through%2520inhibition%2520of%2520vitamin%2520A%2520dimerization%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D8415%26epage%3D8420%26doi%3D10.1073%2Fpnas.1506960112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Hogan, K.</span>; <span class="NLM_string-name">Qin, S.</span>; <span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Bridson, G. W.</span>; <span class="NLM_string-name">Graham, P.</span>; <span class="NLM_string-name">Tung, R.</span>; <span class="NLM_string-name">Wu, L.</span></span> <span> </span><span class="NLM_article-title">CTP-499, a Novel Drug for the Potential Treatment of Chronic Kidney Disease, Has Anti-Fibrotic, Anti-Inflammatory, and Anti-Oxidative Activities with In Vivo Efficacy</span>. Presented at the American Society of Nephrology (ASN) Kidney Week Meeting 2011, Philadelphia, PA, November 8–13, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Aslanian&author=K.+Hogan&author=S.+Qin&author=J.+F.+Liu&author=C.+Cheng&author=G.+W.+Bridson&author=P.+Graham&author=R.+Tung&author=L.+Wu&title=CTP-499%2C+a+Novel+Drug+for+the+Potential+Treatment+of+Chronic+Kidney+Disease%2C+Has+Anti-Fibrotic%2C+Anti-Inflammatory%2C+and+Anti-Oxidative+Activities+with+In+Vivo+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAslanian%26aufirst%3DA.%26atitle%3DCTP-499%252C%2520a%2520Novel%2520Drug%2520for%2520the%2520Potential%2520Treatment%2520of%2520Chronic%2520Kidney%2520Disease%252C%2520Has%2520Anti-Fibrotic%252C%2520Anti-Inflammatory%252C%2520and%2520Anti-Oxidative%2520Activities%2520with%2520In%2520Vivo%2520Efficacy%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit118b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Hogan, K.</span>; <span class="NLM_string-name">West, K.</span>; <span class="NLM_string-name">Bridson, G.</span>; <span class="NLM_string-name">Wu, L.</span></span> <span> </span><span class="NLM_article-title">CTP-499, a Novel Drug for the Treatment of Chronic Kidney Disease, Ameliorates Renal Fibrosis and Inflammation In Vivo</span>. Presented at the American Society of Nephrology (ASN) Kidney Week 2012, San Diego, CA, October 30–November 4, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Aslanian&author=K.+Hogan&author=K.+West&author=G.+Bridson&author=L.+Wu&title=CTP-499%2C+a+Novel+Drug+for+the+Treatment+of+Chronic+Kidney+Disease%2C+Ameliorates+Renal+Fibrosis+and+Inflammation+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAslanian%26aufirst%3DA.%26atitle%3DCTP-499%252C%2520a%2520Novel%2520Drug%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Kidney%2520Disease%252C%2520Ameliorates%2520Renal%2520Fibrosis%2520and%2520Inflammation%2520In%2520Vivo%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parasrampuria, D.</span>; <span class="NLM_string-name">Braman, V.</span>; <span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Grotbeck, B.</span>; <span class="NLM_string-name">Turnquist, D.</span>; <span class="NLM_string-name">Hogan, K.</span>; <span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Wu, L.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Zelle, R.</span>; <span class="NLM_string-name">Graham, P.</span>; <span class="NLM_string-name">Shipley, J.</span>; <span class="NLM_string-name">Tung, R.</span></span> <span> </span><span class="NLM_article-title">First Human Exposure Suggests a Unique Metabolic Profile with Multiple Active Species for CTP-499, a Novel Agent for Treatment of Chronic Kidney Disease</span>. Presented at the American Society of Nephrology (ASN) Kidney Week Meeting, Philadelphia, PA, November 8–13, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Parasrampuria&author=V.+Braman&author=C.+Cheng&author=B.+Grotbeck&author=D.+Turnquist&author=K.+Hogan&author=A.+Aslanian&author=L.+Wu&author=J.+Liu&author=R.+Zelle&author=P.+Graham&author=J.+Shipley&author=R.+Tung&title=First+Human+Exposure+Suggests+a+Unique+Metabolic+Profile+with+Multiple+Active+Species+for+CTP-499%2C+a+Novel+Agent+for+Treatment+of+Chronic+Kidney+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DParasrampuria%26aufirst%3DD.%26atitle%3DFirst%2520Human%2520Exposure%2520Suggests%2520a%2520Unique%2520Metabolic%2520Profile%2520with%2520Multiple%2520Active%2520Species%2520for%2520CTP-499%252C%2520a%2520Novel%2520Agent%2520for%2520Treatment%2520of%2520Chronic%2520Kidney%2520Disease%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnquist, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harnett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabounjian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, J.</span></span> <span> </span><span class="NLM_article-title">A randomized phase I evaluation of CTP-499, a novel deuterium-containing drug candidate for diabetic nephropathy</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1002/cpdd.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fcpdd.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27121560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=53-66&author=V.+Bramanauthor=P.+Grahamauthor=C.+Chengauthor=D.+Turnquistauthor=M.+Harnettauthor=L.+Sabounjianauthor=J.+Shipley&title=A+randomized+phase+I+evaluation+of+CTP-499%2C+a+novel+deuterium-containing+drug+candidate+for+diabetic+nephropathy&doi=10.1002%2Fcpdd.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase I evaluation of CTP-499, a novel deuterium-containing drug candidate for diabetic nephropathy</span></div><div class="casAuthors">Braman, Virginia; Graham, Philip; Cheng, Changfu; Turnquist, David; Harnett, Mark; Sabounjian, LuAnn; Shipley, James</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-66</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. max. tolerated dose and food effect for CTP-499, a novel agent being studied for the treatment of diabetic kidney disease.  CTP-499 has demonstrated anti-inflammatory, anti-fibrotic and anti-oxidative activities in vitro as well as anti-inflammatory and renoprotective effects in a diabetic nephropathy (DN) model.  Two studies were performed.  Study 1 was a single-dose escalation study with 600, 1200, 1800, and 2400 mg doses of controlled-release (CR) CTP-499 and a 400 mg immediate release dose to aid in the development of prototype formulations of CTP-499.  Study 2 was a food-effect study.  Plasma concns. of CTP-499 and its metabolites were measured to det. pharmacokinetic parameters in each study.  Safety was assessed to det. tolerability.  Doses up to and including 1800 mg were well tolerated.  Cmax was either equiv. (CTP-499) or slightly lower (metabolites) for the fed condition, while overall exposure was equiv. (CTP-499) or slightly higher (metabolites) for the fed condition.  The range of tolerated doses of CTP-499 and the effects of food on exposure were identified, contributing to selection of the dose for Phase II development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo4De1hQV0irVg90H21EOLACvtfcHk0lhcWW8emhV5PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLbE&md5=d02f89105fee1176c0363f5a5eccfb18</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.3%26sid%3Dliteratum%253Aachs%26aulast%3DBraman%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DTurnquist%26aufirst%3DD.%26aulast%3DHarnett%26aufirst%3DM.%26aulast%3DSabounjian%26aufirst%3DL.%26aulast%3DShipley%26aufirst%3DJ.%26atitle%3DA%2520randomized%2520phase%2520I%2520evaluation%2520of%2520CTP-499%252C%2520a%2520novel%2520deuterium-containing%2520drug%2520candidate%2520for%2520diabetic%2520nephropathy%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2013%26volume%3D2%26spage%3D53%26epage%3D66%26doi%3D10.1002%2Fcpdd.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabounjian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neutel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, M.</span></span> <span> </span><span class="NLM_article-title">A first-in-patient, multicenter, double-blind, 2-arm, placebo-controlled, randomized safety and tolerability study of a novel oral drug candidate, CTP-499, in chronic kidney disease</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1002/cpdd.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fcpdd.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27310332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvV2gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=314-325&author=L.+Sabounjianauthor=P.+Grahamauthor=L.+Wuauthor=V.+Bramanauthor=C.+Chengauthor=J.+Liuauthor=J.+Shipleyauthor=J.+Neutelauthor=M.+Dao&title=A+first-in-patient%2C+multicenter%2C+double-blind%2C+2-arm%2C+placebo-controlled%2C+randomized+safety+and+tolerability+study+of+a+novel+oral+drug+candidate%2C+CTP-499%2C+in+chronic+kidney+disease&doi=10.1002%2Fcpdd.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease</span></div><div class="casAuthors">Sabounjian, LuAnn; Graham, Philip; Wu, Lijun; Braman, Virginia; Cheng, Changfu; Liu, Julie; Shipley, James; Neutel, Joel; Dao, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-325</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The prevalence of chronic kidney disease (CKD) related to type 2 diabetes is increasing worldwide.  In addn. to std. of care, treatment with anti-inflammatory and antifibrotic agents such as CTP-499, a novel oral, multisubtype selective inhibitor of phosphodiesterases, may be important in CKD treatment.  A phase 1b randomized, double-blind, placebo-controlled clin. trial of CTP-499 in CKD patients (25 active, 8 placebo) with an estd. glomerular filtration rate of 30-59 mL/min/1.73 m2 was conducted to assess safety and tolerability.  Secondary outcomes included pharmacokinetics and exploratory effects on inflammatory and hematol. markers.  Patients received 600 mg CTP-499 or matching placebo tablets orally once daily for 2 wk, then twice daily for 2 addnl. weeks.  CTP-499 was well tolerated with no serious or severe adverse events, or adverse events leading to discontinuation.  CTP-499 was rapidly absorbed and produced acceptable interpatient variability.  Of the 5 metabolites (M1-M5), M5 was the most abundant in plasma and urine.  Exposure to CTP-499 and metabolites was higher in CKD patients than previously reported in healthy volunteers.  No statistically significant differences were detected between the CTP-499- and placebo-treated groups for any of the biomarkers tested.  This study provides data supporting further evaluation of CTP-499 in CKD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39ABdKmZnibVg90H21EOLACvtfcHk0lhcWW8emhV5PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvV2gs7s%253D&md5=f7accb0d8439bfe45d2c52c6490c8206</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.241%26sid%3Dliteratum%253Aachs%26aulast%3DSabounjian%26aufirst%3DL.%26aulast%3DGraham%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBraman%26aufirst%3DV.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DShipley%26aufirst%3DJ.%26aulast%3DNeutel%26aufirst%3DJ.%26aulast%3DDao%26aufirst%3DM.%26atitle%3DA%2520first-in-patient%252C%2520multicenter%252C%2520double-blind%252C%25202-arm%252C%2520placebo-controlled%252C%2520randomized%2520safety%2520and%2520tolerability%2520study%2520of%2520a%2520novel%2520oral%2520drug%2520candidate%252C%2520CTP-499%252C%2520in%2520chronic%2520kidney%2520disease%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2016%26volume%3D5%26spage%3D314%26epage%3D325%26doi%3D10.1002%2Fcpdd.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherdale, S. T.</span></span> <span> </span><span class="NLM_article-title">Stable isotopes in clinical research: safety reaffirmed</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1042/cs0800277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1042%2Fcs0800277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1851061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADyaK3M3itlOlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1991&pages=277-280&author=P.%0AJ.+Jonesauthor=S.+T.+Leatherdale&title=Stable+isotopes+in+clinical+research%3A+safety+reaffirmed&doi=10.1042%2Fcs0800277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Stable isotopes in clinical research: safety reaffirmed</span></div><div class="casAuthors">Jones P J; Leatherdale S T</div><div class="citationInfo"><span class="NLM_cas:title">Clinical science (London, England : 1979)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-80</span>
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    </div><div class="casAbstract">Approaching half a century of stable-isotope usage in human metabolic studies has been without documented significant adverse effect.  Side-effects with acute D dosing are transitory with no demonstrated evidence of permanent deleterious action.  The threshold of D toxicity has been defined in animals and is far in excess of concentrations conceivably used in human studies.  The possibility that D may have additional beneficial pharmacological applications cannot be excluded.  For isotopes other than D, evidence of observed toxicity remains to be produced even at dosages far in excess of the range used in metabolic studies.  Absence of adverse effect may be attributable to small mass differences and the similar properties of tracer and predominantly abundant isotope.  Absolute determination of stable isotope toxicity in humans is rendered impossible by ethical considerations.  Also, the precision of extrapolating toxicity thresholds from animal studies remains unknown.  However, should perturbation of the delicate homoeostatic characteristic of living organisms occur with use of stable isotopes, it is almost undoubtedly at some level of administration greatly in excess of those administered currently in biomedical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoe27cQnGfu-WhZTslLrfffW6udTcc2eY2lVRDslWqhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3itlOlug%253D%253D&md5=9c8238257b48d73340a84c6d5c322ec6</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1042%2Fcs0800277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fcs0800277%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BJ.%26aulast%3DLeatherdale%26aufirst%3DS.%2BT.%26atitle%3DStable%2520isotopes%2520in%2520clinical%2520research%253A%2520safety%2520reaffirmed%26jtitle%3DClin.%2520Sci.%26date%3D1991%26volume%3D80%26spage%3D277%26epage%3D280%26doi%3D10.1042%2Fcs0800277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit122b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bila, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamounier, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everton de Freitas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra de Oliveira, J. E.</span></span> <span> </span><span class="NLM_article-title">Stable isotopes and body composition in children: History, fundamentals, and clinical applications</span>. <i>Health</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.4236/health.2013.58A3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.4236%2Fhealth.2013.58A3009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=61-68&author=W.+C.+Bilaauthor=J.+A.+Lamounierauthor=A.+Everton+de+Freitasauthor=V.+R.+Silvaauthor=S.+D.+Turaniauthor=J.+E.+Dutra+de+Oliveira&title=Stable+isotopes+and+body+composition+in+children%3A+History%2C+fundamentals%2C+and+clinical+applications&doi=10.4236%2Fhealth.2013.58A3009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122b&amp;dbid=16384&amp;doi=10.4236%2Fhealth.2013.58A3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fhealth.2013.58A3009%26sid%3Dliteratum%253Aachs%26aulast%3DBila%26aufirst%3DW.%2BC.%26aulast%3DLamounier%26aufirst%3DJ.%2BA.%26aulast%3DEverton%2Bde%2BFreitas%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DV.%2BR.%26aulast%3DTurani%26aufirst%3DS.%2BD.%26aulast%3DDutra%2Bde%2BOliveira%26aufirst%3DJ.%2BE.%26atitle%3DStable%2520isotopes%2520and%2520body%2520composition%2520in%2520children%253A%2520History%252C%2520fundamentals%252C%2520and%2520clinical%2520applications%26jtitle%3DHealth%26date%3D2013%26volume%3D5%26spage%3D61%26epage%3D68%26doi%3D10.4236%2Fhealth.2013.58A3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs draw heavier backing</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fnrd.2016.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27032821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=219-221&author=A.+Mullard&title=Deuterated+drugs+draw+heavier+backing&doi=10.1038%2Fnrd.2016.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs draw heavier backing</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The FDA is considering a first approval of a deuterated drug, and large pharmaceutical companies have started to incorporate 'heavy hydrogen' into novel candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvu-ucz_PqFbVg90H21EOLACvtfcHk0lj_qXC26e--yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D&md5=8c61bbc57d480f91b59d197894a771d5</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.63%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DDeuterated%2520drugs%2520draw%2520heavier%2520backing%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D219%26epage%3D221%26doi%3D10.1038%2Fnrd.2016.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27a','cit27b','cit27c'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':['cit32'],'ref33':['cit33a','cit33b','cit33c'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66a','cit66b','cit66c','cit66d','cit66e'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81a','cit81b','cit81c'],'ref82':['cit82a','cit82b'],'ref83':['cit83'],'ref84':['cit84a','cit84b'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88a','cit88b'],'ref89':['cit89a','cit89b','cit89c'],'ref90':['cit90a','cit90b'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110a','cit110b','cit110c','cit110d','cit110e'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117a','cit117b'],'ref118':['cit118a','cit118b'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122','cit122b'],'ref123':['cit123']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 113 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Takeshi Yamada, Kazuki Arai, Rie Kikuchi, <span class="NLM_string-name hlFld-ContribAuthor">Sentaro Okamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Deuteration of Indole Compounds: Synthesis of Deuterated Auxins, Indole-3-acetic Acid-d5 and Indole-3-butyric Acid-d5. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (30)
                                     , 19956-19963. <a href="https://doi.org/10.1021/acsomega.1c02940" title="DOI URL">https://doi.org/10.1021/acsomega.1c02940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c02940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c02940%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDeuteration%252Bof%252BIndole%252BCompounds%25253A%252BSynthesis%252Bof%252BDeuterated%252BAuxins%25252C%252BIndole-3-acetic%252BAcid-d5%252Band%252BIndole-3-butyric%252BAcid-d5%26aulast%3DYamada%26aufirst%3DTakeshi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05062021%26date%3D08072021%26date%3D19072021%26volume%3D6%26issue%3D30%26spage%3D19956%26epage%3D19963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chamandi S. Dampalla, Yunjeong Kim, Naemi Bickmeier, Athri D. Rathnayake, Harry Nhat Nguyen, Jian Zheng, Maithri M. Kashipathy, Matthew A. Baird, Kevin P. Battaile, Scott Lovell, Stanley Perlman, Kyeong-Ok Chang, <span class="NLM_string-name hlFld-ContribAuthor">William C. Groutas</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10047-10058. <a href="https://doi.org/10.1021/acs.jmedchem.1c00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDesign%252Bof%252BConformationally%252BConstrained%252BCyclohexane%252BInhibitors%252Bof%252BSevere%252BAcute%252BRespiratory%252BSyndrome%252BCoronavirus-2%252B3CL%252BProtease%26aulast%3DDampalla%26aufirst%3DChamandi%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20022021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D10047%26epage%3D10058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junqing Liang, Gangao Wang, Lefeng Dong, Xiwen Pang, Jiawei Qin, Xiaoyong Xu, Xusheng Shao, <span class="NLM_string-name hlFld-ContribAuthor">Zhong Li</span>. </span><span class="cited-content_cbyCitation_article-title">CF2DSO2Na: An Effective Precursor Reagent for Deuteriodifluoromethylthiolation and Deuteriodifluoromethylation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (14)
                                     , 5545-5548. <a href="https://doi.org/10.1021/acs.orglett.1c01882" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01882%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCF2DSO2Na%25253A%252BAn%252BEffective%252BPrecursor%252BReagent%252Bfor%252BDeuteriodifluoromethylthiolation%252Band%252BDeuteriodifluoromethylation%26aulast%3DLiang%26aufirst%3DJunqing%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07062021%26date%3D07072021%26volume%3D23%26issue%3D14%26spage%3D5545%26epage%3D5548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hao Xiao, Seok Rye Choi, Ruiyue Zhao, Karl Ploessl, David Alexoff, Lin Zhu, Zhihao Zha, <span class="NLM_string-name hlFld-ContribAuthor">Hank F. Kung</span>. </span><span class="cited-content_cbyCitation_article-title">A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1086-1092. <a href="https://doi.org/10.1021/acsmedchemlett.1c00062" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00062%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252BNew%252BHighly%252BDeuterated%252B%25255B18F%25255DAV-45%25252C%252B%25255B18F%25255DD15FSP%25252C%252Bfor%252BImaging%252B%2525CE%2525B2-Amyloid%252BPlaques%252Bin%252Bthe%252BBrain%26aulast%3DXiao%26aufirst%3DHao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26012021%26date%3D17062021%26date%3D21062021%26volume%3D12%26issue%3D7%26spage%3D1086%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zoua Pa Vang, Albert Reyes, Reilly E. Sonstrom, Martin S. Holdren, Samantha E. Sloane, Isabella Y. Alansari, Justin L. Neill, Brooks H. Pate, <span class="NLM_string-name hlFld-ContribAuthor">Joseph R. Clark</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Transfer Hydrodeuteration of Aryl Alkenes with Quantitative Isotopomer Purity Analysis by Molecular Rotational Resonance Spectroscopy. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (20)
                                     , 7707-7718. <a href="https://doi.org/10.1021/jacs.1c00884" title="DOI URL">https://doi.org/10.1021/jacs.1c00884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c00884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c00884%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCopper-Catalyzed%252BTransfer%252BHydrodeuteration%252Bof%252BAryl%252BAlkenes%252Bwith%252BQuantitative%252BIsotopomer%252BPurity%252BAnalysis%252Bby%252BMolecular%252BRotational%252BResonance%252BSpectroscopy%26aulast%3DVang%26aufirst%3DZoua%2BPa%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23012021%26date%3D17052021%26volume%3D143%26issue%3D20%26spage%3D7707%26epage%3D7718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin G. Reed-Berendt, Daniel E. Latham, Mubarak B. Dambatta, <span class="NLM_string-name hlFld-ContribAuthor">Louis C. Morrill</span>. </span><span class="cited-content_cbyCitation_article-title">Borrowing Hydrogen for Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2021,</strong> <em>7 </em>
                                    (4)
                                     , 570-585. <a href="https://doi.org/10.1021/acscentsci.1c00125" title="DOI URL">https://doi.org/10.1021/acscentsci.1c00125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.1c00125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.1c00125%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DBorrowing%252BHydrogen%252Bfor%252BOrganic%252BSynthesis%26aulast%3DReed-Berendt%26aufirst%3DBenjamin%2BG.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D24012021%26date%3D25032021%26volume%3D7%26issue%3D4%26spage%3D570%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lengwan Li, Jacek Jakowski, Changwoo Do, <span class="NLM_string-name hlFld-ContribAuthor">Kunlun Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Deuteration and Polymers: Rich History with Great Potential. </span><span class="cited-content_cbyCitation_journal-name">Macromolecules</span><span> <strong>2021,</strong> <em>54 </em>
                                    (8)
                                     , 3555-3584. <a href="https://doi.org/10.1021/acs.macromol.0c02284" title="DOI URL">https://doi.org/10.1021/acs.macromol.0c02284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.macromol.0c02284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.macromol.0c02284%26sid%3Dliteratum%253Aachs%26jtitle%3DMacromolecules%26atitle%3DDeuteration%252Band%252BPolymers%25253A%252BRich%252BHistory%252Bwith%252BGreat%252BPotential%26aulast%3DLi%26aufirst%3DLengwan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D07102020%26date%3D25022021%26date%3D20032021%26volume%3D54%26issue%3D8%26spage%3D3555%26epage%3D3584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marta Serafini, Sarah Cargnin, Alberto Massarotti, Gian Cesare Tron, Tracey Pirali, <span class="NLM_string-name hlFld-ContribAuthor">Armando A. Genazzani</span>. </span><span class="cited-content_cbyCitation_article-title">What’s in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4410-4429. <a href="https://doi.org/10.1021/acs.jmedchem.1c00181" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00181%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhat%2525E2%252580%252599s%252Bin%252Ba%252BName%25253F%252BDrug%252BNomenclature%252Band%252BMedicinal%252BChemistry%252BTrends%252Busing%252BINN%252BPublications%26aulast%3DSerafini%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01022021%26date%3D13042021%26volume%3D64%26issue%3D8%26spage%3D4410%26epage%3D4429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu Zheng, Zhen-Zhen Xie, Xian-Chen He, Yan-Shan Chen, Wen-Shuo Cheng, Kai Chen, Hao-Yue Xiang, Xiao-Qing Chen, <span class="NLM_string-name hlFld-ContribAuthor">Hua Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphonium Ylide-Mediated Programmable Fluorination to Access Mono- and Difluoromethylarenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (7)
                                     , 2538-2542. <a href="https://doi.org/10.1021/acs.orglett.1c00457" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00457%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPhosphonium%252BYlide-Mediated%252BProgrammable%252BFluorination%252Bto%252BAccess%252BMono-%252Band%252BDifluoromethylarenes%26aulast%3DZheng%26aufirst%3DYu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08022021%26date%3D19032021%26volume%3D23%26issue%3D7%26spage%3D2538%26epage%3D2542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Priyadeep Bhutani, Gaurav Joshi, Nivethitha Raja, Namrata Bachhav, Prabhakar K. Rajanna, Hemant Bhutani, Atish T. Paul, <span class="NLM_string-name hlFld-ContribAuthor">Raj Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">U.S. FDA Approved Drugs from 2015–June 2020: A Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2339-2381. <a href="https://doi.org/10.1021/acs.jmedchem.0c01786" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01786%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DU.S.%252BFDA%252BApproved%252BDrugs%252Bfrom%252B2015%2525E2%252580%252593June%252B2020%25253A%252BA%252BPerspective%26aulast%3DBhutani%26aufirst%3DPriyadeep%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12102020%26date%3D22022021%26volume%3D64%26issue%3D5%26spage%3D2339%26epage%3D2381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Linwei Huang, Wei Liu, Liang-Liang Zhao, Zengyu Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Base-Catalyzed H/D Exchange Reaction of Difluoromethylarenes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (5)
                                     , 3981-3988. <a href="https://doi.org/10.1021/acs.joc.0c02827" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02827%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBase-Catalyzed%252BH%25252FD%252BExchange%252BReaction%252Bof%252BDifluoromethylarenes%26aulast%3DHuang%26aufirst%3DLinwei%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26112020%26date%3D16022021%26volume%3D86%26issue%3D5%26spage%3D3981%26epage%3D3988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jack S. Rowbotham, Holly A. Reeve, <span class="NLM_string-name hlFld-ContribAuthor">Kylie A. Vincent</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Chemo-, Bio-, and Electrocatalysis for Atom-Efficient Deuteration of Cofactors in Heavy Water. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (5)
                                     , 2596-2604. <a href="https://doi.org/10.1021/acscatal.0c03437" title="DOI URL">https://doi.org/10.1021/acscatal.0c03437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03437%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DHybrid%252BChemo-%25252C%252BBio-%25252C%252Band%252BElectrocatalysis%252Bfor%252BAtom-Efficient%252BDeuteration%252Bof%252BCofactors%252Bin%252BHeavy%252BWater%26aulast%3DRowbotham%26aufirst%3DJack%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D06082020%26date%3D31012021%26date%3D11022021%26volume%3D11%26issue%3D5%26spage%3D2596%26epage%3D2604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Ning, Hengzhao Li, Zemin Lai, Michal Szostak, Xingyue Chen, Yanhong Dong, Shuhui Jin, <span class="NLM_string-name hlFld-ContribAuthor">Jie An</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-Deuterated Primary Amines via Reductive Deuteration of Oximes Using D2O as a Deuterium Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (3)
                                     , 2907-2916. <a href="https://doi.org/10.1021/acs.joc.0c02829" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02829%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-Deuterated%252BPrimary%252BAmines%252Bvia%252BReductive%252BDeuteration%252Bof%252BOximes%252BUsing%252BD2O%252Bas%252Ba%252BDeuterium%252BSource%26aulast%3DNing%26aufirst%3DLei%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26112020%26date%3D25012021%26volume%3D86%26issue%3D3%26spage%3D2907%26epage%3D2916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fumito Saito, Dennis Gerbig, Jonathan Becker, <span class="NLM_string-name hlFld-ContribAuthor">Peter R. Schreiner</span>. </span><span class="cited-content_cbyCitation_article-title">Breaking the Symmetry of a Meso Compound by Isotopic Substitution: Synthesis and Stereochemical Assignment of Monodeuterated cis-Perhydroazulene. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     , 113-117. <a href="https://doi.org/10.1021/acs.orglett.0c03795" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03795%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DBreaking%252Bthe%252BSymmetry%252Bof%252Ba%252BMeso%252BCompound%252Bby%252BIsotopic%252BSubstitution%25253A%252BSynthesis%252Band%252BStereochemical%252BAssignment%252Bof%252BMonodeuterated%252Bcis-Perhydroazulene%26aulast%3DSaito%26aufirst%3DFumito%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D15112020%26date%3D11122020%26volume%3D23%26issue%3D1%26spage%3D113%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vinod G. Landge, Kendra K. Shrestha, Aaron J. Grant, <span class="NLM_string-name hlFld-ContribAuthor">Michael C. Young</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective α-Deuteration of Michael Acceptors Mediated by Isopropylamine in D2O/AcOD. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (24)
                                     , 9745-9750. <a href="https://doi.org/10.1021/acs.orglett.0c03839" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03839%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRegioselective%252B%2525CE%2525B1-Deuteration%252Bof%252BMichael%252BAcceptors%252BMediated%252Bby%252BIsopropylamine%252Bin%252BD2O%25252FAcOD%26aulast%3DLandge%26aufirst%3DVinod%2BG.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19112020%26date%3D01122020%26volume%3D22%26issue%3D24%26spage%3D9745%26epage%3D9750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li-Qiang Sun, Eric Mull, Stanley D’Andrea, Barbara Zheng, Sheldon Hiebert, Eric Gillis, Michael Bowsher, Sarkunam Kandhasamy, Venkata Rao Baratam, Sunitha Puttaswamy, Nagalakshmi Pulicharla, Sureshbabu Vishwakrishnan, Subba Reddy, Ravi Trivedi, Sarmistha Sinha, Sankar Sivaprasad, Abhijith Rao, Salil Desai, Kaushik Ghosh, Rushith Anumula, Amit Kumar, Ramkumar Rajamani, Ying-Kai Wang, Hua Fang, Arvind Mathur, Richard Rampulla, Tatyana A. Zvyaga, Kathy Mosure, Susan Jenkins, Paul Falk, Debarati M. Tagore, Chaoqun Chen, Kishore Rendunchintala, James Loy, Nicholas A. Meanwell, Fiona McPhee, <span class="NLM_string-name hlFld-ContribAuthor">Paul M. Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14740-14760. <a href="https://doi.org/10.1021/acs.jmedchem.0c01296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBMS-986144%25252C%252Ba%252BThird-Generation%25252C%252BPan-Genotype%252BNS3%25252F4A%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DSun%26aufirst%3DLi-Qiang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24072020%26date%3D23112020%26volume%3D63%26issue%3D23%26spage%3D14740%26epage%3D14760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qingjie Liu, Douglas G. Batt, Carolyn A. Weigelt, Shiuhang Yip, Dauh-Rurng Wu, Max Ruzanov, John S. Sack, Jinhong Wang, Melissa Yarde, Sha Li, David J. Shuster, Jenny H. Xie, Tara Sherry, Mary T. Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, Purnima Khandelwal, Joseph A. Tino, John E. Macor, Luisa Salter-Cid, Rex Denton, Qihong Zhao, <span class="NLM_string-name hlFld-ContribAuthor">T. G. Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening Approach. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2510-2518. <a href="https://doi.org/10.1021/acsmedchemlett.0c00496" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00496%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BTricyclic%252BPyroglutamide%252BDerivatives%252Bas%252BPotent%252BROR%2525CE%2525B3t%252BInverse%252BAgonists%252BIdentified%252Busing%252Ba%252BVirtual%252BScreening%252BApproach%26aulast%3DLiu%26aufirst%3DQingjie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11092020%26date%3D03112020%26date%3D06112020%26volume%3D11%26issue%3D12%26spage%3D2510%26epage%3D2518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng-Mi Huang, Jian Li, Jing-Jing Ai, Xin-Yu Liu, Weidong Rao, <span class="NLM_string-name hlFld-ContribAuthor">Shun-Yi Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-Light-Promoted Cross-Coupling Reactions of Aryldiazonium Salts with S-Methyl-d3 Sulfonothioate or Se-Methyl-d3 Selenium Sulfonate: Synthesis of Trideuteromethylated Sulfides, Sulfoxides, and Selenides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (22)
                                     , 9128-9132. <a href="https://doi.org/10.1021/acs.orglett.0c03562" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03562%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVisible-Light-Promoted%252BCross-Coupling%252BReactions%252Bof%252BAryldiazonium%252BSalts%252Bwith%252BS-Methyl-d3%252BSulfonothioate%252Bor%252BSe-Methyl-d3%252BSelenium%252BSulfonate%25253A%252BSynthesis%252Bof%252BTrideuteromethylated%252BSulfides%25252C%252BSulfoxides%25252C%252Band%252BSelenides%26aulast%3DHuang%26aufirst%3DCheng-Mi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25102020%26date%3D04112020%26volume%3D22%26issue%3D22%26spage%3D9128%26epage%3D9132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samantha E. Sloane, Albert Reyes, Zoua Pa Vang, Lingzi Li, Kiera T. Behlow, <span class="NLM_string-name hlFld-ContribAuthor">Joseph R. Clark</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Formal Transfer Hydrogenation/Deuteration of Aryl Alkynes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (22)
                                     , 9139-9144. <a href="https://doi.org/10.1021/acs.orglett.0c03632" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03632%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BFormal%252BTransfer%252BHydrogenation%25252FDeuteration%252Bof%252BAryl%252BAlkynes%26aulast%3DSloane%26aufirst%3DSamantha%2BE.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31102020%26date%3D10112020%26volume%3D22%26issue%3D22%26spage%3D9139%26epage%3D9144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng Yang, Li Zhang, Kaiyue Fu, Yaxin Sun, Xiuhua Wang, Jieyu Yue, Yu Ma, <span class="NLM_string-name hlFld-ContribAuthor">Bo Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Asymmetric Transfer Hydrogenation and α-Selective Deuteration of N-Sulfonyl Imines with Alcohols: Access to α-Deuterated Chiral Amines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (21)
                                     , 8278-8284. <a href="https://doi.org/10.1021/acs.orglett.0c02921" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02921%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNickel-Catalyzed%252BAsymmetric%252BTransfer%252BHydrogenation%252Band%252B%2525CE%2525B1-Selective%252BDeuteration%252Bof%252BN-Sulfonyl%252BImines%252Bwith%252BAlcohols%25253A%252BAccess%252Bto%252B%2525CE%2525B1-Deuterated%252BChiral%252BAmines%26aulast%3DYang%26aufirst%3DPeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31082020%26date%3D12102020%26volume%3D22%26issue%3D21%26spage%3D8278%26epage%3D8284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sheila DeWitt, Anthony W. Czarnik, <span class="NLM_string-name hlFld-ContribAuthor">Vincent Jacques</span>. </span><span class="cited-content_cbyCitation_article-title">Deuterium-Enabled Chiral Switching (DECS) Yields Chirally Pure Drugs from Chemically Interconverting Racemates. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1789-1792. <a href="https://doi.org/10.1021/acsmedchemlett.0c00052" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00052%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDeuterium-Enabled%252BChiral%252BSwitching%252B%252528DECS%252529%252BYields%252BChirally%252BPure%252BDrugs%252Bfrom%252BChemically%252BInterconverting%252BRacemates%26aulast%3DDeWitt%26aufirst%3DSheila%26date%3D2020%26date%3D2020%26date%3D05032020%26volume%3D11%26issue%3D10%26spage%3D1789%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Javier Corpas, Peter Viereck, <span class="NLM_string-name hlFld-ContribAuthor">Paul J. Chirik</span>. </span><span class="cited-content_cbyCitation_article-title">C(sp2)–H Activation with Pyridine Dicarbene Iron Dialkyl Complexes: Hydrogen Isotope Exchange of Arenes Using Benzene-d6 as a Deuterium Source. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (15)
                                     , 8640-8647. <a href="https://doi.org/10.1021/acscatal.0c01714" title="DOI URL">https://doi.org/10.1021/acscatal.0c01714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c01714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c01714%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DC%252528sp2%252529%2525E2%252580%252593H%252BActivation%252Bwith%252BPyridine%252BDicarbene%252BIron%252BDialkyl%252BComplexes%25253A%252BHydrogen%252BIsotope%252BExchange%252Bof%252BArenes%252BUsing%252BBenzene-d6%252Bas%252Ba%252BDeuterium%252BSource%26aulast%3DCorpas%26aufirst%3DJavier%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16042020%26date%3D02072020%26date%3D21072020%26date%3D09072020%26volume%3D10%26issue%3D15%26spage%3D8640%26epage%3D8647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tyson F. Belz, Paul T. Bremer, Bin Zhou, Beverly Ellis, Lisa M. Eubanks, <span class="NLM_string-name hlFld-ContribAuthor">Kim D. Janda</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancement of a Heroin Vaccine through Hapten Deuteration. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (31)
                                     , 13294-13298. <a href="https://doi.org/10.1021/jacs.0c05219" title="DOI URL">https://doi.org/10.1021/jacs.0c05219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c05219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c05219%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DEnhancement%252Bof%252Ba%252BHeroin%252BVaccine%252Bthrough%252BHapten%252BDeuteration%26aulast%3DBelz%26aufirst%3DTyson%2BF.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12052020%26date%3D27072020%26date%3D22072020%26volume%3D142%26issue%3D31%26spage%3D13294%26epage%3D13298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinquan Zhang, Shuaizhong Zhang, Thirupathi Gogula, <span class="NLM_string-name hlFld-ContribAuthor">Hongbin Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Versatile Regioselective Deuteration of Indoles via Transition-Metal-Catalyzed H/D Exchange. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (14)
                                     , 7486-7494. <a href="https://doi.org/10.1021/acscatal.0c01674" title="DOI URL">https://doi.org/10.1021/acscatal.0c01674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c01674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c01674%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DVersatile%252BRegioselective%252BDeuteration%252Bof%252BIndoles%252Bvia%252BTransition-Metal-Catalyzed%252BH%25252FD%252BExchange%26aulast%3DZhang%26aufirst%3DJinquan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14042020%26date%3D05062020%26date%3D25062020%26date%3D16062020%26volume%3D10%26issue%3D14%26spage%3D7486%26epage%3D7494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Adam Cook, Sekar Prakash, Yan-Long Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Stephen G. Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Exhaustive Reduction of Esters Enabled by Nickel Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (18)
                                     , 8109-8115. <a href="https://doi.org/10.1021/jacs.0c02405" title="DOI URL">https://doi.org/10.1021/jacs.0c02405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c02405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c02405%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DExhaustive%252BReduction%252Bof%252BEsters%252BEnabled%252Bby%252BNickel%252BCatalysis%26aulast%3DCook%26aufirst%3DAdam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01032020%26date%3D28042020%26date%3D22042020%26volume%3D142%26issue%3D18%26spage%3D8109%26epage%3D8115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jacob P. Sorrentino, Brett R. Ambler, <span class="NLM_string-name hlFld-ContribAuthor">Ryan A. Altman</span>. </span><span class="cited-content_cbyCitation_article-title">Late-Stage Conversion of a Metabolically Labile Aryl Methyl Ether-Containing Natural Product to Fluoroalkyl Analogues. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 5416-5427. <a href="https://doi.org/10.1021/acs.joc.0c00125" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00125%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLate-Stage%252BConversion%252Bof%252Ba%252BMetabolically%252BLabile%252BAryl%252BMethyl%252BEther-Containing%252BNatural%252BProduct%252Bto%252BFluoroalkyl%252BAnalogues%26aulast%3DSorrentino%26aufirst%3DJacob%2BP.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16012020%26date%3D27032020%26date%3D19032020%26volume%3D85%26issue%3D8%26spage%3D5416%26epage%3D5427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marta Serafini, Enza Torre, Silvio Aprile, Erika Del Grosso, Alessandro Gesù, Alessia Griglio, Giorgia Colombo, Cristina Travelli, Salvatore Paiella, Annalisa Adamo, Elena Orecchini, Alice Coletti, Maria Teresa Pallotta, Stefano Ugel, Alberto Massarotti, Tracey Pirali, <span class="NLM_string-name hlFld-ContribAuthor">Silvia Fallarini</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3047-3065. <a href="https://doi.org/10.1021/acs.jmedchem.9b01809" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01809%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%252BBenzimidazole%252BDerivatives%252Bas%252BIndoleamine%252B2%25252C3-Dioxygenase-1%252B%252528IDO1%252529%252BInhibitors%25253A%252BFrom%252BStructure-Based%252BVirtual%252BScreening%252Bto%252Bin%252BVivo%252BPharmacodynamic%252BActivity%26aulast%3DSerafini%26aufirst%3DMarta%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D31102019%26date%3D17032020%26date%3D09032020%26volume%3D63%26issue%3D6%26spage%3D3047%26epage%3D3065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Liu, Lei Cao, Zengyu Zhang, Gang Zhang, Shiqing Huang, Linwei Huang, Peng Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Mesoionic Carbene–Iridium Complex Catalyzed Ortho-Selective Hydrogen Isotope Exchange of Anilines with High Functional Group Tolerance. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (6)
                                     , 2210-2214. <a href="https://doi.org/10.1021/acs.orglett.0c00402" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00402%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DMesoionic%252BCarbene%2525E2%252580%252593Iridium%252BComplex%252BCatalyzed%252BOrtho-Selective%252BHydrogen%252BIsotope%252BExchange%252Bof%252BAnilines%252Bwith%252BHigh%252BFunctional%252BGroup%252BTolerance%26aulast%3DLiu%26aufirst%3DWei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31012020%26date%3D03032020%26volume%3D22%26issue%3D6%26spage%3D2210%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zejin Song, Jing Zeng, Ting Li, Xiang Zhao, Jing Fang, Lingkui Meng, <span class="NLM_string-name hlFld-ContribAuthor">Qian Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Water Compatible Hypophosphites-d2 Reagents: Deuteration Reaction via Deutero-deiodination in Aqueous Solution. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (5)
                                     , 1736-1741. <a href="https://doi.org/10.1021/acs.orglett.0c00001" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00001%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DWater%252BCompatible%252BHypophosphites-d2%252BReagents%25253A%252BDeuteration%252BReaction%252Bvia%252BDeutero-deiodination%252Bin%252BAqueous%252BSolution%26aulast%3DSong%26aufirst%3DZejin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01012020%26date%3D21022020%26volume%3D22%26issue%3D5%26spage%3D1736%26epage%3D1741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng Ji, Yueteng Zhang, Yue Dong, He Huang, Yongyi Wei, <span class="NLM_string-name hlFld-ContribAuthor">Wei Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Enantioenriched α-Deuterated α-Amino Acids Enabled by an Organophotocatalytic Radical Approach. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (4)
                                     , 1557-1562. <a href="https://doi.org/10.1021/acs.orglett.0c00154" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00154%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BEnantioenriched%252B%2525CE%2525B1-Deuterated%252B%2525CE%2525B1-Amino%252BAcids%252BEnabled%252Bby%252Ban%252BOrganophotocatalytic%252BRadical%252BApproach%26aulast%3DJi%26aufirst%3DPeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11012020%26date%3D11022020%26volume%3D22%26issue%3D4%26spage%3D1557%26epage%3D1562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hengzhao Li, Yuxia Hou, Chengwei Liu, Zemin Lai, Lei Ning, Roman Szostak, Michal Szostak, <span class="NLM_string-name hlFld-ContribAuthor">Jie An</span>. </span><span class="cited-content_cbyCitation_article-title">Pentafluorophenyl Esters: Highly Chemoselective Ketyl Precursors for the Synthesis of α,α-Dideuterio Alcohols Using SmI2 and D2O as a Deuterium Source. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (4)
                                     , 1249-1253. <a href="https://doi.org/10.1021/acs.orglett.9b04383" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04383%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPentafluorophenyl%252BEsters%25253A%252BHighly%252BChemoselective%252BKetyl%252BPrecursors%252Bfor%252Bthe%252BSynthesis%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B1-Dideuterio%252BAlcohols%252BUsing%252BSmI2%252Band%252BD2O%252Bas%252Ba%252BDeuterium%252BSource%26aulast%3DLi%26aufirst%3DHengzhao%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D06122019%26date%3D08012020%26volume%3D22%26issue%3D4%26spage%3D1249%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nengbo Zhu, Min Su, Wen-Ming Wan, Yajun Li, <span class="NLM_string-name hlFld-ContribAuthor">Hongli Bao</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Method for Reductive Deuteration of Ketones with Magnesium and D2O. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (3)
                                     , 991-996. <a href="https://doi.org/10.1021/acs.orglett.9b04536" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04536%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPractical%252BMethod%252Bfor%252BReductive%252BDeuteration%252Bof%252BKetones%252Bwith%252BMagnesium%252Band%252BD2O%26aulast%3DZhu%26aufirst%3DNengbo%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18122019%26date%3D22012020%26volume%3D22%26issue%3D3%26spage%3D991%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yueteng Zhang, Peng Ji, Yue Dong, Yongyi Wei, <span class="NLM_string-name hlFld-ContribAuthor">Wei Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Deuteration of Formyl Groups via a Catalytic Radical H/D Exchange Approach. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 2226-2230. <a href="https://doi.org/10.1021/acscatal.9b05300" title="DOI URL">https://doi.org/10.1021/acscatal.9b05300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b05300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b05300%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DDeuteration%252Bof%252BFormyl%252BGroups%252Bvia%252Ba%252BCatalytic%252BRadical%252BH%25252FD%252BExchange%252BApproach%26aulast%3DZhang%26aufirst%3DYueteng%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2020%26date%3D09122019%26date%3D21012020%26date%3D24012020%26date%3D23012020%26volume%3D10%26issue%3D3%26spage%3D2226%26epage%3D2230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang-Liang Zhao, Wei Liu, Zengyu Zhang, Hongyan Zhao, Qi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed ortho- and meta-H/D Exchange of Arenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (24)
                                     , 10023-10027. <a href="https://doi.org/10.1021/acs.orglett.9b03955" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03955%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRuthenium-Catalyzed%252Bortho-%252Band%252Bmeta-H%25252FD%252BExchange%252Bof%252BArenes%26aulast%3DZhao%26aufirst%3DLiang-Liang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06112019%26date%3D04122019%26volume%3D21%26issue%3D24%26spage%3D10023%26epage%3D10027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuxuan Ding, Shihui Luo, Chaoqun Weng, <span class="NLM_string-name hlFld-ContribAuthor">Jie An</span>. </span><span class="cited-content_cbyCitation_article-title">Reductive Deuteration of Nitriles Using D2O as a Deuterium Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (23)
                                     , 15098-15105. <a href="https://doi.org/10.1021/acs.joc.9b02056" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02056%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DReductive%252BDeuteration%252Bof%252BNitriles%252BUsing%252BD2O%252Bas%252Ba%252BDeuterium%252BSource%26aulast%3DDing%26aufirst%3DYuxuan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27072019%26date%3D28102019%26date%3D14102019%26volume%3D84%26issue%3D23%26spage%3D15098%26epage%3D15105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yejin Chang, Ahmet Yesilcimen, Min Cao, Yuyang Zhang, Bochao Zhang, Jessica Z. Chan, <span class="NLM_string-name hlFld-ContribAuthor">Masayuki Wasa</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Deuterium Incorporation within Metabolically Stable β-Amino C–H Bonds of Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (37)
                                     , 14570-14575. <a href="https://doi.org/10.1021/jacs.9b08662" title="DOI URL">https://doi.org/10.1021/jacs.9b08662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b08662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b08662%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCatalytic%252BDeuterium%252BIncorporation%252Bwithin%252BMetabolically%252BStable%252B%2525CE%2525B2-Amino%252BC%2525E2%252580%252593H%252BBonds%252Bof%252BDrug%252BMolecules%26aulast%3DChang%26aufirst%3DYejin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10082019%26date%3D09092019%26date%3D03092019%26volume%3D141%26issue%3D37%26spage%3D14570%26epage%3D14575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joseph
J. Gair, Ronald L. Grey, Simon Giroux, <span class="NLM_string-name hlFld-ContribAuthor">Michael A. Brodney</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium Catalyzed Hydrodefluorination of Fluoro-(hetero)arenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (7)
                                     , 2482-2487. <a href="https://doi.org/10.1021/acs.orglett.9b00889" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00889%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium%252BCatalyzed%252BHydrodefluorination%252Bof%252BFluoro-%252528hetero%252529arenes%26aulast%3DGair%26aufirst%3DJoseph%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12032019%26date%3D26032019%26volume%3D21%26issue%3D7%26spage%3D2482%26epage%3D2487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangzhi  Hu</span>, <span class="hlFld-ContribAuthor ">Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Chunyan  Ge</span>, <span class="hlFld-ContribAuthor ">Xinyao  Li</span>, <span class="hlFld-ContribAuthor ">Zhanshuai  Ding</span>, <span class="hlFld-ContribAuthor ">Lubin  Xu</span>, <span class="hlFld-ContribAuthor ">Shuai-Shuai  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent α-functionalization of cyclic amines
              via
              ring construction by molecular O
              2
              oxidized dearomatization and ring deconstruction by aromatization-driven C–C σ-bond cleavage. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2021,</strong> <em>23 </em>
                                    (15)
                                     , 5535-5541. <a href="https://doi.org/10.1039/D1GC00941A" title="DOI URL">https://doi.org/10.1039/D1GC00941A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1GC00941A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1GC00941A%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DDivergent%252B%2525CE%2525B1-functionalization%252Bof%252Bcyclic%252Bamines%252Bvia%252Bring%252Bconstruction%252Bby%252Bmolecular%252BO%252B2%252Boxidized%252Bdearomatization%252Band%252Bring%252Bdeconstruction%252Bby%252Baromatization-driven%252BC%2525E2%252580%252593C%252B%2525CF%252583-bond%252Bcleavage%26aulast%3DHu%26aufirst%3DFangzhi%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D15%26spage%3D5535%26epage%3D5541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian‐Yun  Jin</span>, <span class="hlFld-ContribAuthor ">Ping‐Lin  Li</span>, <span class="hlFld-ContribAuthor ">Ci‐Li  Wang</span>, <span class="hlFld-ContribAuthor ">Xu‐Li  Tang</span>, <span class="hlFld-ContribAuthor ">Mei‐Mei  Cheng</span>, <span class="hlFld-ContribAuthor ">Yuan  Zong</span>, <span class="hlFld-ContribAuthor ">Lian‐Zhong  Luo</span>, <span class="hlFld-ContribAuthor ">Hui‐Long  Ou</span>, <span class="hlFld-ContribAuthor ">Ke‐Chun  Liu</span>, <span class="hlFld-ContribAuthor ">Guo‐Qiang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Racemic Bisindole Alkaloids: Structure, Bioactivity, and Computational Study. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>2011 </em><a href="https://doi.org/10.1002/cjoc.202100255" title="DOI URL">https://doi.org/10.1002/cjoc.202100255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202100255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202100255%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DRacemic%252BBisindole%252BAlkaloids%25253A%252BStructure%25252C%252BBioactivity%25252C%252Band%252BComputational%252BStudy%26aulast%3DJin%26aufirst%3DTian%25E2%2580%2590Yun%26date%3D2021%26date%3D2021%26volume%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyadarshi  Manna</span>, <span class="hlFld-ContribAuthor ">Mrinalkanti  Kundu</span>, <span class="hlFld-ContribAuthor ">Ashis  Roy</span>, <span class="hlFld-ContribAuthor ">Susanta  Adhikari</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed directed synthesis of
              ortho
              -deuterated phenylacetic acid and analogues. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (28)
                                     , 6244-6249. <a href="https://doi.org/10.1039/D1OB00663K" title="DOI URL">https://doi.org/10.1039/D1OB00663K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00663K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00663K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium-catalyzed%252Bdirected%252Bsynthesis%252Bof%252Bortho%252B-deuterated%252Bphenylacetic%252Bacid%252Band%252Banalogues%26aulast%3DManna%26aufirst%3DPriyadarshi%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D28%26spage%3D6244%26epage%3D6249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chamandi S.  Dampalla</span>, <span class="hlFld-ContribAuthor ">Jian  Zheng</span>, <span class="hlFld-ContribAuthor ">Krishani Dinali  Perera</span>, <span class="hlFld-ContribAuthor ">Lok-Yin Roy  Wong</span>, <span class="hlFld-ContribAuthor ">David K.  Meyerholz</span>, <span class="hlFld-ContribAuthor ">Harry Nhat  Nguyen</span>, <span class="hlFld-ContribAuthor ">Maithri M.  Kashipathy</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Battaile</span>, <span class="hlFld-ContribAuthor ">Scott  Lovell</span>, <span class="hlFld-ContribAuthor ">Yunjeong  Kim</span>, <span class="hlFld-ContribAuthor ">Stanley  Perlman</span>, <span class="hlFld-ContribAuthor ">William C.  Groutas</span>, <span class="hlFld-ContribAuthor ">Kyeong-Ok  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (29)
                                     , e2101555118. <a href="https://doi.org/10.1073/pnas.2101555118" title="DOI URL">https://doi.org/10.1073/pnas.2101555118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2101555118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2101555118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DPostinfection%252Btreatment%252Bwith%252Ba%252Bprotease%252Binhibitor%252Bincreases%252Bsurvival%252Bof%252Bmice%252Bwith%252Ba%252Bfatal%252BSARS-CoV-2%252Binfection%26aulast%3DDampalla%26aufirst%3DChamandi%2BS.%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D29%26spage%3De2101555118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongxin  Chen</span>, <span class="hlFld-ContribAuthor ">Jingting  Song</span>, <span class="hlFld-ContribAuthor ">Xinwen  Peng</span>, <span class="hlFld-ContribAuthor ">Shibo  Xi</span>, <span class="hlFld-ContribAuthor ">Jia  Liu</span>, <span class="hlFld-ContribAuthor ">Wenhui  Zhou</span>, <span class="hlFld-ContribAuthor ">Runlai  Li</span>, <span class="hlFld-ContribAuthor ">Rile  Ge</span>, <span class="hlFld-ContribAuthor ">Cuibo  Liu</span>, <span class="hlFld-ContribAuthor ">Haisen  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoxu  Zhao</span>, <span class="hlFld-ContribAuthor ">Haohan  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Zhou</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Xing  Li</span>, <span class="hlFld-ContribAuthor ">Linxin  Zhong</span>, <span class="hlFld-ContribAuthor ">Alexandre I.  Rykov</span>, <span class="hlFld-ContribAuthor ">Junhu  Wang</span>, <span class="hlFld-ContribAuthor ">Ming Joo  Koh</span>, <span class="hlFld-ContribAuthor ">Kian Ping  Loh</span>. </span><span class="cited-content_cbyCitation_article-title">Iron Single Atom Catalyzed Quinoline Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials</span><span> <strong>2021,</strong> <em>17 </em>, 2101382. <a href="https://doi.org/10.1002/adma.202101382" title="DOI URL">https://doi.org/10.1002/adma.202101382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adma.202101382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadma.202101382%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%26atitle%3DIron%252BSingle%252BAtom%252BCatalyzed%252BQuinoline%252BSynthesis%26aulast%3DChen%26aufirst%3DZhongxin%26date%3D2021%26date%3D2021%26volume%3D17%26spage%3D2101382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Xia</span>, <span class="hlFld-ContribAuthor ">Volker  Derdau</span>, <span class="hlFld-ContribAuthor ">Armido  Studer</span>. </span><span class="cited-content_cbyCitation_article-title">Remote Site‐Selective Radical C(sp
              3
              )−H Monodeuteration of Amides using D
              2
              O. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>305 </em><a href="https://doi.org/10.1002/anie.202104254" title="DOI URL">https://doi.org/10.1002/anie.202104254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202104254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202104254%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRemote%252BSite%2525E2%252580%252590Selective%252BRadical%252BC%252528sp%252B3%252B%252529%2525E2%252588%252592H%252BMonodeuteration%252Bof%252BAmides%252Busing%252BD%252B2%252BO%26aulast%3DWang%26aufirst%3DLin%26date%3D2021%26date%3D2021%26volume%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Xia</span>, <span class="hlFld-ContribAuthor ">Volker  Derdau</span>, <span class="hlFld-ContribAuthor ">Armido  Studer</span>. </span><span class="cited-content_cbyCitation_article-title">Remote Site‐Selective Radical C(sp
              3
              )−H Monodeuteration of Amides using D
              2
              O. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>305 </em><a href="https://doi.org/10.1002/ange.202104254" title="DOI URL">https://doi.org/10.1002/ange.202104254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202104254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202104254%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRemote%252BSite%2525E2%252580%252590Selective%252BRadical%252BC%252528sp%252B3%252B%252529%2525E2%252588%252592H%252BMonodeuteration%252Bof%252BAmides%252Busing%252BD%252B2%252BO%26aulast%3DWang%26aufirst%3DLin%26date%3D2021%26date%3D2021%26volume%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria S.  Ledovskaya</span>, <span class="hlFld-ContribAuthor ">Mikhail V.  Polynski</span>, <span class="hlFld-ContribAuthor ">Valentine P.  Ananikov</span>. </span><span class="cited-content_cbyCitation_article-title">One‐Pot and Two‐Chamber Methodologies for Using Acetylene Surrogates in the Synthesis of Pyridazines and Their D‐Labeled Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2021,</strong> <em>57 </em><a href="https://doi.org/10.1002/asia.202100562" title="DOI URL">https://doi.org/10.1002/asia.202100562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.202100562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.202100562%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DOne%2525E2%252580%252590Pot%252Band%252BTwo%2525E2%252580%252590Chamber%252BMethodologies%252Bfor%252BUsing%252BAcetylene%252BSurrogates%252Bin%252Bthe%252BSynthesis%252Bof%252BPyridazines%252Band%252BTheir%252BD%2525E2%252580%252590Labeled%252BDerivatives%26aulast%3DLedovskaya%26aufirst%3DMaria%2BS.%26date%3D2021%26date%3D2021%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoua Pa  Vang</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Hintzsche</span>, <span class="hlFld-ContribAuthor ">Joseph R.  Clark</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Transfer Deuteration and Hydrodeuteration: Emerging Techniques to Selectively Transform Alkenes and Alkynes to Deuterated Alkanes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (39)
                                     , 9988-10000. <a href="https://doi.org/10.1002/chem.202100635" title="DOI URL">https://doi.org/10.1002/chem.202100635</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100635%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DCatalytic%252BTransfer%252BDeuteration%252Band%252BHydrodeuteration%25253A%252BEmerging%252BTechniques%252Bto%252BSelectively%252BTransform%252BAlkenes%252Band%252BAlkynes%252Bto%252BDeuterated%252BAlkanes%26aulast%3DVang%26aufirst%3DZoua%2BPa%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D39%26spage%3D9988%26epage%3D10000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Cheng‐Pan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Additive‐Free Visible‐Light‐Mediated Hydro‐/Deuterodediazoniation of Arenediazonium Tetrafluoroborates in THF/THF‐
              
                d
                8
              . </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>16 </em><a href="https://doi.org/10.1002/ajoc.202100322" title="DOI URL">https://doi.org/10.1002/ajoc.202100322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100322%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAdditive%2525E2%252580%252590Free%252BVisible%2525E2%252580%252590Light%2525E2%252580%252590Mediated%252BHydro%2525E2%252580%252590%25252FDeuterodediazoniation%252Bof%252BArenediazonium%252BTetrafluoroborates%252Bin%252BTHF%25252FTHF%2525E2%252580%252590%252Bd%252B8%26aulast%3DYang%26aufirst%3DLian%26date%3D2021%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joost  Steverlynck</span>, <span class="hlFld-ContribAuthor ">Ruzal  Sitdikov</span>, <span class="hlFld-ContribAuthor ">Magnus  Rueping</span>. </span><span class="cited-content_cbyCitation_article-title">The Deuterated “Magic Methyl” Group: A Guide to Site‐Selective Trideuteromethyl Incorporation and Labeling by Using CD
              3
              Reagents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>26 </em><a href="https://doi.org/10.1002/chem.202101179" title="DOI URL">https://doi.org/10.1002/chem.202101179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202101179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202101179%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DThe%252BDeuterated%252B%2525E2%252580%25259CMagic%252BMethyl%2525E2%252580%25259D%252BGroup%25253A%252BA%252BGuide%252Bto%252BSite%2525E2%252580%252590Selective%252BTrideuteromethyl%252BIncorporation%252Band%252BLabeling%252Bby%252BUsing%252BCD%252B3%252BReagents%26aulast%3DSteverlynck%26aufirst%3DJoost%26date%3D2021%26date%3D2021%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Kopf</span>, <span class="hlFld-ContribAuthor ">Fei  Ye</span>, <span class="hlFld-ContribAuthor ">Helfried  Neumann</span>, <span class="hlFld-ContribAuthor ">Matthias  Beller</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium‐Catalyzed Deuteration of Aromatic Carbonyl Compounds with a Catalytic Transient Directing Group. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (38)
                                     , 9768-9773. <a href="https://doi.org/10.1002/chem.202100468" title="DOI URL">https://doi.org/10.1002/chem.202100468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100468%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DRuthenium%2525E2%252580%252590Catalyzed%252BDeuteration%252Bof%252BAromatic%252BCarbonyl%252BCompounds%252Bwith%252Ba%252BCatalytic%252BTransient%252BDirecting%252BGroup%26aulast%3DKopf%26aufirst%3DSara%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D38%26spage%3D9768%26epage%3D9773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haruna  Mizutani</span>, <span class="hlFld-ContribAuthor ">Ryouta  Kawanishi</span>, <span class="hlFld-ContribAuthor ">Kazutaka  Shibatomi</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective decarboxylative protonation and deuteration of β-ketocarboxylic acids. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (54)
                                     , 6676-6679. <a href="https://doi.org/10.1039/D1CC01610E" title="DOI URL">https://doi.org/10.1039/D1CC01610E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC01610E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC01610E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DEnantioselective%252Bdecarboxylative%252Bprotonation%252Band%252Bdeuteration%252Bof%252B%2525CE%2525B2-ketocarboxylic%252Bacids%26aulast%3DMizutani%26aufirst%3DHaruna%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D54%26spage%3D6676%26epage%3D6679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiyi  Wang</span>, <span class="hlFld-ContribAuthor ">Yibo  Yu</span>, <span class="hlFld-ContribAuthor ">Bao  Cheng</span>, <span class="hlFld-ContribAuthor ">Huayi  Fang</span>, <span class="hlFld-ContribAuthor ">Xue  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Qian</span>, <span class="hlFld-ContribAuthor ">Shengming  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Stereodefined rhodium-catalysed 1,4-H/D delivery for modular syntheses and deuterium integration. </span><span class="cited-content_cbyCitation_journal-name">Nature Catalysis</span><span> <strong>2021,</strong> <em>4 </em>
                                    (7)
                                     , 586-594. <a href="https://doi.org/10.1038/s41929-021-00643-9" title="DOI URL">https://doi.org/10.1038/s41929-021-00643-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41929-021-00643-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41929-021-00643-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Catalysis%26atitle%3DStereodefined%252Brhodium-catalysed%252B1%25252C4-H%25252FD%252Bdelivery%252Bfor%252Bmodular%252Bsyntheses%252Band%252Bdeuterium%252Bintegration%26aulast%3DWang%26aufirst%3DWeiyi%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D7%26spage%3D586%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Kuebler</span>, <span class="hlFld-ContribAuthor ">Sabrina  Buss</span>, <span class="hlFld-ContribAuthor ">Andrei  Leonov</span>, <span class="hlFld-ContribAuthor ">Sergey  Ryazanov</span>, <span class="hlFld-ContribAuthor ">Felix  Schmidt</span>, <span class="hlFld-ContribAuthor ">Andreas  Maurer</span>, <span class="hlFld-ContribAuthor ">Daniel  Weckbecker</span>, <span class="hlFld-ContribAuthor ">Anne M.  Landau</span>, <span class="hlFld-ContribAuthor ">Thea P.  Lillethorup</span>, <span class="hlFld-ContribAuthor ">Daniel  Bleher</span>, <span class="hlFld-ContribAuthor ">Ran Sing  Saw</span>, <span class="hlFld-ContribAuthor ">Bernd J.  Pichler</span>, <span class="hlFld-ContribAuthor ">Christian  Griesinger</span>, <span class="hlFld-ContribAuthor ">Armin  Giese</span>, <span class="hlFld-ContribAuthor ">Kristina  Herfert</span>. </span><span class="cited-content_cbyCitation_article-title">[11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2021,</strong> <em>48 </em>
                                    (6)
                                     , 1759-1772. <a href="https://doi.org/10.1007/s00259-020-05133-x" title="DOI URL">https://doi.org/10.1007/s00259-020-05133-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-05133-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-05133-x%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3D%25255B11C%25255DMODAG-001%2525E2%252580%252594towards%252Ba%252BPET%252Btracer%252Btargeting%252B%2525CE%2525B1-synuclein%252Baggregates%26aulast%3DKuebler%26aufirst%3DLaura%26date%3D2021%26date%3D2020%26volume%3D48%26issue%3D6%26spage%3D1759%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheting  Wang</span>, <span class="hlFld-ContribAuthor ">Chunhui  Yang</span>, <span class="hlFld-ContribAuthor ">Jingchao  Chen</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Ruhima  Khan</span>, <span class="hlFld-ContribAuthor ">Yong  Yang</span>, <span class="hlFld-ContribAuthor ">Xingfang  Qiao</span>, <span class="hlFld-ContribAuthor ">Zhimin  Su</span>, <span class="hlFld-ContribAuthor ">Baomin  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Transfer Hydrogenation of Trifluoromethylated Imines to Chiral
              α
              ‐Trifluoromethylated Amines With Alcohol as The Hydrogen Source. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 1530-1535. <a href="https://doi.org/10.1002/ajoc.202100201" title="DOI URL">https://doi.org/10.1002/ajoc.202100201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100201%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BTransfer%252BHydrogenation%252Bof%252BTrifluoromethylated%252BImines%252Bto%252BChiral%252B%2525CE%2525B1%252B%2525E2%252580%252590Trifluoromethylated%252BAmines%252BWith%252BAlcohol%252Bas%252BThe%252BHydrogen%252BSource%26aulast%3DWang%26aufirst%3DZheting%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D1530%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent  Porte</span>, <span class="hlFld-ContribAuthor ">Haoqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Daniel  Kaiser</span>, <span class="hlFld-ContribAuthor ">Nuno  Maulide</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing ynamide activation to access deuterated carbonyls. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>90 </em>, 132211. <a href="https://doi.org/10.1016/j.tet.2021.132211" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132211%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DHarnessing%252Bynamide%252Bactivation%252Bto%252Baccess%252Bdeuterated%252Bcarbonyls%26aulast%3DPorte%26aufirst%3DVincent%26date%3D2021%26volume%3D90%26spage%3D132211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengzhao  Li</span>, <span class="hlFld-ContribAuthor ">Mengqi  Peng</span>, <span class="hlFld-ContribAuthor ">Zemin  Lai</span>, <span class="hlFld-ContribAuthor ">Lei  Ning</span>, <span class="hlFld-ContribAuthor ">Xingyue  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoxu  Zhang</span>, <span class="hlFld-ContribAuthor ">Pengjie  Wang</span>, <span class="hlFld-ContribAuthor ">Roman  Szostak</span>, <span class="hlFld-ContribAuthor ">Michal  Szostak</span>, <span class="hlFld-ContribAuthor ">Jie  An</span>. </span><span class="cited-content_cbyCitation_article-title">Acyl fluorides as direct precursors to fluoride ketyl radicals: reductive deuteration using SmI
              2
              and D
              2
              O. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (42)
                                     , 5195-5198. <a href="https://doi.org/10.1039/D1CC01381E" title="DOI URL">https://doi.org/10.1039/D1CC01381E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC01381E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC01381E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DAcyl%252Bfluorides%252Bas%252Bdirect%252Bprecursors%252Bto%252Bfluoride%252Bketyl%252Bradicals%25253A%252Breductive%252Bdeuteration%252Busing%252BSmI%252B2%252Band%252BD%252B2%252BO%26aulast%3DLi%26aufirst%3DHengzhao%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D42%26spage%3D5195%26epage%3D5198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuangyang  Chen</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Lan-Gui  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Transition metal-free formal hydro/deuteromethylthiolation of unactivated alkenes. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (18)
                                     , 4037-4042. <a href="https://doi.org/10.1039/D1OB00413A" title="DOI URL">https://doi.org/10.1039/D1OB00413A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00413A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00413A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTransition%252Bmetal-free%252Bformal%252Bhydro%25252Fdeuteromethylthiolation%252Bof%252Bunactivated%252Balkenes%26aulast%3DChen%26aufirst%3DShuangyang%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D18%26spage%3D4037%26epage%3D4042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongpei  Wu</span>, <span class="hlFld-ContribAuthor ">Ke  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">B(C
              6
              F
              5
              )
              3
              -catalyzed tandem protonation/deuteration and reduction of
              in situ
              -formed enamines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (18)
                                     , 4032-4036. <a href="https://doi.org/10.1039/D1OB00316J" title="DOI URL">https://doi.org/10.1039/D1OB00316J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00316J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00316J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DB%252528C%252B6%252BF%252B5%252B%252529%252B3%252B-catalyzed%252Btandem%252Bprotonation%25252Fdeuteration%252Band%252Breduction%252Bof%252Bin%252Bsitu%252B-formed%252Benamines%26aulast%3DWu%26aufirst%3DRongpei%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D18%26spage%3D4032%26epage%3D4036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Ding</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Fener  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (3)
                                     , 1255-1290. <a href="https://doi.org/10.1002/med.21760" title="DOI URL">https://doi.org/10.1002/med.21760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21760%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDruggability%252Bmodification%252Bstrategies%252Bof%252Bthe%252Bdiarylpyrimidine%2525E2%252580%252590type%252Bnon%2525E2%252580%252590nucleoside%252Breverse%252Btranscriptase%252Binhibitors%26aulast%3DDing%26aufirst%3DLi%26date%3D2021%26date%3D2021%26volume%3D41%26issue%3D3%26spage%3D1255%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tsuyoshi  Yamada</span>, <span class="hlFld-ContribAuthor ">Kwihwan  Park</span>, <span class="hlFld-ContribAuthor ">Hironao  Sajiki</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Solid Catalysts for Selective Reactions and their Application to Continuous-Flow Reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Synthetic Organic Chemistry, Japan</span><span> <strong>2021,</strong> <em>79 </em>
                                    (5)
                                     , 472-482. <a href="https://doi.org/10.5059/yukigoseikyokaishi.79.472" title="DOI URL">https://doi.org/10.5059/yukigoseikyokaishi.79.472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5059/yukigoseikyokaishi.79.472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5059%2Fyukigoseikyokaishi.79.472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Synthetic%2520Organic%2520Chemistry%252C%2520Japan%26atitle%3DDevelopment%252Bof%252BSolid%252BCatalysts%252Bfor%252BSelective%252BReactions%252Band%252Btheir%252BApplication%252Bto%252BContinuous-Flow%252BReactions%26aulast%3DYamada%26aufirst%3DTsuyoshi%26date%3D2021%26volume%3D79%26issue%3D5%26spage%3D472%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mitchell A.  Klenner</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Pascali</span>, <span class="hlFld-ContribAuthor ">Benjamin H.  Fraser</span>, <span class="hlFld-ContribAuthor ">Tamim A.  Darwish</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>96-97 </em>, 112-147. <a href="https://doi.org/10.1016/j.nucmedbio.2021.03.011" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2021.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2021.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2021.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DKinetic%252Bisotope%252Beffects%252Band%252Bsynthetic%252Bstrategies%252Bfor%252Bdeuterated%252Bcarbon-11%252Band%252Bfluorine-18%252Blabelled%252BPET%252Bradiopharmaceuticals%26aulast%3DKlenner%26aufirst%3DMitchell%2BA.%26date%3D2021%26volume%3D96-97%26spage%3D112%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zedong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Wen</span>, <span class="hlFld-ContribAuthor ">Minyan  Wang</span>, <span class="hlFld-ContribAuthor ">Chao-Guo  Yan</span>, <span class="hlFld-ContribAuthor ">Zhuangzhi  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Green synthesis of α-deuterated boronates using DMTT reagent. </span><span class="cited-content_cbyCitation_journal-name">Green Synthesis and Catalysis</span><span> <strong>2021,</strong> <em>57 </em><a href="https://doi.org/10.1016/j.gresc.2021.05.001" title="DOI URL">https://doi.org/10.1016/j.gresc.2021.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gresc.2021.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gresc.2021.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Synthesis%2520and%2520Catalysis%26atitle%3DGreen%252Bsynthesis%252Bof%252B%2525CE%2525B1-deuterated%252Bboronates%252Busing%252BDMTT%252Breagent%26aulast%3DZhang%26aufirst%3DZedong%26date%3D2021%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Into the Fray! A Beginner's Guide to Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (8)
                                     , 1199-1225. <a href="https://doi.org/10.1002/cmdc.202000929" title="DOI URL">https://doi.org/10.1002/cmdc.202000929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000929%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DInto%252Bthe%252BFray%252521%252BA%252BBeginner%252527s%252BGuide%252Bto%252BMedicinal%252BChemistry%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D8%26spage%3D1199%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanshan  Cao</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Chunyi  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Fang</span>, <span class="hlFld-ContribAuthor ">Linyang  Ji</span>, <span class="hlFld-ContribAuthor ">Yingjiao  Xu</span>, <span class="hlFld-ContribAuthor ">Zhengping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of [18F]FECNT-d4 as a Novel PET Agent for Dopamine Transporter Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2021,</strong> <em>18 </em><a href="https://doi.org/10.1007/s11307-021-01603-2" title="DOI URL">https://doi.org/10.1007/s11307-021-01603-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-021-01603-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-021-01603-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B%25255B18F%25255DFECNT-d4%252Bas%252Ba%252BNovel%252BPET%252BAgent%252Bfor%252BDopamine%252BTransporter%252BImaging%26aulast%3DCao%26aufirst%3DShanshan%26date%3D2021%26date%3D2021%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nimisha  Thakur</span>, <span class="hlFld-ContribAuthor ">Saba  Aslani</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Armstrong</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of gas chromatography for the separation of a broad range of isotopic compounds. </span><span class="cited-content_cbyCitation_journal-name">Analytica Chimica Acta</span><span> <strong>2021,</strong> <em>62 </em>, 338490. <a href="https://doi.org/10.1016/j.aca.2021.338490" title="DOI URL">https://doi.org/10.1016/j.aca.2021.338490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aca.2021.338490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aca.2021.338490%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytica%2520Chimica%2520Acta%26atitle%3DEvaluation%252Bof%252Bgas%252Bchromatography%252Bfor%252Bthe%252Bseparation%252Bof%252Ba%252Bbroad%252Brange%252Bof%252Bisotopic%252Bcompounds%26aulast%3DThakur%26aufirst%3DNimisha%26date%3D2021%26volume%3D62%26spage%3D338490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaogang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Ren</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A practical synthesis of deuterated methylamine and dimethylamine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2021,</strong> <em>45 </em>
                                    (3-4)
                                     , 265-268. <a href="https://doi.org/10.1177/1747519820969636" title="DOI URL">https://doi.org/10.1177/1747519820969636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1747519820969636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1747519820969636%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DA%252Bpractical%252Bsynthesis%252Bof%252Bdeuterated%252Bmethylamine%252Band%252Bdimethylamine%26aulast%3DLiu%26aufirst%3DZhaogang%26date%3D2021%26date%3D2020%26volume%3D45%26issue%3D3-4%26spage%3D265%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Bruña</span>, <span class="hlFld-ContribAuthor ">Alan. R.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Michael  Fairley</span>, <span class="hlFld-ContribAuthor ">Charles T.  O'Hara</span>. </span><span class="cited-content_cbyCitation_article-title">Facile Access to Hetero‐poly‐functional Arenes and
              meta
              ‐Substituted Arenes via Two‐Step Dimetalation and Mg/Halogen‐Exchange Protocol. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (12)
                                     , 4134-4140. <a href="https://doi.org/10.1002/chem.202004696" title="DOI URL">https://doi.org/10.1002/chem.202004696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202004696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202004696%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFacile%252BAccess%252Bto%252BHetero%2525E2%252580%252590poly%2525E2%252580%252590functional%252BArenes%252Band%252Bmeta%252B%2525E2%252580%252590Substituted%252BArenes%252Bvia%252BTwo%2525E2%252580%252590Step%252BDimetalation%252Band%252BMg%25252FHalogen%2525E2%252580%252590Exchange%252BProtocol%26aulast%3DBru%25C3%25B1a%26aufirst%3DSonia%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D12%26spage%3D4134%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong  Zhou</span>, <span class="hlFld-ContribAuthor ">Lishuang  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaona  Yang</span>, <span class="hlFld-ContribAuthor ">Jilei  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in visible-light photocatalytic deuteration reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (3)
                                     , 426-444. <a href="https://doi.org/10.1039/D0QO01299H" title="DOI URL">https://doi.org/10.1039/D0QO01299H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01299H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01299H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRecent%252Badvances%252Bin%252Bvisible-light%252Bphotocatalytic%252Bdeuteration%252Breactions%26aulast%3DZhou%26aufirst%3DRong%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D3%26spage%3D426%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun Kumar  Sinha</span>, <span class="hlFld-ContribAuthor ">Rakesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances for construction and late-stage diversification of indole core via C–H bond activation/functionalization. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 207-248. <a href="https://doi.org/10.1016/B978-0-12-820586-0.00003-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-820586-0.00003-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820586-0.00003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820586-0.00003-0%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252Badvances%252Bfor%252Bconstruction%252Band%252Blate-stage%252Bdiversification%252Bof%252Bindole%252Bcore%252Bvia%252BC%2525E2%252580%252593H%252Bbond%252Bactivation%25252Ffunctionalization%26aulast%3DSinha%26aufirst%3DArun%2BKumar%26date%3D2021%26spage%3D207%26epage%3D248%26pub%3DElsevier%26atitle%3DGreen%252BSynthetic%252BApproaches%252Bfor%252BBiologically%252BRelevant%252BHeterocycles%26date%3D2021%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihao  Zha</span>, <span class="hlFld-ContribAuthor ">Karl  Ploessl</span>, <span class="hlFld-ContribAuthor ">Seok Rye  Choi</span>, <span class="hlFld-ContribAuthor ">David  Alexoff</span>, <span class="hlFld-ContribAuthor ">Hank F.  Kung</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>92 </em>, 97-106. <a href="https://doi.org/10.1016/j.nucmedbio.2020.03.003" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DPreclinical%252Bevaluation%252Bof%252B%25255B18F%25255DD3FSP%25252C%252Bdeuterated%252BAV-45%25252C%252Bfor%252Bimaging%252Bof%252B%2525CE%2525B2-amyloid%252Bin%252Bthe%252Bbrain%26aulast%3DZha%26aufirst%3DZhihao%26date%3D2021%26volume%3D92%26spage%3D97%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaping  Wu</span>, <span class="hlFld-ContribAuthor ">Baiyang  Qian</span>, <span class="hlFld-ContribAuthor ">Lili  Lu</span>, <span class="hlFld-ContribAuthor ">Haitao  Yang</span>, <span class="hlFld-ContribAuthor ">Yongjia  Shang</span>, <span class="hlFld-ContribAuthor ">Jitan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Access to the C2 C–H olefination, alkylation and deuteration of indoles by rhodium(
              iii
              ) catalysis: an opportunity for diverse syntheses. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>119 </em><a href="https://doi.org/10.1039/D1QO00133G" title="DOI URL">https://doi.org/10.1039/D1QO00133G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00133G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00133G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DAccess%252Bto%252Bthe%252BC2%252BC%2525E2%252580%252593H%252Bolefination%25252C%252Balkylation%252Band%252Bdeuteration%252Bof%252Bindoles%252Bby%252Brhodium%252528%252Biii%252B%252529%252Bcatalysis%25253A%252Ban%252Bopportunity%252Bfor%252Bdiverse%252Bsyntheses%26aulast%3DWu%26aufirst%3DJiaping%26date%3D2021%26date%3D2021%26volume%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Xiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonghai  Liu</span>, <span class="hlFld-ContribAuthor ">Chengtao  Sun</span>, <span class="hlFld-ContribAuthor ">Guoyin  Kai</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Hao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-free decarbonylative alkylation towards
              N
              -aryl α-hydroxy amides
              via
              triple C–C bond cleavages and their selective deuteration. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>114 </em><a href="https://doi.org/10.1039/D1QO00530H" title="DOI URL">https://doi.org/10.1039/D1QO00530H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00530H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00530H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DTransition-metal-free%252Bdecarbonylative%252Balkylation%252Btowards%252BN%252B-aryl%252B%2525CE%2525B1-hydroxy%252Bamides%252Bvia%252Btriple%252BC%2525E2%252580%252593C%252Bbond%252Bcleavages%252Band%252Btheir%252Bselective%252Bdeuteration%26aulast%3DSun%26aufirst%3DChengyu%26date%3D2021%26date%3D2021%26volume%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Lei  Nan</span>, <span class="hlFld-ContribAuthor ">Yao  Wang</span>, <span class="hlFld-ContribAuthor ">Xu-Bing  Li</span>, <span class="hlFld-ContribAuthor ">Chen-Ho  Tung</span>, <span class="hlFld-ContribAuthor ">Li-Zhu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Site-selective D
              2
              O-mediated deuteration of diaryl alcohols
              via
              quantum dots photocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>46 </em><a href="https://doi.org/10.1039/D1CC02551A" title="DOI URL">https://doi.org/10.1039/D1CC02551A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC02551A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC02551A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSite-selective%252BD%252B2%252BO-mediated%252Bdeuteration%252Bof%252Bdiaryl%252Balcohols%252Bvia%252Bquantum%252Bdots%252Bphotocatalysis%26aulast%3DNan%26aufirst%3DXiao-Lei%26date%3D2021%26date%3D2021%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daria S.  Timofeeva</span>, <span class="hlFld-ContribAuthor ">David M.  Lindsay</span>, <span class="hlFld-ContribAuthor ">William J.  Kerr</span>, <span class="hlFld-ContribAuthor ">David J.  Nelson</span>. </span><span class="cited-content_cbyCitation_article-title">Are rate and selectivity correlated in iridium-catalysed hydrogen isotope exchange reactions?. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Science & Technology</span><span> <strong>2021,</strong> <em>112 </em><a href="https://doi.org/10.1039/D1CY00708D" title="DOI URL">https://doi.org/10.1039/D1CY00708D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CY00708D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CY00708D%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Science%2520%2526%2520Technology%26atitle%3DAre%252Brate%252Band%252Bselectivity%252Bcorrelated%252Bin%252Biridium-catalysed%252Bhydrogen%252Bisotope%252Bexchange%252Breactions%25253F%26aulast%3DTimofeeva%26aufirst%3DDaria%2BS.%26date%3D2021%26date%3D2021%26volume%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie  Meyer</span>, <span class="hlFld-ContribAuthor ">Joel  Häfliger</span>, <span class="hlFld-ContribAuthor ">Ryan  Gilmour</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding organofluorine chemical space: the design of chiral fluorinated isosteres enabled by I(
              i
              )/I(
              iii
              ) catalysis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>37 </em><a href="https://doi.org/10.1039/D1SC02880D" title="DOI URL">https://doi.org/10.1039/D1SC02880D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC02880D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC02880D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DExpanding%252Borganofluorine%252Bchemical%252Bspace%25253A%252Bthe%252Bdesign%252Bof%252Bchiral%252Bfluorinated%252Bisosteres%252Benabled%252Bby%252BI%252528%252Bi%252B%252529%25252FI%252528%252Biii%252B%252529%252Bcatalysis%26aulast%3DMeyer%26aufirst%3DStephanie%26date%3D2021%26date%3D2021%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgan  Lecomte</span>, <span class="hlFld-ContribAuthor ">Mounsef  Lahboubi</span>, <span class="hlFld-ContribAuthor ">Pierre  Thilmany</span>, <span class="hlFld-ContribAuthor ">Adil  El Bouzakhi</span>, <span class="hlFld-ContribAuthor ">Gwilherm  Evano</span>. </span><span class="cited-content_cbyCitation_article-title">A general, versatile and divergent synthesis of selectively deuterated amines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>71 </em><a href="https://doi.org/10.1039/D1SC02622D" title="DOI URL">https://doi.org/10.1039/D1SC02622D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC02622D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC02622D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DA%252Bgeneral%25252C%252Bversatile%252Band%252Bdivergent%252Bsynthesis%252Bof%252Bselectively%252Bdeuterated%252Bamines%26aulast%3DLecomte%26aufirst%3DMorgan%26date%3D2021%26date%3D2021%26volume%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent  Porte</span>, <span class="hlFld-ContribAuthor ">Giovanni  Di Mauro</span>, <span class="hlFld-ContribAuthor ">Manuel  Schupp</span>, <span class="hlFld-ContribAuthor ">Daniel  Kaiser</span>, <span class="hlFld-ContribAuthor ">Nuno  Maulide</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselective Alpha‐Deuteration of Amides via Retro‐ene Reaction. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (67)
                                     , 15509-15512. <a href="https://doi.org/10.1002/chem.202004103" title="DOI URL">https://doi.org/10.1002/chem.202004103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202004103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202004103%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DChemoselective%252BAlpha%2525E2%252580%252590Deuteration%252Bof%252BAmides%252Bvia%252BRetro%2525E2%252580%252590ene%252BReaction%26aulast%3DPorte%26aufirst%3DVincent%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D67%26spage%3D15509%26epage%3D15512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. S.  Rowbotham</span>, <span class="hlFld-ContribAuthor ">M. A.  Ramirez</span>, <span class="hlFld-ContribAuthor ">O.  Lenz</span>, <span class="hlFld-ContribAuthor ">H. A.  Reeve</span>, <span class="hlFld-ContribAuthor ">K. A.  Vincent</span>. </span><span class="cited-content_cbyCitation_article-title">Bringing biocatalytic deuteration into the toolbox of asymmetric isotopic labelling techniques. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-15310-z" title="DOI URL">https://doi.org/10.1038/s41467-020-15310-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-15310-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-15310-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DBringing%252Bbiocatalytic%252Bdeuteration%252Binto%252Bthe%252Btoolbox%252Bof%252Basymmetric%252Bisotopic%252Blabelling%252Btechniques%26aulast%3DRowbotham%26aufirst%3DJ.%2BS.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaofei  Zhang</span>, <span class="hlFld-ContribAuthor ">Chuntian  Qiu</span>, <span class="hlFld-ContribAuthor ">Yangsen  Xu</span>, <span class="hlFld-ContribAuthor ">Qing  Han</span>, <span class="hlFld-ContribAuthor ">Junwang  Tang</span>, <span class="hlFld-ContribAuthor ">Kian Ping  Loh</span>, <span class="hlFld-ContribAuthor ">Chenliang  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Semiconductor photocatalysis to engineering deuterated N-alkyl pharmaceuticals enabled by synergistic activation of water and alkanols. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-18458-w" title="DOI URL">https://doi.org/10.1038/s41467-020-18458-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-18458-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-18458-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DSemiconductor%252Bphotocatalysis%252Bto%252Bengineering%252Bdeuterated%252BN-alkyl%252Bpharmaceuticals%252Benabled%252Bby%252Bsynergistic%252Bactivation%252Bof%252Bwater%252Band%252Balkanols%26aulast%3DZhang%26aufirst%3DZhaofei%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prabhat  Ranjan</span>, <span class="hlFld-ContribAuthor ">Serena  Pillitteri</span>, <span class="hlFld-ContribAuthor ">Erik V.  Van der Eycken</span>, <span class="hlFld-ContribAuthor ">Upendra K.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Photochemical methods for deuterium labelling of organic molecules. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (22)
                                     , 7725-7736. <a href="https://doi.org/10.1039/D0GC02901G" title="DOI URL">https://doi.org/10.1039/D0GC02901G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC02901G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC02901G%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DPhotochemical%252Bmethods%252Bfor%252Bdeuterium%252Blabelling%252Bof%252Borganic%252Bmolecules%26aulast%3DRanjan%26aufirst%3DPrabhat%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D22%26spage%3D7725%26epage%3D7736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haibo  Xie</span>, <span class="hlFld-ContribAuthor ">Ka  Yang</span>, <span class="hlFld-ContribAuthor ">Gabrielle N.  Winston-McPherson</span>, <span class="hlFld-ContribAuthor ">Donnie S.  Stapleton</span>, <span class="hlFld-ContribAuthor ">Mark P.  Keller</span>, <span class="hlFld-ContribAuthor ">Alan D.  Attie</span>, <span class="hlFld-ContribAuthor ">Kerry A.  Smith</span>, <span class="hlFld-ContribAuthor ">Weiping  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">From methylene bridged diindole to carbonyl linked benzimidazoleindole: Development of potent and metabolically stable PCSK9 modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112678. <a href="https://doi.org/10.1016/j.ejmech.2020.112678" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112678%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252Bmethylene%252Bbridged%252Bdiindole%252Bto%252Bcarbonyl%252Blinked%252Bbenzimidazoleindole%25253A%252BDevelopment%252Bof%252Bpotent%252Band%252Bmetabolically%252Bstable%252BPCSK9%252Bmodulators%26aulast%3DXie%26aufirst%3DHaibo%26date%3D2020%26volume%3D206%26spage%3D112678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing  Peng</span>, <span class="hlFld-ContribAuthor ">Fa‐Guang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun‐An  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Cu‐Catalysed Three‐Component Reaction of Aryldiazonium Salts with Fluorinated Diazo Reagents and Nitriles: Access to Difluoro‐ and Trifluoromethylated
              N
              1
              ‐Aryl‐1,2,4‐triazoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (20)
                                     , 4432-4437. <a href="https://doi.org/10.1002/adsc.202000776" title="DOI URL">https://doi.org/10.1002/adsc.202000776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000776%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCu%2525E2%252580%252590Catalysed%252BThree%2525E2%252580%252590Component%252BReaction%252Bof%252BAryldiazonium%252BSalts%252Bwith%252BFluorinated%252BDiazo%252BReagents%252Band%252BNitriles%25253A%252BAccess%252Bto%252BDifluoro%2525E2%252580%252590%252Band%252BTrifluoromethylated%252BN%252B1%252B%2525E2%252580%252590Aryl%2525E2%252580%2525901%25252C2%25252C4%2525E2%252580%252590triazoles%26aulast%3DPeng%26aufirst%3DXing%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D20%26spage%3D4432%26epage%3D4437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus  Laube</span>, <span class="hlFld-ContribAuthor ">Cemena  Gassner</span>, <span class="hlFld-ContribAuthor ">Christin  Neuber</span>, <span class="hlFld-ContribAuthor ">Robert  Wodtke</span>, <span class="hlFld-ContribAuthor ">Martin  Ullrich</span>, <span class="hlFld-ContribAuthor ">Cathleen  Haase-Kohn</span>, <span class="hlFld-ContribAuthor ">Reik  Löser</span>, <span class="hlFld-ContribAuthor ">Martin  Köckerling</span>, <span class="hlFld-ContribAuthor ">Klaus  Kopka</span>, <span class="hlFld-ContribAuthor ">Torsten  Kniess</span>, <span class="hlFld-ContribAuthor ">Evamarie  Hey-Hawkins</span>, <span class="hlFld-ContribAuthor ">Jens  Pietzsch</span>. </span><span class="cited-content_cbyCitation_article-title">Deuteration
              versus
              ethylation – strategies to improve the metabolic fate of an
              18
              F-labeled celecoxib derivative. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (63)
                                     , 38601-38611. <a href="https://doi.org/10.1039/D0RA04494F" title="DOI URL">https://doi.org/10.1039/D0RA04494F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA04494F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA04494F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDeuteration%252Bversus%252Bethylation%252B%2525E2%252580%252593%252Bstrategies%252Bto%252Bimprove%252Bthe%252Bmetabolic%252Bfate%252Bof%252Ban%252B18%252BF-labeled%252Bcelecoxib%252Bderivative%26aulast%3DLaube%26aufirst%3DMarkus%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D63%26spage%3D38601%26epage%3D38611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Siyu  Wang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Huazhou  Ying</span>, <span class="hlFld-ContribAuthor ">Hao  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jinxin  Che</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Gang  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Pharmacokinetic Study of Deuterated Ticagrelor Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (35)
                                     , 10924-10927. <a href="https://doi.org/10.1002/slct.202002605" title="DOI URL">https://doi.org/10.1002/slct.202002605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002605%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BPharmacokinetic%252BStudy%252Bof%252BDeuterated%252BTicagrelor%252BDerivatives%26aulast%3DChen%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D35%26spage%3D10924%26epage%3D10927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryoya  Takakura</span>, <span class="hlFld-ContribAuthor ">Kaho  Koyama</span>, <span class="hlFld-ContribAuthor ">Marina  Kuwata</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Yamada</span>, <span class="hlFld-ContribAuthor ">Hironao  Sajiki</span>, <span class="hlFld-ContribAuthor ">Yoshinari  Sawama</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroquinone and benzoquinone-catalyzed aqueous Knoevenagel condensation. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (34)
                                     , 6594-6597. <a href="https://doi.org/10.1039/D0OB01397H" title="DOI URL">https://doi.org/10.1039/D0OB01397H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01397H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01397H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DHydroquinone%252Band%252Bbenzoquinone-catalyzed%252Baqueous%252BKnoevenagel%252Bcondensation%26aulast%3DTakakura%26aufirst%3DRyoya%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D34%26spage%3D6594%26epage%3D6597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengfei  Jin</span>, <span class="hlFld-ContribAuthor ">Hang T.  Dang</span>, <span class="hlFld-ContribAuthor ">Graham C.  Haug</span>, <span class="hlFld-ContribAuthor ">Viet D.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Hadi D.  Arman</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Larionov</span>. </span><span class="cited-content_cbyCitation_article-title">Deoxygenative α-alkylation and α-arylation of 1,2-dicarbonyls. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (34)
                                     , 9101-9108. <a href="https://doi.org/10.1039/D0SC03118F" title="DOI URL">https://doi.org/10.1039/D0SC03118F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC03118F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC03118F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDeoxygenative%252B%2525CE%2525B1-alkylation%252Band%252B%2525CE%2525B1-arylation%252Bof%252B1%25252C2-dicarbonyls%26aulast%3DJin%26aufirst%3DShengfei%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D34%26spage%3D9101%26epage%3D9108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Igor  Zlatskiy</span>, <span class="hlFld-ContribAuthor ">Tatiana  Pleteneva</span>, <span class="hlFld-ContribAuthor ">Alexander  Skripnikov</span>, <span class="hlFld-ContribAuthor ">Tatiana  Grebennikova</span>, <span class="hlFld-ContribAuthor ">Tatiana  Maksimova</span>, <span class="hlFld-ContribAuthor ">Nadine  Antipova</span>, <span class="hlFld-ContribAuthor ">Olga  Levitskaya</span>, <span class="hlFld-ContribAuthor ">Mariia  Makarova</span>, <span class="hlFld-ContribAuthor ">Igor  Selivanenko</span>, <span class="hlFld-ContribAuthor ">Anton  Syroeshkin</span>. </span><span class="cited-content_cbyCitation_article-title">Dependence of Biocatalysis on D/H Ratio: Possible Fundamental Differences for High-Level Biological Taxons. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4173. <a href="https://doi.org/10.3390/molecules25184173" title="DOI URL">https://doi.org/10.3390/molecules25184173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184173%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDependence%252Bof%252BBiocatalysis%252Bon%252BD%25252FH%252BRatio%25253A%252BPossible%252BFundamental%252BDifferences%252Bfor%252BHigh-Level%252BBiological%252BTaxons%26aulast%3DZlatskiy%26aufirst%3DIgor%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria S.  Ledovskaya</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Voronin</span>, <span class="hlFld-ContribAuthor ">Mikhail V.  Polynski</span>, <span class="hlFld-ContribAuthor ">Andrey N.  Lebedev</span>, <span class="hlFld-ContribAuthor ">Valentine P.  Ananikov</span>. </span><span class="cited-content_cbyCitation_article-title">Primary Vinyl Ethers as Acetylene Surrogate: A Flexible Tool for Deuterium-Labeled Pyrazole Synthesis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (29)
                                     , 4571-4580. <a href="https://doi.org/10.1002/ejoc.202000674" title="DOI URL">https://doi.org/10.1002/ejoc.202000674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000674%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPrimary%252BVinyl%252BEthers%252Bas%252BAcetylene%252BSurrogate%25253A%252BA%252BFlexible%252BTool%252Bfor%252BDeuterium-Labeled%252BPyrazole%252BSynthesis%26aulast%3DLedovskaya%26aufirst%3DMaria%2BS.%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D29%26spage%3D4571%26epage%3D4580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa A.  Thompson</span>, <span class="hlFld-ContribAuthor ">Jack S.  Rowbotham</span>, <span class="hlFld-ContribAuthor ">Jake H.  Nicholson</span>, <span class="hlFld-ContribAuthor ">Miguel A.  Ramirez</span>, <span class="hlFld-ContribAuthor ">Ceren  Zor</span>, <span class="hlFld-ContribAuthor ">Holly A.  Reeve</span>, <span class="hlFld-ContribAuthor ">Nicole  Grobert</span>, <span class="hlFld-ContribAuthor ">Kylie A.  Vincent</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid, Heterogeneous Biocatalytic Hydrogenation and Deuteration in a Continuous Flow Reactor. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2020,</strong> <em>12 </em>
                                    (15)
                                     , 3913-3918. <a href="https://doi.org/10.1002/cctc.202000161" title="DOI URL">https://doi.org/10.1002/cctc.202000161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.202000161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.202000161%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DRapid%25252C%252BHeterogeneous%252BBiocatalytic%252BHydrogenation%252Band%252BDeuteration%252Bin%252Ba%252BContinuous%252BFlow%252BReactor%26aulast%3DThompson%26aufirst%3DLisa%2BA.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D15%26spage%3D3913%26epage%3D3918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wanmei  Li</span>, <span class="hlFld-ContribAuthor ">Heng  Cai</span>, <span class="hlFld-ContribAuthor ">Lin  Huang</span>, <span class="hlFld-ContribAuthor ">Lei  He</span>, <span class="hlFld-ContribAuthor ">Yilan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Iron(III)-Mediated Rapid Radical-Type Three-Component Deuteration of Quinoxalinones With Olefins and NaBD4. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.00606" title="DOI URL">https://doi.org/10.3389/fchem.2020.00606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.00606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.00606%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DIron%252528III%252529-Mediated%252BRapid%252BRadical-Type%252BThree-Component%252BDeuteration%252Bof%252BQuinoxalinones%252BWith%252BOlefins%252Band%252BNaBD4%26aulast%3DLi%26aufirst%3DWanmei%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuichi  Kambayashi</span>, <span class="hlFld-ContribAuthor ">Mihoko  Hagiwara-Nagasawa</span>, <span class="hlFld-ContribAuthor ">Yoshiki  Kondo</span>, <span class="hlFld-ContribAuthor ">Zhi Jie  Yeo</span>, <span class="hlFld-ContribAuthor ">Ai  Goto</span>, <span class="hlFld-ContribAuthor ">Koki  Chiba</span>, <span class="hlFld-ContribAuthor ">Yoshio  Nunoi</span>, <span class="hlFld-ContribAuthor ">Hiroko  Izumi-Nakaseko</span>, <span class="hlFld-ContribAuthor ">Jacqueline Wen Hui  Leow</span>, <span class="hlFld-ContribAuthor ">Gopalakrishnan  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Akio  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Eric Chun Yong  Chan</span>, <span class="hlFld-ContribAuthor ">Atsushi  Sugiyama</span>. </span><span class="cited-content_cbyCitation_article-title">How the Deuteration of Dronedarone Can Modify Its Cardiovascular Profile: In Vivo Characterization of Electropharmacological Effects of Poyendarone, a Deuterated Analogue of Dronedarone. </span><span class="cited-content_cbyCitation_journal-name">Cardiovascular Toxicology</span><span> <strong>2020,</strong> <em>20 </em>
                                    (4)
                                     , 339-350. <a href="https://doi.org/10.1007/s12012-019-09559-0" title="DOI URL">https://doi.org/10.1007/s12012-019-09559-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12012-019-09559-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12012-019-09559-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiovascular%2520Toxicology%26atitle%3DHow%252Bthe%252BDeuteration%252Bof%252BDronedarone%252BCan%252BModify%252BIts%252BCardiovascular%252BProfile%25253A%252BIn%252BVivo%252BCharacterization%252Bof%252BElectropharmacological%252BEffects%252Bof%252BPoyendarone%25252C%252Ba%252BDeuterated%252BAnalogue%252Bof%252BDronedarone%26aulast%3DKambayashi%26aufirst%3DRyuichi%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D339%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bioisosteres. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 225-304. <a href="https://doi.org/10.1002/9781119607311.ch4" title="DOI URL">https://doi.org/10.1002/9781119607311.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DBioisosteres%26date%3D2020%26date%3D2020%26spage%3D225%26epage%3D304%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  Lázaro-Milla</span>, <span class="hlFld-ContribAuthor ">M. Teresa  Quirós</span>, <span class="hlFld-ContribAuthor ">Diego J.  Cárdenas</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Triflyl-assisted reductive Pd-catalyzed Tsuji–Trost type reaction. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (45)
                                     , 6070-6073. <a href="https://doi.org/10.1039/D0CC02146F" title="DOI URL">https://doi.org/10.1039/D0CC02146F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC02146F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC02146F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTriflyl-assisted%252Breductive%252BPd-catalyzed%252BTsuji%2525E2%252580%252593Trost%252Btype%252Breaction%26aulast%3DL%25C3%25A1zaro-Milla%26aufirst%3DCarlos%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D45%26spage%3D6070%26epage%3D6073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingui  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengya  Gao</span>, <span class="hlFld-ContribAuthor ">Qiang  Fu</span>, <span class="hlFld-ContribAuthor ">Lin  Song</span>, <span class="hlFld-ContribAuthor ">Peiyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Howard  Hendrickson</span>, <span class="hlFld-ContribAuthor ">Peter A.  Crooks</span>, <span class="hlFld-ContribAuthor ">Daohong  Zhou</span>, <span class="hlFld-ContribAuthor ">Guangrong  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Deuteration of the farnesyl terminal methyl groups of δ-tocotrienol and its effects on the metabolic stability and ability of inducing G-CSF production. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (11)
                                     , 115498. <a href="https://doi.org/10.1016/j.bmc.2020.115498" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115498%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDeuteration%252Bof%252Bthe%252Bfarnesyl%252Bterminal%252Bmethyl%252Bgroups%252Bof%252B%2525CE%2525B4-tocotrienol%252Band%252Bits%252Beffects%252Bon%252Bthe%252Bmetabolic%252Bstability%252Band%252Bability%252Bof%252Binducing%252BG-CSF%252Bproduction%26aulast%3DLiu%26aufirst%3DXingui%26date%3D2020%26volume%3D28%26issue%3D11%26spage%3D115498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Jin</span>, <span class="hlFld-ContribAuthor ">Jianying  Tong</span>, <span class="hlFld-ContribAuthor ">Wenbo  Yu</span>, <span class="hlFld-ContribAuthor ">Jun  Qiao</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Iodobenzene-catalyzed oxidative C H d-alkoxylation of quinoxalinones with deuterated alcohols. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Communications</span><span> <strong>2020,</strong> <em>141 </em>, 106008. <a href="https://doi.org/10.1016/j.catcom.2020.106008" title="DOI URL">https://doi.org/10.1016/j.catcom.2020.106008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.catcom.2020.106008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.catcom.2020.106008%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Communications%26atitle%3DIodobenzene-catalyzed%252Boxidative%252BC%252BH%252Bd-alkoxylation%252Bof%252Bquinoxalinones%252Bwith%252Bdeuterated%252Balcohols%26aulast%3DJin%26aufirst%3DJianzhong%26date%3D2020%26volume%3D141%26spage%3D106008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. V.  Syroeshkin</span>, <span class="hlFld-ContribAuthor ">T. E.  Elizarova</span>, <span class="hlFld-ContribAuthor ">T. V.  Pleteneva</span>, <span class="hlFld-ContribAuthor ">E. V.  Uspenskaya</span>, <span class="hlFld-ContribAuthor ">O. V.  Levitskaya</span>, <span class="hlFld-ContribAuthor ">I. A.  Zlatskiy</span>, <span class="hlFld-ContribAuthor ">T. V.  Maksimova</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Deuterium on the Properties of Pharmaceutical Substances (Review). </span><span class="cited-content_cbyCitation_journal-name">Drug development & registration</span><span> <strong>2020,</strong> <em>9 </em>
                                    (2)
                                     , 24-32. <a href="https://doi.org/10.33380/2305-2066-2020-9-2-24-32" title="DOI URL">https://doi.org/10.33380/2305-2066-2020-9-2-24-32</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.33380/2305-2066-2020-9-2-24-32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.33380%2F2305-2066-2020-9-2-24-32%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520development%2520%2526%2520registration%26atitle%3DThe%252BInfluence%252Bof%252BDeuterium%252Bon%252Bthe%252BProperties%252Bof%252BPharmaceutical%252BSubstances%252B%252528Review%252529%26aulast%3DSyroeshkin%26aufirst%3DA.%2BV.%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D2%26spage%3D24%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vu T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Viet D.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Graham C.  Haug</span>, <span class="hlFld-ContribAuthor ">Ngan T. H.  Vuong</span>, <span class="hlFld-ContribAuthor ">Hang T.  Dang</span>, <span class="hlFld-ContribAuthor ">Hadi D.  Arman</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Larionov</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Enabled Direct Decarboxylative N‐Alkylation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (20)
                                     , 7995-8001. <a href="https://doi.org/10.1002/ange.201916710" title="DOI URL">https://doi.org/10.1002/ange.201916710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201916710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201916710%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Enabled%252BDirect%252BDecarboxylative%252BN%2525E2%252580%252590Alkylation%26aulast%3DNguyen%26aufirst%3DVu%2BT.%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D20%26spage%3D7995%26epage%3D8001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vu T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Viet D.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Graham C.  Haug</span>, <span class="hlFld-ContribAuthor ">Ngan T. H.  Vuong</span>, <span class="hlFld-ContribAuthor ">Hang T.  Dang</span>, <span class="hlFld-ContribAuthor ">Hadi D.  Arman</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Larionov</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Enabled Direct Decarboxylative N‐Alkylation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (20)
                                     , 7921-7927. <a href="https://doi.org/10.1002/anie.201916710" title="DOI URL">https://doi.org/10.1002/anie.201916710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201916710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201916710%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Enabled%252BDirect%252BDecarboxylative%252BN%2525E2%252580%252590Alkylation%26aulast%3DNguyen%26aufirst%3DVu%2BT.%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D20%26spage%3D7921%26epage%3D7927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Xu-Jie  Qin</span>, <span class="hlFld-ContribAuthor ">Qiong  Jin</span>, <span class="hlFld-ContribAuthor ">Hao-Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Cai-Feng  Ding</span>, <span class="hlFld-ContribAuthor ">Afsar  Khan</span>, <span class="hlFld-ContribAuthor ">Ya-Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Chengfeng  Xia</span>, <span class="hlFld-ContribAuthor ">Xiao-Dong  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Indole alkaloids with self-activated sp2 C H bond from Alstonia scholaris. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (21)
                                     , 151894. <a href="https://doi.org/10.1016/j.tetlet.2020.151894" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151894%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIndole%252Balkaloids%252Bwith%252Bself-activated%252Bsp2%252BC%252BH%252Bbond%252Bfrom%252BAlstonia%252Bscholaris%26aulast%3DWei%26aufirst%3DXin%26date%3D2020%26volume%3D61%26issue%3D21%26spage%3D151894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minyan  Wang</span>, <span class="hlFld-ContribAuthor ">Yunfei  Zhao</span>, <span class="hlFld-ContribAuthor ">Yue  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhuangzhi  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Bioinspired design of a robust
              d
              3
              -methylating agent. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2020,</strong> <em>6 </em>
                                    (19)
                                     , eaba0946. <a href="https://doi.org/10.1126/sciadv.aba0946" title="DOI URL">https://doi.org/10.1126/sciadv.aba0946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.aba0946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.aba0946%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DBioinspired%252Bdesign%252Bof%252Ba%252Brobust%252Bd%252B3%252B-methylating%252Bagent%26aulast%3DWang%26aufirst%3DMinyan%26date%3D2020%26date%3D2020%26volume%3D6%26issue%3D19%26spage%3Deaba0946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.8b01808&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01808%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-11&amp;citedByCount=113&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of deutetrabenazine, BMS-986165, VX-984, and CTP-354.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>d</i><sub>3</sub>-L-DOPA and its metabolites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of molecules from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> not shown elsewhere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of <i>d</i><sub>5</sub>-rofecoxib, <i>d</i><sub>3</sub>-ligand for GABA<sub>A</sub>-α6, <i>d</i><sub>3</sub>-imatinib, <i>d</i><sub>2</sub>-aurora kinase inhibitor, and <i>d</i><sub>5</sub>-maraviroc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Deuteration of dapaglifozin analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <i>d</i><sub>15</sub>-Atazanavir and <i>d</i><sub>6</sub>-dextromethorphan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Deuteration applied to drug release and polymer biodegradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Metabolic pathway of <i>d</i><sub>4</sub>-ifosfamide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Metabolic pathway of <i>d</i><sub>1</sub>- JNJ38877605.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Metabolic pathway of <i>d</i><sub>1</sub>-erythromycin B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. <i>d</i><sub>9</sub>-Tramadol and its <i>O</i>-desmethyl metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Irreversible complex with CYP2D6 of paroxetine and structure of <i>d</i><sub>2</sub>-paroxetine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Clopidogrel and <i>d</i><sub>6</sub>-clopidogrel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <i>d</i><sub>1</sub>-Telaprevir, <i>d</i><sub>1</sub>-CC-122 and <i>d</i><sub>1</sub>-pioglitazone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Ketamine, its metabolites, and <i>d</i><sub>2</sub>-ketamine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of selected PET tracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Metabolic pathway of <i>d</i><sub>7</sub>-[<sup>11</sup>C]-Cou.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of molecules from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> not shown elsewhere.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">()</a><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">()</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Synthesis of <i>d</i><sub>2</sub>-paroxetine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures of clinical candidates from <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> not shown elsewhere.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">()</a><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">()</a><a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">()</a><a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">()</a><a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">()</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Lipoperoxidation process of linoleic acid and structure of RT001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Biosynthesis of vitamin A polyene dimers and structure of ALK-001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Pentoxifylline, HDX, and <i>d</i><sub>5</sub>-HDX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/medium/jm-2018-01808r_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. <i>d</i><sub>3</sub>-Sorafenib and zilascorb(2H).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.8b01808/20190607/images/large/jm-2018-01808r_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01808&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 123 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> Established by the internationally
accepted Vienna Standard Mean Ocean Water (VSMOW).<span class="NLM_contrib-group"><span class="NLM_string-name">Rosman, K. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P. D. P.</span></span> <span> </span><span class="NLM_article-title">Isotopic compositions of the elements 1997 (Technical Report)</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1351/pac199870010217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1351%2Fpac199870010217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1cXjsVGntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=217-235&author=K.+J.+R.+Rosmanauthor=P.+D.+P.+Taylor&title=Isotopic+compositions+of+the+elements+1997+%28Technical+Report%29&doi=10.1351%2Fpac199870010217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isotopic compositions of the elements, 1997</span></div><div class="casAuthors">Rosman, K. J. R.; Taylor, P. D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-235</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The Commission's Subcommittee for the Isotopic Compn. of the Elements (SIAM) has carried out its biennial review of isotopic compns., such as detd. by mass spectrometry and other relevant methods.  This involves a crit. evaluation of the published literature, element by element, and forms th basis of the Table of Isotopic Compns. of the Elements as detd. by Mass Spectroscopy presented here.  New guidelines have been used to arrive at the uncertainties on the isotopic abundances and there are numerous changes to the Table since it was last published in 1991.  At. wts. calcd. from this table are consistent with Sr(E) values listed in the Table of Std. At. Wts. 1997.  A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5qh2-u64-Z7Vg90H21EOLACvtfcHk0lhYVWKTP-KWnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsVGntLY%253D&md5=209535668c87b00dfb80ea67bea10bb0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1351%2Fpac199870010217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac199870010217%26sid%3Dliteratum%253Aachs%26aulast%3DRosman%26aufirst%3DK.%2BJ.%2BR.%26aulast%3DTaylor%26aufirst%3DP.%2BD.%2BP.%26atitle%3DIsotopic%2520compositions%2520of%2520the%2520elements%25201997%2520%2528Technical%2520Report%2529%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1998%26volume%3D70%26spage%3D217%26epage%3D235%26doi%3D10.1351%2Fpac199870010217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urey, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brickwedde, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G. M.</span></span> <span> </span><span class="NLM_article-title">A hydrogen isotope of mass 2 and its concentration</span>. <i>Phys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1932</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1103/PhysRev.40.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1103%2FPhysRev.40.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaA38XktFWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1932&pages=1-15&author=H.+C.+Ureyauthor=F.+G.+Brickweddeauthor=G.+M.+Murphy&title=A+hydrogen+isotope+of+mass+2+and+its+concentration&doi=10.1103%2FPhysRev.40.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The hydrogen isotope of mass 2 and its concentration</span></div><div class="casAuthors">Urey, Harold C.; Brickwedde, F. G.; Murphy, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Physical Review</span>
        (<span class="NLM_cas:date">1932</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">PHRVAO</span>;
        ISSN:<span class="NLM_cas:issn">0031-899X</span>.
    </div><div class="casAbstract">cf. C. A. 26, 1857.  An isotope of H with mass no. 2 has been found present to the extent of one part in about 4000 in ordinary H.  No evidence for H3 was obtained.  The vapor pressures of pure crystals contg. only a single species of the isotopic mols. H1H1, H1H2, H1F3 were calcd. after postulating (1) that the rotational and vibrational energies of the mols. are the same in the solid and gaseous states; (2) that in the Debye theory of the solid state, θ is inversely proportional to the square root of the mol. mass; (3) that the free energy of the gas is given by the free-energy equation of an ideal monat. gas; and (4) that there is a zero-point lattice energy equal to (9/8) R θ per mol.  The calcd. vapor pressures of the 3 isotopic mols. in equil. with their solids at the triple point for ordinary H are in the ratio p11:p12:p13 = 1:0.37:0.29.  The isotope was concd. in 3 samples of gas by evapg. large quantities of liquid H2 and collecting the gas which evapd. from the last 2 or 3 cc.  These samples and ordinary H2 were investigated for the visible at. Balmer series spectra of H2 and H3 from a H2 discharge tube with a 21-ft. grating that had a dispersion of 1.31 A. U. per mm.  When with ordinary H2 the times of exposure required just to record the strong H2 lines were increased 4000 times, very faint lines appeared at the calcd. positions for the H2 lines accompanying H1β, H1γ and H1δ on the short-wave side and sepd. from them by between 1 and 2 A. U.  These lines do not agree in wave length with any known mol. lines and do not appear on plates recording the strong mol. spectrum.  With ordinary H2 they were so weak that it was difficult to be sure that they were not irregular ghosts of the strongly overexposed at. lines.  Two of the above samples evapd. near the triple point show these lines and another near H1α greatly enhanced relative to the H1 lines over those with ordinary H2, showing that these new lines are not ghosts and that there was a considerable increase in the concn. of the isotope in these samples.  In the other sample evapd. near the b. p. no appreciable increase in concn. was detected.  The new lines agree in wave length with those calcd. for an H2 isotope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2X1i_rUc9prVg90H21EOLACvtfcHk0lg7x9ZcxQ9B0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA38XktFWnsQ%253D%253D&md5=78d56b7779af35e502534b028b6b511c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1103%2FPhysRev.40.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1103%252FPhysRev.40.1%26sid%3Dliteratum%253Aachs%26aulast%3DUrey%26aufirst%3DH.%2BC.%26aulast%3DBrickwedde%26aufirst%3DF.%2BG.%26aulast%3DMurphy%26aufirst%3DG.%2BM.%26atitle%3DA%2520hydrogen%2520isotope%2520of%2520mass%25202%2520and%2520its%2520concentration%26jtitle%3DPhys.%2520Rev.%26date%3D1932%26volume%3D40%26spage%3D1%26epage%3D15%26doi%3D10.1103%2FPhysRev.40.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. L.</span></span> <span> </span><span class="NLM_article-title">A production of amino acids under possible primitive earth conditions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1126/science.117.3046.528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.117.3046.528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=13056598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaG3sXms1aktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1953&pages=528-529&author=S.+L.+Miller&title=A+production+of+amino+acids+under+possible+primitive+earth+conditions&doi=10.1126%2Fscience.117.3046.528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Production of amino acids under possible primitive earth conditions</span></div><div class="casAuthors">Miller, Stanley L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">528-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The hypothesis that org. compds. that served as the basis of life were formed when the earth had an atm. of CH4, NH3, H2O, and H2 was tested by circulating these gases past an elec. discharge for a week.  A description of the app. is given.  The resulting mixt. was assayed for amino acids by paper chromatography, α-Alanine and β-alanine were positively identified in significant amts.  A tentative identification of aspartic acid, α-aminobutyric acid, and possibly β- and γ-amino acids was also made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUGzMBklf_WbVg90H21EOLACvtfcHk0lg7x9ZcxQ9B0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXms1aktA%253D%253D&md5=05aafc0268edcf17220815adf7f0d978</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.117.3046.528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.117.3046.528%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%2BL.%26atitle%3DA%2520production%2520of%2520amino%2520acids%2520under%2520possible%2520primitive%2520earth%2520conditions%26jtitle%3DScience%26date%3D1953%26volume%3D117%26spage%3D528%26epage%3D529%26doi%3D10.1126%2Fscience.117.3046.528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colón-Santos, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gromski, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suárez Marina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, L.</span></span> <span> </span><span class="NLM_article-title">Miller-Urey spark-discharge experiments in the deuterium world</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8079</span>– <span class="NLM_lpage">8082</span>, <span class="refDoi"> DOI: 10.1002/anie.201610837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.201610837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=8079-8082&author=G.+J.+T.+Cooperauthor=A.+J.+Surmanauthor=J.+McIverauthor=S.+M.+Col%C3%B3n-Santosauthor=P.+S.+Gromskiauthor=S.+Buchwaldauthor=I.+Su%C3%A1rez+Marinaauthor=L.+Cronin&title=Miller-Urey+spark-discharge+experiments+in+the+deuterium+world&doi=10.1002%2Fanie.201610837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Miller-Urey spark-discharge experiments in the deuterium world</span></div><div class="casAuthors">Cooper, Geoffrey J. T.; Surman, Andrew J.; McIver, Jim; Colon-Santos, Stephanie M.; Gromski, Piotr S.; Buchwald, Saskia; Suarez Marina, Irene; Cronin, Leroy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">8079-8082</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We designed and conducted a series of primordial-soup Miller-Urey-style expts. with deuterated gases and reagents to compare the spark-discharge products of a "deuterated world" with the std. reaction in the "hydrogenated world".  While the deuteration of the system had little effect on the distribution of amino acid products, significant differences were seen in other regions of the product-space.  Not only did we observe ∼120 new species, we also saw significant differences in their distribution if the 2 hydrogen isotope worlds were compared.  Several isotopolog matches could be identified in both, but a large proportion of products had no equiv. in the corresponding isotope world with ∼43 new species in the D world and ∼39 new species in the H world.  This showed that isotopic exchange (the addn. of only one neutron) may lead to significant addnl. complexity in chem. space under otherwise identical reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW6eGhBl97wbVg90H21EOLACvtfcHk0lg7x9ZcxQ9B0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWqu7w%253D&md5=6b0378229092fcd756d73c231ae961f1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fanie.201610837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201610837%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DG.%2BJ.%2BT.%26aulast%3DSurman%26aufirst%3DA.%2BJ.%26aulast%3DMcIver%26aufirst%3DJ.%26aulast%3DCol%25C3%25B3n-Santos%26aufirst%3DS.%2BM.%26aulast%3DGromski%26aufirst%3DP.%2BS.%26aulast%3DBuchwald%26aufirst%3DS.%26aulast%3DSu%25C3%25A1rez%2BMarina%26aufirst%3DI.%26aulast%3DCronin%26aufirst%3DL.%26atitle%3DMiller-Urey%2520spark-discharge%2520experiments%2520in%2520the%2520deuterium%2520world%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D8079%26epage%3D8082%26doi%3D10.1002%2Fanie.201610837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">The use of stable isotopes in pharmacological research</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=7029573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL38XlsFGksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1981&pages=81-132&author=T.+A.+Baillie&title=The+use+of+stable+isotopes+in+pharmacological+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The use of stable isotopes in pharmacological research</span></div><div class="casAuthors">Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-132</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    </div><div class="casAbstract">A review with 507 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx_TMoDPwOELVg90H21EOLACvtfcHk0lg7x9ZcxQ9B0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlsFGksLw%253D&md5=fb15a0ef3c0405714ad6c5baa2b9d584</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DThe%2520use%2520of%2520stable%2520isotopes%2520in%2520pharmacological%2520research%26jtitle%3DPharmacol.%2520Rev.%26date%3D1981%26volume%3D33%26spage%3D81%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, M.</span></span> <span> </span><span class="NLM_article-title">Deuterium- and tritium-labelled compounds: applications in the life sciences</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1758</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1002/anie.201704146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.201704146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1758-1784&author=J.+Atzrodtauthor=V.+Derdauauthor=W.+J.+Kerrauthor=M.+Reid&title=Deuterium-+and+tritium-labelled+compounds%3A+applications+in+the+life+sciences&doi=10.1002%2Fanie.201704146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences</span></div><div class="casAuthors">Atzrodt, Jens; Derdau, Volker; Kerr, William J.; Reid, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1758-1784</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Hydrogen isotopes are unique tools for identifying and understanding biol. and chem. processes.  Hydrogen isotope labeling allows for the traceless and direct incorporation of an addnl. mass or radioactive tag into an org. mol. with almost no changes in its chem. structure, phys. properties, or biol. activity.  Using deuterium-labeled isotopologues to study the unique mass-spectrometric patterns generated from mixts. of biol. relevant mols. drastically simplifies anal.  Such methods are now providing unprecedented levels of insight in a wide and continuously growing range of applications in the life sciences and beyond.  Tritium (3H), in particular, has seen an increase in utilization, esp. in pharmaceutical drug discovery.  The efforts and costs assocd. with the synthesis of labeled compds. are more than compensated for by the enhanced mol. sensitivity during anal. and the high reliability of the data obtained.  In this Review, advances in the application of hydrogen isotopes in the life sciences are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2Jh-Cv5aPbVg90H21EOLACvtfcHk0lhQAEog0zgCjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Cgtw%253D%253D&md5=4d6ee858335dbe9f59601428a56415bd</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201704146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201704146%26sid%3Dliteratum%253Aachs%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DKerr%26aufirst%3DW.%2BJ.%26aulast%3DReid%26aufirst%3DM.%26atitle%3DDeuterium-%2520and%2520tritium-labelled%2520compounds%253A%2520applications%2520in%2520the%2520life%2520sciences%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D1758%26epage%3D1784%26doi%3D10.1002%2Fanie.201704146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gant, T. G.</span></span> <span> </span><span class="NLM_article-title">Using deuterium in drug discovery: leaving the label in the drug</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3595</span>– <span class="NLM_lpage">3611</span>, <span class="refDoi"> DOI: 10.1021/jm4007998</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4007998" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3595-3611&author=T.+G.+Gant&title=Using+deuterium+in+drug+discovery%3A+leaving+the+label+in+the+drug&doi=10.1021%2Fjm4007998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Using Deuterium in Drug Discovery: Leaving the Label in the Drug</span></div><div class="casAuthors">Gant, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3595-3611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Deuterium, the stable isotope of hydrogen, is known to medicinal chemists for its utility in mechanistic, spectroscopic, and tracer studies.  In fact, well-known applications utilizing deuterium exist within every subdiscipline in pharmaceutical discovery and development.  Recent emphasis on incorporation of deuterium into the active pharmaceutical ingredient has come about as a result of inquiries into the potential for substantial benefits of the deuterium kinetic isotope effect on the safety and disposition of the drug substance.  This Perspective traces the author's experience in reviving and expanding this potential utility, first suggested many decades prior by the discoverer of this, the simplest of all isotopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4z14tbfBfBbVg90H21EOLACvtfcHk0lhQAEog0zgCjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsrvJ&md5=3818a1dba9be431098ad9dd941dababc</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm4007998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4007998%26sid%3Dliteratum%253Aachs%26aulast%3DGant%26aufirst%3DT.%2BG.%26atitle%3DUsing%2520deuterium%2520in%2520drug%2520discovery%253A%2520leaving%2520the%2520label%2520in%2520the%2520drug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3595%26epage%3D3611%26doi%3D10.1021%2Fjm4007998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span> <span> </span><span class="NLM_article-title">Deuterium medicinal chemistry comes of age</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.4155%2Ffmc-2016-0032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27079428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=491-494&author=R.+D.+Tung&title=Deuterium+medicinal+chemistry+comes+of+age&doi=10.4155%2Ffmc-2016-0032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium medicinal chemistry comes of age</span></div><div class="casAuthors">Tung, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-494</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UJsj0IBrHbVg90H21EOLACvtfcHk0lhQAEog0zgCjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsr4%253D&md5=1709a6193f9dee254450a11ee0e523d9</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0032%26sid%3Dliteratum%253Aachs%26aulast%3DTung%26aufirst%3DR.%2BD.%26atitle%3DDeuterium%2520medicinal%2520chemistry%2520comes%2520of%2520age%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D491%26epage%3D494%26doi%3D10.4155%2Ffmc-2016-0032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span> <span> </span><span class="NLM_article-title">Deuterium in drug discovery and development</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-386009-5.00003-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FB978-0-12-386009-5.00003-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCks7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=403-471&author=S.+L.+Harbesonauthor=R.+D.+Tung&title=Deuterium+in+drug+discovery+and+development&doi=10.1016%2FB978-0-12-386009-5.00003-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium in drug discovery and development</span></div><div class="casAuthors">Harbeson, Scott L.; Tung, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">403-417</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review presents the use of deuterium to alter the metabolic properties of compds. and discusses past and current development of potential deuterium-contg. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLrwZvjXhTkrVg90H21EOLACvtfcHk0lhQAEog0zgCjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCks7fL&md5=48188b3d60119f12cad9ae7ebe877ef5</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-386009-5.00003-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-386009-5.00003-5%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DTung%26aufirst%3DR.%2BD.%26atitle%3DDeuterium%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D403%26epage%3D471%26doi%3D10.1016%2FB978-0-12-386009-5.00003-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doller, D.</span></span> <span> </span><span class="NLM_article-title">A decade of deuteration in medicinal chemistry</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1016/bs.armc.2017.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fbs.armc.2017.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOlsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=519-542&author=J.+F.+Liuauthor=S.+L.+Harbesonauthor=C.+L.+Brummelauthor=R.+Tungauthor=R.+Silvermanauthor=D.+Doller&title=A+decade+of+deuteration+in+medicinal+chemistry&doi=10.1016%2Fbs.armc.2017.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of deuteration in medicinal chemistry</span></div><div class="casAuthors">Liu, Julie F.; Harbeson, Scott L.; Brummel, Christopher L.; Tung, Roger; Silverman, Robert; Doller, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519-542</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The use of deuterium to drive DIEs and favorably alter pharmacokinetics and metab. in drug discovery has accelerated in the last decade.  The first major wave of patent applications came from small biotechnol. organizations and were aimed at improving pharmacokinetic properties of marketed drugs or enhancing properties offailed drug candidates.  A substantial no. of patent applications were published beginning in 2006, and the deuterium chem. patent estate continues to expand.  Deuterated drug candidates have progressed from early patent filings to successful proof-of-concept human studies, including the first FDA-approved deuterated drug.  The use of DIEs in drug design has expanded, and now deuteration of drug candidates and tool compds., including imaging ligands, has become a welcome instrument in the arsenal of medicinal chemists.  It is expected that experimentation with strategic introduction of deuterium into the structures of org. compds. will continue to increase and may enable the future development ofa variety ofnovel drugs and chem. tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRWRQHDkKt5LVg90H21EOLACvtfcHk0lgDENsb7FIlzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOlsrvF&md5=18499ed5ccfb021913c4dea9e51946b7</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fbs.armc.2017.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.armc.2017.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DTung%26aufirst%3DR.%26aulast%3DSilverman%26aufirst%3DR.%26aulast%3DDoller%26aufirst%3DD.%26atitle%3DA%2520decade%2520of%2520deuteration%2520in%2520medicinal%2520chemistry%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2017%26volume%3D50%26spage%3D519%26epage%3D542%26doi%3D10.1016%2Fbs.armc.2017.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lgDENsb7FIlzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’
Ferrall, R. A. M.</span></span> <span> </span><span class="NLM_article-title">A pictorial representation of zero-point energy and tunnelling contributions to primary hydrogen isotope effects</span>. <i>J. Phys. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1002/poc.1738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fpoc.1738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVKksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=572-579&author=R.+A.+M.+O%E2%80%99%0AFerrall&title=A+pictorial+representation+of+zero-point+energy+and+tunnelling+contributions+to+primary+hydrogen+isotope+effects&doi=10.1002%2Fpoc.1738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A pictorial representation of zero-point energy and tunnelling contributions to primary hydrogen isotope effects</span></div><div class="casAuthors">O'Ferrall, R. A. More</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">572-579</span>CODEN:
                <span class="NLM_cas:coden">JPOCEE</span>;
        ISSN:<span class="NLM_cas:issn">0894-3230</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The interpretation of primary hydrogen isotope effects in terms of isotopic sensitivities of zero-point energies in the reactants and transition state is reviewed.  The reader is reminded that the transition state for a hydrogen transfer reaction corresponds to the position of max. energy on the min. energy path defined by the motion of the heavy atoms between which hydrogen is transferred.  Tunnelling occurs through the potential energy barrier sepg. the reactant and product channels of the potential energy surface for this reaction.  It is a consequence of rapid vibrational motion of the hydrogen within a collision complex and the overlap of vibrational wave functions between reactant and product sides of the barrier.  Comparing zero-point energies of a tunnelling complex and a hydrogen bond confirms results of calcns. indicating that the zero-point energy of the complex is likely to be less than that of the reactants.  It follows that there should be a compensation between contributions from zero-point energy changes and tunnelling which may explain why tunnelling rarely leads to very large isotope effects at ambient temps.  The isotopic sensitivity of the zero-point energy of the transition state is discussed in terms of variations in force consts. of reacting bonds within a three-center model.  A shift in isotopic sensitivity from the reaction coordinate mode to real stretching vibration as the structure of the transition state becomes more reactant- or product-like, which provides a basis for the Westheimer effect, contrasts with the behavior of hydrogen bonds, for which there is no change in isotopic sensitivity of the two stretching modes.  Copyright © 2010 John Wiley and Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1hJQ_5gMHWLVg90H21EOLACvtfcHk0lhjE2GxmJr4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVKksrg%253D&md5=5afb1d44e4b847c3364b93c24221554f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fpoc.1738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpoc.1738%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599%2BFerrall%26aufirst%3DR.%2BA.%2BM.%26atitle%3DA%2520pictorial%2520representation%2520of%2520zero-point%2520energy%2520and%2520tunnelling%2520contributions%2520to%2520primary%2520hydrogen%2520isotope%2520effects%26jtitle%3DJ.%2520Phys.%2520Org.%2520Chem.%26date%3D2010%26volume%3D23%26spage%3D572%26epage%3D579%26doi%3D10.1002%2Fpoc.1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. P.</span></span> <span> </span><span class="NLM_article-title">Liversidge Lecture. Recent advances in the study of kinetic hydrogen isotope effects</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1039/cs9740300513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2Fcs9740300513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaE2MXktVymsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1974&pages=513-544&author=R.+P.+Bell&title=Liversidge+Lecture.+Recent+advances+in+the+study+of+kinetic+hydrogen+isotope+effects&doi=10.1039%2Fcs9740300513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Liversidge lecture.  Recent advances in the study of kinetic hydrogen isotope effects</span></div><div class="casAuthors">Bell, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-44</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    </div><div class="casAbstract">A review with 78 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJuCuIO5qMALVg90H21EOLACvtfcHk0lhjE2GxmJr4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVymsbw%253D&md5=419c9a2de63db60a0a2058291269c908</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2Fcs9740300513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fcs9740300513%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BP.%26atitle%3DLiversidge%2520Lecture.%2520Recent%2520advances%2520in%2520the%2520study%2520of%2520kinetic%2520hydrogen%2520isotope%2520effects%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D1974%26volume%3D3%26spage%3D513%26epage%3D544%26doi%3D10.1039%2Fcs9740300513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanzlik, R. P.</span></span> <span> </span><span class="NLM_article-title">Deuterium isotope effects on toluene metabolism. Product release as a rate-limiting step in cytochrome P-450 catalysis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">849</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(89)92511-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2F0006-291X%2889%2992511-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=2719701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL1MXktFyqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1989&pages=844-849&author=K.+H.+Lingauthor=R.+P.+Hanzlik&title=Deuterium+isotope+effects+on+toluene+metabolism.+Product+release+as+a+rate-limiting+step+in+cytochrome+P-450+catalysis&doi=10.1016%2F0006-291X%2889%2992511-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects on toluene metabolism.  Product release as a rate-limiting step in cytochrome P-450 catalysis</span></div><div class="casAuthors">Ling, Kah Hiing John; Hanzlik, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">844-9</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Liver microsomes from phenobarbital-induced rats oxidize toluene to a mixt. of benzyl alc. plus o-, m- and p-cresol (∼69 : 31).  Stepwise deuteration of the Me group causes stepwise decreases in the yield of benzyl alc. relative to cresols (∼24 : 76 for toluene-d3).  For benzyl alc. formation from toluene-d3 DV = 1.92 and D(V/K) = 3.53.  Surprisingly, however, stepwise deuteration induces stepwise increase in total oxidn., giving rise to an inverse isotope effect overall (DV = 0.67 for toluene-d3).  Throughout the series (i.e., d0, d1, d2, d3) the ratios of cresol isomers remain const.  These results are interpreted in terms of product release for benzyl alc. being slower than release of cresols (or their epoxide precursors), and slow enough to be partially rate-limiting in turnover.  Thus, metabolic switching to cresol formation causes a net acceleration of turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVHNXMj6jfsrVg90H21EOLACvtfcHk0lhjE2GxmJr4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktFyqtr4%253D&md5=ab9524405e3052d19ea364b0d17a94d1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2889%2992511-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252889%252992511-4%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DK.%2BH.%26aulast%3DHanzlik%26aufirst%3DR.%2BP.%26atitle%3DDeuterium%2520isotope%2520effects%2520on%2520toluene%2520metabolism.%2520Product%2520release%2520as%2520a%2520rate-limiting%2520step%2520in%2520cytochrome%2520P-450%2520catalysis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1989%26volume%3D160%26spage%3D844%26epage%3D849%26doi%3D10.1016%2F0006-291X%2889%2992511-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westheimer, F. H.</span></span> <span> </span><span class="NLM_article-title">The magnitude of the primary kinetic isotope effect for compounds of hydrogen and deuterium</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1021/cr60211a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr60211a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaF3MXnvFKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1961&pages=265-273&author=F.+H.+Westheimer&title=The+magnitude+of+the+primary+kinetic+isotope+effect+for+compounds+of+hydrogen+and+deuterium&doi=10.1021%2Fcr60211a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The magnitude of the primary kinetic isotope effect for compounds of hydrogen and deuterium</span></div><div class="casAuthors">Westheimer, F. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-73</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with 50 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM52N3J2pQWLVg90H21EOLACvtfcHk0lhjE2GxmJr4uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXnvFKgtA%253D%253D&md5=cad6f4241e50d9390a1b50746d4b0f89</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr60211a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60211a004%26sid%3Dliteratum%253Aachs%26aulast%3DWestheimer%26aufirst%3DF.%2BH.%26atitle%3DThe%2520magnitude%2520of%2520the%2520primary%2520kinetic%2520isotope%2520effect%2520for%2520compounds%2520of%2520hydrogen%2520and%2520deuterium%26jtitle%3DChem.%2520Rev.%26date%3D1961%26volume%3D61%26spage%3D265%26epage%3D273%26doi%3D10.1021%2Fcr60211a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klinman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohen, A.</span></span> <span> </span><span class="NLM_article-title">Hydrogen tunneling links protein dynamics to enzyme catalysis</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-051710-133623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1146%2Fannurev-biochem-051710-133623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=23746260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=471-496&author=J.+P.+Klinmanauthor=A.+Kohen&title=Hydrogen+tunneling+links+protein+dynamics+to+enzyme+catalysis&doi=10.1146%2Fannurev-biochem-051710-133623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen tunneling links protein dynamics to enzyme catalysis</span></div><div class="casAuthors">Klinman, Judith P.; Kohen, Amnon</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">471-496</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The relationship between protein dynamics and function is a subject of considerable contemporary interest.  Although protein motions are frequently obsd. during ligand binding and release steps, the contribution of protein motions to the catalysis of bond making/breaking processes is more difficult to probe and verify.  Here, we show how the quantum mech. hydrogen tunneling assocd. with enzymic C-H bond cleavage provides a unique window into the necessity of protein dynamics for achieving optimal catalysis.  Exptl. findings support a hierarchy of thermodynamically equilibrated motions that control the H-donor and -acceptor distance and active-site electrostatics, creating an ensemble of conformations suitable for H-tunneling.  A possible extension of this view to Me transfer and other catalyzed reactions is also presented.  The impact of understanding these dynamics on the conceptual framework for enzyme activity, inhibitor/drug design, and biomimetic catalyst design is likely to be substantial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJuUE_QVx_NrVg90H21EOLACvtfcHk0lhkNROKEMpD_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOqsr3I&md5=6e24730783d3737dc346d51c2a27d473</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-051710-133623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-051710-133623%26sid%3Dliteratum%253Aachs%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26aulast%3DKohen%26aufirst%3DA.%26atitle%3DHydrogen%2520tunneling%2520links%2520protein%2520dynamics%2520to%2520enzyme%2520catalysis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2013%26volume%3D82%26spage%3D471%26epage%3D496%26doi%3D10.1146%2Fannurev-biochem-051710-133623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolczanski, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinckman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundari, T. R.</span></span> <span> </span><span class="NLM_article-title">Inter- and intramolecular experimental and calculated equilibrium isotope effects for (silox)<sub>2</sub>(tBu<sub>3</sub>SiND)TiR + RH (silox = tBu<sub>3</sub>SiO): inferred kinetic isotope effects for RH/D addition to transient (silox)<sub>2</sub>Ti=NSitBu<sub>3</sub></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">7953</span>– <span class="NLM_lpage">7975</span>, <span class="refDoi"> DOI: 10.1021/ja000112q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja000112q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslOltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=7953-7975&author=L.+M.+Slaughterauthor=P.+T.+Wolczanskiauthor=T.+R.+Klinckmanauthor=T.+R.+Cundari&title=Inter-+and+intramolecular+experimental+and+calculated+equilibrium+isotope+effects+for+%28silox%292%28tBu3SiND%29TiR+%2B+RH+%28silox+%3D+tBu3SiO%29%3A+inferred+kinetic+isotope+effects+for+RH%2FD+addition+to+transient+%28silox%292Ti%3DNSitBu3&doi=10.1021%2Fja000112q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inter- and Intramolecular Experimental and Calculated Equilibrium Isotope Effects for (silox)2(tBu3SiND)TiR + RH (silox = tBu3SiO): Inferred Kinetic Isotope Effects for RH/D Addition to Transient (silox)2Ti:NSitBu3</span></div><div class="casAuthors">Slaughter, LeGrande M.; Wolczanski, Peter T.; Klinckman, Thomas R.; Cundari, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7953-7975</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Intermol. equil. isotope effects (EIEs) were measured (26.5°) and calcd. for (silox)2(tBu3SiND)TiRD (1-ND-RD) + RHH ↹ (silox)2(tBu3SiNH)TiRH (1-RH) + RDD: RHH/RDD = CH4/CD4, 2.00(6), calcd. 1.88; C2H6/C2D6, 2.22(8), 1.93; cC3H6/cC3D6, 1.71(4), 1.48; C2H4/C2D4, 1.41(11), 1.34; C6H6/C6D6, 1.22(7), 1.26; C7H8/C7D8 (50.0°), 1.59(6), 1.55.  Related intramol. EIEs for (silox)2(tBu3SiND)TiR' (1-ND-R') ↹ (silox)2(tBu3SiNH)TiR (1-R) are provided: RH = R'D = CH3D, 3.16(25), calcd. 2.60; CH2D2, 1.13(8), 0.911; CHD3, 0.389(20), 0.303; CH3CD3, 1.53(3), 1.44; 1,1-cC3H4D2, 2.58(6), 2.53; trans-HDC:CHD, 1.00(2), 1.00; 1,3,5-C6H3D3, 1.273(4), 1.25; PhCH2D (50.0°), 2.06(2), 1.98.  Calcns. of pertinent model complexes (e.g., (HO)2(H2N)TiR (1'-R)) generated the vibrational frequencies necessary to interpret the EIEs in terms of a statistical mechanics description using gas-phase partition functions; EIE = SYM × MMI × EXC × EXP[-(ΔΔZPE/kBT)].  The large MMI term in the intermol. cases-a consequence of using perprotio vs. perdeuterio small mol. substrates-is attenuated by EXC and EXP[-(ΔΔZPE/kBT)] contributions derived from low-energy core vibrations.  The EIEs are differentiated on the basis of the EXP[-(ΔΔZPE/kBT)] term, with CH-based bending vibrations playing the major role.  Substrate bending vibrations that are absent in intramol. cases are primarily responsible for the greater intermol. values.  Using measured (or calcd.) EIEs and kinetic isotope effects for 1,2-RH-elimination (KIEelim) from 1-R, KIEaddn values for 1,2-RH-addn. to putative intermediate (silox)2Ti:NSitBu3 were inferred via EIE = KIEaddn/KIEelim.  Extraordinary intermol. KIEaddn values ranging from ∼30 (CH4/CD4, C2H6/C2D6) to ∼9 (C6H6/C6D6) are consistent with previous mechanistic accounts and may be conventionally rationalized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrligLZFkNDGLVg90H21EOLACvtfcHk0lhkNROKEMpD_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslOltr0%253D&md5=71a52333014380127ad8a11129906896</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja000112q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000112q%26sid%3Dliteratum%253Aachs%26aulast%3DSlaughter%26aufirst%3DL.%2BM.%26aulast%3DWolczanski%26aufirst%3DP.%2BT.%26aulast%3DKlinckman%26aufirst%3DT.%2BR.%26aulast%3DCundari%26aufirst%3DT.%2BR.%26atitle%3DInter-%2520and%2520intramolecular%2520experimental%2520and%2520calculated%2520equilibrium%2520isotope%2520effects%2520for%2520%2528silox%25292%2528tBu3SiND%2529TiR%2520%252B%2520RH%2520%2528silox%2520%253D%2520tBu3SiO%2529%253A%2520inferred%2520kinetic%2520isotope%2520effects%2520for%2520RH%252FD%2520addition%2520to%2520transient%2520%2528silox%25292Ti%253DNSitBu3%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D7953%26epage%3D7975%26doi%3D10.1021%2Fja000112q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern-Dogru, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillgenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R. G.</span></span> <span> </span><span class="NLM_article-title">Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil</span>. <i>Arzneim. Forsch.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1296622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1055%2Fs-0031-1296622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17688073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFaksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2007&pages=293-298&author=F.+Schneiderauthor=E.+Mattern-Dogruauthor=M.+Hillgenbergauthor=R.+G.+Alken&title=Changed+phosphodiesterase+selectivity+and+enhanced+in+vitro+efficacy+by+selective+deuteration+of+sildenafil&doi=10.1055%2Fs-0031-1296622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil</span></div><div class="casAuthors">Schneider, Frank; Mattern-Dogru, Emine; Hillgenberg, Moritz; Alken, Rudolf-Giesbert</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">In order to explore whether selective deuteration of sildenafil affects selectivity and efficacy of the drug, the inhibitory activity of sildenafil (1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d] pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine citrate, CAS 139755-83-2) and three deuterated sildenafil derivs., D8-piperazine-sildenafil (BDD-10402), D3-methyl-D8-piperazine-sildenafil (BDD-10403) and D5-ethoxy-Sildenafil (BDD-10406) against phosphodiesterases 1-6 was compared.  Furthermore, the relaxant effect of sildenafil and its deuterated derivs. in a contractility assay on rabbit corpus cavernosum strips from New Zealand rabbits was investigated.  BDD-10406 exhibits a 2-fold higher selectivity for phosphodiesterase 5 vs. phosphodiesterase 6 than sildenafil.  BDD-10406 and sildenafil inhibited cGMP formation with IC50 values of 6 nmol/L and 9 nmol/L, resp.  The corresponding IC80 values for BDD-10406 and Sildenafil were 33 nmol/L and 40 nmol/L, resp.  Sildenafil, BDD-10402, BDD-10403 and BDD-10406 relaxed the rabbit corpus cavernosum strips in a dose-dependent manner with ED50 values of 245 nmol/L, 91 nmol/L, 121 nmol/L and 85 nmol/L, resp.  Deuteration of sildenafil on the ethoxy group (BDD-10406) leads to enhanced selectivity for phosphodiesterase 5 vs. phosphodiesterase 6 and higher efficacy in vitro.  This is the first example of a deuteration effect on the inhibitory activity of a reversible enzyme inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_8StsIDodP7Vg90H21EOLACvtfcHk0lhkNROKEMpD_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFaksbY%253D&md5=0a3fcae5b13dc8eaa9563ae72c8e8799</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296622%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DMattern-Dogru%26aufirst%3DE.%26aulast%3DHillgenberg%26aufirst%3DM.%26aulast%3DAlken%26aufirst%3DR.%2BG.%26atitle%3DChanged%2520phosphodiesterase%2520selectivity%2520and%2520enhanced%2520in%2520vitro%2520efficacy%2520by%2520selective%2520deuteration%2520of%2520sildenafil%26jtitle%3DArzneim.%2520Forsch.%26date%3D2007%26volume%3D57%26spage%3D293%26epage%3D298%26doi%3D10.1055%2Fs-0031-1296622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belleau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pindell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiffenstein, J.</span></span> <span> </span><span class="NLM_article-title">Effect of deuterium substitution in sympathomimetic amines on adrenergic responses</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1126/science.133.3446.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.133.3446.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17769335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaF3MXksVKhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1961&pages=102-104&author=B.+Belleauauthor=J.+Burbaauthor=M.+Pindellauthor=J.+Reiffenstein&title=Effect+of+deuterium+substitution+in+sympathomimetic+amines+on+adrenergic+responses&doi=10.1126%2Fscience.133.3446.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of deuterium substitution on sympathomimetic amines on adrenergic responses</span></div><div class="casAuthors">Belleau, B.; Burba, J.; Pindell, M.; Reiffenstein, J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Replacement of the α-H atoms of tyramine and tryptamine by D markedly intensifies the blood-pressure effects and nictitating-membrane contraction normally produced by these amines.  The results are interpreted on the basis of kinetic isotope effects at the level of monoamine oxidase and clearly establish the importance of this enzyme in the limitations of responses when tyramine and tryptamine are involved.  The observed D isotope effects with tyramine-α,α-D2 were reproduced with only one of the optical isomers of monodeuteriotyramine.  This finding shows a high degree of optical specificity for the enzyme.  The use of l-bisdeuterionoradrenaline showed that noradrenaline cannot be attacked by the enzyme at the effector-cell level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWZ5ZrOOJHlrVg90H21EOLACvtfcHk0lgyhxwkBiSKeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXksVKhtg%253D%253D&md5=3eb9b927157a39b5b48f5bf472cf9dd5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.133.3446.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.133.3446.102%26sid%3Dliteratum%253Aachs%26aulast%3DBelleau%26aufirst%3DB.%26aulast%3DBurba%26aufirst%3DJ.%26aulast%3DPindell%26aufirst%3DM.%26aulast%3DReiffenstein%26aufirst%3DJ.%26atitle%3DEffect%2520of%2520deuterium%2520substitution%2520in%2520sympathomimetic%2520amines%2520on%2520adrenergic%2520responses%26jtitle%3DScience%26date%3D1961%26volume%3D133%26spage%3D102%26epage%3D104%26doi%3D10.1126%2Fscience.133.3446.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapoport, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, H. W.</span></span> <span> </span><span class="NLM_article-title">Effect of deuteration of N--CH3 group on potency and enzymatic <i>N</i>-demethylation of morphine</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">1078</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1126/science.134.3485.1078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.134.3485.1078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=13889855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaF38XnvFCj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1961&pages=1078-1079&author=C.+Elisonauthor=H.+Rapoportauthor=R.+Laursenauthor=H.+W.+Elliott&title=Effect+of+deuteration+of+N%2D%2DCH3+group+on+potency+and+enzymatic+N-demethylation+of+morphine&doi=10.1126%2Fscience.134.3485.1078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of deuteration of the N-CH3 group on potency and enzymatic N-demethylation of morphine</span></div><div class="casAuthors">Elison, C.; Rapoport, H.; Laursen, R.; Elliott, H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1078-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Normorphine treated with excess CICO2Et followed by LiAlD4 gave morphine-N-CD3, pKa 8.17 (morphine pKa, 8.05), which was less potent, had a lower rate of oxidative demethylation, and had a weaker bond with enzyme, active centers than morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXIRZRFoSgrVg90H21EOLACvtfcHk0lgyhxwkBiSKeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38XnvFCj&md5=b45fa6f5c8a1b802a3cb2e32e275c251</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.134.3485.1078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.134.3485.1078%26sid%3Dliteratum%253Aachs%26aulast%3DElison%26aufirst%3DC.%26aulast%3DRapoport%26aufirst%3DH.%26aulast%3DLaursen%26aufirst%3DR.%26aulast%3DElliott%26aufirst%3DH.%2BW.%26atitle%3DEffect%2520of%2520deuteration%2520of%2520N--CH3%2520group%2520on%2520potency%2520and%2520enzymatic%2520N-demethylation%2520of%2520morphine%26jtitle%3DScience%26date%3D1961%26volume%3D134%26spage%3D1078%26epage%3D1079%26doi%3D10.1126%2Fscience.134.3485.1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sipes, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandolfi, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. R.</span></span> <span> </span><span class="NLM_article-title">Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">716</span>– <span class="NLM_lpage">720</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=7400974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL3cXlsl2mtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1980&pages=716-720&author=I.+G.+Sipesauthor=A.+J.+Gandolfiauthor=L.+R.+Pohlauthor=G.+Krishnaauthor=B.+R.+Brown&title=Comparison+of+the+biotransformation+and+hepatotoxicity+of+halothane+and+deuterated+halothane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane</span></div><div class="casAuthors">Sipes, I. Glenn; Gandolfi, A. Jay; Pohl, Lance R.; Krishna, Gopal; Brown, Burnell R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">716-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">To investigate the effect of 2H substitution on the biotransformation and hepatotoxicity of halothane (CF3CHBrCl)  [151-67-7] male phenobarbital-pretreated rats were exposed for 2 h to 1% halothane or deuterated halothane delivered in 14% O-85% N.  The exposures were performed at mildly hypoxic conditions (14% O) since it was previously established that the decreased O tension promotes both the reductive metab. of halothane and halothane-induced liver injury.  At the end of anesthesia or at 24 h, the rats were sacrificed so that blood, liver, and urine samples could be obtained for measurement of metabolites and assessment of liver damage.  2H substitution did not affect the levels of reductive metabolites of halothane (CF3CH2Cl and CF2CHCl  [359-10-4]) nor did it alter the degree of hepatotoxicity as assessed by serum glutamic-pyruvic transaminase levels and morphol. examn.  The levels of oxidative metabolites (CF3COOH  [76-05-1] and Br) were significantly reduced at the end of anesthesia and at 24 h.  Apparently, halothane-induced hepatotoxicity is initiated by reactive intermediates formed during its reductive metab. and that cleavage of the C-H bond is not involved in this pathway.  The oxidative biotransformation of halothane proceeds by an oxygen insertion reaction at the C-H bond.  Thus, the increased stability of the C-D bond explains the redn. in oxidative metabolites obsd. after exposure to deuterated halothane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcmrpQrlUjV7Vg90H21EOLACvtfcHk0lgyhxwkBiSKeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlsl2mtbY%253D&md5=95fa5c6822ed681b056022747f4a9347</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSipes%26aufirst%3DI.%2BG.%26aulast%3DGandolfi%26aufirst%3DA.%2BJ.%26aulast%3DPohl%26aufirst%3DL.%2BR.%26aulast%3DKrishna%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%2BR.%26atitle%3DComparison%2520of%2520the%2520biotransformation%2520and%2520hepatotoxicity%2520of%2520halothane%2520and%2520deuterated%2520halothane%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1980%26volume%3D214%26spage%3D716%26epage%3D720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darland, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenheuvel, W. J.</span></span> <span> </span><span class="NLM_article-title">Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=2877824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL2sXnvVWltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1986&pages=668-673&author=G.+K.+Darlandauthor=R.+Hajduauthor=H.+Kroppauthor=F.+M.+Kahanauthor=R.+W.+Walkerauthor=W.+J.+Vandenheuvel&title=Oxidative+and+defluorinative+metabolism+of+fludalanine%2C+2-2H-3-fluoro-D-alanine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine</span></div><div class="casAuthors">Darland, Gary K.; Hajdu, Richard; Kropp, Helmut; Kahan, Frederick M.; Walker, Robert W.; Vandenheuvel, William J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-73</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    </div><div class="casAbstract">The antibacterial agent fludalanine  [35523-45-6] (used in this study as the deuterated analog 2-2H-3-fluoro-D-alanine (DFA)  [35523-45-6]) is a potent inhibitor of bacterial alanine racemase, an enzyme required for the generation of D-alanine, an essential component of the bacterial cell wall.  Primary metab. of DFA involves its oxidn. to fluoropyruvate (FP)  [433-48-7]; this org. F- is then rapidly reduced to fluorolactate (FL)  [433-47-6], which is the major org. metabolite in lab. animals.  Gas-liq. chromatog. chem. ionization mass spectrometric assays were developed for these 2 metabolites.  FL is the predominant organofluoride metabolite of DFA in the circulation.  FP was detected in the urine although recovery was very low.  The rapid conversion of FP to FL precludes assay of the former in serum.  Max. serum FL concns. in the rat appear about 1 h after the dose of DFA and are relatively const. for several hours thereafter.  The peak FL concn. is proportional to the dose of DFA; repeated daily dosing of DFA appears to cause neither satn. nor induction of metabolic pathways.  Comparison of FL concns. detd. using the GC/MS assay with those based on an enzymic method specific for L-(+)-FL  [3130-92-5] demonstrated that only the latter isomer is found in the plasma of monkeys dosed with DFA.  In vivo exchange studies involving the α-proton of FL indicate that a small FP pool exists and is in equil. with FL.  A crude pyruvate dehydrogenase  [9014-20-4] complex isolated from beef heart mitochondria was shown to produce equimolar quantities of acetate  [64-19-7], CO2, and F- from FP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquI8diq2iUbbVg90H21EOLACvtfcHk0lgyhxwkBiSKeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXnvVWltA%253D%253D&md5=554409be533e8ce74036e9ca2cf19dfb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarland%26aufirst%3DG.%2BK.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKropp%26aufirst%3DH.%26aulast%3DKahan%26aufirst%3DF.%2BM.%26aulast%3DWalker%26aufirst%3DR.%2BW.%26aulast%3DVandenheuvel%26aufirst%3DW.%2BJ.%26atitle%3DOxidative%2520and%2520defluorinative%2520metabolism%2520of%2520fludalanine%252C%25202-2H-3-fluoro-D-alanine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1986%26volume%3D14%26spage%3D668%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span> <span> </span><span class="NLM_article-title">Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2016.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.jpba.2016.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27178301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslaltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2016&pages=181-193&author=T.+Higashiauthor=S.+Ogawa&title=Isotope-coded+ESI-enhancing+derivatization+reagents+for+differential+analysis%2C+quantification+and+profiling+of+metabolites+in+biological+samples+by+LC%2FMS%3A+A+review&doi=10.1016%2Fj.jpba.2016.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review</span></div><div class="casAuthors">Higashi, Tatsuya; Ogawa, Shoujiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-193</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The anal. of the qual. and quant. changes of metabolites in body fluids and tissues yields valuable information for the diagnosis, pathol. anal. and treatment of many diseases.  Recently, liq. chromatog./electrospray ionization-(tandem) mass spectrometry [LC/ESI-MS(/MS)] has been widely used for these purposes due to the high sepn. capability of LC, broad coverage of ESI for various compds. and high specificity of MS(/MS).  However, there are still two major problems to be solved regarding the biol. sample anal.; lack of sensitivity and limited availability of stable isotope-labeled analogs (internal stds., ISs) for most metabolites.  Stable isotope-coded derivatization (ICD) can be the answer for these problems.  By the ICD, different isotope-coded moieties are introduced to the metabolites and one of the resulting derivs. can serve as the IS, which minimize the matrix effects.  Furthermore, the derivatization can improve the ESI efficiency, fragmentation property in the MS/MS and chromatog. behavior of the metabolites, which lead to a high sensitivity and specificity in the various detection modes.  Based on this background, this article reviews the recently-reported isotope-coded ESI-enhancing derivatization (ICEED) reagents, which are key components for the ICD-based LC/MS(/MS) studies, and their applications to the detection, identification, quantification and profiling of metabolites in human and animal samples.  The LC/MS(/MS) using the ICEED reagents is the powerful method esp. for the differential anal. (relative quantification) of metabolites in two comparative samples, simultaneous quantification of multiple metabolites whose stable isotope-labeled ISs are not available, and submetabolome profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocVMjZPX-cS7Vg90H21EOLACvtfcHk0liz1arUvsC32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslaltbY%253D&md5=58fa03f80874ca453470aceda3723623</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DS.%26atitle%3DIsotope-coded%2520ESI-enhancing%2520derivatization%2520reagents%2520for%2520differential%2520analysis%252C%2520quantification%2520and%2520profiling%2520of%2520metabolites%2520in%2520biological%2520samples%2520by%2520LC%252FMS%253A%2520A%2520review%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D130%26spage%3D181%26epage%3D193%26doi%3D10.1016%2Fj.jpba.2016.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Halford, B.</span></span> <span> </span><span class="NLM_article-title">Deuterium switcheroo breathes life into old drugs</span>. <i>Chem. Eng. News</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=32-36&author=B.+Halford&title=Deuterium+switcheroo+breathes+life+into+old+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalford%26aufirst%3DB.%26atitle%3DDeuterium%2520switcheroo%2520breathes%2520life%2520into%2520old%2520drugs%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2016%26volume%3D94%26spage%3D32%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, G. S.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs: where are we now?</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1075</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.943184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1517%2F13543776.2014.943184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25069517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1067-1075&author=G.+S.+Timmins&title=Deuterated+drugs%3A+where+are+we+now%3F&doi=10.1517%2F13543776.2014.943184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs: where are we now?</span></div><div class="casAuthors">Timmins, Graham S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1067-1075</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Deuterated versions of existing drugs can exhibit improved pharmacokinetic or toxicol. properties due the stronger deuterium- carbon bond modifying their metab.  There is great interest in the current state of development of this approach.  Areas covered: This review covers recent US patent applications and prosecutions in this area that are based on beneficial modifications in metab. of deuterated versions of existing drugs.  The current state of 35 U.S.C. 103 'obviousness' rejections are emphasized, as is the development of strategies to overcome such rejections.  Current trials and market considerations are also discussed.  Expert opinion: Deuterated drugs collectively are worth at least US$1 billion.  It would seem that the likelihood of obviousness rejections is increasing in this area.  However, careful elucidation of metabolic outcomes from deuteration that would not be anticipated from the prior art, and are instead unexpected and unobvious, has enabled allowance.  Showing that drug deuteration alters pharmacokinetics by mechanisms not currently part of the prior art surrounding deuterated drugs has also been successful.  Development of these and other strategies, combined with developing the extensive base of issued patents will enable the field to remain com. attractive for some time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0xlLKQqhufrVg90H21EOLACvtfcHk0liz1arUvsC32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE&md5=c697e60a642f7ea3d8ad9f4588bc3ade</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.943184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.943184%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26atitle%3DDeuterated%2520drugs%253A%2520where%2520are%2520we%2520now%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1067%26epage%3D1075%26doi%3D10.1517%2F13543776.2014.943184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, G. S.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs; updates and obviousness analysis</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1353</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1378350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1080%2F13543776.2017.1378350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28885861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFSmtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1353-1361&author=G.+S.+Timmins&title=Deuterated+drugs%3B+updates+and+obviousness+analysis&doi=10.1080%2F13543776.2017.1378350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs; updates and obviousness analysis</span></div><div class="casAuthors">Timmins, Graham S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1353-1361</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The pharmacokinetics and/or toxicity of many known drugs can be modified by selective deuteration, an area of significant com. interest and scientific and regulatory progress.  This review firstly discusses recent developments in deuterated drugs including the FDA approval of deutetrabenazine.  Secondly, it discusses 35 U.S.C. Sec. 103 'obviousness' as it relates to recent patent prosecution, and also to Inter Partes Review (IPR).  IPR is a new post-award review of patentability under Sec. 102 or Sec. 103, two IPR petitions upon deuterated drugs have been instituted and included Sec. 103 arguments.  Finally, an extended anal. of Sec. 103 obviousness based upon the practices of major pharmaceutical companies is provided, that supports rather late priority dates, while Sec. 102 is also discussed.  The total value of transactions involving deuterated drugs is close to $5 billion.  While the importance of Sec. 103 'obviousness' rejections remains in patent applications under current prosecution, IPR of issued patents is developing and will affect likely affect Sec. 103 interpretations in this area.  However, patents are still issuing with later priority dates, and further litigation will likely occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplgaJXt_pSD7Vg90H21EOLACvtfcHk0liz1arUvsC32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFSmtbjO&md5=d29367a0daec2c70367a58327fbccd9c</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1378350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1378350%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26atitle%3DDeuterated%2520drugs%253B%2520updates%2520and%2520obviousness%2520analysis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D1353%26epage%3D1361%26doi%3D10.1080%2F13543776.2017.1378350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span> <span> </span><span class="NLM_article-title">First deuterated drug approved</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.1038/nbt0617-493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fnbt0617-493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28591114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlOhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=493-494&author=C.+Schmidt&title=First+deuterated+drug+approved&doi=10.1038%2Fnbt0617-493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">First deuterated drug approved</span></div><div class="casAuthors">Schmidt, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">493-494</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwr4PZKkjHN7Vg90H21EOLACvtfcHk0liz1arUvsC32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlOhsL8%253D&md5=cd594cc4762bd153c41e797e8526c090</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnbt0617-493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt0617-493%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%26atitle%3DFirst%2520deuterated%2520drug%2520approved%26jtitle%3DNat.%2520Biotechnol.%26date%3D2017%26volume%3D35%26spage%3D493%26epage%3D494%26doi%3D10.1038%2Fnbt0617-493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claassen, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Boer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayyagari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamler, D.</span></span> <span> </span><span class="NLM_article-title">Indirect tolerability comparison of deutetrabenazine and tetrabenazine for Huntington disease</span>. <i>J. Clin. Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1186/s40734-017-0051-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1186%2Fs40734-017-0051-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28265459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1czjsVShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=3-13&author=D.+O.+Claassenauthor=B.+Carrollauthor=L.+M.+De+Boerauthor=E.+Wuauthor=R.+Ayyagariauthor=S.+Gandhiauthor=D.+Stamler&title=Indirect+tolerability+comparison+of+deutetrabenazine+and+tetrabenazine+for+Huntington+disease&doi=10.1186%2Fs40734-017-0051-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease</span></div><div class="casAuthors">Claassen Daniel O; Carroll Benjamin; Gandhi Sanjay; De Boer Lisa M; Stamler David; Wu Eric; Ayyagari Rajeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical movement disorders</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn">2054-7072</span>.
    </div><div class="casAbstract">BACKGROUND:  Vesicular monoamine transporter 2 (VMAT2) inhibitors can improve hyperkinetic movements, and are effective treatment options for chorea of Huntington disease (HD).  Tetrabenazine was assessed for treating chorea in the TETRA-HD trial, and while efficacious, there are tolerability concerns possibly due to its pharmacokinetic properties.  Deutetrabenazine is a novel VMAT2 inhibitor that contains deuterium, which extends active metabolite half-lives and minimizes drug concentration fluctuations.  In the First-HD trial, deutetrabenazine was efficacious in treating chorea and was generally well tolerated.  In the absence of a head-to-head trial, we performed an indirect treatment comparison (ITC) of the tolerability of deutetrabenazine and tetrabenazine for the treatment of HD-associated chorea, as observed in the First-HD and TETRA-HD trials, using well-established comparison methods.  METHODS:  Data from the Phase III, 12-week, parallel-group, clinical trials First-HD (N = 90) and TETRA-HD (N = 84) were used to conduct an ITC of the tolerability of deutetrabenazine versus tetrabenazine using two anchor-based methods: Bucher comparison for unadjusted ITCs, and matching indirect comparison for adjusted ITCs.  Overall adverse events (AEs; mild, moderate, and severe), serious AEs, specific AEs occurring in ≥10% of patients, and discontinuations (all-cause and AE-related) were included in the analysis.  The risk differences of these outcomes for deutetrabenazine and tetrabenazine were estimated by subtracting the applicable placebo-adjusted risk in First-HD from that of TETRA-HD.  Sensitivity analyses were performed to address differences between trials, and p-values were obtained from z-tests.  RESULTS:  Compared with tetrabenazine, deutetrabenazine was associated with a significantly lower risk of moderate to severe AEs and neuropsychiatric AEs including agitation, akathisia, depression, depression/agitated depression, drowsiness/somnolence, insomnia, and parkinsonism in both adjusted and unadjusted analyses (p < 0.05 for each).  Deutetrabenazine had a significantly lower rate of dose reduction or dose reduction/suspension in the unadjusted and adjusted analyses (p < 0.001 for each).  Deutetrabenazine resulted in numerically more mild AEs, such as diarrhea and coughing; however, these results were not statistically significant.  CONCLUSIONS:  This indirect treatment comparison demonstrates that for the treatment of HD chorea, deutetrabenazine has a favorable tolerability profile compared to tetrabenazine.  TRIAL REGISTRATION:  ClinicalTrials.gov NCT01795859 and NCT00219804.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0nI0g9LkSp-2mnZh2OgS0fW6udTcc2eYO2Oa6NOeZMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjsVShsA%253D%253D&md5=c7a5245c020613fcf6d48f8f77e4fe6c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs40734-017-0051-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40734-017-0051-5%26sid%3Dliteratum%253Aachs%26aulast%3DClaassen%26aufirst%3DD.%2BO.%26aulast%3DCarroll%26aufirst%3DB.%26aulast%3DDe%2BBoer%26aufirst%3DL.%2BM.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DAyyagari%26aufirst%3DR.%26aulast%3DGandhi%26aufirst%3DS.%26aulast%3DStamler%26aufirst%3DD.%26atitle%3DIndirect%2520tolerability%2520comparison%2520of%2520deutetrabenazine%2520and%2520tetrabenazine%2520for%2520Huntington%2520disease%26jtitle%3DJ.%2520Clin.%2520Mov.%2520Disord.%26date%3D2017%26volume%3D4%26spage%3D3%26epage%3D13%26doi%3D10.1186%2Fs40734-017-0051-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, E. J.</span></span> <span> </span><span class="NLM_article-title">Tetrabenazine versus deutetrabenazine for Huntington’s disease: twins or distant cousins?</span>. <i>Mov. Disord. Clin. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1002/mdc3.12483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fmdc3.12483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28920068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1cbpsFagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=582-585&author=F.+B.+Rodriguesauthor=G.+S.+Duarteauthor=J.+Costaauthor=J.+J.+Ferreiraauthor=E.+J.+Wild&title=Tetrabenazine+versus+deutetrabenazine+for+Huntington%E2%80%99s+disease%3A+twins+or+distant+cousins%3F&doi=10.1002%2Fmdc3.12483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?</span></div><div class="casAuthors">Rodrigues Filipe B; Wild Edward J; Rodrigues Filipe B; Duarte Goncalo S; Costa Joao; Ferreira Joaquim J; Rodrigues Filipe B; Duarte Goncalo S; Costa Joao; Ferreira Joaquim J; Costa Joao; Costa Joao</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders clinical practice</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">582-585</span>
        ISSN:<span class="NLM_cas:issn">2330-1619</span>.
    </div><div class="casAbstract">BACKGROUND:  Tetrabenazine is the only US Food and Drug Administration-approved drug for Huntington's disease, and deutetrabenazine was recently tested against placebo.  A switching-trial from tetrabenazine to deutetrabenazine is underway, but no head-to-head, blinded, randomized controlled trial is planned.  Using meta-analytical methodology, the authors compared these molecules.  METHODS:  RCTs comparing tetrabenazine or deutetrabenazine with placebo in Huntington's disease were searched.  The authors assessed the Cochrane risk-of-bias tool, calculated indirect treatment comparisons, and applied the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework.  RESULTS:  The evidence network for this report comprised 1 tetrabenazine trial and 1 deutetrabenazine trial, both against placebo.  Risk of bias was moderate in both.  Participants in the tetrabenazine and deutetrabenazine trials did not differ significantly on motor scores or adverse events.  Depression and somnolence scales significantly favored deutetrabenazine.  CONCLUSION:  There is low-quality evidence that tetrabenazine and deutetrabenazine do not differ in efficacy or safety.  It is important to note that these results are likely to remain the only head-to-head comparison between these 2 compounds in Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvkk3DHdxs8lm8bhe6roZYfW6udTcc2eYO2Oa6NOeZMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbpsFagsA%253D%253D&md5=bc9902048211ec9978d92f95e53ac2f3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmdc3.12483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmdc3.12483%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DF.%2BB.%26aulast%3DDuarte%26aufirst%3DG.%2BS.%26aulast%3DCosta%26aufirst%3DJ.%26aulast%3DFerreira%26aufirst%3DJ.%2BJ.%26aulast%3DWild%26aufirst%3DE.%2BJ.%26atitle%3DTetrabenazine%2520versus%2520deutetrabenazine%2520for%2520Huntington%25E2%2580%2599s%2520disease%253A%2520twins%2520or%2520distant%2520cousins%253F%26jtitle%3DMov.%2520Disord.%2520Clin.%2520Pract.%26date%3D2017%26volume%3D4%26spage%3D582%26epage%3D585%26doi%3D10.1002%2Fmdc3.12483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garay, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossberg, G. T.</span></span> <span> </span><span class="NLM_article-title">AVP-786 for the treatment of agitation in dementia of the Alzheimer’s type</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1080/13543784.2017.1267726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1080%2F13543784.2017.1267726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27936965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOlu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=121-132&author=R.+P.+Garayauthor=G.+T.+Grossberg&title=AVP-786+for+the+treatment+of+agitation+in+dementia+of+the+Alzheimer%E2%80%99s+type&doi=10.1080%2F13543784.2017.1267726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">AVP-786 for the treatment of agitation in dementia of the Alzheimer's type</span></div><div class="casAuthors">Garay, Ricardo P.; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-132</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Agitation is common and distressing in patients with Alzheimer-type dementia, but safe, effective treatments remain elusive.  Psychol. treatments are first-line options, but they have limited efficacy.  Off-label psychotropic medications are frequently used, but they also have limited effectiveness, and their use may have harmful side effects, including death.  This review discusses the history leading to the conception of AVP-786 (deuterated (d6)-dextromethorphan/quinidine), its pharmacokinetic and pharmacodynamic profiles and safety issues, together with an overview of recent clin. trials.  Data were found in the medical literature, in US and EU clin. trial registries and in information provided by the manufacturer.: AVP-786 is one of six investigational compds. in recent phase III clin. development for agitation in Alzheimer disease (AD).  Quinidine and deuteration appear to prolong dextromethorphan's plasma half-life and facilitate brain penetration.  The FDA granted fast-track designation to AVP-786 and allowed use of data generated on dextromethorphan-quinidine (AVP-923, Nuedexta) for regulatory filings.  AVP-923 reduced agitation in AD and was well tolerated in a phase II RCT that included more than 200 patients.  A phase III clin. development program of AVP-786 for AD agitation was recently initiated.  This program is expected to start generating results in July 2018.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_AL-sfgaS9bVg90H21EOLACvtfcHk0ljaORDP2-COsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOlu7fP&md5=87b364678882778445cb4dabc5a65b57</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F13543784.2017.1267726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2017.1267726%26sid%3Dliteratum%253Aachs%26aulast%3DGaray%26aufirst%3DR.%2BP.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DAVP-786%2520for%2520the%2520treatment%2520of%2520agitation%2520in%2520dementia%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520type%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2017%26volume%3D26%26spage%3D121%26epage%3D132%26doi%3D10.1080%2F13543784.2017.1267726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupa-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moslin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobleski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J.</span></span> <span> </span><span class="NLM_article-title">349 - BMS-986165 is a highly potent and selective allosteric inhibitor of TYK2, blocks IL-12, IL-23 and type I interferon signaling and provides for robust efficacy in preclinical models of systemic lupus erythematosus and inflammatory bowel disease</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">S-1357</span>, <span class="refDoi"> DOI: 10.1016/S0016-5085(18)34439-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0016-5085%2818%2934439-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=S-1357&author=J.+H.+Xieauthor=K.+Gilloolyauthor=Y.+Zhangauthor=X.+Yangauthor=A.+Zupa-Fernandezauthor=L.+Chengauthor=J.+Strnadauthor=E.+Heimrichauthor=X.+Zhouauthor=J.+Chenauthor=C.+Chaudhryauthor=S.+Liauthor=R.+Moslinauthor=S.+Wrobleskiauthor=D.+Weinsteinauthor=J.+Burke&title=349+-+BMS-986165+is+a+highly+potent+and+selective+allosteric+inhibitor+of+TYK2%2C+blocks+IL-12%2C+IL-23+and+type+I+interferon+signaling+and+provides+for+robust+efficacy+in+preclinical+models+of+systemic+lupus+erythematosus+and+inflammatory+bowel+disease&doi=10.1016%2FS0016-5085%2818%2934439-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2818%2934439-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252818%252934439-1%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DGillooly%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZupa-Fernandez%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DStrnad%26aufirst%3DJ.%26aulast%3DHeimrich%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMoslin%26aufirst%3DR.%26aulast%3DWrobleski%26aufirst%3DS.%26aulast%3DWeinstein%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DJ.%26atitle%3D349%2520-%2520BMS-986165%2520is%2520a%2520highly%2520potent%2520and%2520selective%2520allosteric%2520inhibitor%2520of%2520TYK2%252C%2520blocks%2520IL-12%252C%2520IL-23%2520and%2520type%2520I%2520interferon%2520signaling%2520and%2520provides%2520for%2520robust%2520efficacy%2520in%2520preclinical%2520models%2520of%2520systemic%2520lupus%2520erythematosus%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DGastroenterology%26date%3D2018%26volume%3D154%26spage%3DS-1357%26doi%3D10.1016%2FS0016-5085%2818%2934439-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D.</span>; <span class="NLM_string-name">Wrobleski, S.</span>; <span class="NLM_string-name">Moslin, R.</span>; <span class="NLM_string-name">Lin, S.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Spergel, S.</span>; <span class="NLM_string-name">Mertzman, M.</span>; <span class="NLM_string-name">Tokarski, J.</span>; <span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Chiney, M.</span>; <span class="NLM_string-name">Elzinga, P.</span>; <span class="NLM_string-name">Aranibar, N.</span>; <span class="NLM_string-name">Chimalakonda, A.</span>; <span class="NLM_string-name">Strnad, J.</span>; <span class="NLM_string-name">Zupa-Fernandez, A.</span>; <span class="NLM_string-name">Cheng, L.</span>; <span class="NLM_string-name">Gillooly, K.</span>; <span class="NLM_string-name">Mcintyre, K.</span>; <span class="NLM_string-name">Carter, P.</span>; <span class="NLM_string-name">Lombardo, L.</span>; <span class="NLM_string-name">Burke, J.</span>; <span class="NLM_string-name">Macor, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Pseudokinase Domain Ligand as an Allosteric Inhibitor of TYK2 for the Treatment of Autoimmune Diseases</span>.  <i>Abstracts of Papers</i>, 252nd National Meeting and Exposition of the American Chemical Society, Philadelphia, PA, August 21–25, 2016; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+Weinstein&author=S.+Wrobleski&author=R.+Moslin&author=S.+Lin&author=Y.+Zhang&author=S.+Spergel&author=M.+Mertzman&author=J.+Tokarski&author=H.+Sun&author=M.+Chiney&author=P.+Elzinga&author=N.+Aranibar&author=A.+Chimalakonda&author=J.+Strnad&author=A.+Zupa-Fernandez&author=L.+Cheng&author=K.+Gillooly&author=K.+Mcintyre&author=P.+Carter&author=L.+Lombardo&author=J.+Burke&author=J.+Macor&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520Pseudokinase%2520Domain%2520Ligand%2520as%2520an%2520Allosteric%2520Inhibitor%2520of%2520TYK2%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520Diseases%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooderham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girgis, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span> <span> </span><span class="NLM_article-title">Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1806382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1056%2FNEJMoa1806382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=30205746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWlsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2018&pages=1313-1321&author=K.+Pappauthor=K.+Gordonauthor=D.+Thaciauthor=A.+Moritaauthor=M.+Gooderhamauthor=P.+Foleyauthor=I.+G.+Girgisauthor=S.+Kunduauthor=S.+Banerjee&title=Phase+2+trial+of+selective+tyrosine+kinase+2+inhibition+in+psoriasis&doi=10.1056%2FNEJMoa1806382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis</span></div><div class="casAuthors">Papp, Kim; Gordon, Kenneth; Thaci, Diamant; Morita, Akimichi; Gooderham, Melinda; Foley, Peter; Girgis, Ihab G.; Kundu, Sudeep; Banerjee, Subhashis</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1313-1321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Tyrosine kinase 2 (TYK2) signaling pathways, which mediate cytokine signaling, are implicated in the pathophysiol. of psoriasis.  Selective inhibitors of TYK2 may be effective in treating psoriasis. methods We conducted a phase 2, double-blind trial of a TYK2 inhibitor, BMS-986165, in adults with moderate-to-severe psoriasis, excluding patients with a previous lack of response to agents targeting cytokine signaling through the same tyrosine kinase pathway.  Patients were randomly assigned to receive the drug orally at a dose of 3 mg every other day, 3 mg daily, 3 mg twice daily, 6 mg twice daily, or 12 mg daily or to receive placebo.  The primary end point was a 75% or greater redn. from baseline in the Psoriasis Area and Severity Index (PASI) score at week 12 (higher scores indicate greater severity of psoriasis). results A total of 267 patients received at least one dose in an intervention group of the trial.  At week 12, the percentage of patients with a 75% or greater redn. in the PASI score was 7% (3 of 45 patients) with placebo, 9% (4 of 44 patients) with 3 mg of BMS-986165 every other day (P = 0.49 vs. placebo), 39% (17 of 44 patients) with 3 mg daily (P<0.001 vs. placebo), 69% (31 of 45 patients) with 3 mg twice daily (P<0.001 vs. placebo), 67% (30 of 45 patients) with 6 mg twice daily (P<0.001 vs. placebo), and 75% (33 of 44 patients) with 12 mg daily (P<0.001 vs. placebo).  There were three serious adverse events in patients receiving the active drug, as well as one case of malignant melanoma 96 days after the start of treatment. conclusions Selective inhibition of TYK2 with the oral agent BMS-986165 at doses of 3 mg daily and higher resulted in greater clearing of psoriasis than did placebo over a period of 12 wk.  Larger and longer-duration trials of this drug are required to det. its safety and durability of effect in patients with psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhqWANKhDdt7Vg90H21EOLACvtfcHk0lg93V-8a8uDWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWlsrbE&md5=ededd5d925dd557cceacc472839a966a</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1806382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1806382%26sid%3Dliteratum%253Aachs%26aulast%3DPapp%26aufirst%3DK.%26aulast%3DGordon%26aufirst%3DK.%26aulast%3DThaci%26aufirst%3DD.%26aulast%3DMorita%26aufirst%3DA.%26aulast%3DGooderham%26aufirst%3DM.%26aulast%3DFoley%26aufirst%3DP.%26aulast%3DGirgis%26aufirst%3DI.%2BG.%26aulast%3DKundu%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DPhase%25202%2520trial%2520of%2520selective%2520tyrosine%2520kinase%25202%2520inhibition%2520in%2520psoriasis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D379%26spage%3D1313%26epage%3D1321%26doi%3D10.1056%2FNEJMoa1806382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span>An Investigational Study To Evaluate Experimental Medication
BMS-986165 Compared to Placebo and a Currently Available Treatment
in Participants with Moderate to Severe Plaque Psoriasis (POETYK-PSO-1).
ClinicalTrials.gov identifier: NCT03624127. Last update: October 10,
2018. Accessed on October 22, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Investigational+Study+To+Evaluate+Experimental+Medication%0ABMS-986165+Compared+to+Placebo+and+a+Currently+Available+Treatment%0Ain+Participants+with+Moderate+to+Severe+Plaque+Psoriasis+%28POETYK-PSO-1%29.%0AClinicalTrials.gov+identifier%3A+NCT03624127.+Last+update%3A+October+10%2C%0A2018.+Accessed+on+October+22%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span>An Investigational Study To Evaluate Experimental
Medication BMS-986165 Compared to Placebo and a Currently Available
Treatment in Participants with Moderate-to-Severe Plaque Psoriasis
(POETYK-PSO-2). ClinicalTrials.gov identifier: NCT03611751. Last update:
October 10, 2018. Accessed on October 22, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Investigational+Study+To+Evaluate+Experimental%0AMedication+BMS-986165+Compared+to+Placebo+and+a+Currently+Available%0ATreatment+in+Participants+with+Moderate-to-Severe+Plaque+Psoriasis%0A%28POETYK-PSO-2%29.+ClinicalTrials.gov+identifier%3A+NCT03611751.+Last+update%3A%0AOctober+10%2C+2018.+Accessed+on+October+22%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misenko, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thandoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhawar, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunting, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffty, B. G.</span></span> <span> </span><span class="NLM_article-title">VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">25833</span>– <span class="NLM_lpage">25841</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.25383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.18632%2Foncotarget.25383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29899825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1MbntVGntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=25833-25841&author=A.+J.+Khanauthor=S.+M.+Misenkoauthor=A.+Thandoniauthor=D.+Schiffauthor=S.+R.+Jhawarauthor=S.+F.+Buntingauthor=B.+G.+Haffty&title=VX-984+is+a+selective+inhibitor+of+non-homologous+end+joining%2C+with+possible+preferential+activity+in+transformed+cells&doi=10.18632%2Foncotarget.25383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells</span></div><div class="casAuthors">Khan Atif J; Khan Atif J; Thandoni Aditya; Schiff Devora; Jhawar Sachin R; Haffty Bruce G; Misenko Sarah M; Bunting Samuel F</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">25833-25841</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Purpose:  DNA double-strand breaks (DSBs) can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR).  We demonstrate the selectivity of VX-984, a DNA-PK inhibitor, using assays not previously reported.  Experimental Design:  The class switch recombination assay (CSR) in primary B cells was used to measure efficiency of NHEJ.  A cellular reporter assay (U2OS EJ-DR) was used to assess the efficiency of HR and NHEJ in cells treated with VX-984.  Immunofluorescence assays (IF) evaluated γ-H2AX foci for DSB repair kinetics in human astrocytes and T98G glioma cells.  Western blotting was used to evaluate phosphorylation of DNA-PKcs substrates.  Results:  We found a dose-dependent reduction in CSR efficiency with VX-984, and through the EJ-DR assay, dramatic dose-dependent increases in HR and mNHEJ.  Immunofluorescence assays showed an inability of malignant cells to resolve γ-H2AX foci in the presence of VX-984.  Radiation-induced phosphorylation of DNA-PK substrates was further reduced by treatment with VX-984.  Conclusions:  VX-984 efficiently inhibits NHEJ, resulting in compensatory increases in alternative repair pathways, increases DSBs, and appears to affect transformed cells preferentially.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMzH74v_wRzcyail4HZd-ifW6udTcc2eY29S-25udlC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbntVGntQ%253D%253D&md5=6af1738162bf28f56ab9431546488993</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.25383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.25383%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%2BJ.%26aulast%3DMisenko%26aufirst%3DS.%2BM.%26aulast%3DThandoni%26aufirst%3DA.%26aulast%3DSchiff%26aufirst%3DD.%26aulast%3DJhawar%26aufirst%3DS.%2BR.%26aulast%3DBunting%26aufirst%3DS.%2BF.%26aulast%3DHaffty%26aufirst%3DB.%2BG.%26atitle%3DVX-984%2520is%2520a%2520selective%2520inhibitor%2520of%2520non-homologous%2520end%2520joining%252C%2520with%2520possible%2520preferential%2520activity%2520in%2520transformed%2520cells%26jtitle%3DOncotarget%26date%3D2018%26volume%3D9%26spage%3D25833%26epage%3D25841%26doi%3D10.18632%2Foncotarget.25383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, D.</span>; <span class="NLM_string-name">Newsome, D.</span>; <span class="NLM_string-name">Takemoto, D.</span>; <span class="NLM_string-name">Hillier, S.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Arimoto, R.</span>; <span class="NLM_string-name">Maxwell, J.</span>; <span class="NLM_string-name">Charifson, P.</span>; <span class="NLM_string-name">Fields, S. Z.</span>; <span class="NLM_string-name">Tanner, K.</span>; <span class="NLM_string-name">Penney, M. S.</span></span> <span> </span><span class="NLM_article-title">Preclinical Characterization of VX-984, a Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor in Combination with Doxorubicin in Breast and Ovarian Cancers</span>.  <i>Abstracts of Papers</i>, 2016 San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+Boucher&author=D.+Newsome&author=D.+Takemoto&author=S.+Hillier&author=Y.+Wang&author=R.+Arimoto&author=J.+Maxwell&author=P.+Charifson&author=S.+Z.+Fields&author=K.+Tanner&author=M.+S.+Penney&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DD.%26atitle%3DPreclinical%2520Characterization%2520of%2520VX-984%252C%2520a%2520Selective%2520DNA-Dependent%2520Protein%2520Kinase%2520%2528DNA-PK%2529%2520Inhibitor%2520in%2520Combination%2520with%2520Doxorubicin%2520in%2520Breast%2520and%2520Ovarian%2520Cancers%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span>First-in-Human
Study of the Safety,
Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984
in Combination with Chemotherapy. ClinicalTrials.gov identifier: NCT02644278.
Last update: June 5, 2018. Accessed on November 15, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=First-in-Human%0AStudy+of+the+Safety%2C%0ATolerability%2C+and+Pharmacokinetic%2FPharmacodynamic+Profile+of+VX-984%0Ain+Combination+with+Chemotherapy.+ClinicalTrials.gov+identifier%3A+NCT02644278.%0ALast+update%3A+June+5%2C+2018.+Accessed+on+November+15%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Stevens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worboys, P.</span></span> <span> </span><span class="NLM_article-title">Rodent pharmacokinetics and receptor occupancy of the GABA<sub>A</sub> receptor subtype selective benzodiazepine site ligand L-838417</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1002/bdd.423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fbdd.423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=15578749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=13-20&author=P.+Scott-Stevensauthor=J.+R.+Atackauthor=B.+Sohalauthor=P.+Worboys&title=Rodent+pharmacokinetics+and+receptor+occupancy+of+the+GABAA+receptor+subtype+selective+benzodiazepine+site+ligand+L-838417&doi=10.1002%2Fbdd.423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417</span></div><div class="casAuthors">Scott-Stevens, P.; Atack, J. R.; Sohal, B.; Worboys, P.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The pharmacokinetics of L-838417, a GABAA receptor subtype selective benzodiazepine site agonist, were studied in rats and mice after single oral (p.o.), i.p., and i.v. doses.  In both species L-838417 was well absorbed following i.p. administration and while in rats p.o. bioavailability was good (41%), in mice it was negligible (<1%), precluding this as a route of administration for mouse behavioral studies.  Despite having a similar vol. of distribution (ca 1.41/kg) in rats and mice, L-838417 was cleared at twice liver blood flow in mice (161 mL/min/kg) and moderately cleared in rats (24 mL/min/kg), potentially explaining the poor oral bioavailability in mice.  Finally, as a pharmacodynamic readout the benzodiazepine binding site occupancy was detd. in rats (0.3-3 mg/kg, p.o.) and mice (1-30 mg/kg, i.p.) using a [3H]Ro 15-1788 in vivo binding assay.  Although the resulting dose-occupancy relationship for both species demonstrated a dose-dependent increase in receptor occupancy, appreciable variability was obsd. at low dose levels, potentially making interpretation of behavioral responses difficult.  In contrast, a clear relationship between plasma and brain concns. and receptor occupancy were detd. suggesting the obsd. dose-occupancy variability is a consequence of the pharmacokinetic properties of L-838417.  The plasma and brain concns. required to occupy 50% of the benzodiazepine binding sites were similar in both rats (28 ng/mL and 33 ng/mlg, resp.) and mice (63 ng/mL and 53 ng/mlg, resp.), with a non-linear concn. response obsd. with increasing doses of L-838417.  These studies demonstrate the importance of utilizing pharmacokinetic/receptor occupancy data when interpreting pharmacodynamic responses at a given dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaynJT0wl1-LVg90H21EOLACvtfcHk0ljtVaMmrhIg3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFamtA%253D%253D&md5=6deed2c048d9edb5f54f8a4b7497ebc1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fbdd.423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.423%26sid%3Dliteratum%253Aachs%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DWorboys%26aufirst%3DP.%26atitle%3DRodent%2520pharmacokinetics%2520and%2520receptor%2520occupancy%2520of%2520the%2520GABAA%2520receptor%2520subtype%2520selective%2520benzodiazepine%2520site%2520ligand%2520L-838417%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2005%26volume%3D26%26spage%3D13%26epage%3D20%26doi%3D10.1002%2Fbdd.423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Scott Harbeson, S.</span>; <span class="NLM_string-name">Vinita Uttamsingh, V.</span>; <span class="NLM_string-name">Morales, A. J.</span>; <span class="NLM_string-name">Nguyen, S.</span>; <span class="NLM_string-name">Bridson, G.</span>; <span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Wu, L.</span></span> <span> </span><span class="NLM_article-title">CTP-354: A Novel Deuterated Subtype-Selective GABA(A) Modulator for Treatment of Neuropathic Pain, Spasticity and Anxiety Disorders</span>. Presented at the American College of Neuropsychopharmacology (ACNP) 51st Annual Meeting, Hollywood, FL, December 2–6, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+F.+Liu&author=S.+Scott+Harbeson&author=V.+Vinita+Uttamsingh&author=A.+J.+Morales&author=S.+Nguyen&author=G.+Bridson&author=C.+Cheng&author=A.+Aslanian&author=L.+Wu&title=CTP-354%3A+A+Novel+Deuterated+Subtype-Selective+GABA%28A%29+Modulator+for+Treatment+of+Neuropathic+Pain%2C+Spasticity+and+Anxiety+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26atitle%3DCTP-354%253A%2520A%2520Novel%2520Deuterated%2520Subtype-Selective%2520GABA%2528A%2529%2520Modulator%2520for%2520Treatment%2520of%2520Neuropathic%2520Pain%252C%2520Spasticity%2520and%2520Anxiety%2520Disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span>; <span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Harbeson, S.</span>; <span class="NLM_string-name">Uttamsingh, V.</span>; <span class="NLM_string-name">Bridson, G.</span>; <span class="NLM_string-name">Wu, L.</span>; <span class="NLM_string-name">Shipley, J. E.</span></span> <span> </span><span class="NLM_article-title">Preliminary Clinical Outcomes for CTP-354, a Novel Subtype-Selective GABA(A) Modulator</span>. Presented at the American Neurological Association (ANA) 2014 Annual Meeting, Baltimore, MD, October 12–14, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=V.+Braman&author=J.+F.+Liu&author=S.+Harbeson&author=V.+Uttamsingh&author=G.+Bridson&author=L.+Wu&author=J.+E.+Shipley&title=Preliminary+Clinical+Outcomes+for+CTP-354%2C+a+Novel+Subtype-Selective+GABA%28A%29+Modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBraman%26aufirst%3DV.%26atitle%3DPreliminary%2520Clinical%2520Outcomes%2520for%2520CTP-354%252C%2520a%2520Novel%2520Subtype-Selective%2520GABA%2528A%2529%2520Modulator%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A. A.</span>; <span class="NLM_string-name">Harris, C. J.</span>; <span class="NLM_string-name">Smith, D. A.</span></span> <i>Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+A.+Alex&author=C.+J.+Harris&author=D.+A.+Smith&title=Attrition+in+the+Pharmaceutical+Industry%3A+Reasons%2C+Implications%2C+and+Pathways+Forward"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%2BA.%26btitle%3DAttrition%2520in%2520the%2520Pharmaceutical%2520Industry%253A%2520Reasons%252C%2520Implications%252C%2520and%2520Pathways%2520Forward%26pub%3DWiley%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trager, W. F.</span></span> <span> </span><span class="NLM_article-title">The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1481</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1124/dmd.31.12.1481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.31.12.1481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=14625345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1KgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1481-1498&author=S.+D.+Nelsonauthor=W.+F.+Trager&title=The+use+of+deuterium+isotope+effects+to+probe+the+active+site+properties%2C+mechanism+of+cytochrome+P450-catalyzed+reactions%2C+and+mechanisms+of+metabolically+dependent+toxicity&doi=10.1124%2Fdmd.31.12.1481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity</span></div><div class="casAuthors">Nelson, Sidney D.; Trager, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1481-1498</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Crit. elements from studies that have led to our current understanding of the factors that cause the obsd. primary deuterium isotope effect, (kH/kD)obs, of most enzymically mediated reactions to be much smaller than the "true" or intrinsic primary deuterium isotope effect, kH/kD, for the reaction are presented.  This new understanding has provided a unique and powerful tool for probing the catalytic and active site properties of enzymes, particularly the cytochromes P 450 (P 450).  Examples are presented that illustrate how the technique has been used to det. kH/kD, and properties such as the catalytic nature of the reactive oxenoid intermediate, prochiral selectivity, the chem. and enzymic mechanisms of cytochrome P 450-catalyzed reactions, and the relative active site size of different P 450 isoforms.  Examples are also presented of how deuterium isotope effects have been used to probe mechanisms of the formation of reactive metabolites that can cause toxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbj0BX3noYBrVg90H21EOLACvtfcHk0ljtVaMmrhIg3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1KgsLw%253D&md5=015951029d6b68dd54a02711e6dac307</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.12.1481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.12.1481%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DS.%2BD.%26aulast%3DTrager%26aufirst%3DW.%2BF.%26atitle%3DThe%2520use%2520of%2520deuterium%2520isotope%2520effects%2520to%2520probe%2520the%2520active%2520site%2520properties%252C%2520mechanism%2520of%2520cytochrome%2520P450-catalyzed%2520reactions%252C%2520and%2520mechanisms%2520of%2520metabolically%2520dependent%2520toxicity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D1481%26epage%3D1498%26doi%3D10.1124%2Fdmd.31.12.1481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic deuterium isotope effects in cytochrome P450 reactions</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>596</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/bs.mie.2017.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fbs.mie.2017.06.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28911772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvFSjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=596&publication_year=2017&pages=217-238&author=F.+P.+Guengerich&title=Kinetic+deuterium+isotope+effects+in+cytochrome+P450+reactions&doi=10.1016%2Fbs.mie.2017.06.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic deuterium isotope effects in cytochrome P450 reactions</span></div><div class="casAuthors">Guengerich, Frederick P.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">596</span>
        (<span class="NLM_cas:issue">Measurement and Analysis of Kinetic Isotope Effects</span>),
    <span class="NLM_cas:pages">217-238</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (P 450, CYP) research provides many opportunities for the application of kinetic isotope effect (KIE) strategies.  P450s collectively catalyze oxidns. of more substrates than any other group of enzymes, and C - H bond cleavage is a major feature in a large fraction of these reactions.  The presence of a significant primary deuterium KIE is evidence that hydrogen abstraction is at least partially rate-limiting in the reactions, and this appears to be the case in many P 450 reactions.  The first report of a KIE in (P 450-linked) drug metab. appeared in 1961 (for morphine N-demethylation), and in a no. of cases, it has been possible to modulate the in vivo metab. or toxicity of chems. by deuterium substitution.  A no. of efforts are in progress to utilize deuterium substitution to alter the metab. of drugs in an advantageous manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Wfw_I6hKCLVg90H21EOLACvtfcHk0ljXEufy0EdqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvFSjtbc%253D&md5=b16fdb188155619cc2cd49ddbd9ce25e</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1016%2Fbs.mie.2017.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.mie.2017.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520deuterium%2520isotope%2520effects%2520in%2520cytochrome%2520P450%2520reactions%26jtitle%3DMethods%2520Enzymol.%26date%3D2017%26volume%3D596%26spage%3D217%26epage%3D238%26doi%3D10.1016%2Fbs.mie.2017.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Kinetic deuterium isotope effects in cytochrome P450 oxidation reactions</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fjlcr.3031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=24285515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=428-431&author=F.+P.+Guengerich&title=Kinetic+deuterium+isotope+effects+in+cytochrome+P450+oxidation+reactions&doi=10.1002%2Fjlcr.3031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic deuterium isotope effects in cytochrome P 450 oxidation reactions</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (P 450) isoforms account for ∼75% of the metab. of drugs.  Most of the reactions catalyzed by P 450 isoforms are mixed-function oxidns., and a C-H bond is (usually) broken.  The rate-limiting nature of this step can be analyzed using the kinetic isotope effect (KIE) approach.  The most relevant type of KIE is one termed intermol. noncompetitive, indicative of rate-limiting C-H bond breaking.  A plot of KIE vs. kcat for several P 450s showed a correlation coeff. (r2) of 0.62.  Deuterium substitution has been considered as a potential means of slowing drug metab. or redirecting sites of metab. in some cases, and several general points can be made regarding the potential for application of deuterium in drug design/development based on what is known about P 450 KIEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKzliIFqb7trVg90H21EOLACvtfcHk0ljXEufy0EdqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVemsbw%253D&md5=b06a7c3232f556435d16bf97b567199f</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3031%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DKinetic%2520deuterium%2520isotope%2520effects%2520in%2520cytochrome%2520P450%2520oxidation%2520reactions%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D428%26epage%3D431%26doi%3D10.1002%2Fjlcr.3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schildknegt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaz, A. D. N.</span></span> <span> </span><span class="NLM_article-title">Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.042770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.111.042770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=22190693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=625-634&author=R.+Sharmaauthor=T.+J.+Strelevitzauthor=H.+Gaoauthor=A.+J.+Clarkauthor=K.+Schildknegtauthor=R.+S.+Obachauthor=S.+L.+Rippauthor=D.+K.+Spracklinauthor=L.+M.+Tremaineauthor=A.+D.+N.+Vaz&title=Deuterium+isotope+effects+on+drug+pharmacokinetics.+I.+System-dependent+effects+of+specific+deuteration+with+aldehyde+oxidase+cleared+drugs&doi=10.1124%2Fdmd.111.042770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs</span></div><div class="casAuthors">Sharma, Raman; Strelevitz, Timothy J.; Gao, Hongying; Clark, Alan J.; Schildknegt, Klaas; Obach, R. Scott; Ripp, Sharon L.; Spracklin, Douglas K.; Tremaine, Larry M.; Vaz, Alfin D. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The pharmacokinetic properties of drugs may be altered by kinetic deuterium isotope effects.  With specifically deuterated model substrates and drugs metabolized by aldehyde oxidase, we demonstrate how knowledge of the enzyme's reaction mechanism, species differences in the role played by other enzymes in a drug's metabolic clearance, and differences in systemic clearance mechanisms are critically important for the pharmacokinetic application of deuterium isotope effects.  Ex vivo methods to project the in vivo outcome using deuterated carbazeran and zoniporide with hepatic systems demonstrate the importance of establishing the extent to which other metabolic enzymes contribute to the metabolic clearance mechanism.  Differences in pharmacokinetic outcomes in guinea pig and rat, with the same metabolic clearance mechanism, show how species differences in the systemic clearance mechanism can affect the in vivo outcome.  Overall, to gain from the application of deuteration as a strategy to alter drug pharmacokinetics, these studies demonstrate the importance of understanding the systemic clearance mechanism and knowing the identity of the metabolic enzymes involved, the extent to which they contribute to metabolic clearance, and the extent to which metab. contributes to the systemic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCSMFZQoq7tbVg90H21EOLACvtfcHk0ljXEufy0EdqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1ajsrc%253D&md5=8d94242f5ef844ab3f45cfe92275ecda</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.042770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.042770%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26aulast%3DSchildknegt%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26atitle%3DDeuterium%2520isotope%2520effects%2520on%2520drug%2520pharmacokinetics.%2520I.%2520System-dependent%2520effects%2520of%2520specific%2520deuteration%2520with%2520aldehyde%2520oxidase%2520cleared%2520drugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D625%26epage%3D634%26doi%3D10.1124%2Fdmd.111.042770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malmlöf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rylander, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cenci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilström, B.</span></span> <span> </span><span class="NLM_article-title">Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>225</i></span>,  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2010.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.expneurol.2010.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=20659451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC3cfhtVSqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2010&pages=408-415&author=T.+Malml%C3%B6fauthor=D.+Rylanderauthor=R.+G.+Alkenauthor=F.+Schneiderauthor=T.+H.+Svenssonauthor=M.+A.+Cenciauthor=B.+Schilstr%C3%B6m&title=Deuterium+substitutions+in+the+L-DOPA+molecule+improve+its+anti-akinetic+potency+without+increasing+dyskinesias&doi=10.1016%2Fj.expneurol.2010.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias</span></div><div class="casAuthors">Malmlof Torun; Rylander Daniella; Alken Rudolf-Giesbert; Schneider Frank; Svensson Torgny H; Cenci M Angela; Schilstrom Bjorn</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">408-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment of Parkinson's disease is complicated by a high incidence of L-DOPA-induced dyskinesias (LID).  Strategies to prevent the development of LID aim at providing more stable dopaminergic stimulation.  We have previously shown that deuterium substitutions in the L-DOPA molecule (D3-L-DOPA) yield dopamine that appears more resistant to enzymatic breakdown.  We here investigated the effects of D3-L-DOPA on motor performance and development of dyskinesias in a rodent model of Parkinson's disease.  Through acute experiments, monitoring rotational behavior, dose-effect curves were established for D3-L-DOPA and L-DOPA.  The equipotent dose of D3-L-DOPA was estimated to be 60% of L-DOPA.  Subsequently, animals were treated with either the equipotent dose of D3-L-DOPA (5 mg/kg), the equivalent dose of D3-L-DOPA (8 mg/kg), L-DOPA (8 mg/kg) or vehicle.  The equivalent dose of D3-L-DOPA produced superior anti-akinetic effects compared to L-DOPA in the cylinder test (p<0.05), whereas the equipotent dose of D3-L-DOPA produced an anti-akinetic effect similar to L-DOPA.  Dyskinesias developed to the same degree in the groups treated with equivalent doses of D3-L-DOPA and L-DOPA.  The equipotent dose of D3-L-DOPA induced fewer dyskinesias than L-DOPA (p<0.05).  In conclusion, our study provides evidence for improved potency and reduced side-effects of L-DOPA by deuterium substitutions in the molecule.  These results are of clinical interest since the occurrence of LID is related to the total L-DOPA dose administered.  D3-L-DOPA may thus represent a novel strategy to reduce the total dose requirement and yet achieve an effective control of parkinsonian symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCCKPVGe_D6_6BottYdIAWfW6udTcc2eZj35Z_Hn1pYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfhtVSqsw%253D%253D&md5=1b36548fa566e2bb7b71e0206ab494a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2010.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2010.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DMalml%25C3%25B6f%26aufirst%3DT.%26aulast%3DRylander%26aufirst%3DD.%26aulast%3DAlken%26aufirst%3DR.%2BG.%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DSvensson%26aufirst%3DT.%2BH.%26aulast%3DCenci%26aufirst%3DM.%2BA.%26aulast%3DSchilstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DDeuterium%2520substitutions%2520in%2520the%2520L-DOPA%2520molecule%2520improve%2520its%2520anti-akinetic%2520potency%2520without%2520increasing%2520dyskinesias%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D225%26spage%3D408%26epage%3D415%26doi%3D10.1016%2Fj.expneurol.2010.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erisson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beygi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Barak, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grachev, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loupe, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savola, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracewell, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velinova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelstein, O.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">2422</span>– <span class="NLM_lpage">2432</span>, <span class="refDoi"> DOI: 10.1111/bcp.13702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1111%2Fbcp.13702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29959802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=2422-2432&author=F.+Schneiderauthor=L.+Erissonauthor=H.+Beygiauthor=M.+Bradburyauthor=O.+Cohen-Barakauthor=I.+D.+Grachevauthor=S.+Guzyauthor=P.+S.+Loupeauthor=M.+Leviauthor=M.+McDonaldauthor=J.+M.+Savolaauthor=S.+Papapetropoulosauthor=W.+G.+Tracewellauthor=M.+Velinovaauthor=O.+Spiegelstein&title=Pharmacokinetics%2C+metabolism+and+safety+of+deuterated+L-DOPA+%28SD-1077%29%2Fcarbidopa+compared+to+L-DOPA%2Fcarbidopa+following+single+oral+dose+administration+in+healthy+subjects&doi=10.1111%2Fbcp.13702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects</span></div><div class="casAuthors">Schneider, Frank; Erisson, Lavi; Beygi, Hooman; Bradbury, Margaret; Cohen-Barak, Orit; Grachev, Igor D.; Guzy, Serge; Loupe, Pippa S.; Levi, Micha; McDonald, Mirna; Savola, Juha-Matti; Papapetropoulos, Spyros; Tracewell, William G.; Velinova, Maria; Spiegelstein, Ofer</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2422-2432</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : SD-1077, a selectively deuterated precursor of dopamine (DA) structurally related to L-3,4-dihydroxyphenylalanine (L-DOPA), is under development for treatment of motor symptoms of Parkinson's disease.  Preclin. models have shown slower metab. of central deuterated DA.  The present study investigated the peripheral pharmacokinetics (PK), metab. and safety of SD-1077.  Methods : Plasma and urine PK of drug and metabolites and safety after a single oral 150 mg SD-1077 dose were compared to 150 mg L-DOPA, each in combination with 37.5 mg carbidopa (CD) in a double-blind, two-period, crossover study in healthy volunteers (n = 16).  Results : Geometric least squares mean ratios (GMRs) and 90% confidence intervals (90% CI) of SD-1077 vs. L-DOPA for Cmax, AUC0-t, and AUC0-inf were 88.4 (75.9-103.1), 89.5 (84.1-95.3), and 89.6 (84.2-95.4), resp.  Systemic exposure to DA was significantly higher after SD-1077/CD compared to that after L-DOPA/CD, with GMRs (90% CI) of 1.8 (1.45-2.24; P = 0.0005) and 2.06 (1.68-2.52; P < 0.0001) for Cmax and AUC0-t and a concomitant redn. in the ratio of 3,4-dihydroxyphenylacetic acid/DA confirming slower metabolic breakdown of DA by monoamine oxidase (MAO).  There were increases in systemic exposures to metabolites of catechol O-methyltransferase (COMT) reaction, 3-methoxytyramine (3-MT) and 3-O-methyldopa (3-OMD) with GMRs (90% CI) for SD-1077/CD to L-DOPA/CD for 3-MT exposure of 1.33 (1.14-1.56; P = 0.0077) and 1.66 (1.42-1.93; P < 0.0001) for Cmax and AUC0-t, resp. and GMRs (90% CI) for 3-OMD of 1.19 (1.15, 1.23; P < 0.0001) and 1.31 (1.27, 1.36; P < 0.0001) for Cmax and AUC0-t.  SD-1077/CD exhibited comparable tolerability and safety to L-DOPA/CD.  Conclusions : SD-1077/CD demonstrated the potential to prolong exposure to central DA at comparable peripheral PK and safety to the ref. L-DOPA/CD combination.  A single dose of SD-1077 is safe for further clin. development in Parkinson's disease patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnz4G1z5uGtLVg90H21EOLACvtfcHk0ljDXnrxm-kmNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslaqt7nM&md5=e9d5896c4b86af0a661bddad5cd6db8b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13702%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DErisson%26aufirst%3DL.%26aulast%3DBeygi%26aufirst%3DH.%26aulast%3DBradbury%26aufirst%3DM.%26aulast%3DCohen-Barak%26aufirst%3DO.%26aulast%3DGrachev%26aufirst%3DI.%2BD.%26aulast%3DGuzy%26aufirst%3DS.%26aulast%3DLoupe%26aufirst%3DP.%2BS.%26aulast%3DLevi%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DM.%26aulast%3DSavola%26aufirst%3DJ.%2BM.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DTracewell%26aufirst%3DW.%2BG.%26aulast%3DVelinova%26aufirst%3DM.%26aulast%3DSpiegelstein%26aufirst%3DO.%26atitle%3DPharmacokinetics%252C%2520metabolism%2520and%2520safety%2520of%2520deuterated%2520L-DOPA%2520%2528SD-1077%2529%252Fcarbidopa%2520compared%2520to%2520L-DOPA%252Fcarbidopa%2520following%2520single%2520oral%2520dose%2520administration%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2018%26volume%3D84%26spage%3D2422%26epage%3D2432%26doi%3D10.1111%2Fbcp.13702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zane, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Horn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czepczor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardon, M.</span></span> <span> </span><span class="NLM_article-title">Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3831</span>– <span class="NLM_lpage">3842</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmc.2015.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25900628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVeqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3831-3842&author=J.+Schofieldauthor=V.+Derdauauthor=J.+Atzrodtauthor=P.+Zaneauthor=Z.+Guoauthor=R.+van+Hornauthor=V.+Czepczorauthor=A.+Stoltzauthor=M.+Pardon&title=Effect+of+deuteration+on+metabolism+and+clearance+of+Nerispirdine+%28HP184%29+and+AVE5638&doi=10.1016%2Fj.bmc.2015.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638</span></div><div class="casAuthors">Schofield, Joseph; Derdau, Volker; Atzrodt, Jens; Zane, Patricia; Guo, Zuyu; van Horn, Robert; Czepczor, Valerie; Stoltz, Axelle; Pardon, Magalie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3831-3842</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Replacing hydrogen with deuterium as a means of altering ADME properties of drug mols. has recently enjoyed a renaissance, such that at least two deuterated chem. entities are currently in clin. development.  Although most research in this area aims to increase the metabolic stability, and hence half-life of the active species, experience has shown that prediction of the in vivo behavior of deuterated mols. is difficult and depends on multiple factors including the complexity of the metabolic scheme, the enzymes involved and hence the mechanism of the rate-detg. step in the biotransformation.  In an effort to elucidate some of these factors we examd. the metabolic behavior of two mols. from the Sanofi portfolio in a range of in vitro and in vivo systems.  Although some key metabolic reactions of the acetylcholine release stimulator HP184 4 were slowed in vitro and in vivo when deuterium was present at the sites of metab., this did not translate to an increase in overall metabolic stability.  By contrast, the tryptase inhibitor AVE5638 13 was much more metabolically stable in vitro in its deuterated form than when unlabeled.  These results indicate that it could be of value to conc. efforts in this area to mols. which are metabolised by a major pathway that involves enzymes of the amine oxidase family or other low-capacity enzyme families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0Zfh2LmGWu7Vg90H21EOLACvtfcHk0ljDXnrxm-kmNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVeqtbk%253D&md5=376f5c853c811f8e8a7aaae21d4f0b46</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DSchofield%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DZane%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3Dvan%2BHorn%26aufirst%3DR.%26aulast%3DCzepczor%26aufirst%3DV.%26aulast%3DStoltz%26aufirst%3DA.%26aulast%3DPardon%26aufirst%3DM.%26atitle%3DEffect%2520of%2520deuteration%2520on%2520metabolism%2520and%2520clearance%2520of%2520Nerispirdine%2520%2528HP184%2529%2520and%2520AVE5638%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3831%26epage%3D3842%26doi%3D10.1016%2Fj.bmc.2015.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pestov, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okkelman, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmanai, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurski, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Control of lysyl oxidase activity through site-specific deuteration of lysine</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2010.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21106372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=255-258&author=N.+B.+Pestovauthor=I.+A.+Okkelmanauthor=V.+V.+Shmanaiauthor=A.+L.+Hurskiauthor=A.+J.+Giacciaauthor=M.+S.+Shchepinov&title=Control+of+lysyl+oxidase+activity+through+site-specific+deuteration+of+lysine&doi=10.1016%2Fj.bmcl.2010.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Control of lysyl oxidase activity through site-specific deuteration of lysine</span></div><div class="casAuthors">Pestov, Nikolay B.; Okkelman, Irina A.; Shmanai, Vadim V.; Hurski, Alaksiej L.; Giaccia, Amato J.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">255-258</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lysyl oxidase (LOX) is implicated in several extracellular matrix related disorders, including fibrosis and cancer.  Methods of inhibition of LOX in vivo include antibodies, copper sequestration and toxic small mols. such as β-aminopropionitrile.  Here, we propose a novel approach to modulation of LOX activity based on the kinetic isotope effect (KIE).  We show that 6,6-D2-lysine is oxidized by LOX at substantially lower rate, with apparent deuterium effect on V max/K m as high as 4.35 ± 0.22.  Lys is an essential nutrient, so dietary ingestion of D2Lys and its incorporation via normal Lys turnover suggests new approaches to mitigating LOX-assocd. pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJbj0BwwCWn7Vg90H21EOLACvtfcHk0ljDXnrxm-kmNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sqsb7E&md5=f50a798d4f7ba12fd8f2999da1f118ff</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DPestov%26aufirst%3DN.%2BB.%26aulast%3DOkkelman%26aufirst%3DI.%2BA.%26aulast%3DShmanai%26aufirst%3DV.%2BV.%26aulast%3DHurski%26aufirst%3DA.%2BL.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DControl%2520of%2520lysyl%2520oxidase%2520activity%2520through%2520site-specific%2520deuteration%2520of%2520lysine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D255%26epage%3D258%26doi%3D10.1016%2Fj.bmcl.2010.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillgenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koytchev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R. G.</span></span> <span> </span><span class="NLM_article-title">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span>. <i>Arzneim. Forsch.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1296724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1055%2Fs-0031-1296724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=16724516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2006&pages=295-300&author=F.+Schneiderauthor=M.+Hillgenbergauthor=R.+Koytchevauthor=R.+G.+Alken&title=Enhanced+plasma+concentration+by+selective+deuteration+of+rofecoxib+in+rats&doi=10.1055%2Fs-0031-1296724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced plasma concentration by selective deuteration of rofecoxib in rats</span></div><div class="casAuthors">Schneider, Frank; Hillgenberg, Moritz; Koytchev, Rossen; Alken, Rudolf-Giesbert</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel Forschung</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-300</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    
            (<span class="NLM_cas:orgname">Editio Cantor Verlag</span>)
        </div><div class="casAbstract">The plasma concns. of BDD-11602 (4-[4-(methanesulfonyl)phenyl]-3-(pentadeuterophenyl)-5H-furan-2-one), a rofecoxib deriv. in which the positions 2', 3', 4', 5' and 6' of the Ph ring were deuterated, and rofecoxib (4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one, CAS 162011-90-7) were compared in order to explore the effects of selective deuteration on the systemic bioavailability.  The COX-2 selectivity in vitro was also compared.  Following oral gavage administration of 0.1, 1 or 10 mg/kg BDD-11602 to Sprague Dawley rats, AUCo-t (area under the curve) and Cmax (max. concn.) values were statistically significant higher than those of rofecoxib at the same doses.  The overall increase in AUCo-t and Cmax for BDD-11602 over rofecoxib was 1.53-fold and 1.60-fold, resp.  BDD-11602 and rofecoxib inhibited COX-2-derived PGE(2) synthesis with IC50 values of 173 nmol/1 and 169 nmol/1, resp.  IC50 values for inhibition of human platelet COX-1 were estd. to be above 1 μmol/l for both compds.  The substitution of hydrogen by deuterium on the positions 2', 3', 4', 5' and 6' in BDD-11602 leads to superior oral availability compared to the non-deuterated compd., whereas the COX-2 selectivity is not affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLsIVPsmwYBrVg90H21EOLACvtfcHk0lhOlgUc9Ftndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2hurY%253D&md5=55f8165f69f41ed6113c6761297a1fd1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296724%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DHillgenberg%26aufirst%3DM.%26aulast%3DKoytchev%26aufirst%3DR.%26aulast%3DAlken%26aufirst%3DR.%2BG.%26atitle%3DEnhanced%2520plasma%2520concentration%2520by%2520selective%2520deuteration%2520of%2520rofecoxib%2520in%2520rats%26jtitle%3DArzneim.%2520Forsch.%26date%3D2006%26volume%3D56%26spage%3D295%26epage%3D300%26doi%3D10.1055%2Fs-0031-1296724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divović, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treven, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobričić, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meirelles, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzigmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihovilovic, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savić, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieghart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel deuterated ligands functionally selective for the γ-aminobutyric acid type A receptor (GABA<sub>A</sub>R) α6 subtype with improved metabolic stability and enhanced bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2422</span>– <span class="NLM_lpage">2446</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01664</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2422-2446&author=D.+E.+Knutsonauthor=R.+Kodaliauthor=B.+Divovi%C4%87author=M.+Trevenauthor=M.+R.+Stephenauthor=N.+M.+Zahnauthor=V.+Dobri%C4%8Di%C4%87author=A.+T.+Huberauthor=M.+A.+Meirellesauthor=R.+S.+Vermaauthor=L.+Wimmerauthor=C.+Witzigmannauthor=L.+A.+Arnoldauthor=L.+C.+Chiouauthor=M.+Ernstauthor=M.+D.+Mihovilovicauthor=M.+M.+Savi%C4%87author=W.+Sieghartauthor=J.+M.+Cook&title=Design+and+synthesis+of+novel+deuterated+ligands+functionally+selective+for+the+%CE%B3-aminobutyric+acid+type+A+receptor+%28GABAAR%29+%CE%B16+subtype+with+improved+metabolic+stability+and+enhanced+bioavailability&doi=10.1021%2Facs.jmedchem.7b01664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability</span></div><div class="casAuthors">Knutson, Daniel E.; Kodali, Revathi; Divovic, Branka; Treven, Marco; Stephen, Michael R.; Zahn, Nicolas M.; Dobricic, Vladimir; Huber, Alec T.; Meirelles, Matheus A.; Verma, Ranjit S.; Wimmer, Laurin; Witzigmann, Christopher; Arnold, Leggy A.; Chiou, Lih-Chu; Ernst, Margot; Mihovilovic, Marko D.; Savic, Miroslav M.; Sieghart, Werner; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2422-2446</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent reports indicate that α6β2/3γ2 GABAAR selective ligands may be important for the treatment of trigeminal activation-related pain and neuropsychiatric disorders with sensorimotor gating deficits.  Based on 3 functionally α6β2/3γ2 GABAAR selective pyrazoloquinolinones I (R1 = 7-OMe, R2 = 4'-OMe; R1 = 8-Cl, R2 = 3'-OMe; R1 = 7-Br, R2 = 4'-OMe), 42 novel analogs were synthesized, and their in vitro metabolic stability and cytotoxicity as well as their in vivo pharmacokinetics, basic behavioral pharmacol., and effects on locomotion were investigated.  Incorporation of deuterium into the methoxy substituents of the ligands increased their duration of action via improved metabolic stability and bioavailability, while their selectivity for the GABAAR α6 subtype was retained. 8b was identified as the lead compd. with a substantially improved pharmacokinetic profile.  The ligands allosterically modulated diazepam insensitive α6β2/3γ2 GABAARs and were functionally silent at diazepam sensitive α1β2/3γ2 GABAARs, thus no sedation was detected.  In addn., these analogs were not cytotoxic, which render them interesting candidates for treatment of CNS disorders mediated by GABAAR α6β2/3γ2 subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMM96AABYKIbVg90H21EOLACvtfcHk0lhOlgUc9Ftndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOls7k%253D&md5=e0591a3a9c7af56343483ff7aa0c254c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01664%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DD.%2BE.%26aulast%3DKodali%26aufirst%3DR.%26aulast%3DDivovi%25C4%2587%26aufirst%3DB.%26aulast%3DTreven%26aufirst%3DM.%26aulast%3DStephen%26aufirst%3DM.%2BR.%26aulast%3DZahn%26aufirst%3DN.%2BM.%26aulast%3DDobri%25C4%258Di%25C4%2587%26aufirst%3DV.%26aulast%3DHuber%26aufirst%3DA.%2BT.%26aulast%3DMeirelles%26aufirst%3DM.%2BA.%26aulast%3DVerma%26aufirst%3DR.%2BS.%26aulast%3DWimmer%26aufirst%3DL.%26aulast%3DWitzigmann%26aufirst%3DC.%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DChiou%26aufirst%3DL.%2BC.%26aulast%3DErnst%26aufirst%3DM.%26aulast%3DMihovilovic%26aufirst%3DM.%2BD.%26aulast%3DSavi%25C4%2587%26aufirst%3DM.%2BM.%26aulast%3DSieghart%26aufirst%3DW.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520deuterated%2520ligands%2520functionally%2520selective%2520for%2520the%2520%25CE%25B3-aminobutyric%2520acid%2520type%2520A%2520receptor%2520%2528GABAAR%2529%2520%25CE%25B16%2520subtype%2520with%2520improved%2520metabolic%2520stability%2520and%2520enhanced%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2422%26epage%3D2446%26doi%3D10.1021%2Facs.jmedchem.7b01664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manley, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aichholz, R.</span></span> <span> </span><span class="NLM_article-title">The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3239</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmc.2013.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=23611771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3231-3239&author=P.+W.+Manleyauthor=F.+Blascoauthor=J.+Mestanauthor=R.+Aichholz&title=The+kinetic+deuterium+isotope+effect+as+applied+to+metabolic+deactivation+of+imatinib+to+the+des-methyl+metabolite%2C+CGP74588&doi=10.1016%2Fj.bmc.2013.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588</span></div><div class="casAuthors">Manley, Paul W.; Blasco, Francesca; Mestan, Jurgen; Aichholz, Reiner</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3231-3239</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There has recently been a burgeoning interest in impeding drug metab. by replacing hydrogen atoms with deuterium to invoke a kinetic isotope effect.  Imatinib, a front-line therapy for both chronic myeloid leukemia and of gastrointestinal stromal tumors, is often substantially metabolised via N-demethylation to the significantly less active CGP74588.  Since deuterium-carbon bonds are stronger than hydrogen-carbon bonds, we hypothesised that the N-trideuteromethyl analog of imatinib might be subject to a reduced metabolic turnover as compared to imatinib and lead to different pharmacokinetic properties, and hence improved efficacy, in vivo.  Consequently, we investigated whether the N-trideuteromethyl analog would maintain target inhibition and show a reduced propensity for N-demethylation in in vitro assays with liver microsomes and following oral administration to rats.  The N-trideuteromethyl compd. exhibited similar activity as a tyrosine kinase inhibitor as imatinib and similar efficacy as an antiproliferative in cellular assays.  In comparison to imatinib, the trideuterated analog also showed reduced N-demethylation upon incubation with both rat and human liver microsomes, consistent with a deuterium isotope effect.  However, the reduced in vitro metab. did not translate into increased exposure of the N-trideuteromethyl analog following i.v. administration of the compd. to rats and no significant difference was obsd. for the formation of the N-desmethyl metabolite from either parent drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhr0hlhno4rVg90H21EOLACvtfcHk0lhOlgUc9Ftndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12htL4%253D&md5=5b5f26913b519661be875550cff41af0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DAichholz%26aufirst%3DR.%26atitle%3DThe%2520kinetic%2520deuterium%2520isotope%2520effect%2520as%2520applied%2520to%2520metabolic%2520deactivation%2520of%2520imatinib%2520to%2520the%2520des-methyl%2520metabolite%252C%2520CGP74588%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3231%26epage%3D3239%26doi%3D10.1016%2Fj.bmc.2013.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerekes, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposite, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doll, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagat, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelusky, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tevar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span> <span> </span><span class="NLM_article-title">Aurora kinase inhibitors based on the imidazo[1,2-a]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1021/jm1010995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1010995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=201-210&author=A.+D.+Kerekesauthor=S.+J.+Espositeauthor=R.+J.+Dollauthor=J.+R.+Tagatauthor=T.+Yuauthor=Y.+Xiaoauthor=Y.+Zhangauthor=D.+B.+Preluskyauthor=S.+Tevarauthor=K.+Grayauthor=G.+A.+Terracinaauthor=S.+Leeauthor=J.+Jonesauthor=M.+Liuauthor=A.+D.+Bassoauthor=E.+B.+Smith&title=Aurora+kinase+inhibitors+based+on+the+imidazo%5B1%2C2-a%5Dpyrazine+core%3A+fluorine+and+deuterium+incorporation+improve+oral+absorption+and+exposure&doi=10.1021%2Fjm1010995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure</span></div><div class="casAuthors">Kerekes, Angela D.; Esposite, Sara J.; Doll, Ronald J.; Tagat, Jayaram R.; Yu, Tao; Xiao, Yushi; Zhang, Yonglian; Prelusky, Dan B.; Tevar, Seema; Gray, Kimberly; Terracina, Gaby A.; Lee, Suining; Jones, Jennifer; Liu, Ming; Basso, Andrea D.; Smith, Elizabeth B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aurora kinases are cell cycle regulated serine/threonine kinases that have been linked to cancer.  Compd. 1 was identified as a potent Aurora inhibitor but lacked oral bioavailability.  Optimization of 1 led to the discovery of a series of fluoroamine and deuterated analogs, exemplified by compd. 25 (I), with an improved pharmacokinetic profile.  We found that blocking oxidative metab. at the benzylic position and decreasing the basicity of the amine are important to obtaining compds. with good biol. profiles and oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3YIdBKno7NLVg90H21EOLACvtfcHk0liIi6B-mH4x0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP&md5=af7c338866058e7d63116c8c8aa2d3fd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm1010995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010995%26sid%3Dliteratum%253Aachs%26aulast%3DKerekes%26aufirst%3DA.%2BD.%26aulast%3DEsposite%26aufirst%3DS.%2BJ.%26aulast%3DDoll%26aufirst%3DR.%2BJ.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPrelusky%26aufirst%3DD.%2BB.%26aulast%3DTevar%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DTerracina%26aufirst%3DG.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26atitle%3DAurora%2520kinase%2520inhibitors%2520based%2520on%2520the%2520imidazo%255B1%252C2-a%255Dpyrazine%2520core%253A%2520fluorine%2520and%2520deuterium%2520incorporation%2520improve%2520oral%2520absorption%2520and%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D201%26epage%3D210%26doi%3D10.1021%2Fjm1010995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberge, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welihinda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of deuterated <i>C</i>-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1021/jm401780b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401780b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1236-1251&author=G.+Xuauthor=B.+Lvauthor=J.+Y.+Robergeauthor=B.+Xuauthor=J.+Duauthor=J.+Dongauthor=Y.+Chenauthor=K.+Pengauthor=L.+Zhangauthor=X.+Tangauthor=Y.+Fengauthor=M.+Xuauthor=W.+Fuauthor=W.+Zhangauthor=L.+Zhuauthor=Z.+Dengauthor=Z.+Shengauthor=A.+Welihindaauthor=X.+Sun&title=Design%2C+synthesis%2C+and+biological+evaluation+of+deuterated+C-aryl+glycoside+as+a+potent+and+long-acting+renal+sodium-dependent+glucose+cotransporter+2+inhibitor+for+the+treatment+of+type+2+diabetes&doi=10.1021%2Fjm401780b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Xu, Ge; Lv, Binhua; Roberge, Jacques Y.; Xu, Baihua; Du, Jiyan; Dong, Jiajia; Chen, Yuanwei; Peng, Kun; Zhang, Lili; Tang, Xinxing; Feng, Yan; Xu, Min; Fu, Wei; Zhang, Wenbin; Zhu, Liangcheng; Deng, Zhongping; Sheng, Zelin; Welihinda, Ajith; Sun, Xun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1236-1251</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SGLT2 inhibitors deuterated at sites susceptible to oxidative metab. were found to have a slightly longer tmax and half-life (t1/2), dose-dependent increase in urinary glucose excretion (UGE) in rats, and slightly superior effects on UGE in dogs while retaining similar in vitro inhibitory activities against hSGLT2.  In particular, deuterated compd. 41 has the potential to be a robust long-acting antidiabetic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpflgQPhYZ21rVg90H21EOLACvtfcHk0liIi6B-mH4x0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eiu7w%253D&md5=3923fd85107c3cd4c0aa872a2fa65d83</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm401780b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401780b%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DG.%26aulast%3DLv%26aufirst%3DB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DWelihinda%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520deuterated%2520C-aryl%2520glycoside%2520as%2520a%2520potent%2520and%2520long-acting%2520renal%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1236%26epage%3D1251%26doi%3D10.1021%2Fjm401780b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span> <span> </span><span class="NLM_article-title">Evaluation of deuterium-labeled JNJ38877605: pharmacokinetic, metabolic, and <i>in vivo</i> antitumor profiles</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=1213-1218&author=Z.+Zhanauthor=X.+Pengauthor=Y.+Sunauthor=J.+Aiauthor=W.+Duan&title=Evaluation+of+deuterium-labeled+JNJ38877605%3A+pharmacokinetic%2C+metabolic%2C+and+in+vivo+antitumor+profiles&doi=10.1021%2Facs.chemrestox.8b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Deuterium-Labeled JNJ38877605: Pharmacokinetic, Metabolic, and in Vivo Antitumor Profiles</span></div><div class="casAuthors">Zhan, Zhengsheng; Peng, Xia; Sun, Yiming; Ai, Jing; Duan, Wenhu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1213-1218</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C-Met inhibitor JNJ38877605 has proven curative as an antitumor agent, while its clin. study was terminated due to renal toxicity.  It was reported that the renal toxicity was caused by the poor soly. of its aldehyde oxidase (AO) metabolites.  Therefore, blocking AO oxidn. of JNJ38877605 might diminish the toxic metabolites and overcome the renal toxicity.  Compd. 3, the AO metabolic site deuterated JNJ38877605, was then synthesized as the target mol.  In vitro monkey liver S9 fraction incubation of 3 manifested that the renal toxic metabolite M2-2 was significantly reduced, which connoted that this deuteration has partly blocked AO oxidn.  After po. nasal gavage to cynomolgus monkeys, compd. 3 revealed decreased AO metabolites M2-2 and M3-2 in the plasma as well as 1.88-fold AUC and 1.56-fold Cmax compared with JNJ38877605, indicating that deuterium replacement significantly blocked AO metab. in vivo.  Besides, metabolic profiles of 3 were investigated by anal. of the plasma and the urine of the po. administrated cynomolgus monkeys.  Moreover, after oral administration to the EBC-1 tumor-bearing nude mice, compd. 3 exhibited a better antitumor efficacy than JNJ38877605.  In conclusion, deuteration on the AO metabolic site of JNJ38877605 improved its AO metab., oral exposure, as well as in vivo antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbsjIia0zdsbVg90H21EOLACvtfcHk0liIi6B-mH4x0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVChtrbM&md5=a9e66686424cd885998b17b603827313</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00191%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DW.%26atitle%3DEvaluation%2520of%2520deuterium-labeled%2520JNJ38877605%253A%2520pharmacokinetic%252C%2520metabolic%252C%2520and%2520in%2520vivo%2520antitumor%2520profiles%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26spage%3D1213%26epage%3D1218%26doi%3D10.1021%2Facs.chemrestox.8b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunsaed, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornish, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. O.</span></span> <span> </span><span class="NLM_article-title">The bioavailability and dose dependency of the deuterated anti-tumour agent 4,6-benzylidene-<i>d</i><sub><i>1</i></sub><i>-D</i>-glucose in mice and rats</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1007/BF00686830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1007%2FBF00686830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=7882455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK2MXmtVWntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1995&pages=464-470&author=C.+B.+Dunsaedauthor=J.+M.+Dornishauthor=E.+O.+Pettersen&title=The+bioavailability+and+dose+dependency+of+the+deuterated+anti-tumour+agent+4%2C6-benzylidene-d1-D-glucose+in+mice+and+rats&doi=10.1007%2FBF00686830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The bioavailability and dose dependency of the deuterated anti-tumor agent 4,6-benzylidene-d1-D-glucose in mice and rats</span></div><div class="casAuthors">Dunsaed, Camilla Bruno; Dornish, John Michael; Pettersen, Erik Olai</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-70</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The benzaldehyde deriv. 4,6-benzylidene-D-glucose (BG) induces an inhibition of protein synthesis at otherwise non-toxic doses in cells grown in vitro.  To increase the biol. effect of BG, the hydrogen in the formyl group was exchanged with deuterium, resulting in 4,6-benzylidene-d1-D-glucose (P-1013).  In this study we compared the bioavailability of BG and P-1013, since both i.p. and, esp., oral administration of the drugs would be a great advantage.  We also examd. whether or not P-1013 displays dose-dependent pharmacokinetics.  Pharmacokinetics were studied by analyzing plasma samples using reversed-phase high-performance liq. chromatog. (HPLC).  P-1013 was given at four different doses i.v. (60, 120, 145 and 230 mg/kg) and p.o. (60, 120, 170 and 230 mg/kg) to female Bom:NMRI-numice.  The bioavailability was more than 50% for all doses.  The results also indicate that P-1013 shows linear pharmacokinetics, with no change being obsd. in the half-life (t1/2) with increasing dose and only a slightly more than proportional increase in the area under the concn. time curve (AUC) occurring with increasing dose.  A doubling in dose resulted in a 2.2-fold increase in the AUC. P-1013 and BG were also given i.v., p.o. and i.p. to female nu/nu-BALB/cABom mice and male Wistar rats.  A high degree of bioavailability was found in both species, with 55-100% of the delivered dose being absorbed.  Deuteration of BG does not seem to alter its bioavailability, as we found the same bioavailability for P-1013 as for BG.  We conclude that the pharmacokinetics of P-1013 does not prevent its use as a cancer treatment drug given orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjkHTMHLx-rrVg90H21EOLACvtfcHk0lgmRh5J77v4bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtVWntLc%253D&md5=178f53f64b220ed6619be336c81e07c1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2FBF00686830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00686830%26sid%3Dliteratum%253Aachs%26aulast%3DDunsaed%26aufirst%3DC.%2BB.%26aulast%3DDornish%26aufirst%3DJ.%2BM.%26aulast%3DPettersen%26aufirst%3DE.%2BO.%26atitle%3DThe%2520bioavailability%2520and%2520dose%2520dependency%2520of%2520the%2520deuterated%2520anti-tumour%2520agent%25204%252C6-benzylidene-d1-D-glucose%2520in%2520mice%2520and%2520rats%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D35%26spage%3D464%26epage%3D470%26doi%3D10.1007%2FBF00686830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of deuterated tivozanib for improving pharmacokinetic properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2425</span>– <span class="NLM_lpage">2428</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2015.03.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25908516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2425-2428&author=S.+Guoauthor=X.+Pangauthor=L.+Pengauthor=M.+Zhanauthor=L.+Fanauthor=Y.+Gongauthor=F.+Kangauthor=Y.+Chen&title=Design%2C+synthesis+and+biological+evaluation+of+deuterated+tivozanib+for+improving+pharmacokinetic+properties&doi=10.1016%2Fj.bmcl.2015.03.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic properties</span></div><div class="casAuthors">Guo, Shiwei; Pang, Xuehai; Peng, Lingling; Zhan, Miao; Fan, Lei; Gong, Yu; Kang, Fanyuan; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2425-2428</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tivozanib is a potent and selective tyrosine kinase inhibitor of vascular endothelial growth factor receptor-1(VEGFR1), -2(VEGFR2), and -3(VEGFR3).  Analog of Tivozanib with deuterium-for-hydrogen replacement in metabolically active site was prepd. and evaluated in vitro.  Compared to its prototype, deuterated Tivozanib compd. HC-1144 retained in vitro activity against VEGFR tyrosine kinases.  In vivo pharmacokinetic studies indicated HC-1144 clearly altered the blood circulation behavior, which was proved by significantly prolonged blood circulation half life time (t1/2) and increased AUC0-∞.  Therefore, HC-1144 has the potential to be a novel inhibitor against VEGFR tyrosine kinases with long-acting plasma exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYY9xvMR4V2bVg90H21EOLACvtfcHk0lgmRh5J77v4bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2rs7g%253D&md5=734920cd5f849f1f8498d16ec5b59454</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.088%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DZhan%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520deuterated%2520tivozanib%2520for%2520improving%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2425%26epage%3D2428%26doi%3D10.1016%2Fj.bmcl.2015.03.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2803</span>– <span class="NLM_lpage">2806</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2017.04.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28478926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2803-2806&author=X.+Pangauthor=Y.+Wangauthor=Y.+Chen&title=Design%2C+synthesis%2C+and+biological+evaluation+of+deuterated+apalutamide+with+improved+pharmacokinetic+profiles&doi=10.1016%2Fj.bmcl.2017.04.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles</span></div><div class="casAuthors">Pang, Xuehai; Wang, Yingwei; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2803-2806</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of deuterated apalutamide were designed and prepd.  Compared to apalutamide I (R = Me, R1 = H, X = CH2), deuterated analogs I (R = CD3, R1 = H, X = CH2; R = CD3, R1 = D, X = CH2) showed obviously higher plasma concns. and better PK parameters after oral administration in mice.  In rats, N-trideuteromethyl compd. I (R = CD3, R1 = H, X = CH2) displayed 1.8-fold peak concn. (Cmax), and nearly doubled its drug exposure in plasma (AUC0-∞) compared to apalutamide.  Unsurprisingly, apalutamide and I (R = CD3, R1 = H, X = CH2) had similar affinity for AR in vitro.  In summary, the deuteration strategy could obviously improve PK parameters of apalutamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9_FtfnSPBILVg90H21EOLACvtfcHk0lgmRh5J77v4bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWku7k%253D&md5=674f20b10eface6a39641bc37b8f4b16</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.071%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520deuterated%2520apalutamide%2520with%2520improved%2520pharmacokinetic%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2803%26epage%3D2806%26doi%3D10.1016%2Fj.bmcl.2017.04.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velthuisen, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baughman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.ejmech.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=23474906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=202-212&author=E.+J.+Velthuisenauthor=T.+M.+Baughmanauthor=B.+A.+Johnsauthor=D.+P.+Temelkoffauthor=J.+G.+Weatherhead&title=Synthesis+and+pharmacokinetic+profile+of+highly+deuterated+brecanavir+analogs&doi=10.1016%2Fj.ejmech.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs</span></div><div class="casAuthors">Velthuisen, Emile J.; Baughman, Todd M.; Johns, Brian A.; Temelkoff, David P.; Weatherhead, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">202-212</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Two highly deuterated analogs of the HIV-1 protease inhibitor brecanavir have been prepd. to study the effect of deuterium upon metabolic stability.  The sites for deuterium incorporation were initially chosen to maximize the potential for a kinetic isotope effect; locations where C-H bond breaking is the rate limiting step.  The analogs have been profiled in both in vitro and in vivo pharmacokinetic studies and the result are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoermaHUY6pyrVg90H21EOLACvtfcHk0lhHedpo-wGEZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaqsr4%253D&md5=5b50523d7205335cb683f41be15d0973</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DVelthuisen%26aufirst%3DE.%2BJ.%26aulast%3DBaughman%26aufirst%3DT.%2BM.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520and%2520pharmacokinetic%2520profile%2520of%2520highly%2520deuterated%2520brecanavir%2520analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D63%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.ejmech.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Effect of <i>N</i>-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fjlcr.3516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28432800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1ertbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=401-409&author=X.+Pangauthor=L.+Pengauthor=Y.+Chen&title=Effect+of+N-methyl+deuteration+on+pharmacokinetics+and+pharmacodynamics+of+enzalutamide&doi=10.1002%2Fjlcr.3516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of N-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide</span></div><div class="casAuthors">Pang, Xuehai; Peng, Lingling; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">401-409</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Enzalutamide, a second-generation antiandrogen, has been developed for the treatment of castration-resistance prostate cancer.  We synthesized the deuterated analogs 6 and found that it showed higher drug exposure and thus stronger antitumor potency in preclin. settings.  Compd. I is being developed clin. for the potential to be differentiated from enzalutamide through reduced dosages and a higher safety margin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnd9MVelxwsbVg90H21EOLACvtfcHk0lhHedpo-wGEZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1ertbo%253D&md5=2ff3c608d528e516aa69b500063bb58c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3516%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DEffect%2520of%2520N-methyl%2520deuteration%2520on%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520enzalutamide%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2017%26volume%3D60%26spage%3D401%26epage%3D409%26doi%3D10.1002%2Fjlcr.3516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Effect of <i>N</i>-methyl deuteration on metabolism and pharmacokinetics of enzalutamide</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S111352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.2147%2FDDDT.S111352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27462143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslSitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=2181-2191&author=J.+Jiangauthor=X.+Pangauthor=L.+Liauthor=X.+Daiauthor=X.+Diaoauthor=X.+Chenauthor=D.+Zhongauthor=Y.+Wangauthor=Y.+Chen&title=Effect+of+N-methyl+deuteration+on+metabolism+and+pharmacokinetics+of+enzalutamide&doi=10.2147%2FDDDT.S111352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide</span></div><div class="casAuthors">Jiang, Jinfang; Pang, Xuehai; Li, Liang; Dai, Xiaojian; Diao, Xingxing; Chen, Xiaoyan; Zhong, Dafang; Wang, Yingwei; Chen, Yuanwei</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2181-2191</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: The replacement of hydrogen with deuterium invokes a kinetic isotope effect.  Thus, this method is an attractive way to slow down the metabolic rate and modulate pharmacokinetics.  Purpose: Enzalutamide (ENT) acts as a competitive inhibitor of the androgen receptor and has been approved for the treatment of metastatic castration-resistant prostate cancer by the US Food and Drug Administration in 2012.  To attenuate the N-demethylation pathway, hydrogen atoms of the N-CH3 moiety were replaced by the relatively stable isotope deuterium, which showed similar pharmacol. activities but exhibited favorable pharmacokinetic properties.  Methods: We estd. in vitro and in vivo pharmacokinetic parameters for ENT and its deuterated analog (d3-ENT).  For in vitro studies, intrinsic primary isotope effects (KH/KD) were detd. by the ratio of intrinsic clearance (CLint) obtained for ENT and d3-ENT.  The CLint values were obtained by the substrate depletion method.  For in vivo studies, ENT and d3-ENT were orally given to male Sprague Dawley rats sep. and simultaneously to assess the disposition and metab. of them.  We also investigated the main metabolic pathway of ENT by comparing the rate of oxidn. and hydrolysis in vitro.  Results: The in vitro CLint (max. velocity/Michaelis const. [Vmax/Km]) of d3-ENT in rat and human liver microsomes were 49.7% and 72.9% lower than those of the non-deuterated compd., corresponding to the KH/KD value of ∼2.  The max. obsd. plasma concn., Cmax, and area under the plasma concn. -time curve from time zero to the last measurable sampling time point (AUC0-t) were 35% and 102% higher than those of ENT when orally administered to rats (10 mg/kg).  The exposure of the N-demethyl metabolite M2 was eightfold lower, whereas that of the amide hydrolysis metabolite M1 and other minor metabolites was unchanged.  The obsd. hydrolysis rate of M2 was at least ten times higher than that of ENT and d3-ENT in rat plasma.  Conclusion: ENT was mainly metabolized through the "parent→M2→M1" pathway based on in vitro and in vivo elimination behavior.  The obsd. in vitro deuterium isotope effect translated into increased exposure of the deuterated analog in rats.  Once the carbon-hydrogen was replaced with carbon-deuterium (C-D) bonds, the major metabolic pathway was retarded because of the relatively stable C-D bonds.  The systemic exposure to d3-ENT can increase in humans, so the dose requirements can be reduced appropriately.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Eb9Ddza7HrVg90H21EOLACvtfcHk0lhHedpo-wGEZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslSitbk%253D&md5=9880328f912b0816d7a875197b61d4be</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S111352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S111352%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DDiao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DEffect%2520of%2520N-methyl%2520deuteration%2520on%2520metabolism%2520and%2520pharmacokinetics%2520of%2520enzalutamide%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2016%26volume%3D10%26spage%3D2181%26epage%3D2191%26doi%3D10.2147%2FDDDT.S111352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J. A.</span></span> <span> </span><span class="NLM_article-title">Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.057265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.114.057265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=24616265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFSjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=954-962&author=R.+A.+Stringerauthor=G.+Williamsauthor=F.+Picardauthor=B.+Sohalauthor=O.+Kretzauthor=J.+McKennaauthor=J.+A.+Krauser&title=Application+of+a+deuterium+replacement+strategy+to+modulate+the+pharmacokinetics+of+7-%283%2C5-dimethyl-1H-1%2C2%2C4-triazol-1-yl%29-3-%284-methoxy-2-methylphenyl%29-2%2C6-dimethylpyrazolo%5B5%2C1-b%5Doxazole%2C+a+novel+CRF1+antagonist&doi=10.1124%2Fdmd.114.057265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist</span></div><div class="casAuthors">Stringer, Rowan A.; Williams, Gareth; Picard, Franck; Sohal, Bindi; Kretz, Olivier; McKenna, Jeff; Krauser, Joel A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">954-962, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Deuterium isotope effects were evaluated as a strategy to optimize the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole (NVS-CRF38), a novel corticotropin-releasing factor receptor 1 (CRF1) antagonist.  In an attempt to suppress O-demethylation of NVS-CRF38 without losing activity against the CRF1 receptor, the protons at the site of metab. were replaced with deuterium.  For in vitro and in vivo studies, intrinsic primary isotope effects (KH/KD) were detd. by the ratio of intrinsic clearance (CLint) obtained for NVS-CRF38 and deuterated NVS-CRF38.  In vitro kinetic isotope effects (KH/KD) were more pronounced when CLint values were calcd. based on the rate of formation of the O-desmethyl metabolite (KH/KD ∼7) compared with the substrate depletion method (KH/KD ∼2).  In vivo isotope effects were measured in rats after i.v. (1 mg/kg) and oral (10 mg/kg) administration.  For both administration routes, isotope effects calcd. from in vivo CLint corresponding to all biotransformation pathways were lower (KH/KD ∼2) compared with CLint values calcd. from the O-demethylation reaction alone (KH/KD ∼7).  Comparative metabolite identification studies were undertaken using rat and human microsomes to explore the potential for metabolic switching.  As expected, a marked redn. of the O-demethylated metabolite was obsd. for NVS-CRF38; however, levels of NVS-CRF38's other metabolites increased, compensating to some extent for the isotope effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodlJXqyxbZSbVg90H21EOLACvtfcHk0lhHedpo-wGEZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFSjs7Y%253D&md5=62cc533373f96e6fe53d46a3d4867aa1</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.057265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.057265%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DPicard%26aufirst%3DF.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DKretz%26aufirst%3DO.%26aulast%3DMcKenna%26aufirst%3DJ.%26aulast%3DKrauser%26aufirst%3DJ.%2BA.%26atitle%3DApplication%2520of%2520a%2520deuterium%2520replacement%2520strategy%2520to%2520modulate%2520the%2520pharmacokinetics%2520of%25207-%25283%252C5-dimethyl-1H-1%252C2%252C4-triazol-1-yl%2529-3-%25284-methoxy-2-methylphenyl%2529-2%252C6-dimethylpyrazolo%255B5%252C1-b%255Doxazole%252C%2520a%2520novel%2520CRF1%2520antagonist%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D954%26epage%3D962%26doi%3D10.1124%2Fdmd.114.057265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridson, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttamsingh, V.</span></span> <span> </span><span class="NLM_article-title">Altering metabolic profiles of drugs by precision deuteration 2: discovery of a deuterated analog of ivacaftor with differentiated pharmacokinetics for clinical development</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.241497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fjpet.117.241497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28611092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CmtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2017&pages=359-367&author=S.+L.+Harbesonauthor=A.+J.+Morganauthor=J.+F.+Liuauthor=A.+M.+Aslanianauthor=S.+Nguyenauthor=G.+W.+Bridsonauthor=C.+L.+Brummelauthor=L.+Wuauthor=R.+D.+Tungauthor=L.+Piljaauthor=V.+Bramanauthor=V.+Uttamsingh&title=Altering+metabolic+profiles+of+drugs+by+precision+deuteration+2%3A+discovery+of+a+deuterated+analog+of+ivacaftor+with+differentiated+pharmacokinetics+for+clinical+development&doi=10.1124%2Fjpet.117.241497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Altering metabolic profiles of drugs by precision deuteration 2: discovery of a deuterated analog of ivacaftor with differentiated pharmacokinetics for clinical development</span></div><div class="casAuthors">Harbeson, Scott L.; Morgan, Adam J.; Liu, Julie F.; Aslanian, Ara M.; Nguyen, Sophia; Bridson, Gary W.; Brummel, Christopher L.; Wu, Lijun; Tung, Roger D.; Pilja, Lana; Braman, Virginia; Uttamsingh, Vinita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-367</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination therapy with lumacaftor (Orkambi; Vertex Pharmaceuticals).  Each therapy targets specific patient populations: Kalydeco treats patients carrying one of nine gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein, whereas Orkambi treats patients homozygous for the F508del CFTR mutation.  In this study, we explored the pharmacol. and metabolic effects of precision deuteration chem. on ivacaftor by synthesizing two novel deuterated ivacaftor analogs, CTP-656 (d9-ivacaftor) and d18-ivacaftor.  Ivacaftor is administered twice daily and is extensively converted in humans to major metabolites M1 and M6; therefore, the corresponding deuterated metabolites were also prepd.  Both CTP-656 and d18-ivacaftor showed in vitro pharmacol. potency similar to that in ivacaftor, and the deuterated M1 and M6 metabolites showed pharmacol. equiv. to that in the corresponding metabolites of ivacaftor, which is consistent with the findings of previous studies of deuterated compds.  However, CTP-656 exhibited markedly enhanced stability when tested in vitro.  The deuterium isotope effects for CTP-656 metab. (DV = 3.8, DV/K = 2.2) were notably large for a cytochrome P 450-mediated oxidn.  The pharmacokinetic (PK) profile of CTP-656 and d18-ivacaftor were assessed in six healthy volunteers in a single-dose crossover study, which provided the basis for advancing CTP-656 in development.  The overall PK profile, including the 15.9-h half-life for CTP-656, suggests that CTP-656 may be dosed once daily, thereby enhancing patient adherence.  Together, these data continue to validate deuterium substitution as a viable approach for creating novel therapeutic agents with properties potentially differentiated from existing drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopNUSS95AadbVg90H21EOLACvtfcHk0ljkCOiGw5IJ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CmtbbI&md5=bf7d11a94c047902d2c6e1a3cd3e8a62</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.241497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.241497%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DMorgan%26aufirst%3DA.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DAslanian%26aufirst%3DA.%2BM.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3DBridson%26aufirst%3DG.%2BW.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DPilja%26aufirst%3DL.%26aulast%3DBraman%26aufirst%3DV.%26aulast%3DUttamsingh%26aufirst%3DV.%26atitle%3DAltering%2520metabolic%2520profiles%2520of%2520drugs%2520by%2520precision%2520deuteration%25202%253A%2520discovery%2520of%2520a%2520deuterated%2520analog%2520of%2520ivacaftor%2520with%2520differentiated%2520pharmacokinetics%2520for%2520clinical%2520development%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D362%26spage%3D359%26epage%3D367%26doi%3D10.1124%2Fjpet.117.241497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helfenbein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noirault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legailliard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmier, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madelmont, J. C.</span></span> <span> </span><span class="NLM_article-title">Isotopic effect study of propofol deuteration on the metabolism, activity, and toxicity of the anesthetic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5806</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1021/jm020864q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020864q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVSnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5806-5808&author=J.+Helfenbeinauthor=C.+Lartigueauthor=E.+Noiraultauthor=E.+Azimauthor=J.+Legailliardauthor=M.+J.+Galmierauthor=J.+C.+Madelmont&title=Isotopic+effect+study+of+propofol+deuteration+on+the+metabolism%2C+activity%2C+and+toxicity+of+the+anesthetic&doi=10.1021%2Fjm020864q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Isotopic Effect Study of Propofol Deuteration on the Metabolism, Activity, and Toxicity of the Anesthetic</span></div><div class="casAuthors">Helfenbein, J.; Lartigue, C.; Noirault, E.; Azim, E.; Legailliard, J.; Galmier, M. J.; Madelmont, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5806-5808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of isotopic substitution to delay the oxidative metab. of the anesthetic propofol 1 was studied.  The arom. hydrogens of propofol 1 were replaced by deuterium to produce the mono- and trideuterated derivs. 4 and 5.  In vitro metabolic studies on human hepatic microsomes showed no isotopic effect in the para hydroxylation of propofol, and 1, 4, and 5 display similar hypnotic activity and toxicity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1QQcND8virVg90H21EOLACvtfcHk0ljkCOiGw5IJ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVSnsLo%253D&md5=f16d4e122ef9fdd0d1149b148178c590</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm020864q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020864q%26sid%3Dliteratum%253Aachs%26aulast%3DHelfenbein%26aufirst%3DJ.%26aulast%3DLartigue%26aufirst%3DC.%26aulast%3DNoirault%26aufirst%3DE.%26aulast%3DAzim%26aufirst%3DE.%26aulast%3DLegailliard%26aufirst%3DJ.%26aulast%3DGalmier%26aufirst%3DM.%2BJ.%26aulast%3DMadelmont%26aufirst%3DJ.%2BC.%26atitle%3DIsotopic%2520effect%2520study%2520of%2520propofol%2520deuteration%2520on%2520the%2520metabolism%252C%2520activity%252C%2520and%2520toxicity%2520of%2520the%2520anesthetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5806%26epage%3D5808%26doi%3D10.1021%2Fjm020864q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czarnik, A. W.</span></span> <span> </span><span class="NLM_article-title">Deuterium-Enriched Maraviroc</span>. U.S. Patent <span class="NLM_patent">0,062,331</span>, March 05, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+W.+Czarnik&title=Deuterium-Enriched+Maraviroc"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCzarnik%26aufirst%3DA.%2BW.%26atitle%3DDeuterium-Enriched%2520Maraviroc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barratt, M. J.</span>; <span class="NLM_string-name">Frail, D. E.</span></span> <i>Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2F9781118274408" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+J.+Barratt&author=D.+E.+Frail&title=Drug+Repositioning%3A+Bringing+New+Life+to+Shelved+Assets+and+Existing+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2F9781118274408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118274408%26sid%3Dliteratum%253Aachs%26aulast%3DBarratt%26aufirst%3DM.%2BJ.%26btitle%3DDrug%2520Repositioning%253A%2520Bringing%2520New%2520Life%2520to%2520Shelved%2520Assets%2520and%2520Existing%2520Drugs%26pub%3DWiley%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontaine, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henise, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D. V.</span></span> <span> </span><span class="NLM_article-title">Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2018.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.jconrel.2018.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29577950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1ersrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2018&pages=74-79&author=B.+R.+Hearnauthor=S.+D.+Fontaineauthor=S.+J.+Pfaffauthor=E.+L.+Schneiderauthor=J.+Heniseauthor=G.+W.+Ashleyauthor=D.+V.+Santi&title=Primary+deuterium+kinetic+isotope+effects+prolong+drug+release+and+polymer+biodegradation+in+a+drug+delivery+system&doi=10.1016%2Fj.jconrel.2018.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system</span></div><div class="casAuthors">Hearn, Brian R.; Fontaine, Shaun D.; Pfaff, Samuel J.; Schneider, Eric L.; Henise, Jeff; Ashley, Gary W.; Santi, Daniel V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed a chem.-controlled drug delivery system in which a drug is covalently attached via a carbamate to hydrogel microspheres using a β-eliminative linker; rate-detg. proton removal from a C-H bond adjacent to an electron withdrawing group results in a β-elimination to cleave the carbamate and release the drug.  After s.c. injection of the hydrogel-drug conjugate, the drug is slowly released into the systemic circulation and acquires an elimination t1/2,β that matches the t1/2 of linker cleavage.  A similar β-eliminative linker with a slower cleavage rate is installed into crosslinks of the polymer to trigger gel degrdn. after drug release.  We have now prepd. β-eliminative linkers that contain deuterium in place of the hydrogen whose removal initiates cleavage.  In vitro model systems of drug release and degelation show large primary deuterium kinetic isotope effects of kH/kD ∼ 2.5 to 3.5.  Using a deuterated linker to attach the peptide octreotide to hydrogel-microspheres, the in vivo t1/2,β of the drug was increased from ∼1.5 to 4.5 wk in the rat.  Similarly, the in vivo time to biodegrdn. of hydrogels with deuterium-contg. crosslinks could be extended ∼2.5-fold compared to hydrogen-contg. counterparts.  Thus, the use of primary deuterium kinetic isotope effects in a single platform technol. can control rates of β-elimination reactions in drug release and polymer biodegrdn. rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAj_ME0TbvcbVg90H21EOLACvtfcHk0lj4WZqhhqdZcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1ersrw%253D&md5=ae3bfd165fa65ce7f6cf6269bf8be380</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2018.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2018.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DHearn%26aufirst%3DB.%2BR.%26aulast%3DFontaine%26aufirst%3DS.%2BD.%26aulast%3DPfaff%26aufirst%3DS.%2BJ.%26aulast%3DSchneider%26aufirst%3DE.%2BL.%26aulast%3DHenise%26aufirst%3DJ.%26aulast%3DAshley%26aufirst%3DG.%2BW.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26atitle%3DPrimary%2520deuterium%2520kinetic%2520isotope%2520effects%2520prolong%2520drug%2520release%2520and%2520polymer%2520biodegradation%2520in%2520a%2520drug%2520delivery%2520system%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2018%26volume%3D278%26spage%3D74%26epage%3D79%26doi%3D10.1016%2Fj.jconrel.2018.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannargudi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J.</span></span> <span> </span><span class="NLM_article-title">Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1870</span>, <span class="refDoi"> DOI: 10.1021/tx800177k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800177k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVaru7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1862-1870&author=J.+Chenauthor=B.+M.+Mannargudiauthor=L.+Xuauthor=J.+Uetrecht&title=Demonstration+of+the+metabolic+pathway+responsible+for+nevirapine-induced+skin+rash&doi=10.1021%2Ftx800177k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Demonstration of the Metabolic Pathway Responsible for Nevirapine-Induced Skin Rash</span></div><div class="casAuthors">Chen, Jie; Mannargudi, Baskar M.; Xu, Ling; Uetrecht, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1862-1870</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The reverse transcriptase inhibitor, nevirapine (NVP), causes skin rashes and hepatotoxicity.  We used a rat model to det. if the rash is caused by the parent drug or a reactive metabolite.  By manipulation of metabolic pathways and testing analogs, we eliminated all but one pathway, 12-hydroxylation, which involves the oxidn. of an exocyclic Me group, as being responsible for the rash.  Treatment with 12-OH-NVP caused a rash, and an analog in which the Me hydrogens were replaced by deuterium to inhibit the 12-OH pathway did not cause a rash; however, quite unexpectedly, blood levels of the deuterated analog were very low.  This is due to partitioning of the benzylic free radial intermediate between oxygen rebound to form 12-OH-NVP and loss of another hydrogen atom to form a reactive quinone methide, which inactivates P 450.  Cotreatment with the P 450 inhibitor, 1-aminobenzotriazole, led to comparable levels of NVP and the deuterated analog, and the deuterated analog still caused a lower rash incidence.  These data clearly point to the 12-hydroxy pathway being responsible for NVP skin rash.  We propose that the hepatotoxicity of NVP in humans is due to the quinone methide formed by P 450 in the liver, while the skin rash may be due to the quinone methide formed in the skin by sulfation of 12-OH metabolite followed by loss of sulfate.  This is the first example in which a valid animal model of an idiosyncratic drug reaction was used to det. the metabolic pathway responsible for the reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlMJkFo6EdMLVg90H21EOLACvtfcHk0lj4WZqhhqdZcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVaru7fK&md5=be5f10bfb4ef8579c80eaa30c6778cc9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Ftx800177k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800177k%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMannargudi%26aufirst%3DB.%2BM.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DDemonstration%2520of%2520the%2520metabolic%2520pathway%2520responsible%2520for%2520nevirapine-induced%2520skin%2520rash%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1862%26epage%3D1870%26doi%3D10.1021%2Ftx800177k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemzik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krahn, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwalder, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, G. T.</span></span> <span> </span><span class="NLM_article-title">The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1006/taap.2000.9055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1006%2Ftaap.2000.9055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=11076702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFyrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2000&pages=102-113&author=A.+E.+Mutlibauthor=R.+J.+Gersonauthor=P.+C.+Meunierauthor=P.+J.+Haleyauthor=H.+Chenauthor=L.+S.+Ganauthor=M.+H.+Daviesauthor=B.+Gemzikauthor=D.+D.+Christauthor=D.+F.+Krahnauthor=J.+A.+Markwalderauthor=S.+P.+Seitzauthor=R.+T.+Robertsonauthor=G.+T.+Miwa&title=The+species-dependent+metabolism+of+efavirenz+produces+a+nephrotoxic+glutathione+conjugate+in+rats&doi=10.1006%2Ftaap.2000.9055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Species-Dependent Metabolism of Efavirenz Produces a Nephrotoxic Glutathione Conjugate in Rats</span></div><div class="casAuthors">Mutlib, Abdul E.; Gerson, Ronald J.; Meunier, Paul C.; Haley, Patrick J.; Chen, Hao; Gan, Lawrence S.; Davies, Marc H.; Gemzik, Brian; Christ, David D.; Krahn, David F.; Markwalder, Jay A.; Seitz, Steven P.; Robertson, Richard T.; Miwa, Gerald T.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-113</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Efavirenz, a potent nonnucleoside reverse transcriptase inhibitor widely prescribed for the treatment of HIV infection, produces renal tubular epithelial cell necrosis in rats but not in cynomolgus monkeys or humans.  This species selectivity in nephrotoxicity could result from differences in the prodn. or processing of reactive metabolites, or both.  A detailed comparison of the metabolites produced by rats, monkeys, and humans revealed that rats produce a unique glutathione adduct.  The mechanism of formation and role of this glutathione adduct in the renal toxicity were investigated using both chem. and biochem. probes.  Efavirenz was labeled at the methine position on the cyclopropyl ring with the stable isotope deuterium, effectively reducing the formation of the cyclopropanol metabolite, an obligate precursor to the glutathione adduct.  This substitution markedly reduced both the incidence and severity of nephrotoxicity as measured histol.  Further processing of this glutathione adduct was also important in producing the lesion and was demonstrated by inhibiting γ-glutamyltranspeptidase with acivicin pretreatment (10 mg/kg, IV) prior to dosing with efavirenz.  Again, both the incidence and severity of the nephrotoxicity were reduced, such that four of nine rats given acivicin were without detectable lesions.  These studies provide compelling evidence that a species-specific formation of glutathione conjugate(s) from efavirenz is involved in producing nephrotoxicity in rats.  Mechanisms are proposed for the formation of reactive metabolites that could be responsible for the renal toxicity obsd. in rats.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtZ2yUYxMePrVg90H21EOLACvtfcHk0lj4WZqhhqdZcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFyrt7Y%253D&md5=13f8d2f66902fef25d827b2f492f88ce</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1006%2Ftaap.2000.9055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ftaap.2000.9055%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DGerson%26aufirst%3DR.%2BJ.%26aulast%3DMeunier%26aufirst%3DP.%2BC.%26aulast%3DHaley%26aufirst%3DP.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DGan%26aufirst%3DL.%2BS.%26aulast%3DDavies%26aufirst%3DM.%2BH.%26aulast%3DGemzik%26aufirst%3DB.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DKrahn%26aufirst%3DD.%2BF.%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DRobertson%26aufirst%3DR.%2BT.%26aulast%3DMiwa%26aufirst%3DG.%2BT.%26atitle%3DThe%2520species-dependent%2520metabolism%2520of%2520efavirenz%2520produces%2520a%2520nephrotoxic%2520glutathione%2520conjugate%2520in%2520rats%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2000%26volume%3D169%26spage%3D102%26epage%3D113%26doi%3D10.1006%2Ftaap.2000.9055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crofton-Sleigh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venitt, S.</span></span> <span> </span><span class="NLM_article-title">Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1487</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1093/carcin/15.8.1487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1093%2Fcarcin%2F15.8.1487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=8055624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK2cXlslakurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=1487-1492&author=D.+H.+Phillipsauthor=G.+A.+Potterauthor=M.+N.+Hortonauthor=A.+Hewkerauthor=C.+Crofton-Sleighauthor=M.+Jarmanauthor=S.+Venitt&title=Reduced+genotoxicity+of+%5BD5-ethyl%5D-tamoxifen+implicates+alpha-hydroxylation+of+the+ethyl+group+as+a+major+pathway+of+tamoxifen+activation+to+a+liver+carcinogen&doi=10.1093%2Fcarcin%2F15.8.1487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen</span></div><div class="casAuthors">Phillips, David H.; Potter, Gerard A.; Horton, Martin N.; Hewer, Alan; Crofton-Sleigh, Christopher; Jarman, Michael; Venitt, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1487-92</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    </div><div class="casAbstract">A proposed mechanism for the metabolic activation of tamoxifen to electrophilic species that form DNA adducts leading to liver cancer involves α-hydroxylation of the Et group in the crit. first step.  This mechanism predicts that tamoxifen deuterated at the α-position would be less genotoxic than the non-deuterated compd. owing to an isotope effect that would reduce the rate of oxidative metab. at this position.  This hypothesis has now been tested with expts. conducted in rats in vivo and in human cells in vitro.  It was found that the deuterated compd. [D5-ethyl]-tamoxifen is significantly less genotoxic than tamoxifen.  Administration of 0.06 and 0.12 mmol/kg [D5-ethyl]-tamoxifen to female Fischer rats by gavage resulted in a 2.5- and 1.7-fold redn. resp. in the levels of hepatic DNA adducts present 24 h after treatment, compared with the non-deuterated compd.  Treatment of MCL-5 cells with [D5-ethyl]-tamoxifen resulted in a 2- to 3-fold decrease, compared with tamoxifen, in the no. of micronuclei induced in cells arrested in cytokinesis by cytochalasin-B.  Further evidence is provided by UV irradn. of the major hepatic DNA adducts isolated from tamoxifen-treated rats, which caused a large shift in the chromatog. mobility of the adducts, consistent with the presence of a 1,2-olefinic linkage in the tamoxifen residue of the adduct leading to cyclization to a phenanthrenylic compd., and consistent with this adduct having arisen from reaction with DNA at the α-position of tamoxifen.  Taken together, these data strongly suggest that tamoxifen is metabolized to a liver carcinogen by α-hydroxylation of its Et group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEXQzaVDyDbVg90H21EOLACvtfcHk0lgrJR-EzVig9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslakurY%253D&md5=a7c5764d6c99261714312c767fc62597</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F15.8.1487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F15.8.1487%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DD.%2BH.%26aulast%3DPotter%26aufirst%3DG.%2BA.%26aulast%3DHorton%26aufirst%3DM.%2BN.%26aulast%3DHewker%26aufirst%3DA.%26aulast%3DCrofton-Sleigh%26aufirst%3DC.%26aulast%3DJarman%26aufirst%3DM.%26aulast%3DVenitt%26aufirst%3DS.%26atitle%3DReduced%2520genotoxicity%2520of%2520%255BD5-ethyl%255D-tamoxifen%2520implicates%2520alpha-hydroxylation%2520of%2520the%2520ethyl%2520group%2520as%2520a%2520major%2520pathway%2520of%2520tamoxifen%2520activation%2520to%2520a%2520liver%2520carcinogen%26jtitle%3DCarcinogenesis%26date%3D1994%26volume%3D15%26spage%3D1487%26epage%3D1492%26doi%3D10.1093%2Fcarcin%2F15.8.1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calinski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludeman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenberg, P. F.</span></span> <span> </span><span class="NLM_article-title">Hydroxylation and <i>N</i>-dechloroethylation of ifosfamide and deuterated ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1084</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.063628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fdmd.115.063628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25934575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1084-1090&author=D.+M.+Calinskiauthor=H.+Zhangauthor=S.+Ludemanauthor=M.+E.+Dolanauthor=P.+F.+Hollenberg&title=Hydroxylation+and+N-dechloroethylation+of+ifosfamide+and+deuterated+ifosfamide+by+the+human+cytochrome+p450s+and+their+commonly+occurring+polymorphisms&doi=10.1124%2Fdmd.115.063628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylation and N-dechloroethylation of ifosfamide and deuterated ifosfamide by the human cytochrome P450s and their commonly occurring polymorphisms</span></div><div class="casAuthors">Calinski, Diane M.; Zhang, Haoming; Ludeman, Susan; Dolan, M. Eileen; Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1084-1090</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The hydroxylation and N-dechloroethylation of deuterated ifosfamide (d4IFO) and ifosfamide (IFO) by several human P450s have been detd. and compared.  D4IFO was synthesized with deuterium at the alpha and alpha' carbons to decrease the rate of N-dechloroethylation and thereby enhance hydroxylation of the drug at the 4' position.  The purpose was to decrease the toxic and increase the efficacious metabolites of IFO.  For all of the P450s tested, hydroxylation of d4IFO was improved and dechloroethylation was reduced as compared with nondeuterated IFO.  Although the differences were not statistically significant, the trend favoring the 4'-hydroxylation pathway was noteworthy.  CYP3A5 and CYP2C19 were the most efficient enzymes for catalyzing IFO hydroxylation.  The importance of these enzymes in IFO metab. has not been reported previously and warrants further investigation.  The catalytic ability of the common polymorphisms of CYP2B6 and CYP2C9 for both reactions were tested with IFO and d4IFO.  It was detd. that the commonly expressed polymorphisms CYP2B6*4 and CYP2B6*6 had reduced catalytic ability for IFO compared with CYP2B6*1, whereas CYP2B6*7 and CYP2B6*9 had enhanced catalytic ability.  As with the wild-type enzymes, d4IFO was more readily hydroxylated by the polymorphic variants than IFO, and d4IFO was not dechloroethylated by any of the polymorphic forms.  We also assessed the use of specific inhibitors of P 450 to favor hydroxylation in human liver microsomes.  We were unable to sep. the pathways with these expts., suggesting that multiple P450s are responsible for catalyzing both metabolic pathways for IFO, which is not obsd. with the closely related drug cyclophosphamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHBNrWzkX76rVg90H21EOLACvtfcHk0lgrJR-EzVig9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFKltLw%253D&md5=72886338328f517a0c47abaf9e41c6fd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.063628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.063628%26sid%3Dliteratum%253Aachs%26aulast%3DCalinski%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLudeman%26aufirst%3DS.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DHydroxylation%2520and%2520N-dechloroethylation%2520of%2520ifosfamide%2520and%2520deuterated%2520ifosfamide%2520by%2520the%2520human%2520cytochrome%2520p450s%2520and%2520their%2520commonly%2520occurring%2520polymorphisms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26spage%3D1084%26epage%3D1090%26doi%3D10.1124%2Fdmd.115.063628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7577</span>– <span class="NLM_lpage">7589</span>, <span class="refDoi"> DOI: 10.1021/jm500510f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500510f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7577-7589&author=H.+Jiaauthor=G.+Daiauthor=J.+Wengauthor=Z.+Zhangauthor=Q.+Wangauthor=F.+Zhouauthor=L.+Jiaoauthor=Y.+Cuiauthor=Y.+Renauthor=S.+Fanauthor=J.+Zhouauthor=W.+Qingauthor=Y.+Guauthor=J.+Wangauthor=Y.+Saiauthor=W.+Su&title=Discovery+of+%28S%29-1-%281-%28Imidazo%5B1%2C2-a%5Dpyridin-6-yl%29ethyl%29-6-%281-methyl-1H-pyrazol-4-yl%29-1H-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-b%5Dpyrazine+%28volitinib%29+as+a+highly+potent+and+selective+mesenchymal-epithelial+transition+factor+%28c-Met%29+inhibitor+in+clinical+development+for+treatment+of+cancer&doi=10.1021%2Fjm500510f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer</span></div><div class="casAuthors">Jia, Hong; Dai, Guangxiu; Weng, Jianyang; Zhang, Zhulin; Wang, Qing; Zhou, Feng; Jiao, Longxian; Cui, Yumin; Ren, Yongxin; Fan, Shiming; Zhou, Jinghong; Qing, Weiguo; Gu, Yi; Wang, Jian; Sai, Yang; Su, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7577-7589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HGF/c-Met signaling has been implicated in human cancers.  Herein we describe the invention of a series of novel triazolopyrazine c-Met inhibitors.  The structure-activity relation of these compds. was investigated, leading to the identification of Volitinib (I), which demonstrated favorable pharmacokinetic properties in mice and good antitumor activities in the human glioma xenograft model in athymic nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmuzIGrPGZbVg90H21EOLACvtfcHk0lgrJR-EzVig9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns7jN&md5=aced38bbd7431f5ac01b6698e8657261</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm500510f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500510f%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%2528Imidazo%255B1%252C2-a%255Dpyridin-6-yl%2529ethyl%2529-6-%25281-methyl-1H-pyrazol-4-yl%2529-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-b%255Dpyrazine%2520%2528volitinib%2529%2520as%2520a%2520highly%2520potent%2520and%2520selective%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-Met%2529%2520inhibitor%2520in%2520clinical%2520development%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7577%26epage%3D7589%26doi%3D10.1021%2Fjm500510f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhadra, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanzadeh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J.</span></span> <span> </span><span class="NLM_article-title">Enhancement of the properties of a drug by mono-deuteriation: reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6289</span>– <span class="NLM_lpage">6296</span>, <span class="refDoi"> DOI: 10.1039/C6OB00785F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2FC6OB00785F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27273525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVyisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=6289-6296&author=P.+B.+Bhadraauthor=A.+Hassanzadehauthor=B.+Arsicauthor=D.+G.+Allisonauthor=G.+A.+Morrisauthor=J.+Barber&title=Enhancement+of+the+properties+of+a+drug+by+mono-deuteriation%3A+reduction+of+acid-catalysed+formation+of+a+gut-motilide+enol+ether+from+8-deuterio-erythromycin+B&doi=10.1039%2FC6OB00785F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of the properties of a drug by mono-deuteration: reduction of acid-catalyzed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B</span></div><div class="casAuthors">Bhadra, Pranab K.; Hassanzadeh, Abdolreza; Arsic, Biljana; Allison, David G.; Morris, Gareth A.; Barber, Jill</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6289-6296</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Erythromycin B is structurally very similar to erythromycin A, and also shares its clin. important antibacterial activity.  Its potential advantage is that it is much more stable to acid.  Both compds. are susceptible to 6-9-enol ether formation, involving loss of a proton from C-8.  The enol ethers lack antibacterial activity and can give rise to unpleasant gut motilide side-effects.  Our previous work on degrdn. kinetics revealed that the formation of erythromycin B enol ether from erythromycin B is subject to a large deuterium isotope effect.  We therefore synthesized 8-d-erythromycin B (in 87% yield) in the hope that acid-catalyzed enol ether formation would be reduced, relative to erythromycin B.  In a range of microbiol. and biochem. assays, deuteration did not appear to compromise the efficacy of the drug.  Degrdn. studies showed, however, that incorporation of deuterium into erythromycin B reduces (though does not completely suppress) enol ether formation, providing the possibility of using a facile mono-deuteration to reduce the gut motilide side-effects of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMp1KCLuoU67Vg90H21EOLACvtfcHk0lhr89F91OZdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVyisbY%253D&md5=4a7980698997bdc156fecc1e2be4bff9</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1039%2FC6OB00785F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB00785F%26sid%3Dliteratum%253Aachs%26aulast%3DBhadra%26aufirst%3DP.%2BB.%26aulast%3DHassanzadeh%26aufirst%3DA.%26aulast%3DArsic%26aufirst%3DB.%26aulast%3DAllison%26aufirst%3DD.%2BG.%26aulast%3DMorris%26aufirst%3DG.%2BA.%26aulast%3DBarber%26aufirst%3DJ.%26atitle%3DEnhancement%2520of%2520the%2520properties%2520of%2520a%2520drug%2520by%2520mono-deuteriation%253A%2520reduction%2520of%2520acid-catalysed%2520formation%2520of%2520a%2520gut-motilide%2520enol%2520ether%2520from%25208-deuterio-erythromycin%2520B%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D6289%26epage%3D6296%26doi%3D10.1039%2FC6OB00785F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abolin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varney, M.</span></span> <span> </span><span class="NLM_article-title">Derivatives of tramadol for increased duration of effect</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">691</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2005.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=16257206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCiu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=691-694&author=L.+Shaoauthor=C.+Abolinauthor=M.+C.+Hewittauthor=P.+Kochauthor=M.+Varney&title=Derivatives+of+tramadol+for+increased+duration+of+effect&doi=10.1016%2Fj.bmcl.2005.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives of tramadol for increased duration of effect</span></div><div class="casAuthors">Shao, Liming; Abolin, Craig; Hewitt, Michael C.; Koch, Patrick; Varney, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">691-694</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tramadol is a centrally acting opioid analgesic structurally related to codeine and morphine.  Analogs of tramadol with deuterium-for-hydrogen replacement at metabolically active sites were prepd. and evaluated in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqySbghRXcnxbVg90H21EOLACvtfcHk0lhr89F91OZdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCiu7bE&md5=6670712406293bbd421e52ac1f693781</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DL.%26aulast%3DAbolin%26aufirst%3DC.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DVarney%26aufirst%3DM.%26atitle%3DDerivatives%2520of%2520tramadol%2520for%2520increased%2520duration%2520of%2520effect%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D691%26epage%3D694%26doi%3D10.1016%2Fj.bmcl.2005.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uttamsingh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallegos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridson, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R.</span></span> <span> </span><span class="NLM_article-title">Altering metabolic profiles of drugs by precision deuteration: reducing mechanism-based inhibition of CYP2D6 by paroxetine</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.223768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1124%2Fjpet.115.223768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25943764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFalsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=43-54&author=V.+Uttamsinghauthor=R.+Gallegosauthor=J.+F.+Liuauthor=S.+L.+Harbesonauthor=G.+W.+Bridsonauthor=C.+Chengauthor=D.+S.+Wellsauthor=P.+B.+Grahamauthor=R.+Zelleauthor=R.+Tung&title=Altering+metabolic+profiles+of+drugs+by+precision+deuteration%3A+reducing+mechanism-based+inhibition+of+CYP2D6+by+paroxetine&doi=10.1124%2Fjpet.115.223768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Altering metabolic profiles of drugs by precision deuteration: reducing mechanism-based inhibition of CYP2D6 by paroxetine</span></div><div class="casAuthors">Uttamsingh, Vinita; Gallegos, Richard; Liu, Julie F.; Harbeson, Scott L.; Bridson, Gary W.; Cheng, Changfu; Wells, David S.; Graham, Philip B.; Zelle, Robert; Tung, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-54</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Selective deuterium substitution as a means of ameliorating clin. relevant pharmacokinetic drug interactions is demonstrated in this study.  Carbon-deuterium bonds are more stable than corresponding carbon-hydrogen bonds.  Using a precision deuteration platform, the two hydrogen atoms at the methylenedioxy carbon of paroxetine were substituted with deuterium.  The new chem. entity, CTP-347 [(3S,4R)-3-((2,2-dideuterobenzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine], demonstrated similar selectivity for the serotonin receptor, as well as similar neurotransmitter uptake inhibition in an in vitro rat synaptosome model, as unmodified paroxetine.  However, human liver microsomes cleared CTP-347 faster than paroxetine as a result of decreased inactivation of CYP2D6.  In phase 1 studies, CTP-347 wasmetabolized more rapidly in humans and exhibited a lower pharmacokinetic accumulation index than paroxetine.  These alterations in the metab. profile resulted in significantly reduced drug-drug interactions between CTP-347 and two other CYP2D6-metabolized drugs: tamoxifen (in vitro) and dextromethorphan (in humans).  Our results show that precision deuteration can improve the metab. profiles of existing pharmacotherapies without affecting their intrinsic pharmacologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr61zgvmYDyg7Vg90H21EOLACvtfcHk0lhr89F91OZdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFalsLrN&md5=8e7fa68ba7ab319df75badeb50700c20</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.223768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.223768%26sid%3Dliteratum%253Aachs%26aulast%3DUttamsingh%26aufirst%3DV.%26aulast%3DGallegos%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DBridson%26aufirst%3DG.%2BW.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DD.%2BS.%26aulast%3DGraham%26aufirst%3DP.%2BB.%26aulast%3DZelle%26aufirst%3DR.%26aulast%3DTung%26aufirst%3DR.%26atitle%3DAltering%2520metabolic%2520profiles%2520of%2520drugs%2520by%2520precision%2520deuteration%253A%2520reducing%2520mechanism-based%2520inhibition%2520of%2520CYP2D6%2520by%2520paroxetine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D43%26epage%3D54%26doi%3D10.1124%2Fjpet.115.223768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Deuterated clopidogrel analogues as a new generation of antiplatelet agents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1021/ml300460t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300460t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFalur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=349-352&author=Y.+Zhuauthor=J.+Zhouauthor=B.+Jiao&title=Deuterated+clopidogrel+analogues+as+a+new+generation+of+antiplatelet+agents&doi=10.1021%2Fml300460t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated Clopidogrel Analogues as a New Generation of Antiplatelet Agents</span></div><div class="casAuthors">Zhu, Yaoqiu; Zhou, Jiang; Jiao, Bo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-352</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clopidogrel (CPG) is an antithrombotic prodrug that needs hepatic cytochrome P 450 (CYP) enzymes for its bioactivation.  The clin. effects of CPG have been assocd. with high intersubject variability and a certain level of resistance.  Recently, comprehensive biotransformation studies of CPG support that the obsd. clin. uncertainty stems from the low bioactivation efficiency, which is attributed to extensive attritional metab. (e.g., hydrolysis of the Me ester functionality and oxidn. of the piperidine moiety).  With the goal of potentiating the desired thiophene 2-oxidn. through minimal structural modification, we have adopted the strategy of targeted metab. shift and have designed and synthesized deuterated piperidine analogs of CPG.  In vitro studies showed that the prodrug activation percentages have been significantly increased for the deuterated analogs as a result of stability enhancement of the piperidine moiety.  In a pharmacol. study with a rat model, oral administration of the deuterated analogs also demonstrated higher inhibitory activity than that of CPG against ADP (ADP) induced platelet aggregation.  These deuterated analogs represent a new generation of antiplatelet agents with the potential to overcome the major clin. drawbacks of CPG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWV-TRwwRc2LVg90H21EOLACvtfcHk0lhr89F91OZdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFalur0%253D&md5=854953ae4202446b44807d14a277423c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fml300460t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300460t%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DDeuterated%2520clopidogrel%2520analogues%2520as%2520a%2520new%2520generation%2520of%2520antiplatelet%2520agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D349%26epage%3D352%26doi%3D10.1021%2Fml300460t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. W.</span></span> <span> </span><span class="NLM_article-title">Chiral toxicology: It’s the same thing···only different</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfp097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1093%2Ftoxsci%2Fkfp097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=19414517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=4-30&author=S.+W.+Smith&title=Chiral+toxicology%3A+It%E2%80%99s+the+same+thing%C2%B7%C2%B7%C2%B7only+different&doi=10.1093%2Ftoxsci%2Fkfp097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral Toxicology: It's the Same Thing...Only Different</span></div><div class="casAuthors">Smith, Silas W.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-30</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Chiral substances possess a unique architecture such that, despite sharing identical mol. formulas, atom-to-atom linkages, and bonding distances, they cannot be superimposed.  Thus, in the environment of living systems, where specific structure-activity relationships may be required for effect (e.g., enzymes, receptors, transporters, and DNA), the physiochem. and biochem. properties of racemic mixts. and individual stereoisomers can differ significantly.  In drug development, enantiomeric selection to maximize clin. effects or mitigate drug toxicity has yielded both success and failure.  Further complicating genetic polymorphisms in drug disposition, stereoselective metab. of chiral compds. can addnl. influence pharmacokinetics, pharmacodynamics, and toxicity.  Optically pure pharmaceuticals may undergo racemization in vivo, negating single enantiomer benefits or inducing unexpected effects.  Appropriate chiral antidotes must be selected for therapeutic benefit and to minimize adverse events.  Enantiomers may possess different carcinogenicity and teratogenicity.  Environmental toxicol. provides several examples in which compd. bioaccumulation, persistence, and toxicity show chiral dependence.  In forensic toxicol., chiral anal. has been applied to illicit drug prepns. and biol. specimens, with the potential to assist in detn. of cause of death and aid in the correct interpretation of substance abuse and "doping" screens.  Adrenergic agonists and antagonist, nonsteroidal anti-inflammatory agents, SSRIs, opioids, warfarin, valproate, thalidomide, retinoic acid, N-acetylcysteine, carnitine, penicillamine, leucovorin, glucarpidase, pesticides, polychlorinated biphenyls, phenylethylamines, and addnl. compds. will be discussed to illustrate important concepts in "chiral toxicol.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOidSllleGK7Vg90H21EOLACvtfcHk0lh7BbjwfGHBjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKktbg%253D&md5=abfbe5e7d6bdc98e217ed4c66e674786</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfp097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfp097%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BW.%26atitle%3DChiral%2520toxicology%253A%2520It%25E2%2580%2599s%2520the%2520same%2520thing%25C2%25B7%25C2%25B7%25C2%25B7only%2520different%26jtitle%3DToxicol.%2520Sci.%26date%3D2009%26volume%3D110%26spage%3D4%26epage%3D30%26doi%3D10.1093%2Ftoxsci%2Fkfp097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit66b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Csuk, R.</span></span> <i>Biocatalysis in the Pharma and Biotech Industries</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. N.</span></span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">716</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=699-716&author=R.+Csukauthor=R.+N.+Patel&title=Biocatalysis+in+the+Pharma+and+Biotech+Industries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCsuk%26aufirst%3DR.%26btitle%3DBiocatalysis%2520in%2520the%2520Pharma%2520and%2520Biotech%2520Industries%26aulast%3DPatel%26aufirst%3DR.%2BN.%26pub%3DCRC%2520Press%26date%3D2007%26spage%3D699%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit66c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hutt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentova, J.</span></span> <span> </span><span class="NLM_article-title">The chiral switch: The development of single enantiomer drugs from racemates</span>. <i>Acta Fac. Pharm. Univ. Comenianae</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2003&pages=7-23&author=A.+J.+Huttauthor=J.+Valentova&title=The+chiral+switch%3A+The+development+of+single+enantiomer+drugs+from+racemates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutt%26aufirst%3DA.%2BJ.%26aulast%3DValentova%26aufirst%3DJ.%26atitle%3DThe%2520chiral%2520switch%253A%2520The%2520development%2520of%2520single%2520enantiomer%2520drugs%2520from%2520racemates%26jtitle%3DActa%2520Fac.%2520Pharm.%2520Univ.%2520Comenianae%26date%3D2003%26volume%3D50%26spage%3D7%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit66d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, I.</span></span> <span> </span><span class="NLM_article-title">Homochiral drug design and development by racemization</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.2174/138620707781662835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.2174%2F138620707781662835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17896928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFansb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=326-335&author=I.+Ali&title=Homochiral+drug+design+and+development+by+racemization&doi=10.2174%2F138620707781662835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66dR"><div class="casContent"><span class="casTitleNuber">66d</span><div class="casTitle"><span class="NLM_cas:atitle">Homochiral drug design and development by racemization</span></div><div class="casAuthors">Ali, Imran</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">326-335</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the enantiomers of a racemic drug may be pharmacol. inactive or toxic or ballast and, hence, U.S. FDA and European agencies have issued certain guidelines for marketing of optically active (homochiral) drugs.  However, some homochiral drug enantiomers racemize in to human body leading to the generation of other antipodes, which may be toxic or ballast to the human beings.  In addn., racemization reduces the administered dosage concn. when the optically active enantiomer is converted into its inactive form.  Therefore, racemization studies of homochiral drugs are the important and urgent need of today.  This article reviews in vitro and in vivo racemization of homochiral drugs.  The racemization of some homochiral drugs is described considering the affect of different variables such as temp., concn. of the drug, ionic concn., pH, addn. of cyclodextrins, formation of inclusion complexes, etc.  Efforts have also been made to discuss the mechanisms of the racemization process.  Attempts have been made to suggest safe dosages of such drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOBwW0qOPFNrVg90H21EOLACvtfcHk0lh7BbjwfGHBjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFansb3K&md5=2eee57bc284fdea2780aa09e30a1cb98</span></div><a href="/servlet/linkout?suffix=cit66d&amp;dbid=16384&amp;doi=10.2174%2F138620707781662835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620707781662835%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DI.%26atitle%3DHomochiral%2520drug%2520design%2520and%2520development%2520by%2520racemization%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2007%26volume%3D10%26spage%3D326%26epage%3D335%26doi%3D10.2174%2F138620707781662835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit66e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Somogyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D.</span></span> <span> </span><span class="NLM_article-title">Inside the isomers: The tale of chiral switches</span>. <i>Aust. Prescr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.18773/austprescr.2004.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.18773%2Faustprescr.2004.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=47-49&author=A.+Somogyiauthor=F.+Bochnerauthor=D.+Foster&title=Inside+the+isomers%3A+The+tale+of+chiral+switches&doi=10.18773%2Faustprescr.2004.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66e&amp;dbid=16384&amp;doi=10.18773%2Faustprescr.2004.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18773%252Faustprescr.2004.039%26sid%3Dliteratum%253Aachs%26aulast%3DSomogyi%26aufirst%3DA.%26aulast%3DBochner%26aufirst%3DF.%26aulast%3DFoster%26aufirst%3DD.%26atitle%3DInside%2520the%2520isomers%253A%2520The%2520tale%2520of%2520chiral%2520switches%26jtitle%3DAust.%2520Prescr.%26date%3D2004%26volume%3D27%26spage%3D47%26epage%3D49%26doi%3D10.18773%2Faustprescr.2004.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanoury, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perni, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawgo, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Town, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazhanisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raybuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namchuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennani, Y. L.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo isotope effects with hepatitis C protease inhibitors: enhanced plasma exposure of deuterated telaprevir versus telaprevir in rats</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7993</span>– <span class="NLM_lpage">8001</span>, <span class="refDoi"> DOI: 10.1021/jm901023f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901023f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7993-8001&author=F.+Maltaisauthor=Y.+C.+Jungauthor=M.+Chenauthor=J.+Tanouryauthor=R.+B.+Perniauthor=N.+Maniauthor=L.+Laitinenauthor=H.+Huangauthor=S.+Liaoauthor=H.+Gaoauthor=H.+Tsaoauthor=E.+Blockauthor=C.+Maauthor=R.+S.+Shawgoauthor=C.+Townauthor=C.+L.+Brummelauthor=D.+Howeauthor=S.+Pazhanisamyauthor=S.+Raybuckauthor=M.+Namchukauthor=Y.+L.+Bennani&title=In+vitro+and+in+vivo+isotope+effects+with+hepatitis+C+protease+inhibitors%3A+enhanced+plasma+exposure+of+deuterated+telaprevir+versus+telaprevir+in+rats&doi=10.1021%2Fjm901023f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and In Vivo Isotope Effects with Hepatitis C Protease Inhibitors: Enhanced Plasma Exposure of Deuterated Telaprevir versus Telaprevir in Rats</span></div><div class="casAuthors">Maltais, Francois; Jung, Young Chun; Chen, Minzhang; Tanoury, Jerry; Perni, Robert B.; Mani, Nagraj; Laitinen, Leena; Huang, Hui; Liao, Shengkai; Gao, Hongying; Tsao, Hong; Block, Eric; Ma, Chien; Shawgo, Rebecca S.; Town, Christopher; Brummel, Christopher L.; Howe, David; Pazhanisamy, S.; Raybuck, Scott; Namchuk, Mark; Bennani, Youssef L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7993-8001</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Telaprevir (I) (VX-950), an inhibitor of the hepatitis C virus (HCVa) NS3-4A protease, is in phase 3 clin. trials.  One of the major metabolites of I is its P1-(R)-diastereoisomer (VRT-394), contg. an inversion at the chiral center next to the α-ketoamide on exchange of a proton with solvent.  Compd. VRT-394 is approx. 30-fold less active against HCV protease.  In an attempt to suppress the epimerization of I without losing activity against the HCV protease, the proton at that chiral site was replaced with deuterium (d).  The compd. II (d-telaprevir) is as efficacious as I in in vitro inhibition of protease activity and viral replication (replicon) assays.  The kinetics of in vitro stability of I and II in buffered pH solns. and plasma samples, including human plasma, suggest that II is significantly more stable than I.  Oral administration (10 mg/kg) in rats resulted in a ∼13% increase of AUC for II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkqwA80elhh7Vg90H21EOLACvtfcHk0lhUPFXcCC4tuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrbI&md5=244f41b401086e8541efc9203d22b503</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm901023f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901023f%26sid%3Dliteratum%253Aachs%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DJung%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DLaitinen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DTsao%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DE.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DShawgo%26aufirst%3DR.%2BS.%26aulast%3DTown%26aufirst%3DC.%26aulast%3DBrummel%26aufirst%3DC.%2BL.%26aulast%3DHowe%26aufirst%3DD.%26aulast%3DPazhanisamy%26aufirst%3DS.%26aulast%3DRaybuck%26aufirst%3DS.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520isotope%2520effects%2520with%2520hepatitis%2520C%2520protease%2520inhibitors%253A%2520enhanced%2520plasma%2520exposure%2520of%2520deuterated%2520telaprevir%2520versus%2520telaprevir%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7993%26epage%3D8001%26doi%3D10.1021%2Fjm901023f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakoshima, T.</span></span> <span> </span><span class="NLM_article-title">Structural basis of thalidomide enantiomer binding to cereblon</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1294</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-19202-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fs41598-018-19202-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29358579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1MvjtFOksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1294-1307&author=T.+Moriauthor=T.+Itoauthor=S.+Liuauthor=H.+Andoauthor=S.+Sakamotoauthor=Y.+Yamaguchiauthor=E.+Tokunagaauthor=N.+Shibataauthor=H.+Handaauthor=T.+Hakoshima&title=Structural+basis+of+thalidomide+enantiomer+binding+to+cereblon&doi=10.1038%2Fs41598-018-19202-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of thalidomide enantiomer binding to cereblon</span></div><div class="casAuthors">Mori Tomoyuki; Hakoshima Toshio; Ito Takumi; Ando Hideki; Handa Hiroshi; Ito Takumi; Liu Shujie; Sakamoto Satoshi; Yamaguchi Yuki; Tokunaga Etsuko; Shibata Norio</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Thalidomide possesses two optical isomers which have been reported to exhibit different pharmacological and toxicological activities.  However, the precise mechanism by which the two isomers exert their different activities remains poorly understood.  Here, we present structural and biochemical studies of (S)- and (R)-enantiomers bound to the primary target of thalidomide, cereblon (CRBN).  Our biochemical studies employed deuterium-substituted thalidomides to suppress optical isomer conversion, and established that the (S)-enantiomer exhibited ~10-fold stronger binding to CRBN and inhibition of self-ubiquitylation compared to the (R)-enantiomer.  The crystal structures of the thalidomide-binding domain of CRBN bound to each enantiomer show that both enantiomers bind the tri-Trp pocket, although the bound form of the (S)-enantiomer exhibited a more relaxed glutarimide ring conformation.  The (S)-enantiomer induced greater teratogenic effects on fins of zebrafish compared to the (R)-enantiomer.  This study has established a mechanism by which thalidomide exerts its effects in a stereospecific manner at the atomic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9kUcSD4Ihdlf1XRtfYM0dfW6udTcc2eYQCzr2rQQ0B7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvjtFOksw%253D%253D&md5=d211214d07ec35f76fd5e0bd9080f800</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-19202-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-19202-7%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DTokunaga%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DHakoshima%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520of%2520thalidomide%2520enantiomer%2520binding%2520to%2520cereblon%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D1294%26epage%3D1307%26doi%3D10.1038%2Fs41598-018-19202-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toru, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and configurational stability of (S)- and (R)-deuteriothalidomides</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1248/cpb.58.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1248%2Fcpb.58.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=20045977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVWrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=110-112&author=T.+Yamamotoauthor=E.+Tokunagaauthor=S.+Nakamuraauthor=N.+Shibataauthor=T.+Toru&title=Synthesis+and+configurational+stability+of+%28S%29-+and+%28R%29-deuteriothalidomides&doi=10.1248%2Fcpb.58.110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and configurational stability of (S)- and (R)-deuteriothalidomides</span></div><div class="casAuthors">Yamamoto, Takeshi; Tokunaga, Etsuko; Nakamura, Shuichi; Shibata, Norio; Toru, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-112</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">(±)-3'-Deuteriothalidomide (I) was synthesized and resolved into its enantiomers.  S-I was five times more stable than S-thalidomide toward racemization at physiol. pH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKN76kpCl-TrVg90H21EOLACvtfcHk0lhUPFXcCC4tuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVWrtrw%253D&md5=e8771280b945e2ab0a28499c4ffbd28e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1248%2Fcpb.58.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.58.110%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DTokunaga%26aufirst%3DE.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DToru%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520configurational%2520stability%2520of%2520%2528S%2529-%2520and%2520%2528R%2529-deuteriothalidomides%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D58%26spage%3D110%26epage%3D112%26doi%3D10.1248%2Fcpb.58.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnik, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Ploeg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWitt, S. H.</span></span> <span> </span><span class="NLM_article-title">Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E1471</span>– <span class="NLM_lpage">E1479</span>, <span class="refDoi"> DOI: 10.1073/pnas.1417832112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1073%2Fpnas.1417832112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=25775521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E1471-E1479&author=V.+Jacquesauthor=A.+W.+Czarnikauthor=T.+M.+Judgeauthor=L.+H.+Van+der+Ploegauthor=S.+H.+DeWitt&title=Differentiation+of+antiinflammatory+and+antitumorigenic+properties+of+stabilized+enantiomers+of+thalidomide+analogs&doi=10.1073%2Fpnas.1417832112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs</span></div><div class="casAuthors">Jacques, Vincent; Czarnik, Anthony W.; Judge, Thomas M.; Van der Ploeg, Lex H. T.; De Witt, Sheila H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">E1471-E1479</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Therapeutics developed and sold as racemates can exhibit a limited therapeutic index because of side effects resulting from the undesired enantiomer (distomer) and/or its metabolites, which at times, forces researchers to abandon valuable scaffolds.  Therefore, most chiral drugs are developed as single enantiomers.  Unfortunately, the development of some chirally pure drug mols. is hampered by rapid in vivo racemization.  The class of compds. known as immunomodulatory drugs derived from thalidomide is developed and sold as racemates because of racemization at the chiral center of the 3-aminoglutarimide moiety.  Herein, the authors show that replacement of the exchangeable hydrogen at the chiral center with deuterium allows the stabilization and testing of individual enantiomers for two thalidomide analogs, including CC-122, a compd. currently in human clin. trials for hematol. cancers and solid tumors.  Using "deuterium-enabled chiral switching" (DECS), in vitro anti-inflammatory differences of up to 20-fold are obsd. between the deuterium-stabilized enantiomers.  In vivo, the exposure is dramatically increased for each enantiomer while they retain similar pharmacokinetics.  Furthermore, the single deuterated enantiomers related to CC-122 exhibit profoundly different in vivo responses in an NCI-H929 myeloma xenograft model.  The (-)-deuterated enantiomer is antitumorigenic, whereas the (+)-deuterated enantiomer has little to no effect on tumor growth.  The ability to stabilize and differentiate enantiomers by DECS opens up a vast window of opportunity to characterize the class effects of thalidomide analogs and improve on the therapeutic promise of other racemic compds., including the development of safer therapeutics and the discovery of new mechanisms and clin. applications for existing therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf_lmu7VE5AbVg90H21EOLACvtfcHk0liqE14Wz9-K-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCgurk%253D&md5=c4d855163335f0cf839ce4cc25c1a33f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1417832112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1417832112%26sid%3Dliteratum%253Aachs%26aulast%3DJacques%26aufirst%3DV.%26aulast%3DCzarnik%26aufirst%3DA.%2BW.%26aulast%3DJudge%26aufirst%3DT.%2BM.%26aulast%3DVan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%26aulast%3DDeWitt%26aufirst%3DS.%2BH.%26atitle%3DDifferentiation%2520of%2520antiinflammatory%2520and%2520antitumorigenic%2520properties%2520of%2520stabilized%2520enantiomers%2520of%2520thalidomide%2520analogs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3DE1471%26epage%3DE1479%26doi%3D10.1073%2Fpnas.1417832112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, V.</span>; <span class="NLM_string-name">Van der Ploeg, L.</span>; <span class="NLM_string-name">Dewitt, S. H.</span></span> <span> </span><span class="NLM_article-title">DRX- 065, the Deuterated (<i>R</i>)-Enantiomer of Pioglitazone, as a Nonalcoholic Steatohepatitis (NASH) Drug Candidate: Preclinical and Phase 1 Results</span>.  <i>Abstracts of Papers</i>, 256th National Meeting and Exposition of the American Chemical Society, Boston, MA, August 19–23, 2018; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=V.+Jacques&author=L.+Van+der+Ploeg&author=S.+H.+Dewitt&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJacques%26aufirst%3DV.%26atitle%3DDRX-%2520065%252C%2520the%2520Deuterated%2520%2528R%2529-Enantiomer%2520of%2520Pioglitazone%252C%2520as%2520a%2520Nonalcoholic%2520Steatohepatitis%2520%2528NASH%2529%2520Drug%2520Candidate%253A%2520Preclinical%2520and%2520Phase%25201%2520Results%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdallah, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelmendi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esterlis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanacora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span> <span> </span><span class="NLM_article-title">Ketamine’s mechanism of action: a path to rapid-acting antidepressants</span>. <i>Depression Anxiety</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1002/da.22501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fda.22501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27062302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1eht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=689-697&author=C.+G.+Abdallahauthor=T.+G.+Adamsauthor=B.+Kelmendiauthor=I.+Esterlisauthor=G.+Sanacoraauthor=J.+H.+Krystal&title=Ketamine%E2%80%99s+mechanism+of+action%3A+a+path+to+rapid-acting+antidepressants&doi=10.1002%2Fda.22501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS</span></div><div class="casAuthors">Abdallah, Chadi G.; Adams, Thomas G.; Kelmendi, Benjamin; Esterlis, Irina; Sanacora, Gerard; Krystal, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Depression and Anxiety</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">689-697</span>CODEN:
                <span class="NLM_cas:coden">DEANF5</span>;
        ISSN:<span class="NLM_cas:issn">1091-4269</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Major depressive disorder (MDD) is a common and debilitating psychiatric disorder.  Traditional antidepressants are of limited efficacy and take weeks to months to yield full therapeutic effects.  Thus, there is a clear need for effective rapid-acting antidepressant medications.  The N-methyl-D-aspartate receptor (NMDA-R) antagonist, ketamine, has received a great deal of attention over the last 20 years due to the discovery that a single subanesthetic dose leads to a rapid antidepressant effect in individuals with treatment-resistant depression.  Animal and human research suggest that ketamine's antidepressant effects are mediated by a glutamate surge that leads to a cascade of events that result in synaptogenesis and reversal of the neg. effects of chronic stress and depression, particularly within the prefrontal cortex (PFC).  Preclin. and clin. data have provided compelling insights into the mechanisms underlying the rapid-acting antidepressant effects of ketamine.  This review discusses stress-related neurobiol. of depression and the safety, tolerability, and efficacy of ketamine for MDD, along with a review of ketamine's mechanism of action and prospective predictors of treatment response.  Research limitations and future clin. prospects are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd3oDPBjGt0rVg90H21EOLACvtfcHk0liqE14Wz9-K-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1eht7fI&md5=b020b2afdffce0393a5e4920d26a8115</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fda.22501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fda.22501%26sid%3Dliteratum%253Aachs%26aulast%3DAbdallah%26aufirst%3DC.%2BG.%26aulast%3DAdams%26aufirst%3DT.%2BG.%26aulast%3DKelmendi%26aufirst%3DB.%26aulast%3DEsterlis%26aufirst%3DI.%26aulast%3DSanacora%26aufirst%3DG.%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26atitle%3DKetamine%25E2%2580%2599s%2520mechanism%2520of%2520action%253A%2520a%2520path%2520to%2520rapid-acting%2520antidepressants%26jtitle%3DDepression%2520Anxiety%26date%3D2016%26volume%3D33%26spage%3D689%26epage%3D697%26doi%3D10.1002%2Fda.22501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moaddel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkondon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribut, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossou, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainer, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T. D.</span></span> <span> </span><span class="NLM_article-title">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>533</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nature17998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fnature17998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27144355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=481-486&author=P.+Zanosauthor=R.+Moaddelauthor=P.+J.+Morrisauthor=P.+Georgiouauthor=J.+Fischellauthor=G.+I.+Elmerauthor=M.+Alkondonauthor=P.+Yuanauthor=H.+J.+Pributauthor=N.+S.+Singhauthor=K.+S.+Dossouauthor=Y.+Fangauthor=X.+P.+Huangauthor=C.+L.+Mayoauthor=I.+W.+Wainerauthor=E.+X.+Albuquerqueauthor=S.+M.+Thompsonauthor=C.+J.+Thomasauthor=C.+A.+Zarateauthor=T.+D.+Gould&title=NMDAR+inhibition-independent+antidepressant+actions+of+ketamine+metabolites&doi=10.1038%2Fnature17998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">NMDAR inhibition-independent antidepressant actions of ketamine metabolites</span></div><div class="casAuthors">Zanos, Panos; Moaddel, Ruin; Morris, Patrick J.; Georgiou, Polymnia; Fischell, Jonathan; Elmer, Greg I.; Alkondon, Manickavasagom; Yuan, Peixiong; Pribut, Heather J.; Singh, Nagendra S.; Dossou, Katina S. S.; Fang, Yuhong; Huang, Xi-Ping; Mayo, Cheryl L.; Wainer, Irving W.; Albuquerque, Edson X.; Thompson, Scott M.; Thomas, Craig J.; Zarate, Carlos A., Jr; Gould, Todd D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7604</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Major depressive disorder affects around 16% of the world population at some point in their lives.  Despite the availability of numerous monoaminergic-based antidepressants, most patients require several weeks, if not months, to respond to these treatments, and many patients never attain sustained remission of their symptoms.  The noncompetitive, glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist (R,S)-ketamine exerts rapid and sustained antidepressant effects after a single dose in patients with depression, but its use is assocd. with undesirable side effects.  Here the authors show that the metab. of (R,S)-ketamine to (2S,6S;2R,6R)-hydroxynorketamine (HNK) is essential for its antidepressant effects, and that the (2R,6R)-HNK enantiomer exerts behavioral, electroencephalog., electrophysiol. and cellular antidepressant-related actions in mice.  These antidepressant actions are independent of NMDAR inhibition but involve early and sustained activation of AMPARs (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors).  The authors also establish that (2R,6R)-HNK lacks ketamine-related side effects.  The data implicate a novel mechanism underlying the antidepressant properties of (R,S)-ketamine and have relevance for the development of next-generation, rapid-acting antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzu3ydujHJ37Vg90H21EOLACvtfcHk0liqE14Wz9-K-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1Ogs70%253D&md5=fcb8479079696cf3dc0ee89f5fadd72a</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fnature17998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17998%26sid%3Dliteratum%253Aachs%26aulast%3DZanos%26aufirst%3DP.%26aulast%3DMoaddel%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DP.%2BJ.%26aulast%3DGeorgiou%26aufirst%3DP.%26aulast%3DFischell%26aufirst%3DJ.%26aulast%3DElmer%26aufirst%3DG.%2BI.%26aulast%3DAlkondon%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DPribut%26aufirst%3DH.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%2BS.%26aulast%3DDossou%26aufirst%3DK.%2BS.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMayo%26aufirst%3DC.%2BL.%26aulast%3DWainer%26aufirst%3DI.%2BW.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DThompson%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26aulast%3DGould%26aufirst%3DT.%2BD.%26atitle%3DNMDAR%2520inhibition-independent%2520antidepressant%2520actions%2520of%2520ketamine%2520metabolites%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature17998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of <i>N</i>-(5-fluoro-2-phenoxyphenyl)-<i>N</i>-(2-[<sup>18</sup>F]fluoromethoxy-d<sub>2</sub>-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1811</span>– <span class="NLM_lpage">1818</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.11.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmc.2004.11.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=15698799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1811-1818&author=M.-R.+Zhangauthor=J.+Maedaauthor=T.+Itoauthor=T.+Okauchiauthor=M.+Ogawaauthor=J.+Noguchiauthor=T.+Suharaauthor=C.+Halldinauthor=K.+Suzuki&title=Synthesis+and+evaluation+of+N-%285-fluoro-2-phenoxyphenyl%29-N-%282-%5B18F%5Dfluoromethoxy-d2-5-methoxybenzyl%29acetamide%3A+a+deuterium-substituted+radioligand+for+peripheral+benzodiazepine+receptor&doi=10.1016%2Fj.bmc.2004.11.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoromethoxy-d2-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor</span></div><div class="casAuthors">Zhang, Ming-Rong; Maeda, Jun; Ito, Takehito; Okauchi, Takashi; Ogawa, Masanao; Noguchi, Junko; Suhara, Tetsuya; Halldin, Christer; Suzuki, Kazutoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1811-1818</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoromethoxy-d2-5-methoxybenzyl)acetamide ([18F]2) is a potent ligand (IC50: 1.71 nM) for peripheral benzodiazepine receptor (PBR).  However, in vivo evaluation on rodents and primates showed that this ligand was unstable and rapidly metabolized to [18F]F- by defluorination of the [18F]fluoromethyl moiety.  In this study, we designed a deuterium-substituted analog, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoromethoxy-d2-5-methoxybenzyl)acetamide ([18F]5) as a radioligand for PBR to reduce the in vivo metabolic rate of the non-deuterated [18F]2.  The design principle was based on the hypothesis that the deuterium substitution may reduce the rate of defluorination initiated by cleavage of the C-H bond without altering the binding affinity for PBR.  The non-radioactive 5 was prepd. by reacting diiodomethane-d2 (CD2I2, 6) with a phenol precursor 7, followed by treatment with tetrabutylammonium fluoride.  The ligand [18F]5 was synthesized by the alkylation of 7 with [18F]fluoromethyl iodide-d2 ([18F]FCD2I, [18F]9).  Compd. 5 displayed a similar in vitro affinity to PBR (IC50: 1.90 nM) with 2.  In vivo evaluation demonstrated that [18F]5 was metabolized by defluorination to [18F]F- as a main radioactive component, but its metabolic rate was slower than that of [18F]2 in the brain of mice.  The deuterium substitution decreased the radioactivity level of [18F]5 in the bone of mouse, augmented by the percentage of specific binding to PBR in the rat brain detd. by ex vivo autoradiog.  However, the PET image of [18F]5 for monkey brain showed high radioactivity in the brain and skull, suggesting a possible species difference between rodents and primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1VeN13UDtaLVg90H21EOLACvtfcHk0lgL5czkVUuvDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs7k%253D&md5=4a74d02933e376b0761fea175300c50c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.11.058%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DJ.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520N-%25285-fluoro-2-phenoxyphenyl%2529-N-%25282-%255B18F%255Dfluoromethoxy-d2-5-methoxybenzyl%2529acetamide%253A%2520a%2520deuterium-substituted%2520radioligand%2520for%2520peripheral%2520benzodiazepine%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D1811%26epage%3D1818%26doi%3D10.1016%2Fj.bmc.2004.11.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span> <span> </span><span class="NLM_article-title">[<sup>18</sup>F]Fluoromethyl-PBR28 as a potential radiotracer for TSPO: preclinical comparison with [<sup>11</sup>C]PBR28 in a rat model of neuroinflammation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1021/bc400556h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc400556h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=442-450&author=B.+S.+Moonauthor=B.+S.+Kimauthor=C.+Parkauthor=J.+H.+Jungauthor=Y.+W.+Leeauthor=H.-Y.+Leeauthor=D.+Y.+Chiauthor=B.+C.+Leeauthor=S.+E.+Kim&title=%5B18F%5DFluoromethyl-PBR28+as+a+potential+radiotracer+for+TSPO%3A+preclinical+comparison+with+%5B11C%5DPBR28+in+a+rat+model+of+neuroinflammation&doi=10.1021%2Fbc400556h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]Fluoromethyl-PBR28 as a Potential Radiotracer for TSPO: Preclinical Comparison with [11C]PBR28 in a Rat Model of Neuroinflammation</span></div><div class="casAuthors">Moon, Byung Seok; Kim, Bom Sahn; Park, Chansoo; Jung, Jae Ho; Lee, Youn Woo; Lee, Ho-Young; Chi, Dae Yoon; Lee, Byung Chul; Kim, Sang Eun</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To develop radiotracer for the translocator protein 18 kDa (TSPO) in vivo, N-(2-[18F]-fluoromethoxybenzyl)-N-(4-phenoxypyridin-3-yl)-acetamide ([18F]1, [18F]-fluoromethyl-PBR28) was prepd. by incorporating of fluorine-18 into triazolium triflate-PBR28 precursor (7).  The radiochem. yield of [18F]1 after HPLC purifn. was 35.8 ± 3.2% (n = 11, decay cor.).  Radiotracer [18F]1 was found to be chem. stable when incubated in human serum for 4 h at 37 °C.  Both aryloxyanilide analogs (1 and 2) behaved similarly in terms of lipophilicity and in vitro affinity for TSPO.  Here, both radiotracers were directly compared in the same inflammatory rat to det. whether either radiotracer provides more promising in vivo TSPO binding.  Uptake of [18F]1 in the inflammatory lesion was comparable to that of [11C]-PBR28, and [18F]1 rapidly approached the highest target-to-background ratio at early imaging time (35 min postinjection vs. 85 min postinjection for [11C]-PBR28).  These results suggest that [18F]1 is a promising radiotracer for imaging acute neuroinflammation in rat.  In addn., our use of a triazolium triflate precursor for [18F]-fluoromethyl ether group provides the convenient application for radiofluorination of radiotracer contg. a methoxy group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5aYe0CJbIkLVg90H21EOLACvtfcHk0lgL5czkVUuvDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVOhtQ%253D%253D&md5=e3348cc433b34d2d59e8193990f9f601</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fbc400556h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc400556h%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DY.%2BW.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BE.%26atitle%3D%255B18F%255DFluoromethyl-PBR28%2520as%2520a%2520potential%2520radiotracer%2520for%2520TSPO%253A%2520preclinical%2520comparison%2520with%2520%255B11C%255DPBR28%2520in%2520a%2520rat%2520model%2520of%2520neuroinflammation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2014%26volume%3D25%26spage%3D442%26epage%3D450%26doi%3D10.1021%2Fbc400556h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span> <span> </span><span class="NLM_article-title">Preclinical comparison study between [<sup>18</sup>F]fluoromethyl-PBR28 and its deuterated analog in a rat model of neuroinflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2925</span>– <span class="NLM_lpage">2929</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.bmcl.2018.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=30122224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2925-2929&author=B.+S.+Moonauthor=J.+H.+Jungauthor=H.+S.+Parkauthor=M.+Continoauthor=N.+Denoraauthor=B.+C.+Leeauthor=S.+E.+Kim&title=Preclinical+comparison+study+between+%5B18F%5Dfluoromethyl-PBR28+and+its+deuterated+analog+in+a+rat+model+of+neuroinflammation&doi=10.1016%2Fj.bmcl.2018.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical comparison study between [18F]fluoromethyl-PBR28 and its deuterated analog in a rat model of neuroinflammation</span></div><div class="casAuthors">Moon, Byung Seok; Jung, Jae Ho; Park, Hyun Soo; Contino, Marialessandra; Denora, Nunzio; Lee, Byung Chul; Kim, Sang Eun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2925-2929</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We designed and synthesized deuterium-substituted [18F]fluoromethyl-PBR28 ([18F]1-d2) as a novel translocator protein 18 kDa (TSPO)-targeted radioligand with enhanced in vivo stability.  The comparison studies between [18F]fluoromethyl-PBR28 ([18F]1) and its deuterate analog ([18F]1-d2) were investigated in terms of in vitro binding affinity, lipophilicity and in vivo stability.  In addn., the accuracies of both radioligands were detd. by comparing the PET imaging data in the same LPS-induced neuroinflammation rat model.  Both aryloxyanilide analogs showed similar lipophilicity and in vitro affinity for TSPO.  However, [18F]1-d2 provided significantly lower femur uptake than [18F]1 (1.5 ± 1.2 vs. 4.1 ± 1.7%ID/g at 2 h post-injection) in an ex vivo biodistribution study. [18F]1-d2 was also selectively accumulated in the inflammatory lesion with the binding potential of the specifically bound radioligand relative to the non-displaceable radioligand in tissue (BPND = 3.17 ± 0.48), in a LPS-induced acute neuroinflammation rat model, comparable to that of [18F]1 (BPND = 2.13 ± 0.51).  These results indicate that [18F]1-d2 had higher in vivo stability, which resulted in an enhanced target-to-background ratio compared to that induced by [18F]1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Fy-Dh-PJbLVg90H21EOLACvtfcHk0lgL5czkVUuvDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yrsrfI&md5=537cd26cacc8be34f39e6ea881d72749</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DB.%2BS.%26aulast%3DJung%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DB.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BE.%26atitle%3DPreclinical%2520comparison%2520study%2520between%2520%255B18F%255Dfluoromethyl-PBR28%2520and%2520its%2520deuterated%2520analog%2520in%2520a%2520rat%2520model%2520of%2520neuroinflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2925%26epage%3D2929%26doi%3D10.1016%2Fj.bmcl.2018.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettschau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svedberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catafau, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannestad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">In vivo and in vitro characterization of a novel MAO-B inhibitor radioligand, <sup>18</sup>F-labeled deuterated fluorodeprenyl</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.161083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.2967%2Fjnumed.115.161083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=26585057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=315-320&author=S.+Nagauthor=P.+Fazioauthor=L.+Lehmannauthor=G.+Kettschauauthor=T.+Heinrichauthor=A.+Thieleauthor=M.+Svedbergauthor=N.+Aminiauthor=S.+Leeschauthor=A.+M.+Catafauauthor=J.+Hannestadauthor=A.+Varroneauthor=C.+Halldin&title=In+vivo+and+in+vitro+characterization+of+a+novel+MAO-B+inhibitor+radioligand%2C+18F-labeled+deuterated+fluorodeprenyl&doi=10.2967%2Fjnumed.115.161083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro characterization of a novel MAO-B inhibitor radioligand, 18F-labeled deuterated fluorodeprenyl</span></div><div class="casAuthors">Nag, Sangram; Fazio, Patrik; Lehmann, Lutz; Kettschau, Georg; Heinrich, Tobias; Thiele, Andrea; Svedberg, Marie; Amini, Nahid; Leesch, Samira; Catafau, Ana M.; Hannestad, Jonas; Varrone, Andrea; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">The aim of this study was to radiolabel a novel bis-deuterium substituted l-deprenyl analog (fluorodeprenyl-D2) with 18F and to evaluate its potential to visualize and quantify monoamine oxidase (MAO) B activity in vivo.  Methods: The precursor compd. (5a + 5b) and ref. std. (6) were synthesized in multistep syntheses.  Recombinant human MAO-B and MAO-A enzyme prepns. were used to det. inhibitory concns. of 50%.  Radiolabeling was accomplished by a nucleophilic substitution reaction.  Whole-hemisphere autoradiog. was performed with 18F-fluorodeprenyl-D2.  A PET study was performed on a cynomolgus monkey.  Radiometabolites were measured in monkey plasma using high-performance liq. chromatog.  Results: The 50% inhibitory concn. of compd. 6 for MAO-B was 227 ± 36.8 nM.  Radiolabeling was accomplished with high radiochem. yield, purity, and specific radioactivity.  The autoradiog. binding d. of 18F-fluorodeprenyl-D2 was consistent with known MAO-B expression in the human brain.  In vivo, 18F-fluorodeprenyl-D2 showed favorable kinetic properties, with relatively fast washout from the brain.  Regional time-activity curves were better described by the 2-tissue-compartment model.  Administration of a 1 mg/kg dose of l-deprenyl yielded 70% inhibition of MAO-B in all regions.  Radiometabolite studies demonstrated 20% unchanged radioligand at 120 min after injection. 18F-fluorodeprenyl-D2 showed less irreversibility than did previously reported MAO-B radioligands.  Conclusion: The results suggest that 18F-fluorodeprenyl-D2 is a suitable PET radioligand for visualization of MAO-B activity in the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy_X--Sdcf4rVg90H21EOLACvtfcHk0lghd2is_Ob2tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVKlsA%253D%253D&md5=2934d0478f5981d0e72921fe49330246</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.161083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.161083%26sid%3Dliteratum%253Aachs%26aulast%3DNag%26aufirst%3DS.%26aulast%3DFazio%26aufirst%3DP.%26aulast%3DLehmann%26aufirst%3DL.%26aulast%3DKettschau%26aufirst%3DG.%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DThiele%26aufirst%3DA.%26aulast%3DSvedberg%26aufirst%3DM.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DLeesch%26aufirst%3DS.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26aulast%3DHannestad%26aufirst%3DJ.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520characterization%2520of%2520a%2520novel%2520MAO-B%2520inhibitor%2520radioligand%252C%252018F-labeled%2520deuterated%2520fluorodeprenyl%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D315%26epage%3D320%26doi%3D10.2967%2Fjnumed.115.161083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tóth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettschau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">In vivo evaluation in cynomolgus monkey brain and metabolism of [<sup>18</sup>F]fluorodeprenyl: a new MAO-B pet radioligand</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1002/syn.21514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fsyn.21514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=22124971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12mur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=323-330&author=S.+Nagauthor=A.+Varroneauthor=M.+T%C3%B3thauthor=A.+Thieleauthor=G.+Kettschauauthor=T.+Heinrichauthor=L.+Lehmannauthor=C.+Halldin&title=In+vivo+evaluation+in+cynomolgus+monkey+brain+and+metabolism+of+%5B18F%5Dfluorodeprenyl%3A+a+new+MAO-B+pet+radioligand&doi=10.1002%2Fsyn.21514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo evaluation in cynomolgus monkey brain and metabolism of [18F]fluorodeprenyl: A new MAO-B pet radioligand</span></div><div class="casAuthors">Nag, Sangram; Varrone, Andrea; Toth, Miklos; Thiele, Andrea; Kettschau, Georg; Heinrich, Tobias; Lehmann, Lutz; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-330</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In this study, we evaluated the in vivo characteristics of a new monoamine oxidase type B (MAO-B) radioligand, [18F]fluorodeprenyl, by positron emission tomog. (PET) in two cynomolgus monkeys.  The brain uptake of [18F]fluorodeprenyl was more than 7% (600% SUV) of the total injected radioactivity and similar to that of [11C]deprenyl, an established MAO-B radioligand.  The highest uptake was obsd. in the striatum, one of the MAO-B-rich regions, with a peak at approx. 2-3 min after injection, followed by lower uptake in the thalamus and the cortex and lowest uptake in the cerebellum.  Brain uptake of [18F]fluorodeprenyl was largely inhibited by preadministration of the MAO-B inhibitor, L-deprenyl, whereas clorgyline, a MAO Type A blocker, had no significant inhibitory effect, thus demonstrating selectivity for MAO-B. [18F]Fluorodeprenyl showed relatively slow metab. with the presence of two radiometabolite peaks with similar retention time as the labeled metabolites of [11C]deprenyl.  These results suggest that [18F]fluorodeprenyl is a potential PET radioligand for visualization of MAO-B activity.  Synapse, 2011. © 2011 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyrFOKakuTCLVg90H21EOLACvtfcHk0lghd2is_Ob2tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12mur7L&md5=d3caf0ddce8198b533c5446f53ecc8b3</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21514%26sid%3Dliteratum%253Aachs%26aulast%3DNag%26aufirst%3DS.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DT%25C3%25B3th%26aufirst%3DM.%26aulast%3DThiele%26aufirst%3DA.%26aulast%3DKettschau%26aufirst%3DG.%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DLehmann%26aufirst%3DL.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DIn%2520vivo%2520evaluation%2520in%2520cynomolgus%2520monkey%2520brain%2520and%2520metabolism%2520of%2520%255B18F%255Dfluorodeprenyl%253A%2520a%2520new%2520MAO-B%2520pet%2520radioligand%26jtitle%3DSynapse%26date%3D2012%26volume%3D66%26spage%3D323%26epage%3D330%26doi%3D10.1002%2Fsyn.21514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ottoboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagnoli, N.</span></span> <span> </span><span class="NLM_article-title">Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">13684</span>– <span class="NLM_lpage">13688</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=2788162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaL1MXlsVyht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=13684-13688&author=S.+Ottoboniauthor=P.+Calderaauthor=A.+Trevorauthor=N.+Castagnoli&title=Deuterium+isotope+effect+measurements+on+the+interactions+of+the+neurotoxin+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+with+monoamine+oxidase+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B</span></div><div class="casAuthors">Ottoboni, Susanne; Caldera, Patricia; Trevor, Anthony; Castagnoli, Neal, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13684-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Kinetic deuterium isotope effects for the noncompetitive, intermol. monoamine oxidase B-catalyzed oxidn. of MPTP to the corresponding 1-methyl-4-phenyl-2,3-dihydropyridinium species MPDP+ were 3.55 on Vmax and 8.01 on Vmax/Km with MPTP-6,6-d2 as the deuterated substrate.  Similar values were obtained with MPTP-2,2,6,6-d4 and MPTP-CD3-2,2,6,6-d4.  The deuterium isotope effect for the electrochem. oxidn. of 1 mM MPTP-2,2,6,6-d4 was only 1.35.  These results indicate that the monoamine oxidase B-catalyzed oxidn. of this substrate may not proceed via a reaction pathway involving α-carbon deprotonation of an aminium radical intermediate.  Isotope effect measurements also established that the rate of inactivation of monoamine oxidase B by MPTP is unaffected by replacement of the C-6 methylene protons with deuterons, but is retarded by replacement of the C-2 methylene protons (DKi = 1.9).  The mechanism-based inactivation of monoamine oxidase B by MPTP, therefore, is likely to be mediated by a species derived from the enzyme-generated 2,3-dihydropyridinium oxidn. product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGbhYn3avwrVg90H21EOLACvtfcHk0lghd2is_Ob2tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlsVyht7w%253D&md5=356a2c8952b6ba8481aa39d43e7de1cb</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOttoboni%26aufirst%3DS.%26aulast%3DCaldera%26aufirst%3DP.%26aulast%3DTrevor%26aufirst%3DA.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DDeuterium%2520isotope%2520effect%2520measurements%2520on%2520the%2520interactions%2520of%2520the%2520neurotoxin%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520with%2520monoamine%2520oxidase%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D13684%26epage%3D13688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drake, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mufarreh, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeppe, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilbourn, M. R.</span></span> <span> </span><span class="NLM_article-title">Deuterium kinetic isotope effect studies of a potential in vivo metabolic trapping agent for monoamine oxidase B</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3024</span>– <span class="NLM_lpage">3027</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVemtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3024-3027&author=L.+R.+Drakeauthor=A.+F.+Brooksauthor=A.+J.+Mufarrehauthor=J.+M.+Phamauthor=R.+A.+Koeppeauthor=X.+Shaoauthor=P.+J.+H.+Scottauthor=M.+R.+Kilbourn&title=Deuterium+kinetic+isotope+effect+studies+of+a+potential+in+vivo+metabolic+trapping+agent+for+monoamine+oxidase+B&doi=10.1021%2Facschemneuro.8b00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium Kinetic Isotope Effect Studies of a Potential in Vivo Metabolic Trapping Agent for Monoamine Oxidase B</span></div><div class="casAuthors">Drake, Lindsey R.; Brooks, Allen F.; Mufarreh, Anthony J.; Pham, Jonathan M.; Koeppe, Robert A.; Shao, Xia; Scott, Peter J. H.; Kilbourn, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3024-3027</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Visualizing the in vivo activity of monoamine oxidase B (MAO-B) is a valuable tool in the ongoing investigation into astrogliosis in neurodegeneration.  Existing strategies for imaging changes in MAO enzyme expression or activity have utilized the irreversible suicide inhibitors or high-affinity reversibly binding inhibitors as PET ligands.  As an alternative approach, we developed 4-methyl-7-((1-[11C]methyl-1,2,3,6-tetrahydropyridin-4-yl)oxy)-2H-chromen-2-one ([11C]Cou) as a metabolic trapping agent for MAO-B.  Trapping of [11C]Cou in rhesus monkey brain demonstrated MAO-B selectivity.  In this work we have attempted to improve on the in vivo pharmacokinetics of [11C]Cou by using the deuterium kinetic isotope effect (KIE) to slow the MAO-B mediated oxidn. step and thus reduce the rate of trapping in brain tissues.  However, in vitro assays of enzyme kinetics and in vivo PET imaging of pharmacokinetics in primate brain showed no effects of deuterium substitution on the tetrahydropyridine ring of [11C]Cou.  The results are possibly due to masking of the KIE by a second step in the overall metab. of the new imaging agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjw1zi8AKxRrVg90H21EOLACvtfcHk0liF_vWhtX_7rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVemtLfN&md5=9db622b5b8a8eb194ff438505dd75bbc</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00219%26sid%3Dliteratum%253Aachs%26aulast%3DDrake%26aufirst%3DL.%2BR.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DMufarreh%26aufirst%3DA.%2BJ.%26aulast%3DPham%26aufirst%3DJ.%2BM.%26aulast%3DKoeppe%26aufirst%3DR.%2BA.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26atitle%3DDeuterium%2520kinetic%2520isotope%2520effect%2520studies%2520of%2520a%2520potential%2520in%2520vivo%2520metabolic%2520trapping%2520agent%2520for%2520monoamine%2520oxidase%2520B%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D3024%26epage%3D3027%26doi%3D10.1021%2Facschemneuro.8b00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Qahtani, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleator, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danks, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmonds, A. J.</span></span> <span> </span><span class="NLM_article-title">Microwave enhanced hydrogenation reactions using solid hydrogen, deuterium and tritium donors</span>. <i>J. Chem. Res., Synop.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1039/a802040j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2Fa802040j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1cXktlemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=400-401&author=M.+H.+Al-Qahtaniauthor=N.+Cleatorauthor=T.+N.+Danksauthor=R.+N.+Garmanauthor=J.+R.+Jonesauthor=S.+Stefaniakauthor=A.+D.+Morganauthor=A.+J.+Simmonds&title=Microwave+enhanced+hydrogenation+reactions+using+solid+hydrogen%2C+deuterium+and+tritium+donors&doi=10.1039%2Fa802040j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81aR"><div class="casContent"><span class="casTitleNuber">81a</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave Enhanced Hydrogenation Reactions using Solid Hydrogen, Deuterium and Tritium Donors</span></div><div class="casAuthors">Al-Qahtani, Mohammed H.; Cleator, Nicola; Danks, Timothy N.; Garman, Russell N.; Jones, John R.; Stefaniak, Stefan; Morgan, Alan D.; Simmonds, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Research, Synopses</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">400-401</span>CODEN:
                <span class="NLM_cas:coden">JRPSDC</span>;
        ISSN:<span class="NLM_cas:issn">0308-2342</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Microwave enhanced hydrogenation reactions in which H2/D2/T2 gases are replaced by various formates proceed very rapidly.  The pattern of labeling can be easily modified, and the advantages are particularly noteworthy in the case of tritium, where problems assocd. with handling T2 gas are avoided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEkJ6i5xcsT7Vg90H21EOLACvtfcHk0liF_vWhtX_7rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktlemsbw%253D&md5=43b8d07a765459ba61a73c60de039933</span></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1039%2Fa802040j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa802040j%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Qahtani%26aufirst%3DM.%2BH.%26aulast%3DCleator%26aufirst%3DN.%26aulast%3DDanks%26aufirst%3DT.%2BN.%26aulast%3DGarman%26aufirst%3DR.%2BN.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DStefaniak%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DA.%2BD.%26aulast%3DSimmonds%26aufirst%3DA.%2BJ.%26atitle%3DMicrowave%2520enhanced%2520hydrogenation%2520reactions%2520using%2520solid%2520hydrogen%252C%2520deuterium%2520and%2520tritium%2520donors%26jtitle%3DJ.%2520Chem.%2520Res.%252C%2520Synop.%26date%3D1998%26spage%3D400%26epage%3D401%26doi%3D10.1039%2Fa802040j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit81b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. Y.</span></span> <span> </span><span class="NLM_article-title">Microwave enhanced deuterations in the solid state using alumina doped sodium borodeuteride</span>. <i>J. Chem. Res., Synop.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">729</span>, <span class="refDoi"> DOI: 10.1039/a906977a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1039%2Fa906977a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1MXnsFyntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=728-729&author=T.+W.+Erbauthor=J.+R.+Jonesauthor=S.+Y.+Lu&title=Microwave+enhanced+deuterations+in+the+solid+state+using+alumina+doped+sodium+borodeuteride&doi=10.1039%2Fa906977a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave enhanced deuteriations in the solid state using alumina doped sodium borodeuteride</span></div><div class="casAuthors">Erb, Wouter Th.; Jones, John R.; Lu, Shui-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Research, Synopses</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">728-729</span>CODEN:
                <span class="NLM_cas:coden">JRPSDC</span>;
        ISSN:<span class="NLM_cas:issn">0308-2342</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Deuteriated alcs. were rapidly (ca. 1 min) prepd. through the microwave enhanced solid state redn. of aldehydes and ketones using alumina doped sodium borodeuteride (NaBD4).  Thus, microwave irradn. of PhCHO and alumina doped NaBD4 for one minute gave 37% PhCHDOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7fW6PnFuJsbVg90H21EOLACvtfcHk0liF_vWhtX_7rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsFyntbo%253D&md5=85c2e0e9afe0fcb4d81d76a0e73e60a3</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1039%2Fa906977a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa906977a%26sid%3Dliteratum%253Aachs%26aulast%3DErb%26aufirst%3DT.%2BW.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DLu%26aufirst%3DS.%2BY.%26atitle%3DMicrowave%2520enhanced%2520deuterations%2520in%2520the%2520solid%2520state%2520using%2520alumina%2520doped%2520sodium%2520borodeuteride%26jtitle%3DJ.%2520Chem.%2520Res.%252C%2520Synop.%26date%3D1999%26spage%3D728%26epage%3D729%26doi%3D10.1039%2Fa906977a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit81c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guaragna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedatella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of C-protected 2,2-dideutero β3-amino acids</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2006</i></span>,  <span class="NLM_fpage">4013</span>– <span class="NLM_lpage">4016</span>, <span class="refDoi"> DOI: 10.1055/s-2006-950314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1055%2Fs-2006-950314" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=4013-4016&author=A.+Guaragnaauthor=S.+Pedatellaauthor=V.+Pintoauthor=G.+Palumbo&title=Synthesis+of+C-protected+2%2C2-dideutero+%CE%B23-amino+acids&doi=10.1055%2Fs-2006-950314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81c&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-950314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-950314%26sid%3Dliteratum%253Aachs%26aulast%3DGuaragna%26aufirst%3DA.%26aulast%3DPedatella%26aufirst%3DS.%26aulast%3DPinto%26aufirst%3DV.%26aulast%3DPalumbo%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520C-protected%25202%252C2-dideutero%2520%25CE%25B23-amino%2520acids%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D4013%26epage%3D4016%26doi%3D10.1055%2Fs-2006-950314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chapelle, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. D.</span></span> <span> </span><span class="NLM_article-title">Development of combined microwave-enhanced labelling procedures for maximising deuterium incorporation</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">5117</span>– <span class="NLM_lpage">5118</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(02)00986-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0040-4039%2802%2900986-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVent7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=5117-5118&author=M.+R.+Chapelleauthor=B.+B.+Kentauthor=J.+R.+Jonesauthor=S.+Y.+Luauthor=A.+D.+Morgan&title=Development+of+combined+microwave-enhanced+labelling+procedures+for+maximising+deuterium+incorporation&doi=10.1016%2FS0040-4039%2802%2900986-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82aR"><div class="casContent"><span class="casTitleNuber">82a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of combined microwave-enhanced labelling procedures for maximizing deuterium incorporation</span></div><div class="casAuthors">Chapelle, Michael R.; Kent, Barry B.; Jones, John R.; Lu, Shui-Yu; Morgan, Alan D.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5117-5118</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Combined hydrogenation/arom. dehalogenation under microwave-enhanced conditions provides a rapid route to deuterium labeled compds. with enhanced isotopic incorporation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHy2NnX4zkzrVg90H21EOLACvtfcHk0lhPi_UKdySe8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVent7k%253D&md5=5a57bfc0af2563dd38196c18afbcf858</span></div><a href="/servlet/linkout?suffix=cit82a&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900986-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900986-3%26sid%3Dliteratum%253Aachs%26aulast%3DChapelle%26aufirst%3DM.%2BR.%26aulast%3DKent%26aufirst%3DB.%2BB.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DLu%26aufirst%3DS.%2BY.%26aulast%3DMorgan%26aufirst%3DA.%2BD.%26atitle%3DDevelopment%2520of%2520combined%2520microwave-enhanced%2520labelling%2520procedures%2520for%2520maximising%2520deuterium%2520incorporation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D5117%26epage%3D5118%26doi%3D10.1016%2FS0040-4039%2802%2900986-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit82b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span> <span> </span><span class="NLM_article-title">Deuterated ammonium formate as deuterium source in a mild catalytic deuterium transfer reaction of pyridines, pyrazines and isoquinolines</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">8889</span>– <span class="NLM_lpage">8893</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2004.09.165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.tetlet.2004.09.165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1SrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=8889-8893&author=V.+Derdau&title=Deuterated+ammonium+formate+as+deuterium+source+in+a+mild+catalytic+deuterium+transfer+reaction+of+pyridines%2C+pyrazines+and+isoquinolines&doi=10.1016%2Fj.tetlet.2004.09.165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82bR"><div class="casContent"><span class="casTitleNuber">82b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated ammonium formate as deuterium source in a mild catalytic deuterium transfer reaction of pyridines, pyrazines, and isoquinolines</span></div><div class="casAuthors">Derdau, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">8889-8893</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The application of deuterated ammonium formate as deuterium source in transfer deuteration reactions of arom. heterocycles for the synthesis of highly deuterated, substituted piperidines, piperazines, and tetrahydroisoquinolines has been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1lzC6eAUtx7Vg90H21EOLACvtfcHk0lhPi_UKdySe8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1SrsLY%253D&md5=b2230835f8144a2acf1962cebb646a71</span></div><a href="/servlet/linkout?suffix=cit82b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2004.09.165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2004.09.165%26sid%3Dliteratum%253Aachs%26aulast%3DDerdau%26aufirst%3DV.%26atitle%3DDeuterated%2520ammonium%2520formate%2520as%2520deuterium%2520source%2520in%2520a%2520mild%2520catalytic%2520deuterium%2520transfer%2520reaction%2520of%2520pyridines%252C%2520pyrazines%2520and%2520isoquinolines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D8889%26epage%3D8893%26doi%3D10.1016%2Fj.tetlet.2004.09.165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span> <span> </span><span class="NLM_article-title">The renaissance of H/D exchange</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7744</span>– <span class="NLM_lpage">7765</span>, <span class="refDoi"> DOI: 10.1002/anie.200700039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.200700039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=17886815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1alsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7744-7765&author=J.+Atzrodtauthor=V.+Derdauauthor=T.+Feyauthor=J.+Zimmermann&title=The+renaissance+of+H%2FD+exchange&doi=10.1002%2Fanie.200700039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The renaissance of H/D exchange</span></div><div class="casAuthors">Atzrodt, Jens; Derdau, Volker; Fey, Thorsten; Zimmermann, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7744-7765</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The increasing demand for stable isotopically labeled compds. has led to an increased interest in H/D-exchange reactions at carbon centers.  Today deuterium-labeled compds. are used as internal stds. in mass spectrometry or to help elucidate mechanistic theories.  Access to these deuterated compds. takes place significantly more efficiently and more cost effectively by exchange of hydrogen by deuterium in the target mol. than by classical synthesis.  This review will conc. on the preparative application of the H/D-exchange reaction in the prepn. of deuterium-labeled compds.  Advances over the last ten years are brought together and critically evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxcoKufJE7Vg90H21EOLACvtfcHk0lhPi_UKdySe8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1alsL3M&md5=d4c01740a03e307d6e89ab954bd11809</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fanie.200700039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200700039%26sid%3Dliteratum%253Aachs%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DFey%26aufirst%3DT.%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3DThe%2520renaissance%2520of%2520H%252FD%2520exchange%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D7744%26epage%3D7765%26doi%3D10.1002%2Fanie.200700039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, K. P.</span></span> <span> </span><span class="NLM_article-title">Controllable deuteration of halogenated compounds by photocatalytic D<sub>2</sub>O splitting</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02551-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fs41467-017-02551-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29311606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1MzosFWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=80-88&author=C.+Liuauthor=Z.+Chenauthor=C.+Suauthor=X.+Zhaoauthor=Q.+Gaoauthor=G.+H.+Ningauthor=H.+Zhuauthor=W.+Tangauthor=K.+Lengauthor=W.+Fuauthor=B.+Tianauthor=X.+Pengauthor=J.+Liauthor=Q.+H.+Xuauthor=W.+Zhouauthor=K.+P.+Loh&title=Controllable+deuteration+of+halogenated+compounds+by+photocatalytic+D2O+splitting&doi=10.1038%2Fs41467-017-02551-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84aR"><div class="casContent"><span class="casTitleNuber">84a</span><div class="casTitle"><span class="NLM_cas:atitle">Controllable deuteration of halogenated compounds by photocatalytic D2O splitting</span></div><div class="casAuthors">Liu Cuibo; Su Chenliang; Gao Qiang; Tian Bingbing; Li Jing; Xu Qing-Hua; Loh Kian Ping; Liu Cuibo; Chen Zhongxin; Su Chenliang; Zhao Xiaoxu; Gao Qiang; Ning Guo-Hong; Zhu Hai; Leng Kai; Fu Wei; Tian Bingbing; Peng Xinwen; Li Jing; Xu Qing-Hua; Loh Kian Ping; Chen Zhongxin; Zhao Xiaoxu; Tang Wei; Zhou Wu</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Deuterium labeling is of great value in organic synthesis and the pharmaceutical industry.  However, the state-of-the-art C-H/C-D exchange using noble metal catalysts or strong bases/acids suffers from poor functional group tolerances, poor selectivity and lack of scope for generating molecular complexity.  Herein, we demonstrate the deuteration of halides using heavy water as the deuteration reagent and porous CdSe nanosheets as the catalyst.  The deuteration mechanism involves the generation of highly active carbon and deuterium radicals via photoinduced electron transfer from CdSe to the substrates, followed by tandem radicals coupling process, which is mechanistically distinct from the traditional methods involving deuterium cations or anions.  Our deuteration strategy shows better selectivity and functional group tolerances than current C-H/C-D exchange methods.  Extending the synthetic scope, deuterated boronic acids, halides, alkynes, and aldehydes can be used as synthons in Suzuki coupling, Click reaction, C-H bond insertion reaction etc. for the synthesis of complex deuterated molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__KWoaDFa1dXdcedVHT5tfW6udTcc2eYeLJspSUnqmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzosFWksg%253D%253D&md5=354d6efd3da9b6e77c02c34868eb867c</span></div><a href="/servlet/linkout?suffix=cit84a&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02551-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02551-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DNing%26aufirst%3DG.%2BH.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLeng%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DQ.%2BH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLoh%26aufirst%3DK.%2BP.%26atitle%3DControllable%2520deuteration%2520of%2520halogenated%2520compounds%2520by%2520photocatalytic%2520D2O%2520splitting%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D80%26epage%3D88%26doi%3D10.1038%2Fs41467-017-02551-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit84b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, Y.
Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, D. W.C.</span></span> <span> </span><span class="NLM_article-title">Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1126/science.aap9674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1126%2Fscience.aap9674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29123019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=1182-1187&author=Y.%0AY.+Lohauthor=K.+Nagaoauthor=A.+J.+Hooverauthor=D.+Heskauthor=N.+R.+Riveraauthor=S.+L.+Collettiauthor=I.+W.+Daviesauthor=D.+W.C.+MacMillan&title=Photoredox-catalyzed+deuteration+and+tritiation+of+pharmaceutical+compounds&doi=10.1126%2Fscience.aap9674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84bR"><div class="casContent"><span class="casTitleNuber">84b</span><div class="casTitle"><span class="NLM_cas:atitle">Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds</span></div><div class="casAuthors">Loh, Yong Yao; Nagao, Kazunori; Hoover, Andrew J.; Hesk, David; Rivera, Nelo R.; Colletti, Steven L.; Davies, Ian W.; MacMillan, David W. C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">6367</span>),
    <span class="NLM_cas:pages">1182-1187</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Deuterium- and tritium-labeled pharmaceutical compds. are pivotal diagnostic tools in drug discovery research, providing vital information about the biol. fate of drugs and drug metabolites.  Herein we demonstrate that a photoredox-mediated hydrogen atom transfer protocol can efficiently and selectively install deuterium (D) and tritium (T) at α-amino sp3 carbon-hydrogen bonds in a single step, using isotopically labeled water (D2O or T2O) as the source of hydrogen isotope.  In this context, we also report a convenient synthesis of T2O from T2, providing access to high-specific-activity T2O.  This protocol has been successfully applied to the high incorporation of deuterium and tritium in 18 drug mols., which meet the requirements for use in ligand-binding assays and absorption, distribution, metab., and excretion studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8CqSF3I-fbVg90H21EOLACvtfcHk0ljW31L6NatwWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73L&md5=5897756ff395dd790e5a3b7f587f5c64</span></div><a href="/servlet/linkout?suffix=cit84b&amp;dbid=16384&amp;doi=10.1126%2Fscience.aap9674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aap9674%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DY.%2BY.%26aulast%3DNagao%26aufirst%3DK.%26aulast%3DHoover%26aufirst%3DA.%2BJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DRivera%26aufirst%3DN.%2BR.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.C.%26atitle%3DPhotoredox-catalyzed%2520deuteration%2520and%2520tritiation%2520of%2520pharmaceutical%2520compounds%26jtitle%3DScience%26date%3D2017%26volume%3D358%26spage%3D1182%26epage%3D1187%26doi%3D10.1126%2Fscience.aap9674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thulasiram, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulter, C. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of deuterium-labeled derivatives of dimethylallyl diphosphate</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1741</span>, <span class="refDoi"> DOI: 10.1021/jo052384n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052384n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1739-1741&author=H.+V.+Thulasiramauthor=R.+M.+Phanauthor=S.+B.+Riveraauthor=C.+D.+Poulter&title=Synthesis+of+deuterium-labeled+derivatives+of+dimethylallyl+diphosphate&doi=10.1021%2Fjo052384n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Deuterium-Labeled Derivatives of Dimethylallyl Diphosphate</span></div><div class="casAuthors">Thulasiram, Hirekodathakallu V.; Phan, Richard M.; Rivera, Susan B.; Poulter, C. Dale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1739-1741</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Short practical syntheses for five deuterium-labeled derivs. of dimethylallyl diphosphate (DMAPP) useful for enzymol. studies are reported.  These include the prepn. of the C1-labeled derivs. (R)-[1-2H]3-methylbut-2-enyl diphosphate ((R)-[1-2H]1-OPP) and (S)-[1-2H]3-methylbut-2-enyl diphosphate ((S)-[1-2H]1-OPP), the C2-labeled deriv. [2-2H]3-methylbut-2-enyl diphosphate ([2-2H]1-OPP), and the methyl-labeled derivs. (E)-[4,4,4-2H3]3-methylbut-2-enyl diphosphate ((E)-[4,4,4-2H3]1-OPP) and (Z)-[4,4,4-2H3]3-methyl-but-2-enyl diphosphate ((Z)-[4,4,4-2H3]1-OPP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_m6zukyilG7Vg90H21EOLACvtfcHk0ljW31L6NatwWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWlsw%253D%253D&md5=437dff76a4aeae7d87bcec6105c185e2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjo052384n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052384n%26sid%3Dliteratum%253Aachs%26aulast%3DThulasiram%26aufirst%3DH.%2BV.%26aulast%3DPhan%26aufirst%3DR.%2BM.%26aulast%3DRivera%26aufirst%3DS.%2BB.%26aulast%3DPoulter%26aufirst%3DC.%2BD.%26atitle%3DSynthesis%2520of%2520deuterium-labeled%2520derivatives%2520of%2520dimethylallyl%2520diphosphate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1739%26epage%3D1741%26doi%3D10.1021%2Fjo052384n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, A.</span></span> <span> </span><span class="NLM_article-title">Hydrogen/Deuterium (H/D) exchange catalysis in alkanes</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2312</span>, <span class="refDoi"> DOI: 10.1021/acscatal.7b04201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.7b04201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=2296-2312&author=A.+Sattler&title=Hydrogen%2FDeuterium+%28H%2FD%29+exchange+catalysis+in+alkanes&doi=10.1021%2Facscatal.7b04201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen/Deuterium (H/D) Exchange Catalysis in Alkanes</span></div><div class="casAuthors">Sattler, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2296-2312</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The catalytic exchange of hydrogen and deuterium (H/D exchange) in light alkanes has been studied for almost a century.  While alkanes and their C-H bonds are relatively inert, H/D exchange studies have shown that a large no. of materials can catalytically activate these bonds.  These studies helped elucidate the mechanisms by which alkane C-H bonds interact with catalytic materials.  This perspective serves to review this area of research, focusing on two main classes of heterogeneous materials, metals and metal oxides, and their trends in reactivities and selectivities are described in detail.  Furthermore, the ability of these materials to carry out C-H bond activation and H/D exchange catalysis is compared with that of mol. organometallic complexes, and the mechanistic relationships and similarities in these processes are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5r5ybp23TbVg90H21EOLACvtfcHk0ljW31L6NatwWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCju78%253D&md5=6b760852f6baad8d4fd46a028aaf446d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facscatal.7b04201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.7b04201%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DA.%26atitle%3DHydrogen%252FDeuterium%2520%2528H%252FD%2529%2520exchange%2520catalysis%2520in%2520alkanes%26jtitle%3DACS%2520Catal.%26date%3D2018%26volume%3D8%26spage%3D2296%26epage%3D2312%26doi%3D10.1021%2Facscatal.7b04201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span> <span> </span><span class="NLM_article-title">Pd- and Pt-catalyzed H/D exchange methods and their application for internal MS standard preparation from a Sanofi-Aventis perspective</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1002/jlcr.1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fjlcr.1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1SjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=674-685&author=J.+Atzrodtauthor=V.+Derdau&title=Pd-+and+Pt-catalyzed+H%2FD+exchange+methods+and+their+application+for+internal+MS+standard+preparation+from+a+Sanofi-Aventis+perspective&doi=10.1002%2Fjlcr.1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Pd- and Pt-catalyzed H/D exchange methods and their application for internal MS standard preparation from a Sanofi-Aventis perspective</span></div><div class="casAuthors">Atzrodt, Jens; Derdau, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">674-685</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">This review addresses method developments both homogeneous and heterogeneous Pd- and Pt-catalyzed exchange, including catalyst activation principles and recent practical applications together with example procedures.  Specific requirements for isotopically labeled internal MS std. prepn. are discussed from a Sanofi-Aventis perspective on recent examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfpdKfsKZvh7Vg90H21EOLACvtfcHk0liVb_qGeHxgUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1SjsA%253D%253D&md5=7cb25562f3949122991f6b6aa776e73f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1818%26sid%3Dliteratum%253Aachs%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26atitle%3DPd-%2520and%2520Pt-catalyzed%2520H%252FD%2520exchange%2520methods%2520and%2520their%2520application%2520for%2520internal%2520MS%2520standard%2520preparation%2520from%2520a%2520Sanofi-Aventis%2520perspective%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2010%26volume%3D53%26spage%3D674%26epage%3D685%26doi%3D10.1002%2Fjlcr.1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yung, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, R. G.</span></span> <span> </span><span class="NLM_article-title">Stoichiometric and catalytic H/D incorporation by cationic iridium complexes:  a common monohydrido-iridium intermediate</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">13033</span>– <span class="NLM_lpage">13043</span>, <span class="refDoi"> DOI: 10.1021/ja046825g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja046825g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlOjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=13033-13043&author=C.+M.+Yungauthor=M.+B.+Skaddanauthor=R.+G.+Bergman&title=Stoichiometric+and+catalytic+H%2FD+incorporation+by+cationic+iridium+complexes%3A%E2%80%89+a+common+monohydrido-iridium+intermediate&doi=10.1021%2Fja046825g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88aR"><div class="casContent"><span class="casTitleNuber">88a</span><div class="casTitle"><span class="NLM_cas:atitle">Stoichiometric and Catalytic H/D Incorporation by Cationic Iridium Complexes: A Common Monohydrido-Iridium Intermediate</span></div><div class="casAuthors">Yung, Cathleen M.; Skaddan, Marc B.; Bergman, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">13033-13043</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mechanistic study of the stoichiometric and catalytic H/D exchange reactions involving cationic iridium complexes is presented.  Strong evidence suggests that both stoichiometric and catalytic reactions proceed via a monohydrido-iridium species.  Stoichiometric deuterium incorporation reactions introduce multiple deuterium atoms into the org. products when aryliridium compds. Cp*PMe3Ir(C6H4X)(OTf) (X = H, o-CH3, m-CH3, p-CH3) react with D2.  Multiple deuteration occurs at the unhindered positions (para and meta) of toluene, when X = CH3.  The multiple-deuteration pathway is suppressed in the presence of an excess of the coordinating ligand, CH3CN.  The compd. Cp*PMe3IrH(OTf) (1-OTf) is obsd. in low-temp., stoichiometric expts. to support a monohydrido-iridium intermediate that is responsible for catalyzing multiple deuteration in the stoichiometric system.  When paired with acetone-d6, [Cp*PMe3IrH3][OTf] (4)catalytically deuterates a wide range of substrates with a variety of functional groups.  Catalyst 4 decomps. to [Cp*PMe3Ir(η3-CH2C(OH)CH2)][OTf] in acetone and to [Cp*PMe3IrH(CO)][OTf] in CH3OH.  The catalytic H/D exchange reaction is not catalyzed by simple H+ transfer, but instead proceeds by a reversible C-H bond activation mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqBh5IDNZQ4bVg90H21EOLACvtfcHk0liVb_qGeHxgUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlOjsbs%253D&md5=cc791c061e7de018e91bd1fc24cd8ff8</span></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=10.1021%2Fja046825g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046825g%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DC.%2BM.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DBergman%26aufirst%3DR.%2BG.%26atitle%3DStoichiometric%2520and%2520catalytic%2520H%252FD%2520incorporation%2520by%2520cationic%2520iridium%2520complexes%253A%25E2%2580%2589%2520a%2520common%2520monohydrido-iridium%2520intermediate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D13033%26epage%3D13043%26doi%3D10.1021%2Fja046825g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit88b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Iridium-catalyzed H/D exchange at vinyl groups without olefin isomerization</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5783</span>– <span class="NLM_lpage">5787</span>, <span class="refDoi"> DOI: 10.1002/anie.200801992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.200801992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVelsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5783-5787&author=J.+Zhouauthor=J.+F.+Hartwig&title=Iridium-catalyzed+H%2FD+exchange+at+vinyl+groups+without+olefin+isomerization&doi=10.1002%2Fanie.200801992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88bR"><div class="casContent"><span class="casTitleNuber">88b</span><div class="casTitle"><span class="NLM_cas:atitle">Iridium-catalyzed H/D exchange at vinyl groups without olefin isomerization</span></div><div class="casAuthors">Zhou, Jianrong; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5783-5787</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The title reaction represents a rare example of olefinic C-H activation without olefin isomerization.  The conditions are sufficiently mild so that functional groups such as ketones, esters, nitriles, amines, sulfides, and alcs. are tolerated.  This selectivity is demonstrated by deuterium labeling of several complex mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqlvqgRi3M1LVg90H21EOLACvtfcHk0liVb_qGeHxgUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVelsLw%253D&md5=4f56325a45a0fb7cbcb71f55c5bd8829</span></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=10.1002%2Fanie.200801992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200801992%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DIridium-catalyzed%2520H%252FD%2520exchange%2520at%2520vinyl%2520groups%2520without%2520olefin%2520isomerization%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D5783%26epage%3D5787%26doi%3D10.1002%2Fanie.200801992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, S.</span></span> <span> </span><span class="NLM_article-title">Ruthenium catalyzed deuterium labelling of α-carbon in primary alcohol and primary/secondary amine in D<sub>2</sub>O</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">192</span>, <span class="refDoi"> DOI: 10.1246/cl.2005.192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1246%2Fcl.2005.192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2005&pages=192&author=M.+Takahashiauthor=K.+Oshimaauthor=S.+Matsubara&title=Ruthenium+catalyzed+deuterium+labelling+of+%CE%B1-carbon+in+primary+alcohol+and+primary%2Fsecondary+amine+in+D2O&doi=10.1246%2Fcl.2005.192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89aR"><div class="casContent"><span class="casTitleNuber">89a</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium catalyzed deuterium labeling of α-carbon in primary alcohol and primary/secondary amine in D2O</span></div><div class="casAuthors">Takahashi, Masaaki; Oshima, Koichiro; Matsubara, Seijiro</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">192-193</span>CODEN:
                <span class="NLM_cas:coden">CMLTAG</span>;
        ISSN:<span class="NLM_cas:issn">0366-7022</span>.
    
            (<span class="NLM_cas:orgname">Chemical Society of Japan</span>)
        </div><div class="casAbstract">Primary alcs. and primary/secondary amines are labeled with deuterium atom at α-position regioselectively by means of deuterium oxide and ruthenium catalyst.  For example, the microwave-mediated ruthenium-catalyzed deuteration of (1S,2S,5S)-6,6-dimethylbicyclo[3.1.1]heptane-2-methanol (myrtanol) gave (1S,2S,5S)-6,6-dimethylbicyclo[3.1.1]heptane-2-methan-α,α-d2-ol.  Deuteration at the β-position could be suppressed, if the reaction was carried out below 100° with the use of microwaves.  In the case of primary amines H-D-exchange was obsd. at the α-position selectively. a work-up with NaOD gave high contents of deuterium on nitrogen as well.  H-D-exchange on a tertiary amine gave only a small amt. of exchanged product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoS8VI0DMVgbVg90H21EOLACvtfcHk0lhHRYT87Hx2iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCisr0%253D&md5=bc69130e9c7543884da4050e3c12155d</span></div><a href="/servlet/linkout?suffix=cit89a&amp;dbid=16384&amp;doi=10.1246%2Fcl.2005.192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.2005.192%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DMatsubara%26aufirst%3DS.%26atitle%3DRuthenium%2520catalyzed%2520deuterium%2520labelling%2520of%2520%25CE%25B1-carbon%2520in%2520primary%2520alcohol%2520and%2520primary%252Fsecondary%2520amine%2520in%2520D2O%26jtitle%3DChem.%2520Lett.%26date%3D2005%26volume%3D34%26spage%3D192%26doi%3D10.1246%2Fcl.2005.192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit89b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzrodt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derdau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beller, M.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed selective α,β-deuteration of bioactive amines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">12239</span>– <span class="NLM_lpage">12244</span>, <span class="refDoi"> DOI: 10.1021/ja3041338</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3041338" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=12239-12244&author=L.+Neubertauthor=D.+Michalikauthor=S.+Bahnauthor=S.+Immauthor=H.+Neumannauthor=J.+Atzrodtauthor=V.+Derdauauthor=W.+Hollaauthor=M.+Beller&title=Ruthenium-catalyzed+selective+%CE%B1%2C%CE%B2-deuteration+of+bioactive+amines&doi=10.1021%2Fja3041338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89bR"><div class="casContent"><span class="casTitleNuber">89b</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Selective α,β-Deuteration of Bioactive Amines</span></div><div class="casAuthors">Neubert, Lorenz; Michalik, Dirk; Baehn, Sebastian; Imm, Sebastian; Neumann, Helfried; Atzrodt, Jens; Derdau, Volker; Holla, Wolfgang; Beller, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">12239-12244</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel and convenient protocol for the catalytic hydrogen-deuterium exchange of biol. active tertiary amines using the borrowing hydrogen methodol. has been developed.  In the presence of the readily available Shvo catalyst, excellent chemoselectivity toward α- and β-protons with respect to the nitrogen atom as well as high degree of deuterium incorporation and functional group tolerance is achieved.  This allowed for the deuteration of complex pharmaceutically interesting substrates, including examples for actual marketed drug compds.  Notably, this method constitutes a powerful tool for the generation of valuable internal std. materials for LC-MS/MS analyses highly demanded for various life-science applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCbbBCFEhJobVg90H21EOLACvtfcHk0lhHRYT87Hx2iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmtrY%253D&md5=83d0827f35573bc1c507dbbcf8f9ea4b</span></div><a href="/servlet/linkout?suffix=cit89b&amp;dbid=16384&amp;doi=10.1021%2Fja3041338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3041338%26sid%3Dliteratum%253Aachs%26aulast%3DNeubert%26aufirst%3DL.%26aulast%3DMichalik%26aufirst%3DD.%26aulast%3DBahn%26aufirst%3DS.%26aulast%3DImm%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DH.%26aulast%3DAtzrodt%26aufirst%3DJ.%26aulast%3DDerdau%26aufirst%3DV.%26aulast%3DHolla%26aufirst%3DW.%26aulast%3DBeller%26aufirst%3DM.%26atitle%3DRuthenium-catalyzed%2520selective%2520%25CE%25B1%252C%25CE%25B2-deuteration%2520of%2520bioactive%2520amines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D12239%26epage%3D12244%26doi%3D10.1021%2Fja3041338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit89c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span> <span> </span><span class="NLM_article-title">A convenient and effective method for the regioselective deuteration of alcohols</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2218</span>, <span class="refDoi"> DOI: 10.1002/adsc.200800407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fadsc.200800407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2008&pages=2215-2218&author=T.+Maegawaauthor=Y.+Fujiwaraauthor=Y.+Inagakiauthor=Y.+Monguchiauthor=H.+Sajiki&title=A+convenient+and+effective+method+for+the+regioselective+deuteration+of+alcohols&doi=10.1002%2Fadsc.200800407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89cR"><div class="casContent"><span class="casTitleNuber">89c</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient and effective method for the regioselective deuteration of alcohols</span></div><div class="casAuthors">Maegawa, Tomohiro; Fujiwara, Yuta; Inagaki, Yuya; Monguchi, Yasunari; Sajiki, Hironao</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">14+15</span>),
    <span class="NLM_cas:pages">2215-2218</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The convenient and regioselective deuteration of hydroxy groups on vicinal carbons was achieved by the combination of 5% ruthenium on carbon (Ru/C), hydrogen gas and deuterium oxide (D2O).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmZ-_j8k9M7Vg90H21EOLACvtfcHk0lhHRYT87Hx2iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjs7zI&md5=8220f072ac5590b8344da2f698e620bf</span></div><a href="/servlet/linkout?suffix=cit89c&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200800407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200800407%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DMonguchi%26aufirst%3DY.%26aulast%3DSajiki%26aufirst%3DH.%26atitle%3DA%2520convenient%2520and%2520effective%2520method%2520for%2520the%2520regioselective%2520deuteration%2520of%2520alcohols%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2008%26volume%3D350%26spage%3D2215%26epage%3D2218%26doi%3D10.1002%2Fadsc.200800407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Boun, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-Q.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed ortho-selective C-H deuteration of arenes: evidence for superior reactivity of weakly coordinated palladacycles</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1002/anie.201305388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fanie.201305388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOhsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=734-737&author=S.+Maauthor=G.+Villaauthor=P.+S.+Thuy-Bounauthor=A.+Homsauthor=J.-Q.+Yu&title=Palladium-catalyzed+ortho-selective+C-H+deuteration+of+arenes%3A+evidence+for+superior+reactivity+of+weakly+coordinated+palladacycles&doi=10.1002%2Fanie.201305388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90aR"><div class="casContent"><span class="casTitleNuber">90a</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed ortho-Selective C-H Deuteration of Arenes: Evidence for Superior Reactivity of Weakly Coordinated Palladacycles</span></div><div class="casAuthors">Ma, Sandy; Villa, Giorgio; Thuy-Boun, Peter S.; Homs, Anna; Yu, Jin-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">734-737</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We disclose a protocol for the palladium-catalyzed ortho-selective C-H deuteration of arenes.  Phenylacetic acids and benzoic acids are suitable substrates for this reaction.  This reaction offers a catalytic route to ortho-deuterated phenylacetic acids and benzoic acids and demonstrates the sharp difference in reactivity of palladacycle intermediates held together by weak and strong coordination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJvGaB7OeZF7Vg90H21EOLACvtfcHk0lhHRYT87Hx2iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOhsLbK&md5=a2a7f70d33b75a62b79a8161f81245ad</span></div><a href="/servlet/linkout?suffix=cit90a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201305388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201305388%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DG.%26aulast%3DThuy-Boun%26aufirst%3DP.%2BS.%26aulast%3DHoms%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.-Q.%26atitle%3DPalladium-catalyzed%2520ortho-selective%2520C-H%2520deuteration%2520of%2520arenes%253A%2520evidence%2520for%2520superior%2520reactivity%2520of%2520weakly%2520coordinated%2520palladacycles%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D734%26epage%3D737%26doi%3D10.1002%2Fanie.201305388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit90b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span> <span> </span><span class="NLM_article-title">Efficient C–H/C–D exchange reaction on the alkyl side chain of aromatic compounds using heterogeneous Pd/C in D<sub>2</sub>O</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1485</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1021/ol0496374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0496374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitl2qsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1485-1487&author=H.+Sajikiauthor=F.+Aokiauthor=H.+Esakiauthor=T.+Maegawaauthor=K.+Hirota&title=Efficient+C%E2%80%93H%2FC%E2%80%93D+exchange+reaction+on+the+alkyl+side+chain+of+aromatic+compounds+using+heterogeneous+Pd%2FC+in+D2O&doi=10.1021%2Fol0496374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90bR"><div class="casContent"><span class="casTitleNuber">90b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient C-H/C-D Exchange Reaction on the Alkyl Side Chain of Aromatic Compounds Using Heterogeneous Pd/C in D2O</span></div><div class="casAuthors">Sajiki, Hironao; Aoki, Fumiyo; Esaki, Hiroyoshi; Maegawa, Tomohiro; Hirota, Kosaku</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1485-1487</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient and extensive deuterium incorporation using heterogeneous Pd/C-D2O-H2 system into many different types of unactivated C-H bond positions was developed.  The present method provides a deuterium gas-free, totally catalytic, and post-synthetic deuterium labeling method in D2O media.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovG5xvSTvc57Vg90H21EOLACvtfcHk0ljtvlhkZ007Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitl2qsLs%253D&md5=9de0ad361005195046893eacb4c6214b</span></div><a href="/servlet/linkout?suffix=cit90b&amp;dbid=16384&amp;doi=10.1021%2Fol0496374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0496374%26sid%3Dliteratum%253Aachs%26aulast%3DSajiki%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DF.%26aulast%3DEsaki%26aufirst%3DH.%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DEfficient%2520C%25E2%2580%2593H%252FC%25E2%2580%2593D%2520exchange%2520reaction%2520on%2520the%2520alkyl%2520side%2520chain%2520of%2520aromatic%2520compounds%2520using%2520heterogeneous%2520Pd%252FC%2520in%2520D2O%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D1485%26epage%3D1487%26doi%3D10.1021%2Fol0496374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sajiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maesawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span> <span> </span><span class="NLM_article-title">Aromatic ring favorable and efficient H–D exchange reaction catalyzed by Pt/C</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6995</span>– <span class="NLM_lpage">6998</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2005.08.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.tetlet.2005.08.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVSnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=6995-6998&author=H.+Sajikiauthor=N.+Itoauthor=H.+Esakiauthor=T.+Maesawaauthor=T.+Maegawaauthor=K.+Hirota&title=Aromatic+ring+favorable+and+efficient+H%E2%80%93D+exchange+reaction+catalyzed+by+Pt%2FC&doi=10.1016%2Fj.tetlet.2005.08.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic ring favorable and efficient H-D exchange reaction catalyzed by Pt/C</span></div><div class="casAuthors">Sajiki, Hironao; Ito, Nobuhiro; Esaki, Hiroyoshi; Maesawa, Tsuneaki; Maegawa, Tomohiro; Hirota, Kosaku</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6995-6998</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An effective and applicable Pt/C-catalyzed deuteration method of arom. rings using D2O as a deuterium source under hydrogen atm. was developed.  Five percent Pt/C would lead to quite effective H-D exchange results on the arom. ring systems.  The reaction is general for a variety of arom. compds. including biol. active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo06277ll_RdbVg90H21EOLACvtfcHk0ljtvlhkZ007Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVSnu7w%253D&md5=73f0a8ecebc1ba74a83723c676f3125a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.08.067%26sid%3Dliteratum%253Aachs%26aulast%3DSajiki%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DEsaki%26aufirst%3DH.%26aulast%3DMaesawa%26aufirst%3DT.%26aulast%3DMaegawa%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DAromatic%2520ring%2520favorable%2520and%2520efficient%2520H%25E2%2580%2593D%2520exchange%2520reaction%2520catalyzed%2520by%2520Pt%252FC%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D6995%26epage%3D6998%26doi%3D10.1016%2Fj.tetlet.2005.08.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span>; <span class="NLM_string-name">Cottrell, K. M.</span>; <span class="NLM_string-name">Deng, H.</span>; <span class="NLM_string-name">Duffy, J.
P.</span>; <span class="NLM_string-name">Gao, H.</span>; <span class="NLM_string-name">Giroux, S.</span>; <span class="NLM_string-name">Green, J.</span>; <span class="NLM_string-name">Jackson, K. L.</span>; <span class="NLM_string-name">Kennedy, J. M.</span>; <span class="NLM_string-name">Lauffer, D. J.</span>; <span class="NLM_string-name">Ledeboer, M. W.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Maxwell, J. P.</span>; <span class="NLM_string-name">Morris, M. A.</span>; <span class="NLM_string-name">Pierce, A. C.</span>; <span class="NLM_string-name">Waal, N. D.</span>; <span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">DNA-PK Inhibitors</span>. U.S. Patent <span class="NLM_patent">9,925,188</span>, March 27, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+S.+Charifson&author=K.+M.+Cottrell&author=H.+Deng&author=J.%0AP.+Duffy&author=H.+Gao&author=S.+Giroux&author=J.+Green&author=K.+L.+Jackson&author=J.+M.+Kennedy&author=D.+J.+Lauffer&author=M.+W.+Ledeboer&author=P.+Li&author=J.+P.+Maxwell&author=M.+A.+Morris&author=A.+C.+Pierce&author=N.+D.+Waal&author=J.+Xu&title=DNA-PK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DDNA-PK%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alken, R.-G.</span>; <span class="NLM_string-name">Stabingis, T.</span></span> <span> </span><span class="NLM_article-title">Deuterated 3-Piperidinopropiophenone and Medicaments Containing Said Compounds</span>. Eur. Pat. Appl. <span class="NLM_patent">1383752</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.-G.+Alken&author=T.+Stabingis&title=Deuterated+3-Piperidinopropiophenone+and+Medicaments+Containing+Said+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlken%26aufirst%3DR.-G.%26atitle%3DDeuterated%25203-Piperidinopropiophenone%2520and%2520Medicaments%2520Containing%2520Said%2520Compounds%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gant, T. G.</span>; <span class="NLM_string-name">Sarshar, S.</span></span> <span> </span><span class="NLM_article-title">Methods of Reduction of Interpatient Variability</span>. U.S. Patent <span class="NLM_patent">0,076,087</span>, March 25, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+G.+Gant&author=S.+Sarshar&title=Methods+of+Reduction+of+Interpatient+Variability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGant%26aufirst%3DT.%2BG.%26atitle%3DMethods%2520of%2520Reduction%2520of%2520Interpatient%2520Variability%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><a href="http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1-clinical-trial-ctp-354" class="extLink">http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1-clinical-trial-ctp-354</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fir.concertpharma.com%2Fnews-releases%2Fnews-release-details%2Fconcert-pharmaceuticals-initiates-phase-1-clinical-trial-ctp-354+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><a href="https://www.tevapharm.com/files/pipeline/Public_pipeline_Feb2017.pdf" class="extLink">https://www.tevapharm.com/files/pipeline/Public_pipeline_Feb2017.pdf</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.tevapharm.com%2Ffiles%2Fpipeline%2FPublic_pipeline_Feb2017.pdf+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><a href="http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1b-clinical-trial-ctp" class="extLink">http://ir.concertpharma.com/news-releases/news-release-details/concert-pharmaceuticals-initiates-phase-1b-clinical-trial-ctp</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fir.concertpharma.com%2Fnews-releases%2Fnews-release-details%2Fconcert-pharmaceuticals-initiates-phase-1b-clinical-trial-ctp+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><a href="http://ir.concertpharma.com/static-files/9dddc59a-d13d-4c64-86e5-d343562fda1b" class="extLink">http://ir.concertpharma.com/static-files/9dddc59a-d13d-4c64-86e5-d343562fda1b</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fir.concertpharma.com%2Fstatic-files%2F9dddc59a-d13d-4c64-86e5-d343562fda1b+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><a href="https://adisinsight.springer.com/trials/700276018" class="extLink">https://adisinsight.springer.com/trials/700276018</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fadisinsight.springer.com%2Ftrials%2F700276018+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><a href="https://www.businesswire.com/news/home/20081023005201/en/Auspex-Pharmaceuticals-Announces-Positive-Results-Clinical-Study" class="extLink">https://www.businesswire.com/news/home/20081023005201/en/Auspex-Pharmaceuticals-Announces-Positive-Results-Clinical-Study</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20081023005201%2Fen%2FAuspex-Pharmaceuticals-Announces-Positive-Results-Clinical-Study+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><a href="https://www.sec.gov/Archives/edgar/data/1454189/000156459015001726/aspx-ex991_2015031628.htm" class="extLink">https://www.sec.gov/Archives/edgar/data/1454189/000156459015001726/aspx-ex991_2015031628.htm</a> (accessed on Oct 16, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1454189%2F000156459015001726%2Faspx-ex991_2015031628.htm+%28accessed+on+Oct+16%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><a href="https://www.concertpharma.com/product-pipeline/" class="extLink">https://www.concertpharma.com/product-pipeline/</a> (accessed on Dec 27, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.concertpharma.com%2Fproduct-pipeline%2F+%28accessed+on+Dec+27%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tung, R. D.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxybutyric Acid Analogs</span>. U.S. Patent <span class="NLM_patent">9,815,763</span>, November 14, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+D.+Tung&title=4-Hydroxybutyric+Acid+Analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTung%26aufirst%3DR.%2BD.%26atitle%3D4-Hydroxybutyric%2520Acid%2520Analogs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. T.</span>; <span class="NLM_string-name">Cassella, J. V.</span>; <span class="NLM_string-name">Graham, P. B.</span>; <span class="NLM_string-name">Braman, V.</span>, <span class="NLM_string-name">Uttamsingh, V.</span>; <span class="NLM_string-name">Von Hehn, J.</span>; <span class="NLM_string-name">Hamilton, C. E.</span></span> <span> </span><span class="NLM_article-title">Treatment of Hair Loss Disorders with Deuterated JAK Inhibitors</span>. WO Patent <span class="NLM_patent">192,905</span>, September 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+T.+Wagner&author=J.+V.+Cassella&author=P.+B.+Graham&author=V.+Braman&author=V.+Uttamsingh&author=J.+Von+Hehn&author=C.+E.+Hamilton&title=Treatment+of+Hair+Loss+Disorders+with+Deuterated+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DA.%2BT.%26atitle%3DTreatment%2520of%2520Hair%2520Loss%2520Disorders%2520with%2520Deuterated%2520JAK%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span> <span> </span><span class="NLM_article-title">Deuterated Isoindoline-1,3-Dione Derivatives as PDE4 and TNF-Alpha Inhibitors</span>. Eur. Pat. Appl. <span class="NLM_patent">2690092</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+F.+Liu&title=Deuterated+Isoindoline-1%2C3-Dione+Derivatives+as+PDE4+and+TNF-Alpha+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26atitle%3DDeuterated%2520Isoindoline-1%252C3-Dione%2520Derivatives%2520as%2520PDE4%2520and%2520TNF-Alpha%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julie, F.</span>; <span class="NLM_string-name">Liu, J.
F.</span>; <span class="NLM_string-name">Dong, Y.</span></span> <span> </span><span class="NLM_article-title">Deuterated Pirfenidone</span>. U.S. Patent <span class="NLM_patent">0,131,485</span>, May 21, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=F.+Julie&author=J.%0AF.+Liu&author=Y.+Dong&title=Deuterated+Pirfenidone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJulie%26aufirst%3DF.%26atitle%3DDeuterated%2520Pirfenidone%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masse, C. E.</span></span> <span> </span><span class="NLM_article-title">Deuterated 2-Amino-3-hydroxypropanoic Acid Derivatives</span>. U.S. Patent <span class="NLM_patent">8,704,001</span>, April 22, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+E.+Masse&title=Deuterated+2-Amino-3-hydroxypropanoic+Acid+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMasse%26aufirst%3DC.%2BE.%26atitle%3DDeuterated%25202-Amino-3-hydroxypropanoic%2520Acid%2520Derivatives%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spiteller, G.</span></span> <span> </span><span class="NLM_article-title">Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0009-3084(98)00091-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0009-3084%2898%2900091-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=9853364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=105-162&author=G.+Spiteller&title=Linoleic+acid+peroxidation%2D%2Dthe+dominant+lipid+peroxidation+process+in+low+density+lipoprotein%2D%2Dand+its+relationship+to+chronic+diseases&doi=10.1016%2FS0009-3084%2898%2900091-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Linoleic acid peroxidation - the dominant lipid peroxidation process in low density lipoprotein - and its relationship to chronic diseases</span></div><div class="casAuthors">Spiteller, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-162</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with ∼550 refs.  Modern sepn. and identification methods enable detailed insight in lipid peroxidn. (LPO) processes.  The following deductions can be made:.  (1) Cell injury activates enzymes: lipoxygenases generate lipid hydroperoxides (LOOHs), proteases liberate Fe ions - these two processes are prerequisites to produce radicals.  (2) Radicals attack any activated CH2-group of polyunsatd. fatty acids (PUFAs) with about a similar probability.  Since linoleic acid (LA) is the most abundant PUFA in mammals, its LPO products dominate.  (3) LOOHs are easily reduced in biol. surroundings to corresponding hydroxy acids (LOHs).  LOHs derived from LA, hydroxyoctadecadienoic acids (HODEs), surmount other markers of LPO.  HODEs are of high physiol. relevance.  (4) In some diseases characterized by inflammation or cell injury HODEs are present in low d. lipoproteins (LDL) at 10-100 higher concn., compared to LDL from healthy individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1T1V74IFAbVg90H21EOLACvtfcHk0ljPBJBdDPZWWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWgtL4%253D&md5=23e0ba4cce9a16e5f110571c3aab03d0</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2FS0009-3084%2898%2900091-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-3084%252898%252900091-7%26sid%3Dliteratum%253Aachs%26aulast%3DSpiteller%26aufirst%3DG.%26atitle%3DLinoleic%2520acid%2520peroxidation--the%2520dominant%2520lipid%2520peroxidation%2520process%2520in%2520low%2520density%2520lipoprotein--and%2520its%2520relationship%2520to%2520chronic%2520diseases%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D1998%26volume%3D95%26spage%3D105%26epage%3D162%26doi%3D10.1016%2FS0009-3084%2898%2900091-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. A.</span></span> <span> </span><span class="NLM_article-title">Free radical lipid peroxidation: mechanisms and analysis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">5944</span>– <span class="NLM_lpage">5972</span>, <span class="refDoi"> DOI: 10.1021/cr200084z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200084z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=5944-5972&author=H.+Yinauthor=L.+Xuauthor=N.+A.+Porter&title=Free+radical+lipid+peroxidation%3A+mechanisms+and+analysis&doi=10.1021%2Fcr200084z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Free Radical Lipid Peroxidation: Mechanisms and Analysis</span></div><div class="casAuthors">Yin, Huiyong; Xu, Libin; Porter, Ned A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5944-5972</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is the aim of this Review to discuss the chem. assocd. with each of the steps of the free radical chain sequence in the reaction of lipids and mol. oxygen.  The primary reactions of lipid peroxidn. include hydrogen-atom abstraction by peroxyl or alkoxyl radicals; oxygen addn. to carbon radicals; peroxyl radical fragmentation or rearrangement; peroxyl radical addn. to carbon-carbon double bonds or cyclization; and peroxylperoxyl termination.  There are a no. of reviews of lipid peroxidn. that have appeared in recent years, particularly related to the biol. of lipid oxidn. products.  We focus here principally on the basic free radical chem. of lipid peroxidn. and recent developments for the detection and anal. of free radical lipid peroxidn. products and their biol. relevance.  The anal. of lipid peroxidn. products has been particularly important in the advancement of research in this field because of the complexity of product mixts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqho2_FEY6sLrVg90H21EOLACvtfcHk0ljPBJBdDPZWWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsrvM&md5=ffbd9a5547deb1b9e6d962f95d1a26a2</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fcr200084z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200084z%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26atitle%3DFree%2520radical%2520lipid%2520peroxidation%253A%2520mechanisms%2520and%2520analysis%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D5944%26epage%3D5972%26doi%3D10.1021%2Fcr200084z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langston, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning-Boğ, A. B.</span></span> <span> </span><span class="NLM_article-title">Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson’s disease</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2011.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.toxlet.2011.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21906664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2011&pages=97-103&author=M.+S.+Shchepinovauthor=V.+P.+Chouauthor=E.+Pollockauthor=J.+W.+Langstonauthor=C.+R.+Cantorauthor=R.+J.+Molinariauthor=A.+B.+Manning-Bo%C4%9F&title=Isotopic+reinforcement+of+essential+polyunsaturated+fatty+acids+diminishes+nigrostriatal+degeneration+in+a+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.toxlet.2011.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110aR"><div class="casContent"><span class="casTitleNuber">110a</span><div class="casTitle"><span class="NLM_cas:atitle">Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease</span></div><div class="casAuthors">Shchepinov, Mikhail S.; Chou, Vivian P.; Pollock, Erik; Langston, J. William; Cantor, Charles R.; Molinari, Robert J.; Manning-Bog, Amy B.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Oxidative damage of membrane polyunsatd. fatty acids (PUFA) is thought to play a major role in mitochondrial dysfunction related to Parkinson's disease (PD).  The toxic products formed by PUFA oxidn. inflict further damage on cellular components and contribute to neuronal degeneration.  Here, we tested the hypothesis that isotopic reinforcement, by deuteration of the bisallylic sites most susceptible to oxidn. in PUFA may provide at least partial protection against nigrostriatal injury in a mouse model of oxidative stress and cell death, the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model.  Mice were fed a fat-free diet supplemented with satd. acids, oleic acid and essential PUFA: either normal, hydrogenated linoleic (LA, 18:2n - 6) and α-linolenic (ALA, 18:3n - 3) or deuterated 11,11-D2-LA and 11,11,14,14-D4-ALA in a ratio of 1:1 (to a total of 10% mass fat) for 6 days; each group was divided into two cohorts receiving either MPTP or saline and then continued on resp. diets for 6 days.  Brain homogenates from mice receiving deuterated PUFA (D-PUFA) vs. hydrogenated PUFA (H-PUFA) demonstrated a significant incorporation of deuterium as measured by isotope ratio mass-spectrometry.  Following MPTP exposure, mice fed H-PUFA revealed 78.7% striatal dopamine (DA) depletion compared to a 46.8% redn. in the D-PUFA cohort (as compared to their resp. saline-treated controls), indicating a significant improvement in DA concn. with D-PUFA.  Similarly, higher levels of the DA metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) were detected in MPTP-exposure mice administered D-PUFA; however, saline-treated mice revealed no change in DA or DOPAC levels.  Western blot analyses of tyrosine hydroxylase (TH) confirmed neuroprotection with D-PUFA, as striatal homogenates showed higher levels of TH immunoreactivity in D-PUFA (88.5% control) vs. H-PUFA (50.4% control) in the MPTP-treated cohorts.  In the substantia nigra, a significant improvement was noted in the no. of nigral dopaminergic neurons following MPTP exposure in the D-PUFA (79.5% control) vs. H-PUFA (58.8% control) mice using unbiased stereol. cell counting.  Taken together, these findings indicate that dietary isotopic reinforcement with D-PUFA partially protects against nigrostriatal damage from oxidative injury elicited by MPTP in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZvaUEvBv5rVg90H21EOLACvtfcHk0ljQGQwA_IKtsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt7zK&md5=c1753c25878a7fa974fe3e69daa75a46</span></div><a href="/servlet/linkout?suffix=cit110a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2011.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2011.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26aulast%3DChou%26aufirst%3DV.%2BP.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DLangston%26aufirst%3DJ.%2BW.%26aulast%3DCantor%26aufirst%3DC.%2BR.%26aulast%3DMolinari%26aufirst%3DR.%2BJ.%26aulast%3DManning-Bo%25C4%259F%26aufirst%3DA.%2BB.%26atitle%3DIsotopic%2520reinforcement%2520of%2520essential%2520polyunsaturated%2520fatty%2520acids%2520diminishes%2520nigrostriatal%2520degeneration%2520in%2520a%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DToxicol.%2520Lett.%26date%3D2011%26volume%3D207%26spage%3D97%26epage%3D103%26doi%3D10.1016%2Fj.toxlet.2011.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit110b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Elharram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czegledy, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golod, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer’s disease</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">4083</span>– <span class="NLM_lpage">4095</span>, <span class="refDoi"> DOI: 10.1111/febs.14291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1111%2Ffebs.14291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29024570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaltbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=4083-4095&author=A.+Elharramauthor=N.+M.+Czegledyauthor=M.+Golodauthor=G.+L.+Milneauthor=E.+Pollockauthor=B.+M.+Bennettauthor=M.+S.+Shchepinov&title=Deuterium-reinforced+polyunsaturated+fatty+acids+improve+cognition+in+a+mouse+model+of+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1111%2Ffebs.14291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110bR"><div class="casContent"><span class="casTitleNuber">110b</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease</span></div><div class="casAuthors">Elharram, Ahmed; Czegledy, Nicole M.; Golod, Michael; Milne, Ginger L.; Pollock, Erik; Bennett, Brian M.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4083-4095</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Oxidative damage resulting from increased lipid peroxidn. (LPO) is considered an important factor in the development of late onset/age-related Alzheimer's disease (AD).  Deuterium-reinforced polyunsatd. fatty acids (D-PUFAs) are more resistant to the reactive oxygen species-initiated chain reaction of LPO than regular hydrogenated (H-) PUFAs.  The authors investigated the effect of D-PUFA treatment on LPO and cognitive performance in aldehyde dehydrogenase 2 (Aldh2) null mice, an established model of oxidative stress-related cognitive impairment that exhibits AD-like pathologies.  Mice were fed a Western-type diet contg. either D- or H-PUFAs for 18 wk.  D-PUFA treatment markedly decreased cortex and hippocampus F2-isoprostanes by approx. 55% and prostaglandin F2α by 20-25% as compared to H-PUFA treatment.  D-PUFAs consistently improved performance in cognitive/memory tests, essentially resetting performance of the D-PUFA-fed Aldh2-/- mice to that of wild-type mice fed a typical lab. diet.  D-PUFAs therefore represent a promising new strategy to broadly reduce rates of LPO, and combat cognitive decline in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGf_rv48oL7Vg90H21EOLACvtfcHk0ljQGQwA_IKtsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaltbrO&md5=b800a84fa86cb85d08a623d71ba078c1</span></div><a href="/servlet/linkout?suffix=cit110b&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14291%26sid%3Dliteratum%253Aachs%26aulast%3DElharram%26aufirst%3DA.%26aulast%3DCzegledy%26aufirst%3DN.%2BM.%26aulast%3DGolod%26aufirst%3DM.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DDeuterium-reinforced%2520polyunsaturated%2520fatty%2520acids%2520improve%2520cognition%2520in%2520a%2520mouse%2520model%2520of%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D4083%26epage%3D4095%26doi%3D10.1111%2Ffebs.14291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit110c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Raefsky, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid beta-peptide levels, without discernible behavioural effects in an APP/PS1 mutant transgenic mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2018.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.neurobiolaging.2018.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29579687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlt1Sru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=165-176&author=S.+M.+Raefskyauthor=R.+Furmanauthor=G.+Milneauthor=E.+Pollockauthor=P.+Axelsenauthor=M.+P.+Mattsonauthor=M.+S.+Shchepinov&title=Deuterated+polyunsaturated+fatty+acids+reduce+brain+lipid+peroxidation+and+hippocampal+amyloid+beta-peptide+levels%2C+without+discernible+behavioural+effects+in+an+APP%2FPS1+mutant+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2018.02.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110cR"><div class="casContent"><span class="casTitleNuber">110c</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Raefsky, Sophia M.; Furman, Ran; Milne, Ginger; Pollock, Erik; Axelsen, Paul; Mattson, Mark P.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) involves progressive deposition of amyloid β-peptide (Aβ), synapse loss, and neuronal death, which occur in brain regions crit. for learning and memory.  Considerable evidence suggests that lipid peroxidn. contributes to synaptic dysfunction and neuronal degeneration, both upstream and downstream of Aβ pathol.  Recent findings suggest that lipid peroxidn. can be inhibited by replacement of polyunsatd. fatty acids (PUFA) with isotope-reinforced (deuterated) PUFA (D-PUFA), and that D-PUFA can protect neurons in exptl. models of Parkinson's disease.  Here, we detd. whether dietary D-PUFA would ameliorate Aβ pathol. and/or cognitive deficits in a mouse model of AD (amyloid precursor protein/presenilin 1 double mutant transgenic mice).  The D-PUFA diet did not ameliorate spatial learning and memory deficits in the AD mice.  Compared to mice fed an hydrogenated-PUFA control diet, those fed D-PUFA for 5 mo exhibited high levels of incorporation of deuterium into arachidonic acid and docosahexaenoic acid, and reduced concns. of lipid peroxidn. products (F2 isoprostanes and neuroprostanes), in the brain tissues.  Concns. of Aβ40 and Aβ38 in the hippocampus were significantly lower, with a trend to reduced concns. of Aβ42, in mice fed D-PUFA compared to those fed hydrogenated-PUFA.  We conclude that a D-PUFA diet reduces the brain tissue concns. of both arachidonic acid and docosahexaenoic acid oxidn. products, as well as the concn. of Aβs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRCOVwXpYgerVg90H21EOLACvtfcHk0ljQGQwA_IKtsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlt1Sru70%253D&md5=3dbf86ac42adc8f45ba3f079b7e10c55</span></div><a href="/servlet/linkout?suffix=cit110c&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2018.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2018.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DRaefsky%26aufirst%3DS.%2BM.%26aulast%3DFurman%26aufirst%3DR.%26aulast%3DMilne%26aufirst%3DG.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DAxelsen%26aufirst%3DP.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DDeuterated%2520polyunsaturated%2520fatty%2520acids%2520reduce%2520brain%2520lipid%2520peroxidation%2520and%2520hippocampal%2520amyloid%2520beta-peptide%2520levels%252C%2520without%2520discernible%2520behavioural%2520effects%2520in%2520an%2520APP%252FPS1%2520mutant%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2018%26volume%3D66%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.neurobiolaging.2018.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit110d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Berbée, J. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mol, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lütjohann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rensen, P. C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Ploeg, L. H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2017.06.916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.atherosclerosis.2017.06.916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28655430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=2017&pages=100-107&author=J.+F.+P.+Berb%C3%A9eauthor=I.+M.+Molauthor=G.+L.+Milneauthor=E.+Pollockauthor=G.+Hoekeauthor=D.+L%C3%BCtjohannauthor=C.+Monacoauthor=P.+C.+N.+Rensenauthor=L.+H.+T.+van+der+Ploegauthor=M.+S.+Shchepinov&title=Deuterium-reinforced+polyunsaturated+fatty+acids+protect+against+atherosclerosis+by+lowering+lipid+peroxidation+and+hypercholesterolemia&doi=10.1016%2Fj.atherosclerosis.2017.06.916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110dR"><div class="casContent"><span class="casTitleNuber">110d</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia</span></div><div class="casAuthors">Berbee, Jimmy F. P.; Mol, Isabel M.; Milne, Ginger L.; Pollock, Erik; Hoeke, Geerte; Luetjohann, Dieter; Monaco, Claudia; Rensen, Patrick C. N.; van der Ploeg, Lex H. T.; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Oxidative modification of lipoproteins is a crucial step in atherosclerosis development.  Isotopic-reinforced polyunsatd. fatty acids (D-PUFAs) are more resistant to reactive oxygen species-initiated chain reaction of lipid peroxidn. than regular hydrogenated (H-)PUFAs.  We aimed at investigating the effect of D-PUFA treatment on lipid peroxidn., hypercholesterolemia and atherosclerosis development.Transgenic APOE*3-Leiden.  CETP mice, a well-established model for human-like lipoprotein metab., were pre-treated with D-PUFAs or control H-PUFAs-contg. diet (1.2%, wt./wt.) for 4 wk.  Thereafter, mice were fed a Western-type diet (contg. 0.15% cholesterol, wt./wt.) for another 12 wk, while continuing the D-/H-PUFA treatment.  D-PUFA treatment markedly decreased hepatic and plasma F2-isoprostanes (approx. -80%) and prostaglandin F2α (approx. -40%) as compared to H-PUFA treatment.  Moreover, D-PUFAs reduced body wt. gain during the study (-54%) by decreasing body fat mass gain (-87%) without altering lean mass.  D-PUFAs consistently reduced plasma total cholesterol levels (approx. -25%), as reflected in reduced plasma non-HDL-cholesterol (-28%).  Addnl. analyses of hepatic cholesterol metab. indicated that D-PUFAs reduced the hepatic cholesterol content (-21%).  Sterol markers of intestinal cholesterol absorption and cholesterol breakdown were decreased.  Markers of cholesterol synthesis were increased.  Finally, D-PUFAs reduced atherosclerotic lesion area formation throughout the aortic root of the heart (-26%).  D-PUFAs reduce body wt. gain, improve cholesterol handling and reduce atherosclerosis development by reducing lipid peroxidn. and plasma cholesterol levels.  D-PUFAs, therefore, represent a promising new strategy to broadly reduce rates of lipid peroxidn., and combat hypercholesterolemia and cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsRc9Kipy7KLVg90H21EOLACvtfcHk0lg_3OHLX46UIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjt7%252FF&md5=bbb5158d3fa757f86f8e158dff40906f</span></div><a href="/servlet/linkout?suffix=cit110d&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2017.06.916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2017.06.916%26sid%3Dliteratum%253Aachs%26aulast%3DBerb%25C3%25A9e%26aufirst%3DJ.%2BF.%2BP.%26aulast%3DMol%26aufirst%3DI.%2BM.%26aulast%3DMilne%26aufirst%3DG.%2BL.%26aulast%3DPollock%26aufirst%3DE.%26aulast%3DHoeke%26aufirst%3DG.%26aulast%3DL%25C3%25BCtjohann%26aufirst%3DD.%26aulast%3DMonaco%26aufirst%3DC.%26aulast%3DRensen%26aufirst%3DP.%2BC.%2BN.%26aulast%3Dvan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%2BT.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DDeuterium-reinforced%2520polyunsaturated%2520fatty%2520acids%2520protect%2520against%2520atherosclerosis%2520by%2520lowering%2520lipid%2520peroxidation%2520and%2520hypercholesterolemia%26jtitle%3DAtherosclerosis%26date%3D2017%26volume%3D264%26spage%3D100%26epage%3D107%26doi%3D10.1016%2Fj.atherosclerosis.2017.06.916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit110e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abeti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renganathan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunti, P.</span></span> <span> </span><span class="NLM_article-title">Targeting lipid peroxidation and mitochondrial imbalance in Friedreich’s ataxia</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.phrs.2015.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=26141703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2015&pages=344-350&author=R.+Abetiauthor=E.+Uzunauthor=I.+Renganathanauthor=T.+Hondaauthor=M.+A.+Pookauthor=P.+Giunti&title=Targeting+lipid+peroxidation+and+mitochondrial+imbalance+in+Friedreich%E2%80%99s+ataxia&doi=10.1016%2Fj.phrs.2015.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110eR"><div class="casContent"><span class="casTitleNuber">110e</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia</span></div><div class="casAuthors">Abeti, Rosella; Uzun, Ebru; Renganathan, Indhushri; Honda, Tadashi; Pook, Mark A.; Giunti, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">344-350</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Friedreich's ataxia (FRDA) is an autosomal recessive disorder, caused by reduced levels of the protein frataxin.  This protein is located in the mitochondria, where it functions in the biogenesis of iron-sulfur clusters (ISCs), which are important for the function of the mitochondrial respiratory chain complexes.  Moreover, disruption in iron biogenesis may lead to oxidative stress.  Oxidative stress can be the cause and/or the consequence of mitochondrial energy imbalance, leading to cell death.  Fibroblasts from two FRDA mouse models, YG8R and KIKO, were used to analyze two different categories of protective compds.: deuterised poly-unsatd. fatty acids (dPUFAs) and Nrf2-inducers.  The former have been shown to protect the cell from damage induced by lipid peroxidn. and the latter trigger the well-known Nrf2 antioxidant pathway.  Our results show that the sensitivity to oxidative stress of YG8R and KIKO mouse fibroblasts, resulting in cell death and lipid peroxidn., can be prevented by d4-PUFA and Nrf2-inducers (SFN and TBE-31).  The mitochondrial membrane potential (ΔΨm) of YG8R and KIKO fibroblasts revealed a difference in their mitochondrial pathophysiol., which may be due to the different genetic basis of the two models.  This suggests that variable levels of reduced frataxin may act differently on mitochondrial pathophysiol. and that these two cell models could be useful in recapitulating the obsd. differences in the FRDA phenotype.  This may reflect a different modulatory effect towards cell death that will need to be investigated further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZe5gSWElTSbVg90H21EOLACvtfcHk0lg_3OHLX46UIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemsLrF&md5=e56cdbc2d5453868739f5709db413fef</span></div><a href="/servlet/linkout?suffix=cit110e&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DAbeti%26aufirst%3DR.%26aulast%3DUzun%26aufirst%3DE.%26aulast%3DRenganathan%26aufirst%3DI.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DPook%26aufirst%3DM.%2BA.%26aulast%3DGiunti%26aufirst%3DP.%26atitle%3DTargeting%2520lipid%2520peroxidation%2520and%2520mitochondrial%2520imbalance%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D99%26spage%3D344%26epage%3D350%26doi%3D10.1016%2Fj.phrs.2015.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zesiewicz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerinckx, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omidvar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shchepinov, M. S.</span></span> <span> </span><span class="NLM_article-title">Randomized, clinical trial of RT001: early signals of efficacy in Friedreich’s ataxia</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1002/mds.27353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fmds.27353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=29624723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOku7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=1000-1005&author=T.+Zesiewiczauthor=F.+Heerinckxauthor=R.+De+Jagerauthor=O.+Omidvarauthor=M.+Kilpatrickauthor=J.+Shawauthor=M.+S.+Shchepinov&title=Randomized%2C+clinical+trial+of+RT001%3A+early+signals+of+efficacy+in+Friedreich%E2%80%99s+ataxia&doi=10.1002%2Fmds.27353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia</span></div><div class="casAuthors">Zesiewicz, Theresa; Heerinckx, Frederic; De Jager, Robert; Omidvar, Omid; Kilpatrick, Marcus; Shaw, Jessica; Shchepinov, Mikhail S.</div><div class="citationInfo"><span class="NLM_cas:title">Movement Disorders</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1000-1005</span>CODEN:
                <span class="NLM_cas:coden">MOVDEA</span>;
        ISSN:<span class="NLM_cas:issn">0885-3185</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : RT001 is a deuterated Et linoleate that inhibits lipid peroxidn. and is hypothesized to reduce cellular damage and recover mitochondrial function in degenerative diseases such as Friedreich's ataxia.  Objective : To evaluate the safety, pharmacokinetics, and preliminary efficacy of RT001 in Friedreich's ataxia patients.  Design/Methods : We conducted a phase I/II double-blind, comparator-controlled trial with 2 doses of RT001 in Friedreich's ataxia patients (9 subjects each cohort).  Subjects were randomized 2:1 to receive either RT001 (1.8 or 9.0 g/day), or a matching dose of nondeuterated Et linoleate as comparator for 28 days.  The primary endpoints were safety, tolerability, and pharmacokinetic anal.  Secondary endpoints included cardiopulmonary exercise testing and timed 25-ft walk.  Results : Nineteen patients enrolled in the trial, and 18 completed all safety and efficacy measurements.  RT001 was found to be safe and tolerable, with plasma levels approaching satn. by 28 days.  One subject with a low body mass index experienced steatorrhea taking a high dose and discontinued the study.  Deuterated arachidonic acid (a brain-penetrant metabolite of RT001) was found to be present in plasma on day 28.  There was an improvement in peak workload in the drug group compared to placebo (0.16 W/kg; P = 0.008), as well as an improvement trend in peak oxygen consumption (change of 0.16 L/min; P = 0.116), and in stride speed (P = 0.15).  Conclusions : RT001 was found to be safe and tolerable over 28 days, and improved peak workload.  Further research into the effect of RT001 in Friedreich's ataxia is warranted. © 2018 International Parkinson and Movement Disorder Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXK9u3lsoLM7Vg90H21EOLACvtfcHk0lg_3OHLX46UIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOku7vF&md5=513306408c100e7ca67842d49fcc51f5</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fmds.27353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.27353%26sid%3Dliteratum%253Aachs%26aulast%3DZesiewicz%26aufirst%3DT.%26aulast%3DHeerinckx%26aufirst%3DF.%26aulast%3DDe%2BJager%26aufirst%3DR.%26aulast%3DOmidvar%26aufirst%3DO.%26aulast%3DKilpatrick%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DShchepinov%26aufirst%3DM.%2BS.%26atitle%3DRandomized%252C%2520clinical%2520trial%2520of%2520RT001%253A%2520early%2520signals%2520of%2520efficacy%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%26jtitle%3DMov.%2520Disord.%26date%3D2018%26volume%3D33%26spage%3D1000%26epage%3D1005%26doi%3D10.1002%2Fmds.27353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abeti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelova, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giunti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramov, A. Y.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich’s ataxia</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e2237</span> <span class="refDoi"> DOI: 10.1038/cddis.2016.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fcddis.2016.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27228352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVyqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=R.+Abetiauthor=M.+H.+Parkinsonauthor=I.+P.+Hargreavesauthor=P.+R.+Angelovaauthor=C.+Sandiauthor=M.+A.+Pookauthor=P.+Giuntiauthor=A.+Y.+Abramov&title=Mitochondrial+energy+imbalance+and+lipid+peroxidation+cause+cell+death+in+Friedreich%E2%80%99s+ataxia&doi=10.1038%2Fcddis.2016.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'</span></div><div class="casAuthors">Abeti, R.; Parkinson, M. H.; Hargreaves, I. P.; Angelova, P. R.; Sandi, C.; Pook, M. A.; Giunti, P.; Abramov, A. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2237</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Friedreich's ataxia (FRDA) is an inherited neurodegenerative disease.  The mutation consists of a GAA repeat expansion within the FXN gene, which downregulates frataxin, leading to abnormal mitochondrial iron accumulation, which may in turn cause changes in mitochondrial function.  Although, many studies of FRDA patients and mouse models have been conducted in the past two decades, the role of frataxin in mitochondrial pathophysiol. remains elusive.  Are the mitochondrial abnormalities only a side effect of the increased accumulation of reactive iron, generating oxidative stress Or does the progressive lack of iron-sulfur clusters (ISCs), induced by reduced frataxin, cause an inhibition of the electron transport chain complexes (CI, II and III) leading to reactive oxygen species escaping from oxidative phosphorylation reactions To answer these crucial questions, we have characterised the mitochondrial pathophysiol. of a group of disease-relevant and readily accessible neurons, cerebellar granule cells, from a validated FRDA mouse model.  By using live cell imaging and biochem. techniques we were able to demonstrate that mitochondria are deregulated in neurons from the YG8R FRDA mouse model, causing a decrease in mitochondrial membrane potential (ΔΨm) due to an inhibition of Complex I, which is partially compensated by an overactivation of Complex II.  This complex activity imbalance leads to ROS generation in both mitochondrial matrix and cytosol, which results in glutathione depletion and increased lipid peroxidn.  Preventing this increase in lipid peroxidn., in neurons, protects against in cell death.  This work describes the pathophysiol. properties of the mitochondria in neurons from a FRDA mouse model and shows that lipid peroxidn. could be an important target for novel therapeutic strategies in FRDA, which still lacks a cure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjVgk3SappW7Vg90H21EOLACvtfcHk0lgPMPUxkdmkbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVyqsrk%253D&md5=c0e7adafffd68cd8f0211e8b7f7df473</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.111%26sid%3Dliteratum%253Aachs%26aulast%3DAbeti%26aufirst%3DR.%26aulast%3DParkinson%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DI.%2BP.%26aulast%3DAngelova%26aufirst%3DP.%2BR.%26aulast%3DSandi%26aufirst%3DC.%26aulast%3DPook%26aufirst%3DM.%2BA.%26aulast%3DGiunti%26aufirst%3DP.%26aulast%3DAbramov%26aufirst%3DA.%2BY.%26atitle%3DMitochondrial%2520energy%2520imbalance%2520and%2520lipid%2520peroxidation%2520cause%2520cell%2520death%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26doi%3D10.1038%2Fcddis.2016.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvadurai, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corben, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou-Karistianis, N.</span></span> <span> </span><span class="NLM_article-title">Cerebral abnormalities in Friedreich ataxia: A review</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2017.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2Fj.neubiorev.2017.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=28823857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC1cfpvFelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2018&pages=394-406&author=L.+P.+Selvaduraiauthor=I.+H.+Hardingauthor=L.+A.+Corbenauthor=N.+Georgiou-Karistianis&title=Cerebral+abnormalities+in+Friedreich+ataxia%3A+A+review&doi=10.1016%2Fj.neubiorev.2017.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral abnormalities in Friedreich ataxia: A review</span></div><div class="casAuthors">Selvadurai Louisa P; Harding Ian H; Corben Louise A; Georgiou-Karistianis Nellie</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience and biobehavioral reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">394-406</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Friedreich ataxia (FRDA) is an inherited degenerative disorder affecting multiple systems of the body and resulting in symptoms which include progressive ataxia, dysarthria, and cardiomyopathy.  Central nervous system pathology has been traditionally ascribed to the spinal cord and dentate nucleus of the cerebellum.  However, cerebral abnormalities in FRDA are being increasingly documented via multiple neuroimaging techniques.  Understanding the nature and implications of cerebral abnormalities in FRDA provides more comprehensive knowledge of nervous system involvement in this disorder and increases the prospects of identifying effective treatment targets.  We review the cerebellar and the cerebral involvement with a focus on the emerging in vivo human neuroimaging findings suggesting wide-spread cerebral involvement, including aberrant cerebellar-cerebral connectivity.  We synthesise the findings by proposing potential mechanisms that may drive these effects.  Finally, we identify future research directions which, we argue, will lead to a better understanding of the extent and potential mechanisms of cerebral aberrations in FRDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQyzGsRbgbKXqj_yg7twvpfW6udTcc2eZm577E4f1kYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfpvFelsA%253D%253D&md5=5ae6c861bcb168de8985f800c3ae9b2a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2017.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DSelvadurai%26aufirst%3DL.%2BP.%26aulast%3DHarding%26aufirst%3DI.%2BH.%26aulast%3DCorben%26aufirst%3DL.%2BA.%26aulast%3DGeorgiou-Karistianis%26aufirst%3DN.%26atitle%3DCerebral%2520abnormalities%2520in%2520Friedreich%2520ataxia%253A%2520A%2520review%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D84%26spage%3D394%26epage%3D406%26doi%3D10.1016%2Fj.neubiorev.2017.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelides, M.</span></span> <span> </span><span class="NLM_article-title">Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options</span>. <i>Br. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1136/bjophthalmol-2016-308823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1136%2Fbjophthalmol-2016-308823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27491360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC2s3nvVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2017&pages=25-30&author=P.+Tannaauthor=R.+W.+Straussauthor=K.+Fujinamiauthor=M.+Michaelides&title=Stargardt+disease%3A+clinical+features%2C+molecular+genetics%2C+animal+models+and+therapeutic+options&doi=10.1136%2Fbjophthalmol-2016-308823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options</span></div><div class="casAuthors">Tanna Preena; Strauss Rupert W; Fujinami Kaoru; Michaelides Michel; Tanna Preena; Strauss Rupert W; Fujinami Kaoru; Michaelides Michel; Strauss Rupert W; Fujinami Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Stargardt disease (STGD1; MIM 248200) is the most prevalent inherited macular dystrophy and is associated with disease-causing sequence variants in the gene ABCA4 Significant advances have been made over the last 10 years in our understanding of both the clinical and molecular features of STGD1, and also the underlying pathophysiology, which has culminated in ongoing and planned human clinical trials of novel therapies.  The aims of this review are to describe the detailed phenotypic and genotypic characteristics of the disease, conventional and novel imaging findings, current knowledge of animal models and pathogenesis, and the multiple avenues of intervention being explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1O7dKCBnilFm8bhe6roZYfW6udTcc2eZm577E4f1kYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3nvVCqtA%253D%253D&md5=5e14416ce301aef335552542142c7b77</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1136%2Fbjophthalmol-2016-308823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjophthalmol-2016-308823%26sid%3Dliteratum%253Aachs%26aulast%3DTanna%26aufirst%3DP.%26aulast%3DStrauss%26aufirst%3DR.%2BW.%26aulast%3DFujinami%26aufirst%3DK.%26aulast%3DMichaelides%26aufirst%3DM.%26atitle%3DStargardt%2520disease%253A%2520clinical%2520features%252C%2520molecular%2520genetics%252C%2520animal%2520models%2520and%2520therapeutic%2520options%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2017%26volume%3D101%26spage%3D25%26epage%3D30%26doi%3D10.1136%2Fbjophthalmol-2016-308823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azarian, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzekov, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travis, G. H.</span></span> <span> </span><span class="NLM_article-title">Insights into the function of Rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80602-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1016%2FS0092-8674%2800%2980602-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10412977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADyaK1MXks1Kksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=13-23&author=J.+Wengauthor=N.+L.+Mataauthor=S.+M.+Azarianauthor=R.+T.+Tzekovauthor=D.+G.+Birchauthor=G.+H.+Travis&title=Insights+into+the+function+of+Rim+protein+in+photoreceptors+and+etiology+of+Stargardt%E2%80%99s+disease+from+the+phenotype+in+abcr+knockout+mice&doi=10.1016%2FS0092-8674%2800%2980602-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice</span></div><div class="casAuthors">Weng, Jian; Mata, Nathan L.; Azarian, Sassan M.; Tzekov, Radouil T.; Birch, David G.; Travis, Gabriel H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-23</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rim protein (RmP) is an ABC transporter of unknown function in rod outer segment disks.  The human gene for RmP (ABCR) is affected in several recessive retinal degenerations.  Here, the authors characterize the ocular phenotype in abcr knockout mice.  Mice lacking RmP show delayed dark adaptation, increased all-trans-retinaldehyde (all-trans-RAL) following light exposure, elevated phosphatidylethanolamine (PE) in outer segments, accumulation of the protonated Schiff base complex of all-trans-RAL and PE (N-retinylidene-PE), and striking deposition of a major lipofuscin fluorophore (A2-E) in retinal pigment epithelium (RPE).  These data suggest that RmP functions as an outwardly directed flippase for N-retinylidene-PE.  Delayed dark adaptation is likely due to accumulation in disks of the noncovalent complex between opsin and all-trans-RAL.  Finally, ABCR-mediated retinal degeneration may result from "poisoning" of the RPE due to A2-E accumulation, with secondary photoreceptor degeneration due to loss of the RPE support role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZy7tbqxEaJLVg90H21EOLACvtfcHk0lgPMPUxkdmkbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1Kksbg%253D&md5=27252383bb56fa6b75b66e878eab8ec1</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980602-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980602-9%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DMata%26aufirst%3DN.%2BL.%26aulast%3DAzarian%26aufirst%3DS.%2BM.%26aulast%3DTzekov%26aufirst%3DR.%2BT.%26aulast%3DBirch%26aufirst%3DD.%2BG.%26aulast%3DTravis%26aufirst%3DG.%2BH.%26atitle%3DInsights%2520into%2520the%2520function%2520of%2520Rim%2520protein%2520in%2520photoreceptors%2520and%2520etiology%2520of%2520Stargardt%25E2%2580%2599s%2520disease%2520from%2520the%2520phenotype%2520in%2520abcr%2520knockout%2520mice%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D13%26epage%3D23%26doi%3D10.1016%2FS0092-8674%2800%2980602-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, I.</span></span> <span> </span><span class="NLM_article-title">Deuterium enrichment of vitamin A at the C20 position slows the formation of detrimental vitamin A dimers in wild-type rodents</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">7958</span>– <span class="NLM_lpage">7965</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.178640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1074%2Fjbc.M110.178640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21075840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislylsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=7958-7965&author=Y.+Kaufmanauthor=L.+Maauthor=I.+Washington&title=Deuterium+enrichment+of+vitamin+A+at+the+C20+position+slows+the+formation+of+detrimental+vitamin+A+dimers+in+wild-type+rodents&doi=10.1074%2Fjbc.M110.178640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium Enrichment of Vitamin A at the C20 Position Slows the Formation of Detrimental Vitamin A Dimers in Wild-type Rodents</span></div><div class="casAuthors">Kaufman, Yardana; Ma, Li; Washington, Ilyas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7958-7965</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Degenerative eye diseases are the most common causes of untreatable blindness.  Accumulation of lipofuscin (granular deposits) in the retinal pigment epithelium (RPE) is a hallmark of major degenerative eye diseases such as Stargardt disease, Best disease, and age-related macular degeneration.  The intrinsic reactivity of vitamin A leads to its dimerization and to the formation of pigments such as A2E, and is believed to play a key role in the formation of ocular lipofuscin.  We sought a clin. pragmatic method to slow vitamin A dimerization as a means to elucidate the pathogenesis of macular degenerations and to develop a therapeutic intervention.  We prepd. vitamin A enriched with the stable isotope deuterium at carbon twenty (C20-D3-vitamin A).  Results showed that dimerization of deuterium-enriched vitamin A was considerably slower than that of vitamin A at natural abundance as measured in vitro.  Administration of C20-D3-vitamin A to wild-type rodents with no obvious genetic defects in vitamin A processing, slowed A2E biosynthesis.  This study elucidates the mechanism of A2E biosynthesis and suggests that administration of C20-D3-vitamin A may be a viable, long-term approach to retard vitamin A dimerization and by extension, may slow lipofuscin deposition and the progression of common degenerative eye diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxwDhq5_pVl7Vg90H21EOLACvtfcHk0lhgRF5RcNxM1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislylsbg%253D&md5=e9d667f82e20835a3c737c832e77c896</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.178640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.178640%26sid%3Dliteratum%253Aachs%26aulast%3DKaufman%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWashington%26aufirst%3DI.%26atitle%3DDeuterium%2520enrichment%2520of%2520vitamin%2520A%2520at%2520the%2520C20%2520position%2520slows%2520the%2520formation%2520of%2520detrimental%2520vitamin%2520A%2520dimers%2520in%2520wild-type%2520rodents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D7958%26epage%3D7965%26doi%3D10.1074%2Fjbc.M110.178640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, I.</span></span> <span> </span><span class="NLM_article-title">C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">7966</span>– <span class="NLM_lpage">7974</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.178657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1074%2Fjbc.M110.178657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=21156790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislylsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=7966-7974&author=L.+Maauthor=Y.+Kaufmanauthor=J.+Zhangauthor=I.+Washington&title=C20-D3-vitamin+A+slows+lipofuscin+accumulation+and+electrophysiological+retinal+degeneration+in+a+mouse+model+of+Stargardt+disease&doi=10.1074%2Fjbc.M110.178657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117aR"><div class="casContent"><span class="casTitleNuber">117a</span><div class="casTitle"><span class="NLM_cas:atitle">C20-D3-vitamin A Slows Lipofuscin Accumulation and Electrophysiological Retinal Degeneration in a Mouse Model of Stargardt Disease</span></div><div class="casAuthors">Ma, Li; Kaufman, Yardana; Zhang, Jun-Hua; Washington, Ilyas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7966-7974</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Stargardt disease, also known as juvenile macular degeneration, occurs in approx. one in 10,000 people and results from genetic defects in the ABCA4 gene.  The disease is characterized by premature accumulation of lipofuscin in the retinal pigment epithelium (RPE) of the eye and by vision loss.  No cure or treatment is available.  Although lipofuscin is considered a hallmark of Stargardt disease, its mechanism of formation and its role in disease pathogenesis are poorly understood.  In this work we investigated the effects of long-term administration of D3-enriched vitamin A, C20-D3-vitamin A, on RPE lipofuscin deposition and eye function in a mouse model of Stargardt's disease.  Results support the notion that lipofuscin forms partly as a result of the aberrant reactivity of vitamin A through the formation of vitamin A dimers, provide evidence that preventing vitamin A dimerization may slow disease related, retinal physiol. changes and perhaps vision loss and suggest that administration of C20-D3-vitamin A may be a potential clin. strategy to ameliorate clin. symptoms resulting from ABCA4 genetic defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwr5N5Cud57Vg90H21EOLACvtfcHk0lhgRF5RcNxM1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislylsbk%253D&md5=f1edbe3819d5b754b6a38025faf7f9b4</span></div><a href="/servlet/linkout?suffix=cit117a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.178657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.178657%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DKaufman%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWashington%26aufirst%3DI.%26atitle%3DC20-D3-vitamin%2520A%2520slows%2520lipofuscin%2520accumulation%2520and%2520electrophysiological%2520retinal%2520degeneration%2520in%2520a%2520mouse%2520model%2520of%2520Stargardt%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D7966%26epage%3D7974%26doi%3D10.1074%2Fjbc.M110.178657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit117b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Charbel Issa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washington, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLaren, R. E.</span></span> <span> </span><span class="NLM_article-title">Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">8415</span>– <span class="NLM_lpage">8420</span>, <span class="refDoi"> DOI: 10.1073/pnas.1506960112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1073%2Fpnas.1506960112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=26106163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADC%252BC2MbmsVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=8415-8420&author=P.+Charbel+Issaauthor=A.+R.+Barnardauthor=P.+Herrmannauthor=I.+Washingtonauthor=R.+E.+MacLaren&title=Rescue+of+the+Stargardt+phenotype+in+Abca4+knockout+mice+through+inhibition+of+vitamin+A+dimerization&doi=10.1073%2Fpnas.1506960112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117bR"><div class="casContent"><span class="casTitleNuber">117b</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization</span></div><div class="casAuthors">Charbel Issa Peter; Barnard Alun R; Herrmann Philipp; Washington Ilyas; MacLaren Robert E</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">8415-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Stargardt disease, an ATP-binding cassette, subfamily A, member 4 (ABCA4)-related retinopathy, is a genetic condition characterized by the accelerated accumulation of lipofuscin in the retinal pigment epithelium, degeneration of the neuroretina, and loss of vision.  No approved treatment exists.  Here, using a murine model of Stargardt disease, we show that the propensity of vitamin A to dimerize is responsible for triggering the formation of the majority of lipofuscin and transcriptional dysregulation of genes associated with inflammation.  Data further demonstrate that replacing vitamin A with vitamin A deuterated at the carbon 20 position (C20-D3-vitamin A) impedes the dimerization rate of vitamin A--by approximately fivefold for the vitamin A dimer A2E--and subsequent lipofuscinogenesis and normalizes the aberrant transcription of complement genes without impairing retinal function.  Phenotypic rescue by C20-D3-vitamin A was also observed noninvasively by quantitative autofluorescence, an imaging technique used clinically, in as little as 3 months after the initiation of treatment, whereas upon interruption of treatment, the age-related increase in autofluorescence resumed.  Data suggest that C20-D3-vitamin A is a clinically amiable tool to inhibit vitamin A dimerization, which can be used to determine whether slowing the dimerization of vitamin A can prevent vision loss caused by Stargardt disease and other retinopathies associated with the accumulation of lipofuscin in the retina.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbMx_OWblUPoYPsCkJIw00fW6udTcc2ea6cRMZVmJUV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MbmsVSqsg%253D%253D&md5=dead140a5a2719fea37d79fb65bf60ae</span></div><a href="/servlet/linkout?suffix=cit117b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1506960112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1506960112%26sid%3Dliteratum%253Aachs%26aulast%3DCharbel%2BIssa%26aufirst%3DP.%26aulast%3DBarnard%26aufirst%3DA.%2BR.%26aulast%3DHerrmann%26aufirst%3DP.%26aulast%3DWashington%26aufirst%3DI.%26aulast%3DMacLaren%26aufirst%3DR.%2BE.%26atitle%3DRescue%2520of%2520the%2520Stargardt%2520phenotype%2520in%2520Abca4%2520knockout%2520mice%2520through%2520inhibition%2520of%2520vitamin%2520A%2520dimerization%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D8415%26epage%3D8420%26doi%3D10.1073%2Fpnas.1506960112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Hogan, K.</span>; <span class="NLM_string-name">Qin, S.</span>; <span class="NLM_string-name">Liu, J. F.</span>; <span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Bridson, G. W.</span>; <span class="NLM_string-name">Graham, P.</span>; <span class="NLM_string-name">Tung, R.</span>; <span class="NLM_string-name">Wu, L.</span></span> <span> </span><span class="NLM_article-title">CTP-499, a Novel Drug for the Potential Treatment of Chronic Kidney Disease, Has Anti-Fibrotic, Anti-Inflammatory, and Anti-Oxidative Activities with In Vivo Efficacy</span>. Presented at the American Society of Nephrology (ASN) Kidney Week Meeting 2011, Philadelphia, PA, November 8–13, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Aslanian&author=K.+Hogan&author=S.+Qin&author=J.+F.+Liu&author=C.+Cheng&author=G.+W.+Bridson&author=P.+Graham&author=R.+Tung&author=L.+Wu&title=CTP-499%2C+a+Novel+Drug+for+the+Potential+Treatment+of+Chronic+Kidney+Disease%2C+Has+Anti-Fibrotic%2C+Anti-Inflammatory%2C+and+Anti-Oxidative+Activities+with+In+Vivo+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAslanian%26aufirst%3DA.%26atitle%3DCTP-499%252C%2520a%2520Novel%2520Drug%2520for%2520the%2520Potential%2520Treatment%2520of%2520Chronic%2520Kidney%2520Disease%252C%2520Has%2520Anti-Fibrotic%252C%2520Anti-Inflammatory%252C%2520and%2520Anti-Oxidative%2520Activities%2520with%2520In%2520Vivo%2520Efficacy%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit118b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Hogan, K.</span>; <span class="NLM_string-name">West, K.</span>; <span class="NLM_string-name">Bridson, G.</span>; <span class="NLM_string-name">Wu, L.</span></span> <span> </span><span class="NLM_article-title">CTP-499, a Novel Drug for the Treatment of Chronic Kidney Disease, Ameliorates Renal Fibrosis and Inflammation In Vivo</span>. Presented at the American Society of Nephrology (ASN) Kidney Week 2012, San Diego, CA, October 30–November 4, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Aslanian&author=K.+Hogan&author=K.+West&author=G.+Bridson&author=L.+Wu&title=CTP-499%2C+a+Novel+Drug+for+the+Treatment+of+Chronic+Kidney+Disease%2C+Ameliorates+Renal+Fibrosis+and+Inflammation+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAslanian%26aufirst%3DA.%26atitle%3DCTP-499%252C%2520a%2520Novel%2520Drug%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Kidney%2520Disease%252C%2520Ameliorates%2520Renal%2520Fibrosis%2520and%2520Inflammation%2520In%2520Vivo%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parasrampuria, D.</span>; <span class="NLM_string-name">Braman, V.</span>; <span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Grotbeck, B.</span>; <span class="NLM_string-name">Turnquist, D.</span>; <span class="NLM_string-name">Hogan, K.</span>; <span class="NLM_string-name">Aslanian, A.</span>; <span class="NLM_string-name">Wu, L.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Zelle, R.</span>; <span class="NLM_string-name">Graham, P.</span>; <span class="NLM_string-name">Shipley, J.</span>; <span class="NLM_string-name">Tung, R.</span></span> <span> </span><span class="NLM_article-title">First Human Exposure Suggests a Unique Metabolic Profile with Multiple Active Species for CTP-499, a Novel Agent for Treatment of Chronic Kidney Disease</span>. Presented at the American Society of Nephrology (ASN) Kidney Week Meeting, Philadelphia, PA, November 8–13, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Parasrampuria&author=V.+Braman&author=C.+Cheng&author=B.+Grotbeck&author=D.+Turnquist&author=K.+Hogan&author=A.+Aslanian&author=L.+Wu&author=J.+Liu&author=R.+Zelle&author=P.+Graham&author=J.+Shipley&author=R.+Tung&title=First+Human+Exposure+Suggests+a+Unique+Metabolic+Profile+with+Multiple+Active+Species+for+CTP-499%2C+a+Novel+Agent+for+Treatment+of+Chronic+Kidney+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DParasrampuria%26aufirst%3DD.%26atitle%3DFirst%2520Human%2520Exposure%2520Suggests%2520a%2520Unique%2520Metabolic%2520Profile%2520with%2520Multiple%2520Active%2520Species%2520for%2520CTP-499%252C%2520a%2520Novel%2520Agent%2520for%2520Treatment%2520of%2520Chronic%2520Kidney%2520Disease%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnquist, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harnett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabounjian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, J.</span></span> <span> </span><span class="NLM_article-title">A randomized phase I evaluation of CTP-499, a novel deuterium-containing drug candidate for diabetic nephropathy</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1002/cpdd.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fcpdd.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27121560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=53-66&author=V.+Bramanauthor=P.+Grahamauthor=C.+Chengauthor=D.+Turnquistauthor=M.+Harnettauthor=L.+Sabounjianauthor=J.+Shipley&title=A+randomized+phase+I+evaluation+of+CTP-499%2C+a+novel+deuterium-containing+drug+candidate+for+diabetic+nephropathy&doi=10.1002%2Fcpdd.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase I evaluation of CTP-499, a novel deuterium-containing drug candidate for diabetic nephropathy</span></div><div class="casAuthors">Braman, Virginia; Graham, Philip; Cheng, Changfu; Turnquist, David; Harnett, Mark; Sabounjian, LuAnn; Shipley, James</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-66</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. max. tolerated dose and food effect for CTP-499, a novel agent being studied for the treatment of diabetic kidney disease.  CTP-499 has demonstrated anti-inflammatory, anti-fibrotic and anti-oxidative activities in vitro as well as anti-inflammatory and renoprotective effects in a diabetic nephropathy (DN) model.  Two studies were performed.  Study 1 was a single-dose escalation study with 600, 1200, 1800, and 2400 mg doses of controlled-release (CR) CTP-499 and a 400 mg immediate release dose to aid in the development of prototype formulations of CTP-499.  Study 2 was a food-effect study.  Plasma concns. of CTP-499 and its metabolites were measured to det. pharmacokinetic parameters in each study.  Safety was assessed to det. tolerability.  Doses up to and including 1800 mg were well tolerated.  Cmax was either equiv. (CTP-499) or slightly lower (metabolites) for the fed condition, while overall exposure was equiv. (CTP-499) or slightly higher (metabolites) for the fed condition.  The range of tolerated doses of CTP-499 and the effects of food on exposure were identified, contributing to selection of the dose for Phase II development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo4De1hQV0irVg90H21EOLACvtfcHk0lgbtL6WbyU_cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLbE&md5=d02f89105fee1176c0363f5a5eccfb18</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.3%26sid%3Dliteratum%253Aachs%26aulast%3DBraman%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DTurnquist%26aufirst%3DD.%26aulast%3DHarnett%26aufirst%3DM.%26aulast%3DSabounjian%26aufirst%3DL.%26aulast%3DShipley%26aufirst%3DJ.%26atitle%3DA%2520randomized%2520phase%2520I%2520evaluation%2520of%2520CTP-499%252C%2520a%2520novel%2520deuterium-containing%2520drug%2520candidate%2520for%2520diabetic%2520nephropathy%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2013%26volume%3D2%26spage%3D53%26epage%3D66%26doi%3D10.1002%2Fcpdd.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabounjian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neutel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, M.</span></span> <span> </span><span class="NLM_article-title">A first-in-patient, multicenter, double-blind, 2-arm, placebo-controlled, randomized safety and tolerability study of a novel oral drug candidate, CTP-499, in chronic kidney disease</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1002/cpdd.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1002%2Fcpdd.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27310332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvV2gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=314-325&author=L.+Sabounjianauthor=P.+Grahamauthor=L.+Wuauthor=V.+Bramanauthor=C.+Chengauthor=J.+Liuauthor=J.+Shipleyauthor=J.+Neutelauthor=M.+Dao&title=A+first-in-patient%2C+multicenter%2C+double-blind%2C+2-arm%2C+placebo-controlled%2C+randomized+safety+and+tolerability+study+of+a+novel+oral+drug+candidate%2C+CTP-499%2C+in+chronic+kidney+disease&doi=10.1002%2Fcpdd.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease</span></div><div class="casAuthors">Sabounjian, LuAnn; Graham, Philip; Wu, Lijun; Braman, Virginia; Cheng, Changfu; Liu, Julie; Shipley, James; Neutel, Joel; Dao, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-325</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The prevalence of chronic kidney disease (CKD) related to type 2 diabetes is increasing worldwide.  In addn. to std. of care, treatment with anti-inflammatory and antifibrotic agents such as CTP-499, a novel oral, multisubtype selective inhibitor of phosphodiesterases, may be important in CKD treatment.  A phase 1b randomized, double-blind, placebo-controlled clin. trial of CTP-499 in CKD patients (25 active, 8 placebo) with an estd. glomerular filtration rate of 30-59 mL/min/1.73 m2 was conducted to assess safety and tolerability.  Secondary outcomes included pharmacokinetics and exploratory effects on inflammatory and hematol. markers.  Patients received 600 mg CTP-499 or matching placebo tablets orally once daily for 2 wk, then twice daily for 2 addnl. weeks.  CTP-499 was well tolerated with no serious or severe adverse events, or adverse events leading to discontinuation.  CTP-499 was rapidly absorbed and produced acceptable interpatient variability.  Of the 5 metabolites (M1-M5), M5 was the most abundant in plasma and urine.  Exposure to CTP-499 and metabolites was higher in CKD patients than previously reported in healthy volunteers.  No statistically significant differences were detected between the CTP-499- and placebo-treated groups for any of the biomarkers tested.  This study provides data supporting further evaluation of CTP-499 in CKD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39ABdKmZnibVg90H21EOLACvtfcHk0lgbtL6WbyU_cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvV2gs7s%253D&md5=f7accb0d8439bfe45d2c52c6490c8206</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.241%26sid%3Dliteratum%253Aachs%26aulast%3DSabounjian%26aufirst%3DL.%26aulast%3DGraham%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBraman%26aufirst%3DV.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DShipley%26aufirst%3DJ.%26aulast%3DNeutel%26aufirst%3DJ.%26aulast%3DDao%26aufirst%3DM.%26atitle%3DA%2520first-in-patient%252C%2520multicenter%252C%2520double-blind%252C%25202-arm%252C%2520placebo-controlled%252C%2520randomized%2520safety%2520and%2520tolerability%2520study%2520of%2520a%2520novel%2520oral%2520drug%2520candidate%252C%2520CTP-499%252C%2520in%2520chronic%2520kidney%2520disease%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2016%26volume%3D5%26spage%3D314%26epage%3D325%26doi%3D10.1002%2Fcpdd.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherdale, S. T.</span></span> <span> </span><span class="NLM_article-title">Stable isotopes in clinical research: safety reaffirmed</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1042/cs0800277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1042%2Fcs0800277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1851061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A280%3ADyaK3M3itlOlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1991&pages=277-280&author=P.%0AJ.+Jonesauthor=S.+T.+Leatherdale&title=Stable+isotopes+in+clinical+research%3A+safety+reaffirmed&doi=10.1042%2Fcs0800277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Stable isotopes in clinical research: safety reaffirmed</span></div><div class="casAuthors">Jones P J; Leatherdale S T</div><div class="citationInfo"><span class="NLM_cas:title">Clinical science (London, England : 1979)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-80</span>
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    </div><div class="casAbstract">Approaching half a century of stable-isotope usage in human metabolic studies has been without documented significant adverse effect.  Side-effects with acute D dosing are transitory with no demonstrated evidence of permanent deleterious action.  The threshold of D toxicity has been defined in animals and is far in excess of concentrations conceivably used in human studies.  The possibility that D may have additional beneficial pharmacological applications cannot be excluded.  For isotopes other than D, evidence of observed toxicity remains to be produced even at dosages far in excess of the range used in metabolic studies.  Absence of adverse effect may be attributable to small mass differences and the similar properties of tracer and predominantly abundant isotope.  Absolute determination of stable isotope toxicity in humans is rendered impossible by ethical considerations.  Also, the precision of extrapolating toxicity thresholds from animal studies remains unknown.  However, should perturbation of the delicate homoeostatic characteristic of living organisms occur with use of stable isotopes, it is almost undoubtedly at some level of administration greatly in excess of those administered currently in biomedical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoe27cQnGfu-WhZTslLrfffW6udTcc2eagvD0uh-NlQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3itlOlug%253D%253D&md5=9c8238257b48d73340a84c6d5c322ec6</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1042%2Fcs0800277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fcs0800277%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BJ.%26aulast%3DLeatherdale%26aufirst%3DS.%2BT.%26atitle%3DStable%2520isotopes%2520in%2520clinical%2520research%253A%2520safety%2520reaffirmed%26jtitle%3DClin.%2520Sci.%26date%3D1991%26volume%3D80%26spage%3D277%26epage%3D280%26doi%3D10.1042%2Fcs0800277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit122b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bila, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamounier, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everton de Freitas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra de Oliveira, J. E.</span></span> <span> </span><span class="NLM_article-title">Stable isotopes and body composition in children: History, fundamentals, and clinical applications</span>. <i>Health</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.4236/health.2013.58A3009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.4236%2Fhealth.2013.58A3009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=61-68&author=W.+C.+Bilaauthor=J.+A.+Lamounierauthor=A.+Everton+de+Freitasauthor=V.+R.+Silvaauthor=S.+D.+Turaniauthor=J.+E.+Dutra+de+Oliveira&title=Stable+isotopes+and+body+composition+in+children%3A+History%2C+fundamentals%2C+and+clinical+applications&doi=10.4236%2Fhealth.2013.58A3009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122b&amp;dbid=16384&amp;doi=10.4236%2Fhealth.2013.58A3009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fhealth.2013.58A3009%26sid%3Dliteratum%253Aachs%26aulast%3DBila%26aufirst%3DW.%2BC.%26aulast%3DLamounier%26aufirst%3DJ.%2BA.%26aulast%3DEverton%2Bde%2BFreitas%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DV.%2BR.%26aulast%3DTurani%26aufirst%3DS.%2BD.%26aulast%3DDutra%2Bde%2BOliveira%26aufirst%3DJ.%2BE.%26atitle%3DStable%2520isotopes%2520and%2520body%2520composition%2520in%2520children%253A%2520History%252C%2520fundamentals%252C%2520and%2520clinical%2520applications%26jtitle%3DHealth%26date%3D2013%26volume%3D5%26spage%3D61%26epage%3D68%26doi%3D10.4236%2Fhealth.2013.58A3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Deuterated drugs draw heavier backing</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=10.1038%2Fnrd.2016.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=27032821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=219-221&author=A.+Mullard&title=Deuterated+drugs+draw+heavier+backing&doi=10.1038%2Fnrd.2016.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs draw heavier backing</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The FDA is considering a first approval of a deuterated drug, and large pharmaceutical companies have started to incorporate 'heavy hydrogen' into novel candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvu-ucz_PqFbVg90H21EOLACvtfcHk0ljjHip8wKVe0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlWjtLk%253D&md5=8c61bbc57d480f91b59d197894a771d5</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.63%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DDeuterated%2520drugs%2520draw%2520heavier%2520backing%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D219%26epage%3D221%26doi%3D10.1038%2Fnrd.2016.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01808&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01808%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01808" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990183ab49d1b3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
